,CUI1,CUI2,label
0,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8,0
1,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleural Schwannoma,0
2,Abundance of Small Lymphocytes,Small Intestinal Signet Ring Cell Carcinoma,0
3,Fenestrated Pattern,Neurofibromatosis 2,0
4,Progressive Clinical Course,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,0
5,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Intermediate Atypical Prostate Carcinoma,0
6,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0
7,Large Spaces Filled with Blood Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),0
8,Increased megakaryocytes (bone marrow),Locally Advanced Pancreatic Ductal Adenocarcinoma,0
9,Fenestrated Pattern,Anal Ectopic Fibroadenoma,0
10,Mixed Neoplastic Glandular and Squamous Cell Population,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11,Blasts Expressing CD56 and Immature T-Cell Markers Present,Immature Gastric Teratoma,0
12,Eccrine Differentiation,Benign Breast Eccrine Spiradenoma,0
13,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of blood vessel,0
14,Increased megakaryocytes (bone marrow),Philadelphia-Positive Myelogenous Leukemia,0
15,Recurrent Malignant Neoplasm,Penile Urethral Malignant Neoplasm,0
16,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelioid glioblastoma,0
17,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
18,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyoma of extrahepatic bile duct,0
19,Hypertensive disease,Fox Fordyce disease,0
20,Absence of Malignant Features,Benign tumor of external ear,0
21,Endometrial Type Glands and Stroma Present,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",0
22,Glandular Differentiation,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation,0
23,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Localized Extrahepatic Bile Duct Carcinoma,0
24,Increased megakaryocytes (bone marrow),Nodular Sclerosis Classical Hodgkin Lymphoma,0
25,Solar Radiation Toxicity,Secondary Central Chondrosarcoma,0
26,Breast Implant-Related Lesion,Occult Breast Carcinoma,0
27,Recurrent Malignant Neoplasm,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,0
28,Absence of Malignant Features,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,0
29,Malignant Primitive Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,0
30,Mature Neutrophils Present,Mature Gastric Teratoma,0
31,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,0
32,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Gastric Neuroendocrine Carcinoma,0
33,Nodular and Diffuse Pattern,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
34,Increased megakaryocytes (bone marrow),Thyroid Gland Hyperfunctioning Adenoma,0
35,Human Papillomavirus Positive,Hormone Receptor Positive Breast Carcinoma,0
36,Increased megakaryocytes (bone marrow),Stage IB Vulvar Carcinoma AJCC v6,0
37,Malignant Primitive Cellular Infiltrate,Malignant Neoplasms,0
38,Solar Radiation Toxicity,Mucin-producing adenocarcinoma,0
39,Well Differentiated Hyaline Cartilage Present,Advanced Well Differentiated Neuroendocrine Neoplasm,0
40,Solar Radiation Toxicity,Cholangiocarcinoma non-resectable,0
41,Intersecting Sharply Marginated Clusters of Spindle Cells Present,ductal papilloma of salivary gland,0
42,Increased megakaryocytes (bone marrow),Stage IIIC Eyelid Carcinoma AJCC v7,0
43,Recurrent Genetic Abnormalities Present,Recurrent WHO Grade III Glioma,0
44,Moderately Differentiated Lesion,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
45,Squamous metaplasia of bladder,Squamous Cell Carcinoma of Unknown Primary,0
46,Increased megakaryocytes (bone marrow),Stage IIIC Uterine Corpus Cancer AJCC v7,0
47,Melanoma Cells Present,Stage IIIA Cutaneous Melanoma AJCC v7,0
48,Endometrial Type Glands and Stroma Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,0
49,Absence of Malignant Features,leiomyosarcoma of extrahepatic bile duct,0
50,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleural Lymphoma,0
51,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Unfavorable Prognosis Hodgkin Lymphoma,0
52,Solar Radiation Toxicity,Burkitt Leukemia,0
53,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Synovial Neoplasm,0
54,Intersecting Sharply Marginated Clusters of Spindle Cells Present,yolk sac tumor of mediastinum,0
55,Large Spaces Filled with Blood Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
56,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Jejunal Neuroendocrine Tumor G1,0
57,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Conventional Cardiac Rhabdomyoma,0
58,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,0
59,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
60,High Grade Lesion,High Grade Appendix Mucinous Adenocarcinoma,0
61,Solar Radiation Toxicity,"Ichthyosis, X-Linked",0
62,Fenestrated Pattern,Stage IV Adult Liver Cancer AJCC v7,0
63,Fenestrated Pattern,"Serous cystadenoma, borderline malignancy",0
64,Large Spaces Filled with Blood Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
65,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Supraglottic Verrucous Carcinoma,0
66,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Osteosarcoma AJCC v7,0
67,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Brain Medulloblastoma,0
68,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Rectosigmoid Cancer AJCC v6 and v7,0
69,Cervical lymphadenopathy,Cervical Squamous Intraepithelial Neoplasia,0
70,Increased megakaryocytes (bone marrow),Stage III Hepatocellular Carcinoma AJCC v8,0
71,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Acute Megakaryoblastic Leukemia,0
72,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Vaginal Cancer AJCC v8,0
73,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Blastema Predominant Kidney Wilms Tumor,0
74,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal Cancer by AJCC v8 Stage,0
75,Multihormonal Immunoreactivity Present in a Single Cell Type,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
76,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
77,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Uterine Corpus Cancer AJCC v6,0
78,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mixed Tumor of the Major Salivary Gland,0
79,Intraepithelial Neoplasia,Intraepithelial Squamous Cell Carcinoma,0
80,Malignant Primitive Cellular Infiltrate,Malignant Testicular Leydig Cell Tumor,0
81,Solar Radiation Toxicity,"Cystadenoma, Mucinous",0
82,Recurrent Genetic Abnormalities Present,Recurrent Childhood Brain Stem Astrocytoma,0
83,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Central Nervous System Germ Cell Tumor,0
84,Solitary Skin Tumor,Dedifferentiated Solitary Fibrous Tumor,0
85,Absence of Malignant Features,leiomyosarcoma of vagina,0
86,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Refractory Primary Lymphoma of Bone,0
87,Solar Radiation Toxicity,Vaginal Tubulovillous Adenoma,0
88,Increased megakaryocytes (bone marrow),Bile duct cystadenoma,0
89,Low Grade Neuroendocrine Lesion,Low Grade Salivary Gland Mucoepidermoid Carcinoma,0
90,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neuroblastoma recurrent,0
91,Mediastinal mass,Mediastinal Leiomyoma,0
92,Fenestrated Pattern,Cervix carcinoma,0
93,Increased megakaryocytes (bone marrow),Broad Ligament Serous Cystadenoma,0
94,Malignant Primitive Cellular Infiltrate,Cellular fibroma,0
95,Endometrial Type Glands and Stroma Present,Stage IIC Testicular Cancer AJCC v6 and v7,0
96,Increased megakaryocytes (bone marrow),Stage II Rectal Cancer AJCC v7,0
97,Inoperable Disease,Hallopeau-Siemens Disease,0
98,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sex Hormone-Producing Adrenal Cortex Adenoma,0
99,Melanoma Cells Present,Stage IB Cutaneous Melanoma AJCC v7,0
100,Fenestrated Pattern,Colorectal Microvesicular Hyperplastic Polyp,0
101,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Nasopharyngeal Carcinoma,0
102,Cervical lymphadenopathy,Stage IVA Cervical Cancer AJCC v8,0
103,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
104,Fried-Egg Appearance of the Bone Marrow,Refractory Primary Lymphoma of Bone,0
105,Increased megakaryocytes (bone marrow),Philadelphia-Positive Myelogenous Leukemia,0
106,Metaplasia of Malignant Cells Present,Malignant neoplasm of sweat gland,0
107,Increased megakaryocytes (bone marrow),Acute promyelocytic leukemia - hypogranular variant,0
108,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,0
109,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic neuroendocrine tumor metastatic,0
110,Increased megakaryocytes (bone marrow),Uterine Carcinosarcoma,0
111,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of oropharynx,0
112,Recurrent Malignant Neoplasm,Refractory Malignant Head and Neck Neoplasm,0
113,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Ovarian Dermoid Cyst with Leiomyosarcoma,0
114,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
115,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Cervical Basaloid Carcinoma,0
116,Intravascular papillary endothelial hyperplasia,Clear cell papillary renal cell carcinoma,0
117,Abundance of Small Lymphocytes,Small plaque parapsoriasis,0
118,Fenestrated Pattern,Multiple Intraspinal Meningiomas,0
119,Fenestrated Pattern,"Lymphoma, T-Cell, Cutaneous",0
120,White blood cell count increased (lab result),Stage III renal cell cancer,0
121,Fenestrated Pattern,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,0
122,Fenestrated Pattern,Testicular gonadoblastoma,0
123,Increased megakaryocytes (bone marrow),Lung Mucinous Adenocarcinoma In Situ,0
124,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Hepatocellular Carcinoma AJCC v7,0
125,Solar Radiation Toxicity,Stage IB Fallopian Tube Cancer AJCC v8,0
126,Non-Encapsulated Neoplasm,Unresectable Solid Neoplasm,0
127,Solar Radiation Toxicity,Stage IIIC Adult Liver Cancer AJCC v7,0
128,Spindle Cell Metaplasia of Malignant Cells Present,Endometrial Small Cell Carcinoma,0
129,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Angiosarcoma Associated with Lymphedema,0
130,Increased megakaryocytes (bone marrow),Refractory Leukemia,0
131,Large Spaces Filled with Blood Present,Refractory anemia with excess blasts I,0
132,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Recurrent Ovarian Clear Cell Adenocarcinoma,0
133,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Fibroma,0
134,Fenestrated Pattern,"Neoplasms, Therapy-Associated",0
135,Solar Radiation Toxicity,"Adenocarcinoma, metastatic",0
136,Endometrial Type Glands and Stroma Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
137,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Focal Epithelial Hyperplasia,0
138,Fenestrated Pattern,Strumal carcinoid,0
139,Tumor Mass,Adult Yolk Sac Tumor,0
140,Intracytoplasmic Eosinophilic Spherical Inclusion,Eosinophilic Granuloma,0
141,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IIIB Testicular Cancer AJCC v6 and v7,0
142,Spindle Cell Metaplasia of Malignant Cells Present,Digestive System Small Cell Neuroendocrine Carcinoma,0
143,Exposure to asbestos,Contact dermatitis due to alkali,0
144,High Grade Non Cartilaginous Sarcomatous Stroma Present,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
145,Bone Marrow Involvement,Localized Bone Ewing Sarcoma,0
146,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Gemistocytic Astrocytoma,0
147,Tumor Mass,Supratentorial Ependymal Tumor,0
148,Increased megakaryocytes (bone marrow),Unresectable Leiomyosarcoma,0
149,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Subcutaneous Disorder,0
150,Large Spaces Filled with Blood Present,Common Variant Anaplastic Large Cell Lymphoma,0
151,"Undifferentiated ""Fetal-Type"" Tissues Present",Prostate Undifferentiated Carcinoma,0
152,Recurrent Genetic Abnormalities Present,"Recurrent Medulloblastoma, SHH-Activated",0
153,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cigarette Smoking-Related Carcinoma,0
154,Solar Radiation Toxicity,Gardner Fibroma,0
155,Villous Projections of the Neoplastic Epithelium Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
156,Cartilaginous Metaplasia of Malignant Cells Present,Cartilaginous exostosis,0
157,Diffuse Cellular Infiltrate,Thyroid Diffuse Large B-Cell Lymphoma,0
158,Nodular and Diffuse Pattern,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,0
159,Solitary Skin Tumor,Recurrent Ependymal Tumor,0
160,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
161,Increased megakaryocytes (bone marrow),Pleural Desmoplastic Mesothelioma,0
162,Fenestrated Pattern,Ureteric polyp,0
163,High Grade Lesion,High Grade Intraepithelial Neoplasia,0
164,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Struma Ovarii,0
165,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Distal Esophagus Adenocarcinoma,0
166,Small Lesion,Stage IIIA Small Intestinal Adenocarcinoma AJCC v8,0
167,Solar Radiation Toxicity,Ependymoblastoma,0
168,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intrahepatic Cholangiocarcinoma,0
169,Solar Radiation Toxicity,Thymolipoma,0
170,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
171,Intraepithelial Neoplasia,Multiple Endocrine Neoplasia,0
172,Fenestrated Pattern,Myofibroblastoma,0
173,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Diffuse large B-cell lymphoma of central nervous system,0
174,Glandular cell atypia,"Leydig cell tumor, benign",0
175,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Lung Non-Small Cell Carcinoma,0
176,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0
177,No Evidence of Metastatic Disease,Metastatic Unresectable Gastric Adenocarcinoma,0
178,Endometrial Type Glands and Stroma Present,Recurrent Endometrial Undifferentiated Carcinoma,0
179,Nodular and Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
180,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Childhood Testicular Mature Teratoma,0
181,Absence of Malignant Features,Malignant Gastric Gastrointestinal Stromal Tumor,0
182,Recurrent Genetic Abnormalities Present,Recurrent Ureter Carcinoma,0
183,Clear Perinuclear Halo Present,Clear cell odontogenic carcinoma,0
184,Absence of Malignant Features,Asbestos-Related Malignant Mesothelioma,0
185,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cavernous hemangioma of the face,0
186,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Breast Adenomyoepithelioma,0
187,Spindle Cell Metaplasia of Malignant Cells Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
188,Fenestrated Pattern,Lung Mucinous Cystadenoma,0
189,Large Spaces Filled with Blood Present,Acute panmyelosis with myelofibrosis,0
190,Solar Radiation Toxicity,Stage IV Lung Cancer AJCC v7,0
191,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Endodermal sinus tumor of ovary,0
192,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,0
193,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
194,Mammary Gland Type Features Present,Functioning Pituitary Gland Microadenoma,0
195,Increased megakaryocytes (bone marrow),Adult Leiomyosarcoma,0
196,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of eye,0
197,Fenestrated Pattern,Urothelial Hyperplasia,0
198,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Liposarcoma,0
199,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cavernous hemangioma of retina,0
200,White blood cell count increased (lab result),Adenosquamous cell lung cancer,0
201,Tumor Mass,Stage IIB Gestational Trophoblastic Tumor AJCC v7,0
202,Spindle Cell Metaplasia of Malignant Cells Present,Polyp of external auditory meatus,0
203,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
204,Fenestrated Pattern,Craniopharyngioma,0
205,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphangitis carcinomatosa,0
206,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,0
207,Melanoma Cells Present,Recurrent Uveal Melanoma,0
208,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Cancer by AJCC v8 Stage,0
209,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,0
210,Solar Radiation Toxicity,Stage 0 Gallbladder Cancer AJCC v8,0
211,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Diffuse Laminar Endocervical Hyperplasia,0
212,Primary Site Unspecified,Overt Primary Myelofibrosis,0
213,Recurrent Malignant Neoplasm,Recurrent Uterine Corpus Carcinoma,0
214,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse follicle center lymphoma,0
215,Absence of Malignant Features,Fibrous histiocytoma of tendon sheath,0
216,Low Grade Cartilaginous Component Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
217,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bile duct adenocarcinoma resectable,0
218,High Grade Lesion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
219,Locally Aggressive Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
220,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,0
221,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
222,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of subglottis,0
223,Solitary Skin Tumor,Parietal Lobe Ependymal Tumor,0
224,Melanoma Cells Present,Cutaneous Melanoma by AJCC v6 Stage,0
225,Spindle Cell Metaplasia of Malignant Cells Present,hepatoid adenocarcinoma of gallbladder,0
226,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,0
227,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Mucinous Adenocarcinoma,0
228,Low Grade Neuroendocrine Lesion,Grade 3 Rectal Adenocarcinoma,0
229,Nodular lesions,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
230,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ampulla of Vater Villous Adenoma,0
231,Primary Lesion,Primary mediastinal large B-cell lymphoma stage I,0
232,Solar Radiation Toxicity,Adult Brain Medulloblastoma,0
233,Solar Radiation Toxicity,Neurofibromatosis aggravated,0
234,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
235,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIC Appendix Carcinoma AJCC v7,0
236,Breast Implant-Related Lesion,Prognostic Stage IIIB Breast Cancer AJCC v8,0
237,Absence of Malignant Features,basaloid squamous cell carcinoma of vulva,0
238,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Hodgkin Lymphoma,0
239,Multicentric Lesion,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
240,Solar Radiation Toxicity,Nodal marginal zone B-cell lymphoma stage III,0
241,Gastric dysplasia,Gastric Hemangioma,0
242,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma in situ of trachea,0
243,Spindle Cell Metaplasia of Malignant Cells Present,Adult Systemic Anaplastic Large Cell Lymphoma,0
244,Solar Radiation Toxicity,Stage II Adult Burkitt Lymphoma,0
245,Fenestrated Pattern,Retinoma,0
246,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Parotid Gland Warthin Tumor,0
247,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Recurrent Digestive System Neuroendocrine Carcinoma,0
248,Florid Follicular Hyperplasia,Nodular Bartholin Gland Hyperplasia,0
249,Mixture of Embryonal and Alveolar Features Present,Adult Central Nervous System Embryonal Carcinoma,0
250,Increased megakaryocytes (bone marrow),Adult Brain Ependymoma,0
251,Increased megakaryocytes (bone marrow),Stage II Laryngeal Cancer AJCC v8,0
252,Increased megakaryocytes (bone marrow),Stage III Oropharyngeal Carcinoma AJCC v6,0
253,Increased megakaryocytes (bone marrow),Lipoblastoma,0
254,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Primary malignant neoplasm of pericardium,0
255,Schwannian Stroma More than 50 Percent of the Tumor Volume,Jejunal Neuroendocrine Tumor G1,0
256,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anatomic Stage IIA Breast Cancer AJCC v8,0
257,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Head and Neck Carcinoma,0
258,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,FIGO Stage III Carcinoma of the Fallopian Tube,0
259,Human Papillomavirus Negative,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0
260,Spindle Cell Metaplasia of Malignant Cells Present,Primary malignant neoplasm of oculomotor nerve,0
261,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,0
262,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Spindle cell hemangioma,0
263,Fenestrated Pattern,BCLC Stage 0 Hepatocellular Carcinoma,0
264,Increased megakaryocytes (bone marrow),Locally Advanced Digestive System Carcinoma,0
265,Fenestrated Pattern,Ovarian cancer stage III,0
266,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Bladder Cancer by AJCC v7 Stage,0
267,Increased megakaryocytes (bone marrow),Lugano Classification Stage III Hodgkin Lymphoma AJCC v8,0
268,Intersecting Sharply Marginated Clusters of Spindle Cells Present,large cell neuroendocrine carcinoma of appendix,0
269,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Ovarian Transitional Cell Carcinoma,0
270,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IC Uterine Corpus Cancer AJCC v6,0
271,Increased megakaryocytes (bone marrow),Vulvar Seborrheic Keratosis,0
272,Fenestrated Pattern,Intracanalicular fibroadenoma,0
273,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Gastric Soft Tissue Neoplasm,0
274,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Kidney Mixed Epithelial and Stromal Tumor Family,0
275,Distortion of the Hair Follicle,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
276,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Salivary duct carcinoma,0
277,Absence of Malignant Features,Malignant neoplasm of appendix,0
278,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pityriasis Lichenoides,0
279,Intravascular papillary endothelial hyperplasia,Atypical adenomatous hyperplasia,0
280,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Coronary Venous Dissection,0
281,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Familial Nonmedullary Thyroid Gland Carcinoma,0
282,Fenestrated Pattern,Adenocarcinoma,0
283,Intersecting Sharply Marginated Clusters of Spindle Cells Present,fibrosarcoma of soft tissue,0
284,Mammary Gland Type Features Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,0
285,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pseudoepitheliomatous hyperplasia,0
286,Increased megakaryocytes (bone marrow),Pericardial mesothelioma malignant advanced,0
287,Fenestrated Pattern,Adenoma,0
288,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Cancer by AJCC v6 Stage,0
289,Venous Type Vascular Channel Formation,Turcot Syndrome Type 1,0
290,Fenestrated Pattern,Stage 0 Vulvar Carcinoma,0
291,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Angiomatous Meningioma,0
292,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endobronchial lipoma,0
293,Tissue Differentiation Uncertain,Locally Advanced Soft Tissue Sarcoma,0
294,Fenestrated Pattern,Ameloblastic fibrosarcoma,0
295,Fenestrated Pattern,Stage IIIC Rectal Cancer AJCC v8,0
296,Solitary Skin Tumor,Frontal Lobe Ependymal Tumor,0
297,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Esophageal Cancer by AJCC v8 Stage,0
298,Small Aggregates of Tumor Cells Present,Small cell carcinoma of prostate,0
299,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of endocervix,0
300,High Grade Lesion,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,0
301,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Vaginal Cancer AJCC v6 and v7,0
302,Fenestrated Pattern,Lymphoma stage II,0
303,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of prostate,0
304,Intraepithelial Neoplasia,Lobular Neoplasia,0
305,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphoid leukemia,0
306,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
307,Multihormonal Immunoreactivity Present in a Single Cell Type,Parotid Gland Acinic Cell Carcinoma,0
308,Diffuse Cellular Infiltrate,Diffuse Pulmonary Lymphangiomatosis,0
309,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent WHO Grade II Glioma,0
310,Fenestrated Pattern,Trichilemmoma,0
311,Endometrial Type Glands and Stroma Present,Stage IVA Oral Cavity Cancer AJCC v6 and v7,0
312,Gastric dysplasia,Gastric Cronkhite Canada Polyposis,0
313,Solar Radiation Toxicity,FIGO Stage IVA Ovarian Cancer,0
314,Large Spaces Filled with Blood Present,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,0
315,Basal Cells with Pale Cytoplasm Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
316,Low Grade Neuroendocrine Lesion,Childhood Grade II Meningioma,0
317,Neutral Epithelial Mucin Present,Epithelial Predominant Kidney Wilms Tumor,0
318,Fenestrated Pattern,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,0
319,Spindle Cell Metaplasia of Malignant Cells Present,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,0
320,Multihormonal Immunoreactivity Present in a Single Cell Type,Crooke Cell Adenoma,0
321,Mixture of Embryonal and Alveolar Features Present,"Supratentorial Embryonal Tumor, Not Otherwise Specified",0
322,Increased megakaryocytes (bone marrow),Stage IIIC Breast Cancer AJCC v7,0
323,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Mature Testicular Teratoma,0
324,Fenestrated Pattern,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
325,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0
326,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Fallopian Tube Carcinoma,0
327,Non-Encapsulated Neoplasm,Intrahepatic Bile Duct Papillary Neoplasm,0
328,Increased megakaryocytes (bone marrow),Myofibroblastoma,0
329,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Aortic Neoplasm,0
330,Low Grade Cartilaginous Component Present,Low Grade Fallopian Tube Serous Adenocarcinoma,0
331,Fenestrated Pattern,Stage IV Hepatocellular Carcinoma AJCC v8,0
332,Solar Radiation Toxicity,alopecia congenita,0
333,Increased megakaryocytes (bone marrow),Splenic Marginal Zone B-Cell Lymphoma,0
334,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Advanced Digestive System Neuroendocrine Neoplasm,0
335,Fenestrated Pattern,Pituicytoma,0
336,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,0
337,Skin Erosion,Skin carcinoma,0
338,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Uterine Corpus Cancer AJCC v8,0
339,Mammary Gland Type Features Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,0
340,Increased megakaryocytes (bone marrow),Stage IIIB Lung Cancer AJCC v7,0
341,Large Spaces Filled with Blood Present,Stage III Anaplastic Large Cell Lymphoma,0
342,IDH Gene Family Mutation Status Unknown,"Neoplasms, Unknown Primary",0
343,Increased megakaryocytes (bone marrow),Sellar Chordoma,0
344,Increased megakaryocytes (bone marrow),Major Salivary Gland Carcinoma,0
345,Fenestrated Pattern,Childhood Unfavorable Prognosis Hodgkin Lymphoma,0
346,Non-Encapsulated Neoplasm,Childhood Liver and Intrahepatic Bile Duct Neoplasm,0
347,Absence of Malignant Features,Refractory Malignant Endocrine Neoplasm,0
348,Primary Lesion,Primary Cutaneous Plasmablastic Lymphoma,0
349,Fenestrated Pattern,Ureter Carcinoma,0
350,Juvenile Lesion,Juvenile Myelomonocytic Leukemia,0
351,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Esophageal Adenocarcinoma,0
352,Fenestrated Pattern,Hemangioma,0
353,Spindle Cell Osteo-Fibrous Component Present,Adult Subependymal Giant Cell Astrocytoma,0
354,Increased megakaryocytes (bone marrow),Cutaneous T Lymphoblastic Leukemia/Lymphoma,0
355,Absence of Malignant Features,Stage III Ampulla of Vater Cancer AJCC v7,0
356,Abundance of Small Lymphocytes,Small Intestinal Tubulovillous Adenoma,0
357,Solar Radiation Toxicity,Diencephalic Astrocytoma,0
358,Fenestrated Pattern,Laryngeal Liposarcoma,0
359,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Monomorphic Post-Transplant Lymphoproliferative Disorder,0
360,Nodular and Diffuse Pattern,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,0
361,Moderately Differentiated Lesion,Well Differentiated Leiomyosarcoma,0
362,Low Grade Neuroendocrine Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0
363,Hyperplastic Tissue Present,Stage IV Adult Soft Tissue Sarcoma AJCC v7,0
364,Immature Myeloid Cells Increased in Bone Marrow,Carcinoma Arising in Nasal Papillomatosis,0
365,Malignant Primitive Cellular Infiltrate,Refractory Childhood Malignant Germ Cell Tumor,0
366,Fenestrated Pattern,Pericanalicular fibroadenoma,0
367,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
368,Solitary Skin Tumor,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
369,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Condyloma Acuminatum with Dysplasia,0
370,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
371,Fenestrated Pattern,Stage III Breast Cancer AJCC v6,0
372,Fenestrated Pattern,Immunodeficiency-associated Burkitt's lymphoma,0
373,Solar Radiation Toxicity,Urothelial carcinoma urethra recurrent,0
374,Increased megakaryocytes (bone marrow),Dedifferentiated chordoma,0
375,Large Spaces Filled with Blood Present,Esophageal Large Cell Neuroendocrine Carcinoma,0
376,Endometrial Type Glands and Stroma Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,0
377,Fenestrated Pattern,Stage IV Ureter Cancer AJCC v8,0
378,Absence of Malignant Features,Carcinoid tumor of pancreas,0
379,Nodular and Diffuse Pattern,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,0
380,Fenestrated Pattern,Laryngeal Leiomyoma,0
381,Fenestrated Pattern,Mucin-producing adenocarcinoma,0
382,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adult Kidney Wilms Tumor,0
383,Aggressive Clinical Course,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,0
384,Spindle Cell Metaplasia of Malignant Cells Present,Stage II Renal Cell Cancer,0
385,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Ampulla of Vater Cancer AJCC v8,0
386,Increased megakaryocytes (bone marrow),Uterine Carcinosarcoma,0
387,Increased megakaryocytes (bone marrow),Stage IVA Hilar Cholangiocarcinoma AJCC v7,0
388,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,0
389,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stage III Ampulla of Vater Cancer AJCC v7,0
390,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Testicular Tumor of the Thecoma/Fibroma Group,0
391,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Localized Parathyroid Gland Carcinoma,0
392,Large Spaces Filled with Blood Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
393,Erythroid hyperplasia,Pseudoangiomatous stromal hyperplasia,0
394,Fenestrated Pattern,Stage I Adult Lymphoblastic Lymphoma,0
395,Solar Radiation Toxicity,"Leukemia, Prolymphocytic, B-Cell",0
396,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Epithelioid Leiomyoma,0
397,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Leiomyosarcoma of small intestine,0
398,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of epidermal appendage,0
399,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stage II Ampulla of Vater Cancer AJCC v8,0
400,Fenestrated Pattern,Stage I Renal Pelvis Cancer AJCC v8,0
401,Fenestrated Pattern,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
402,Follicular Differentiation,"Lymphoma, Follicular",0
403,Dilated Terminal Duct Lobular Units Present,Stage 0 Distal Bile Duct Cancer AJCC v8,0
404,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Buccal Mucosa Verrucous Carcinoma,0
405,Schwannian Stroma More than 50 Percent of the Tumor Volume,Urinary Bladder Inflammatory Myofibroblastic Tumor,0
406,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Ovarian Sex Cord-Stromal Tumor,0
407,Toxic effect,Toxic Epidermal Necrolysis,0
408,Malignant Primitive Cellular Infiltrate,Malignant Leptomeningeal Neoplasm,0
409,Absence of Malignant Features,liposarcoma of mediastinum,0
410,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8,0
411,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
412,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gastric Carcinoid Tumor,0
413,Metaplasia of Malignant Cells Present,Malignant neoplasm of appendix,0
414,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myoblastoma,0
415,Increased megakaryocytes (bone marrow),Stage I Colon Cancer AJCC v8,0
416,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0
417,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of sphenoidal sinus,0
418,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
419,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tinea Versicolor,0
420,Fenestrated Pattern,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
421,Fenestrated Pattern,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,0
422,Abundance of Small Lymphocytes,Anal Canal Small Cell Neuroendocrine Carcinoma,0
423,Absence of Malignant Features,Juvenile osteochondrosis of tibial tubercle,0
424,Villous Projections of the Neoplastic Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
425,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Cancer by AJCC v7 Stage,0
426,Recurrent Genetic Abnormalities Present,Recurrent Central Nervous System Non-Hodgkin Lymphoma,0
427,High Grade Non Cartilaginous Sarcomatous Stroma Present,Sarcoma by AJCC Grade,0
428,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urethral cancer regional,0
429,Endometrial Type Glands and Stroma Present,Stage IA Pancreatic Cancer AJCC v6 and v7,0
430,Spindle Cell Osteo-Fibrous Component Present,Leukemic Nonnodal Mantle Cell Lymphoma,0
431,Recurrent Malignant Neoplasm,Pilar-Associated Mesenchyme Neoplasm,0
432,Increased megakaryocytes (bone marrow),recurrent gastric cancer,0
433,Fenestrated Pattern,Stage II Burkitt Lymphoma,0
434,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of rectum,0
435,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal lymphoepithelioma stage III,0
436,Microinvasive tumor,Testicular germ cell tumor mixed,0
437,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Appendix Carcinoma AJCC v7,0
438,Diffuse Lesion,Adult Diffuse Large B-Cell Lymphoma,0
439,Gastric dysplasia,Gastric Neuroendocrine Carcinoma,0
440,Mammary Gland Type Features Present,Major Salivary Gland Acinic Cell Carcinoma,0
441,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
442,Solar Radiation Toxicity,Lymphoma stage,0
443,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Stage IIB Distal Bile Duct Cancer AJCC v8,0
444,Solar Radiation Toxicity,Peutz Jehgers polyp,0
445,Localized Hydropic Villous Change,Localized Carcinoma,0
446,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of middle third of esophagus,0
447,Increased megakaryocytes (bone marrow),Pediatric Intraocular Retinoblastoma,0
448,Large Spaces Filled with Blood Present,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0
449,Increased megakaryocytes (bone marrow),Lugano Classification Adult Lymphoma by AJCC v8 Stage,0
450,Absence of Malignant Features,Malignant medulloepithelioma of ciliary body,0
451,Mixed Neoplastic Glandular and Squamous Cell Population,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,0
452,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Central Nervous System Yolk Sac Tumor,0
453,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
454,Absence of Malignant Features,Malignant neoplasm of prostate,0
455,Solar Radiation Toxicity,Stage III Colorectal Cancer AJCC v8,0
456,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thymic Adenosquamous Carcinoma,0
457,Solar Radiation Toxicity,Vaginal Carcinosarcoma,0
458,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fibrillary Astrocytoma,0
459,Gastric-Type Epithelial Differentiation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
460,Increased megakaryocytes (bone marrow),Mycosis fungoides/Sezary syndrome stage II,0
461,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0
462,Cervical Glandular Dysplasia,Cervical Alveolar Soft Part Sarcoma,0
463,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pituitary Gland Oncocytic Adenoma,0
464,Plasma cell inflammation,"Transitional cell carcinoma, spindle cell",0
465,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,mucoepidermoid carcinoma of lacrimal gland,0
466,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
467,Spindle Cell Metaplasia of Malignant Cells Present,Fibrosarcoma of bone,0
468,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colonic tubulovillous adenoma,0
469,Solar Radiation Toxicity,Marginal zone lymphoma stage II,0
470,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Biliary Tract Carcinoma,0
471,Increased megakaryocytes (bone marrow),Mixed phenotype acute leukemia,0
472,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Early Favorable Hodgkin Lymphoma,0
473,Local disease,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,0
474,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Serrated Polyposis,0
475,Fenestrated Pattern,Aleukemic leukemia,0
476,Fenestrated Pattern,Refractory Myxoid Liposarcoma,0
477,Recurrent Genetic Abnormalities Present,Recurrent Anal Adenocarcinoma,0
478,Recurrent Genetic Abnormalities Present,Recurrent Adult Acute Lymphoblastic Leukemia,0
479,Solitary Skin Tumor,Stage IVB Gestational Trophoblastic Tumor AJCC v7,0
480,Increased megakaryocytes (bone marrow),Sarcomatosis,0
481,Fenestrated Pattern,Stage IV Childhood Non-Hodgkin Lymphoma,0
482,Fenestrated Pattern,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
483,NRBC - Nucleated red blood cell present result,Non-small cell lung cancer recurrent,0
484,Fenestrated Pattern,Crohn Disease-Associated Colorectal Adenocarcinoma,0
485,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Giant cell carcinoma of lung,0
486,Absence of Malignant Features,adenoid cystic carcinoma of pharynx,0
487,Spindle Cell Metaplasia of Malignant Cells Present,Spindle cell squamous cell carcinoma,0
488,Fenestrated Pattern,Gastric Synovial Sarcoma,0
489,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rete Ovarii Cystadenofibroma,0
490,Increased megakaryocytes (bone marrow),Constitutional Mismatch Repair Deficiency Syndrome,0
491,Spindle Cell Metaplasia of Malignant Cells Present,Esophageal Spindle Cell Carcinoma,0
492,Absence of Malignant Features,Malignant Rectal Neoplasm,0
493,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gardner Fibroma,0
494,Solar Radiation Toxicity,Chondroid lipoma,0
495,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Cystosarcoma Phyllodes,0
496,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
497,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,0
498,Recurrent Malignant Neoplasm,Malignant Sternal Neoplasm,0
499,Immature Myeloid Cells Increased in Bone Marrow,Intraductal carcinoma and lobular carcinoma in situ,0
500,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,0
501,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic thymic carcinoma,0
502,Solar Radiation Toxicity,Stage IIIA Lung Cancer AJCC v7,0
503,Absence of Malignant Features,Malignant Ovarian Granulosa Cell Tumor,0
504,Fenestrated Pattern,Urothelial carcinoma ureter metastatic,0
505,Fenestrated Pattern,Myofibroblastoma,0
506,Spindle Cell Metaplasia of Malignant Cells Present,Bartholin Gland Squamous Cell Carcinoma,0
507,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Testicular Cancer AJCC v8,0
508,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary ameloblastic carcinoma,0
509,Increased megakaryocytes (bone marrow),Trichofolliculoma,0
510,Nodular and Diffuse Pattern,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,0
511,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Squamous Cell Carcinoma of the Penis,0
512,Intersecting Sharply Marginated Clusters of Spindle Cells Present,small cell carcinoma of extrahepatic bile duct,0
513,Solar Radiation Toxicity,Osteochondritis juvenilis,0
514,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Colorectal Cancer,0
515,Ionizing Radiation Toxicity,Radiation Anemia,0
516,Multihormonal Immunoreactivity Present in a Single Cell Type,Adult Giant Cell Glioblastoma,0
517,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sclerosing Breast Papilloma,0
518,Prominent Elastic Tissue Cores Present,Stage IIB Soft Tissue Sarcoma AJCC v7,0
519,Fenestrated Pattern,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,0
520,Increased megakaryocytes (bone marrow),Infiltrating Bladder Urothelial Carcinoma,0
521,Skin Red Dot,Skin squamous cell carcinoma metastatic,0
522,Endometrial Type Glands and Stroma Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
523,Proliferation of Follicular Dendritic Cells Present,Follicular ameloblastoma,0
524,Nodular and Diffuse Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
525,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Fibrohistiocytic Neoplasm,0
526,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Lymphoma of colon,0
527,Retiform Structures Comprise 90% or More of the Tumor,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Prostate Cancer AJCC v8,0
529,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,0
530,Multihormonal Immunoreactivity Present in a Single Cell Type,Breast Columnar Cell Mucinous Carcinoma,0
531,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign digestive system neoplasms,0
532,Absence of Malignant Features,Adenocarcinoma of duodenum,0
533,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Soft Tissues,0
534,Increased megakaryocytes (bone marrow),Stage 0a Renal Pelvis Cancer AJCC v8,0
535,Inoperable Disease,mu-Chain Disease,0
536,Endometrial Type Glands and Stroma Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
537,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mantle cell lymphoma of spleen,0
538,Fenestrated Pattern,Stage II Thymoma AJCC v8,0
539,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
540,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Preauricular skin tag,0
541,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Lymphoblastic Lymphoma,0
542,Increased megakaryocytes (bone marrow),Metastatic melanoma,0
543,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant hepatobiliary neoplasms,0
544,Fenestrated Pattern,Osteochondromatosis,0
545,Cervical lymphadenopathy,Stage IIA Cervical Cancer AJCC v7,0
546,Low Grade Neuroendocrine Lesion,Angiosarcoma NCI Grade 3,0
547,Nodular and Diffuse Pattern,Ventricular and Brain Stem Ependymal Tumor,0
548,Malignant Primitive Cellular Infiltrate,Grade 3 Malignant Neoplasm,0
549,Fenestrated Pattern,FIGO Stage IIIA2 Ovarian Cancer,0
550,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Female Reproductive System Adenofibroma,0
551,Breast Implant-Related Lesion,Breast Lymphoma,0
552,Fenestrated Pattern,Pilosebaceous Hamartoma,0
553,Epithelioid Differentiation,Epithelioid Sarcoma NCI Grade 3,0
554,Nodular lesions,Subcutaneous Nodular Fasciitis,0
555,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood,0
556,Fenestrated Pattern,Alveolar adenoma,0
557,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Ovarian Carcinoma,0
558,Tumor Mass,Intestinal Neuroendocrine Tumor G2,0
559,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tumorlet,0
560,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Malignant Peripheral Nerve Sheath Tumor,0
561,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",0
562,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of ciliary body,0
563,Increased megakaryocytes (bone marrow),Leukemia recurrent,0
564,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adrenal Gland Sarcoma,0
565,Absence of Malignant Features,Splenic Manifestation of Leukemia,0
566,Hyperplastic Tissue Present,Non-Metastatic Childhood Soft Tissue Sarcoma,0
567,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pharyngeal cancer stage I,0
568,Increased megakaryocytes (bone marrow),Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,0
569,Fenestrated Pattern,Angiomyofibroblastoma,0
570,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Eccrine Neoplasm,0
571,Increased megakaryocytes (bone marrow),Adult Teratoma,0
572,Granuloma,Granuloma annulare aggravated,0
573,Intraepithelial Neoplasia,Lobular Neoplasia Type B,0
574,Fenestrated Pattern,Stage III Lung Cancer AJCC v7,0
575,Increased megakaryocytes (bone marrow),Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,0
576,Mammary Gland Type Features Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,0
577,Nodular and Diffuse Pattern,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
578,Fenestrated Pattern,Mycosis fungoides/Sezary syndrome NOS,0
579,Increased megakaryocytes (bone marrow),Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8,0
580,Fenestrated Pattern,Lymphoepithelioid lymphoma (clinical),0
581,Primary Lesion,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0
582,Nodular and Diffuse Pattern,EZB Diffuse Large B-Cell Lymphoma,0
583,Recurrent Malignant Neoplasm,Locally Advanced Malignant Solid Neoplasm,0
584,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Ureter Cancer AJCC v7,0
585,Spindle Cell Metaplasia of Malignant Cells Present,Benign tumor of iris,0
586,Fenestrated Pattern,Spongiotic dermatitis,0
587,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage,0
588,Intermediate Grade Neuroendocrine Lesion,Childhood Grade III Meningioma,0
589,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,0
590,Epithelial hyperplasia of skin,Epithelioid hemangioma of skin,0
591,Absence of Malignant Features,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
592,Increased megakaryocytes (bone marrow),Mediastinal Angiosarcoma,0
593,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Class 1b Uveal Melanoma,0
594,Increased megakaryocytes (bone marrow),Syringoma,0
595,Increased megakaryocytes (bone marrow),Unresectable Ewing Sarcoma,0
596,Spindle Cell Metaplasia of Malignant Cells Present,Resectable Pleural Malignant Mesothelioma,0
597,Multihormonal Immunoreactivity Present in a Single Cell Type,Platinum-Resistant Lung Small Cell Carcinoma,0
598,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile cataract,0
599,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
600,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Breast Cancer AJCC v7,0
601,Fenestrated Pattern,Medullomyoblastoma,0
602,Solar Radiation Toxicity,Stage IV Prostate Cancer AJCC v7,0
603,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8,0
604,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Choriocarcinoma,0
605,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",0
606,Epithelial hyperplasia of skin,Angiolymphoid hyperplasia,0
607,Fenestrated Pattern,"Bronchiolo-alveolar carcinoma, non-mucinous",0
608,Increased megakaryocytes (bone marrow),Lung Cancer by AJCC v8 Stage,0
609,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mucoepidermoid carcinoma of submandibular gland,0
610,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal Papillary Hidradenoma,0
611,Melanoma Cells Present,Melanoma recurrent,0
612,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular yolk sac tumor stage III,0
613,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Ligament Adenocarcinoma,0
614,White blood cell count increased (lab result),Adenosquamous cell lung cancer stage III,0
615,Well Differentiated Lesion,Moderately Differentiated Prostate Adenocarcinoma,0
616,Solar Radiation Toxicity,Stage IB Lung Cancer AJCC v7,0
617,Fenestrated Pattern,Myxoid leiomyoma,0
618,Solar Radiation Toxicity,Liver carcinoma,0
619,Solar Radiation Toxicity,Oropharyngeal Polyp,0
620,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Colorectal Carcinoma,0
621,No Evidence of Metastatic Disease,Metastatic Lung Carcinoma,0
622,Cervical lymphadenopathy,Early Invasive Cervical Adenocarcinoma,0
623,Diffuse Lesion,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
624,Fenestrated Pattern,Necrotizing Funisitis,0
625,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intracranial Benign Fibrous Histiocytoma,0
626,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
627,Fenestrated Pattern,Placenta Accreta,0
628,Tumor Mass,Digestive System Neuroendocrine Tumor G2,0
629,Neoplastic Plasma Cells Present in Bone Marrow,Proliferative dermal lesion in congenital nevus,0
630,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Triple-Negative Breast Carcinoma,0
631,Increased megakaryocytes (bone marrow),Retinoblastoma by AJCC v8 Stage,0
632,Loss of INI 1 Protein Expression,"Colorectal cancer, hereditary nonpolyposis, type 1",0
633,Solar Radiation Toxicity,Nasopharyngeal carcinoma,0
634,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Vaginal Yolk Sac Tumor,0
635,Recurrent Genetic Abnormalities Present,Recurrent Mediastinal Lymphoma,0
636,Multihormonal Immunoreactivity Present in a Single Cell Type,Thyroid Gland Langerhans Cell Histiocytosis,0
637,Fenestrated Pattern,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,0
638,Absence of Stromal Invasion,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
639,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,0
640,Immature Myeloid Cells Increased in Bone Marrow,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10,0
641,Squamous Differentiation,Vaginal Squamous Papilloma,0
642,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Giant Cell Glioblastoma,0
643,Spindle Cell Metaplasia of Malignant Cells Present,benign fibrous histiocytoma of bone,0
644,Endometrial Type Glands and Stroma Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,0
645,Nodular and Diffuse Pattern,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma,0
646,Intestinal metaplasia of gastric mucosa,Intestinal T-cell lymphoma recurrent,0
647,Solitary Skin Tumor,Ovarian Wilms Tumor,0
648,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Gallbladder Cancer AJCC v8,0
649,Fenestrated Pattern,Adult Hodgkin Lymphoma,0
650,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intramuscular Myxoma,0
651,Multihormonal Immunoreactivity Present in a Single Cell Type,Squamous Cell Bile Duct Carcinoma,0
652,Fenestrated Pattern,Aleukemic Lymphoid Leukemia,0
653,Chronic lymphocytic inflammation,B-cell small lymphocytic lymphoma stage III,0
654,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,0
655,Increased megakaryocytes (bone marrow),Endemic African Kaposi Sarcoma,0
656,Solar Radiation Toxicity,Stage IB Osteosarcoma AJCC v7,0
657,Small Aggregates of Tumor Cells Present,Small cell glioblastoma,0
658,Small Aggregates of Tumor Cells Present,Small cell osteosarcoma,0
659,Fenestrated Pattern,Stage 0a Ureter Cancer AJCC v8,0
660,Endometrial Type Glands and Stroma Present,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,0
661,Fenestrated Pattern,Vulvar Keratoacanthoma,0
662,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7,0
663,Cervical Glandular Dysplasia,Cervical Cancer by AJCC v6 Stage,0
664,Spindle Cell Metaplasia of Malignant Cells Present,Ovarian Granulosa-Stromal Cell Tumor,0
665,Immature Granulocytes in Peripheral Blood Increased,Central Nervous System Immature Teratoma,0
666,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Burkitt Lymphoma,0
667,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal Carcinoma,0
668,Spindle Cell Osteo-Fibrous Component Present,Stage IVA Basal Cell Lip Carcinoma,0
669,Spindle Cell Metaplasia of Malignant Cells Present,Congenital spondylolysis of lumbosacral region,0
670,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,0
671,Neoplastic Plasma Cells Present in Bone Marrow,Stage IB Bone Cancer AJCC v7,0
672,Fenestrated Pattern,Colorectal Microvesicular Hyperplastic Polyp,0
673,Fenestrated Pattern,Stage III Urethral Cancer AJCC v7,0
674,Fenestrated Pattern,Hypocellular Myelodysplastic Syndrome,0
675,Increased megakaryocytes (bone marrow),Prognostic Stage IIA Breast Cancer AJCC v8,0
676,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of cecum,0
677,Large Mass,Occult Lung Large Cell Carcinoma,0
678,Vacuolated Plasma Cells in the Bone Marrow,Metastatic Malignant Neoplasm in the Viscera,0
679,Lesion with Diameter of 4mm or More,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,0
680,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intracranial Liposarcoma,0
681,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage,0
682,Recurrent Malignant Neoplasm,Malignant Lipomatous Neoplasm,0
683,Increased megakaryocytes (bone marrow),Sellar Neurocytoma,0
684,Solar Radiation Toxicity,Gallbladder adenoma,0
685,Prominent In Situ Component Present,Gastric Fundus Carcinoma In Situ AJCC v6 and v7,0
686,Recurrent Genetic Abnormalities Present,Recurrent Childhood Gliosarcoma,0
687,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage 0 Cutaneous Melanoma AJCC v6 and v7,0
688,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Intrahepatic Cholangiocarcinoma,0
689,Defective Mu Heavy Chain Present,Heavy Chain Disease,0
690,Increased megakaryocytes (bone marrow),Stage IVB Rectal Cancer AJCC v8,0
691,Lobular Pattern,"Carcinoma, Lobular",0
692,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,signet ring cell carcinoma of pancreas,0
693,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillomatosis,0
694,Non-Encapsulated Neoplasm,Gestational Trophoblastic Neoplasm by AJCC v8 Stage,0
695,Increased megakaryocytes (bone marrow),Conventional Fibrosarcoma,0
696,Increased megakaryocytes (bone marrow),Constitutional Mismatch Repair Deficiency Syndrome,0
697,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,0
698,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
699,Multihormonal Immunoreactivity Present in a Single Cell Type,Type B Lymphomatoid Papulosis,0
700,Fenestrated Pattern,"Leishmaniasis, Cutaneous",0
701,Disease regression,Hodgkin Disease,0
702,Slit-Like Vascular Channel Formation,"Skin Diseases, Vascular",0
703,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Angiosarcoma,0
704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Anaplastic Astrocytoma, IDH-Wildtype",0
705,Solar Radiation Toxicity,Stage IV Lung Cancer AJCC v7,0
706,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0
707,Multihormonal Immunoreactivity Present in a Single Cell Type,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
708,Absence of Malignant Features,Benign neoplasm of chest wall,0
709,Malignant Primitive Cellular Infiltrate,Malignant Bladder Paraganglioma,0
710,Absence of Malignant Features,Metastatic Malignant Solid Neoplasm,0
711,Mixture of Germ Cell Neoplastic Components Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,0
712,Absence of Malignant Features,Benign neoplasm of pyriform sinus,0
713,Increased megakaryocytes (bone marrow),Stage II Testicular Cancer AJCC v8,0
714,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of testis,0
715,Solar Radiation Toxicity,Ovarian Myxoid Liposarcoma,0
716,Spindle Cell Osteo-Fibrous Component Present,Unresectable Transitional Cell Carcinoma,0
717,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, SHH-Activated, TP53-Wildtype",0
718,Mixture of Germ Cell Neoplastic Components Present,Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7,0
719,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Tubular Adenoma,0
720,Basal Cells with Pale Cytoplasm Present,Basal Cell Nevus Syndrome,0
721,Nodular and Diffuse Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
722,Villous Projections of the Neoplastic Epithelium Present,Granulosa cell tumor of the testis,0
723,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of exocervix,0
724,Fenestrated Pattern,Prognostic Stage IB Breast Cancer AJCC v8,0
725,Solitary Skin Tumor,Blastema Predominant Kidney Wilms Tumor,0
726,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent Grade 1 Follicular Lymphoma,0
727,Drop Metastasis,Stage IV Major Salivary Gland Carcinoma without Metastasis,0
728,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Carcinosarcoma,0
729,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Peripheral T-Cell Lymphoma,0
730,Increased megakaryocytes (bone marrow),Somatostatinoma,0
731,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign cerebral tumor,0
732,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
733,Fenestrated Pattern,"Hemangioma, Cavernous, Central Nervous System",0
734,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,TSH-Producing Pituitary Gland Carcinoma,0
735,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of ovary,0
736,Dilated Terminal Duct Lobular Units Present,Stage IIIB Distal Bile Duct Cancer AJCC v8,0
737,Endometrial Type Glands and Stroma Present,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,0
738,Epithelioid Differentiation,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",0
739,Dermal Involvement,Paraganglioma-Like Dermal Melanocytic Tumor,0
740,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Abscess of skin AND/OR subcutaneous tissue,0
741,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Locally Advanced Lung Carcinoma,0
742,No Evidence of Metastatic Disease,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
743,Malignant Primitive Cellular Infiltrate,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
744,Increased megakaryocytes (bone marrow),Ichthyoses,0
745,Fenestrated Pattern,Schwannomatosis,0
746,Fenestrated Pattern,Stage I Urethral Cancer AJCC v8,0
747,Windblown Appearance of Atypical Keratinocytes,Atypical Spitz Nevus,0
748,Abundance of Small Lymphocytes,Small cell glioblastoma,0
749,Multihormonal Immunoreactivity Present in a Single Cell Type,Kidney Epithelioid Type Angiomyolipoma,0
750,Absence of Malignant Features,carcinosarcoma of liver,0
751,Increased megakaryocytes (bone marrow),Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,0
752,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Fourth Ventricle and Brain Stem Ependymal Tumor,0
753,Fenestrated Pattern,Colon Sarcoma,0
754,Increased megakaryocytes (bone marrow),Nasal Cavity Lymphoma,0
755,Inoperable Disease,Immunoproliferative Small Intestinal Disease,0
756,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,0
757,Confluent Sheets of Anaplastic T-Lymphocytes Present,Anaplastic Oligoastrocytoma,0
758,Absence of Malignant Features,Stage IIIA Ampulla of Vater Cancer AJCC v8,0
759,Malignant Primitive Cellular Infiltrate,"Malignant melanoma, regressing",0
760,Large Spaces Filled with Blood Present,Adenocarcinoma with neuroendocrine differentiation,0
761,Increased megakaryocytes (bone marrow),Stage III Colorectal Cancer,0
762,Endometrial Type Glands and Stroma Present,Simple Endometrial Hyperplasia with Atypia,0
763,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
764,Prominent In Situ Component Present,High Grade Ductal Breast Carcinoma In Situ,0
765,Solar Radiation Toxicity,Genitourinary Cancer,0
766,Fenestrated Pattern,Osteochondritis juvenilis,0
767,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Small Intestinal Neuroendocrine Neoplasm,0
768,Mixed Neoplastic Glandular and Squamous Cell Population,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,0
769,Solar Radiation Toxicity,Gestational Ovarian Choriocarcinoma,0
770,Exophytic Papillary Lesion,Ovarian Papillary Cystadenoma,0
771,Fenestrated Pattern,"Pheochromocytoma, Extra-Adrenal",0
772,Fenestrated Pattern,Stage IIIC Colon Cancer AJCC v8,0
773,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Breast Cancer by AJCC v8 Stage,0
774,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Rectal Cancer,0
775,Absence of Malignant Features,Malignant neoplasm of spermatic cord,0
776,Mixed Cellular Population,Mixed epithelial-mesenchymal hepatoblastoma,0
777,Fenestrated Pattern,Pancreatic Vipoma,0
778,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma in situ of fallopian tube,0
779,Recurrent disease,Chronic graft-versus-host disease,0
780,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Gastric Cancer by AJCC v8 Stage,0
781,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage,0
782,Solar Radiation Toxicity,Disseminated carcinoma,0
783,Endometrial Type Glands and Stroma Present,Refractory Endometrial Mixed Cell Adenocarcinoma,0
784,Increased megakaryocytes (bone marrow),Rectal Kaposi Sarcoma,0
785,Increased megakaryocytes (bone marrow),FIGO Stage IVA Ovarian Cancer,0
786,Pseudo-Psammoma Body Formation,Benign Carotid Body Paraganglioma,0
787,Increased megakaryocytes (bone marrow),Alveolar soft part sarcoma recurrent,0
788,Epidermotropic Lymphocytic Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System,0
789,Spindle Cell Metaplasia of Malignant Cells Present,Malignant nipple neoplasm,0
790,Fenestrated Pattern,Penile intraepithelial neoplasia,0
791,Increased megakaryocytes (bone marrow),Refractory Transformed B-cell Non-Hodgkin Lymphoma,0
792,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,0
793,Fenestrated Pattern,Stage IA Uterine Sarcoma AJCC v7,0
794,Locally Aggressive Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
795,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Laryngeal Adenoid Cystic Carcinoma,0
796,Spindle Cell Metaplasia of Malignant Cells Present,Laryngeal Acantholytic Squamous Cell Carcinoma,0
797,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of lower third of esophagus,0
798,Villous Projections of the Neoplastic Epithelium Present,Adenoid cystic carcinoma of the oral cavity stage II,0
799,Increased megakaryocytes (bone marrow),Childhood Astrocytoma,0
800,Endometrial Type Glands and Stroma Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,0
801,Increased megakaryocytes (bone marrow),Stage IIC Rectal Cancer AJCC v8,0
802,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,epithelial-myoepithelial carcinoma of salivary gland,0
803,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
804,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Neuroendocrine Carcinoma,0
805,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of subglottis,0
806,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of conjunctiva,0
807,Squamous metaplasia of bladder,Squamous intraepithelial lesion,0
808,Moderately Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0
809,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Cancer by AJCC v7 Stage,0
810,Fenestrated Pattern,Stage IIIC2 Uterine Corpus Cancer AJCC v7,0
811,Solar Radiation Toxicity,Germinoma,0
812,NRBC - Nucleated red blood cell present result,Bladder transitional cell carcinoma stage 0,0
813,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Choroid Necrotic Melanoma,0
814,Solar Radiation Toxicity,AIDS-Related Oropharyngeal Candidiasis,0
815,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Pancreatic Cancer by AJCC v8 Stage,0
816,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Acute myeloid leukemia, t(8;21) (q22;q22)",0
817,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Diffuse large B-cell lymphoma of central nervous system,0
818,Argentaffin Positive Neoplastic Cells Present,"Neoplastic Syndromes, Hereditary",0
819,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenosquamous carcinoma of salivary gland,0
820,Intersecting Sharply Marginated Clusters of Spindle Cells Present,"Benign neoplasm of eye, unspecified",0
821,Fenestrated Pattern,Minor Salivary Gland Adenocarcinoma,0
822,Increased megakaryocytes (bone marrow),Vaginal intraepithelial neoplasia grade 2,0
823,Exophytic Papillary Lesion,Hereditary Papillary Renal Carcinoma,0
824,Fenestrated Pattern,Centroblastic lymphoma recurrent,0
825,Locally Aggressive Lesion,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,0
826,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Vaginal Cancer AJCC v8,0
827,Tissue Differentiation Uncertain,Resectable Soft Tissue Sarcoma,0
828,Increased megakaryocytes (bone marrow),Adenocarcinoma Of Esophagus,0
829,Questionable Invasive Lesion,Invasive Carcinoma,0
830,Well Differentiated Neuroendocrine Lesion,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0
831,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Central Nervous System Teratoma with Malignant Transformation,0
832,Diffuse Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
833,Fenestrated Pattern,Stage II Testicular Cancer AJCC v8,0
834,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
835,Follicular Cell Differentiation,Follicular Bronchitis/Bronchiolitis,0
836,Solar Radiation Toxicity,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
837,Solar Radiation Toxicity,Pedunculated conjunctival papilloma,0
838,Florid Follicular Hyperplasia,Intraepithelial Melanocytic Hyperplasia,0
839,Multihormonal Immunoreactivity Present in a Single Cell Type,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
840,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
841,Spindle Cell Metaplasia of Malignant Cells Present,Unresectable Pleural Malignant Mesothelioma,0
842,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Craniopharyngioma,0
843,Increased megakaryocytes (bone marrow),Functioning Endocrine Neoplasm,0
844,Squamous Differentiation,"Squamous cell carcinoma, microinvasive",0
845,Increased megakaryocytes (bone marrow),Stage I Adrenal Cortex Carcinoma AJCC v7,0
846,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
847,Fenestrated Pattern,Alveolar Soft Part Sarcoma,0
848,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Differentiated Angiosarcoma,0
849,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IVB Gestational Trophoblastic Tumor AJCC v7,0
850,Spindle Cell Metaplasia of Malignant Cells Present,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,0
851,Absence of Malignant Features,histiocytic sarcoma of central nervous system,0
852,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,0
853,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Cancer by AJCC v6 Stage,0
854,Favorable Clinical Outcome,Early Favorable Hodgkin Lymphoma,0
855,Well Differentiated Neuroendocrine Lesion,Well Differentiated Malignant Neoplasm,0
856,Fenestrated Pattern,AIDS-Related Anal Canal Carcinoma,0
857,Spindle Cell Metaplasia of Malignant Cells Present,Sellar Mixed Germ Cell Tumor,0
858,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 2 Invasive Breast Carcinoma,0
859,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pineocytoma,0
860,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
861,Mixed Neoplastic Glandular and Squamous Cell Population,Anterior Tongue Squamous Cell Carcinoma,0
862,Marked Thickening of the Bladder Urothelium Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
863,Fenestrated Pattern,"Histiocytosis, Langerhans-Cell",0
864,Recurrent Malignant Neoplasm,Recurrent Endometrial Serous Adenocarcinoma,0
865,Recurrent Malignant Neoplasm,Recurrent Adult Non-Hodgkin Lymphoma,0
866,Less than 2 Mitoses per 10HPF,Grade 2 Endometrial Endometrioid Adenocarcinoma,0
867,Fenestrated Pattern,"NEVUS, EPIDERMAL (disorder)",0
868,Mammary Gland Type Features Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
869,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,signet ring cell carcinoma of pancreas,0
870,IDH Gene Family Mutation Status Unknown,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
871,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular embryonal carcinoma stage III,0
872,Increased megakaryocytes (bone marrow),Urticaria Pigmentosa,0
873,Increased megakaryocytes (bone marrow),Rhabdoid tumor predisposition syndrome,0
874,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IVA Gestational Trophoblastic Tumor AJCC v7,0
875,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Anaplastic Astrocytoma,0
876,Solitary Skin Tumor,Extrahepatic Bile Duct Benign Granular Cell Tumor,0
877,Increased megakaryocytes (bone marrow),Refractory Liver Carcinoma,0
878,Fenestrated Pattern,"Acinar Prostate Adenocarcinoma, Atrophic Variant",0
879,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0
880,Solar Radiation Toxicity,Secondary Heart Lymphoma,0
881,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
882,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of ampulla of Vater,0
883,Increased megakaryocytes (bone marrow),Advanced Unresectable Gastric Adenocarcinoma,0
884,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Penile Cancer by AJCC v7 Stage,0
885,Malignant Primitive Cellular Infiltrate,Malignant Bladder Paraganglioma,0
886,Small Aggregates of Tumor Cells Present,Adult Desmoplastic Small Round Cell Tumor,0
887,Blasts Expressing CD56 and Immature T-Cell Markers Present,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
888,Increased megakaryocytes (bone marrow),Ovarian Myxoma,0
889,Absence of Malignant Features,Malignant Female Reproductive System Neoplasm,0
890,Absence of Malignant Features,Malignant neoplasm of submandibular gland,0
891,Metaplasia of Malignant Cells Present,Malignant tumor of dermis,0
892,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chorioamnionitis,0
893,Metaplasia of Malignant Cells Present,Malignant tumor of mediastinum,0
894,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Recurrent Childhood Fibrillary Astrocytoma,0
895,Increased megakaryocytes (bone marrow),Childhood Brain Glioblastoma,0
896,Increased megakaryocytes (bone marrow),Anterior Tongue Mucoepidermoid Carcinoma,0
897,Small Lesion,Small Intestinal Gangliocytic Paraganglioma,0
898,Well Differentiated Lesion,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,0
899,Endometrial Type Glands and Stroma Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,0
900,Schwannian Stroma More than 50 Percent of the Tumor Volume,Testicular Tumor of the Thecoma/Fibroma Group,0
901,Fenestrated Pattern,Stage II Urethral Cancer AJCC v8,0
902,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Penile Cancer by AJCC v6 Stage,0
903,Fenestrated Pattern,Myxofibroma,0
904,Erythroid hyperplasia,Parathyroid hyperplasia,0
905,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of bone,0
906,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7,0
907,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Childhood Acute Myeloid Leukemia without Maturation,0
908,Exophytic Papillary Lesion,Hereditary Papillary Renal Carcinoma,0
909,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stage I Ampulla of Vater Cancer AJCC v7,0
910,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Masaoka-Koga Stage IVb,0
911,Fenestrated Pattern,Pancreatic carcinoma recurrent,0
912,Absence of Stromal Invasion,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
913,Dilated Terminal Duct Lobular Units Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,0
914,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign tumor of choroid plexus,0
915,Increased megakaryocytes (bone marrow),Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
916,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Recurrent Kidney Wilms Tumor,0
917,Fenestrated Pattern,Stage IA Breast Cancer AJCC v7,0
918,Spindle Cell Metaplasia of Malignant Cells Present,Benign Mediastinal Germ Cell Tumor,0
919,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
920,Fenestrated Pattern,Basal-Like Prostate Carcinoma,0
921,Increased megakaryocytes (bone marrow),"Glucagonoma, malignant",0
922,Breast Implant-Related Lesion,Metastatic Breast Carcinoma,0
923,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Colorectal Carcinoma,0
924,Villous Projections of the Neoplastic Epithelium Present,Anaplastic Sarcoma of the Kidney,0
925,Fenestrated Pattern,Childhood Brain Stem Glioma,0
926,Pleural effusion disorder,Pleural Carcinomatosis,0
927,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Occult Lung Adenocarcinoma,0
928,Solar Radiation Toxicity,Pituitary Adenoma,0
929,Intraepithelial Neoplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
930,Proliferation of Follicular Dendritic Cells Present,Ann Arbor Stage III Grade 1 Follicular Lymphoma,0
931,Fenestrated Pattern,Uterine Corpus PEComa,0
932,Increased megakaryocytes (bone marrow),Sclerosing liposarcoma,0
933,Intermediate Grade Neuroendocrine Lesion,Kaposi Sarcoma NCI Grade 3,0
934,Recurrent Malignant Neoplasm,Recurrent Adult Hepatocellular Carcinoma,0
935,Increased megakaryocytes (bone marrow),Marginal zone lymphoma stage I,0
936,Epithelial hyperplasia of skin,adenosquamous carcinoma of skin,0
937,Spindle Cell Metaplasia of Malignant Cells Present,follicular lymphoma of thyroid gland,0
938,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Verrucous carcinoma of oral cavity,0
939,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oxyphilic Adenoma,0
940,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Cutaneous Melanoma AJCC v7,0
941,Gastric dysplasia,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,0
942,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Adenocarcinoma, Clear Cell",0
943,Spindle Cell Osteo-Fibrous Component Present,Unresectable Transitional Cell Carcinoma,0
944,Solitary Skin Tumor,Benign Prostate Phyllodes Tumor,0
945,Exophytic Papillary Lesion,Gastric Papillary Adenocarcinoma,0
946,Recurrent Genetic Abnormalities Present,Recurrent Renal Pelvis Urothelial Carcinoma,0
947,Glandular cell atypia,Anal squamous cell carcinoma,0
948,Increased megakaryocytes (bone marrow),Stage III Eyelid Carcinoma AJCC v8,0
949,Increased megakaryocytes (bone marrow),"Cystadenocarcinoma, Mucinous",0
950,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adrenal Gland Schwannoma,0
951,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenoid cystic carcinoma of pharynx,0
952,Solar Radiation Toxicity,Ann Arbor Stage III AIDS-Related Lymphoma,0
953,Recurrent Malignant Neoplasm,Borderline Fallopian Tube Neoplasm,0
954,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,0
955,Low Grade Neuroendocrine Lesion,High Grade Appendix Mucinous Adenocarcinoma,0
956,Fenestrated Pattern,Adrenocortical carcinoma,0
957,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated Neuroblastoma,0
958,Increased megakaryocytes (bone marrow),"Mucinous adenocarcinoma, endocervical type",0
959,Intermediate Grade Neuroendocrine Lesion,Grade III Lymphomatoid Granulomatosis,0
960,Increased megakaryocytes (bone marrow),Serous surface papillary carcinoma,0
961,Low Grade Neuroendocrine Lesion,Refractory WHO Grade III Glioma,0
962,Melanoma Cells Present,Refractory Cutaneous Melanoma,0
963,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Post-Radiotherapy Breast Angiosarcoma,0
964,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,0
965,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,AIDS-Related Human Papillomavirus Infection,0
966,Progressive Clinical Course,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,0
967,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of axilla,0
968,Multihormonal Immunoreactivity Present in a Single Cell Type,Polyp in nasopharynx,0
969,Fenestrated Pattern,Vestibular Papilloma,0
970,Fenestrated Pattern,External Auditory Canal Ceruminous Adenoma,0
971,Increased megakaryocytes (bone marrow),Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8,0
972,Recurrent Malignant Neoplasm,Low Grade Malignant Neoplasm,0
973,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
974,Monoclonal Myeloid or Lymphoid Cells Present,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
975,Solitary Skin Tumor,Urinary Bladder Inflammatory Myofibroblastic Tumor,0
976,Stromal Invasion,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
977,Spindle Cell Metaplasia of Malignant Cells Present,"Papilloma, Squamous Cell",0
978,Solar Radiation Toxicity,"Neoplasms, Radiation-Induced",0
979,Progressive Clinical Course,Clinical Stage IV Cutaneous Melanoma AJCC v8,0
980,Increased megakaryocytes (bone marrow),Esophageal adenocarcinoma recurrent,0
981,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
982,Increased megakaryocytes (bone marrow),leiomyosarcoma,0
983,Spindle Cell Metaplasia of Malignant Cells Present,"Malignant Mixed Tumor, Not Otherwise Specified",0
984,Photosensitivity of skin,Pilomatrix carcinoma of skin,0
985,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Pineal Region Germ Cell Tumor,0
986,Solitary Skin Tumor,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
987,Metaplasia of Malignant Cells Present,Malignant neoplasm of endocervix,0
988,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
989,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
990,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Fibrous tissue neoplasm of skin,0
991,Breast Implant-Related Lesion,Hereditary Male Breast Carcinoma,0
992,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
993,Benign Cellular Infiltrate,Benign cystic nephroma,0
994,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Nasopharyngeal Carcinoma AJCC v7,0
995,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Neuroendocrine Carcinoma,0
996,Broad Fibrous Bands Formation,Cutaneous Fibrous Histiocytoma,0
997,Fenestrated Pattern,CARCINOMA OF VULVA,0
998,Increased megakaryocytes (bone marrow),Parotid Gland Sarcoma,0
999,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
1000,Spindle Cell Osteo-Fibrous Component Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
1001,Increased megakaryocytes (bone marrow),Masaoka-Koga Stage IIa,0
1002,Non-Encapsulated Neoplasm,Benign Ovarian Neoplasm,0
1003,Recurrent Malignant Neoplasm,Recurrent Uterine Corpus Carcinoma,0
1004,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Cystadenocarcinoma,0
1005,High Grade Non Cartilaginous Sarcomatous Stroma Present,Ann Arbor Stage II Grade 3 Follicular Lymphoma,0
1006,Solar Radiation Toxicity,Opisthorchis Viverrini-Related Cholangiocarcinoma,0
1007,Spindle Cell Osteo-Fibrous Component Present,Plasma Cell Myeloma by ISS Stage,0
1008,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenomatoid tumor of epididymis,0
1009,Multihormonal Immunoreactivity Present in a Single Cell Type,Mixed Cell Uveal Melanoma,0
1010,Nodular lesions,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1011,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Lymphoma, Non-Hodgkin",0
1012,Spindle Cell Metaplasia of Malignant Cells Present,Ewing's sarcoma of bone,0
1013,Malignant Primitive Cellular Infiltrate,Childhood Malignant Solid Neoplasm,0
1014,Increased megakaryocytes (bone marrow),Gastric Cronkhite Canada Polyposis,0
1015,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,0
1016,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
1017,Nodular and Diffuse Pattern,Stage II Testicular Seminoma AJCC v6 and v7,0
1018,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",0
1019,Increased megakaryocytes (bone marrow),Appendix Lipoma,0
1020,Spindle Cell Osteo-Fibrous Component Present,Stage IVB Basal Cell Lip Carcinoma,0
1021,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Familial Waldenstrom's Macroglobulinaemia,0
1022,Increased megakaryocytes (bone marrow),Mesothelioma malignant recurrent,0
1023,Solar Radiation Toxicity,Stage III Colon Cancer AJCC v7,0
1024,Fenestrated Pattern,Stage IV Rectal Carcinoma,0
1025,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,0
1026,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage II Lip Basal Cell Carcinoma,0
1027,Increased megakaryocytes (bone marrow),Refractory Ovarian Carcinoma,0
1028,Loss of INI 1 Protein Expression,Brown-Vialetto-Van Laere Syndrome 1,0
1029,Villous Projections of the Neoplastic Epithelium Present,Inverting papilloma of the paranasal sinus,0
1030,Solar Radiation Toxicity,Stage IIC Rectal Cancer AJCC v7,0
1031,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vaginal Adenoma,0
1032,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Metastatic Malignant Neoplasm in the Sellar Region,0
1033,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Renal Cell Cancer AJCC v7,0
1034,Intermediate Grade Neuroendocrine Lesion,Childhood Grade I Meningioma,0
1035,Large Spaces Filled with Blood Present,AIDS-Related Diffuse Large B-cell Lymphoma,0
1036,Fenestrated Pattern,Central Nervous System Paraganglioma,0
1037,Increased megakaryocytes (bone marrow),BCLC Stage 0 Hepatocellular Carcinoma,0
1038,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Liposarcoma,0
1039,Recurrent Malignant Neoplasm,Well Differentiated Malignant Neoplasm,0
1040,Fenestrated Pattern,Stage IIB Testicular Cancer AJCC v8,0
1041,Ventricular Involvement Only,Ventricular myxoma,0
1042,Osseous Metaplasia of Malignant Cells Present,Malignant phyllodes tumor of breast,0
1043,Mammary Gland Type Features Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,0
1044,Cervical Glandular Dysplasia,Cervical Leiomyoma,0
1045,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of eyelid,0
1046,Absence of Malignant Features,Capillary hemangioma of eyelid,0
1047,Diffuse Cellular Infiltrate,Ovarian Cellular Fibroma,0
1048,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Appendix Neuroendocrine Tumor,0
1049,Malignant Primitive Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor,0
1050,Absence of Malignant Features,Primary malignant neoplasm of oculomotor nerve,0
1051,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Angiosarcoma,0
1052,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Abdominal Rhabdomyosarcoma,0
1053,Absence of Malignant Features,Benign neoplasm of small intestine,0
1054,Increased megakaryocytes (bone marrow),Ann Arbor Stage II AIDS-Related Lymphoma,0
1055,Cervical Glandular Dysplasia,Cervical Endometrioid Adenocarcinoma,0
1056,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of esophagus,0
1057,Nodular and Diffuse Pattern,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
1058,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse follicle center lymphoma,0
1059,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Colon Cancer by AJCC v6 Stage,0
1060,Spindle Cell Metaplasia of Malignant Cells Present,Laryngeal Acantholytic Squamous Cell Carcinoma,0
1061,Pancreatobiliary-Type Malignant Cells Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
1062,Intermediate Grade Lesion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1063,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of ampulla of Vater,0
1064,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Keratoderma, Palmoplantar",0
1065,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,0
1066,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adrenal Cortex Oncocytic Adenoma,0
1067,Increased megakaryocytes (bone marrow),Pacinian tumor,0
1068,Schwannian Stroma More than 50 Percent of the Tumor Volume,Inflammatory Myofibroblastic Tumor,0
1069,Spindle Cell Metaplasia of Malignant Cells Present,leiomyosarcoma of bone,0
1070,Fenestrated Pattern,Eccrine ductal carcinoma,0
1071,Solar Radiation Toxicity,"Hepatocellular carcinoma, scirrhous",0
1072,Nodular lesions,Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1073,Mammary Gland Type Features Present,Salivary Gland Oncocytic Carcinoma,0
1074,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Proliferating Pilar Tumor,0
1075,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Anaplastic Large Cell Lymphoma,0
1076,Increased megakaryocytes (bone marrow),Stage IV Nasopharyngeal Carcinoma AJCC v7,0
1077,High Grade Non Cartilaginous Sarcomatous Stroma Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",0
1078,Windblown Appearance of Atypical Keratinocytes,Atypical Breast Myoepitheliosis,0
1079,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Cataract associated with radiation,0
1080,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Masaoka-Koga Stage IVb,0
1081,Fenestrated Pattern,Hereditary sideroblastic anemia,0
1082,Increased megakaryocytes (bone marrow),Necrotic intraocular melanoma,0
1083,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cerebellar hemangioblastoma,0
1084,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Splenic Lymphoblastic Lymphoma,0
1085,Spindle Cell Metaplasia of Malignant Cells Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,0
1086,Fenestrated Pattern,FIGO Stage IIIA1(ii) Ovarian Cancer,0
1087,Malignant Primitive Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma,0
1088,Absence of Malignant Features,adenoid cystic carcinoma of floor of mouth,0
1089,Solar Radiation Toxicity,Adult Spinal Cord Ependymoma,0
1090,Increased megakaryocytes (bone marrow),Hamartomatous polyposis,0
1091,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,0
1092,Increased megakaryocytes (bone marrow),Mucin-Producing Intrahepatic Cholangiocarcinoma,0
1093,Recurrent Genetic Abnormalities Present,Recurrent Childhood Brain Neoplasm,0
1094,Dilated Terminal Duct Lobular Units Present,Stage IV Distal Bile Duct Cancer AJCC v8,0
1095,Epithelial hyperplasia of skin,Kaposi's sarcoma of skin,0
1096,Endometrial Type Glands and Stroma Present,Stage I Choroidal and Ciliary Body Melanoma AJCC v8,0
1097,Fenestrated Pattern,Refractory Cholangiocarcinoma,0
1098,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Microcystic adnexal carcinoma,0
1099,Metaplasia of Malignant Cells Present,Malignant tumor of peritoneum,0
1100,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleomorphic adenoma of parotid gland,0
1101,Multihormonal Immunoreactivity Present in a Single Cell Type,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),0
1102,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ichthyoses,0
1103,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Hairy Cell Leukemia,0
1104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Sarcoma,0
1105,Spindle Cell Osteo-Fibrous Component Present,Subependymal Giant Cell Astrocytoma,0
1106,Primary Site Unspecified,Primary Peritoneal Cancer by AJCC v8 Stage,0
1107,Solar Radiation Toxicity,Cholangiocarcinoma metastatic,0
1108,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear Cell Adrenal Cortical Adenoma,0
1109,Progressive Clinical Course,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
1110,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endometrial stromal nodule,0
1111,Increased megakaryocytes (bone marrow),Adult Angiosarcoma,0
1112,Recurrent Malignant Neoplasm,Refractory Childhood Spinal Cord Neoplasm,0
1113,Mammary Gland Type Features Present,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,0
1114,Follicular Structures Present,Vulvar Inverted Follicular Keratosis,0
1115,Nodular and Diffuse Pattern,Stage III Cervical Cancer AJCC v6 and v7,0
1116,Increased megakaryocytes (bone marrow),Extra-osseous Ewing's sarcoma,0
1117,Peau d'orange surface of breast,adenocarcinoma of breast with squamous metaplasia,0
1118,Increased megakaryocytes (bone marrow),Radiation-Induced Dermatitis,0
1119,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Ureter Cancer AJCC v7,0
1120,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of body of uterus,0
1121,Absence of Malignant Features,Benign neoplasm of epididymis,0
1122,Fenestrated Pattern,Stage IIIB Colon Cancer AJCC v8,0
1123,Absence of Malignant Features,benign granular cell tumor of gallbladder,0
1124,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermatofibrosarcoma Protuberans,0
1125,High Grade Lesion,Sarcoma by FNCLCC Grade,0
1126,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign chondrogenic neoplasm,0
1127,Fenestrated Pattern,Stage I Childhood Hodgkin Lymphoma,0
1128,Systemic disease,"Mastocytosis, Systemic",0
1129,Progressive Clinical Course,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,0
1130,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIB Gastric Cancer AJCC v8,0
1131,Increased megakaryocytes (bone marrow),Childhood Brain Stem Glioma,0
1132,Acute inflammation,Childhood Acute Lymphoblastic Leukemia,0
1133,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Gastric Neuroendocrine Tumor G2,0
1134,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Apocrine adenoma,0
1135,Solar Radiation Toxicity,Vaginal Dermoid Cyst,0
1136,Large Spaces Filled with Blood Present,Refractory Intravascular Large B-Cell Lymphoma,0
1137,Solitary Skin Tumor,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
1138,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,0
1139,Malignant Primitive Cellular Infiltrate,Undifferentiated Malignant Neoplasm,0
1140,Endometrial Type Glands and Stroma Present,"Cervical, Thoracic, and Lumbosacral Spinal Cord Ependymal Tumor",0
1141,Increased megakaryocytes (bone marrow),Stage IIB Vaginal Cancer AJCC v8,0
1142,Moderately Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,0
1143,Increased megakaryocytes (bone marrow),Stage IIA Testicular Cancer AJCC v8,0
1144,Fenestrated Pattern,Childhood Brain Stem Glioma,0
1145,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Cancer by AJCC v8 Stage,0
1146,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ichthyosis Bullosa of Siemens,0
1147,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Fibroma,0
1148,Neoplastic Plasma Cells Present in Bone Marrow,Stage IVB Bone Cancer AJCC v7,0
1149,Fenestrated Pattern,Extracranial Neuroblastoma,0
1150,Absence of Malignant Features,Malignant Esophageal Neoplasm by Anatomic Region,0
1151,Cervical Glandular Dysplasia,Metastatic Cervical Adenocarcinoma,0
1152,Diffuse Lesion,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
1153,Increased megakaryocytes (bone marrow),Refractory Transformed Non-Hodgkin Lymphoma,0
1154,Solitary Skin Tumor,Ventricular and Brain Stem Ependymal Tumor,0
1155,Multihormonal Immunoreactivity Present in a Single Cell Type,"Lung Large Cell Carcinoma, Clear Cell Variant",0
1156,Mammary Gland Type Features Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,0
1157,Mixed Neoplastic Glandular and Squamous Cell Population,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1158,Fenestrated Pattern,Stage IVB Colon Cancer AJCC v8,0
1159,Mucocele of appendix,large cell neuroendocrine carcinoma of appendix,0
1160,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Urothelial cancer of renal pelvis,0
1161,Diffuse Lesion,Adult Diffuse Large B-Cell Lymphoma,0
1162,Increased megakaryocytes (bone marrow),Fusion-Negative Rhabdomyosarcoma,0
1163,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sebaceous Adenocarcinoma,0
1164,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,0
1165,Solar Radiation Toxicity,"Fibromatosis, Plantar",0
1166,Increased megakaryocytes (bone marrow),Lymphomatoid Papulosis,0
1167,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Vaginal Mixed Tumor,0
1168,Fried-Egg Appearance of the Bone Marrow,Mucoepidermoid carcinoma of the oral cavity stage III,0
1169,Mixture of Germ Cell Neoplastic Components Present,Ampulla of Vater Signet Ring Cell Carcinoma,0
1170,Endometrial Type Glands and Stroma Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,0
1171,Nests of Nevus Cells Resembling Nerve Bundles Present,Oculomotor Nerve Paralysis,0
1172,Blasts Expressing CD56 and Immature T-Cell Markers Present,Gastric T-Cell Non-Hodgkin Lymphoma,0
1173,Solar Radiation Toxicity,Chondroblastoma,0
1174,Fenestrated Pattern,AIDS-Related Plasmablastic Lymphoma,0
1175,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Adrenal Cortex Carcinoma AJCC v7,0
1176,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
1177,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7,0
1178,Neoplastic Plasma Cells Present in Bone Marrow,Locally Advanced Unresectable Bone Sarcoma,0
1179,Fenestrated Pattern,Mediastinal Schwannoma,0
1180,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical adenoma,0
1181,Fenestrated Pattern,Stage IIB Eyelid Carcinoma AJCC v8,0
1182,Intraepithelial Neoplasia,Prostatic Intraepithelial Neoplasias,0
1183,Plasma cell inflammation,Giant cell angiofibroma,0
1184,Photosensitivity of skin,Kaposi's sarcoma of skin,0
1185,Low Grade Neuroendocrine Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
1186,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Ovarian Neoplasm,0
1187,Solar Radiation Toxicity,Myxopapillary ependymoma,0
1188,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,PRETEXT Stage 4 Hepatoblastoma,0
1189,White blood cell count increased (lab result),Bile duct clear cell adenocarcinoma,0
1190,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage II Gastric Cancer AJCC v8,0
1191,Nodular and Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
1192,Pleural effusion disorder,Pleural Biphasic Mesothelioma,0
1193,Malignant Primitive Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,0
1194,Large Spaces Filled with Blood Present,Refractory anaemia with excess blasts,0
1195,Fenestrated Pattern,Stage IIIA Ovarian Cancer AJCC v8,0
1196,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0
1197,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of base of tongue,0
1198,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Medulloblastoma with Leptomeningeal Spread,0
1199,Immature Myeloid Cells Increased in Bone Marrow,Myeloid Neoplasms with Germline RUNX1 Mutation,0
1200,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of cervix,0
1201,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Central Nervous System Germ Cell Tumor,0
1202,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,0
1203,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chondroid chordoma,0
1204,Fenestrated Pattern,Liposarcoma metastatic,0
1205,Increased megakaryocytes (bone marrow),Stage IC Uterine Sarcoma AJCC v7,0
1206,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Luminal A Prostate Carcinoma,0
1207,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Mucinous Cystadenoma,0
1208,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1209,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory Leiomyosarcoma,0
1210,Increased megakaryocytes (bone marrow),Congenital Vena Cava Abnormality,0
1211,Locally Aggressive Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
1212,Absence of Malignant Features,mucinous adenocarcinoma of lung,0
1213,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Pancreatic Cancer AJCC v6 and v7,0
1214,Mixture of Germ Cell Neoplastic Components Present,Childhood Gonadal Germ Cell Tumor,0
1215,Increased megakaryocytes (bone marrow),Chondrogenic Neoplasm,0
1216,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon cancer recurrent,0
1217,Tumor Mass,Proliferating Brenner Tumor,0
1218,Large Spaces Filled with Blood Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
1219,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVA Oral Cavity Cancer AJCC v6 and v7,0
1220,Increased megakaryocytes (bone marrow),Plurihormonal Pituitary Gland Adenoma,0
1221,Solar Radiation Toxicity,Conventional Leiomyosarcoma,0
1222,Solar Radiation Toxicity,"Nevus, Intradermal",0
1223,Diffuse Immunoblastic Proliferation,Immunoblastic Large-Cell Lymphoma,0
1224,Endometrial Type Glands and Stroma Present,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
1225,Increased megakaryocytes (bone marrow),Stage III Cervical Cancer AJCC v8,0
1226,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,0
1227,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC2 Uterine Corpus Cancer AJCC v8,0
1228,Melanoma Cells Present,Old Burn Scar-Related Cutaneous Melanoma,0
1229,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of anus,0
1230,Fenestrated Pattern,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,0
1231,Fenestrated Pattern,Ann Arbor Stage III AIDS-Related Lymphoma,0
1232,No Evidence of Metastatic Disease,Metastatic hepatocellular carcinoma,0
1233,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Appendix Carcinoma AJCC v8,0
1234,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood,0
1235,Increased megakaryocytes (bone marrow),Thymic Hodgkin Lymphoma,0
1236,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Lobular Endocervical Glandular Hyperplasia,0
1237,Absence of Malignant Features,Childhood Malignant Kidney Neoplasm,0
1238,Increased megakaryocytes (bone marrow),Ann Arbor Stage IVA Hodgkin Lymphoma,0
1239,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Adult Brain Neoplasm,0
1240,Fenestrated Pattern,Uterine Carcinosarcoma,0
1241,Solar Radiation Toxicity,Radiation Pneumonitis,0
1242,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,keratinizing squamous cell carcinoma of lung,0
1243,Fenestrated Pattern,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,0
1244,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Alopecia,0
1245,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Anal Cancer AJCC v8,0
1246,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary myoepithelial carcinoma of lung,0
1247,Diffuse Lesion,Diffuse Astrocytoma,0
1248,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Grade 3 Invasive Breast Carcinoma,0
1249,Fenestrated Pattern,Adult T Lymphoblastic Lymphoma,0
1250,Fenestrated Pattern,Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8,0
1251,Aggressive Clinical Course,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,0
1252,Solar Radiation Toxicity,Stage IA Retroperitoneal Sarcoma AJCC v8,0
1253,Fenestrated Pattern,Rhabdoid meningioma,0
1254,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Neoplasm of aortic body,0
1255,White blood cell count increased (lab result),Adenosquamous cell lung cancer stage II,0
1256,Spindle Cell Osteo-Fibrous Component Present,Non-Secretory Plasma Cell Myeloma,0
1257,Metaplasia of Malignant Cells Present,Malignant neoplasm of middle third of esophagus,0
1258,Multihormonal Immunoreactivity Present in a Single Cell Type,Hurthle Cell Tumor,0
1259,Endometrial Type Glands and Stroma Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",0
1260,Abundance of Small Lymphocytes,Digestive System Small Cell Neuroendocrine Carcinoma,0
1261,Cervical Glandular Dysplasia,Cervical Neuroendocrine Neoplasm,0
1262,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Appendix Tubulovillous Adenoma,0
1263,Abundance of Small Lymphocytes,Vulvar Small Cell Carcinoma,0
1264,Fenestrated Pattern,Elastofibroma,0
1265,Intermediate Grade Neuroendocrine Lesion,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
1266,Solar Radiation Toxicity,Stage IVC Laryngeal Cancer AJCC v7,0
1267,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Fundus Carcinoma,0
1268,Schwannian Stroma More than 50 Percent of the Tumor Volume,Digestive System Neuroendocrine Tumor G2,0
1269,Increased megakaryocytes (bone marrow),Vaginal Cancer by AJCC v8 Stage,0
1270,Finding related to pregnancy,Metastatic malignant neoplasm to oropharynx,0
1271,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIA Lung Small Cell Carcinoma AJCC v7,0
1272,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meningothelial sarcoma,0
1273,Increased megakaryocytes (bone marrow),Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,0
1274,Fenestrated Pattern,"Myeloproliferative Neoplasm, Unclassifiable",0
1275,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of male breast,0
1276,Blasts Expressing CD56 and Immature T-Cell Markers Present,Childhood Immature Teratoma,0
1277,Fenestrated Pattern,Neuronevus,0
1278,Fenestrated Pattern,Stage 0 Rectal Cancer AJCC v8,0
1279,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Nasopharyngeal Carcinoma AJCC v8,0
1280,Multihormonal Immunoreactivity Present in a Single Cell Type,Keratinizing Head and Neck Squamous Cell Carcinoma,0
1281,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1282,Diffuse Cellular Infiltrate,"Diffuse Astrocytoma, IDH-Wildtype",0
1283,Increased megakaryocytes (bone marrow),Mediastinal seminoma,0
1284,Absence of Malignant Features,sarcoma of anus,0
1285,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Congenital spondylolysis,0
1286,Primary Lesion,Refractory Primary Cutaneous Lymphoma,0
1287,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Mucinous Cystadenoma,0
1288,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Nasopharyngeal Carcinoma AJCC v7,0
1289,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pseudoepitheliomatous hyperplasia,0
1290,Absence of Malignant Features,Carcinoma of anal canal,0
1291,Solar Radiation Toxicity,Precancerous Dermatitis,0
1292,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent Grade 3a Follicular Lymphoma,0
1293,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVB Pharyngeal Carcinoma,0
1294,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Prostate Carcinoma,0
1295,Atypical Mitotic Figures,Atypical neurofibroma,0
1296,Fenestrated Pattern,Pityriasis Lichenoides,0
1297,Endometrial Type Glands and Stroma Present,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8,0
1298,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Granulosa Cell Tumor,0
1299,Increased megakaryocytes (bone marrow),Unresectable Rhabdomyosarcoma,0
1300,Increased megakaryocytes (bone marrow),Brain Stem Hemangioblastoma,0
1301,Fenestrated Pattern,Parotid Gland Sarcoma,0
1302,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,"Acute Myeloid Leukemia, M1",0
1303,Solar Radiation Toxicity,"Sarcoma, metastatic",0
1304,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Juvenile Polyp,0
1305,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,HIV-Associated Lymphoproliferative Disorder,0
1306,Rubbery Skin Lesion,Recurrent Skin Carcinoma,0
1307,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Refractory NK-Cell Lymphoma, Unclassifiable",0
1308,Recurrent Malignant Neoplasm,Benign Adult Brain Neoplasm,0
1309,Fenestrated Pattern,Proliferative fasciitis,0
1310,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Hodgkin Lymphoma by Ann Arbor Stage,0
1311,Spindle Cell Metaplasia of Malignant Cells Present,sarcoma of mediastinum,0
1312,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 4 Clear Cell Renal Cell Carcinoma,0
1313,Neoplastic Plasma Cells Present in Bone Marrow,Stage III Bone Cancer AJCC v7,0
1314,Fenestrated Pattern,"Medulloblastoma, Not Otherwise Specified",0
1315,Increased megakaryocytes (bone marrow),Congenital Nonbullous Ichthyosiform Erythroderma,0
1316,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,0
1317,Spindle Cell Metaplasia of Malignant Cells Present,Benign tumor of iris,0
1318,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of Unknown Primary,0
1319,Fenestrated Pattern,Central Nervous System Germinoma,0
1320,Increased megakaryocytes (bone marrow),Chondromyxoid fibroma,0
1321,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Germ Cell Tumor,0
1322,Increased megakaryocytes (bone marrow),Precursor T-lymphoblastic lymphoma/leukemia stage I,0
1323,Increased megakaryocytes (bone marrow),Pineal Gland Astrocytoma,0
1324,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Hypopharyngeal Carcinoma AJCC v8,0
1325,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign mixed epithelial and stromal tumor of kidney,0
1326,Fenestrated Pattern,Colon Juvenile Polyp,0
1327,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nodular fasciitis,0
1328,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
1329,Fenestrated Pattern,Hyperacute allograft rejection,0
1330,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Desmoplastic fibroma,0
1331,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,0
1332,Endometrial Type Glands and Stroma Present,Stage I Nasal Cavity Cancer AJCC v6 and v7,0
1333,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Burkitt Lymphoma,0
1334,Absence of Malignant Features,papillary adenoma of extrahepatic bile duct,0
1335,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Alveolar rhabdomyosarcoma,0
1336,Immature Granulocytes in Peripheral Blood Increased,Peripheral Ganglioneuroblastoma,0
1337,Fenestrated Pattern,Stage IIIB Retroperitoneal Sarcoma AJCC v8,0
1338,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of vulva,0
1339,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoid cystic carcinoma of the oral cavity stage II,0
1340,NRBC - Nucleated red blood cell present result,Blastic plasmacytoid dendritic cell neoplasm,0
1341,Absence of Malignant Features,Adenocarcinoma of Accessory Sinus,0
1342,Absence of Malignant Features,Malignant Solitary Fibrous Tumor,0
1343,Increased megakaryocytes (bone marrow),Plantar wart,0
1344,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of the lip,0
1345,Increased megakaryocytes (bone marrow),Funisitis (disorder),0
1346,Spindle Cell Metaplasia of Malignant Cells Present,Adenoma of Minor Vestibular Glands,0
1347,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Merkel Cell Carcinoma,0
1348,Acute inflammation,Acute Megakaryocytic Leukemias,0
1349,Increased megakaryocytes (bone marrow),Spermatocytic seminoma,0
1350,Schwannian Stroma More than 50 Percent of the Tumor Volume,Pleural Solitary Fibrous Tumor,0
1351,Increased megakaryocytes (bone marrow),Nodal marginal zone B-cell lymphoma stage III,0
1352,Increased megakaryocytes (bone marrow),Ganglioneuroma,0
1353,Absence of Malignant Features,neuroendocrine carcinoma of anal canal,0
1354,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Fibroblastic Neoplasm,0
1355,Fenestrated Pattern,Adult Alveolar Soft Part Sarcoma,0
1356,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Cranial Nerve Neoplasms, Malignant",0
1357,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Burkitt Lymphoma,0
1358,Increased megakaryocytes (bone marrow),Gastrointestinal tract adenoma,0
1359,Distortion of the Hair Follicle,"Follicle center lymphoma, follicular grade I, II, III stage IV",0
1360,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,0
1361,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,"Cervical, Thoracic, and Lumbosacral Spinal Cord Ependymal Tumor",0
1362,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of cecum,0
1363,Locally Aggressive Lesion,Refractory Aggressive NK-Cell Leukemia,0
1364,Endometrial Type Glands and Stroma Present,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
1365,Primary Site Unspecified,Primary Peritoneal Cancer by AJCC v7 Stage,0
1366,Aberrant Thyroid Tissue Present,Thyroid Gland Leiomyoma,0
1367,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8,0
1368,Mammary Gland Type Features Present,Stage IVA Major Salivary Gland Cancer AJCC v8,0
1369,White blood cell count increased (lab result),Esophageal squamous cell carcinoma recurrent,0
1370,Increased megakaryocytes (bone marrow),Prostatic Cribriform Hyperplasia,0
1371,Fenestrated Pattern,Stage II Rectosigmoid Cancer AJCC v6,0
1372,Aberrant Thyroid Tissue Present,Thyroid Gland Mucinous Follicular Adenoma,0
1373,Spindle Cell Metaplasia of Malignant Cells Present,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0
1374,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
1375,Spindle Cell Metaplasia of Malignant Cells Present,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",0
1376,Low Grade Neuroendocrine Lesion,"Neuroendocrine carcinoma, metastatic",0
1377,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Cutaneous Melanoma AJCC v6,0
1378,Epithelial hyperplasia of skin,Lymphoid hyperplasia,0
1379,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
1380,Fenestrated Pattern,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1381,Multihormonal Immunoreactivity Present in a Single Cell Type,Unclassified Renal Cell Carcinoma,0
1382,Recurrent Malignant Neoplasm,Recurrent Childhood Burkitt Lymphoma,0
1383,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Germ Cell Tumor,0
1384,Increased megakaryocytes (bone marrow),Salpingitis isthmica nodosa,0
1385,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Osteosarcoma AJCC v7,0
1386,Absence of Malignant Features,Secondary malignant neoplasm of urethra,0
1387,Tumor Mass,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
1388,Fenestrated Pattern,Lung Pleomorphic Adenoma,0
1389,Neoplastic Cells with TFH Cell Phenotype Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),0
1390,Mixed Cellular Population,Choroid Mixed Cell Melanoma,0
1391,Fenestrated Pattern,Intramuscular Myxoma,0
1392,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Cribriform Neuroepithelial Tumor,0
1393,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Acral Fibromyxoma,0
1394,Aberrant Thyroid Tissue Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,0
1395,Recurrent Genetic Abnormalities Present,Recurrent Acute Megakaryoblastic Leukemia,0
1396,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Intraocular Medulloepithelioma,0
1397,Multihormonal Immunoreactivity Present in a Single Cell Type,Submandibular Gland Acinic Cell Carcinoma,0
1398,Tubular Pattern,"Testicular Yolk Sac Tumor, Solid Pattern",0
1399,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Kaposi's sarcoma of conjunctiva,0
1400,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Perivascular epithelioid tumor, malignant",0
1401,Spindle Cell Metaplasia of Malignant Cells Present,benign mature teratoma of pancreas,0
1402,Spindle Cell Metaplasia of Malignant Cells Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type",0
1403,Recurrent Genetic Abnormalities Present,Recurrent Chronic Leukemia,0
1404,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Anal Canal Cancer AJCC v6 and v7,0
1405,Absence of Malignant Features,Paget's disease of vulva,0
1406,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prognostic Stage IV Breast Cancer AJCC v8,0
1407,Nodular and Diffuse Pattern,Head and Neck Basaloid Carcinoma,0
1408,Increased megakaryocytes (bone marrow),Stage IIIC Colorectal Cancer AJCC v7,0
1409,Low Grade Cartilaginous Component Present,Low grade appendiceal mucinous neoplasm,0
1410,Spindle Cell Osteo-Fibrous Component Present,Basal Cell Ameloblastoma,0
1411,Malignant Primitive Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,0
1412,Aberrant Thyroid Tissue Present,Thyroid Gland Schwannoma,0
1413,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of bone marrow,0
1414,Malignant Primitive Cellular Infiltrate,Recurrent Primitive Neuroectodermal Tumor,0
1415,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Prostate Cancer AJCC v8,0
1416,Solitary Skin Tumor,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
1417,Spindle Cell Metaplasia of Malignant Cells Present,"Malignant lymphoma centroblastic, diffuse",0
1418,IDH Gene Family Mutation Status Unknown,Myeloid Neoplasms with Germline GATA2 Mutation,0
1419,Absence of Malignant Features,Microinvasive Malignant Neoplasm,0
1420,Mammary Gland Type Features Present,Stage III Major Salivary Gland Cancer AJCC v7,0
1421,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,0
1422,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Endometrial Serous Adenocarcinoma,0
1423,Spindle Cell Metaplasia of Malignant Cells Present,Stage IV Esophageal Squamous Cell Carcinoma,0
1424,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleural Schwannoma,0
1425,High Grade Non Cartilaginous Sarcomatous Stroma Present,High grade B-cell lymphoma,0
1426,Fenestrated Pattern,Supratentorial Pleomorphic Xanthoastrocytoma,0
1427,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillary adenocarcinoma,0
1428,Increased megakaryocytes (bone marrow),Stage IIIC Appendix Carcinoma AJCC v7,0
1429,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,0
1430,Tumor Mass,Digestive System Neuroendocrine Tumor G2,0
1431,Solar Radiation Toxicity,Esophageal Liposarcoma,0
1432,Fenestrated Pattern,Stage IA Eyelid Carcinoma AJCC v8,0
1433,Malignant Primitive Cellular Infiltrate,Malignant myoepithelioma,0
1434,Increased megakaryocytes (bone marrow),tumor miofibroblástico peribronquial congénito,0
1435,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Vulvar Cancer AJCC v8,0
1436,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nasopharyngeal lymphoepithelioma stage III,0
1437,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Plasmacytoma,0
1438,Solar Radiation Toxicity,Asian desert cutaneous leishmaniasis,0
1439,Breast Implant-Related Lesion,Atypical Breast Myoepitheliosis,0
1440,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant tumor of male genital organ,0
1441,Absence of Malignant Features,mucoepidermoid carcinoma of accessory sinus,0
1442,Tumor Mass,Ovarian Mucinous Carcinoid Tumor,0
1443,Intraepithelial Neoplasia,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
1444,Fenestrated Pattern,Kidney Synovial Sarcoma,0
1445,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Central Nervous System Embryonal Carcinoma,0
1446,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Verumontanum Mucosal Gland Hyperplasia,0
1447,Villous Projections of the Neoplastic Epithelium Present,Squamous cell carcinoma of the paranasal sinus,0
1448,Absence of Malignant Features,adenosquamous carcinoma of esophagus,0
1449,Spindle Cell Osteo-Fibrous Component Present,Stage III Renal Cell Cancer AJCC v8,0
1450,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Sarcoma of orbit,0
1451,Tumor Mass,Fourth Ventricle Ependymal Tumor,0
1452,Solar Radiation Toxicity,MGMT-Methylated Glioblastoma,0
1453,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Ovarian Granulosa Cell Tumor,0
1454,Spindle Cell Metaplasia of Malignant Cells Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0
1455,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0
1456,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Clear cell squamous cell carcinoma of skin,0
1457,Fenestrated Pattern,Stage IV Hepatocellular Carcinoma AJCC v8,0
1458,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Cutaneous Adult T-Cell Leukemia/Lymphoma,0
1459,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Core binding factor acute myeloid leukemia,0
1460,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intestinal Intraepithelial Neoplasia,0
1461,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukemia, Prolymphocytic, B-Cell",0
1462,Bone Marrow Involvement,Stage IVB Bone Sarcoma AJCC v7,0
1463,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Buccal Mucosa Verrucous Carcinoma,0
1464,Increased megakaryocytes (bone marrow),Stage I Hypopharyngeal Carcinoma AJCC v7,0
1465,Solar Radiation Toxicity,Myopericytoma,0
1466,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endobronchial Hamartoma,0
1467,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Glioblastoma,0
1468,Spindle Cell Metaplasia of Malignant Cells Present,sarcoma of anus,0
1469,Solar Radiation Toxicity,Laryngeal Paraganglioma,0
1470,High Grade Lesion,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
1471,Increased megakaryocytes (bone marrow),"Lymphangioma, Cystic",0
1472,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ureter Schwannoma,0
1473,Fenestrated Pattern,Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8,0
1474,Solar Radiation Toxicity,Stage I Renal Pelvis Cancer AJCC v8,0
1475,Fenestrated Pattern,Stage IIB Appendix Carcinoma AJCC v8,0
1476,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
1477,Increased megakaryocytes (bone marrow),Stage II Major Salivary Gland Cancer AJCC v7,0
1478,Fenestrated Pattern,Precursor T-lymphoblastic lymphoma/leukemia recurrent,0
1479,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Ovarian Neoplasm,0
1480,Absence of Malignant Features,Secondary malignant neoplasm of larynx,0
1481,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mantle cell lymphoma of spleen,0
1482,Spindle Cell Osteo-Fibrous Component Present,Childhood Langerhans Cell Histiocytosis,0
1483,Solar Radiation Toxicity,Stage IVC Laryngeal Cancer AJCC v7,0
1484,Increased megakaryocytes (bone marrow),Stage 1 Neuroblastoma,0
1485,Increased megakaryocytes (bone marrow),Oligodendroglial Neoplasm,0
1486,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Parietal Lobe Ependymal Tumor,0
1487,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma in situ of prostate,0
1488,Absence of Malignant Features,Polyp of vocal cord,0
1489,bone marrow fibrosis,Benign bone neoplasm,0
1490,Squamous Metaplasia of Malignant Cells Present,Squamous cell carcinoma,0
1491,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of accessory sinus,0
1492,Solar Radiation Toxicity,Adult Subependymoma,0
1493,Mammary Gland Type Features Present,Intermediate Cell Type Uveal Melanoma,0
1494,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,0
1495,Fenestrated Pattern,Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8,0
1496,Nodular and Diffuse Pattern,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,0
1497,Absence of Malignant Features,Malignant Paraganglionic Neoplasm,0
1498,Folliculotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
1499,Spindle Cell Metaplasia of Malignant Cells Present,"Lung Large Cell Carcinoma, Clear Cell Variant",0
1500,Absence of Malignant Features,Localized Malignant Neoplasm,0
1501,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0
1502,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
1503,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Atrial Paraganglioma,0
1504,Absence of Malignant Features,Malignant Cardiovascular Neoplasm,0
1505,Mammary Gland Type Features Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1506,Solitary Skin Tumor,Non-Neoplastic Skin Disorder,0
1507,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myoma,0
1508,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,mucoepidermoid carcinoma of lacrimal gland,0
1509,Absence of Malignant Features,Benign neoplasm of soft tissue,0
1510,Increased megakaryocytes (bone marrow),Stage II Adult Non-Hodgkin Lymphoma,0
1511,Spindle Cell Metaplasia of Malignant Cells Present,Adult Type Testicular Granulosa Cell Tumor,0
1512,Spindle Cell Osteo-Fibrous Component Present,Gallbladder Goblet Cell Carcinoid,0
1513,Increased megakaryocytes (bone marrow),Stage IIIC Fallopian Tube Cancer AJCC v8,0
1514,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Contact dermatitis due to solar radiation,0
1515,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Macrotrabecular Hepatoblastoma,0
1516,Increased megakaryocytes (bone marrow),Stage 0is Bladder Cancer AJCC v8,0
1517,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Scrotal Sarcoma,0
1518,Systemic disease,Acute alcoholic liver disease,0
1519,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ampulla of Vater Tubulovillous Adenoma,0
1520,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,0
1521,Endodermal Sinus Pattern,Sphenoid Sinus Squamous Cell Carcinoma,0
1522,Spindle Cell Metaplasia of Malignant Cells Present,Hereditary Malignant Urinary System Neoplasm,0
1523,Intravascular papillary endothelial hyperplasia,Infiltrating papillary adenocarcinoma,0
1524,Blasts Expressing CD56 and Immature T-Cell Markers Present,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0
1525,Multihormonal Immunoreactivity Present in a Single Cell Type,Acidophil Stem Cell Pituitary Gland Adenoma,0
1526,Spindle Cell Metaplasia of Malignant Cells Present,Ciliary Body Mixed Cell Melanoma,0
1527,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Adenocarcinoma with cartilaginous metaplasia,0
1528,Fenestrated Pattern,Stage IIIA Uterine Corpus Cancer AJCC v7,0
1529,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Epithelioid Leiomyoma,0
1530,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Lung Clear Cell Tumor,0
1531,Increased megakaryocytes (bone marrow),Stage IV Thymoma AJCC v8,0
1532,Endodermal Sinus Pattern,Stage IVC Paranasal Sinus Cancer AJCC v7,0
1533,Inflammatory infiltrate,Inflammatory liposarcoma,0
1534,Increased megakaryocytes (bone marrow),Refractory HIV-Associated Lymphoproliferative Disorder,0
1535,Spindle Cell Metaplasia of Malignant Cells Present,Intermediate Cell Type Choroid Melanoma,0
1536,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Xeroderma Pigmentosum, Complementation Group D",0
1537,Absence of Malignant Features,Malignant Skull Base Neoplasm,0
1538,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infant Acute Undifferentiated Leukemia,0
1539,Mammary Gland Type Features Present,Sweat Gland Tubular Carcinoma,0
1540,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,B-cell small lymphocytic lymphoma stage I,0
1541,Increased megakaryocytes (bone marrow),Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,0
1542,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade II Penile Intraepithelial Neoplasia,0
1543,Immature Myeloid Cells Increased in Bone Marrow,acute biphenotypic leukemia in relapse,0
1544,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Gastroesophageal Junction Adenocarcinoma,0
1545,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,0
1546,Solar Radiation Toxicity,Hemangiosarcoma,0
1547,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,stage IV pancreatic cancer,0
1548,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thrombocythemia, Essential",0
1549,Schwannian Stroma More than 50 Percent of the Tumor Volume,Krukenberg Tumor,0
1550,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult cystic teratoma,0
1551,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pulmonary Artery Intimal Sarcoma,0
1552,Solar Radiation Toxicity,Childhood Rhabdomyosarcoma,0
1553,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Lip Basal Cell Carcinoma,0
1554,NRBC - Nucleated red blood cell present result,Ovarian germ cell choriocarcinoma stage I,0
1555,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Parietal Lobe Ependymal Tumor,0
1556,Squamous metaplasia of bladder,Cervical Squamous Papilloma,0
1557,Well Differentiated Lesion,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,0
1558,Cutaneous plaque,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0
1559,Metaplasia of Malignant Cells Present,Malignant melanoma of iris,0
1560,Fenestrated Pattern,EBV-Related Carcinoma,0
1561,Solar Radiation Toxicity,Stage IIB Prostate Cancer AJCC v8,0
1562,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Cervical Cancer AJCC v6,0
1563,Low Grade Cartilaginous Component Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
1564,Fenestrated Pattern,Childhood Parosteal Osteosarcoma,0
1565,Fenestrated Pattern,Stage IIC Colon Cancer AJCC v8,0
1566,Increased megakaryocytes (bone marrow),Stage I Hypopharyngeal Carcinoma AJCC v8,0
1567,High Grade Lesion,Grade III Lymphomatoid Granulomatosis,0
1568,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
1569,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1570,Spindle Cell Metaplasia of Malignant Cells Present,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1571,Absence of Malignant Features,non-Hodgkin's lymphoma of liver,0
1572,Fenestrated Pattern,NK-lymphoblastic leukemia/lymphoma,0
1573,Increased megakaryocytes (bone marrow),Cholangiocarcinoma resectable,0
1574,Recurrent Genetic Abnormalities Present,Recurrent Thyroid Gland Medullary Carcinoma,0
1575,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Ovarian Dermoid Cyst with Secondary Sarcoma,0
1576,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Sarcoma,0
1577,Glandular cell atypia,Acantholytic squamous cell carcinoma,0
1578,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Indolent Adult Non-Hodgkin Lymphoma,0
1579,Increased megakaryocytes (bone marrow),Stage II Prostate Cancer AJCC v7,0
1580,Fenestrated Pattern,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,0
1581,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Distal Bile Duct Cancer AJCC v8,0
1582,Increased megakaryocytes (bone marrow),Stage IIIB Distal Bile Duct Cancer AJCC v8,0
1583,Venous Type Vascular Channel Formation,Type A Tylosis,0
1584,Immature Granulocytes in Peripheral Blood Increased,Immature Ovarian Teratoma,0
1585,Solar Radiation Toxicity,Stage III Adult Hodgkin Lymphoma,0
1586,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,0
1587,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Childhood Rhabdomyosarcoma,0
1588,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Colorectal Cancer AJCC v7,0
1589,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Malignant Mesothelioma,0
1590,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,pleomorphic carcinoma of breast,0
1591,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8,0
1592,Spindle Cell Osteo-Fibrous Component Present,Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7,0
1593,Low Grade Neuroendocrine Lesion,Grade 1 Ovarian Teratoma,0
1594,Neoplastic Plasma Cells Present in Bone Marrow,Adenocarcinoma in Situ,0
1595,Endometrial Type Glands and Stroma Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,0
1596,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8,0
1597,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 3 Clear Cell Renal Cell Carcinoma,0
1598,Mammary Gland Type Features Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1599,Increased megakaryocytes (bone marrow),Stage IIIC2 Uterine Corpus Cancer AJCC v8,0
1600,Intermediate Grade Neuroendocrine Lesion,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
1601,Increased megakaryocytes (bone marrow),adult nasal type extranodal NK/T-cell lymphoma,0
1602,Solitary Skin Tumor,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
1603,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Ovarian Cancer AJCC v6 and v7,0
1604,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Mediastinal Psammomatous Schwannoma,0
1605,Spindle Cell Osteo-Fibrous Component Present,Basal Cell Ameloblastoma,0
1606,Multihormonal Immunoreactivity Present in a Single Cell Type,Epithelioid Type Angiomyolipoma,0
1607,Nodular and Diffuse Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
1608,Fenestrated Pattern,Colon Micropapillary Adenocarcinoma,0
1609,Spindle Cell Osteo-Fibrous Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,0
1610,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Allograft Thrombosis,0
1611,Confluent Sheets of Anaplastic T-Lymphocytes Present,Adult Anaplastic Oligodendroglioma,0
1612,Antoni B Pattern,"Spindle cell melanoma, type B",0
1613,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fascial fibrosarcoma,0
1614,Increased megakaryocytes (bone marrow),Metastatic leiomyosarcoma,0
1615,Increased megakaryocytes (bone marrow),ROSE Cluster 4,0
1616,Multihormonal Immunoreactivity Present in a Single Cell Type,Clear Cell Adrenal Cortical Adenoma,0
1617,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Lung Cancer AJCC v7,0
1618,Absence of Malignant Features,Carcinoma of subglottis,0
1619,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Vipoma,0
1620,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucosal lentiginous melanoma,0
1621,Gastrointestinal Type Epithelium Present,Gastrointestinal Stromal Sarcoma,0
1622,Metaplasia of Malignant Cells Present,Malignant neoplasm of brain,0
1623,Gastric dysplasia,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
1624,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of esophagus,0
1625,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Maturing Ganglioneuroma,0
1626,Solar Radiation Toxicity,Stage III Osteosarcoma AJCC v7,0
1627,Solar Radiation Toxicity,"Thymoma, type A, malignant",0
1628,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,AIDS-Related Gastric Kaposi Sarcoma,0
1629,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Peritoneal Serous Adenocarcinoma,0
1630,High Grade Non Cartilaginous Sarcomatous Stroma Present,Appendix High Grade Intraepithelial Neoplasia,0
1631,Solar Radiation Toxicity,Kaposi Sarcoma,0
1632,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Ampulla of Vater Cancer by AJCC v7 Stage,0
1633,Recurrent Malignant Neoplasm,Stage IV Gestational Trophoblastic Neoplasm AJCC v8,0
1634,Recurrent Malignant Neoplasm,Biochemically Recurrent Prostate Carcinoma,0
1635,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline RUNX1 Mutation,0
1636,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
1637,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Anemia, Diamond-Blackfan",0
1638,Small Lesion,Small Intestinal Follicular Lymphoma,0
1639,Epithelial hyperplasia of skin,Squamous cell carcinoma of skin,0
1640,Increased megakaryocytes (bone marrow),Stage IIB Uveal Melanoma AJCC v7,0
1641,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
1642,Solar Radiation Toxicity,Pityriasis Rosea,0
1643,Multihormonal Immunoreactivity Present in a Single Cell Type,Squamous Cell Bile Duct Carcinoma,0
1644,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenoid cystic carcinoma of esophagus,0
1645,Progressive Clinical Course,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0
1646,Solar Radiation Toxicity,"Leukoplakia, Hairy",0
1647,Mixed Neoplastic Glandular and Squamous Cell Population,Glucagon Cell Hyperplasia and Neoplasia,0
1648,Spindle Cell Metaplasia of Malignant Cells Present,"Squamous Cell Carcinoma of the Penis, Usual Type",0
1649,Arborising Network of Cords of Basaloid Cells Present,Laryngeal Basaloid Carcinoma,0
1650,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0
1651,Increased megakaryocytes (bone marrow),"Cancer, Supratentorial",0
1652,Increased megakaryocytes (bone marrow),Breast Complex Fibroadenoma,0
1653,Solar Radiation Toxicity,Stage IIIB Anal Cancer AJCC v8,0
1654,Recurrent Malignant Neoplasm,Recurrent Central Nervous System Non-Hodgkin Lymphoma,0
1655,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma in situ of cecum,0
1656,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Sebaceous Breast Carcinoma,0
1657,Fenestrated Pattern,Lymphoepithelioid lymphoma (clinical),0
1658,Increased megakaryocytes (bone marrow),Psammomatous Meningioma,0
1659,Increased megakaryocytes (bone marrow),Chest Wall Hodgkin Lymphoma,0
1660,Spindle Cell Metaplasia of Malignant Cells Present,Pyriform Fossa Squamous Cell Carcinoma,0
1661,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Benign mixed epithelial and stromal tumor of kidney,0
1662,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8,0
1663,Nodular and Diffuse Pattern,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,0
1664,Solar Radiation Toxicity,Solid/Multicystic Ameloblastoma,0
1665,Photosensitivity of skin,Malignant neoplasm of skin,0
1666,Villous Projections of the Neoplastic Epithelium Present,Intestinal Metaplasia of Bladder Urachal Epithelium,0
1667,Fenestrated Pattern,Stage IV Ureter Cancer AJCC v7,0
1668,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anatomic Stage IIIA Breast Cancer AJCC v8,0
1669,Small Aggregates of Tumor Cells Present,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
1670,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Lip Squamous Cell Carcinoma,0
1671,Fenestrated Pattern,Stage III Adult Hodgkin Lymphoma,0
1672,Nests of Nevus Cells Resembling Nerve Bundles Present,Abducens Nerve Palsy,0
1673,Increased megakaryocytes (bone marrow),Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
1674,Solar Radiation Toxicity,Corneal intraepithelial neoplasia,0
1675,Solar Radiation Toxicity,Steroid Lipomatosis,0
1676,Absence of Stromal Invasion,Childhood Gastrointestinal Stromal Tumor,0
1677,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tonsillar Carcinoma,0
1678,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Major Salivary Gland Cancer AJCC v7,0
1679,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,FIGO Stage IC3 Ovarian Cancer,0
1680,More Than Two Separate Tumor Masses Present in the Same Organ,Prostate Carcinoma Metastatic in the Soft Tissue,0
1681,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Cohesive Gastric Carcinoma,0
1682,Aberrant Thyroid Tissue Present,Recurrent Thyroid Carcinoma,0
1683,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Stage I Superficial Spreading Melanoma AJCC v7,0
1684,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Nasal Cavity Cancer AJCC v6 and v7,0
1685,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 4,0
1686,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Hodgkin Lymphoma,0
1687,Glandular cell atypia,Spindle cell liposarcoma,0
1688,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
1689,Moderately Differentiated Lesion,Poorly Differentiated Fibrosarcoma,0
1690,Fenestrated Pattern,Childhood Craniopharyngioma,0
1691,Mucocele of appendix,Neuroendocrine neoplasm of appendix,0
1692,Solar Radiation Toxicity,Childhood Pleomorphic Xanthoastrocytoma,0
1693,Absence of Malignant Features,Secondary malignant neoplasm of spinal cord,0
1694,Increased megakaryocytes (bone marrow),Esophageal adenocarcinoma recurrent,0
1695,Solitary Skin Tumor,Skin Papilloma,0
1696,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, Non-WNT/Non-SHH",0
1697,Fenestrated Pattern,Central Nervous System Carcinoma,0
1698,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Tubal Epithelial Hyperplasia,0
1699,Fenestrated Pattern,Stage I Hilar Cholangiocarcinoma AJCC v7,0
1700,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0
1701,Increased megakaryocytes (bone marrow),Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,0
1702,Fenestrated Pattern,Liver Lymphangiomatosis,0
1703,High Grade Lesion,Grade 2 Endometrial Mucinous Adenocarcinoma,0
1704,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Non-Hodgkin's lymphoma of lung,0
1705,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Borderline cystadenoma,0
1706,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
1707,Skin Erosion,Skin Squamous Cell Carcinoma In Situ,0
1708,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endobronchial Hamartoma,0
1709,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Extragonadal Malignant Germ Cell Tumor,0
1710,Cutaneous plaque,Grade 3 Cutaneous Follicular Lymphoma,0
1711,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mesothelioma malignant advanced,0
1712,Solar Radiation Toxicity,ACTH-Secreting Pituitary Adenoma,0
1713,Multihormonal Immunoreactivity Present in a Single Cell Type,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,0
1714,Non-Encapsulated Neoplasm,Benign Genitourinary System Neoplasm,0
1715,Aberrant Thyroid Tissue Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
1716,Primary Lesion,Primary mediastinal large B-cell lymphoma stage IV,0
1717,Increased megakaryocytes (bone marrow),Stage IIB Eyelid Carcinoma AJCC v8,0
1718,Spindle Cell Osteo-Fibrous Component Present,RISS Stage III Plasma Cell Myeloma,0
1719,Increased megakaryocytes (bone marrow),Stage III Prostate Cancer AJCC v7,0
1720,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Mucinous Cystadenocarcinoma,0
1721,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Childhood Non-Hodgkin Lymphoma,0
1722,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mesothelial hyperplasia,0
1723,Acute inflammation,Recurrent Acute Myelomonocytic Leukemia,0
1724,Solar Radiation Toxicity,Vulvar Lichen Sclerosus,0
1725,Solar Radiation Toxicity,Enchondroma,0
1726,Absence of Malignant Features,Malignant Leptomeningeal Neoplasm,0
1727,Cutaneous plaque,Cutaneous Angioimmunoblastic T-Cell Lymphoma,0
1728,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Adenoma, Microcystic",0
1729,Multihormonal Immunoreactivity Present in a Single Cell Type,Gliomatosis Cerebri Type I,0
1730,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Clear cell sarcoma of kidney,0
1731,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Borderline Ovarian Clear Cell Cystadenofibroma,0
1732,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome,0
1733,Intermediate Grade Neuroendocrine Lesion,Kaposi Sarcoma NCI Grade 3,0
1734,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Ovarian Carcinoma,0
1735,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,0
1736,Large Spaces Filled with Blood Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,0
1737,Spindle Cell Metaplasia of Malignant Cells Present,Distal Esophagus Squamous Cell Carcinoma,0
1738,Increased megakaryocytes (bone marrow),Parotid Gland Lipoma,0
1739,Fenestrated Pattern,Refractory Plasmablastic Lymphoma,0
1740,Absence of Malignant Features,Malignant neoplasm of great vessels,0
1741,Increased megakaryocytes (bone marrow),"Acute myeloid leukemia, inv(16)(p13q22)",0
1742,Multihormonal Immunoreactivity Present in a Single Cell Type,Thymic Clear Cell Carcinoma,0
1743,Solar Radiation Toxicity,Cardiac Rhabdomyosarcoma,0
1744,Increased megakaryocytes (bone marrow),Refractory Fibrosarcoma,0
1745,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,fibrosarcoma of ovary,0
1746,Primary Site Unspecified,"Brain Tumor, Primary",0
1747,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Carcinoma in the Lung,0
1748,Large Mass,Mediastinal (Thymic) Large B-Cell Lymphoma,0
1749,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,0
1750,Increased megakaryocytes (bone marrow),Benign chondrogenic neoplasm,0
1751,Spindle Cell Metaplasia of Malignant Cells Present,cystadenocarcinoma of intrahepatic bile duct,0
1752,Solar Radiation Toxicity,Urethral Condyloma Acuminatum,0
1753,Fenestrated Pattern,Thoracic Esophagus Adenocarcinoma,0
1754,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of epididymis,0
1755,Increased megakaryocytes (bone marrow),Refractory Fibrosarcoma,0
1756,Nodular and Diffuse Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
1757,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Bladder Paraganglioma,0
1758,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory carcinoma of breast stage IV,0
1759,Multihormonal Immunoreactivity Present in a Single Cell Type,Ovarian Sertoli-Stromal Cell Tumor,0
1760,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intramuscular Myxoma,0
1761,Glandular cell atypia,Testicular germ cell tumor mixed stage III,0
1762,Increased megakaryocytes (bone marrow),Stage IVB Oropharyngeal Carcinoma AJCC v7,0
1763,Schwannian Stroma More than 50 Percent of the Tumor Volume,AIDS-Related Non-Hodgkin Lymphoma of the Cervix,0
1764,Spindle Cell Metaplasia of Malignant Cells Present,Hereditary Malignant Neoplasm,0
1765,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0
1766,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Laryngeal Cancer by AJCC v8 Stage,0
1767,Non-Encapsulated Neoplasm,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
1768,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Lung Small Cell Carcinoma,0
1769,Fenestrated Pattern,Stage IIIC Colon Cancer AJCC v7,0
1770,Fenestrated Pattern,Childhood Extraskeletal Osteosarcoma,0
1771,Fenestrated Pattern,Acquired keratoderma,0
1772,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenosquamous carcinoma of salivary gland,0
1773,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant lymphomatous polyposis,0
1774,Recurrent Malignant Neoplasm,Benign Uveal Neoplasm,0
1775,Squamous metaplasia of bladder,Squamous cell carcinoma of pharynx,0
1776,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Carcinoma,0
1777,Increased megakaryocytes (bone marrow),Metaplastic meningioma,0
1778,Absence of Malignant Features,Leiomyoma of Gallbladder,0
1779,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory anemia with ringed sideroblasts,0
1780,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Fallopian Tube Carcinoma,0
1781,Endometrial Type Glands and Stroma Present,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1782,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of prostate,0
1783,Fenestrated Pattern,Macrofollicular adenoma,0
1784,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
1785,Solar Radiation Toxicity,Plexosarcoma,0
1786,Recurrent Genetic Abnormalities Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
1787,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of bladder,0
1788,Solar Radiation Toxicity,Lugano Classification Stage IV Adult Lymphoma AJCC v8,0
1789,Spindle Cell Metaplasia of Malignant Cells Present,Columnar Cell Change of the Breast,0
1790,Increased megakaryocytes (bone marrow),Sclerosing liposarcoma,0
1791,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenoma of Minor Vestibular Glands,0
1792,Fenestrated Pattern,Refractory Hemophagocytic Lymphohistiocytosis,0
1793,Spindle Cell Metaplasia of Malignant Cells Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
1794,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,0
1795,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Burkitt-like lymphoma,0
1796,Solar Radiation Toxicity,Anal Leiomyoma,0
1797,Neoplastic Cells with TFH Cell Phenotype Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
1798,Spindle Cell Metaplasia of Malignant Cells Present,"Adenocarcinoma, Clear Cell",0
1799,Fenestrated Pattern,Stage I Liver Carcinoma,0
1800,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Klatskin Tumor,0
1801,Endometrial Type Glands and Stroma Present,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1802,Solar Radiation Toxicity,Marginal Zone B-Cell Lymphoma,0
1803,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pituitary Gland Microadenoma,0
1804,Progressive Clinical Course,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
1805,Spindle Cell Metaplasia of Malignant Cells Present,Metastatic Lung Small Cell Carcinoma,0
1806,Increased megakaryocytes (bone marrow),Stage IA Eyelid Carcinoma AJCC v8,0
1807,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Odontogenic myxoma,0
1808,Fenestrated Pattern,Ceruminous adenocarcinoma,0
1809,Increased megakaryocytes (bone marrow),Hypopharyngeal Carcinoma,0
1810,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Neoplasm,0
1811,Solar Radiation Toxicity,Pancreatic sarcoma,0
1812,Mammary Gland Type Features Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1813,Solar Radiation Toxicity,Masaoka-Koga Stage IV,0
1814,Fenestrated Pattern,Meningothelial meningioma,0
1815,Recurrent Malignant Neoplasm,Recurrent Pancreatic Ductal Adenocarcinoma,0
1816,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extraventricular neurocytoma,0
1817,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of endocervix,0
1818,Radial Growth Phase,Radial scar,0
1819,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lymphoma by Site,0
1820,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Recurrent Childhood Astrocytic Tumor,0
1821,Solar Radiation Toxicity,Cutis Laxa,0
1822,Solar Radiation Toxicity,Lentigo simplex,0
1823,Diffuse Cellular Infiltrate,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,0
1824,Fried-Egg Appearance of the Bone Marrow,Intermediate Bone Neoplasm,0
1825,Schwannian Stroma More than 50 Percent of the Tumor Volume,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
1826,Increased megakaryocytes (bone marrow),Stage I Lip Carcinoma,0
1827,Absence of Malignant Features,Hemangioma of subcutaneous tissue,0
1828,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Sarcoma of breast,0
1829,Nodular and Diffuse Pattern,Stage IIB Pancreatic Cancer AJCC v6 and v7,0
1830,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Luminal A Prostate Carcinoma,0
1831,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Favorable Non-Hodgkin Lymphoma,0
1832,Diffuse Lesion,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
1833,Increased megakaryocytes (bone marrow),Lugano Classification Limited Stage Adult Lymphoma AJCC v8,0
1834,Solar Radiation Toxicity,Lymphoma stage I,0
1835,Fenestrated Pattern,Stage I Childhood Lymphoblastic Lymphoma,0
1836,Skin Erosion,Unresectable Skin Squamous Cell Carcinoma,0
1837,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IIB Cervical Cancer AJCC v6 and v7,0
1838,Chronic Inflammatory Infiltrate,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
1839,Spindle Cell Metaplasia of Malignant Cells Present,Serous cystadenoma of pancreas,0
1840,Absence of Malignant Features,Stage IB Pleural Malignant Mesothelioma AJCC v8,0
1841,Large Spaces Filled with Blood Present,Refractory anaemia with excess blasts,0
1842,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pituitary Gland Multiple Adenomas,0
1843,Metaplasia of Malignant Cells Present,Intestinal Metaplasia of Bladder Urothelium,0
1844,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,0
1845,Recurrent Malignant Neoplasm,Prostatic Urethral Malignant Neoplasm,0
1846,Large Spaces Filled with Blood Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
1847,Schwannian Stroma More than 50 Percent of the Tumor Volume,Temporal Lobe Ependymal Tumor,0
1848,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant ganglioneuroblastoma of adrenal gland,0
1849,Intermediate Grade Neuroendocrine Lesion,AJCC Grade 1 Sarcoma,0
1850,Spindle Cell Metaplasia of Malignant Cells Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0
1851,Increased megakaryocytes (bone marrow),Gastric dysplasia,0
1852,Mixture of Germ Cell Neoplastic Components Present,Stage II Renal Cell Cancer AJCC v7,0
1853,Solar Radiation Toxicity,Anal Lymphoma,0
1854,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,0
1855,Multihormonal Immunoreactivity Present in a Single Cell Type,Papillary Renal Cell Carcinoma,0
1856,Increased megakaryocytes (bone marrow),Ceruminous adenocarcinoma,0
1857,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),0
1858,Fried-Egg Appearance of the Bone Marrow,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
1859,Increased megakaryocytes (bone marrow),Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
1860,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ampulla of Vater Neuroendocrine Neoplasm,0
1861,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary haemophagocytic lymphohistiocytosis,0
1862,Absence of Malignant Features,malignant ganglioneuroblastoma of adrenal gland,0
1863,Benign Cellular Infiltrate,Benign Lymphoproliferative Disorder,0
1864,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Transformed Non-Hodgkin Lymphoma,0
1865,Chronic Inflammatory Infiltrate,Recurrent Chronic Lymphoid Leukemia,0
1866,Absence of Malignant Features,Secondary malignant neoplasm of pleura,0
1867,Increased megakaryocytes (bone marrow),Childhood Ganglioglioma,0
1868,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of ovary,0
1869,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of subglottis,0
1870,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of eyelid,0
1871,Low Grade Neuroendocrine Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
1872,Large Spaces Filled with Blood Present,Small Intestinal Diffuse Large B-Cell Lymphoma,0
1873,Increased megakaryocytes (bone marrow),DDIT4L Acute Lymphoblastic Leukemia,0
1874,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
1875,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of ovary,0
1876,Fenestrated Pattern,Duodenal Extraskeletal Osteosarcoma,0
1877,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of epiglottis,0
1878,Fenestrated Pattern,Stage IVB Gallbladder Carcinoma,0
1879,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IVB Oral Cavity Cancer AJCC v6 and v7,0
1880,Low Grade Cartilaginous Component Present,Low Grade Salivary Gland Carcinoma,0
1881,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Liver Carcinoma,0
1882,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of breast,0
1883,Fenestrated Pattern,Masaoka-Koga Stage I,0
1884,Increased megakaryocytes (bone marrow),Post-Radiotherapy Breast Angiosarcoma,0
1885,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of placenta,0
1886,Absence of Malignant Features,Malignant tumor of external ear,0
1887,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bizarre parosteal osteochondromatous proliferation,0
1888,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Early Favorable Non-Hodgkin Lymphoma,0
1889,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,0
1890,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Eyelid Carcinoma by AJCC v8 Stage,0
1891,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Cell Carcinoma,0
1892,Villous Projections of the Neoplastic Epithelium Present,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,0
1893,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal Verrucous Carcinoma,0
1894,Large Spaces Filled with Blood Present,Adult Systemic Anaplastic Large Cell Lymphoma,0
1895,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
1896,Increased megakaryocytes (bone marrow),Histiocytoid hemangioma,0
1897,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Follicular Variant Thyroid Gland Papillary Carcinoma,0
1898,High Grade Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
1899,Glandular cell atypia,Lung squamous cell carcinoma stage IV,0
1900,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
1901,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Small cell carcinoma of prostate,0
1902,Fenestrated Pattern,Angiocentric glioma,0
1903,Mammary Gland Type Features Present,Atypical Pituitary Gland Adenoma,0
1904,Lesion with Diameter of 2cm or Less,Colorectal Adenoma with Mild Dysplasia,0
1905,More Than Two Separate Tumor Masses Present in the Same Organ,Uveal Melanoma Metastatic in the Liver,0
1906,Intermediate Grade Neuroendocrine Lesion,Grade 3 Colorectal Adenocarcinoma,0
1907,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tanycytic ependymoma,0
1908,Chronic lymphocytic inflammation,Chronic lymphocytic leukemia stage 4,0
1909,Increased megakaryocytes (bone marrow),Stage IB Distal Bile Duct Cancer AJCC v7,0
1910,Increased megakaryocytes (bone marrow),Pleomorphic carcinoma,0
1911,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1912,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukemia, Myeloid, Accelerated Phase",0
1913,Fenestrated Pattern,Gallbladder adenosquamous carcinoma,0
1914,Spindle Cell Metaplasia of Malignant Cells Present,Hemangiosarcoma of heart,0
1915,Schwannian Stroma More than 50 Percent of the Tumor Volume,Recurrent Gastrointestinal Stromal Tumor,0
1916,Localized Lesion,Localized Resectable Adult Liver Carcinoma,0
1917,Lobular Pattern,Atypical Lobular Breast Hyperplasia,0
1918,Increased megakaryocytes (bone marrow),Ameloblastic fibrosarcoma,0
1919,High Grade Non Cartilaginous Sarcomatous Stroma Present,AJCC Grade 2 Sarcoma,0
1920,Increased megakaryocytes (bone marrow),"Trophoblastic tumor, epithelioid",0
1921,Nodular and Diffuse Pattern,Stage IIB Ovarian Cancer AJCC v6 and v7,0
1922,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of fallopian tube,0
1923,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
1924,Exophytic Papillary Lesion,Papillary Meningioma,0
1925,Less than 2 Mitoses per 10HPF,Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma,0
1926,Recurrent Malignant Neoplasm,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,0
1927,Intraepithelial Neoplasia,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
1928,Increased megakaryocytes (bone marrow),"Trophoblastic tumor, epithelioid",0
1929,Solar Radiation Toxicity,Stage IIIB Lung Cancer AJCC v7,0
1930,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of scrotum,0
1931,Chronic Clinical Course,Refractory Chronic Myelomonocytic Leukemia,0
1932,Primary Lesion,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
1933,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Ovarian Mature Teratoma,0
1934,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Mixed Glioma,0
1935,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Distal Bile Duct Cancer AJCC v8,0
1936,Metaplasia of Malignant Cells Present,Malignant neoplasm of mandible,0
1937,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Parasite-Related Carcinoma,0
1938,Squamous metaplasia of bladder,Squamous cell carcinoma of lip,0
1939,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
1940,Absence of Malignant Features,Benign neoplasm of renal pelvis,0
1941,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Pleomorphic Adenoma,0
1942,Low Grade Neuroendocrine Lesion,Low Grade Ductal Breast Carcinoma In Situ,0
1943,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Moderate epithelial dysplasia,0
1944,Absence of Malignant Features,Stage IIIA Pleural Malignant Mesothelioma AJCC v8,0
1945,Increased megakaryocytes (bone marrow),Adenosarcoma,0
1946,Cutaneous plaque,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,0
1947,Plasma cell inflammation,Superficial basal cell carcinoma,0
1948,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Supratentorial Glioblastoma,0
1949,Spindle Cell Metaplasia of Malignant Cells Present,Borderline Ovarian Clear Cell Cystadenofibroma,0
1950,Progressive Clinical Course,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,0
1951,Chronic Inflammatory Infiltrate,Chronic lymphocytic leukemia refractory,0
1952,Large Spaces Filled with Blood Present,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,0
1953,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Verrucous Carcinoma,0
1954,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Retroperitoneal Sarcoma AJCC v8,0
1955,Fenestrated Pattern,Stage II Esophageal Cancer AJCC v7,0
1956,Fenestrated Pattern,Stage IIIC Vulvar Cancer AJCC v8,0
1957,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Carcinoma in the Liver,0
1958,Spindle Cell Metaplasia of Malignant Cells Present,Serous cystadenoma of ovary,0
1959,Fenestrated Pattern,Sebaceous adenoma,0
1960,Cervical lymphadenopathy,Cervical Intraepithelial Neoplasia,0
1961,Recurrent Malignant Neoplasm,Cutaneous Precursor Lymphoid Neoplasm,0
1962,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Osteoma of skull,0
1963,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chondrogenic Neoplasm,0
1964,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
1965,Confluent Sheets of Anaplastic T-Lymphocytes Present,Secondary Supratentorial Anaplastic Astrocytoma,0
1966,Nodular and Diffuse Pattern,Benign Peritoneal and Retroperitoneal Neoplasm,0
1967,Herringbone Growth Pattern,Growth Hormone-Secreting Pituitary Adenoma,0
1968,Non-Encapsulated Neoplasm,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
1969,Fenestrated Pattern,Pleuropulmonary blastoma type II,0
1970,Fenestrated Pattern,Hereditary benign intraepithelial dyskeratosis,0
1971,Chronic Inflammatory Infiltrate,Chronic Myelomonocytic Leukemia with Eosinophilia,0
1972,Increased megakaryocytes (bone marrow),Fibrous polyp,0
1973,Solitary Skin Tumor,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
1974,Absence of Malignant Features,Peutz-Jeghers polyps of small bowel,0
1975,Large Mass,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0
1976,No Evidence of Metastatic Disease,Chronic Bullous Disease of Childhood,0
1977,Fenestrated Pattern,"Ovarian Yolk Sac Tumor, Glandular Pattern",0
1978,Solar Radiation Toxicity,Ectopic hamartomatous thymoma,0
1979,Increased megakaryocytes (bone marrow),Radiation-induced fibrous mediastinitis,0
1980,Follicular Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1981,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Distal Bile Duct Cancer AJCC v8,0
1982,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Ovarian Teratoma AJCC v6 and v7,0
1983,Increased megakaryocytes (bone marrow),Fanconi Anemia,0
1984,Microinvasive tumor,Mixed parotid tumor,0
1985,Endometrial Type Glands and Stroma Present,Invasive Ductal and Lobular Carcinoma,0
1986,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Thymoma,0
1987,Fenestrated Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma,0
1988,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Clivus Chondroid Chordoma,0
1989,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Liver Cavernous Hemangioma,0
1990,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,lymphangiosarcoma,0
1991,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extrarenal rhabdoid tumor,0
1992,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Rectal Cancer by AJCC v6 Stage,0
1993,Gastric dysplasia,Unresectable Gastric Adenocarcinoma,0
1994,Increased megakaryocytes (bone marrow),Rectal hyperplastic polyp,0
1995,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
1996,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pilocytic astrocytoma of cerebellum,0
1997,Spindle Cell Metaplasia of Malignant Cells Present,Leiomyosarcoma of small intestine,0
1998,Marked Thickening of the Bladder Urothelium Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,0
1999,Blasts Expressing CD56 and Immature T-Cell Markers Present,Small Intestinal T-Cell Non-Hodgkin Lymphoma,0
2000,Aggressive Clinical Course,Aggressive osteoblastoma,0
2001,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
2002,Endometrial Type Glands and Stroma Present,Stage IA Cervical Cancer AJCC v6 and v7,0
2003,Diffuse Cellular Infiltrate,Diffuse neurofibroma,0
2004,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
2005,Spindle Cell Metaplasia of Malignant Cells Present,Pigmented Basal Cell Carcinoma,0
2006,Schwannian Stroma More than 50 Percent of the Tumor Volume,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2007,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ceruminous Neoplasm,0
2008,Diffuse Cellular Infiltrate,Diffuse Large B-Cell Lymphoma,0
2009,Intersecting Sharply Marginated Clusters of Spindle Cells Present,large B-cell diffuse lymphoma of accessory sinus,0
2010,Intersecting Sharply Marginated Clusters of Spindle Cells Present,mucoepidermoid carcinoma of esophagus,0
2011,Sarcomatoid Features,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,0
2012,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Oral Cavity Carcinoma,0
2013,Absence of Malignant Features,Sarcoma of ovary,0
2014,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fundic gland polyp,0
2015,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bullous pemphigoid,0
2016,Spindle Cell Metaplasia of Malignant Cells Present,rhabdomyosarcoma of extrahepatic bile duct,0
2017,Neoplastic Plasma Cells Present in Bone Marrow,Carcinoma Arising in Nasal Papillomatosis,0
2018,Recurrent Malignant Neoplasm,Malignant Intracranial Neoplasm,0
2019,Increased megakaryocytes (bone marrow),Stage IIA Lung Cancer AJCC v7,0
2020,Metastatic/Recurrent Disease,Refractory Erdheim-Chester Disease,0
2021,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Monocytoid B-cell lymphoma,0
2022,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Refractory anemia with ringed sideroblasts,0
2023,Solar Radiation Toxicity,Stage 0 Ureter Cancer AJCC v7,0
2024,NRBC - Nucleated red blood cell present result,Acantholytic squamous cell carcinoma,0
2025,Spindle Cell Metaplasia of Malignant Cells Present,squamous cell carcinoma of lacrimal gland,0
2026,Increased megakaryocytes (bone marrow),"Lymphohistiocytosis, Hemophagocytic",0
2027,Fenestrated Pattern,"Optic Atrophy, Hereditary, Leber",0
2028,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenomatous polyp of colon,0
2029,Fenestrated Pattern,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2030,Increased megakaryocytes (bone marrow),Prognostic Stage IIIC Breast Cancer AJCC v8,0
2031,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Appendix Tubular Adenoma,0
2032,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Medullary carcinoma of breast,0
2033,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2034,Gastric dysplasia,Pathologic Stage III Gastric Cancer AJCC v8,0
2035,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Lung Cancer AJCC v8,0
2036,Recurrent Malignant Neoplasm,Benign Anterior Tongue Neoplasm,0
2037,Increased megakaryocytes (bone marrow),Dermatofibrosarcoma Protuberans,0
2038,Increased megakaryocytes (bone marrow),Stage IV Adult Hodgkin Lymphoma,0
2039,Abundance of Small Lymphocytes,Small Intestinal Myeloid Sarcoma,0
2040,Increased megakaryocytes (bone marrow),Mucinous Adenocarcinoma,0
2041,Solitary Skin Tumor,Dermal Duct Tumor,0
2042,Increased megakaryocytes (bone marrow),Gingival fibroepithelial polyp,0
2043,Fenestrated Pattern,Lymphoma,0
2044,Absence of Malignant Features,Metachronous Malignant Neoplasm,0
2045,Increased megakaryocytes (bone marrow),Retinoblastoma unilateral,0
2046,Increased megakaryocytes (bone marrow),Deep Penetrating Nevus,0
2047,Malignant Primitive Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm,0
2048,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Testicular Tumor of the Thecoma/Fibroma Group,0
2049,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Colorectal Adenoma with Severe Dysplasia,0
2050,Endometrial Type Glands and Stroma Present,Endometrial Dedifferentiated Carcinoma,0
2051,Increased megakaryocytes (bone marrow),"Dermatitis, Allergic Contact",0
2052,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of epiglottis,0
2053,Malignant Primitive Cellular Infiltrate,Malignant Mediastinal Non-Seminomatous Germ Cell Tumor,0
2054,Fenestrated Pattern,bilateral breast cancer,0
2055,Fenestrated Pattern,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
2056,Absence of Malignant Features,Adenoid basal carcinoma of cervix uteri,0
2057,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Central Nervous System Ganglioneuroblastoma,0
2058,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIB Fallopian Tube Cancer AJCC v6 and v7,0
2059,Fenestrated Pattern,Cerebellar Glioblastoma,0
2060,Increased megakaryocytes (bone marrow),Lymphoplasmacyte-rich meningioma,0
2061,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thyroid Hyalinizing Trabecular Adenoma,0
2062,Fenestrated Pattern,External Auditory Canal Ceruminous Adenoma,0
2063,Fenestrated Pattern,Acute lymphoblastic leukemia recurrent,0
2064,Fenestrated Pattern,Fibromatosis,0
2065,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chordoid meningioma,0
2066,Fenestrated Pattern,Colorectal Kaposi Sarcoma,0
2067,Recurrent Malignant Neoplasm,Intermediate Osteogenic Neoplasm,0
2068,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0
2069,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic osteosarcoma,0
2070,Lesion with Diameter of 2cm or Less,Ovarian Dermoid Cyst with Adenocarcinoma,0
2071,Increased megakaryocytes (bone marrow),Adult Classical Hodgkin Lymphoma,0
2072,Increased megakaryocytes (bone marrow),Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8,0
2073,Fenestrated Pattern,Oral Cavity Mucosal Melanoma,0
2074,Fenestrated Pattern,Nipple Carcinoma,0
2075,Dilated Terminal Duct Lobular Units Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0
2076,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Ureter Urothelial Carcinoma,0
2077,Schwannian Stroma More than 50 Percent of the Tumor Volume,Jejunal Neuroendocrine Tumor G1,0
2078,Fenestrated Pattern,Tumorlet,0
2079,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,0
2080,Neoplastic Plasma Cells Present in Bone Marrow,Localized Bone Ewing Sarcoma,0
2081,Multihormonal Immunoreactivity Present in a Single Cell Type,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
2082,Fenestrated Pattern,Adult Ependymoma,0
2083,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIC Appendix Carcinoma AJCC v8,0
2084,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
2085,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
2086,Absence of Stromal Invasion,Childhood Gastrointestinal Stromal Tumor,0
2087,Solar Radiation Toxicity,Beckwith-Wiedemann Syndrome,0
2088,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Traditional Serrated Adenoma,0
2089,Skin Red Dot,Skin Mastocytoma,0
2090,Mammary Gland Type Features Present,Parotid Gland Lipoma,0
2091,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic thymic carcinoma,0
2092,Villous Projections of the Neoplastic Epithelium Present,squamous cell carcinoma of the thyroid gland,0
2093,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,0
2094,Photosensitivity of skin,Precancerous skin lesion,0
2095,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),0
2096,Increased megakaryocytes (bone marrow),Stage IVB Vulvar Cancer AJCC v8,0
2097,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Atrophoderma maculatum,0
2098,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Urethral Cancer AJCC v8,0
2099,Mammary Gland Type Features Present,Childhood Parathyroid Gland Carcinoma,0
2100,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA1 Cervical Cancer,0
2101,Nodular and Diffuse Pattern,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2102,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,0
2103,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Soft Tissues,0
2104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,PRETEXT Stage 1 Hepatoblastoma,0
2105,Non-Encapsulated Neoplasm,Small Intestinal Neuroendocrine Neoplasm,0
2106,Mixed Neoplastic Glandular and Squamous Cell Population,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",0
2107,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fibrolipoma,0
2108,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Benign Ovarian Transitional Cell Tumor,0
2109,Endometrial Type Glands and Stroma Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
2110,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Bladder Signet Ring Cell Adenocarcinoma,0
2111,Solar Radiation Toxicity,'Refractory Paraganglioma',0
2112,Increased megakaryocytes (bone marrow),Vaginal Myofibroblastoma,0
2113,Absence of Malignant Features,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,0
2114,Cervical lymphadenopathy,High Grade Cervical Intraepithelial Neoplasia,0
2115,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIA Gastric Cancer AJCC v8,0
2116,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Uveal Melanoma AJCC v7,0
2117,Fenestrated Pattern,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,0
2118,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides stage I,0
2119,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Central Nervous System Immature Teratoma,0
2120,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage II Gastric Cancer AJCC v8,0
2121,Mammary Gland Type Features Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,0
2122,Fenestrated Pattern,Extraskeletal osteosarcoma metastatic,0
2123,Increased megakaryocytes (bone marrow),polyps,0
2124,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,undifferentiated carcinoma of liver,0
2125,Epithelioid Differentiation,Kidney Epithelioid Type Angiomyolipoma,0
2126,Fenestrated Pattern,Pleuropulmonary blastoma,0
2127,Increased megakaryocytes (bone marrow),Renal Pelvis Urothelial Papilloma,0
2128,Increased megakaryocytes (bone marrow),Refractory Hepatoblastoma,0
2129,Diffuse Lesion,Childhood Cerebral Diffuse Astrocytoma,0
2130,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult B Lymphoblastic Lymphoma,0
2131,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
2132,Solar Radiation Toxicity,Spongiotic dermatitis,0
2133,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged,0
2134,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of labium minus,0
2135,Non-Encapsulated Neoplasm,Cervical Squamous Neoplasm,0
2136,Increased megakaryocytes (bone marrow),Myxoinflammatory fibroblastic sarcoma,0
2137,Increased megakaryocytes (bone marrow),"Retinoblastoma, diffuse",0
2138,Recurrent Malignant Neoplasm,Recurrent Kaposi Sarcoma,0
2139,Recurrent Malignant Neoplasm,Recurrent Childhood Hodgkin Lymphoma,0
2140,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Medullary Carcinoma,0
2141,Glandular cell atypia,Blastic plasmacytoid dendritic cell neoplasm,0
2142,Tumor Mass,Rhabdoid Tumor,0
2143,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2144,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,0
2145,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2146,Solar Radiation Toxicity,Renal Pelvis Urothelial Papilloma,0
2147,Absence of Malignant Features,Benign tumor of mediastinum,0
2148,Fenestrated Pattern,Stage IV Vulvar Cancer AJCC v6,0
2149,Increased megakaryocytes (bone marrow),Stage IIC Colorectal Cancer AJCC v8,0
2150,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2151,Mammary Gland Type Features Present,Parotid Gland Carcinoma,0
2152,Increased megakaryocytes (bone marrow),Locally Advanced Angiosarcoma,0
2153,Well Differentiated Lesion,Poorly Differentiated Fibrosarcoma,0
2154,Breast Implant-Related Lesion,Stage IIB Breast Carcinoma,0
2155,Solar Radiation Toxicity,"Cystadenoma, Mucinous",0
2156,Increased megakaryocytes (bone marrow),Stage IV Adult Lymphoblastic Lymphoma,0
2157,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Phosphaturic mesenchymal tumor, malignant",0
2158,Tumor Mass,Pancoast Tumor,0
2159,Fenestrated Pattern,Dermatosis Papulosa Nigra,0
2160,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Subsequent Malignant Neoplasm,0
2161,Absence of Malignant Features,Adenocarcinoma of anal canal,0
2162,Breast Implant-Related Lesion,Sebaceous Breast Carcinoma,0
2163,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,0
2164,Endometrial Type Glands and Stroma Present,Endometrial Mucinous Adenocarcinoma,0
2165,Absence of Malignant Features,Malignant melanoma of retina,0
2166,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bowenoid papulosis,0
2167,Solitary Skin Tumor,Refractory Rhabdoid Tumor,0
2168,Absence of Stromal Invasion,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
2169,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parotid Gland Kaposi Sarcoma,0
2170,Fenestrated Pattern,Erythema multiforme minor,0
2171,Spindle Cell Metaplasia of Malignant Cells Present,Grade 1 Clear Cell Renal Cell Carcinoma,0
2172,Increased megakaryocytes (bone marrow),ROSE Cluster 4,0
2173,Increased megakaryocytes (bone marrow),Central Nervous System Chondroma,0
2174,Increased megakaryocytes (bone marrow),Urethral Verrucous Carcinoma,0
2175,Endometrial Type Glands and Stroma Present,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,0
2176,Endometrial Type Glands and Stroma Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,0
2177,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
2178,Broad Fibrous Bands Formation,Fibrous Meningioma,0
2179,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage,0
2180,Recurrent Malignant Neoplasm,Recurrent Childhood Brain Stem Astrocytoma,0
2181,Fried-Egg Appearance of the Bone Marrow,Stage IIA Bone Sarcoma AJCC v7,0
2182,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of parathyroid gland,0
2183,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Hepatocellular Carcinoma AJCC v8,0
2184,Fenestrated Pattern,Stage IIA Colorectal Cancer AJCC v7,0
2185,Fenestrated Pattern,Stage IIB Penile Cancer AJCC v8,0
2186,Solar Radiation Toxicity,Asbestos-Related Lung Disorder,0
2187,Solar Radiation Toxicity,Ear carcinoma,0
2188,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Esophagus Adenocarcinoma,0
2189,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory Hepatocellular Adenoma,0
2190,Solitary Skin Tumor,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
2191,Spindle Cell Metaplasia of Malignant Cells Present,Sellar Mixed Germ Cell Tumor,0
2192,Gastric dysplasia,Stage IB Gastric Carcinoma,0
2193,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,0
2194,Solar Radiation Toxicity,Lentigo maligna melanoma,0
2195,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IC Uterine Corpus Cancer AJCC v6,0
2196,Endometrial Type Glands and Stroma Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,0
2197,Aberrant Thyroid Tissue Present,Stage IA Soft Tissue Sarcoma AJCC v7,0
2198,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Metastatic Lung Neuroendocrine Neoplasm,0
2199,Absence of Malignant Features,Stage IA Pleural Malignant Mesothelioma AJCC v7,0
2200,Solar Radiation Toxicity,Ichthyosis Vulgaris,0
2201,Bone Marrow Involvement,Stage I Bone Cancer AJCC v8,0
2202,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of vulva,0
2203,Fenestrated Pattern,Stage IIIA Rectal Cancer AJCC v8,0
2204,Absence of Malignant Features,carcinosarcoma of liver,0
2205,Unfavorable Clinical Outcome,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0
2206,Absence of Muscle Invasion,Benign Smooth Muscle Neoplasm,0
2207,Increased megakaryocytes (bone marrow),Platinum-Resistant Ovarian Carcinoma,0
2208,Squamous metaplasia of bladder,Squamous cell carcinoma of floor of mouth,0
2209,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile polyp,0
2210,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Gastric Intraepithelial Neoplasia,0
2211,Recurrent Malignant Neoplasm,Recurrent Malignant Ovarian Brenner Tumor,0
2212,Increased megakaryocytes (bone marrow),Colonic tubulovillous adenoma,0
2213,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign tumor of endocrine gland,0
2214,Solar Radiation Toxicity,"Phyllodes tumor, benign",0
2215,Fenestrated Pattern,Stage IV Esophageal Cancer AJCC v7,0
2216,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Cervical Mesonephric Remnants and Hyperplasia,0
2217,Tumor Mass,Childhood Yolk Sac Tumor,0
2218,Solar Radiation Toxicity,Proneural Glioblastoma,0
2219,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Basophilic Adenocarcinoma,0
2220,Increased megakaryocytes (bone marrow),"Myositis, Proliferative",0
2221,Fenestrated Pattern,Esophageal Melanoma,0
2222,Hydropic Villous Change,Vaginal Villous Adenoma,0
2223,Large Mass,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",0
2224,Invasive Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma,0
2225,Increased megakaryocytes (bone marrow),Exfoliative dermatitis,0
2226,Nodular and Diffuse Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
2227,Invasive Lesion,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
2228,Increased megakaryocytes (bone marrow),Stage IVA Uterine Corpus Adenosarcoma AJCC v8,0
2229,Increased megakaryocytes (bone marrow),Conventional Lipoma,0
2230,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Sarcoma of pelvis,0
2231,Recurrent Malignant Neoplasm,Recurrent Appendix Carcinoma,0
2232,Spindle Cell Metaplasia of Malignant Cells Present,Fallopian Tube Transitional Cell Carcinoma,0
2233,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Colon Cancer AJCC v8,0
2234,Mixture of Germ Cell Neoplastic Components Present,Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,0
2235,Large Mass,"Carcinoma, Large Cell",0
2236,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Kaposi's sarcoma of conjunctiva,0
2237,Fenestrated Pattern,Immunodeficiency-Associated Lymphoproliferative Disorder,0
2238,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2239,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
2240,Lesion Less than 5mm in Diameter,Adenocarcinoma in adenomatous polyp,0
2241,Malignant Primitive Cellular Infiltrate,Undifferentiated Malignant Neoplasm,0
2242,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Notochordal Cell Tumor,0
2243,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma,0
2244,Recurrent Genetic Abnormalities Present,Recurrent Childhood Hepatocellular Carcinoma,0
2245,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, SHH-Activated",0
2246,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,0
2247,Solitary Skin Tumor,Uterine Corpus Carcinoid Tumor,0
2248,Tumor Mass,Fallopian Tube Metaplastic Papillary Tumor,0
2249,Increased megakaryocytes (bone marrow),Stage III Nasopharyngeal Carcinoma,0
2250,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,0
2251,Fenestrated Pattern,Benign Intracranial Meningioma,0
2252,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Ovarian Primitive Germ Cell Tumor,0
2253,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of salivary gland,0
2254,Solar Radiation Toxicity,Childhood Meningioma,0
2255,Marked Thickening of the Bladder Urothelium Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2256,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Neoplasm,0
2257,Absence of Malignant Features,Unresectable Malignant Neoplasm,0
2258,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Localized Askin Tumor,0
2259,Recurrent Malignant Neoplasm,Recurrent Thymic Carcinoma,0
2260,Absence of Malignant Features,Ovarian Malignant Mesothelioma,0
2261,Fenestrated Pattern,Stage I Nasopharyngeal Carcinoma AJCC v7,0
2262,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0
2263,Acute inflammation,Acute bilineal leukemia,0
2264,Small Aggregates of Tumor Cells Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,0
2265,Absence of Malignant Features,Malignant neoplasm of muscle,0
2266,Aberrant Thyroid Tissue Present,Stage II Adult Soft Tissue Sarcoma AJCC v7,0
2267,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Esophageal Neuroendocrine Carcinoma,0
2268,Solar Radiation Toxicity,Myofibromatosis,0
2269,Multihormonal Immunoreactivity Present in a Single Cell Type,Vaginal Large Cell Neuroendocrine Carcinoma,0
2270,Neoplastic Plasma Cells Present in Bone Marrow,Melanoma Arising in Giant Congenital Nevus,0
2271,Increased megakaryocytes (bone marrow),Lung Pleomorphic Adenoma,0
2272,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
2273,Solar Radiation Toxicity,Stage II Adult Liver Cancer AJCC v7,0
2274,Malignant Primitive Cellular Infiltrate,Primary Malignant Liver Neoplasm,0
2275,Fenestrated Pattern,Non-Functioning Corticotroph Adenoma,0
2276,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Glioma,0
2277,Fenestrated Pattern,Stage IIIC Rectal Cancer AJCC v7,0
2278,Metaplasia of Malignant Cells Present,Malignant neoplasm of nasopharynx,0
2279,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Undifferentiated Pleomorphic Sarcoma,0
2280,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,0
2281,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8,0
2282,Malignant Primitive Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,0
2283,Follicular Differentiation,Grade 3 Cutaneous Follicular Lymphoma,0
2284,Dilated Terminal Duct Lobular Units Present,Stage IIA Distal Bile Duct Cancer AJCC v7,0
2285,Low Grade Neuroendocrine Lesion,Low Grade Salivary Gland Carcinoma,0
2286,Fenestrated Pattern,Anaplastic (Malignant) Intracranial Meningioma,0
2287,Plasma cell inflammation,Acinar cell tumor,0
2288,Fenestrated Pattern,T-cell lymphoma stage IV,0
2289,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,0
2290,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Breast Carcinoma with Choriocarcinomatous Features,0
2291,Increased megakaryocytes (bone marrow),Colon Lymphangioma,0
2292,Fenestrated Pattern,Stage IIB Esophageal Adenocarcinoma AJCC v7,0
2293,Recurrent Malignant Neoplasm,Recurrent Rhabdomyosarcoma,0
2294,Non-Encapsulated Neoplasm,Recurrent Spinal Cord Neoplasm,0
2295,Chronic Inflammatory Infiltrate,Chronic lymphocytic leukemia stage 0,0
2296,Large Spaces Filled with Blood Present,Myelodysplastic Syndrome with Gene Mutation,0
2297,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Atrophic Variant",0
2298,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Synovial Sarcoma,0
2299,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hypertrophic lichen planus,0
2300,Solar Radiation Toxicity,Stage IIIA Uterine Corpus Cancer AJCC v8,0
2301,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
2302,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the oral cavity stage I,0
2303,Metaplasia of Malignant Cells Present,Malignant neoplasm of mouth,0
2304,Absence of Malignant Features,Angiomyolipoma of kidney,0
2305,Aberrant Thyroid Tissue Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
2306,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,0
2307,Increased megakaryocytes (bone marrow),Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
2308,Recurrent Genetic Abnormalities Present,Recurrent Urethral Cancer,0
2309,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Breast Solid Neuroendocrine Carcinoma,0
2310,Lymphocyte count increased,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2311,Non-Encapsulated Neoplasm,Benign Fibroblastic Neoplasm,0
2312,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Ampulla of Vater Cancer AJCC v8,0
2313,Unfavorable Clinical Outcome,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
2314,Microinvasive tumor,Pancreatic neuroendocrine tumor metastatic,0
2315,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
2316,Solar Radiation Toxicity,Periosteal Osteosarcoma,0
2317,Villous Projections of the Neoplastic Epithelium Present,Plasmablastic Lymphoma of the Oral Mucosa,0
2318,Absence of Malignant Features,Malignant Mediastinal Soft Tissue Neoplasm,0
2319,Neoplastic Plasma Cells Present in Bone Marrow,Bone Leiomyoma,0
2320,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,Malignant Neoplasm with Regional Lymph Node Involvement,0
2321,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Skin Squamous Cell Carcinoma,0
2322,Absence of Stromal Invasion,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
2323,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-neoplastic nevus of skin,0
2324,Increased megakaryocytes (bone marrow),Stage III Liver Cancer,0
2325,Absence of Malignant Features,rhabdomyosarcoma of testis,0
2326,Recurrent Genetic Abnormalities Present,Recurrent Ovarian Cystadenocarcinoma,0
2327,Apocrine metaplasia,Invasive Apocrine Breast Carcinoma,0
2328,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
2329,Fenestrated Pattern,Stage IIIC1 Uterine Corpus Cancer AJCC v8,0
2330,Spindle Cell Metaplasia of Malignant Cells Present,Lung Squamous Cell Papilloma,0
2331,Dedifferentiated Malignant Infiltrate,Unresectable Dedifferentiated Liposarcoma,0
2332,Increased megakaryocytes (bone marrow),Gastric hyperplastic polyp,0
2333,Solar Radiation Toxicity,Stage IA Ovarian Cancer AJCC v8,0
2334,Lesion Less than 5mm in Diameter,Melanoma Arising in Giant Congenital Nevus,0
2335,Immature Myeloid Cells Increased in Bone Marrow,Myeloid Neoplasms with Germline ETV6 Mutation,0
2336,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Bladder Cancer AJCC v8,0
2337,Absence of Malignant Features,Malignant Synovial Neoplasm,0
2338,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Trichoadenoma,0
2339,Fenestrated Pattern,Colorectal Adenosquamous Carcinoma,0
2340,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Adrenal Cortex Carcinoma AJCC v7,0
2341,Solar Radiation Toxicity,Cardiac Kaposi's Sarcoma,0
2342,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Invasive Ductal Breast Carcinoma,0
2343,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,0
2344,Endometrial Type Glands and Stroma Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,0
2345,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adenocarcinoma of the prostate metastatic,0
2346,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infiltrating Cervical Carcinoma,0
2347,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Carcinoma,0
2348,Apocrine metaplasia,Invasive Apocrine Breast Carcinoma,0
2349,Locally Aggressive Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
2350,Questionable Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
2351,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Poorly Cohesive Gastric Carcinoma,0
2352,Solar Radiation Toxicity,Marginal zone lymphoma stage I,0
2353,Neoplastic Plasma Cells Present in Bone Marrow,Bone Epithelioid Hemangioma,0
2354,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meningeal Leukemia,0
2355,Solar Radiation Toxicity,Vaginal Mullerian Papilloma,0
2356,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IA Gastric Carcinoma,0
2357,Increased megakaryocytes (bone marrow),Extranodal marginal zone B-cell lymphoma (MALT type) stage II,0
2358,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Metastatic Malignant Neoplasm to the Thyroid,0
2359,Mixture of Germ Cell Neoplastic Components Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,0
2360,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Uveal Melanoma AJCC v7,0
2361,Recurrent Malignant Neoplasm,Benign Fibroblastic Neoplasm,0
2362,Fenestrated Pattern,"Trophoblastic tumor, epithelioid",0
2363,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,0
2364,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Maxillary Sinus Adenoid Cystic Carcinoma,0
2365,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ovarian Yolk Sac Tumor,0
2366,Fenestrated Pattern,Postauricular lymphadenitis,0
2367,Bone Marrow Involvement,Metastatic Bone Ewing Sarcoma,0
2368,Fenestrated Pattern,Acne Keloid,0
2369,Spindle Cell Metaplasia of Malignant Cells Present,cystadenoma of salivary gland,0
2370,Increased megakaryocytes (bone marrow),Stage I Laryngeal Cancer AJCC v8,0
2371,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioma of skin,0
2372,Multihormonal Immunoreactivity Present in a Single Cell Type,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
2373,Unfavorable Clinical Outcome,Clinical Stage II Gastric Cancer AJCC v8,0
2374,Increased megakaryocytes (bone marrow),Stage II Hepatocellular Carcinoma AJCC v8,0
2375,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Epithelial tumor of ovary,0
2376,Cystic Lesion,Vaginal Adenoid Cystic Carcinoma,0
2377,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0a Ureter Cancer AJCC v8,0
2378,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,0
2379,Large Spaces Filled with Blood Present,Ductal Carcinoma In Situ with Microinvasion,0
2380,Increased megakaryocytes (bone marrow),Stage II Eyelid Carcinoma AJCC v7,0
2381,Increased megakaryocytes (bone marrow),Ameloblastic Carcinoma,0
2382,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Laryngeal papillomatosis,0
2383,Spindle Cell Metaplasia of Malignant Cells Present,Ichthyosis Bullosa of Siemens,0
2384,Fenestrated Pattern,Colon Medullary Carcinoma,0
2385,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Penile Carcinoma,0
2386,Solitary Skin Tumor,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
2387,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Carcinoma,0
2388,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Angiomyoma,0
2389,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Eyelid Carcinoma AJCC v8,0
2390,Monoclonal Myeloid or Lymphoid Cells Present,Myeloid Neoplasms with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction,0
2391,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Small Intestinal Carcinoma,0
2392,Fenestrated Pattern,"Pemphigoid, Benign Mucous Membrane",0
2393,Recurrent Malignant Neoplasm,Recurrent Adult Spinal Cord Neoplasm,0
2394,Solar Radiation Toxicity,Chest Wall Sarcoma,0
2395,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Metastatic Malignant Neoplasm,0
2396,Solar Radiation Toxicity,Angiosarcoma non-metastatic,0
2397,High Grade Non Cartilaginous Sarcomatous Stroma Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
2398,Fenestrated Pattern,Adult Brain Glioblastoma,0
2399,Neoplastic Plasma Cells Present in Bone Marrow,Stage IB Bone Cancer AJCC v8,0
2400,Low Grade Cartilaginous Component Present,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
2401,Endometrial Type Glands and Stroma Present,Ann Arbor Stage I Mature T- and NK-Cell Lymphoma,0
2402,Lesion Less than 5mm in Diameter,Proliferative dermal lesion in congenital nevus,0
2403,Solitary Skin Tumor,Mixed Salivary Gland Tumor,0
2404,Multihormonal Immunoreactivity Present in a Single Cell Type,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",0
2405,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Mediastinal Germ Cell Tumor,0
2406,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0
2407,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Malignant Testicular Germ Cell Tumor,0
2408,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,malignant epithelioid hemangioendothelioma of liver,0
2409,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Apocrine Adenosis,0
2410,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of conjunctiva,0
2411,Fenestrated Pattern,Cardiac Sarcoma,0
2412,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Eccrine acrospiroma,0
2413,Large Spaces Filled with Blood Present,Adult Anaplastic Large Cell Lymphoma,0
2414,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
2415,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myxosarcoma,0
2416,Endometrial Type Glands and Stroma Present,Refractory Endometrial Endometrioid Adenocarcinoma,0
2417,Increased megakaryocytes (bone marrow),Parathyroid Gland Adenocarcinoma,0
2418,Absence of Malignant Features,Malignant tumor of epidermal appendage,0
2419,Increased megakaryocytes (bone marrow),Childhood Hodgkin Lymphoma,0
2420,Increased megakaryocytes (bone marrow),Nodal marginal zone B-cell lymphoma stage I,0
2421,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,0
2422,Increased megakaryocytes (bone marrow),Paranasal Sinus Cancer,0
2423,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hard Palate Monomorphic Adenoma,0
2424,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,0
2425,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Major Salivary Gland Cancer AJCC v7,0
2426,Increased megakaryocytes (bone marrow),Childhood Pleomorphic Rhabdomyosarcoma,0
2427,Increased megakaryocytes (bone marrow),Spinal Cord Neurofibroma,0
2428,Large Spaces Filled with Blood Present,Acute Myeloid Leukemia with t(11;17)(q23;q21),0
2429,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Ovarian Transitional Cell Tumor,0
2430,Small Aggregates of Tumor Cells Present,Stage IIIB Small Intestinal Cancer AJCC v7,0
2431,Absence of Malignant Features,Mantle cell lymphoma of spleen,0
2432,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Acute myeloid leukemia with mutated RUNX1,0
2433,Cartilaginous Metaplasia of Malignant Cells Present,Cartilaginous exostosis,0
2434,Fenestrated Pattern,Ovarian Adenosarcoma,0
2435,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Childhood Anaplastic Large Cell Lymphoma,0
2436,Fenestrated Pattern,Pancreatic adenocarcinoma metastatic,0
2437,Nodular lesions,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2438,Absence of Malignant Features,Kaposi's sarcoma of conjunctiva,0
2439,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Osteosarcoma AJCC v7,0
2440,Intersecting Sharply Marginated Clusters of Spindle Cells Present,cystadenoma of extrahepatic bile duct,0
2441,Schwannian Stroma More than 50 Percent of the Tumor Volume,Thymic Atypical Carcinoid Tumor,0
2442,Radial Growth Phase,Radial scar,0
2443,No Evidence of Metastatic Disease,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2444,Spindle Cell Metaplasia of Malignant Cells Present,Benign Mediastinal Germ Cell Tumor,0
2445,Solar Radiation Toxicity,Pemphigus,0
2446,Fenestrated Pattern,Rectal Lymphoma,0
2447,Large Spaces Filled with Blood Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0
2448,Primary Site Unspecified,Refractory Primary Vitreoretinal Lymphoma,0
2449,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Villoglandular Adenocarcinoma,0
2450,Exophytic Papillary Lesion,Fallopian Tube Papillary Adenocarcinoma,0
2451,Poorly Cohesive Malignant Cellular Infiltrate,Cellular Pleomorphic Adenoma,0
2452,Intravascular papillary endothelial hyperplasia,Adrenocortical hyperplasia,0
2453,Fenestrated Pattern,Bladder adenocarcinoma recurrent,0
2454,Absence of Malignant Features,fibroma of testis,0
2455,Blasts Expressing CD56 and Immature T-Cell Markers Present,Sellar Immature Teratoma,0
2456,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parotid Gland Carcinosarcoma,0
2457,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Cerebral Ependymoma,0
2458,Fenestrated Pattern,Beckwith-Wiedemann Syndrome,0
2459,Breast Implant-Related Lesion,Prognostic Stage IIIC Breast Cancer AJCC v8,0
2460,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tobacco-Related Carcinoma,0
2461,Recurrent Genetic Abnormalities Present,Recurrent Uterine Corpus Carcinosarcoma,0
2462,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,undifferentiated carcinoma of liver,0
2463,Mixture of Germ Cell Neoplastic Components Present,Malignant Pineal Region Germ Cell Tumor,0
2464,Spindle Cell Metaplasia of Malignant Cells Present,Serous cystadenoma of pancreas,0
2465,Squamous metaplasia of bladder,Squamous Cell Carcinoma of Anal Margin,0
2466,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Metastatic Malignant Neoplasm in the Adult Brain,0
2467,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Primary Peritoneal Cancer AJCC v7,0
2468,Spindle Cell Metaplasia of Malignant Cells Present,malignant neoplasm of large intestine stage IV,0
2469,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Granuloma annulare aggravated,0
2470,Fenestrated Pattern,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
2471,Multihormonal Immunoreactivity Present in a Single Cell Type,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
2472,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Cerebellar and Ventricular Ependymal Tumor,0
2473,Solar Radiation Toxicity,Precursor T-lymphoblastic lymphoma/leukemia refractory,0
2474,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Elliptocytosis, Hereditary",0
2475,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Low grade appendiceal mucinous neoplasm,0
2476,Increased megakaryocytes (bone marrow),Psoriasis,0
2477,Fenestrated Pattern,Chest Wall Sarcoma,0
2478,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Adenosquamous Carcinoma,0
2479,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
2480,Fenestrated Pattern,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,0
2481,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Pineal parenchymal tumor of intermediate differentiation,0
2482,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Salivary Gland Myoepithelial Carcinoma,0
2483,Fenestrated Pattern,Colon Medullary Carcinoma,0
2484,Metaplasia of Malignant Cells Present,Malignant neoplasm of major salivary gland,0
2485,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Colon Cancer AJCC v7,0
2486,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
2487,Increased megakaryocytes (bone marrow),Pleural mesothelioma malignant localised,0
2488,Breast Implant-Related Lesion,Recurrent Lobular Breast Carcinoma,0
2489,Absence of Malignant Features,Polyp of esophagus,0
2490,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVB Pharyngeal Carcinoma,0
2491,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of the thyroid gland,0
2492,Increased megakaryocytes (bone marrow),Stage III Adrenal Cortex Carcinoma AJCC v7,0
2493,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Dermoid Cyst with Angiosarcoma,0
2494,Solar Radiation Toxicity,Childhood Lymphomatoid Granulomatosis,0
2495,Metaplasia of Malignant Cells Present,Malignant tumor of external ear,0
2496,Solar Radiation Toxicity,"Pheochromocytoma, Extra-Adrenal",0
2497,Increased megakaryocytes (bone marrow),Seborrheic keratosis,0
2498,Increased megakaryocytes (bone marrow),Metastatic Chordoma,0
2499,Intraepithelial Neoplasia,Anal Intraepithelial Neoplasia 2,0
2500,Low Grade Cartilaginous Component Present,Ovarian Low Grade Endometrioid Stromal Sarcoma,0
2501,Solar Radiation Toxicity,Stage IIB Uterine Corpus Cancer AJCC v6,0
2502,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Congenital spondylolysis of lumbosacral region,0
2503,Solar Radiation Toxicity,Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8,0
2504,Lesion Less than 5mm in Diameter,Focal Segmental Glomerulosclerosis Tip Lesion Variant,0
2505,No Evidence of Metastatic Disease,Metastatic gastric adenocarcinoma,0
2506,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,0
2507,Solitary Skin Tumor,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
2508,Spindle Cell Metaplasia of Malignant Cells Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",0
2509,Malignant Primitive Cellular Infiltrate,Malignant Proliferating Pilar Tumor,0
2510,Solar Radiation Toxicity,Childhood Central Nervous System Teratoma,0
2511,Endometrial Type Glands and Stroma Present,Recurrent Endometrial Serous Adenocarcinoma,0
2512,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular Typical Seminoma,0
2513,Mammary Gland Type Features Present,Childhood Parathyroid Gland Carcinoma,0
2514,Multihormonal Immunoreactivity Present in a Single Cell Type,Resectable Head and Neck Squamous Cell Carcinoma,0
2515,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7,0
2516,Mammary Gland Type Features Present,Stage IV Major Salivary Gland Cancer AJCC v7,0
2517,Solar Radiation Toxicity,Masaoka-Koga Stage I,0
2518,Increased megakaryocytes (bone marrow),Esophageal Adenocarcinoma by AJCC v8 Stage,0
2519,Schwannian Stroma More than 50 Percent of the Tumor Volume,Testicular Tumor of the Thecoma/Fibroma Group,0
2520,Mixture of Germ Cell Neoplastic Components Present,Myxoid/Round Cell Liposarcoma,0
2521,Recurrent Malignant Neoplasm,Recurrent Adult Burkitt Lymphoma,0
2522,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Vaginal Cancer by AJCC v8 Stage,0
2523,Non-Encapsulated Neoplasm,Non-Functioning Pituitary Gland Neoplasm,0
2524,Mural Nodule,Liver Dysplastic Nodule,0
2525,Increased megakaryocytes (bone marrow),Adult Hodgkin Lymphoma by Ann Arbor Stage,0
2526,Solitary Skin Tumor,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
2527,Solar Radiation Toxicity,Masaoka-Koga Stage IVa,0
2528,Fenestrated Pattern,Psoriasis,0
2529,Mammary Gland Type Features Present,Type I Endometrial Adenocarcinoma,0
2530,Non-Encapsulated Neoplasm,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0
2531,Spindle Cell Metaplasia of Malignant Cells Present,Congenital anomaly of lens,0
2532,Increased megakaryocytes (bone marrow),Meningeal melanocytoma,0
2533,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Testicular Cancer AJCC v6 and v7,0
2534,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
2535,NRBC - Nucleated red blood cell present result,Non-small cell lung cancer stage IIIB,0
2536,Venous Type Vascular Channel Formation,"Breast Fibrocystic Change, Non-Proliferative Type",0
2537,Non-Encapsulated Neoplasm,Recurrent Anterior Pituitary Gland Neoplasm,0
2538,Neoplastic Growth or Spread,Ovarian Biphasic or Triphasic Teratoma,0
2539,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
2540,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastric Cardia Carcinoma,0
2541,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colon Carcinoma,0
2542,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraosseous well differentiated osteosarcoma,0
2543,Fenestrated Pattern,Fallopian Tube Lymphoma,0
2544,Tumor Mass,Carcinoid Tumor,0
2545,Recurrent Genetic Abnormalities Present,Recurrent Paraganglioma,0
2546,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Serous cystadenoma of ovary,0
2547,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Pulmonary Vein Leiomyosarcoma,0
2548,Malignant Primitive Cellular Infiltrate,Malignant Cutaneous Granular Cell Tumor,0
2549,Folliculotropic Lymphocytic Infiltrate,Cutaneous Chronic Lymphocytic Leukemia,0
2550,Increased megakaryocytes (bone marrow),Stage IV Esophagus Carcinoma,0
2551,Well Differentiated Neuroendocrine Lesion,Well Differentiated Ovarian Steroid Cell Tumor,0
2552,Absence of Malignant Features,keratinizing squamous cell carcinoma of lung,0
2553,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,0
2554,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of salivary gland,0
2555,Absence of Malignant Features,large cell neuroendocrine carcinoma of gallbladder,0
2556,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
2557,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Somatostatinoma,0
2558,Glandular cell atypia,Parathyroid transitional clear cell adenoma,0
2559,Favorable Clinical Outcome,Early Favorable Hodgkin Lymphoma,0
2560,Endometrial Type Glands and Stroma Present,Grade 1 Endometrial Mucinous Adenocarcinoma,0
2561,Absence of Malignant Features,Malignant Uterine Corpus PEComa,0
2562,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2563,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Ampulla of Vater Neuroendocrine Carcinoma,0
2564,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of Skene Gland Origin,0
2565,Fenestrated Pattern,Anatomic Stage IV Breast Cancer AJCC v8,0
2566,Low Grade Neuroendocrine Lesion,Grade 2 Rectal Adenocarcinoma,0
2567,Increased megakaryocytes (bone marrow),Stage IIIC2 Uterine Corpus Cancer AJCC v7,0
2568,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Localized Askin Tumor,0
2569,Diffuse Cellular Infiltrate,Adult Cardiac Cellular Rhabdomyoma,0
2570,Localized Lesion,Localized Unresectable Adult Hepatocellular Carcinoma,0
2571,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Ampulla of Vater Neuroendocrine Tumor G2,0
2572,Increased megakaryocytes (bone marrow),Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,0
2573,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage 0 Pancreatic Cancer AJCC v6 and v7,0
2574,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,0
2575,Fenestrated Pattern,Right atrial myxoma,0
2576,Solar Radiation Toxicity,Scrotal Infection,0
2577,Low Grade Neuroendocrine Lesion,Low Grade Conjunctival Intraepithelial Neoplasia,0
2578,Fenestrated Pattern,Myxofibroma,0
2579,Mammary Gland Type Features Present,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
2580,Metastatic/Recurrent Disease,Central Nervous System Erdheim-Chester Disease,0
2581,Osseous Metaplasia of Malignant Cells Present,"Malignant neoplasm of kidney, except pelvis",0
2582,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Skull Base Neoplasm,0
2583,Metaplasia of Malignant Cells Present,Malignant tumor of colon,0
2584,Fried-Egg Appearance of the Bone Marrow,Recurrent Paget Disease of the Anal Canal,0
2585,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIA Hepatocellular Carcinoma AJCC v7,0
2586,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Rhabdomyosarcoma with ganglionic differentiation,0
2587,Mixture of Germ Cell Neoplastic Components Present,Malignant Peritoneal Germ Cell Tumor,0
2588,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adenocarcinoma of the prostate stage I,0
2589,Spindle Cell Metaplasia of Malignant Cells Present,Leiomyosarcoma of small intestine,0
2590,Benign Cellular Infiltrate,Benign Prostatic Hyperplasia,0
2591,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7,0
2592,Increased megakaryocytes (bone marrow),Adult Extraskeletal Osteosarcoma,0
2593,Cervical Glandular Dysplasia,Cervical Neuroendocrine Neoplasm,0
2594,Increased megakaryocytes (bone marrow),Submandibular Gland Adenocarcinoma,0
2595,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epidermodysplasia Verruciformis,0
2596,Absence of Malignant Features,benign granular cell tumor of gallbladder,0
2597,Spindle Cell Metaplasia of Malignant Cells Present,hemangioendothelial sarcoma of bone,0
2598,Arborising Network of Cords of Basaloid Cells Present,Basaloid carcinoma,0
2599,Multihormonal Immunoreactivity Present in a Single Cell Type,"Adenocarcinoma, Clear Cell",0
2600,Spindle Cell Osteo-Fibrous Component Present,Conventional (Clear Cell) Renal Cell Carcinoma,0
2601,Mammary Gland Type Features Present,Major Salivary Gland Carcinoma,0
2602,Nodular and Diffuse Pattern,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,0
2603,Spindle Cell Osteo-Fibrous Component Present,Advanced Renal Cell Carcinoma,0
2604,Cellular Stratification,Ovarian Cellular Fibroma,0
2605,Spindle Cell Metaplasia of Malignant Cells Present,Transplant-Related Squamous Cell Carcinoma,0
2606,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoid cystic carcinoma of oropharynx,0
2607,Recurrent Malignant Neoplasm,Childhood Solid Neoplasm,0
2608,Fenestrated Pattern,Stage IB Osteosarcoma AJCC v7,0
2609,Villous Projections of the Neoplastic Epithelium Present,Mucoepidermoid carcinoma of the oral cavity stage I,0
2610,Mediastinal mass,Mediastinal Extraskeletal Osteosarcoma,0
2611,Systemic disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,0
2612,Increased megakaryocytes (bone marrow),"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
2613,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Malignant Endocrine Neoplasm,0
2614,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage III,0
2615,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,0
2616,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of colon,0
2617,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Giant Cell Glioblastoma,0
2618,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precursor T-lymphoblastic lymphoma/leukemia stage IV,0
2619,Multihormonal Immunoreactivity Present in a Single Cell Type,Postcricoid Squamous Cell Carcinoma,0
2620,White blood cell count increased (lab result),Parathyroid mixed cell type adenoma,0
2621,Tumor Mass,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
2622,Proliferation of Follicular Dendritic Cells Present,Follicular Myxoma,0
2623,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Eyelid Carcinoma AJCC v7,0
2624,Increased megakaryocytes (bone marrow),Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,0
2625,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Eyelid Carcinoma AJCC v7,0
2626,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vertebral chordoma,0
2627,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed Squamous Cell Carcinoma of the Penis,0
2628,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2629,Fenestrated Pattern,Nasopharyngeal carcinoma,0
2630,Intravascular papillary endothelial hyperplasia,Intravascular fasciitis,0
2631,Fenestrated Pattern,Unresectable Intrahepatic Cholangiocarcinoma,0
2632,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,PRETEXT Stage 2 Hepatoblastoma,0
2633,Marked Thickening of the Bladder Urothelium Present,Bladder cancer recurrent,0
2634,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Cancer by AJCC v6 Stage,0
2635,Solar Radiation Toxicity,Childhood Myelodysplastic Syndrome,0
2636,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Epithelioid Hemangioendothelioma,0
2637,Increased megakaryocytes (bone marrow),mixed gliomas,0
2638,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
2639,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,undifferentiated carcinoma of extrahepatic bile duct,0
2640,Unfavorable Clinical Outcome,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,0
2641,Clinical TNM Finding,Clinical Chorioamnionitis,0
2642,Absence of Malignant Features,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
2643,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Brain Stem Glioma,0
2644,Absence of Malignant Features,Posterior Urethral Malignant Neoplasm,0
2645,Generalized Hydropic Villous Change,Colorectal Villous Adenoma,0
2646,Breast Implant-Related Lesion,Breast Lymphoma,0
2647,Stable Disease,Steroid Refractory Graft Versus Host Disease,0
2648,Fenestrated Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
2649,Intersecting Sharply Marginated Clusters of Spindle Cells Present,large cell neuroendocrine carcinoma of gallbladder,0
2650,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,BCLC Stage 0 Hepatocellular Carcinoma,0
2651,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
2652,Increased megakaryocytes (bone marrow),Benign Meningioma,0
2653,Bone Marrow Involvement,Bone Leiomyoma,0
2654,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Gingival Spindle Cell Carcinoma,0
2655,Solar Radiation Toxicity,Non-Hodgkin Lymphoma During Pregnancy,0
2656,Recurrent Genetic Abnormalities Present,Recurrent Grade 3 Follicular Lymphoma,0
2657,Nodular and Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
2658,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Hodgkin Lymphoma by Ann Arbor Stage,0
2659,High Grade Lesion,WHO Grade III Glioma,0
2660,Lesion with Diameter of 2cm or Less,AIDS with Kaposi's sarcoma,0
2661,Solitary Skin Tumor,Glomus Jugulare Tumor,0
2662,Increased megakaryocytes (bone marrow),Pancreatic Hepatoid Adenocarcinoma,0
2663,Low Grade Neuroendocrine Lesion,Liver Neuroendocrine Neoplasm,0
2664,Diffuse Immunoblastic Proliferation,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
2665,Immature Myeloid Cells Increased in Bone Marrow,Recurrent Acute Myeloid Leukemia,0
2666,Fenestrated Pattern,Stage I Uterine Corpus Cancer,0
2667,Follicular Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,0
2668,Nodular and Diffuse Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
2669,Well Differentiated Neuroendocrine Lesion,Well Differentiated Fibrosarcoma,0
2670,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,0
2671,Fenestrated Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",0
2672,Recurrent Malignant Neoplasm,Locally Metastatic Malignant Neoplasm,0
2673,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chondroma,0
2674,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Vaginal Carcinoma,0
2675,Fenestrated Pattern,Paranasal Sinus Schneiderian Papilloma,0
2676,Fenestrated Pattern,Choroid Plexus Carcinoma,0
2677,Mammary Gland Type Features Present,Stage I Major Salivary Gland Cancer AJCC v7,0
2678,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fibroadenoma of breast,0
2679,Solar Radiation Toxicity,Stage IV Prostate Cancer AJCC v7,0
2680,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Adenocarcinoma, Tubular",0
2681,Intermediate Grade Neuroendocrine Lesion,WHO Grade III Glioma,0
2682,Fenestrated Pattern,Stage II Eyelid Carcinoma AJCC v8,0
2683,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIB Lung Large Cell Carcinoma AJCC v7,0
2684,Fenestrated Pattern,Schneiderian carcinoma,0
2685,Increased megakaryocytes (bone marrow),"Non-Neoplastic, Non-Molar Trophoblastic Disorder",0
2686,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Choroidal and Ciliary Body Melanoma AJCC v8,0
2687,Mixed Neoplastic Glandular and Squamous Cell Population,Combined Lung Small Cell and Squamous Cell Carcinoma,0
2688,Fenestrated Pattern,Gemistocytic astrocytoma,0
2689,Increased megakaryocytes (bone marrow),Unresectable Lymphoma,0
2690,Intermediate Grade Neuroendocrine Lesion,Grade 3 Colorectal Adenocarcinoma,0
2691,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,0
2692,Plasma cell inflammation,Renal cell carcinoma recurrent,0
2693,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Apocrine Adenoma,0
2694,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Malignant Mesothelioma,0
2695,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
2696,NRBC - Nucleated red blood cell present result,Balloon cell nevus,0
2697,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unicystic ameloblastoma,0
2698,Solitary Skin Tumor,Extrahepatic Bile Duct Benign Granular Cell Tumor,0
2699,Absence of Malignant Features,Capillary hemangioma of orbit,0
2700,Mixture of Germ Cell Neoplastic Components Present,Unclassified Renal Cell Carcinoma,0
2701,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Esophageal Squamous Cell Carcinoma AJCC v7,0
2702,Fenestrated Pattern,Borderline Ovarian Serous Cystadenofibroma,0
2703,Fenestrated Pattern,Lymphomatoid Papulosis,0
2704,Intraepithelial Neoplasia,Pancreatic Intraepithelial Neoplasia-1B,0
2705,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bowenoid papulosis,0
2706,Fenestrated Pattern,Necrotizing Funisitis,0
2707,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ureter Cancer by AJCC v7 Stage,0
2708,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of endocervix,0
2709,Fenestrated Pattern,Renal Adenoma,0
2710,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Recurrent Clear Cell Renal Cell Carcinoma,0
2711,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Distal Bile Duct Cancer AJCC v8,0
2712,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of lung,0
2713,Increased megakaryocytes (bone marrow),Bartholin Gland Adenomyoma,0
2714,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal hemangioma,0
2715,Mediastinal mass,Mediastinal Paraganglioma,0
2716,Tumor Mass,Proliferating Brenner Tumor,0
2717,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Hilar Cholangiocarcinoma AJCC v8,0
2718,Fenestrated Pattern,Intracranial Germinoma,0
2719,Fenestrated Pattern,Lipoblastomatosis,0
2720,Lesion with Diameter of 2cm or Less,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",0
2721,Increased megakaryocytes (bone marrow),Comedocarcinoma,0
2722,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Paget's disease and intraductal carcinoma of breast,0
2723,Multihormonal Immunoreactivity Present in a Single Cell Type,Adenocarcinoma in situ in villous adenoma,0
2724,Solitary Skin Tumor,Skin squamous cell carcinoma recurrent,0
2725,Fenestrated Pattern,Melanotic medulloblastoma,0
2726,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thyroid Gland Mucinous Carcinoma,0
2727,Fenestrated Pattern,Stage IVB Paranasal Sinus Cancer AJCC v7,0
2728,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mature Pericardial Teratoma,0
2729,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
2730,Fenestrated Pattern,Hepatoblastoma recurrent,0
2731,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Disorder of pregnancy,0
2732,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIC Merkel Cell Carcinoma AJCC v7,0
2733,Increased megakaryocytes (bone marrow),Laryngeal Adenosquamous Carcinoma,0
2734,Increased megakaryocytes (bone marrow),Chemotherapy-Related Leukemia,0
2735,Dilated Terminal Duct Lobular Units Present,Stage IIIA Distal Bile Duct Cancer AJCC v8,0
2736,Lesion with Diameter of 2cm or Less,adenocarcinoma of breast with squamous metaplasia,0
2737,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Polyp of middle ear,0
2738,Plasma cell inflammation,Adenosquamous cell lung cancer stage I,0
2739,Chronic Clinical Course,Chronic Active Colitis,0
2740,Increased megakaryocytes (bone marrow),Parotid Gland Liposarcoma,0
2741,Solar Radiation Toxicity,ROSE Cluster 3,0
2742,Plasma cell inflammation,granulosa cell tumor,0
2743,Increased megakaryocytes (bone marrow),Cobb's syndrome,0
2744,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
2745,Increased megakaryocytes (bone marrow),Burkitt's lymphoma refractory,0
2746,Solar Radiation Toxicity,Necrobiosis Lipoidica,0
2747,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cystadenocarcinoma of kidney,0
2748,Increased megakaryocytes (bone marrow),Stage IIIC Anal Cancer AJCC v8,0
2749,Increased megakaryocytes (bone marrow),Stage IVB Major Salivary Gland Cancer AJCC v8,0
2750,Solar Radiation Toxicity,Adult Fibrosarcoma,0
2751,Large Spaces Filled with Blood Present,Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0
2752,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gestational Trophoblastic Neoplasms,0
2753,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hyperdiploid B Acute Lymphoblastic Leukemia,0
2754,Systemic disease,Hodgkin's disease mixed cellularity recurrent,0
2755,Non-Encapsulated Neoplasm,Cystic Neoplasm,0
2756,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of sublingual gland,0
2757,Spindle Cell Osteo-Fibrous Component Present,Posterior Tongue Squamous Cell Carcinoma,0
2758,Nodular and Diffuse Pattern,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,0
2759,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Mucinous Cystadenoma,0
2760,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,adenoma of extrahepatic bile duct,0
2761,Proliferation of Follicular Dendritic Cells Present,Grade 3a Follicular Lymphoma,0
2762,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Glomangioma of skin,0
2763,Increased megakaryocytes (bone marrow),Vaginal Rhabdomyosarcoma,0
2764,Spindle Cell Metaplasia of Malignant Cells Present,Choroid Epithelioid Cell Melanoma,0
2765,Nodular and Diffuse Pattern,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
2766,Increased megakaryocytes (bone marrow),Suppurative lymphadenopathy,0
2767,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0
2768,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Melanoma,0
2769,Fenestrated Pattern,Adenocarcinoma,0
2770,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Pleural Malignant Mesothelioma by AJCC v8 Stage,0
2771,Epithelioid Differentiation,Epithelioid Type Angiomyolipoma,0
2772,Solitary Skin Tumor,Pineal Region Yolk Sac Tumor,0
2773,Endometrial Type Glands and Stroma Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",0
2774,Multihormonal Immunoreactivity Present in a Single Cell Type,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2775,Peau d'orange surface of breast,Fibrosclerosis of breast,0
2776,Increased megakaryocytes (bone marrow),Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0
2777,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of accessory sinus,0
2778,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,0
2779,Solar Radiation Toxicity,"Pregnancy, Cornual",0
2780,Fenestrated Pattern,Eccrine dermal cylindroma,0
2781,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Fibroma of lung,0
2782,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Kaposi's sarcoma of palate,0
2783,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Retinoblastoma, undifferentiated",0
2784,Nodular and Diffuse Pattern,Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma,0
2785,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian mixed epithelial carcinoma,0
2786,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of vulva,0
2787,Multihormonal Immunoreactivity Present in a Single Cell Type,Type A Tylosis,0
2788,Solar Radiation Toxicity,Ann Arbor Stage IA Hodgkin Lymphoma,0
2789,Solitary Skin Tumor,Gastrointestinal Stromal Tumor by AJCC v8 Stage,0
2790,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of ureter,0
2791,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,0
2792,Intestinal metaplasia of gastric mucosa,Intestinal T-cell lymphoma stage II,0
2793,Primary Site Unspecified,Primary Cutaneous Hodgkin Lymphoma,0
2794,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Major Salivary Gland Carcinoma without Metastasis,0
2795,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Adenocarcinoma with metaplasia,0
2796,Increased megakaryocytes (bone marrow),Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,0
2797,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Cancer by AJCC v7 Stage,0
2798,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Sarcoma,0
2799,Increased megakaryocytes (bone marrow),Hard Palate Monomorphic Adenoma,0
2800,Increased megakaryocytes (bone marrow),Stage IIIB Hilar Cholangiocarcinoma AJCC v7,0
2801,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
2802,Breast Implant-Related Lesion,Breast Ductal Adenoma,0
2803,Increased megakaryocytes (bone marrow),Stage IIA Appendix Carcinoma AJCC v8,0
2804,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
2805,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,0
2806,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lipoma of skin,0
2807,Large Spaces Filled with Blood Present,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
2808,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urothelial carcinoma urethra recurrent,0
2809,Bone Marrow Involvement,Bone Cancer by AJCC v7 Stage,0
2810,Increased megakaryocytes (bone marrow),Stage IIB Colon Cancer AJCC v7,0
2811,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,0
2812,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Appendix Carcinoma AJCC v8,0
2813,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Mixed Phenotype Acute Leukemia,0
2814,Lesion with Diameter of 2cm or Less,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2815,Fenestrated Pattern,Centroblastic lymphoma refractory,0
2816,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of urinary bladder,0
2817,Bone Marrow Involvement,Stage II Bone Sarcoma AJCC v7,0
2818,Solar Radiation Toxicity,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,0
2819,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Nerve Schwannoma,0
2820,Mammary Gland Type Features Present,"Breast Fibrocystic Change, Proliferative Type",0
2821,Fenestrated Pattern,Eyelid Xanthoma,0
2822,Increased megakaryocytes (bone marrow),Pulmonary Subvalvular Stenosis,0
2823,Solar Radiation Toxicity,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",0
2824,Dedifferentiated Malignant Infiltrate,Sellar Dedifferentiated Chordoma,0
2825,Increased megakaryocytes (bone marrow),Fibrodysplasia Ossificans Progressiva,0
2826,Fenestrated Pattern,Stage IB Mycosis Fungoides AJCC v7,0
2827,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage II Retinoblastoma AJCC v8,0
2828,Progressive Clinical Course,Clinical Stage III Cutaneous Melanoma AJCC v8,0
2829,Nodular and Diffuse Pattern,Stage I Laryngeal Cancer AJCC v6 and v7,0
2830,Spindle Cell Metaplasia of Malignant Cells Present,Squamous Cell Carcinoma In Situ of the Nipple,0
2831,Absence of Malignant Features,"Malignant melanoma, regressing",0
2832,Fenestrated Pattern,Ossifying Fibroma,0
2833,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Hodgkin Lymphoma,0
2834,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of Accessory Sinus,0
2835,Increased megakaryocytes (bone marrow),"Carcinoma, Endometrioid",0
2836,Increased megakaryocytes (bone marrow),Barrett's Adenocarcinoma,0
2837,Solar Radiation Toxicity,Adult Classical Hodgkin Lymphoma,0
2838,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleomorphic Xanthoastrocytoma,0
2839,Spindle Cell Metaplasia of Malignant Cells Present,Stage I Ampulla of Vater Cancer AJCC v8,0
2840,Nodular lesions,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2841,Squamous metaplasia of bladder,Squamous cell carcinoma of tonsil,0
2842,Localized Hydropic Villous Change,Villous adenocarcinoma,0
2843,NRBC - Nucleated red blood cell present result,Superficial basal cell carcinoma,0
2844,Increased megakaryocytes (bone marrow),Stage I Adult Non-Hodgkin Lymphoma,0
2845,Increased megakaryocytes (bone marrow),Adrenal Cortex Oncocytic Adenoma,0
2846,Increased megakaryocytes (bone marrow),Primary mediastinal large B-cell lymphoma stage II,0
2847,Cervical lymphadenopathy,Cervical Angiosarcoma,0
2848,Increased megakaryocytes (bone marrow),Stage IIIC Fallopian Tube Cancer AJCC v8,0
2849,Spindle Cell Osteo-Fibrous Component Present,"Langerhans Cell Histiocytosis, Disseminated",0
2850,Increased megakaryocytes (bone marrow),Hemangiosarcoma,0
2851,Low Mitotic Activity,Low grade myofibroblastic sarcoma,0
2852,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Uterine Corpus Cancer by AJCC v6 Stage,0
2853,Unfavorable Clinical Outcome,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,0
2854,Spindle Cell Metaplasia of Malignant Cells Present,Non-Hodgkin's lymphoma of central nervous system,0
2855,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of lung (disorder),0
2856,Bone Marrow Involvement,Stage IB Bone Cancer AJCC v8,0
2857,Neoplastic Plasma Cells Present in Bone Marrow,Neoplastic C-Cell Hyperplasia,0
2858,Recurrent Genetic Abnormalities Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
2859,Malignant Primitive Cellular Infiltrate,Malignant Breast Adenomyoepithelioma,0
2860,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Minor Salivary Gland Mucoepidermoid Carcinoma,0
2861,Increased megakaryocytes (bone marrow),Plexiform Neurofibroma,0
2862,Solar Radiation Toxicity,Stage 0a Urethral Cancer AJCC v8,0
2863,Fenestrated Pattern,Advanced Uveal Melanoma,0
2864,Solar Radiation Toxicity,Odontoameloblastoma,0
2865,Mixture of Germ Cell Neoplastic Components Present,Conventional (Clear Cell) Renal Cell Carcinoma,0
2866,Mixture of Germ Cell Neoplastic Components Present,Splenic Manifestation of Hairy Cell Leukemia,0
2867,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Hodgkin's Lymphoma,0
2868,Increased megakaryocytes (bone marrow),Nasopharyngeal Nonkeratinizing Carcinoma,0
2869,Malignant Primitive Cellular Infiltrate,Refractory Malignant Glioma,0
2870,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Leiomyosarcoma of uterus,0
2871,Mixed Neoplastic Glandular and Squamous Cell Population,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,0
2872,Increased megakaryocytes (bone marrow),AIDS-Related Carcinoma,0
2873,Fenestrated Pattern,Colorectal Micropapillary Adenocarcinoma,0
2874,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Rectal Carcinoma,0
2875,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Papillary Epithelial Neoplasm,0
2876,Schwannian Stroma More than 50 Percent of the Tumor Volume,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,0
2877,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of large intestine,0
2878,Increased megakaryocytes (bone marrow),Retiform hemangioendothelioma,0
2879,Photosensitivity of skin,Eccrine carcinoma of skin,0
2880,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian Thecoma,0
2881,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thymoma, type B2",0
2882,Increased megakaryocytes (bone marrow),Trabecular adenocarcinoma,0
2883,Multihormonal Immunoreactivity Present in a Single Cell Type,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
2884,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,0
2885,Confluent Sheets of Anaplastic T-Lymphocytes Present,Recurrent Thyroid Gland Anaplastic Carcinoma,0
2886,Aberrant Thyroid Tissue Present,Thyroid Nodule,0
2887,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
2888,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IIB Testicular Cancer AJCC v6 and v7,0
2889,Nodular and Diffuse Pattern,Stage IVC Lip and Oral Cavity Cancer AJCC v8,0
2890,Fenestrated Pattern,Ethmoid Sinus Inverted Papilloma,0
2891,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Cutaneous Melanoma,0
2892,Small Lesion,Small intestine carcinoma recurrent,0
2893,Recurrent Malignant Neoplasm,Borderline Fallopian Tube Neoplasm,0
2894,Spindle Cell Osteo-Fibrous Component Present,Stage IIA Merkel Cell Carcinoma AJCC v7,0
2895,Glandular cell atypia,"Intraocular melanoma, spindle cell",0
2896,Solar Radiation Toxicity,Colorectal Leiomyosarcoma,0
2897,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Indolent Adult Non-Hodgkin Lymphoma,0
2898,Fenestrated Pattern,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",0
2899,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Microsatellite Stable Colorectal Carcinoma,0
2900,Increased megakaryocytes (bone marrow),Vulvar Lichen Sclerosus,0
2901,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hereditary Male Breast Carcinoma,0
2902,Mammary Gland Type Features Present,Stage 0 Major Salivary Gland Cancer AJCC v8,0
2903,Fenestrated Pattern,Superficial fibromatosis,0
2904,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Eyelid Carcinoma AJCC v8,0
2905,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Uterine Corpus Leiomyosarcoma AJCC v8,0
2906,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Gallbladder Cancer AJCC v7,0
2907,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Renal Pelvis Cancer AJCC v7,0
2908,Unfavorable Clinical Outcome,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,0
2909,Fenestrated Pattern,Stage II Uterine Corpus Adenosarcoma AJCC v8,0
2910,Fenestrated Pattern,Biliary Intraepithelial Neoplasia-1,0
2911,Solar Radiation Toxicity,Pericardial Leiomyoma,0
2912,Multihormonal Immunoreactivity Present in a Single Cell Type,Glomerulosa Cell Adrenal Cortical Adenoma,0
2913,Increased megakaryocytes (bone marrow),Adult Acute Megakaryoblastic Leukemia,0
2914,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic Ductal Adenocarcinoma,0
2915,Multihormonal Immunoreactivity Present in a Single Cell Type,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0
2916,Aberrant Thyroid Tissue Present,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0
2917,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage I Retinoblastoma AJCC v8,0
2918,Recurrent Malignant Neoplasm,Refractory Neoplasm,0
2919,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraductal Breast Papillomatosis,0
2920,Fenestrated Pattern,Thymic Mucoepidermoid Carcinoma,0
2921,Intersecting Sharply Marginated Clusters of Spindle Cells Present,tubulopapillary adenoma of extrahepatic bile duct,0
2922,High Grade Lesion,Ann Arbor Stage IV Grade 3 Follicular Lymphoma,0
2923,Increased megakaryocytes (bone marrow),Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,0
2924,Solar Radiation Toxicity,Stage 0is Ureter Cancer AJCC v7,0
2925,Congenital Abnormality,Congenital kyphosis,0
2926,Bone Marrow Involvement,Stage IV Bone Sarcoma AJCC v7,0
2927,Hypertensive disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,0
2928,Fried-Egg Appearance of the Bone Marrow,Stage II Bone Cancer AJCC v7,0
2929,Increased megakaryocytes (bone marrow),"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",0
2930,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,High-Grade Prostatic Intraepithelial Neoplasia,0
2931,Aberrant Thyroid Tissue Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,0
2932,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides/Sezary syndrome refractory,0
2933,Increased megakaryocytes (bone marrow),Uterine Fibroids,0
2934,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Cervical Adenosquamous Carcinoma,0
2935,Increased megakaryocytes (bone marrow),Stage IIIA Hilar Cholangiocarcinoma AJCC v8,0
2936,Melanoma Cells Present,Stage II Uveal Melanoma AJCC v7,0
2937,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA1 Cervical Cancer AJCC v7,0
2938,Microinvasive tumor,Benign neuroendocrine tumor,0
2939,Increased megakaryocytes (bone marrow),Refractory Myxoid Liposarcoma,0
2940,Lipomatous Component Present,Cutaneous Lipomatous Neoplasm,0
2941,Fenestrated Pattern,Cutaneous Lymphomatoid Granulomatosis,0
2942,Spindle Cell Osteo-Fibrous Component Present,Stage I Lip Basal Cell Carcinoma,0
2943,Fenestrated Pattern,Aleukemic Leukemia Cutis,0
2944,Increased megakaryocytes (bone marrow),Metastatic Jugulotympanic Paraganglioma,0
2945,Chronic Inflammatory Infiltrate,AIDS-Related Pelvic Inflammatory Disease,0
2946,Solar Radiation Toxicity,"Mucinous adenocarcinoma, endocervical type",0
2947,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
2948,Mammary Gland Type Features Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,0
2949,Acute inflammation,Acute Placental Infarction,0
2950,Increased megakaryocytes (bone marrow),Liver Fibrosarcoma,0
2951,Endometrial Type Glands and Stroma Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,0
2952,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous adenocarcinoma of appendix,0
2953,Absence of Malignant Features,Primary malignant neoplasm of oculomotor nerve,0
2954,Solitary Skin Tumor,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2955,Localized Lesion,Localized Unresectable Neuroblastoma,0
2956,Glandular cell atypia,Mantle cell lymphoma recurrent,0
2957,Metaplasia of Malignant Cells Present,Malignant tumor of external ear,0
2958,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Central Nervous System Germ Cell Tumor,0
2959,Increased megakaryocytes (bone marrow),Acquired kyphosis,0
2960,Dilated Terminal Duct Lobular Units Present,Adenosquamous Bile Duct Carcinoma,0
2961,Fenestrated Pattern,Stage 0a Penile Cancer AJCC v8,0
2962,Immature Granulocytes in Peripheral Blood Increased,Pineal Region Immature Teratoma,0
2963,Increased megakaryocytes (bone marrow),Acne Vulgaris,0
2964,Cystic Lesion,"Lymphangioma, Cystic",0
2965,Increased megakaryocytes (bone marrow),Kidney Fibroma,0
2966,Well Differentiated Neuroendocrine Lesion,Well Differentiated Ovarian Steroid Cell Tumor,0
2967,Schwannian Stroma More than 50 Percent of the Tumor Volume,Lung Inflammatory Myofibroblastic Tumor,0
2968,Spindle Cell Metaplasia of Malignant Cells Present,inverted ductal papilloma of salivary gland,0
2969,Increased megakaryocytes (bone marrow),Stage I Penile Cancer AJCC v6,0
2970,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Acute myeloid leukemia with abnormal marrow eosinophils,0
2971,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of supraglottis,0
2972,Fenestrated Pattern,Anaplastic Ependymoma,0
2973,Schwannian Stroma More than 50 Percent of the Tumor Volume,Malignant Mixed Tumor of the Minor Salivary Gland,0
2974,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Thymoma AJCC v8,0
2975,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Squamous Papilloma,0
2976,Fenestrated Pattern,Uterine Corpus Lipoleiomyoma,0
2977,Intersecting Sharply Marginated Clusters of Spindle Cells Present,basal cell carcinoma of scrotum,0
2978,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of neck,0
2979,Fenestrated Pattern,Mediastinal T Lymphoblastic Leukemia/Lymphoma,0
2980,Increased megakaryocytes (bone marrow),Pericanalicular fibroadenoma,0
2981,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Cerebral Anaplastic Astrocytoma,0
2982,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,0
2983,Absence of Malignant Features,Malignant neoplasm of sublingual gland,0
2984,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carney Complex,0
2985,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Gestational Trophoblastic Neoplasm AJCC v8,0
2986,Recurrent Malignant Neoplasm,Malignant Sternal Neoplasm,0
2987,Increased megakaryocytes (bone marrow),"Testicular Seminoma, Cribriform Variant",0
2988,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Laryngeal Carcinoma,0
2989,Solar Radiation Toxicity,Mucosal lentiginous melanoma,0
2990,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,0
2991,Endometrial Type Glands and Stroma Present,Stage IV Ovarian Teratoma AJCC v6 and v7,0
2992,Solar Radiation Toxicity,Stage I Pancreatic Cancer AJCC v8,0
2993,Solitary mass,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",0
2994,Low Grade Cartilaginous Component Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
2995,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
2996,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIB Gastric Carcinoma,0
2997,Recurrent Malignant Neoplasm,Recurrent Ureter Carcinoma,0
2998,Fenestrated Pattern,Breast Lymphoma,0
2999,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Inflammatory pseudotumor of liver,0
3000,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Blood Vessel Neoplasm,0
3001,Increased megakaryocytes (bone marrow),Papillary ependymoma,0
3002,Less than 2 Mitoses per 10HPF,Epithelioid Sarcoma NCI Grade 2,0
3003,Recurrent Malignant Neoplasm,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0
3004,Spindle Cell Metaplasia of Malignant Cells Present,Bladder Diffuse Clear Cell Adenocarcinoma,0
3005,Neoplastic Plasma Cells Present in Bone Marrow,Bone marrow hyperplasia,0
3006,Mixture of Germ Cell Neoplastic Components Present,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,0
3007,Fenestrated Pattern,Stage II Rectal Cancer AJCC v8,0
3008,Fried-Egg Appearance of the Bone Marrow,Bone Sarcoma by AJCC v7 Stage,0
3009,Fenestrated Pattern,Pericardial Synovial Sarcoma,0
3010,Increased megakaryocytes (bone marrow),Resectable Liposarcoma,0
3011,Fenestrated Pattern,Synovial sarcoma non-metastatic,0
3012,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous adenocarcinoma gastric,0
3013,Increased megakaryocytes (bone marrow),Stage 0 Uterine Corpus Cancer,0
3014,Solar Radiation Toxicity,Colorectal Leiomyosarcoma,0
3015,Fenestrated Pattern,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,0
3016,Fenestrated Pattern,Duodenal Cancer,0
3017,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7,0
3018,Increased megakaryocytes (bone marrow),Primary hepatic neuroendocrine carcinoma,0
3019,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chondrosarcoma metastatic,0
3020,Fenestrated Pattern,Borderline Ovarian Mucinous Adenofibroma,0
3021,Increased megakaryocytes (bone marrow),Posterior Pharyngeal Wall Carcinoma,0
3022,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Kaposi's sarcoma of penis,0
3023,Diffuse Cellular Infiltrate,Cellular angiofibroma,0
3024,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of retina,0
3025,Increased megakaryocytes (bone marrow),Pancreatic adenocarcinoma metastatic,0
3026,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7,0
3027,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fallopian Tube Adenosarcoma,0
3028,Solar Radiation Toxicity,Stage 0 Lung Cancer AJCC v8,0
3029,Solar Radiation Toxicity,Colon Kaposi Sarcoma,0
3030,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of external ear,0
3031,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,0
3032,Localized Hydropic Villous Change,Localized Resectable Adult Liver Carcinoma,0
3033,Solar Radiation Toxicity,Vaginal Adenosarcoma,0
3034,Increased megakaryocytes (bone marrow),Stage IVA Vulvar Cancer AJCC v8,0
3035,Skin Red Dot,Stage I Skin Cancer,0
3036,Nodular and Diffuse Pattern,Stage IIIB Cervical Cancer AJCC v6 and v7,0
3037,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Cervical Cancer AJCC v8,0
3038,Solar Radiation Toxicity,Epidermolysis Bullosa Dystrophica,0
3039,Large Spaces Filled with Blood Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,0
3040,Increased megakaryocytes (bone marrow),"Hydatidiform Mole, Partial",0
3041,Fenestrated Pattern,Filiform Serrated Adenoma,0
3042,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Hodgkin's lymphoma refractory,0
3043,Fenestrated Pattern,Female Reproductive System Adenofibroma,0
3044,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cerebral hemangioma,0
3045,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
3046,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
3047,Fenestrated Pattern,Double expressor lymphoma,0
3048,Tumor Mass,Blastema Predominant Kidney Wilms Tumor,0
3049,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7,0
3050,Fenestrated Pattern,Resectable Sarcoma,0
3051,Increased megakaryocytes (bone marrow),Stage IV Renal Pelvis Cancer AJCC v8,0
3052,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder Papillomatosis,0
3053,Mixed Neoplastic Glandular and Squamous Cell Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
3054,Increased megakaryocytes (bone marrow),Refractory Lymphoblastic Lymphoma,0
3055,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, small cell, nonkeratinizing",0
3056,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Paranasal Sinus Cancer AJCC v7,0
3057,Fibrovascular Stalks Present,Giant Fibrovascular Esophageal Polyp,0
3058,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of vagina,0
3059,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of testis,0
3060,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ossifying Renal Tumor of Infancy,0
3061,Villous Projections of the Neoplastic Epithelium Present,Crohn's disease of the ileum,0
3062,Peau d'orange surface of breast,bilateral breast cancer,0
3063,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Unresectable Extrahepatic Bile Duct Carcinoma,0
3064,Endometrial Type Glands and Stroma Present,Stage IV Lip and Oral Cavity Cancer AJCC v8,0
3065,Stable Disease,mu-Chain Disease,0
3066,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage III Renal Cell Cancer AJCC v7,0
3067,Broad Fibrous Bands Formation,Broad Ligament Papillary Cystadenoma,0
3068,Intermediate Grade Neuroendocrine Lesion,Leiomyosarcoma NCI Grade 3,0
3069,Fenestrated Pattern,Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8,0
3070,Nodular and Diffuse Pattern,Stage I Anal Canal Cancer AJCC v6 and v7,0
3071,Spindle Cell Metaplasia of Malignant Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0
3072,Large Mass,Ki-1+ Anaplastic Large Cell Lymphoma,0
3073,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Esophageal Adenocarcinoma by AJCC v8 Stage,0
3074,Fenestrated Pattern,Refractory Barrett Esophagus,0
3075,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Uveal Melanoma AJCC v7,0
3076,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of tongue,0
3077,Endometrial Type Glands and Stroma Present,Outer Hair Sheath and Infundibulum Neoplasm,0
3078,Endometrial Type Glands and Stroma Present,Hereditary Non-Polyposis Colon Cancer Type 2,0
3079,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant lymphomatous polyposis,0
3080,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Widely Invasive Thymoma,0
3081,Large Spaces Filled with Blood Present,Refractory anemia with excess blasts II,0
3082,Recurrent Genetic Abnormalities Present,Recurrent Grade 1 Follicular Lymphoma,0
3083,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Borderline Uterine Ligament Neoplasm,0
3084,Fenestrated Pattern,Stage IVC Nasopharyngeal Carcinoma AJCC v7,0
3085,Increased megakaryocytes (bone marrow),Urethral Inverted Papilloma,0
3086,Absence of Malignant Features,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3087,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,0
3088,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of kidney,0
3089,Spindle Cell Metaplasia of Malignant Cells Present,Adult Intracranial Germ Cell Tumor,0
3090,Spindle Cell Metaplasia of Malignant Cells Present,Thyroid Gland Spindle Cell Follicular Adenoma,0
3091,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of cecum,0
3092,Sarcomatous or Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
3093,Increased megakaryocytes (bone marrow),Stage I Fallopian Tube Cancer AJCC v8,0
3094,Rubbery Skin Lesion,"Carcinoma, Skin Appendage",0
3095,Increased megakaryocytes (bone marrow),Bile duct cancer recurrent,0
3096,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Carcinoma in the Adrenal Medulla,0
3097,Malignant Primitive Cellular Infiltrate,Malignant Lung Hilum Neoplasm,0
3098,Breast Implant-Related Lesion,Female Breast Carcinoma,0
3099,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
3100,Increased megakaryocytes (bone marrow),Benign Cerebellar Neoplasms,0
3101,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,0
3102,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,0
3103,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sporadic Breast Carcinoma,0
3104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Leukemia, Myeloid, Accelerated Phase",0
3105,Schwannian Stroma More than 50 Percent of the Tumor Volume,Appendix Neuroendocrine Tumor,0
3106,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,large cell neuroendocrine carcinoma of lung,0
3107,Increased megakaryocytes (bone marrow),B-cell lymphoma stage II,0
3108,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Trichofolliculoma,0
3109,Non-Encapsulated Neoplasm,Unresectable Solid Neoplasm,0
3110,Solar Radiation Toxicity,Non-Hematologic Malignancy,0
3111,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of cecum,0
3112,Tubular Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3113,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pseudoporphyria,0
3114,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Malignant Giant Cell Tumor of Bone,0
3115,Solar Radiation Toxicity,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,0
3116,Endometrial Type Glands and Stroma Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",0
3117,Endometrial Type Glands and Stroma Present,Stage IVB Lip Cancer AJCC v6 and v7,0
3118,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cutaneous Radiation-Related Angiosarcoma,0
3119,Diffuse Lesion,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
3120,Increased megakaryocytes (bone marrow),Gallbladder Sarcoma,0
3121,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Fibromatosis, Abdominal",0
3122,Solitary Skin Tumor,Good Prognosis Metastatic Gestational Trophoblastic Tumor,0
3123,Spindle Cell Metaplasia of Malignant Cells Present,Grade 3a Malignant Neoplasm,0
3124,Increased megakaryocytes (bone marrow),"Hamartoma Syndrome, Multiple",0
3125,Folliculotropic Lymphocytic Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,0
3126,Solar Radiation Toxicity,Stage IVA Colorectal Cancer AJCC v7,0
3127,Fenestrated Pattern,Parapsoriasis en Plaques,0
3128,Recurrent Malignant Neoplasm,Stage II Gestational Trophoblastic Neoplasm AJCC v8,0
3129,Fenestrated Pattern,Desmoplastic melanoma,0
3130,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Paget's disease and intraductal carcinoma of breast,0
3131,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pharyngeal Carcinoma by AJCC v8 Stage,0
3132,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prognostic Stage III Breast Cancer AJCC v8,0
3133,Solar Radiation Toxicity,Angioimmunoblastic T-cell lymphoma stage IV,0
3134,Solitary mass,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",0
3135,Slowly Progressive Clinical Course,Non-Hodgkin Lymphoma with Variable Clinical Course,0
3136,Increased megakaryocytes (bone marrow),Locally Advanced Prostate Carcinoma,0
3137,Mixed Neoplastic Glandular and Squamous Cell Population,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
3138,Metaplasia of Malignant Cells Present,Malignant neoplasm of choroid,0
3139,Skin Erosion,Skin Angiosarcoma,0
3140,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Glomangioma of skin,0
3141,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ocular Melanoma with Extraocular Extension,0
3142,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Resectable Carcinoma,0
3143,Increased megakaryocytes (bone marrow),Adult Anaplastic Astrocytoma,0
3144,Large Spaces Filled with Blood Present,Colorectal Adenoma with Mild Dysplasia,0
3145,Lesion with Diameter of 2cm or Less,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,0
3146,High Grade Lesion,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",0
3147,Solar Radiation Toxicity,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
3148,Absence of Malignant Features,Malignant Diencephalic Neoplasm,0
3149,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, Non-WNT/Non-SHH",0
3150,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Cavernous hemangioma of orbit,0
3151,Venous Type Vascular Channel Formation,Classic Type Trichilemmoma,0
3152,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tinea Favosa,0
3153,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous adenocarcinoma of colon,0
3154,Gastric dysplasia,Gastric Kaposi's Sarcoma,0
3155,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intestinal T-cell lymphoma stage I,0
3156,Blasts Expressing CD56 and Immature T-Cell Markers Present,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
3157,Breast Implant-Related Lesion,Prognostic Stage IA Breast Cancer AJCC v8,0
3158,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of heart,0
3159,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3160,Tumor Mass,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
3161,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7,0
3162,Increased megakaryocytes (bone marrow),Stage IIA Cervical Cancer AJCC v6,0
3163,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bile duct carcinoma,0
3164,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Pulmonary Vein Neoplasm,0
3165,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",0
3166,High Grade Lesion,Recurrent Grade 3a Follicular Lymphoma,0
3167,Schwannian Stroma More than 50 Percent of the Tumor Volume,Fallopian Tube Endometrioid Tumor,0
3168,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Histiocytoma, Benign Fibrous",0
3169,Fenestrated Pattern,Transplant-Related Kaposi Sarcoma,0
3170,Fenestrated Pattern,Anaplastic Brain Stem Astrocytoma,0
3171,Villous Projections of the Neoplastic Epithelium Present,Juvenile Polyp of the Small Intestine,0
3172,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myxoid chondrosarcoma,0
3173,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Chondrosarcoma, Clear Cell",0
3174,Nodular and Diffuse Pattern,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
3175,Increased megakaryocytes (bone marrow),Central Nervous System Kaposi Sarcoma,0
3176,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Nerve Schwannoma,0
3177,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Post-transplant lymphoproliferative disorder, polymorphic",0
3178,"Undifferentiated ""Fetal-Type"" Tissues Present",Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
3179,Endometrial Type Glands and Stroma Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,0
3180,Mixture of Germ Cell Neoplastic Components Present,Merkel Cell Carcinoma by AJCC v8 Stage,0
3181,Fenestrated Pattern,Intestinal T-cell lymphoma stage IV,0
3182,Small Lesion,Splenic Small Lymphocytic Lymphoma,0
3183,Canalicular Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
3184,Benign Cellular Infiltrate,Benign Struma Ovarii,0
3185,Increased megakaryocytes (bone marrow),"NK-Cell Lymphoma, Unclassifiable",0
3186,Complex Glandular Pattern,Carney Complex,0
3187,Follicular Structures Present,"Lymphoma, Large-Cell, Follicular",0
3188,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lugano Classification Adult Lymphoma by AJCC v8 Stage,0
3189,Loss of INI 1 Protein Expression,"Seminoma of testis, stage 1",0
3190,No Evidence of Metastatic Disease,Metastatic Adrenal Gland Pheochromocytoma,0
3191,Epithelial hyperplasia of skin,Anal skin tag,0
3192,Breast Implant-Related Lesion,Periductal Breast Myoepitheliosis,0
3193,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Liver Carcinoma,0
3194,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectosigmoid cancer recurrent,0
3195,Increased megakaryocytes (bone marrow),Fallopian Tube Lymphoma,0
3196,Mammary Gland Type Features Present,Lobular Neoplasia Type B,0
3197,Nodular and Diffuse Pattern,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,0
3198,Epithelial hyperplasia of skin,Pseudoepitheliomatous hyperplasia,0
3199,Fenestrated Pattern,Nodal marginal zone B-cell lymphoma stage IV,0
3200,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of labium majus,0
3201,Solar Radiation Toxicity,Lung Mucinous Cystadenoma,0
3202,Abundance of Small Lymphocytes,Stage IB Lung Small Cell Carcinoma AJCC v7,0
3203,Spindle Cell Osteo-Fibrous Component Present,Null Cell Pituitary Gland Adenoma,0
3204,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal Thymoma,0
3205,Fenestrated Pattern,Eccrine Poroma,0
3206,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Astrocytoma of brain stem,0
3207,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placental Non-Neoplastic Disorder,0
3208,Intraepithelial Neoplasia,Colorectal Low Grade Intraepithelial Neoplasia,0
3209,Malignant Primitive Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,0
3210,Fenestrated Pattern,Anal Kaposi Sarcoma,0
3211,Increased megakaryocytes (bone marrow),Familial benign pemphigus,0
3212,Increased megakaryocytes (bone marrow),Refractory Pancreatic Carcinoma,0
3213,Increased megakaryocytes (bone marrow),Metastatic angiosarcoma,0
3214,Solar Radiation Toxicity,Stage II Uterine Sarcoma AJCC v7,0
3215,Fenestrated Pattern,Vaginal adenocarcinoma,0
3216,Intersecting Sharply Marginated Clusters of Spindle Cells Present,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",0
3217,Solar Radiation Toxicity,Digestive System Hodgkin Lymphoma,0
3218,Fenestrated Pattern,Myolipoma,0
3219,Mammary Gland Type Features Present,Major Salivary Gland Non-Hodgkin Lymphoma,0
3220,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult T-Cell Lymphoma/Leukemia,0
3221,Tumor Mass,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
3222,Nodular and Diffuse Pattern,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,0
3223,Nuclear Atypia,Endometrial Hyperplasia without Atypia,0
3224,Schwannian Stroma More than 50 Percent of the Tumor Volume,Thymic Typical Carcinoid Tumor,0
3225,Nodular and Diffuse Pattern,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3226,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nodal marginal zone B-cell lymphoma recurrent,0
3227,Fenestrated Pattern,Nasopharyngeal Angiofibroma,0
3228,Increased megakaryocytes (bone marrow),Composite hemangioendothelioma,0
3229,Fenestrated Pattern,Stomach Carcinoma,0
3230,Tissue Differentiation Uncertain,Scar Tissue,0
3231,Large Spaces Filled with Blood Present,MCD Diffuse Large B-Cell Lymphoma,0
3232,Nodular and Diffuse Pattern,N1 Diffuse Large B-Cell Lymphoma,0
3233,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Head and Neck Neoplasm,0
3234,Solar Radiation Toxicity,Stage II Childhood Burkitt Lymphoma,0
3235,Fenestrated Pattern,Aplasia Cutis Congenita,0
3236,Well Differentiated Hyaline Cartilage Present,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
3237,Spindle Cell Osteo-Fibrous Component Present,Spindle Cell/Pleomorphic Lipoma,0
3238,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular choriocarcinoma stage III,0
3239,Absence of Malignant Features,Sarcoma of vulva,0
3240,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precancerous Polyp,0
3241,Well Differentiated Hyaline Cartilage Present,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
3242,Solitary Skin Tumor,Skin Angiosarcoma,0
3243,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Childhood Liver Cancer,0
3244,Increased megakaryocytes (bone marrow),Blue rubber bleb nevus syndrome,0
3245,Spindle Cell Osteo-Fibrous Component Present,Non-Small Cell Adenocarcinoma,0
3246,Antoni B Pattern,"FANCONI ANEMIA, COMPLEMENTATION GROUP B",0
3247,Mammary Gland Type Features Present,Parotid Gland Lipoma,0
3248,Non-Encapsulated Neoplasm,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
3249,Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage I,0
3250,Exposure to asbestos,Contact dermatitis due to alkali,0
3251,Unfavorable Clinical Outcome,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,0
3252,Nodular and Diffuse Pattern,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0
3253,Breast Implant-Related Lesion,Prognostic Stage IIB Breast Cancer AJCC v8,0
3254,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of gallbladder localized,0
3255,Fenestrated Pattern,Borderline Ovarian Endometrioid Adenofibroma,0
3256,Fenestrated Pattern,Thecoma,0
3257,Increased megakaryocytes (bone marrow),Stage IV Adult Lymphoblastic Lymphoma,0
3258,Solar Radiation Toxicity,AIDS-Related Anal Non-Hodgkin Lymphoma,0
3259,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
3260,Increased megakaryocytes (bone marrow),Locally Advanced Digestive System Carcinoma,0
3261,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0
3262,Nodular and Diffuse Pattern,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
3263,Spindle Cell Metaplasia of Malignant Cells Present,Esophageal Spindle Cell Carcinoma,0
3264,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Spinal Cord Melanoma,0
3265,Mammary Gland Type Features Present,Recurrent Neurofibromatosis Type 1,0
3266,White blood cell count increased (lab result),Anal canal squamous cell carcinoma,0
3267,Absence of Malignant Features,Mucoepidermoid carcinoma of parotid gland,0
3268,IDH Gene Family Mutation Status Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
3269,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of ciliary body,0
3270,Well Differentiated Neuroendocrine Lesion,Moderately Differentiated Prostate Adenocarcinoma,0
3271,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Uterine Corpus Cancer AJCC v8,0
3272,Increased megakaryocytes (bone marrow),Pancreatic carcinoma non-resectable,0
3273,Solar Radiation Toxicity,Stage IIA Prostate Cancer AJCC v7,0
3274,Aberrant Thyroid Tissue Present,Thyroid Gland Leiomyosarcoma,0
3275,Increased megakaryocytes (bone marrow),Radiation-Related Angiosarcoma,0
3276,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Renal Pelvis Cancer AJCC v7,0
3277,Increased megakaryocytes (bone marrow),Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,0
3278,Nodular and Diffuse Pattern,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
3279,Fenestrated Pattern,Advanced cancer,0
3280,Fenestrated Pattern,Colorectal Schwannoma,0
3281,Blasts Expressing CD56 and Immature T-Cell Markers Present,Sellar Immature Teratoma,0
3282,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of pericardium,0
3283,Mixture of Embryonal and Alveolar Features Present,Orbital Alveolar Soft Part Sarcoma,0
3284,Increased megakaryocytes (bone marrow),"Gastric Adenoma, Gastric-Type",0
3285,Absence of Malignant Features,Benign neoplasm of lymph vessels,0
3286,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
3287,Fenestrated Pattern,Bartholin Gland Adenoma,0
3288,Recurrent Genetic Abnormalities Present,Recurrent Parathyroid Gland Carcinoma,0
3289,Mixed Neoplastic Glandular and Squamous Cell Population,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,0
3290,Squamous metaplasia of bladder,Squamous Lung Dysplasia,0
3291,Solar Radiation Toxicity,Kidney Fibroma,0
3292,Microinvasive tumor,Papillary glioneuronal tumor,0
3293,Well Differentiated Lesion,Oropharyngeal Poorly Differentiated Carcinoma,0
3294,Villous Projections of the Neoplastic Epithelium Present,Sarcoma of the Extremity,0
3295,Stromal Invasion,Uterine Corpus Endometrial Stromal Sarcoma,0
3296,Osseous Metaplasia of Malignant Cells Present,Malignant germ cell neoplasm of mediastinum,0
3297,Fenestrated Pattern,Trabecular adenocarcinoma,0
3298,Arborising Network of Cords of Basaloid Cells Present,Oropharyngeal Basaloid Carcinoma,0
3299,Mixture of Germ Cell Neoplastic Components Present,Conventional (Clear Cell) Renal Cell Carcinoma,0
3300,Increased megakaryocytes (bone marrow),Respiratory papilloma,0
3301,Confluent Sheets of Anaplastic T-Lymphocytes Present,Adult Anaplastic Ependymoma,0
3302,High Grade Non Cartilaginous Sarcomatous Stroma Present,Low Grade Adenosquamous Breast Carcinoma,0
3303,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Renal Cell Cancer,0
3304,No Evidence of Metastatic Disease,Metastatic Digestive System Neuroendocrine Neoplasm,0
3305,Increased megakaryocytes (bone marrow),Endocrine Gland Neoplasms,0
3306,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate cancer stage B,0
3307,Increased megakaryocytes (bone marrow),Subungual exostoses,0
3308,Increased megakaryocytes (bone marrow),Childhood Gemistocytic Astrocytoma,0
3309,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Centroblastic lymphoma stage II,0
3310,Primary Site Unspecified,Ethmoid Sinus Primary Ectopic Meningioma,0
3311,Multihormonal Immunoreactivity Present in a Single Cell Type,Turcot Syndrome Type 2,0
3312,Fenestrated Pattern,Stage IIB Fallopian Tube Cancer AJCC v8,0
3313,Mixture of Germ Cell Neoplastic Components Present,Advanced Renal Cell Carcinoma,0
3314,Solar Radiation Toxicity,Central Nervous System Extraskeletal Osteosarcoma,0
3315,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of choroid,0
3316,Systemic disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,0
3317,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Adenosquamous Carcinoma,0
3318,Increased megakaryocytes (bone marrow),Infestation by Phthirus pubis,0
3319,No Evidence of Metastatic Disease,Recurrent Metastatic Digestive System Carcinoma,0
3320,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
3321,Fenestrated Pattern,Benign Cerebellar Neoplasms,0
3322,Increased megakaryocytes (bone marrow),Primary peritoneal carcinoma,0
3323,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of ampulla of Vater,0
3324,Fenestrated Pattern,Genitourinary Cancer,0
3325,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of endocardium,0
3326,Increased megakaryocytes (bone marrow),Rectal Lymphoma,0
3327,Spindle Cell Metaplasia of Malignant Cells Present,Gastric Cardia Squamous Cell Carcinoma,0
3328,Photosensitivity of skin,Epithelial neoplasm of skin,0
3329,Spindle Cell Metaplasia of Malignant Cells Present,Gingival Spindle Cell Carcinoma,0
3330,Intraepithelial Neoplasia,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
3331,Schwannian Stroma More than 50 Percent of the Tumor Volume,Recurrent Rhabdoid Tumor,0
3332,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infiltrating Bladder Carcinoma,0
3333,Increased megakaryocytes (bone marrow),Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
3334,Increased megakaryocytes (bone marrow),Brain Glioblastoma,0
3335,Fenestrated Pattern,Stage IVC Appendix Carcinoma AJCC v7,0
3336,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Carcinoma of lower gum,0
3337,Increased megakaryocytes (bone marrow),Stage III Thymoma AJCC v8,0
3338,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of lacrimal gland,0
3339,Solar Radiation Toxicity,Stage IC Uterine Corpus Adenosarcoma AJCC v8,0
3340,Hyperplastic Tissue Present,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
3341,Increased megakaryocytes (bone marrow),Prolactinoma,0
3342,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Childhood Supratentorial Neoplasm,0
3343,Increased megakaryocytes (bone marrow),Familial benign pemphigus,0
3344,Increased megakaryocytes (bone marrow),Appendix Intraepithelial Neoplasia,0
3345,Increased megakaryocytes (bone marrow),MGMT-Unmethylated Glioblastoma,0
3346,Spindle Cell Metaplasia of Malignant Cells Present,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,0
3347,Spindle Cell Metaplasia of Malignant Cells Present,sarcoma of mediastinum,0
3348,Fenestrated Pattern,Benign male reproductive tract neoplasm,0
3349,Hypertensive disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,0
3350,Fenestrated Pattern,Colorectal Cowden-Associated Polyp,0
3351,Recurrent Genetic Abnormalities Present,Recurrent Endometrial Undifferentiated Carcinoma,0
3352,Mammary Gland Type Features Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,0
3353,Vacuolated Plasma Cells in the Bone Marrow,Prostate Carcinoma Metastatic in the Bone,0
3354,Spindle Cell Metaplasia of Malignant Cells Present,Leuteoma of Pregnancy,0
3355,Fenestrated Pattern,Stage II Gallbladder Cancer AJCC v6,0
3356,Solitary Skin Tumor,Stage IIIA Gestational Trophoblastic Tumor AJCC v7,0
3357,Increased megakaryocytes (bone marrow),Cholangiocarcinoma,0
3358,Fenestrated Pattern,"Medulloblastoma, Not Otherwise Specified",0
3359,Solar Radiation Toxicity,Stage IV Colorectal Cancer AJCC v8,0
3360,Lesion with Diameter of 2cm or Less,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,0
3361,Intersecting Sharply Marginated Clusters of Spindle Cells Present,polyembryoma of ovary,0
3362,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ethmoid Sinus Adenocarcinoma,0
3363,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adrenal Gland Ganglioneuroma,0
3364,IDH Gene Family Mutation Status Unknown,Melanoma of Unknown Primary,0
3365,Recurrent Malignant Neoplasm,Childhood Malignant Solid Neoplasm,0
3366,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Pineal Parenchymal Cell Neoplasm,0
3367,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Anal Cancer AJCC v8,0
3368,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Metastatic Malignant Neoplasm to the Cervix,0
3369,Questionable Invasive Lesion,Minimally Invasive Thymoma,0
3370,Increased megakaryocytes (bone marrow),Esophageal adenocarcinoma recurrent,0
3371,Increased megakaryocytes (bone marrow),Erythema Multiforme,0
3372,Increased megakaryocytes (bone marrow),Stage IV Nasopharyngeal Carcinoma AJCC v6,0
3373,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage IIIA Pleural Malignant Mesothelioma AJCC v8,0
3374,Finding related to pregnancy,Metastatic malignant neoplasm to brain,0
3375,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,0
3376,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Colon Cancer AJCC v7,0
3377,Questionable Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma,0
3378,More Than Two Separate Tumor Masses Present in the Same Organ,Drop Metastasis in the Spinal Cord,0
3379,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oncogenic osteomalacia,0
3380,Intersecting Sharply Marginated Clusters of Spindle Cells Present,squamous cell carcinoma of urethra,0
3381,Neoplastic Cells with TFH Cell Phenotype Present,Ovarian Sertoli Cell Tumor with Lipid Storage,0
3382,Lesion with Diameter of 2cm or Less,Squamous cell carcinoma with horn formation,0
3383,"Undifferentiated ""Fetal-Type"" Tissues Present",Unresectable Undifferentiated Pleomorphic Sarcoma,0
3384,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,0
3385,Absence of Malignant Features,Undifferentiated Malignant Neoplasm,0
3386,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Appendix Carcinoma AJCC v7,0
3387,Well Differentiated Lesion,Poorly Differentiated Angiosarcoma,0
3388,Increased megakaryocytes (bone marrow),Mycosis fungoides/Sezary syndrome stage IV,0
3389,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,0
3390,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Nasopharyngeal Carcinoma,0
3391,Intermediate Grade Neuroendocrine Lesion,Neuroendocrine cervical carcinoma,0
3392,Absence of Malignant Features,Malignant neoplasm of nasopharynx recurrent,0
3393,Mass of pleura,Benign neoplasm of mesothelial tissue of pleura,0
3394,Increased megakaryocytes (bone marrow),Stage IVA Appendix Carcinoma AJCC v8,0
3395,Gastric dysplasia,Gastric Squamous Cell Carcinoma,0
3396,Nodular and Diffuse Pattern,Locally Advanced Head and Neck Carcinoma,0
3397,Non-Encapsulated Neoplasm,Adult Spinal Cord Neoplasm,0
3398,Increased megakaryocytes (bone marrow),Anaplastic Embryonal Rhabdomyosarcoma,0
3399,Fenestrated Pattern,Neuronevus,0
3400,Skin Erosion,Unresectable Skin Basal Cell Carcinoma,0
3401,Blasts Expressing CD56 and Immature T-Cell Markers Present,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0
3402,Windblown Appearance of Atypical Keratinocytes,Cervical Atypical Polypoid Adenomyoma,0
3403,Neutral Epithelial Mucin Present,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
3404,Fenestrated Pattern,Stage I Eyelid Carcinoma AJCC v8,0
3405,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Dedifferentiated Liposarcoma,0
3406,Solar Radiation Toxicity,Stage IVA Laryngeal Cancer AJCC v8,0
3407,Increased megakaryocytes (bone marrow),Acinar Prostate Mucinous Adenocarcinoma,0
3408,Schwannian Stroma More than 50 Percent of the Tumor Volume,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,0
3409,Recurrent Malignant Neoplasm,Benign Childhood Cerebral Neoplasm,0
3410,Low Grade Neuroendocrine Lesion,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
3411,Recurrent Genetic Abnormalities Present,Recurrent Inverted Schneiderian Papilloma,0
3412,Small Aggregates of Tumor Cells Present,Ampulla of Vater Neuroendocrine Tumor G2,0
3413,Intestinal metaplasia of gastric mucosa,Papilloma of buccal mucosa,0
3414,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,follicular dendritic cell sarcoma of thyroid gland,0
3415,Atypical Lymphocytes Present in Peripheral Blood,Peripheral T-Cell Lymphoma,0
3416,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Moniliform hamartoma,0
3417,Recurrent Genetic Abnormalities Present,Recurrent Salivary Duct Carcinoma,0
3418,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Reproductive System Neoplasm,0
3419,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0
3420,Abundance of Small Lymphocytes,Small Intestinal Intraepithelial Neoplasia,0
3421,Fenestrated Pattern,"Vaginal Deep ""Aggressive"" Angiomyxoma",0
3422,Nodular and Diffuse Pattern,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,0
3423,Solar Radiation Toxicity,Lugano Classification Stage IV Adult Lymphoma AJCC v8,0
3424,Fenestrated Pattern,Tracheal Carcinoma,0
3425,Increased megakaryocytes (bone marrow),Occult Breast Carcinoma,0
3426,Fenestrated Pattern,Stage I Vaginal Cancer AJCC v8,0
3427,Solitary Skin Tumor,Thyroid Gland Solitary Fibrous Tumor,0
3428,Increased megakaryocytes (bone marrow),Primary hepatic neuroendocrine carcinoma,0
3429,Low Grade Neuroendocrine Lesion,Ovarian Low Grade Endometrioid Stromal Sarcoma,0
3430,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Masaoka-Koga Stage III,0
3431,Recurrent Malignant Neoplasm,Osteogenic Neoplasm,0
3432,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIB Merkel Cell Carcinoma AJCC v7,0
3433,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Follicular Lymphoma by Ann Arbor Stage,0
3434,Spindle Cell Osteo-Fibrous Component Present,Ciliary Body Spindle Cell Melanoma,0
3435,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
3436,Recurrent Genetic Abnormalities Present,Recurrent Glioma,0
3437,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,large B-cell diffuse lymphoma of accessory sinus,0
3438,Large Spaces Filled with Blood Present,B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH,0
3439,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Pharyngeal Carcinoma by AJCC v8 Stage,0
3440,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Testicular Seminoma, Tubular Variant",0
3441,Neoplastic Plasma Cells Present in Bone Marrow,Recurrent Bone Ewing Sarcoma,0
3442,Breast Implant-Related Lesion,Prognostic Stage IIIC Breast Cancer AJCC v8,0
3443,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
3444,Solar Radiation Toxicity,Stage I Colon Cancer AJCC v8,0
3445,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Crohn's disease of the ileum,0
3446,Spindle Cell Metaplasia of Malignant Cells Present,Clear Cell Hepatocellular Carcinoma,0
3447,Mixture of Germ Cell Neoplastic Components Present,Renal Cell Cancer by AJCC v8 Stage,0
3448,Mixture of Germ Cell Neoplastic Components Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,0
3449,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage,0
3450,Fried-Egg Appearance of the Bone Marrow,Carcinoid tumor of the prostate,0
3451,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,0
3452,Mammary Gland Type Features Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
3453,Aggressive Clinical Course,Recurrent Aggressive Non-Hodgkin Lymphoma,0
3454,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage III Pleural Malignant Mesothelioma AJCC v8,0
3455,High Grade Non Cartilaginous Sarcomatous Stroma Present,Intermediate Grade Lung Neuroendocrine Neoplasm,0
3456,Fenestrated Pattern,Cystadenofibroma,0
3457,Spindle Cell Metaplasia of Malignant Cells Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
3458,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Advanced Carcinoid Tumor,0
3459,Increased megakaryocytes (bone marrow),"Gastrointestinal stromal tumor, benign",0
3460,Spindle Cell Metaplasia of Malignant Cells Present,Advanced Malignant Solid Neoplasm,0
3461,Skin Erosion,Unresectable Skin Carcinoma,0
3462,Increased megakaryocytes (bone marrow),Stage IB Osteosarcoma AJCC v7,0
3463,Canalicular Pattern,"Testicular Yolk Sac Tumor, Enteric Pattern",0
3464,Disease regression,Intestinal Graft Versus Host Disease,0
3465,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,0
3466,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed Oligodendroglioma-Astrocytoma,0
3467,Mesenchymal Differentiation,Mesenchymal Glioblastoma,0
3468,Cutaneous plaque,Cutaneous Leiomyosarcoma,0
3469,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Colorectal Carcinoma,0
3470,Moderately Differentiated Lesion,Cystic Partially Differentiated Nephroblastoma,0
3471,Large Mass,Stage IIIA Lung Large Cell Carcinoma AJCC v7,0
3472,Fenestrated Pattern,Meningeal melanomatosis,0
3473,High Grade Lesion,Grade 2 Endometrial Mucinous Adenocarcinoma,0
3474,Gastric dysplasia,Gastric Carcinoid Tumor,0
3475,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Cancer by AJCC v8 Stage,0
3476,Spindle Cell Metaplasia of Malignant Cells Present,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,0
3477,Increased megakaryocytes (bone marrow),Colon Hodgkin Lymphoma,0
3478,Increased megakaryocytes (bone marrow),Lung Monophasic Synovial Sarcoma,0
3479,Fried-Egg Appearance of the Bone Marrow,Squamous Papilloma of the Nasopharynx,0
3480,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Cervical Neuroendocrine Neoplasm,0
3481,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of salivary gland,0
3482,Solar Radiation Toxicity,Childhood Central Nervous System Choriocarcinoma,0
3483,Spindle Cell Metaplasia of Malignant Cells Present,Transplant-Related Squamous Cell Carcinoma,0
3484,Increased megakaryocytes (bone marrow),Refractory Myelodysplastic Syndrome,0
3485,Mixed Cellular Population,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
3486,Follicular Structures Present,Ann Arbor Stage II Follicular Lymphoma,0
3487,Folliculotropic Lymphocytic Infiltrate,Small Lymphocytic Lymphoma by Ann Arbor Stage,0
3488,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,0
3489,Recurrent Malignant Neoplasm,Recurrent Childhood Pineoblastoma,0
3490,Solar Radiation Toxicity,Struma Ovarii,0
3491,Increased megakaryocytes (bone marrow),Stage IIA Pancreatic Cancer AJCC v8,0
3492,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,HIV-Associated Lymphoproliferative Disorder,0
3493,Solitary Skin Tumor,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,0
3494,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Mixed Salivary Gland Tumor,0
3495,Increased megakaryocytes (bone marrow),Endocervical Carcinoma,0
3496,Increased megakaryocytes (bone marrow),Stage 0 Hilar Cholangiocarcinoma AJCC v7,0
3497,Increased megakaryocytes (bone marrow),Mesonephric Hyperplasia,0
3498,Mesenchymal Component Present,Mesenchymal Glioblastoma,0
3499,Endometrial Type Glands and Stroma Present,Ventricular and Brain Stem Ependymal Tumor,0
3500,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3501,Fenestrated Pattern,Refractory Hepatoblastoma,0
3502,Increased megakaryocytes (bone marrow),Monomorphic Post-Transplant Lymphoproliferative Disorder,0
3503,Increased megakaryocytes (bone marrow),Myxoid chondrosarcoma,0
3504,Endometrial Type Glands and Stroma Present,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0
3505,Lesion with Diameter of 2cm or Less,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0
3506,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Acute myeloid leukemia, inv(16)(p13q22)",0
3507,Tumor Mass,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
3508,Solar Radiation Toxicity,Aplasia Cutis Congenita,0
3509,Increased megakaryocytes (bone marrow),Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,0
3510,Absence of Stromal Invasion,Prostate Stromal Proliferation of Uncertain Malignant Potential,0
3511,Increased megakaryocytes (bone marrow),Pityriasis Rosea,0
3512,Odontogenic Cysts,Calcifying Odontogenic Cyst,0
3513,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anaplastic Astroblastoma,0
3514,Absence of Malignant Features,mucinous adenocarcinoma of cervix,0
3515,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of anus,0
3516,Mixture of Embryonal and Alveolar Features Present,Vulvar Alveolar Soft Part Sarcoma,0
3517,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Renal Pelvis Cancer AJCC v8,0
3518,Schwannian Stroma More than 50 Percent of the Tumor Volume,Rhabdomyosarcoma of the orbit,0
3519,Absence of Malignant Features,Benign neoplasm of endometrium,0
3520,Solar Radiation Toxicity,Seborrheic keratosis,0
3521,Small Aggregates of Tumor Cells Present,Small Intestinal Kaposi Sarcoma,0
3522,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,0
3523,Immature Myeloid Cells Increased in Bone Marrow,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
3524,Fenestrated Pattern,Precursor B-lymphoblastic lymphoma stage III,0
3525,Absence of Malignant Features,Childhood Malignant Kidney Neoplasm,0
3526,Increased megakaryocytes (bone marrow),Upper Gingival Verrucous Carcinoma,0
3527,Malignant Primitive Cellular Infiltrate,Refractory Malignant Peripheral Nerve Sheath Tumor,0
3528,Confluent Sheets of Anaplastic T-Lymphocytes Present,Recurrent Anaplastic Astrocytoma,0
3529,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of vulva,0
3530,Cervical lymphadenopathy,Cervical Adenocarcinoma In Situ,0
3531,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Adenofibroma,0
3532,Increased megakaryocytes (bone marrow),Refractory Melanoma,0
3533,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage,0
3534,Malignant Primitive Cellular Infiltrate,Malignant Intracranial Neoplasm,0
3535,Increased megakaryocytes (bone marrow),Childhood Cerebellar Astrocytoma,0
3536,Large Spaces Filled with Blood Present,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0
3537,Malignant Primitive Cellular Infiltrate,Malignant melanoma in junctional nevus,0
3538,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Peritoneal and Retroperitoneal Neoplasm,0
3539,Well Differentiated Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
3540,Increased megakaryocytes (bone marrow),AIDS-Related Pneumocystis Pneumonia,0
3541,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Gallbladder Cancer AJCC v7,0
3542,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Appendix Carcinoma AJCC v7,0
3543,Nodular lesions,Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3544,Increased megakaryocytes (bone marrow),Superior Vena Cava Angiosarcoma,0
3545,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,verrucous carcinoma of vulva,0
3546,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,0
3547,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Ureter Carcinoma,0
3548,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Recurrent Neuroendocrine Neoplasm,0
3549,Lesion with Diameter of 2cm or Less,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
3550,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,melanoma of scrotum,0
3551,Increased megakaryocytes (bone marrow),Benign Carotid Body Paraganglioma,0
3552,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of spleen,0
3553,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Classic Rhabdomyoma,0
3554,Fenestrated Pattern,Breast Ductal Adenoma,0
3555,Melanoma Cells Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3556,Glandular cell atypia,Lung squamous cell carcinoma stage III,0
3557,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Head and Neck Basaloid Carcinoma,0
3558,Increased megakaryocytes (bone marrow),Mycosis fungoides/Sezary syndrome NOS,0
3559,Spindle Cell Osteo-Fibrous Component Present,"Carcinoma, Basal Cell",0
3560,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage III Pleural Malignant Mesothelioma AJCC v7,0
3561,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,0
3562,Plasma cell inflammation,Stage III renal cell cancer,0
3563,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anatomic Stage IV Breast Cancer AJCC v8,0
3564,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central nervous system melanoma,0
3565,Absence of Malignant Features,basal cell carcinoma of scrotum,0
3566,Absence of Stromal Invasion,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
3567,Spindle Cell Osteo-Fibrous Component Present,Myxoid/Round Cell Liposarcoma,0
3568,Human Papillomavirus Positive,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
3569,Hyperplastic Tissue Present,Stage IB Soft Tissue Sarcoma AJCC v7,0
3570,Endometrial Type Glands and Stroma Present,Metastatic Endometrial Carcinoma,0
3571,Large Spaces Filled with Blood Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
3572,Absence of Malignant Features,Clear cell adenocarcinoma of ovary,0
3573,No Evidence of Metastatic Disease,Metastatic Neuroblastoma,0
3574,Spindle Cell Metaplasia of Malignant Cells Present,sialadenoma papilliferum of salivary gland,0
3575,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,0
3576,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parotid Gland Lymphangioma,0
3577,Plexiform Vasculature Present,Gastric Plexiform Fibromyxoma,0
3578,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,High Grade Salivary Gland Carcinoma,0
3579,Generalized Hydropic Villous Change,Bladder Villous Adenoma,0
3580,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Peripheral Hemangioblastoma,0
3581,Fenestrated Pattern,Stage IIIA Colon Cancer AJCC v7,0
3582,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Rectal Cancer AJCC v8,0
3583,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary leiomyosarcoma,0
3584,Spindle Cell Metaplasia of Malignant Cells Present,Anaplastic Malignant Neoplasm,0
3585,Solitary Skin Tumor,Anaplastic Kidney Wilms Tumor,0
3586,Recurrent Malignant Neoplasm,Recurrent Paraganglioma,0
3587,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Adrenal Cortex Adenomatoid Tumor,0
3588,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Lung Cancer AJCC v7,0
3589,Marked Thickening of the Bladder Urothelium Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",0
3590,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Diencephalic Neoplasm,0
3591,Solar Radiation Toxicity,Impetigo,0
3592,Large Spaces Filled with Blood Present,Stage I Anaplastic Large Cell Lymphoma,0
3593,Solar Radiation Toxicity,Clear-Cell Myomelanocytic Tumors,0
3594,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian Cancer by AJCC v8 Stage,0
3595,Increased megakaryocytes (bone marrow),Bile duct cystadenocarcinoma,0
3596,Malignant Primitive Cellular Infiltrate,Stage IV Pleural Malignant Mesothelioma AJCC v7,0
3597,Spindle Cell Osteo-Fibrous Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,0
3598,Prominent Elastic Tissue Cores Present,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma,0
3599,Increased megakaryocytes (bone marrow),Stage III Non-Hodgkin Lymphoma,0
3600,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Unresectable Cervical Carcinoma,0
3601,Endometrial Type Glands and Stroma Present,Simple Endometrial Hyperplasia without Atypia,0
3602,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
3603,Fenestrated Pattern,Childhood Burkitt Leukemia,0
3604,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Malignant Neoplasm,0
3605,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
3606,High Grade Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3607,Spindle Cell Osteo-Fibrous Component Present,Null Cell Pituitary Gland Adenoma,0
3608,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Carcinoma of Penis,0
3609,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Resectable Liposarcoma,0
3610,Fenestrated Pattern,Burkitt's lymphoma refractory,0
3611,Fenestrated Pattern,Transplant-Related Disorder,0
3612,Fenestrated Pattern,Childhood Osteosarcoma,0
3613,Recurrent Malignant Neoplasm,Benign Hair Follicle Neoplasm,0
3614,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3615,Large Spaces Filled with Blood Present,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3616,Endometrial Type Glands and Stroma Present,Type B Lymphomatoid Papulosis,0
3617,Gastric dysplasia,Pathologic Stage I Gastric Cancer AJCC v8,0
3618,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Cardiac Schwannoma,0
3619,Epithelial hyperplasia of skin,Sarcoma of skin,0
3620,Mixed Neoplastic Glandular and Squamous Cell Population,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,0
3621,Increased megakaryocytes (bone marrow),Gonadal Polyembryoma,0
3622,Solar Radiation Toxicity,Uterine Corpus Adenofibroma,0
3623,Increased megakaryocytes (bone marrow),Pancreatic Intraepithelial Neoplasia-1A,0
3624,Human Papillomavirus Negative,Human Papillomavirus-Related Adenocarcinoma,0
3625,Fenestrated Pattern,Sebaceous Adenocarcinoma,0
3626,High Grade Non Cartilaginous Sarcomatous Stroma Present,FNCLCC Sarcoma Grade 3,0
3627,Solar Radiation Toxicity,Liver Lymphangiomatosis,0
3628,Recurrent Genetic Abnormalities Present,Recurrent B Acute Lymphoblastic Leukemia,0
3629,Absence of Malignant Features,Benign neoplasm of epiglottis,0
3630,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Systemic Anaplastic Large Cell Lymphoma,0
3631,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Pericardial Germ Cell Tumor,0
3632,Systemic disease,"Mastocytosis, Systemic",0
3633,Solar Radiation Toxicity,Stage IIA Lung Cancer AJCC v8,0
3634,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,0
3635,Nodular and Diffuse Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
3636,Spindle Cell Metaplasia of Malignant Cells Present,Ovarian Squamous Cell Tumor,0
3637,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stromal Predominant Kidney Wilms Tumor,0
3638,Endometrial Type Glands and Stroma Present,Stage IIB Cutaneous Melanoma AJCC v6 and v7,0
3639,Well Differentiated Lesion,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,0
3640,Increased megakaryocytes (bone marrow),Labia Minora Carcinoma,0
3641,Breast Implant-Related Lesion,Breast Lymphoma,0
3642,Increased megakaryocytes (bone marrow),Stage I Fallopian Tube Cancer,0
3643,Increased megakaryocytes (bone marrow),Cauda Equina Paraganglioma,0
3644,Spindle Cell Osteo-Fibrous Component Present,Stage IV Lip Basal Cell Carcinoma,0
3645,Increased megakaryocytes (bone marrow),Sellar Ependymoma,0
3646,Increased megakaryocytes (bone marrow),Stage IVB Hilar Cholangiocarcinoma AJCC v7,0
3647,Fenestrated Pattern,Stage IIIB Eyelid Carcinoma AJCC v7,0
3648,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Exfoliative dermatitis,0
3649,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7,0
3650,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Leiomyoma,0
3651,Increased megakaryocytes (bone marrow),Bile duct cystadenoma,0
3652,Unfavorable Clinical Outcome,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
3653,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Tubular adenoma of colon,0
3654,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Retinoblastoma by AJCC v8 Stage,0
3655,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
3656,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Vaginal Cancer AJCC v8,0
3657,Fenestrated Pattern,Stage IVA Laryngeal Cancer AJCC v8,0
3658,Fenestrated Pattern,Uterine Corpus Myxoid Leiomyosarcoma,0
3659,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,"Temporal Lobe, Parietal Lobe, and Lateral Ventricle Ependymal Tumor",0
3660,Schwannian Stroma More than 50 Percent of the Tumor Volume,Plasmablastic Lymphoma of the Oral Mucosa,0
3661,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of ovary,0
3662,Solar Radiation Toxicity,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
3663,Fenestrated Pattern,Secondary Heart Lymphoma,0
3664,Increased megakaryocytes (bone marrow),Stage IA Uterine Corpus Adenosarcoma AJCC v8,0
3665,Increased megakaryocytes (bone marrow),"Childhood Ganglioneuroblastoma, Intermixed",0
3666,Multihormonal Immunoreactivity Present in a Single Cell Type,Small Intestinal Small Cell Neuroendocrine Carcinoma,0
3667,Diffuse Lesion,Diffuse Glioma,0
3668,Fenestrated Pattern,Anaplastic astrocytoma,0
3669,Increased megakaryocytes (bone marrow),Stage IV Nasal Cavity Carcinoma AJCC v7,0
3670,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,"Neoplasm, malignant, uncertain whether primary or metastatic",0
3671,High Grade Lesion,Grade II Prostatic Intraepithelial Neoplasia,0
3672,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Minor Salivary Gland Undifferentiated Carcinoma,0
3673,Solitary Skin Tumor,Hurthle Cell Tumor,0
3674,Schwannian Stroma More than 50 Percent of the Tumor Volume,Refractory Rhabdoid Tumor,0
3675,Fenestrated Pattern,"lymphomatoid papulosis, type A",0
3676,Fenestrated Pattern,Synovial sarcoma non-metastatic,0
3677,Intersecting Sharply Marginated Clusters of Spindle Cells Present,embryonal rhabdomyosarcoma of prostate,0
3678,Absence of Malignant Features,benign tumor of hypopharynx,0
3679,Increased megakaryocytes (bone marrow),Pancreatic Macrocystic Serous Cystadenoma,0
3680,Increased megakaryocytes (bone marrow),Placenta Disorders,0
3681,Fenestrated Pattern,Adenoameloblastoma,0
3682,Intraepithelial Neoplasia,Cervical Intraepithelial Neoplasia,0
3683,Glandular metaplasia,Cervical Glandular Neoplasm,0
3684,Gastric dysplasia,Refractory cytopenia with unilineage dysplasia,0
3685,Recurrent Genetic Abnormalities Present,Recurrent Uterine Corpus Carcinoma,0
3686,Solar Radiation Toxicity,Adult Cholangiocarcinoma,0
3687,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
3688,Fenestrated Pattern,Refractory Testicular Lymphoma,0
3689,Fenestrated Pattern,Angiomatous Meningioma,0
3690,Increased megakaryocytes (bone marrow),Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8,0
3691,Endometrial Type Glands and Stroma Present,Hereditary Non-Polyposis Colon Cancer Type 2,0
3692,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoma of Male Breast,0
3693,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Histiocytic and Dendritic Cell Neoplasm,0
3694,Atypical Lymphocytes Present in Peripheral Blood,Thymic Atypical Carcinoid Tumor,0
3695,Mature Neutrophils Present,Childhood Testicular Mature Teratoma,0
3696,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Adenocarcinoma Metastatic in the Liver,0
3697,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Ovarian Polyembryoma AJCC v6 and v7,0
3698,Tumor Mass,Borderline Fallopian Tube Endometrioid Tumor,0
3699,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Carcinoma of larynx,0
3700,Intersecting Sharply Marginated Clusters of Spindle Cells Present,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,0
3701,Absence of Malignant Features,Intraductal papilloma of breast,0
3702,Increased megakaryocytes (bone marrow),Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,0
3703,Increased megakaryocytes (bone marrow),Stage IV Nasopharyngeal Carcinoma AJCC v6,0
3704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Conventional Schwannoma,0
3705,Blasts Expressing CD56 and Immature T-Cell Markers Present,Chronic Adult T-Cell Leukemia/Lymphoma,0
3706,NRBC - Nucleated red blood cell present result,Transitional cell carcinoma metastatic,0
3707,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infiltrating Intramuscular Lipoma,0
3708,Gastric dysplasia,Clinical Stage IIA Gastric Cancer AJCC v8,0
3709,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Squamous cell carcinoma of lung,0
3710,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Oropharyngeal Poorly Differentiated Carcinoma,0
3711,Fenestrated Pattern,Fallopian Tube Gestational Choriocarcinoma,0
3712,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the hypopharynx recurrent,0
3713,Low Grade Neuroendocrine Lesion,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
3714,Increased megakaryocytes (bone marrow),Ovarian epithelial cancer stage II,0
3715,Questionable Invasive Lesion,Invasive Prostate Carcinoma,0
3716,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8,0
3717,Metaplasia of Malignant Cells Present,Malignant neoplasm of fallopian tube,0
3718,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ganglioneuroblastoma,0
3719,Fenestrated Pattern,Alveolar rhabdomyosarcoma,0
3720,Mixture of Germ Cell Neoplastic Components Present,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0
3721,Fenestrated Pattern,Lipid-rich carcinoma,0
3722,Non-Encapsulated Neoplasm,Childhood Kidney Neoplasm,0
3723,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7,0
3724,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Colon Cancer AJCC v7,0
3725,Fenestrated Pattern,Central Nervous System Rhabdomyosarcoma,0
3726,Fried-Egg Appearance of the Bone Marrow,Carcinoma of the Floor of the Mouth,0
3727,White blood cell count increased (lab result),Mantle cell lymphoma refractory,0
3728,Increased megakaryocytes (bone marrow),"Thymoma, type B1, malignant",0
3729,Spindle Cell Metaplasia of Malignant Cells Present,Lung Basaloid Squamous Cell Carcinoma,0
3730,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Uterine Corpus Sarcoma,0
3731,Spindle Cell Metaplasia of Malignant Cells Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
3732,Increased megakaryocytes (bone marrow),"Supratentorial Embryonal Tumor, Not Otherwise Specified",0
3733,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rhabdomyosarcoma of cervix uteri,0
3734,Spindle Cell Metaplasia of Malignant Cells Present,Unresectable Transitional Cell Carcinoma,0
3735,Increased megakaryocytes (bone marrow),Anaplastic ganglioglioma,0
3736,Multihormonal Immunoreactivity Present in a Single Cell Type,Hepatocellular Small Cell Change,0
3737,Fenestrated Pattern,Parathyroid Gland Adenocarcinoma,0
3738,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,lymphoepithelial squamous cell carcinoma of salivary gland,0
3739,Spindle Cell Metaplasia of Malignant Cells Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
3740,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hemangioma of skin,0
3741,Photosensitivity of skin,Compound nevus of skin,0
3742,Spindle Cell Osteo-Fibrous Component Present,Metastatic Bladder Squamous Cell Carcinoma,0
3743,Mixture of Germ Cell Neoplastic Components Present,Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7,0
3744,Fenestrated Pattern,Cloacogenic carcinoma,0
3745,Acinar Pattern,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",0
3746,Immature Myeloid Cells Increased in Bone Marrow,Osteosarcoma Arising in Paget Disease of Bone,0
3747,Nests of Nevus Cells Resembling Nerve Bundles Present,Breast Nevus,0
3748,Increased megakaryocytes (bone marrow),Early Hepatocellular Carcinoma,0
3749,Increased megakaryocytes (bone marrow),Duodenal carcinoma recurrent,0
3750,Fenestrated Pattern,Refractory Transformed Non-Hodgkin Lymphoma,0
3751,Increased megakaryocytes (bone marrow),Cardiac Biphasic Synovial Sarcoma,0
3752,Schwannian Stroma More than 50 Percent of the Tumor Volume,Recurrent Childhood Astrocytic Tumor,0
3753,Nodular and Diffuse Pattern,Stage III Lip and Oral Cavity Cancer AJCC v8,0
3754,Mixture of Germ Cell Neoplastic Components Present,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,0
3755,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Adult Burkitt Lymphoma,0
3756,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,basal cell carcinoma of scrotum,0
3757,Solar Radiation Toxicity,"Acanthoma, Pilar Sheath",0
3758,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rete Ovarii Cystadenoma,0
3759,Recurrent Malignant Neoplasm,Recurrent Transformed B-cell Non-Hodgkin Lymphoma,0
3760,Blasts Expressing CD56 and Immature T-Cell Markers Present,Acute Adult T-Cell Leukemia/Lymphoma,0
3761,Malignant Primitive Cellular Infiltrate,Malignant Sertoli Cell Tumor,0
3762,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0
3763,Fried-Egg Appearance of the Bone Marrow,Crohn's disease of the ileum,0
3764,Solar Radiation Toxicity,Placenta Increta,0
3765,Increased megakaryocytes (bone marrow),Suppurative lymphadenopathy,0
3766,Progressive Clinical Course,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,0
3767,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tinea Versicolor,0
3768,Increased megakaryocytes (bone marrow),Necrotic intraocular melanoma,0
3769,Absence of Malignant Features,Malignant neoplasm of gallbladder localized,0
3770,Absence of Malignant Features,Disorder of pregnancy,0
3771,Fenestrated Pattern,Oxyphilic Adenoma,0
3772,Peau d'orange surface of breast,malignant myoepithelioma of breast,0
3773,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Hepatocellular Carcinoma by AJCC v8 Stage,0
3774,Cervical lymphadenopathy,Stage IIA1 Cervical Cancer AJCC v8,0
3775,Non-Encapsulated Neoplasm,Advanced Well Differentiated Neuroendocrine Neoplasm,0
3776,Spindle Cell Metaplasia of Malignant Cells Present,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,0
3777,Large Spaces Filled with Blood Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
3778,Increased megakaryocytes (bone marrow),"FANCONI ANEMIA, COMPLEMENTATION GROUP I",0
3779,Large Spaces Filled with Blood Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0
3780,High Grade Lesion,High Grade Malignant Peripheral Nerve Sheath Tumor,0
3781,Fenestrated Pattern,EBV-Related Post-Transplant Lymphoproliferative Disorder,0
3782,Solitary Skin Tumor,Skin Pigmentation Disorder,0
3783,Neutral Epithelial Mucin Present,Calcifying Epithelial Odontogenic Tumor,0
3784,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Foveolar-Type Adenoma,0
3785,Metaplasia of Malignant Cells Present,Malignant neoplasm of ovary,0
3786,Increased megakaryocytes (bone marrow),Intraosseous well differentiated osteosarcoma,0
3787,Multihormonal Immunoreactivity Present in a Single Cell Type,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
3788,Fenestrated Pattern,Tonsillar Carcinoma,0
3789,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lung Cancer by AJCC v7 Stage,0
3790,Multihormonal Immunoreactivity Present in a Single Cell Type,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,0
3791,Malignant Primitive Cellular Infiltrate,Grade 1 Malignant Neoplasm,0
3792,Large Mass,Stage IV Childhood Anaplastic Large Cell Lymphoma,0
3793,Nodular and Diffuse Pattern,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
3794,Osseous Metaplasia of Malignant Cells Present,T-Cell Proliferation of Uncertain Malignant Potential,0
3795,Fenestrated Pattern,Acute Megakaryocytic Leukemias,0
3796,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA Cutaneous Melanoma AJCC v7,0
3797,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Uterine Sarcoma AJCC v7,0
3798,Lesion with Diameter of 2cm or Less,Adenocarcinoma with metaplasia,0
3799,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Urethral Cancer by AJCC v7 Stage,0
3800,Malignant Primitive Cellular Infiltrate,Malignant Aortic Neoplasm,0
3801,Nodular lesions,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3802,Non-Encapsulated Neoplasm,Childhood Testicular Neoplasm,0
3803,Increased megakaryocytes (bone marrow),Stage IVB Hepatocellular Carcinoma AJCC v7,0
3804,Intermediate Grade Neuroendocrine Lesion,High Grade Fallopian Tube Serous Adenocarcinoma,0
3805,Small Lesion,Small Size Posterior Uveal Melanoma,0
3806,Solar Radiation Toxicity,Stage IVB Colon Cancer AJCC v8,0
3807,Increased megakaryocytes (bone marrow),Conventional Cardiac Rhabdomyoma,0
3808,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,AIDS-Related Hodgkin Lymphoma,0
3809,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIC Rectal Cancer AJCC v8,0
3810,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Juvenile Polyp,0
3811,Spindle Cell Metaplasia of Malignant Cells Present,Stage IV Renal Cell Cancer AJCC v7,0
3812,Large Spaces Filled with Blood Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
3813,Mammary Gland Type Features Present,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
3814,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vaginal Endometrioid Adenocarcinoma,0
3815,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Benign Ovarian Mucinous Tumor,0
3816,Chronic Inflammatory Infiltrate,Stage C Chronic Lymphocytic Leukemia,0
3817,Spindle Cell Metaplasia of Malignant Cells Present,Stage IV Childhood Anaplastic Large Cell Lymphoma,0
3818,Fenestrated Pattern,Refractory Osteosarcoma,0
3819,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
3820,Mixed Neoplastic Glandular and Squamous Cell Population,Central Nervous System Mixed Germ Cell Tumor,0
3821,Prominent Elastic Tissue Cores Present,Metastatic Childhood Soft Tissue Sarcoma,0
3822,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory B-Cell Prolymphocytic Leukemia,0
3823,Fenestrated Pattern,Throat cancer,0
3824,Absence of Malignant Features,Malignant Ovarian Thecoma,0
3825,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Vulvar Cancer AJCC v8,0
3826,Fenestrated Pattern,Central Nervous System Hibernoma,0
3827,Endometrial Type Glands and Stroma Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,0
3828,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Plasmacytoma,0
3829,Primary Site Unspecified,Stage IIA Primary Peritoneal Cancer AJCC v8,0
3830,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Advanced Carcinoid Tumor,0
3831,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endometrial Polyp,0
3832,Increased megakaryocytes (bone marrow),Locally Advanced Chordoma,0
3833,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lower Gingival Verrucous Carcinoma,0
3834,Increased megakaryocytes (bone marrow),Vaginal intraepithelial neoplasia,0
3835,Monoclonal Myeloid or Lymphoid Cells Present,Childhood Acute Myeloid Leukemia Not Otherwise Specified,0
3836,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,0
3837,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Brain Glioblastoma,0
3838,Spindle Cell Metaplasia of Malignant Cells Present,Testicular Sclerosing Sertoli Cell Tumor,0
3839,Increased megakaryocytes (bone marrow),Childhood Testicular Teratoma,0
3840,Spindle Cell Metaplasia of Malignant Cells Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,0
3841,White blood cell count increased (lab result),"Transitional cell papilloma, inverted",0
3842,Florid Follicular Hyperplasia,Adrenal Medullary Hyperplasia,0
3843,Prominent Elastic Tissue Cores Present,Locally Advanced Unresectable Soft Tissue Sarcoma,0
3844,Solitary Skin Tumor,Descending Colon Neuroendocrine Tumor G1,0
3845,Increased megakaryocytes (bone marrow),Adrenal Gland Ganglioneuroma,0
3846,Increased megakaryocytes (bone marrow),B-lymphoblastic leukemia lymphoma BCR-ABL1-like,0
3847,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sarcoma of kidney,0
3848,Absence of Malignant Features,Malignant neoplasm of pineal gland,0
3849,High Grade Lesion,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
3850,Spindle Cell Metaplasia of Malignant Cells Present,Skin Clear Cell Basal Cell Carcinoma,0
3851,Multihormonal Immunoreactivity Present in a Single Cell Type,Cervical Keratinizing Squamous Cell Carcinoma,0
3852,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Synovial sarcoma non-metastatic,0
3853,Spindle Cell Metaplasia of Malignant Cells Present,Bowenoid papulosis of penis,0
3854,Spindle Cell Metaplasia of Malignant Cells Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
3855,Aggressive Clinical Course,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
3856,Solar Radiation Toxicity,Salpingitis isthmica nodosa,0
3857,Solar Radiation Toxicity,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,0
3858,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Reproductive System Neoplasm,0
3859,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of epicardium,0
3860,Osseous Metaplasia of Malignant Cells Present,Recurrent Malignant Neoplasm of Multiple Primary Sites,0
3861,Solitary Skin Tumor,Skin Sarcomatoid Basal Cell Carcinoma,0
3862,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Glomangioma of skin,0
3863,Plasma cell inflammation,Lung squamous cell carcinoma stage IV,0
3864,Increased megakaryocytes (bone marrow),Hemangioblastoma,0
3865,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,undifferentiated carcinoma of ureter,0
3866,Increased megakaryocytes (bone marrow),Adult Acute Basophilic Leukemia,0
3867,Follicular Differentiation,Childhood Thyroid Gland Follicular Carcinoma,0
3868,Large Spaces Filled with Blood Present,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,0
3869,Absence of Malignant Features,Oligodendroglioma of spinal cord,0
3870,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
3871,Proliferation of Follicular Dendritic Cells Present,Follicular thyroid carcinoma,0
3872,Antoni B Pattern,"Spindle cell melanoma, type B",0
3873,Mixed Neoplastic Glandular and Squamous Cell Population,Upper Gingival Squamous Cell Carcinoma,0
3874,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Ovarian Luteinized Thecoma,0
3875,Increased megakaryocytes (bone marrow),Unna-Thost Syndrome,0
3876,Increased megakaryocytes (bone marrow),Lymphoid interstitial pneumonia,0
3877,Well Differentiated Lesion,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,0
3878,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Fallopian Tube Cancer,0
3879,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Thymus Solitary Fibrous Tumor,0
3880,Endometrial Type Glands and Stroma Present,Stage III Ovarian Polyembryoma AJCC v6 and v7,0
3881,Endometrial Type Glands and Stroma Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
3882,Increased megakaryocytes (bone marrow),Ann Arbor Stage I AIDS-Related Lymphoma,0
3883,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Cardiac Germ Cell Tumor,0
3884,Exophytic Papillary Lesion,Papillary Urothelial Neoplasm,0
3885,Locally Aggressive Lesion,Recurrent Aggressive NK-Cell Leukemia,0
3886,Spindle Cell Metaplasia of Malignant Cells Present,"Sarcoma, Small Cell",0
3887,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Nervous System Extraskeletal Osteosarcoma,0
3888,Non-Encapsulated Neoplasm,Childhood Infratentorial Neoplasm,0
3889,Fenestrated Pattern,Supraglottic Verrucous Carcinoma,0
3890,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Tracheal Lymphoma,0
3891,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Upper Gingival Verrucous Carcinoma,0
3892,Large Spaces Filled with Blood Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",0
3893,High Grade Lesion,Sarcoma NCI Grade 2,0
3894,Absence of Stromal Invasion,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,0
3895,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of retina,0
3896,Recurrent Malignant Neoplasm,Recurrent T Acute Lymphoblastic Leukemia,0
3897,Nodular and Diffuse Pattern,Stage II Ovarian Teratoma AJCC v6 and v7,0
3898,Moderately Differentiated Lesion,Moderately Differentiated Malignant Neoplasm,0
3899,Nodular and Diffuse Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",0
3900,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
3901,Fenestrated Pattern,Adult Brain Ependymoma,0
3902,Melanoma Cells Present,Spinal Cord Melanoma,0
3903,Increased megakaryocytes (bone marrow),Refractory Digestive System Carcinoma,0
3904,Spindle Cell Metaplasia of Malignant Cells Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,0
3905,Chronic Inflammatory Infiltrate,Chronic lymphocytic leukemia stage 4,0
3906,Increased megakaryocytes (bone marrow),Refractory Uterine Corpus Carcinosarcoma,0
3907,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Pylorus Carcinoma,0
3908,Fenestrated Pattern,Radiation-Related Sarcoma,0
3909,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma,0
3910,Breast Implant-Related Lesion,Benign Breast Eccrine Spiradenoma,0
3911,Fenestrated Pattern,Osteoblastoma,0
3912,Fenestrated Pattern,Myxoid leiomyoma,0
3913,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Leiomyosarcoma,0
3914,Solar Radiation Toxicity,Prolactinoma,0
3915,Solar Radiation Toxicity,Stage IIIC Uterine Corpus Cancer AJCC v7,0
3916,Villous Projections of the Neoplastic Epithelium Present,Columnar Cell Hyperplasia of the Breast,0
3917,Non-Encapsulated Neoplasm,Benign Neoplasm,0
3918,Fenestrated Pattern,Stage II Eyelid Carcinoma AJCC v8,0
3919,Spindle Cell Metaplasia of Malignant Cells Present,Hemangioma of subcutaneous tissue,0
3920,White blood cell count increased (lab result),Nasopharyngeal squamous cell carcinoma stage III,0
3921,Gastric dysplasia,Gastric Lipoma,0
3922,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary mediastinal large B-cell lymphoma stage IV,0
3923,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Cribriform Comedo-Type Adenocarcinoma,0
3924,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical Breast Papilloma,0
3925,Intravascular Fibrin Thrombus Formation,Intravascular Angioleiomyoma,0
3926,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Hilar Cholangiocarcinoma by AJCC v8 Stage,0
3927,Tumor Mass,Stage IVB Gestational Trophoblastic Tumor AJCC v7,0
3928,Solar Radiation Toxicity,Colorectal Leiomyosarcoma,0
3929,Basal Cells with Pale Cytoplasm Present,"Carcinoma, Basal Cell",0
3930,Dedifferentiated Malignant Infiltrate,Dedifferentiated chordoma,0
3931,Well Differentiated Lesion,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3932,Aggressive Clinical Course,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,0
3933,Spindle Cell Metaplasia of Malignant Cells Present,Adult Clear Cell Sarcoma of Soft Parts,0
3934,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Malignant Pharyngeal Neoplasm,0
3935,Increased megakaryocytes (bone marrow),Esophageal Liposarcoma,0
3936,Increased megakaryocytes (bone marrow),Precursor T-lymphoblastic lymphoma/leukemia refractory,0
3937,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IVA Cervical Cancer AJCC v6 and v7,0
3938,Solitary Skin Tumor,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3939,Non-Encapsulated Neoplasm,Urothelial Neoplasm,0
3940,Increased megakaryocytes (bone marrow),Precursor B-lymphoblastic lymphoma stage III,0
3941,Epithelioid Differentiation,Epithelioid sarcoma non-metastatic,0
3942,High Grade Lesion,Refractory WHO Grade III Glioma,0
3943,Multihormonal Immunoreactivity Present in a Single Cell Type,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,0
3944,Fenestrated Pattern,Stage III Major Salivary Gland Cancer AJCC v7,0
3945,Endometrial Type Glands and Stroma Present,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
3946,Malignant Primitive Cellular Infiltrate,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
3947,Fenestrated Pattern,Pelvic lipomatosis,0
3948,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Vulvar Carcinoma,0
3949,Confluent Sheets of Anaplastic T-Lymphocytes Present,Anaplastic ganglioglioma,0
3950,Solar Radiation Toxicity,mediastinal lipomatosis,0
3951,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Tumor of dermis,0
3952,Fenestrated Pattern,Pilomatrixoma,0
3953,Multihormonal Immunoreactivity Present in a Single Cell Type,Squamous Cell Neoplasms,0
3954,Fenestrated Pattern,Childhood Alveolar Rhabdomyosarcoma,0
3955,Squamous metaplasia of bladder,Squamous cell carcinoma of prostate,0
3956,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,0
3957,Islands of Odontogenic Epithelium Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,0
3958,Increased megakaryocytes (bone marrow),Unresectable Urothelial Carcinoma,0
3959,Recurrent Genetic Abnormalities Present,Recurrent Childhood Anaplastic Astrocytoma,0
3960,Mural Nodule,High Grade Liver Dysplastic Nodule,0
3961,Increased megakaryocytes (bone marrow),Fundic gland polyp,0
3962,Increased megakaryocytes (bone marrow),Extraventricular neurocytoma,0
3963,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Sarcoma,0
3964,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of iris,0
3965,Aggressive Clinical Course,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma,0
3966,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,0
3967,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse large B-cell lymphoma recurrent,0
3968,Intersecting Sharply Marginated Clusters of Spindle Cells Present,mucoepidermoid carcinoma of floor of mouth,0
3969,Increased megakaryocytes (bone marrow),Acquired ichthyosis,0
3970,Loss of INI 1 Protein Expression,Stage 1 Neuroblastoma,0
3971,Spindle Cell Osteo-Fibrous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,0
3972,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Mediastinal Germ Cell Tumor,0
3973,Solar Radiation Toxicity,Secondary osteosarcoma,0
3974,Recurrent Genetic Abnormalities Present,Recurrent Chronic Myelomonocytic Leukemia,0
3975,Squamous metaplasia of bladder,"Squamous cell carcinoma, microinvasive",0
3976,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Subcutaneous panniculitis-like T-cell lymphoma,0
3977,Increased megakaryocytes (bone marrow),Kidney Lipoma,0
3978,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage I,0
3979,Abundance of Small Lymphocytes,Stage IIB Lung Small Cell Carcinoma AJCC v7,0
3980,Fenestrated Pattern,Choroid Plexus Neoplasms,0
3981,Recurrent Genetic Abnormalities Present,Recurrent Thyroid Gland Medullary Carcinoma,0
3982,Increased megakaryocytes (bone marrow),Benign melanocytic nevus,0
3983,Microinvasive tumor,Recurrent tumor,0
3984,Low Grade Cartilaginous Component Present,Low Grade Ovarian Serous Adenocarcinoma,0
3985,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Metastatic Malignant Neoplasm to the Cervix,0
3986,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Renal Pelvis and Ureter Cancer AJCC v7,0
3987,Cystic Lesion,Hard Palate Adenoid Cystic Carcinoma,0
3988,Fenestrated Pattern,Juxta-Articular Myxoma,0
3989,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
3990,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Adult Non-Hodgkin Lymphoma,0
3991,Fenestrated Pattern,Childhood Central Nervous System Teratoma,0
3992,Chronic lymphocytic inflammation,Chronic Lymphocytic Leukemia,0
3993,Large Spaces Filled with Blood Present,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0
3994,IDH Gene Family Mutation Status Unknown,Glioblastoma by Gene Expression Profile,0
3995,Eccrine Differentiation,Eccrine dermal cylindroma,0
3996,Absence of Malignant Features,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
3997,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Vulvar Yolk Sac Tumor,0
3998,Multihormonal Immunoreactivity Present in a Single Cell Type,Benign Anal Granular Cell Tumor,0
3999,Solar Radiation Toxicity,Ependymoblastoma,0
4000,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Constitutional Mismatch Repair Deficiency Syndrome,0
4001,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of kidney,0
4002,Spindle Cell Metaplasia of Malignant Cells Present,benign fibrous histiocytoma of bone,0
4003,Multihormonal Immunoreactivity Present in a Single Cell Type,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,0
4004,Solar Radiation Toxicity,Stage IVB Thymoma AJCC v8,0
4005,Increased megakaryocytes (bone marrow),Ovarian Seromucinous Cystadenoma,0
4006,Fenestrated Pattern,Liver Extraskeletal Osteosarcoma,0
4007,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of prostate,0
4008,Blasts Expressing CD56 and Immature T-Cell Markers Present,Stage II Immature Testicular Teratoma AJCC v6 and v7,0
4009,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Smoldering Systemic Mastocytosis,0
4010,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement,0
4011,Intermediate Grade Neuroendocrine Lesion,Low Grade Lung Neuroendocrine Neoplasm,0
4012,Schwannian Stroma More than 50 Percent of the Tumor Volume,Duodenal Neuroendocrine Tumor,0
4013,Mixture of Germ Cell Neoplastic Components Present,Classic Variant of Chromophobe Renal Cell Carcinoma,0
4014,Low Grade Neuroendocrine Lesion,High Grade Broad Ligament Serous Adenocarcinoma,0
4015,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,0
4016,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Burkitt lymphoma associated with AIDS,0
4017,Increased megakaryocytes (bone marrow),Unresectable Ureter Urothelial Carcinoma,0
4018,Humoral hypercalcemia of malignancy (disorder),TUBEROUS SCLEROSIS 1 (disorder),0
4019,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,0
4020,Increased megakaryocytes (bone marrow),Stage IIB Fallopian Tube Cancer AJCC v8,0
4021,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Turcot syndrome (disorder),0
4022,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Primary Peritoneal Cancer AJCC v8,0
4023,Nests of Nevus Cells Resembling Nerve Bundles Present,Facial Nerve Palsy Related to Birth,0
4024,Solar Radiation Toxicity,Adenomatous Polyposis Coli,0
4025,Increased megakaryocytes (bone marrow),Unresectable Desmoid-Type Fibromatosis,0
4026,Small Aggregates of Tumor Cells Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
4027,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,follicular dendritic cell sarcoma of thyroid gland,0
4028,Mixture of Germ Cell Neoplastic Components Present,"Carcinoma, Giant Cell",0
4029,Solitary Skin Tumor,Ovarian Stromal-Leydig Cell Tumor,0
4030,Spindle Cell Osteo-Fibrous Component Present,Thymic Squamous Cell Carcinoma,0
4031,Fenestrated Pattern,Anogenital papillomaviral intraepithelial neoplasia,0
4032,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Uveal Neoplasm,0
4033,Fenestrated Pattern,Retroperitoneal Ganglioneuroma,0
4034,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Advanced Small Intestinal Neuroendocrine Carcinoma,0
4035,Increased megakaryocytes (bone marrow),Focal glomerulosclerosis,0
4036,Spindle Cell Osteo-Fibrous Component Present,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
4037,Absence of Malignant Features,Pseudopolyposis of colon,0
4038,Defective Mu Heavy Chain Present,Heavy Chain Deposition Disease,0
4039,Diffuse Lesion,Childhood Cerebral Diffuse Astrocytoma,0
4040,Increased megakaryocytes (bone marrow),Epiglottic carcinoma,0
4041,Spindle Cell Osteo-Fibrous Component Present,Thymic Squamous Cell Carcinoma,0
4042,Absence of Stromal Invasion,Stromal tumor of ovary,0
4043,Fenestrated Pattern,Stage III Hepatocellular Carcinoma AJCC v6,0
4044,Schwannian Stroma More than 50 Percent of the Tumor Volume,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
4045,Non-Encapsulated Neoplasm,Fallopian Tube Mucinous Neoplasm,0
4046,Fenestrated Pattern,Juxtacortical chondroma,0
4047,Progressive Clinical Course,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,0
4048,Melanoma Cells Present,Class 2 Uveal Melanoma,0
4049,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Palmoplantar keratoderma with leukoplakia,0
4050,Plasma cell inflammation,Clear cell adenoma,0
4051,Increased megakaryocytes (bone marrow),"Brain Tumor, Primary",0
4052,Increased megakaryocytes (bone marrow),Necrotic intraocular melanoma,0
4053,Non-Encapsulated Neoplasm,Refractory Digestive System Neuroendocrine Neoplasm,0
4054,Neoplastic Cells with TFH Cell Phenotype Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
4055,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Carcinoma of upper gum,0
4056,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Colorectal Cancer AJCC v7,0
4057,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of epididymis,0
4058,Increased megakaryocytes (bone marrow),testicular leukemia,0
4059,Confluent Sheets of Anaplastic T-Lymphocytes Present,"Anaplastic Astrocytoma, IDH-Mutant",0
4060,Increased megakaryocytes (bone marrow),Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,0
4061,Solar Radiation Toxicity,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,0
4062,Recurrent Malignant Neoplasm,Malignant Smooth Muscle Neoplasm,0
4063,Absence of Malignant Features,Malignant tumor of eye,0
4064,Cutaneous plaque,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8,0
4065,Intermediate Grade Neuroendocrine Lesion,Kaposi Sarcoma NCI Grade 3,0
4066,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Malignant Giant Cell Tumor of Bone,0
4067,Solar Radiation Toxicity,Nodal marginal zone B-cell lymphoma refractory,0
4068,Aggressive Clinical Course,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,0
4069,Multihormonal Immunoreactivity Present in a Single Cell Type,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
4070,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Squamous cell carcinoma of oropharynx,0
4071,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIA Testicular Cancer AJCC v6 and v7,0
4072,Solar Radiation Toxicity,Stage II Adult Hodgkin Lymphoma,0
4073,Immature Myeloid Cells Increased in Bone Marrow,"Carcinoma bladder stage I, without cancer in situ",0
4074,Tubular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",0
4075,Fenestrated Pattern,Stage II Childhood Hodgkin Lymphoma,0
4076,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Alveolar Soft Part Sarcoma,0
4077,Absence of Malignant Features,adenocarcinoma of extrahepatic bile duct,0
4078,Absence of Malignant Features,Malignant Anterior Tongue Neoplasm,0
4079,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Prostate Cancer by AJCC v8 Stage,0
4080,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of middle ear,0
4081,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,0
4082,Fenestrated Pattern,Laryngeal verrucous carcinoma stage IV,0
4083,Multihormonal Immunoreactivity Present in a Single Cell Type,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0
4084,Less than 2 Mitoses per 10HPF,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2",0
4085,Less than 2 Mitoses per 10HPF,Recurrent Grade 2 Follicular Lymphoma,0
4086,Non-Encapsulated Neoplasm,Benign Apocrine Neoplasm,0
4087,No Evidence of Metastatic Disease,Metastatic Lip Carcinoma,0
4088,Squamous metaplasia of bladder,Cervical Squamous Papilloma,0
4089,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Cutaneous Granular Cell Tumor,0
4090,Fenestrated Pattern,"Neoplasms, Fibroepithelial",0
4091,Increased megakaryocytes (bone marrow),Uterine Corpus Carcinofibroma,0
4092,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Ligament Adenosarcoma,0
4093,Solar Radiation Toxicity,Familial Retinoblastoma,0
4094,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,alveolar rhabdomyosarcoma of orbit,0
4095,Intersecting Sharply Marginated Clusters of Spindle Cells Present,polyembryoma of testis,0
4096,Windblown Appearance of Atypical Keratinocytes,Prostatic Atypical Adenomatous Hyperplasia,0
4097,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Primary Peritoneal Cancer AJCC v8,0
4098,Cystic Lesion,Childhood Cystic Nephroma,0
4099,Fenestrated Pattern,Colorectal Traditional Serrated Adenoma,0
4100,Absence of Malignant Features,Acinar cell carcinoma of pancreas,0
4101,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides stage I,0
4102,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hormone refractory breast cancer,0
4103,Solar Radiation Toxicity,Verrucous keratotic hemangioma,0
4104,Spindle Cell Osteo-Fibrous Component Present,Stage IVC Basal Cell Lip Carcinoma,0
4105,Tumor Mass,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
4106,Endometrial Type Glands and Stroma Present,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
4107,Solar Radiation Toxicity,Testicular choriocarcinoma stage III,0
4108,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4109,Confluent Sheets of Anaplastic T-Lymphocytes Present,Adult Anaplastic Ependymoma,0
4110,Fenestrated Pattern,Stage I Hilar Cholangiocarcinoma AJCC v8,0
4111,Solar Radiation Toxicity,Stage IIIB Ovarian Cancer AJCC v8,0
4112,Recurrent Malignant Neoplasm,Malignant Mediastinal Soft Tissue Neoplasm,0
4113,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Hypopharyngeal Carcinoma AJCC v7,0
4114,Intraepithelial Neoplasia,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
4115,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IA3 Lung Cancer AJCC v8,0
4116,Solar Radiation Toxicity,Metaplastic thymoma,0
4117,Fenestrated Pattern,Diabetic Nephropathy,0
4118,Fenestrated Pattern,Alcohol-Related Carcinoma,0
4119,Spindle Cell Metaplasia of Malignant Cells Present,Papillary Renal Cell Carcinoma,0
4120,Recurrent Malignant Neoplasm,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
4121,Cutaneous plaque,Cutaneous Fibrous Histiocytoma,0
4122,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma In Situ AJCC v6 and v7,0
4123,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Ovarian Transitional Cell Tumor,0
4124,Non-Encapsulated Neoplasm,Vulvar Glandular Neoplasm,0
4125,Aberrant Thyroid Tissue Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
4126,Folliculotropic Lymphocytic Infiltrate,Stage A Chronic Lymphocytic Leukemia,0
4127,Fenestrated Pattern,Nodal marginal zone B-cell lymphoma refractory,0
4128,Non-Encapsulated Neoplasm,Benign Peritoneal and Retroperitoneal Neoplasm,0
4129,Photosensitivity of skin,Neoplasm of skin with adnexal differentiation,0
4130,Gastric dysplasia,Gastric adenoma,0
4131,Nodular and Diffuse Pattern,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
4132,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,neurofibroma of esophagus,0
4133,Schwannian Stroma More than 50 Percent of the Tumor Volume,Ovarian Tumor of the Thecoma/Fibroma Group,0
4134,Increased megakaryocytes (bone marrow),Benign male reproductive tract neoplasm,0
4135,Mixed Neoplastic Glandular and Squamous Cell Population,Anterior Tongue Squamous Cell Carcinoma,0
4136,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Colorectal Undifferentiated Carcinoma,0
4137,Absence of Malignant Features,Leydig cell neoplasm of testis,0
4138,Endometrial Type Glands and Stroma Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,0
4139,Fenestrated Pattern,Stage 0 Vaginal Cancer AJCC v7,0
4140,Chronic lymphocytic inflammation,Chronic lymphadenitis,0
4141,HER2/Neu Negative,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0
4142,Low Grade Neuroendocrine Lesion,Low grade myofibroblastic sarcoma,0
4143,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,0
4144,Metaplasia of Malignant Cells Present,Malignant tumor of ethmoid sinus,0
4145,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,FIGO Stage IVA Ovarian Cancer,0
4146,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Parotid Gland Acinic Cell Carcinoma,0
4147,Fenestrated Pattern,Somatotroph/Lactotroph Adenoma,0
4148,Mammary Gland Type Features Present,Major Salivary Gland Cancer by AJCC v8 Stage,0
4149,Neoplastic Plasma Cells Present in Bone Marrow,Carcinoma Arising in Nasal Papillomatosis,0
4150,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pseudopolyposis of colon,0
4151,Absence of Malignant Features,Malignant lymphoma - lymphoplasmacytic,0
4152,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Urothelial Papilloma,0
4153,Multihormonal Immunoreactivity Present in a Single Cell Type,Grade 4 Clear Cell Renal Cell Carcinoma,0
4154,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hamartoma of lung,0
4155,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
4156,Primary Lesion,Primary ameloblastic carcinoma,0
4157,Microinvasive tumor,Testicular yolk sac tumor stage I,0
4158,Spindle Cell Osteo-Fibrous Component Present,Recurrent Pancreatic Acinar Cell Carcinoma,0
4159,Schwannian Stroma More than 50 Percent of the Tumor Volume,Juvenile Polyp of the Small Intestine,0
4160,Fried-Egg Appearance of the Bone Marrow,Stage IB Bone Sarcoma AJCC v7,0
4161,Absence of Malignant Features,Recurrent Human Papillomavirus-Related Malignant Neoplasm,0
4162,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIA Eyelid Carcinoma AJCC v8,0
4163,Malignant Primitive Cellular Infiltrate,Malignant Anterior Tongue Neoplasm,0
4164,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thymolipoma,0
4165,Increased megakaryocytes (bone marrow),Thyroid stimulating hormone-producing pituitary tumor,0
4166,Recurrent Malignant Neoplasm,Recurrent Childhood Pineoblastoma,0
4167,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,0
4168,Fenestrated Pattern,Stage III Lung Cancer AJCC v7,0
4169,Fenestrated Pattern,Stage III Uterine Corpus Leiomyosarcoma AJCC v8,0
4170,Malignant Primitive Cellular Infiltrate,Malignant Pancreatic Somatostatinoma,0
4171,Mixed Neoplastic Glandular and Squamous Cell Population,Cervical Squamous Papilloma,0
4172,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Borderline Resectable Carcinoma,0
4173,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
4174,Mixture of Germ Cell Neoplastic Components Present,Stage II Renal Cell Cancer AJCC v7,0
4175,Epithelioid Differentiation,Mediastinal Epithelioid Hemangioendothelioma,0
4176,Absence of Malignant Features,Benign neoplasm of kidney,0
4177,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7,0
4178,Fried-Egg Appearance of the Bone Marrow,Intermediate Bone Neoplasm,0
4179,Increased megakaryocytes (bone marrow),Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
4180,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIA Merkel Cell Carcinoma AJCC v7,0
4181,Solar Radiation Toxicity,FIGO Stage IIIA1 Ovarian Cancer,0
4182,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Nonossifying Fibromyxoid Tumor,0
4183,Spindle Cell Metaplasia of Malignant Cells Present,Malignant melanoma of breast,0
4184,Schwannian Stroma More than 50 Percent of the Tumor Volume,Extrahepatic Bile Duct Carcinoid Tumor,0
4185,Fenestrated Pattern,Refractory Liposarcoma,0
4186,Solar Radiation Toxicity,Thymic Lymphoma,0
4187,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Paget's Disease, Mammary",0
4188,Fenestrated Pattern,Stage IIIA Vulvar Cancer AJCC v7,0
4189,Spindle Cell Metaplasia of Malignant Cells Present,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,0
4190,Sonic Hedgehog/Patch Pathway Activated,Recurrent Visual Pathway Glioma,0
4191,Multihormonal Immunoreactivity Present in a Single Cell Type,Unresectable Skin Squamous Cell Carcinoma,0
4192,Cervical Glandular Dysplasia,Cervical Microglandular Hyperplasia,0
4193,Solar Radiation Toxicity,Lung Pleomorphic Adenoma,0
4194,Recurrent Malignant Neoplasm,Recurrent Malignant Female Reproductive System Neoplasm,0
4195,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Transitional cell cancer of the renal pelvis and ureter localized,0
4196,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Retiform parapsoriasis,0
4197,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm,0
4198,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Adenocarcinoma,0
4199,Increased megakaryocytes (bone marrow),Nasopharyngeal Nonkeratinizing Carcinoma,0
4200,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Adult Hepatocellular Carcinoma,0
4201,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Superficial fibromatosis,0
4202,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Adult Burkitt Lymphoma,0
4203,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Kaposi's sarcoma of esophagus,0
4204,Proliferation of High Endothelial Venules Present,High grade B-cell lymphoma,0
4205,Increased megakaryocytes (bone marrow),"Hemangioma, Cavernous, Central Nervous System",0
4206,Increased megakaryocytes (bone marrow),Lung Non-Mucinous Adenocarcinoma In Situ,0
4207,Increased megakaryocytes (bone marrow),Stage I Gestational Trophoblastic Neoplasm AJCC v8,0
4208,Lesion with Diameter of 2cm or Less,Large B-cell lymphoma with IRF4 rearrangement,0
4209,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian gynandroblastoma,0
4210,Osseous Metaplasia of Malignant Cells Present,Malignant blue nevus of skin,0
4211,Fenestrated Pattern,Liver Lymphangiomatosis,0
4212,Intraepithelial Neoplasia,Small Intestinal Intraepithelial Neoplasia,0
4213,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,CNS metastases,0
4214,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Carcinoma Metastatic in the Liver,0
4215,Fenestrated Pattern,Testicular embryonal carcinoma stage I,0
4216,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ureter Carcinoma,0
4217,Large Mass,Recurrent Intravascular Large B-Cell Lymphoma,0
4218,Fenestrated Pattern,Childhood Ovarian Choriocarcinoma,0
4219,Solitary Skin Tumor,Stage III Skin Cancer,0
4220,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Adenocarcinoma, Tubular",0
4221,Increased megakaryocytes (bone marrow),Hydroa vacciniforme-like lymphoma,0
4222,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Cribriform Neuroepithelial Tumor,0
4223,Fenestrated Pattern,Epithelioid sarcoma metastatic,0
4224,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,0
4225,Glandular cell atypia,Metastatic signet ring cell carcinoma,0
4226,Nests of Nevus Cells Resembling Nerve Bundles Present,Vulvar Dysplastic Melanocytic Nevus,0
4227,Fried-Egg Appearance of the Bone Marrow,Bone Sarcoma by AJCC v7 Stage,0
4228,Fried-Egg Appearance of the Bone Marrow,Stage IIA Bone Cancer AJCC v8,0
4229,Endometrial Type Glands and Stroma Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
4230,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Hodgkin Lymphoma,0
4231,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Renal Pelvis Urothelial Carcinoma,0
4232,Increased megakaryocytes (bone marrow),Prostate cancer stage D,0
4233,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Platinum-Resistant Urothelial Carcinoma,0
4234,Marked Thickening of the Bladder Urothelium Present,Childhood Bladder Carcinoma,0
4235,Solar Radiation Toxicity,Childhood Pleomorphic Rhabdomyosarcoma,0
4236,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Uterine Corpus Carcinosarcoma,0
4237,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endemic African Kaposi Sarcoma,0
4238,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Adenoid Cystic Carcinoma,0
4239,Mixture of Embryonal and Alveolar Features Present,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4240,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Major Salivary Gland Adenocarcinoma,0
4241,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Esophageal Glandular Intraepithelial Neoplasia,0
4242,Absence of Malignant Features,Benign tumor of exocrine pancreas,0
4243,Large Spaces Filled with Blood Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",0
4244,Mixed Neoplastic Glandular and Squamous Cell Population,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,0
4245,Multihormonal Immunoreactivity Present in a Single Cell Type,Adenocarcinoma in tubular adenoma,0
4246,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,0
4247,Solitary Skin Tumor,Borderline Ovarian Mucinous Tumor,0
4248,Fenestrated Pattern,Bladder papilloma,0
4249,Increased megakaryocytes (bone marrow),"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",0
4250,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
4251,Canalicular Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0
4252,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage 0 Uterine Corpus Cancer,0
4253,Fenestrated Pattern,Rectosigmoid cancer recurrent,0
4254,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of oropharynx,0
4255,Absence of Stromal Invasion,Uterine Corpus High Grade Endometrial Stromal Sarcoma,0
4256,Cutaneous plaque,Pathologic Stage IB Cutaneous Melanoma AJCC v8,0
4257,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Breast T-Cell Non-Hodgkin Lymphoma,0
4258,Solar Radiation Toxicity,Lugano Classification Stage III Hodgkin Lymphoma AJCC v8,0
4259,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of brain stem,0
4260,Fenestrated Pattern,Stage IIIC Breast Cancer AJCC v6,0
4261,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Differentiated Malignant Neoplasm,0
4262,Glandular Differentiation,Glandular papilloma,0
4263,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,mucoepidermoid carcinoma of floor of mouth,0
4264,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Refractory Digestive System Carcinoma,0
4265,Intersecting Sharply Marginated Clusters of Spindle Cells Present,keratinizing squamous cell carcinoma of vulva,0
4266,Systemic disease,Hodgkin's disease lymphocyte depletion type refractory,0
4267,Increased megakaryocytes (bone marrow),Stage IVB Uterine Sarcoma AJCC v7,0
4268,Nodular and Diffuse Pattern,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
4269,Increased megakaryocytes (bone marrow),"Chondromatosis, Synovial",0
4270,Mammary Gland Type Features Present,Familial Colorectal Cancer Type X,0
4271,Solar Radiation Toxicity,Stage IIIB Fallopian Tube Cancer AJCC v7,0
4272,Peau d'orange surface of breast,Secondary malignant neoplasm of female breast,0
4273,Non-Encapsulated Neoplasm,Metastatic Lung Neuroendocrine Neoplasm,0
4274,Increased megakaryocytes (bone marrow),Stage IIIC Uterine Corpus Cancer AJCC v8,0
4275,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0
4276,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Uterine Corpus Cancer AJCC v8,0
4277,Stable Disease,Metastatic Microsatellite Stable Colorectal Carcinoma,0
4278,Nodular and Diffuse Pattern,Stage IIA Cutaneous Melanoma AJCC v6 and v7,0
4279,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of small intestine,0
4280,Absence of Malignant Features,Inverted papilloma of urinary bladder,0
4281,Breast Implant-Related Lesion,Hereditary Female Breast Carcinoma,0
4282,Absence of Malignant Features,mucinous adenocarcinoma of anus,0
4283,Cervical lymphadenopathy,Cervical Cancer by AJCC v8 Stage,0
4284,Spindle Cell Metaplasia of Malignant Cells Present,Skin Pseudovascular Squamous Cell Carcinoma,0
4285,Multihormonal Immunoreactivity Present in a Single Cell Type,Renal Cell Carcinoma,0
4286,Increased megakaryocytes (bone marrow),Sellar Chordoma,0
4287,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Adenocarcinoma of Sweat Gland Type,0
4288,Fenestrated Pattern,Stage III Breast Cancer AJCC v7,0
4289,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Prostate Carcinoma Metastatic in the Bone,0
4290,Solar Radiation Toxicity,Carcinosarcoma,0
4291,Absence of Malignant Features,Malignant neoplasm of nasopharynx,0
4292,Absence of Malignant Features,Cystadenofibroma of fallopian tube,0
4293,Nodular and Diffuse Pattern,Stage IIA Testicular Cancer AJCC v6 and v7,0
4294,Fenestrated Pattern,Exfoliative dermatitis,0
4295,Endometrial Type Glands and Stroma Present,Endometrial Polyp,0
4296,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precancerous Polyp,0
4297,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
4298,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm,0
4299,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",0
4300,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0
4301,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Ovarian Dysgerminoma,0
4302,Fenestrated Pattern,Kasabach-Merritt syndrome,0
4303,Intersecting Sharply Marginated Clusters of Spindle Cells Present,small cell carcinoma of extrahepatic bile duct,0
4304,Solar Radiation Toxicity,Mycosis fungoides stage II,0
4305,Absence of Malignant Features,Clonal Hematopoiesis of Indeterminate Potential,0
4306,Recurrent Genetic Abnormalities Present,Recurrent Grade 3a Follicular Lymphoma,0
4307,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Xeroderma Pigmentosum,0
4308,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
4309,Nodular and Diffuse Pattern,Stage III Lip and Oral Cavity Cancer AJCC v8,0
4310,Spindle Cell Osteo-Fibrous Component Present,Metastatic Signet Ring Cell Breast Carcinoma,0
4311,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of mediastinum,0
4312,Solar Radiation Toxicity,Necrobiosis Lipoidica,0
4313,Increased megakaryocytes (bone marrow),Stage III Testicular Cancer AJCC v8,0
4314,Increased megakaryocytes (bone marrow),Non-Hodgkin Lymphoma by Ann Arbor Stage,0
4315,Fenestrated Pattern,Aleukemic Monocytic Leukemia Cutis,0
4316,Tubular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
4317,Fenestrated Pattern,Pityriasis Lichenoides et Varioliformis Acuta,0
4318,Fenestrated Pattern,Placenta Disorders,0
4319,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioendothelioma,0
4320,Increased megakaryocytes (bone marrow),Locally Advanced Prostate Carcinoma,0
4321,Follicular Cell Differentiation,Vulvar Inverted Follicular Keratosis,0
4322,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of sternum,0
4323,Tumor Mass,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
4324,Spindle Cell Osteo-Fibrous Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,0
4325,Follicular Cell Differentiation,Follicular ameloblastoma,0
4326,Increased megakaryocytes (bone marrow),Ann Arbor Stage IIIA Hodgkin Lymphoma,0
4327,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of thorax,0
4328,Solitary Skin Tumor,Benign Anal Granular Cell Tumor,0
4329,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,0
4330,Multihormonal Immunoreactivity Present in a Single Cell Type,Bartholin Gland Small Cell Carcinoma,0
4331,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,stage IV pancreatic cancer,0
4332,Lesion with Diameter of 2cm or Less,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),0
4333,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,"Adenocarcinoma, Tubular",0
4334,Spindle Cell Metaplasia of Malignant Cells Present,Borderline Ovarian Clear Cell Adenofibroma,0
4335,Fenestrated Pattern,"Glioblastoma, IDH-Mutant",0
4336,Fenestrated Pattern,Colon Micropapillary Adenocarcinoma,0
4337,Pleural effusion disorder,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,0
4338,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adamantinous Craniopharyngioma,0
4339,Spindle Cell Metaplasia of Malignant Cells Present,Fallopian Tube Clear Cell Adenocarcinoma,0
4340,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermatitis Herpetiformis,0
4341,Recurrent Malignant Neoplasm,Recurrent Hodgkin Lymphoma,0
4342,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Blast Phase,0
4343,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Jugulotympanic Paraganglioma,0
4344,Increased megakaryocytes (bone marrow),"Leukemia, Radiation-Induced",0
4345,Increased megakaryocytes (bone marrow),Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0
4346,Solar Radiation Toxicity,Neurocutaneous Syndromes,0
4347,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IS Testicular Cancer AJCC v6 and v7,0
4348,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphoma stage I,0
4349,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Hepatocellular Carcinoma AJCC v7,0
4350,Increased megakaryocytes (bone marrow),Stage IV Esophageal Cancer AJCC v7,0
4351,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,0
4352,Fenestrated Pattern,Stage IIB Lung Cancer AJCC v8,0
4353,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Pulmonary Sclerosing Hemangioma,0
4354,Increased megakaryocytes (bone marrow),Prostate Acinar Adenocarcinoma,0
4355,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Apocrine Neoplasm,0
4356,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Central Nervous System Mixed Germ Cell Tumor,0
4357,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Anemia, Diamond-Blackfan",0
4358,Fenestrated Pattern,Myelodysplastic-Myeloproliferative Diseases,0
4359,Recurrent Genetic Abnormalities Present,Recurrent Myelodysplastic Syndrome,0
4360,Increased megakaryocytes (bone marrow),Thymolipoma,0
4361,Nodular and Diffuse Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",0
4362,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anal Rhabdomyosarcoma,0
4363,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Metastatic Digestive System Neuroendocrine Neoplasm,0
4364,Abundance of Small Lymphocytes,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
4365,Solar Radiation Toxicity,Lipoblastoma,0
4366,Skin Erosion,Plantar Verrucous Skin Carcinoma,0
4367,Photosensitivity of skin,adenosquamous carcinoma of skin,0
4368,Non-Encapsulated Neoplasm,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0
4369,Mixture of Germ Cell Neoplastic Components Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,0
4370,Nodular and Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma,0
4371,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of the rete testis,0
4372,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B lymphoblastic leukemia lymphoma with iAMP21,0
4373,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of chest wall,0
4374,Increased megakaryocytes (bone marrow),Cervical Adenomyoma,0
4375,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Childhood Spinal Cord Neoplasm,0
4376,Multihormonal Immunoreactivity Present in a Single Cell Type,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
4377,Mixture of Germ Cell Neoplastic Components Present,Childhood Malignant Ovarian Germ Cell Tumor,0
4378,Recurrent disease,Acute GVH disease,0
4379,Spindle Cell Metaplasia of Malignant Cells Present,"Dendritic Cell Sarcoma, Follicular",0
4380,Increased megakaryocytes (bone marrow),Infant T Acute Lymphoblastic Leukemia,0
4381,Increased megakaryocytes (bone marrow),Kidney Lipoma,0
4382,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0
4383,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Anal Mucinous Adenocarcinoma,0
4384,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Peritoneal Serous Adenocarcinoma,0
4385,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
4386,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 2 Colorectal Adenocarcinoma,0
4387,Fenestrated Pattern,Pulmonary Blastoma,0
4388,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extra-abdominal fibromatosis,0
4389,Increased megakaryocytes (bone marrow),Glomangioma,0
4390,Solar Radiation Toxicity,Stage I Uterine Corpus Leiomyosarcoma AJCC v8,0
4391,NRBC - Nucleated red blood cell present result,Parietal cell carcinoma,0
4392,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Ligament Mucinous Adenocarcinoma,0
4393,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",0
4394,Malignant Primitive Cellular Infiltrate,Recurrent Malignant Neoplasm,0
4395,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Digestive System Carcinoma,0
4396,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Hard Palate Neoplasm,0
4397,Spindle Cell Metaplasia of Malignant Cells Present,benign mature teratoma of pancreas,0
4398,Increased megakaryocytes (bone marrow),Colorectal Sessile Serrated Adenoma/Polyp,0
4399,Spindle Cell Metaplasia of Malignant Cells Present,Benign Gastric Granular Cell Tumor,0
4400,Epithelial hyperplasia of skin,Squamous cell papilloma of skin,0
4401,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sellar Chordoma,0
4402,Solar Radiation Toxicity,Testicular choriocarcinoma stage II,0
4403,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Benign Soft Tissue Tumor of Uncertain Differentiation,0
4404,Canalicular Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",0
4405,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Primary Prostate Urothelial Carcinoma,0
4406,Mixture of Germ Cell Neoplastic Components Present,Stage III Merkel Cell Carcinoma AJCC v7,0
4407,Spindle Cell Metaplasia of Malignant Cells Present,Papillary transitional cell neoplasm of low malignant potential,0
4408,Fenestrated Pattern,Neuroblastic tumors,0
4409,Lesion with Diameter of 2cm or Less,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0
4410,Recurrent disease,Lhermitte-Duclos disease,0
4411,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Carcinoma in situ of fallopian tube,0
4412,Fenestrated Pattern,Asian desert cutaneous leishmaniasis,0
4413,Fenestrated Pattern,Adenocarcinoma Of Esophagus,0
4414,Solar Radiation Toxicity,Lymphangitis carcinomatosa,0
4415,Multihormonal Immunoreactivity Present in a Single Cell Type,"Squamous Cell Breast Carcinoma, Acantholytic Variant",0
4416,Rimming of Adipose Tissue Cells Present,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0
4417,Fenestrated Pattern,Necrotizing Funisitis,0
4418,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,0
4419,Spindle Cell Metaplasia of Malignant Cells Present,Adult Type Granulosa Cell Tumor,0
4420,Increased megakaryocytes (bone marrow),Papillary adenofibroma,0
4421,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Grade 3 Invasive Breast Carcinoma,0
4422,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage II Breast Cancer AJCC v6 and v7,0
4423,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Epithelioid Sarcoma,0
4424,Multihormonal Immunoreactivity Present in a Single Cell Type,Small Cell Adenocarcinoma,0
4425,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anterior Tongue Carcinoma,0
4426,Increased megakaryocytes (bone marrow),Stage IA Distal Bile Duct Cancer AJCC v7,0
4427,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal Carcinoma by AJCC v7 Stage,0
4428,Pleural effusion disorder,Pleural Carcinomatosis,0
4429,Increased megakaryocytes (bone marrow),Pediatric Neoplasm,0
4430,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of fallopian tube,0
4431,Increased megakaryocytes (bone marrow),Testicular Cancer by AJCC v8 Stage,0
4432,Fenestrated Pattern,Stage 2 Neuroblastoma,0
4433,Spindle Cell Metaplasia of Malignant Cells Present,Malignant vascular tumor of skin,0
4434,Microinvasive tumor,Benign squamous cell tumor,0
4435,Solitary Skin Tumor,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,0
4436,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of frontal sinus,0
4437,Spindle Cell Metaplasia of Malignant Cells Present,"Nevus, Spindle Cell",0
4438,Increased megakaryocytes (bone marrow),Stage IIA Fallopian Tube Cancer AJCC v8,0
4439,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
4440,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine cell hyperplasia of infancy,0
4441,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of gallbladder localized,0
4442,Plasma cell inflammation,Primary cutaneous diffuse large cell B-cell lymphoma,0
4443,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,0
4444,Systemic disease,Hodgkin's disease mixed cellularity stage III,0
4445,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Traditional Serrated Adenoma,0
4446,Absence of Malignant Features,Malignant tumor of palate,0
4447,Squamous metaplasia of bladder,Urothelial carcinoma bladder recurrent,0
4448,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Paranasal Sinus Cancer AJCC v7,0
4449,Increased megakaryocytes (bone marrow),Congenital hypotrichia,0
4450,Solar Radiation Toxicity,Periosteal fibroma,0
4451,Increased megakaryocytes (bone marrow),Uveal melanoma,0
4452,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Vulvar Sebaceous Carcinoma,0
4453,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of vertebral column,0
4454,Villous Projections of the Neoplastic Epithelium Present,Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7,0
4455,Aberrant Thyroid Tissue Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
4456,Schwannian Stroma More than 50 Percent of the Tumor Volume,Phosphaturic Mesenchymal Tumor,0
4457,Nodular and Diffuse Pattern,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4458,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ameloblastoma,0
4459,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Liver and Intrahepatic Biliary Tract Carcinoma,0
4460,Absence of Malignant Features,Refractory Malignant Thymoma,0
4461,Solar Radiation Toxicity,Eclampsia,0
4462,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Ampulla of Vater Cancer AJCC v8,0
4463,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Ovarian Neoplasm,0
4464,Indolent Clinical Course,Stage I Indolent Adult Non-Hodgkin Lymphoma,0
4465,Nodular and Diffuse Pattern,Nodular tenosynovitis,0
4466,Antoni B Pattern,Hepatitis B Virus-Related Hepatocellular Carcinoma,0
4467,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,0
4468,Fenestrated Pattern,Marginal zone lymphoma stage IV,0
4469,Solar Radiation Toxicity,Precancerous Polyp,0
4470,Endometrial Type Glands and Stroma Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,0
4471,Fried-Egg Appearance of the Bone Marrow,Congenital Bone Marrow Failure Syndromes,0
4472,Increased megakaryocytes (bone marrow),Testicular yolk sac tumor stage II,0
4473,Absence of Malignant Features,Benign neoplasm of rectum,0
4474,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Aggressive Adult Non-Hodgkin Lymphoma,0
4475,Fenestrated Pattern,Adrenal Gland Schwannoma,0
4476,Fenestrated Pattern,Early Unfavorable Hodgkin Lymphoma,0
4477,Locally Aggressive Lesion,Locally Advanced Unresectable Carcinoma,0
4478,Large Mass,Stage IV Childhood Anaplastic Large Cell Lymphoma,0
4479,Hypercellular bone marrow,malignant neoplasm of bone marrow,0
4480,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,0
4481,Erythroid hyperplasia,Pure Erythroid Leukemia,0
4482,Immature Myeloid Cells Increased in Bone Marrow,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0
4483,Solar Radiation Toxicity,Hemangiosarcoma,0
4484,Systemic disease,Polycystic liver disease,0
4485,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Urothelial Carcinoma,0
4486,Spindle Cell Osteo-Fibrous Component Present,Stage II Renal Cell Cancer AJCC v8,0
4487,Fenestrated Pattern,Beta-Catenin-Activated Hepatocellular Adenoma,0
4488,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Malignant Neoplasm,0
4489,Tumor Mass,Anaplastic Kidney Wilms Tumor,0
4490,Fenestrated Pattern,Stage IIB Penile Cancer AJCC v8,0
4491,Increased megakaryocytes (bone marrow),Stage IV Nasopharyngeal Carcinoma AJCC v6,0
4492,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,0
4493,Absence of Malignant Features,adenosquamous carcinoma of pancreas,0
4494,Solitary Skin Tumor,Yolk Sac Tumor,0
4495,Fried-Egg Appearance of the Bone Marrow,Squamous cell carcinoma of the parotid gland,0
4496,Multihormonal Immunoreactivity Present in a Single Cell Type,Unresectable Lung Non-Small Cell Carcinoma,0
4497,Non-Encapsulated Neoplasm,Eccrine Neoplasm,0
4498,Solar Radiation Toxicity,"Bronchiolo-alveolar carcinoma, non-mucinous",0
4499,Increased megakaryocytes (bone marrow),Refractory Ovarian Carcinoma,0
4500,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intramucosal Adenocarcinoma,0
4501,Increased megakaryocytes (bone marrow),Urothelial Carcinoma,0
4502,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic Intraepithelial Neoplasia-1,0
4503,Neoplastic Plasma Cells Present in Bone Marrow,Carcinoma in Situ,0
4504,Increased megakaryocytes (bone marrow),Central Nervous System Angiolipoma,0
4505,Fenestrated Pattern,Stage IIIB Uterine Sarcoma AJCC v7,0
4506,Fenestrated Pattern,Stage IIC Appendix Carcinoma AJCC v8,0
4507,Fenestrated Pattern,Telogen effluvium,0
4508,Increased megakaryocytes (bone marrow),Dermatofibrosarcoma Protuberans,0
4509,Recurrent Malignant Neoplasm,Benign Cutaneous Fibroblastic Neoplasm,0
4510,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Cancer by AJCC v6 Stage,0
4511,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Polymorphus Hemangioendothelioma,0
4512,Solar Radiation Toxicity,Keratoderma,0
4513,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unilateral Breast Carcinoma,0
4514,Metaplasia of Malignant Cells Present,Malignant neoplasm of great vessels,0
4515,Increased megakaryocytes (bone marrow),Mediastinal Paraganglioma,0
4516,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Malignant Neoplasm with Regional Lymph Node Involvement,0
4517,Endometrial Type Glands and Stroma Present,Refractory Endometrial Endometrioid Adenocarcinoma,0
4518,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,0
4519,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,B-cell small lymphocytic lymphoma stage I,0
4520,Aggressive Clinical Course,Refractory Aggressive NK-Cell Leukemia,0
4521,Solar Radiation Toxicity,Stage IV Anal Cancer AJCC v8,0
4522,Solar Radiation Toxicity,Cardiac Sarcoma,0
4523,Fenestrated Pattern,Cervix carcinoma recurrent,0
4524,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Adrenal Cortex Carcinoma AJCC v8,0
4525,Multihormonal Immunoreactivity Present in a Single Cell Type,Refractory Endometrial Clear Cell Adenocarcinoma,0
4526,Hyperplastic Tissue Present,Stage IV Soft Tissue Sarcoma AJCC v7,0
4527,Increased megakaryocytes (bone marrow),Soft Palate Pleomorphic Adenoma,0
4528,Increased megakaryocytes (bone marrow),B-cell lymphoma refractory,0
4529,Increased megakaryocytes (bone marrow),Stage III Primary Peritoneal Cancer AJCC v8,0
4530,Abundance of Small Lymphocytes,Recurrent Extensive Stage Lung Small Cell Carcinoma,0
4531,Large Mass,Common Variant Anaplastic Large Cell Lymphoma,0
4532,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Uterine Corpus Sarcoma by AJCC v7 Stage,0
4533,Tissue Differentiation Uncertain,Soft Tissue Amyloid Neoplasm,0
4534,Increased megakaryocytes (bone marrow),Papillary serous cystadenoma,0
4535,Increased megakaryocytes (bone marrow),Deep Lipoma,0
4536,Osseous Metaplasia of Malignant Cells Present,Malignant germ cell neoplasm of mediastinum,0
4537,Increased megakaryocytes (bone marrow),Coronary Venous Dissection,0
4538,Fenestrated Pattern,Occult Lung Adenosquamous Carcinoma,0
4539,Increased megakaryocytes (bone marrow),Dedifferentiated chordoma,0
4540,Fenestrated Pattern,Rectal Leiomyoma,0
4541,Absence of Malignant Features,Malignant Accessory Urethral Gland Neoplasm,0
4542,Increased megakaryocytes (bone marrow),Refractory Kaposi Sarcoma,0
4543,Increased megakaryocytes (bone marrow),Uterine Corpus Epithelioid Leiomyoma,0
4544,Spindle Cell Metaplasia of Malignant Cells Present,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
4545,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Laryngeal Cancer AJCC v8,0
4546,Epithelioid Differentiation,Ciliary Body Epithelioid Cell Melanoma,0
4547,Fenestrated Pattern,bilateral breast cancer,0
4548,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoma of the Colon with Intramucosal Adenocarcinoma,0
4549,Absence of Malignant Features,Malignant neoplasm of cervical part of esophagus,0
4550,Diffuse Lesion,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
4551,Increased megakaryocytes (bone marrow),Acral Fibromyxoma,0
4552,Metaplasia of Malignant Cells Present,Malignant tumor of minor salivary gland,0
4553,Absence of Malignant Features,Malignant melanoma of ciliary body,0
4554,Exposure to asbestos,Contact dermatitis due to acid,0
4555,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of great vessels,0
4556,Increased megakaryocytes (bone marrow),Sellar Ependymoma,0
4557,Recurrent Genetic Abnormalities Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
4558,Increased megakaryocytes (bone marrow),Colon Leiomyoma,0
4559,Mammary Gland Type Features Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
4560,Solar Radiation Toxicity,FIGO Stage IIIA1 Ovarian Cancer,0
4561,Absence of Malignant Features,Multiple hamartoma of lung,0
4562,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,0
4563,Fenestrated Pattern,PRETEXT Stage 1 Hepatoblastoma,0
4564,Absence of Malignant Features,ganglioneuroblastoma of mediastinum,0
4565,Increased megakaryocytes (bone marrow),Anaplastic Hemispheric Astrocytoma,0
4566,Endodermal Sinus Pattern,Ethmoid Sinus Squamous Cell Carcinoma,0
4567,Increased megakaryocytes (bone marrow),Cholangiocarcinoma resectable,0
4568,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
4569,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Appendix Carcinoma AJCC v8,0
4570,Well Differentiated Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
4571,Solar Radiation Toxicity,Retinoblastoma,0
4572,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cutaneous Radiation-Related Angiosarcoma,0
4573,Absence of Malignant Features,squamous cell carcinoma of salivary gland,0
4574,Nodular and Diffuse Pattern,Ann Arbor Stage I Mature T- and NK-Cell Lymphoma,0
4575,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of ethmoid sinus,0
4576,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,0
4577,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Large B-cell lymphoma with IRF4 rearrangement,0
4578,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder Tubular Carcinoid,0
4579,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
4580,Fenestrated Pattern,Liver Lipoma,0
4581,Immature Myeloid Cells Increased in Bone Marrow,Stage II Bone Cancer AJCC v7,0
4582,Intersecting Sharply Marginated Clusters of Spindle Cells Present,primitive neuroectodermal tumor (PNET) of spinal cord,0
4583,Spindle Cell Metaplasia of Malignant Cells Present,Solar Radiation-Related Skin Squamous Cell Carcinoma,0
4584,Increased megakaryocytes (bone marrow),Cervical carcinoma stage II AJCC v7,0
4585,Fenestrated Pattern,Liver Adenosquamous Carcinoma,0
4586,Recurrent Malignant Neoplasm,AIDS-Related Malignant Neoplasm,0
4587,Questionable Invasive Lesion,Invasive Prostate Carcinoma,0
4588,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Brenner Tumor,0
4589,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign germ cell tumor of ovary,0
4590,Increased megakaryocytes (bone marrow),Stage I Lung Cancer AJCC v8,0
4591,Fenestrated Pattern,Stage I Liver Carcinoma,0
4592,Fenestrated Pattern,"Lymphoma, T-Cell, Cutaneous",0
4593,Bone Marrow Involvement,Stage IVB Bone Sarcoma AJCC v7,0
4594,Breast Implant-Related Lesion,Intracystic Papillary Breast Carcinoma,0
4595,Recurrent Malignant Neoplasm,Megakaryocytic Neoplasm,0
4596,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Folliculitis,0
4597,Increased megakaryocytes (bone marrow),Adult Botryoid-Type Embryonal Rhabdomyosarcoma,0
4598,Multihormonal Immunoreactivity Present in a Single Cell Type,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
4599,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma in situ of vagina,0
4600,High Grade Non Cartilaginous Sarcomatous Stroma Present,Leiomyosarcoma NCI Grade 3,0
4601,Recurrent Genetic Abnormalities Present,Recurrent respiratory papillomatosis,0
4602,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0
4603,Monoclonal Myeloid or Lymphoid Cells Present,Myeloid Leukemia,0
4604,Fenestrated Pattern,Ovarian Seromucinous Cystadenoma,0
4605,Multihormonal Immunoreactivity Present in a Single Cell Type,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",0
4606,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular Cancer by AJCC v8 Stage,0
4607,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Gastric Neuroendocrine Carcinoma,0
4608,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Fallopian Tube Cancer AJCC v8,0
4609,Spindle Cell Metaplasia of Malignant Cells Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,0
4610,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Necrobiosis Lipoidica,0
4611,Fenestrated Pattern,Stage II Vulvar Cancer AJCC v8,0
4612,Solar Radiation Toxicity,Hepatoblastoma recurrent,0
4613,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ocular Cicatricial Pemphigoid,0
4614,Increased megakaryocytes (bone marrow),Gallbladder Melanoma,0
4615,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8,0
4616,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Metastasizing Leiomyoma of the Uterine Corpus,0
4617,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
4618,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pemphigus Vulgaris,0
4619,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,recurrent gastric cancer,0
4620,Primary Lesion,Primary Myelofibrosis,0
4621,Recurrent Malignant Neoplasm,Pilar-Associated Mesenchyme Neoplasm,0
4622,Increased megakaryocytes (bone marrow),recurrent gastric cancer,0
4623,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage,0
4624,Increased megakaryocytes (bone marrow),Stage IVA Gallbladder Cancer AJCC v8,0
4625,Fenestrated Pattern,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,0
4626,Fenestrated Pattern,Gallbladder Lymphoma,0
4627,Fenestrated Pattern,Thymic epithelial tumor,0
4628,Spindle Cell Osteo-Fibrous Component Present,Stage IV Renal Cell Cancer AJCC v8,0
4629,Increased megakaryocytes (bone marrow),Multiple adenomatous polyps,0
4630,Multiple Tumor Masses,Multiple Myeloma,0
4631,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Vulvar Cancer by AJCC v8 Stage,0
4632,Questionable Invasive Lesion,Early Invasive Cervical Adenocarcinoma,0
4633,Primitive Mesenchymal Stroma Formation,Central Nervous System Mesenchymal Chondrosarcoma,0
4634,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Hypopharyngeal Carcinoma AJCC v6,0
4635,Chronic lymphocytic inflammation,Chronic Neutrophilic Leukemia,0
4636,High Grade Lesion,Leiomyosarcoma NCI Grade 2,0
4637,Multihormonal Immunoreactivity Present in a Single Cell Type,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
4638,Schwannian Stroma More than 50 Percent of the Tumor Volume,Uterine Corpus Adenomatoid Tumor,0
4639,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Leiomyosarcoma,0
4640,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unna-Thost Syndrome,0
4641,Schwannian Stroma More than 50 Percent of the Tumor Volume,Anaplastic Sarcoma of the Kidney,0
4642,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage II,0
4643,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage IV AIDS-Related Lymphoma,0
4644,Peau d'orange surface of breast,Intraductal breast neoplasm,0
4645,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Uterine Sarcoma AJCC v7,0
4646,Solar Radiation Toxicity,Colorectal Ganglioneuroma,0
4647,Intersecting Sharply Marginated Clusters of Spindle Cells Present,adenocarcinoma of oral cavity,0
4648,Finding related to pregnancy,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0
4649,Nodular and Diffuse Pattern,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
4650,Fenestrated Pattern,Anatomic Stage IIIC Breast Cancer AJCC v8,0
4651,Solar Radiation Toxicity,Familial Neuroblastoma,0
4652,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Collecting Duct Carcinoma of the Kidney,0
4653,Increased megakaryocytes (bone marrow),Lung Lymphoepithelioma-Like Carcinoma,0
4654,Vacuolated Plasma Cells in the Bone Marrow,Melanoma Metastatic in the Central Nervous System,0
4655,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Endometrial adenocarcinoma metastatic,0
4656,Increased megakaryocytes (bone marrow),Urethral Urothelial Papilloma,0
4657,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Invasive carcinoma of breast,0
4658,Solar Radiation Toxicity,Cerebellar Liponeurocytoma,0
4659,Fenestrated Pattern,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,0
4660,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Widely Invasive Thymoma,0
4661,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Class 2 Uveal Melanoma,0
4662,Increased megakaryocytes (bone marrow),Intracerebral Cystic Meningioma,0
4663,Fenestrated Pattern,Stage IV Indolent Adult Non-Hodgkin Lymphoma,0
4664,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Methotrexate-Associated Peripheral T-Cell Lymphoma,0
4665,Solar Radiation Toxicity,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma,0
4666,Cystic Lesion,Ovarian Cystic Teratoma,0
4667,Spindle Cell Metaplasia of Malignant Cells Present,Distal Esophagus Squamous Cell Carcinoma,0
4668,Increased megakaryocytes (bone marrow),Opisthorchis Viverrini-Related Cholangiocarcinoma,0
4669,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
4670,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Breast Cancer AJCC v6,0
4671,Cervical Glandular Dysplasia,Stage IB1 Cervical Cancer AJCC v8,0
4672,Fenestrated Pattern,Adenoid cystic eccrine carcinoma,0
4673,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Refractory Head and Neck Carcinoma,0
4674,Spindle Cell Metaplasia of Malignant Cells Present,Cervical Clear Cell Adenocarcinoma,0
4675,Increased megakaryocytes (bone marrow),Intra-Abdominal Lymphangioma,0
4676,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IC Uterine Corpus Adenosarcoma AJCC v8,0
4677,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ependymoma of spinal cord,0
4678,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Esophageal Adenocarcinoma AJCC v7,0
4679,Absence of Malignant Features,"Malignant Mixed Tumor, Not Otherwise Specified",0
4680,Spindle Cell Metaplasia of Malignant Cells Present,Solar Radiation-Related Skin Squamous Cell Carcinoma,0
4681,Solitary Skin Tumor,Digestive System Neuroendocrine Tumor G2,0
4682,Absence of Malignant Features,Malignant Apocrine Neoplasm,0
4683,Villous Projections of the Neoplastic Epithelium Present,Recurrent Paget Disease of the Breast,0
4684,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Nonencapsulated sclerosing tumor,0
4685,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,0
4686,Solar Radiation Toxicity,Appendix Lymphoma,0
4687,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pilocytic astrocytoma of cerebellum,0
4688,Mediastinal mass,Mediastinal Neuroblastoma,0
4689,Non-Encapsulated Neoplasm,Prostate Neuroendocrine Neoplasm,0
4690,Increased megakaryocytes (bone marrow),"Non-Neoplastic, Non-Molar Trophoblastic Disorder",0
4691,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of brain stem,0
4692,Immature Granulocytes in Peripheral Blood Increased,Intermediate Blood Vessel Neoplasm,0
4693,Marked Thickening of the Bladder Urothelium Present,Bladder Mixed Adenocarcinoma,0
4694,Mixture of Germ Cell Neoplastic Components Present,Stage IV Malignant Mediastinal Germ Cell Tumor,0
4695,Absence of Malignant Features,liposarcoma of mediastinum,0
4696,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,0
4697,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
4698,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Ganglioglioma,0
4699,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
4700,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of stomach stage III,0
4701,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Rectal Sarcomatoid Carcinoma,0
4702,Increased megakaryocytes (bone marrow),Piloleiomyoma,0
4703,Solar Radiation Toxicity,Lugano Classification Stage I Hodgkin Lymphoma AJCC v8,0
4704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,B Lymphoblastic Lymphoma by Ann Arbor Stage,0
4705,Fenestrated Pattern,Mucin-producing adenocarcinoma,0
4706,Absence of Malignant Features,Villous adenoma of rectum,0
4707,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign neoplasm of the lip,0
4708,Diffuse Cellular Infiltrate,Recurrent Childhood Diffuse Astrocytoma,0
4709,Intersecting Sharply Marginated Clusters of Spindle Cells Present,benign neoplasm of lower jaw bone,0
4710,Nodular and Diffuse Pattern,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
4711,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Appendix Carcinoma by AJCC v7 Stage,0
4712,No Evidence of Metastatic Disease,Metastatic Pancreatic Neuroendocrine Carcinoma,0
4713,Nodular and Diffuse Pattern,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
4714,Intersecting Sharply Marginated Clusters of Spindle Cells Present,lipoma of bone,0
4715,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Pharyngeal Carcinoma,0
4716,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0
4717,Fenestrated Pattern,Precursor T-lymphoblastic lymphoma/leukemia recurrent,0
4718,Solar Radiation Toxicity,Childhood Testicular Teratoma,0
4719,Schwannian Stroma More than 50 Percent of the Tumor Volume,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4720,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thymic Adenocarcinoma,0
4721,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thymic Basaloid Carcinoma,0
4722,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bizarre leiomyoma,0
4723,Solar Radiation Toxicity,Stage III Colorectal Cancer AJCC v7,0
4724,Absence of Malignant Features,Refractory Malignant Oral Neoplasm,0
4725,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix,0
4726,Large Mass,Stage IV Anaplastic Large Cell Lymphoma,0
4727,Malignant Primitive Cellular Infiltrate,Transplant-Related Malignant Neoplasm,0
4728,Absence of Malignant Features,tubular adenoma of extrahepatic bile duct,0
4729,Solitary Skin Tumor,Childhood Testicular Yolk Sac Tumor,0
4730,Increased megakaryocytes (bone marrow),Lung Melanoma,0
4731,Tissue Differentiation Uncertain,Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4732,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,0
4733,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Leiomyosarcoma,0
4734,Nodular and Diffuse Pattern,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma,0
4735,Fenestrated Pattern,Abruptio Placentae,0
4736,Skin Erosion,Skin Angiosarcoma,0
4737,No Evidence of Metastatic Disease,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
4738,Absence of Malignant Features,Malignant vascular tumor of skin,0
4739,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0
4740,Solar Radiation Toxicity,Pericardial Synovial Sarcoma,0
4741,Increased megakaryocytes (bone marrow),Stage IB Ovarian Cancer AJCC v8,0
4742,Mixture of Germ Cell Neoplastic Components Present,"Carcinoma, Granular Cell",0
4743,NRBC - Nucleated red blood cell present result,"Langerhans cell histiocytosis, unifocal",0
4744,Fenestrated Pattern,Hydatidiform Mole,0
4745,Mixture of Germ Cell Neoplastic Components Present,Conventional (Clear Cell) Renal Cell Carcinoma,0
4746,Mixed Neoplastic Glandular and Squamous Cell Population,Bladder Squamous Cell Carcinoma,0
4747,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ovarian Endometrioid Cystadenoma,0
4748,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Regional Adrenal Gland Pheochromocytoma,0
4749,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of chest wall,0
4750,Lesion with Diameter of 2cm or Less,Adenocarcinoma with neuroendocrine differentiation,0
4751,Plasma cell inflammation,Large cell lung cancer stage I,0
4752,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Extragonadal Germ Cell Tumor,0
4753,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,0
4754,Chronic Inflammatory Infiltrate,Inflammatory malignant fibrous histiocytoma,0
4755,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,Glandular cell neoplasm,0
4756,Increased megakaryocytes (bone marrow),McCune-Albright Syndrome,0
4757,Endometrial Type Glands and Stroma Present,Stage 0 Breast Cancer AJCC v6 and v7,0
4758,Solar Radiation Toxicity,Stage IIIA Lung Cancer AJCC v7,0
4759,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of retina,0
4760,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Colon Cancer AJCC v7,0
4761,Absence of Malignant Features,Malignant neoplasm of endometrium,0
4762,Increased megakaryocytes (bone marrow),Leiomyomatosis peritonealis disseminata,0
4763,Fenestrated Pattern,Anatomic Stage IA Breast Cancer AJCC v8,0
4764,Fenestrated Pattern,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0
4765,Increased megakaryocytes (bone marrow),Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
4766,Neoplastic Growth or Spread,Neoplastic C-Cell Hyperplasia,0
4767,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of lung,0
4768,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Breast Apocrine Adenosis,0
4769,Glandular metaplasia,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
4770,Defective Gamma Heavy Chain Present,Heavy Chain Disease,0
4771,High Grade Non Cartilaginous Sarcomatous Stroma Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4772,Fenestrated Pattern,Melanotic Schwannoma,0
4773,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sebaceous Gland Neoplasms,0
4774,Mixture of Germ Cell Neoplastic Components Present,Malignant Central Nervous System Germ Cell Tumor,0
4775,Fenestrated Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
4776,Squamous metaplasia of bladder,Squamous cell carcinoma of cornea,0
4777,Peau d'orange surface of breast,Carcinoma breast stage I,0
4778,Gastric dysplasia,Gastric Glomus Tumor,0
4779,Solar Radiation Toxicity,Subglottic Hemangioma,0
4780,Multihormonal Immunoreactivity Present in a Single Cell Type,Lung Basaloid Squamous Cell Carcinoma,0
4781,Mammary Gland Type Features Present,Anterior Pituitary Gland Endocrine Neoplasm,0
4782,Hyperplastic Tissue Present,Stage IB Adult Soft Tissue Sarcoma AJCC v7,0
4783,Solar Radiation Toxicity,Rectosigmoid cancer,0
4784,Radial Growth Phase,"Leukemia, Myeloid, Accelerated Phase",0
4785,Multihormonal Immunoreactivity Present in a Single Cell Type,Pancreatic Delta Cell Neoplasm,0
4786,Increased megakaryocytes (bone marrow),Conventional Lipoma,0
4787,No Evidence of Metastatic Disease,Metastatic Lung Carcinoma,0
4788,Recurrent Genetic Abnormalities Present,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0
4789,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,0
4790,Endometrial Type Glands and Stroma Present,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,0
4791,Increased megakaryocytes (bone marrow),Phlebitis,0
4792,Progressive Clinical Course,Clinical Stage IIA Cutaneous Melanoma AJCC v8,0
4793,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cystic teratoma,0
4794,Increased megakaryocytes (bone marrow),Colon Cancer by AJCC v7 Stage,0
4795,Schwannian Stroma More than 50 Percent of the Tumor Volume,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
4796,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
4797,Increased megakaryocytes (bone marrow),Papillary adenofibroma,0
4798,Recurrent Genetic Abnormalities Present,Recurrent Adult Hodgkin Lymphoma,0
4799,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,0
4800,Fenestrated Pattern,B Lymphoblastic Lymphoma,0
4801,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Anaplastic Astrocytoma,0
4802,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of the prostate stage I,0
4803,Solar Radiation Toxicity,Stage IV Uterine Sarcoma AJCC v7,0
4804,Mixed Cellular Population,Refractory Mixed Phenotype Acute Leukemia,0
4805,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ductal Breast Hyperplasia,0
4806,Immature Granulocytes in Peripheral Blood Increased,Peripheral Ganglioneuroblastoma,0
4807,Absence of Malignant Features,ganglioneuroblastoma of mediastinum,0
4808,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4809,Fenestrated Pattern,Chondroma,0
4810,Multihormonal Immunoreactivity Present in a Single Cell Type,Submandibular Gland Acinic Cell Carcinoma,0
4811,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of respiratory tract,0
4812,Photosensitivity of skin,Abscess of skin AND/OR subcutaneous tissue,0
4813,Spindle Cell Metaplasia of Malignant Cells Present,Neoplasm of Uncertain Histogenesis,0
4814,Primary Site Unspecified,Primary malignant neoplasm,0
4815,Fenestrated Pattern,Uterine Corpus Cancer,0
4816,Tumor Mass,Klatskin Tumor,0
4817,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Mixed Tumor, Mullerian",0
4818,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoid tumor of rectum,0
4819,Neoplastic Plasma Cells Present in Bone Marrow,Stage II Bone Sarcoma AJCC v7,0
4820,Spindle Cell Metaplasia of Malignant Cells Present,Metastatic Unresectable Malignant Neoplasm,0
4821,Squamous metaplasia of bladder,Squamous cell carcinoma of trachea,0
4822,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,0
4823,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Lymphangioma, Cystic",0
4824,Recurrent Genetic Abnormalities Present,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",0
4825,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of mesothelial tissue of pleura,0
4826,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Fibroepithelial Stromal Polyp,0
4827,Increased megakaryocytes (bone marrow),Mediastinal T Lymphoblastic Leukemia/Lymphoma,0
4828,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Ovarian Transitional Cell Carcinoma,0
4829,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Cutaneous Mature B-Cell Neoplasm,0
4830,Progressive Clinical Course,Clinical Stage II Gastric Cancer AJCC v8,0
4831,Recurrent Genetic Abnormalities Present,Recurrent Classic Hodgkin Lymphoma,0
4832,Solar Radiation Toxicity,"Mucinous adenocarcinoma, endocervical type",0
4833,Fenestrated Pattern,Dysembryoplastic neuroepithelial tumor,0
4834,Increased megakaryocytes (bone marrow),Refractory Ovarian Carcinoma,0
4835,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Primary Peritoneal Cancer AJCC v7,0
4836,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of subglottis,0
4837,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Carcinoma Metastatic in the Liver,0
4838,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Adult Type Testicular Granulosa Cell Tumor,0
4839,Fenestrated Pattern,Lymphomatoid Granulomatosis,0
4840,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sarcoma of liver,0
4841,Gastrointestinal Type Epithelium Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,0
4842,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of parathyroid gland,0
4843,Increased megakaryocytes (bone marrow),Cardiac Epithelioid Hemangioendothelioma,0
4844,Nodular and Diffuse Pattern,Resectable Head and Neck Squamous Cell Carcinoma,0
4845,Fenestrated Pattern,Pineocytoma,0
4846,Primary Site Unspecified,Primary Peritoneal Cancer by AJCC v7 Stage,0
4847,Schwannian Stroma More than 50 Percent of the Tumor Volume,Sex Cord-Stromal Tumor,0
4848,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,0
4849,Spindle Cell Osteo-Fibrous Component Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7,0
4850,Solar Radiation Toxicity,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8,0
4851,Inoperable Disease,Central Nervous System Erdheim-Chester Disease,0
4852,Multihormonal Immunoreactivity Present in a Single Cell Type,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,0
4853,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory anemia with excess blasts I,0
4854,Spindle Cell Metaplasia of Malignant Cells Present,Ann Arbor Stage II Mantle Cell Lymphoma,0
4855,Spindle Cell Metaplasia of Malignant Cells Present,undifferentiated carcinoma of extrahepatic bile duct,0
4856,Intraepithelial Neoplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
4857,Fenestrated Pattern,Colon Burkitt Lymphoma,0
4858,Diffuse Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
4859,Increased megakaryocytes (bone marrow),Stage IVB Uterine Corpus Adenosarcoma AJCC v8,0
4860,Increased megakaryocytes (bone marrow),Clear-Cell Myomelanocytic Tumors,0
4861,Spindle Cell Metaplasia of Malignant Cells Present,Cervical Keratinizing Squamous Cell Carcinoma,0
4862,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vaginal cancer recurrent,0
4863,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Cervical Adenoid Cystic Carcinoma,0
4864,Spindle Cell Metaplasia of Malignant Cells Present,Nasopharyngeal Basaloid Squamous Cell Carcinoma,0
4865,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Kidney Lipoma,0
4866,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Congenital anomaly of lens,0
4867,Spindle Cell Osteo-Fibrous Component Present,RISS Stage III Plasma Cell Myeloma,0
4868,Fenestrated Pattern,Paranasal Sinus Schneiderian Papilloma,0
4869,Abundance of Small Lymphocytes,Small Intestinal Squamous Cell Carcinoma,0
4870,Increased megakaryocytes (bone marrow),Adult Gliosarcoma,0
4871,Increased megakaryocytes (bone marrow),Testicular embryonal carcinoma stage III,0
4872,Solar Radiation Toxicity,Vaginal Tubulovillous Adenoma,0
4873,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Uterine Corpus Dissecting Leiomyoma,0
4874,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Unresectable Renal Pelvis Urothelial Carcinoma,0
4875,Fenestrated Pattern,Stage I Hilar Cholangiocarcinoma AJCC v8,0
4876,Recurrent Malignant Neoplasm,Recurrent Prostate Acinar Adenocarcinoma,0
4877,Nodular and Diffuse Pattern,Sporadic Diffuse Gastric Adenocarcinoma,0
4878,Malignant Primitive Cellular Infiltrate,"Teratoma, Malignant",0
4879,Chronic lymphocytic inflammation,Chronic Active Colitis,0
4880,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Rectal Sessile Serrated Adenoma/Polyp,0
4881,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pyogenic granuloma of oral mucosa,0
4882,Non-Encapsulated Neoplasm,Chest Wall Plexiform Fibrohistiocytic Neoplasm,0
4883,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,embryonal carcinoma of mediastinum,0
4884,Fenestrated Pattern,Stage I Uveal Melanoma AJCC v7,0
4885,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Posterior Cranial Fossa Ependymal Tumor,0
4886,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Smoldering Adult T-Cell Leukemia/Lymphoma,0
4887,Fenestrated Pattern,Testicular embryonal carcinoma stage II,0
4888,Fenestrated Pattern,B-cell small lymphocytic lymphoma stage III,0
4889,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Eyelid Carcinoma AJCC v7,0
4890,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Cyst of Skene's duct,0
4891,Solar Radiation Toxicity,Stage IIB Vaginal Cancer AJCC v8,0
4892,Fetal -Epithelial Differentiation,Fetal Lung Adenocarcinoma,0
4893,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIC Prostate Cancer AJCC v8,0
4894,Fenestrated Pattern,Multiple Skull Base Meningiomas,0
4895,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoid cystic carcinoma of the oral cavity recurrent,0
4896,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Nasopharyngeal Carcinoma AJCC v6,0
4897,Multihormonal Immunoreactivity Present in a Single Cell Type,Endometrial Mixed Cell Adenocarcinoma,0
4898,Malignant Primitive Cellular Infiltrate,Stage IV Malignant Mediastinal Germ Cell Tumor,0
4899,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urethral cancer regional,0
4900,Fenestrated Pattern,Stage III Hilar Cholangiocarcinoma AJCC v8,0
4901,Intersecting Sharply Marginated Clusters of Spindle Cells Present,non-Hodgkin's lymphoma of nasal cavity,0
4902,Spindle Cell Osteo-Fibrous Component Present,Giant Cell Glioblastoma,0
4903,Solar Radiation Toxicity,Radiation-Related Non-Neoplastic Disorder,0
4904,Fenestrated Pattern,Stage IVB Prostate Cancer AJCC v8,0
4905,Fenestrated Pattern,Stage I Nasopharyngeal Carcinoma AJCC v8,0
4906,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of gum,0
4907,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Burkitt Lymphoma,0
4908,Cervical Glandular Dysplasia,Stage IB Cervical Cancer AJCC v8,0
4909,Aberrant Thyroid Tissue Present,Stage II Adult Soft Tissue Sarcoma AJCC v7,0
4910,Cervical Glandular Dysplasia,Cervical Rhabdomyoma,0
4911,Increased megakaryocytes (bone marrow),Vulvar Cancer by AJCC v7 Stage,0
4912,Fenestrated Pattern,Laryngeal Adenosquamous Carcinoma,0
4913,Increased megakaryocytes (bone marrow),Adult Unfavorable Prognosis Hodgkin Lymphoma,0
4914,Increased megakaryocytes (bone marrow),Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,0
4915,Intersecting Sharply Marginated Clusters of Spindle Cells Present,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
4916,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillary serous endometrial carcinoma,0
4917,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
4918,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
4919,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleomorphic hyalinizing angiectatic tumor of soft tissue,0
4920,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
4921,Slowly Progressive Clinical Course,Progressive bulbar palsy,0
4922,Increased megakaryocytes (bone marrow),Stage III Acral Lentiginous Melanoma AJCC v7,0
4923,Recurrent Genetic Abnormalities Present,Recurrent Cervical Adenocarcinoma,0
4924,Solar Radiation Toxicity,T-cell lymphoma stage IV,0
4925,Fenestrated Pattern,Pseudoporphyria,0
4926,Retiform Structures Comprise 90% or More of the Tumor,Calcifying Nested Epithelial Stromal Tumor of the Liver,0
4927,Endometrial Type Glands and Stroma Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",0
4928,Slowly Progressive Clinical Course,"Leukoencephalopathy, Progressive Multifocal",0
4929,Multihormonal Immunoreactivity Present in a Single Cell Type,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
4930,Nodular and Diffuse Pattern,Lip and Oral Cavity Carcinoma,0
4931,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign tumor of endocrine gland,0
4932,Breast Implant-Related Lesion,Breast Epithelioid Hemangioma,0
4933,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
4934,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Epithelioid mesothelioma, malignant",0
4935,Absence of Malignant Features,Burkitt's tumor of spleen,0
4936,Non-Encapsulated Neoplasm,Benign Cervical Soft Tissue Neoplasm,0
4937,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,0
4938,Neoplastic Plasma Cells Present in Bone Marrow,"Castleman Disease, Plasma Cell Type",0
4939,Large Spaces Filled with Blood Present,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
4940,Solar Radiation Toxicity,Hyperacute allograft rejection,0
4941,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
4942,Increased megakaryocytes (bone marrow),Stage I Uterine Corpus Cancer AJCC v6,0
4943,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis Fungoides Variant,0
4944,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Small Intestinal Neuroendocrine Neoplasm,0
4945,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Eyelid Carcinoma AJCC v8,0
4946,Fenestrated Pattern,Prognostic Stage IIA Breast Cancer AJCC v8,0
4947,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IA Gastric Cancer AJCC v8,0
4948,Well Differentiated Lesion,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
4949,Absence of Malignant Features,Malignant neoplasm of scrotum,0
4950,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Blastema Predominant Kidney Wilms Tumor,0
4951,Increased megakaryocytes (bone marrow),Cardiac Epithelioid Hemangioendothelioma,0
4952,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Telangiectatic osteosarcoma,0
4953,Increased megakaryocytes (bone marrow),Lymphoid interstitial pneumonia,0
4954,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Myelofibrosis,0
4955,Increased megakaryocytes (bone marrow),Cystadenofibroma,0
4956,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Advanced Pancreatic Neuroendocrine Tumor,0
4957,Solar Radiation Toxicity,Central Nervous System Leiomyosarcoma,0
4958,Pleural effusion disorder,Pleural mesothelioma malignant recurrent,0
4959,Solitary Skin Tumor,Unresectable Gastrointestinal Stromal Tumor,0
4960,Ionizing Radiation Toxicity,Radiation Pneumonitis,0
4961,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable",0
4962,Lesion with Diameter of 2cm or Less,Adenocarcinoma with cartilaginous metaplasia,0
4963,Mixed Cellular Population,Adult Mixed Cellularity Classical Hodgkin Lymphoma,0
4964,Increased megakaryocytes (bone marrow),Asian desert cutaneous leishmaniasis,0
4965,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Angiocentric immunoproliferative lesion grade 2,0
4966,Fenestrated Pattern,Stage III Gallbladder Cancer AJCC v7,0
4967,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Ileal Neuroendocrine Tumor,0
4968,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Vaginal Mixed Tumor,0
4969,Fenestrated Pattern,Refractory Myxoid Liposarcoma,0
4970,Solar Radiation Toxicity,Stage III Esophageal Adenocarcinoma AJCC v7,0
4971,Increased megakaryocytes (bone marrow),Acute lymphadenitis,0
4972,Absence of Malignant Features,Malignant Leptomeningeal Neoplasm,0
4973,Spindle Cell Metaplasia of Malignant Cells Present,Resectable Pancreatic Acinar Cell Carcinoma,0
4974,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Disorder of vein,0
4975,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical Breast Papilloma,0
4976,Non-Encapsulated Neoplasm,Refractory Brain Neoplasm,0
4977,Absence of Malignant Features,Benign neoplasm of middle ear,0
4978,Mammary Gland Type Features Present,Salivary Gland Oncocytic Carcinoma,0
4979,Absence of Malignant Features,Malignant Uveal Neoplasm,0
4980,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,0
4981,Solar Radiation Toxicity,Stage IV Rectal Cancer AJCC v8,0
4982,Fenestrated Pattern,Stage III Uterine Corpus Cancer AJCC v8,0
4983,Fenestrated Pattern,Adult Unfavorable Prognosis Hodgkin Lymphoma,0
4984,Absence of Malignant Features,AIDS-Related Malignant Neoplasm,0
4985,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,0
4986,Congenital Lesion,Congenital Vena Cava Abnormality,0
4987,Epidermotropic Lymphocytic Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,0
4988,Neutral Epithelial Mucin Present,Combined Thymic Epithelial Neoplasm,0
4989,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Rhabdomyoma,0
4990,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of palate,0
4991,Non-Encapsulated Neoplasm,Germinative Follicular Epithelium Neoplasm,0
4992,Fenestrated Pattern,Adenocarcinoma Of Esophagus,0
4993,Neoplastic Plasma Cells Present in Bone Marrow,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,0
4994,Large Spaces Filled with Blood Present,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
4995,Solitary Skin Tumor,Pancoast Tumor,0
4996,Increased megakaryocytes (bone marrow),Cystadenofibroma,0
4997,Non-Encapsulated Neoplasm,Bladder Neuroendocrine Neoplasm,0
4998,Cystic Lesion,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
4999,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Childhood Anaplastic Large Cell Lymphoma,0
5000,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sarcoma of accessory sinus,0
5001,Mixture of Germ Cell Neoplastic Components Present,Malignant Cardiac Germ Cell Tumor,0
5002,Peau d'orange surface of breast,High grade surface osteosarcoma,0
5003,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7,0
5004,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Childhood Nongerminomatous Germ Cell Tumor,0
5005,Fenestrated Pattern,AIDS-Related Herpes Zoster,0
5006,Acute inflammation,Refractory Acute Leukemia,0
5007,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage IV Pleural Malignant Mesothelioma AJCC v7,0
5008,Solar Radiation Toxicity,Porokeratosis,0
5009,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of anus,0
5010,Non-Encapsulated Neoplasm,Benign Childhood Cerebral Neoplasm,0
5011,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Laryngeal Cancer AJCC v8,0
5012,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Angioimmunoblastic T-cell lymphoma stage IV,0
5013,Solar Radiation Toxicity,Familial Neuroblastoma,0
5014,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of nipple of female breast,0
5015,Bone Marrow Involvement,Bone Cancer by AJCC v8 Stage,0
5016,Fenestrated Pattern,Anatomic Stage III Breast Cancer AJCC v8,0
5017,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Rectal Cancer AJCC v7,0
5018,Acute inflammation,Acute Lymphoblastic Leukemia by ROSE Cluster,0
5019,Cervical lymphadenopathy,Cervical Fibroepithelial Polyp,0
5020,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage,0
5021,Nodular and Diffuse Pattern,Diffuse Glioma,0
5022,Mixed Neoplastic Glandular and Squamous Cell Population,Occult Lung Squamous Cell Carcinoma,0
5023,Absence of Malignant Features,yolk sac tumor of mediastinum,0
5024,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0
5025,Fenestrated Pattern,Stage I Lip Carcinoma,0
5026,Intraepithelial Neoplasia,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5027,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
5028,No Evidence of Metastatic Disease,Metastatic Rectal Carcinoma,0
5029,Dilated Terminal Duct Lobular Units Present,Stage IB Distal Bile Duct Cancer AJCC v7,0
5030,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Cataract associated with radiation,0
5031,Spindle Cell Metaplasia of Malignant Cells Present,Oligodendroglioma of spinal cord,0
5032,Fenestrated Pattern,Acute lymphadenitis,0
5033,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IV Retinoblastoma AJCC v8,0
5034,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Helicobacter Pylori-Related Carcinoma,0
5035,Mixed Neoplastic Glandular and Squamous Cell Population,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
5036,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Focal nodular hyperplasia of liver,0
5037,Immature Myeloid Cells Increased in Bone Marrow,Bone Cancer by AJCC v8 Stage,0
5038,Proliferation of High Endothelial Venules Present,Refractory High Risk Myelodysplastic Syndrome,0
5039,Increased megakaryocytes (bone marrow),Benign Cerebellar Neoplasms,0
5040,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,hepatoid adenocarcinoma of gallbladder,0
5041,Spindle Cell Metaplasia of Malignant Cells Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
5042,Nodular and Diffuse Pattern,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0
5043,Low Grade Cartilaginous Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
5044,Mammary Gland Type Features Present,Submandibular Gland Undifferentiated Carcinoma,0
5045,Fenestrated Pattern,Stage 3 Neuroblastoma,0
5046,Canalicular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
5047,Atypical Lymphocytes Present in Peripheral Blood,Peripheral primitive neuroectodermal bone tumor,0
5048,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lentigo maligna melanoma,0
5049,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Fallopian Tube Cancer by AJCC v7 Stage,0
5050,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thoracic NUT Carcinoma,0
5051,Fenestrated Pattern,Stage I Urethral Cancer AJCC v7,0
5052,Solar Radiation Toxicity,"Cystadenoma, Serous",0
5053,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of urinary bladder,0
5054,Endodermal Sinus Pattern,Stage IVA Paranasal Sinus Cancer AJCC v7,0
5055,Mixture of Germ Cell Neoplastic Components Present,Myxoid/Round Cell Liposarcoma,0
5056,Plasma cell inflammation,Bladder squamous cell carcinoma stage IV,0
5057,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Osteoblastic Osteosarcoma,0
5058,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,0
5059,Multihormonal Immunoreactivity Present in a Single Cell Type,"Dendritic Cell Sarcoma, Interdigitating",0
5060,Dedifferentiated Malignant Infiltrate,Resectable Dedifferentiated Liposarcoma,0
5061,Solar Radiation Toxicity,Adult T-cell lymphoma/leukemia stage III,0
5062,Chronic Inflammatory Infiltrate,Inflammatory Leiomyosarcoma,0
5063,Progressive Clinical Course,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,0
5064,Recurrent Malignant Neoplasm,Recurrent tumor,0
5065,Increased megakaryocytes (bone marrow),Stage IV Hypopharyngeal Carcinoma AJCC v8,0
5066,Solar Radiation Toxicity,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,0
5067,Prominent Elastic Tissue Cores Present,Primary Childhood Soft Tissue Sarcoma,0
5068,Fenestrated Pattern,Stage 2 Neuroblastoma,0
5069,Metaplasia of Malignant Cells Present,Malignant tumor of pleura,0
5070,Large Spaces Filled with Blood Present,Colorectal Adenoma with Mild Dysplasia,0
5071,Fenestrated Pattern,Posterior Tongue Mucoepidermoid Carcinoma,0
5072,Increased megakaryocytes (bone marrow),Stage 0a Renal Pelvis Cancer AJCC v7,0
5073,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma Arising from Craniopharyngioma,0
5074,Mammary Gland Type Features Present,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
5075,Multifocal Multisystem Disease,Asynchronous Multifocal Osteosarcoma,0
5076,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,0
5077,Solitary Skin Tumor,Stage I Gestational Trophoblastic Tumor AJCC v7,0
5078,Glandular cell atypia,Testicular germ cell tumor mixed,0
5079,Absence of Malignant Features,Recurrent Subsequent Malignant Neoplasm,0
5080,Increased megakaryocytes (bone marrow),Parathyroid Gland Adenocarcinoma,0
5081,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Hepatosplenic T-Cell Lymphoma,0
5082,Solar Radiation Toxicity,Stage IIA Colon Cancer AJCC v8,0
5083,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIB Colorectal Cancer AJCC v8,0
5084,Absence of Malignant Features,Immunodeficiency-Related Malignant Neoplasm,0
5085,Immature Granulocytes in Peripheral Blood Increased,Peripheral T-cell lymphoma unspecified refractory,0
5086,Fenestrated Pattern,Resectable Intrahepatic Cholangiocarcinoma,0
5087,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gallbladder Kaposi's Sarcoma,0
5088,Atypical Lymphocytes Present in Peripheral Blood,Peripheral Nerve Schwannoma,0
5089,Follicular Differentiation,Follicular Lymphoma by Ann Arbor Stage,0
5090,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0
5091,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pleural Lymphoma,0
5092,Increased megakaryocytes (bone marrow),Nasopharyngeal Papillary Adenocarcinoma,0
5093,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Congenital kyphosis,0
5094,Plasma cell inflammation,Basaloid squamous cell carcinoma,0
5095,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Roberts-SC phocomelia syndrome,0
5096,Spindle Cell Osteo-Fibrous Component Present,"Carcinoid, Goblet Cell",0
5097,Spindle Cell Metaplasia of Malignant Cells Present,Stage IIIA Ampulla of Vater Cancer AJCC v8,0
5098,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0
5099,Intestinal metaplasia of gastric mucosa,Metastatic gastric adenocarcinoma,0
5100,Increased megakaryocytes (bone marrow),Focal Segmental Glomerulosclerosis Perihilar Variant,0
5101,Multihormonal Immunoreactivity Present in a Single Cell Type,Small Cell Adenocarcinoma,0
5102,Fenestrated Pattern,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,0
5103,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of gum,0
5104,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thecoma, luteinized",0
5105,Fenestrated Pattern,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
5106,High Grade Lesion,Grade 3 Endometrial Endometrioid Adenocarcinoma,0
5107,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IB Eyelid Carcinoma AJCC v7,0
5108,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of large intestine,0
5109,Mediastinal mass,Mediastinal Rhabdomyoma,0
5110,Spindle Cell Metaplasia of Malignant Cells Present,Stage IV Pleural Malignant Mesothelioma AJCC v7,0
5111,Spindle Cell Metaplasia of Malignant Cells Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
5112,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Conjunctival intraepithelial neoplasia,0
5113,White blood cell count increased (lab result),Renal cell carcinoma recurrent,0
5114,Solar Radiation Toxicity,Esophageal Liposarcoma,0
5115,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,CIC-DUX Sarcoma,0
5116,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Breast Cancer by AJCC v7 Stage,0
5117,Gastric dysplasia,Mature Gastric Teratoma,0
5118,Nodular and Diffuse Pattern,Skin Nodular Solid Basal Cell Carcinoma,0
5119,Solar Radiation Toxicity,Hydroa vacciniforme-like lymphoma,0
5120,Multihormonal Immunoreactivity Present in a Single Cell Type,Vulvar Merkel Cell Carcinoma,0
5121,Nests of Nevus Cells Resembling Nerve Bundles Present,Basal Cell Nevus Syndrome,0
5122,Increased megakaryocytes (bone marrow),Urothelial carcinoma recurrent,0
5123,Spindle Cell Metaplasia of Malignant Cells Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0
5124,Spindle Cell Metaplasia of Malignant Cells Present,Stage IV Anaplastic Large Cell Lymphoma,0
5125,Nodular and Diffuse Pattern,Stage IV Oral Cavity Cancer AJCC v6 and v7,0
5126,Recurrent Malignant Neoplasm,Benign Neoplasm,0
5127,Solar Radiation Toxicity,Hypothalamic Gangliocytoma,0
5128,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Lymphoproliferative disorder caused by methotrexate,0
5129,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Ovarian Sex Cord-Stromal Tumor,0
5130,High Grade Non Cartilaginous Sarcomatous Stroma Present,Recurrent High Risk Myelodysplastic Syndrome,0
5131,Mixed Neoplastic Glandular and Squamous Cell Population,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,0
5132,Gastrointestinal Type Epithelium Present,"Gastrointestinal stromal tumor, uncertain malignant potential",0
5133,Non-Encapsulated Neoplasm,Stage IV Gestational Trophoblastic Neoplasm AJCC v8,0
5134,Intestinal metaplasia of gastric mucosa,Metastatic gastric adenocarcinoma,0
5135,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Vulvar Cancer AJCC v8,0
5136,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
5137,Fenestrated Pattern,Stage III Renal Pelvis Cancer AJCC v8,0
5138,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Meningeal melanomatosis,0
5139,Fenestrated Pattern,Adenocarcinoma,0
5140,Fenestrated Pattern,Lymphoepithelial malignant thymoma,0
5141,Venous Type Vascular Channel Formation,Type A Tylosis,0
5142,Increased megakaryocytes (bone marrow),Cloacogenic carcinoma,0
5143,Schwannian Stroma More than 50 Percent of the Tumor Volume,Advanced Pancreatic Neuroendocrine Tumor,0
5144,Recurrent Genetic Abnormalities Present,"Recurrent NK-Cell Lymphoma, Unclassifiable",0
5145,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Vaginal Cancer AJCC v8,0
5146,Spindle Cell Metaplasia of Malignant Cells Present,Polyp of small intestine,0
5147,Spindle Cell Metaplasia of Malignant Cells Present,Borderline Ovarian Clear Cell Tumor,0
5148,Solar Radiation Toxicity,AIDS-Related Vulvovaginal Candidiasis,0
5149,Blasts Expressing T-Lymphoid and Myeloid Markers Present,"Sarcoma, Myeloid",0
5150,Cervical lymphadenopathy,Cervical lymphadenitis,0
5151,Gastric dysplasia,High Grade Gastric Intraepithelial Neoplasia,0
5152,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVC Colorectal Cancer AJCC v8,0
5153,Increased megakaryocytes (bone marrow),Ureter Carcinoma,0
5154,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed phenotype acute leukemia,0
5155,Increased megakaryocytes (bone marrow),Ann Arbor Stage IIIA Hodgkin Lymphoma,0
5156,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Myeloid Neoplasms with Germline GATA2 Mutation,0
5157,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Carcinoma of Unknown Primary,0
5158,Osseous Metaplasia of Malignant Cells Present,Malignant tumor of peritoneum,0
5159,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Polyp of vocal cord,0
5160,Fenestrated Pattern,Colorectal Carcinoma,0
5161,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,0
5162,Solar Radiation Toxicity,Pleomorphic Xanthoastrocytoma,0
5163,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thyroid Gland Oncocytic Adenoma,0
5164,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myoma,0
5165,Proliferation of Follicular Dendritic Cells Present,Primary Intestinal Follicular Lymphoma,0
5166,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Fallopian Tube Cancer AJCC v8,0
5167,Radial Growth Phase,"Leukemia, Myeloid, Accelerated Phase",0
5168,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic carcinoma resectable,0
5169,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with t(5;17)(q35;q21),0
5170,Mammary Gland Type Features Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
5171,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hypopharyngeal Carcinoma by AJCC v6 Stage,0
5172,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Lip Cancer AJCC v6 and v7,0
5173,Increased megakaryocytes (bone marrow),Stage IIIA2 Fallopian Tube Cancer AJCC v8,0
5174,Multihormonal Immunoreactivity Present in a Single Cell Type,Retromolar Trigone Squamous Cell Carcinoma,0
5175,Solar Radiation Toxicity,Beckwith-Wiedemann Syndrome,0
5176,Solitary Skin Tumor,Pancoast Tumor,0
5177,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenocarcinoma of the prostate stage I,0
5178,Neoplastic Plasma Cells Present in Bone Marrow,Carcinoma in situ in a polyp,0
5179,Increased megakaryocytes (bone marrow),Advanced Unfavorable Non-Hodgkin Lymphoma,0
5180,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chest Wall Solitary Plasmacytoma,0
5181,Increased megakaryocytes (bone marrow),Stage IIIB Ovarian Cancer AJCC v8,0
5182,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ovarian Clear Cell Cystadenofibroma,0
5183,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Undifferentiated carcinoma of stomach,0
5184,Solar Radiation Toxicity,Penis carcinoma recurrent,0
5185,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Myxofibroma,0
5186,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Colon Cancer,0
5187,Immature Myeloid Cells Increased in Bone Marrow,Stage II Bone Cancer AJCC v7,0
5188,Malignant Primitive Cellular Infiltrate,Refractory Malignant Soft Tissue Neoplasm,0
5189,Recurrent Malignant Neoplasm,Malignant Sternal Neoplasm,0
5190,Spindle Cell Metaplasia of Malignant Cells Present,Type 1 Papillary Renal Cell Carcinoma,0
5191,Multihormonal Immunoreactivity Present in a Single Cell Type,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",0
5192,High Grade Lesion,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5193,Absence of Malignant Features,Benign tumor of mediastinum,0
5194,Endometrial Type Glands and Stroma Present,Intermediate Cell Type Uveal Melanoma,0
5195,Increased megakaryocytes (bone marrow),Stage I Lung Cancer AJCC v8,0
5196,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostatic Cribriform Hyperplasia,0
5197,Solar Radiation Toxicity,"Childhood Ganglioneuroblastoma, Intermixed",0
5198,Increased megakaryocytes (bone marrow),Lepidic Predominant Adenocarcinoma,0
5199,Multihormonal Immunoreactivity Present in a Single Cell Type,"Sarcoma, Small Cell",0
5200,Spindle Cell Metaplasia of Malignant Cells Present,Endometrial Small Cell Carcinoma,0
5201,Cervical lymphadenopathy,Cervical Fibroepithelial Polyp,0
5202,Absence of Malignant Features,Benign neoplasm of axilla,0
5203,Solar Radiation Toxicity,Stage II Adult Burkitt Lymphoma,0
5204,Fibrous Septa Present,Intracranial Benign Fibrous Histiocytoma,0
5205,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
5206,Solitary Skin Tumor,Skin Metatypical Carcinoma,0
5207,Increased megakaryocytes (bone marrow),Stage I Paranasal Sinus Cancer,0
5208,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Pancreatic Insulinoma,0
5209,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of placenta,0
5210,Spindle Cell Metaplasia of Malignant Cells Present,Pineal parenchymal tumor of intermediate differentiation,0
5211,Solar Radiation Toxicity,Beckwith-Wiedemann Syndrome,0
5212,Fenestrated Pattern,"Glomus tumor, malignant",0
5213,Increased megakaryocytes (bone marrow),Childhood Rhabdomyosarcoma,0
5214,Recurrent Malignant Neoplasm,Malignant Lung Hilum Neoplasm,0
5215,Increased megakaryocytes (bone marrow),Dedifferentiated chordoma,0
5216,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Metastatic malignant neoplasm to oropharynx,0
5217,Increased megakaryocytes (bone marrow),Refractory Rhabdomyosarcoma,0
5218,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",0
5219,Multihormonal Immunoreactivity Present in a Single Cell Type,acute undifferentiated leukemia in relapse,0
5220,Mammary Gland Type Features Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,0
5221,Nodular and Diffuse Pattern,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
5222,Increased megakaryocytes (bone marrow),AIDS-Related Carcinoma,0
5223,Tumor Mass,Anal Canal Neuroendocrine Tumor G1,0
5224,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Ovarian Cancer AJCC v8,0
5225,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Ependymoma of brain stem,0
5226,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Cystadenoma of pancreas,0
5227,Spindle Cell Metaplasia of Malignant Cells Present,Lymphoma of kidney,0
5228,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Unresectable Malignant Mesothelioma,0
5229,Fenestrated Pattern,Aflatoxins-Related Hepatocellular Carcinoma,0
5230,Schwannian Stroma More than 50 Percent of the Tumor Volume,Metastatic Breast Carcinoid Tumor,0
5231,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Flat adenoma,0
5232,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ovarian Clear Cell Tumor,0
5233,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIIB Gastric Cancer AJCC v8,0
5234,Fried-Egg Appearance of the Bone Marrow,Stage IV Bone Sarcoma AJCC v7,0
5235,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5236,White blood cell count increased (lab result),"Langerhans cell histiocytosis, unifocal",0
5237,Increased megakaryocytes (bone marrow),Vulvar Ectopic Fibroadenoma,0
5238,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Brain Germ Cell Tumor,0
5239,Increased megakaryocytes (bone marrow),Breast adenocarcinoma,0
5240,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",0
5241,Multihormonal Immunoreactivity Present in a Single Cell Type,Grade 2 Clear Cell Renal Cell Carcinoma,0
5242,Multihormonal Immunoreactivity Present in a Single Cell Type,Unresectable Renal Cell Carcinoma,0
5243,Solar Radiation Toxicity,Supratentorial Glioblastoma,0
5244,Squamous metaplasia of bladder,hepatoid adenocarcinoma of bladder,0
5245,Increased megakaryocytes (bone marrow),Castration-Sensitive Prostate Carcinoma,0
5246,Less than 2 Mitoses per 10HPF,Squamous intraepithelial neoplasia grade 2,0
5247,Increased megakaryocytes (bone marrow),Nephrogenic adenofibroma,0
5248,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelioid hemangioendothelioma,0
5249,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fibrillary Astrocytoma,0
5250,Fenestrated Pattern,"Fibromatosis, Abdominal",0
5251,Fenestrated Pattern,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
5252,Multihormonal Immunoreactivity Present in a Single Cell Type,Pancreatic Small Cell Neuroendocrine Carcinoma,0
5253,Prominent Elastic Tissue Cores Present,Locally Advanced Soft Tissue Sarcoma,0
5254,Recurrent Malignant Neoplasm,Apocrine Neoplasm,0
5255,Recurrent Malignant Neoplasm,Malignant Blood Vessel Neoplasm,0
5256,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Transitional cell carcinoma of ureter,0
5257,Intravascular papillary endothelial hyperplasia,Mesothelial hyperplasia,0
5258,Gastric dysplasia,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",0
5259,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Refractory Cytopenia of Childhood,0
5260,Endometrial Type Glands and Stroma Present,Ventricular and Brain Stem Ependymal Tumor,0
5261,White blood cell count increased (lab result),Non-small cell lung cancer stage IIIB,0
5262,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Testicular Seminoma, Pseudoglandular Variant",0
5263,Florid Follicular Hyperplasia,Urothelial Hyperplasia,0
5264,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of pleura,0
5265,Increased megakaryocytes (bone marrow),Familial Adenomatous Polyposis Associated Medulloblastoma,0
5266,Increased megakaryocytes (bone marrow),Chondroma,0
5267,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenosarcoma of cervix uteri,0
5268,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Endometrioid Adenocarcinoma,0
5269,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,rhabdomyosarcoma of extrahepatic bile duct,0
5270,Increased megakaryocytes (bone marrow),Ovarian Thecoma,0
5271,Recurrent Genetic Abnormalities Present,Recurrent WHO Grade II Glioma,0
5272,Diffuse Lesion,Diffuse follicle center lymphoma,0
5273,Abundance of Small Lymphocytes,Refractory Small Intestinal Carcinoma,0
5274,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Ovarian Mixed Germ Cell Tumor,0
5275,Non-Encapsulated Neoplasm,Benign Osteogenic Neoplasm,0
5276,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Carcinoma in the Lung,0
5277,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Cutaneous Melanoma AJCC v7,0
5278,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Minor Salivary Gland Undifferentiated Carcinoma,0
5279,Spindle Cell Osteo-Fibrous Component Present,DS Stage I Plasma Cell Myeloma,0
5280,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Descending Colon Neuroendocrine Tumor G1,0
5281,Neoplastic Plasma Cells Present in Bone Marrow,Bone Epithelioid Hemangioendothelioma,0
5282,Solitary Skin Tumor,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
5283,Spindle Cell Metaplasia of Malignant Cells Present,Unclassified Renal Cell Carcinoma,0
5284,Recurrent Malignant Neoplasm,Recurrent Primary Effusion Lymphoma,0
5285,Aberrant Thyroid Tissue Present,Thyroid stimulating hormone-producing pituitary tumor,0
5286,Solar Radiation Toxicity,"Cystadenoma, Mucinous",0
5287,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0
5288,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0
5289,Gastric dysplasia,Gastric Hamartoma,0
5290,Increased megakaryocytes (bone marrow),Appendix Lipoma,0
5291,Glandular cell atypia,Mantle cell lymphoma stage IV,0
5292,Immature Myeloid Cells Increased in Bone Marrow,Bladder Urothelial Carcinoma in Situ,0
5293,Melanoma Cells Present,Lung Melanoma,0
5294,Increased megakaryocytes (bone marrow),Nasal cavity carcinoma,0
5295,Solar Radiation Toxicity,Bile duct adenocarcinoma,0
5296,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Metaplastic carcinoma of breast,0
5297,Mammary Gland Type Features Present,Benign Parathyroid Gland Adenoma,0
5298,Follicular Differentiation,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
5299,Solar Radiation Toxicity,Stage II Liver Cancer,0
5300,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Testicular choriocarcinoma stage III,0
5301,Increased megakaryocytes (bone marrow),Vulvar Cancer by AJCC v6 Stage,0
5302,Solar Radiation Toxicity,Liver Leiomyoma,0
5303,Well Differentiated Neuroendocrine Lesion,Refractory Abdominal Neuroendocrine Neoplasm,0
5304,Hypertensive disease,Hodgkin's disease nodular sclerosis stage II,0
5305,Increased megakaryocytes (bone marrow),Stage IVA Rectal Cancer AJCC v8,0
5306,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Intracranial Neoplasm,0
5307,Low Grade Cartilaginous Component Present,Low Grade Malignant Neoplasm,0
5308,Intermediate Grade Neuroendocrine Lesion,Grade 3 Teratoma,0
5309,Solitary Skin Tumor,Benign Prostate Phyllodes Tumor,0
5310,Spindle Cell Metaplasia of Malignant Cells Present,Malignant germ cell neoplasm of mediastinum,0
5311,Increased megakaryocytes (bone marrow),Alveolar Soft Part Sarcoma,0
5312,Chronic Clinical Course,Chronic lymphocytic leukemia stage 4,0
5313,Lytic lesion,Squamous intraepithelial lesion,0
5314,Solar Radiation Toxicity,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,0
5315,Philadelphia chromosome negative,Philadelphia chromosome negative chronic myelogenous leukemia,0
5316,Fenestrated Pattern,Lymphangiomatosis,0
5317,Increased megakaryocytes (bone marrow),Ameloblastic fibroma,0
5318,Glandular cell atypia,Papillary transitional cell carcinoma,0
5319,Spindle Cell Metaplasia of Malignant Cells Present,Recurrent Giant Cell Glioblastoma,0
5320,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Refractory Primary Lymphoma of Bone,0
5321,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Sarcoma, Epithelioid",0
5322,Spindle Cell Osteo-Fibrous Component Present,Islet Glucagon Cell Hyperplasia,0
5323,Tumor Mass,Colorectal Neuroendocrine Tumor G2,0
5324,Solar Radiation Toxicity,Angiomyolipoma,0
5325,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the hypopharynx recurrent,0
5326,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of eyelid,0
5327,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
5328,Fenestrated Pattern,Stage IIA Vaginal Cancer AJCC v8,0
5329,Well Differentiated Lesion,Well Differentiated Malignant Neoplasm,0
5330,Spindle Cell Metaplasia of Malignant Cells Present,Ependymoma of brain,0
5331,Photosensitivity of skin,Hemangioendothelioma of skin,0
5332,Large Spaces Filled with Blood Present,Borderline Ovarian Serous Tumor with Microinvasion,0
5333,Fenestrated Pattern,Early gastric cancer,0
5334,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,0
5335,Mixture of Germ Cell Neoplastic Components Present,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7,0
5336,Questionable Invasive Lesion,Recurrent Invasive Ductal Breast Carcinoma,0
5337,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Adenosquamous Carcinoma,0
5338,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infantile hemangioma,0
5339,Spindle Cell Metaplasia of Malignant Cells Present,Fibroma of lung,0
5340,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0
5341,Fenestrated Pattern,EBV-Related Non-Hodgkin Lymphoma,0
5342,Fenestrated Pattern,Mesothelioma malignant advanced,0
5343,Increased megakaryocytes (bone marrow),Meningeal melanocytoma,0
5344,Fenestrated Pattern,Acrodermatitis,0
5345,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Tracheal Carcinoma,0
5346,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colon Serrated Adenocarcinoma,0
5347,Endometrial Type Glands and Stroma Present,Uterine Corpus High Grade Endometrial Stromal Sarcoma,0
5348,Fenestrated Pattern,Stage IIIA Ovarian Carcinoma,0
5349,Absence of Malignant Features,Melanoma of Unknown Primary,0
5350,Increased megakaryocytes (bone marrow),Stage III Superficial Spreading Melanoma AJCC v7,0
5351,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Childhood Brain Stem Glioma,0
5352,Melanoma Cells Present,Stage I Acral Lentiginous Melanoma AJCC v7,0
5353,Fenestrated Pattern,Stage III Nasopharyngeal Carcinoma AJCC v8,0
5354,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Hematopoietic Neoplasm,0
5355,Nodular and Diffuse Pattern,Stage 0 Gallbladder Cancer AJCC v6 and v7,0
5356,Recurrent Genetic Abnormalities Present,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,0
5357,Increased megakaryocytes (bone marrow),Gastric Hamartoma,0
5358,Spindle Cell Metaplasia of Malignant Cells Present,Major Salivary Gland Acinic Cell Carcinoma,0
5359,Fenestrated Pattern,Stage IIIC Adult Liver Cancer AJCC v7,0
5360,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chest Wall Lymphoma,0
5361,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
5362,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Sellar Yolk Sac Tumor,0
5363,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Familial Paraganglioma-Pheochromocytoma Syndrome,0
5364,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Anaplastic Medulloblastoma,0
5365,Increased megakaryocytes (bone marrow),Stage III Childhood Non-Hodgkin Lymphoma,0
5366,Increased megakaryocytes (bone marrow),Stage IVA Colorectal Cancer AJCC v8,0
5367,Nodular and Diffuse Pattern,MCD Diffuse Large B-Cell Lymphoma,0
5368,Increased megakaryocytes (bone marrow),Anaplastic Embryonal Rhabdomyosarcoma,0
5369,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline DDX41 Mutation,0
5370,Glandular cell atypia,Papillary transitional cell carcinoma,0
5371,Absence of Malignant Features,Malignant Placental Neoplasm,0
5372,Solar Radiation Toxicity,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8,0
5373,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIB Ovarian Cancer AJCC v6 and v7,0
5374,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Papillary transitional cell neoplasm of low malignant potential,0
5375,Solar Radiation Toxicity,Stage IV Retroperitoneal Sarcoma AJCC v8,0
5376,Mammary Gland Type Features Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
5377,Increased megakaryocytes (bone marrow),Childhood Central Nervous System Choriocarcinoma,0
5378,Exophytic Papillary Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
5379,NRBC - Nucleated red blood cell present result,Non-small cell lung cancer stage IIIB,0
5380,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Appendix Carcinoma AJCC v7,0
5381,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Locally Advanced Lung Carcinoma,0
5382,Microinvasive tumor,Ewings sarcoma-primitive neuroectodermal tumor (PNET),0
5383,Fenestrated Pattern,Thymoma malignant recurrent,0
5384,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ureter Carcinoma,0
5385,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Lip Basal Cell Carcinoma,0
5386,Low Grade Cartilaginous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
5387,Gastric dysplasia,Stage II Gastric Carcinoma,0
5388,Malignant Primitive Cellular Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma,0
5389,Increased megakaryocytes (bone marrow),Cercarial Dermatitis,0
5390,Fenestrated Pattern,Stage I Adult Non-Hodgkin Lymphoma,0
5391,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Anal Adenocarcinoma,0
5392,Immature Myeloid Cells Increased in Bone Marrow,Acute Myeloid Leukemia with t(11;17)(q13;q21),0
5393,Cervical Glandular Dysplasia,Cervical Warty Carcinoma,0
5394,Spindle Cell Metaplasia of Malignant Cells Present,Malignant teratoma of testis,0
5395,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Renal Pelvis Fibroepithelial Polyp,0
5396,Well Differentiated Neuroendocrine Lesion,Well Differentiated Leiomyosarcoma,0
5397,Non-Encapsulated Neoplasm,Old Burn Scar-Related Neoplasm,0
5398,Mammary Gland Type Features Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
5399,Blasts Expressing CD56 and Immature T-Cell Markers Present,Immature Granulocytic Sarcoma,0
5400,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,adenocarcinoma of ureter,0
5401,Intraepithelial Neoplasia,High-Grade Squamous Intraepithelial Lesions,0
5402,Monoclonal Myeloid or Lymphoid Cells Present,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
5403,Increased megakaryocytes (bone marrow),Prostate carcinoma,0
5404,Recurrent Genetic Abnormalities Present,Recurrent Endometrial Endometrioid Adenocarcinoma,0
5405,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Parotid Gland Carcinoma,0
5406,Nerve palsy,"Optic Nerve Glioma, Childhood",0
5407,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Asbestos-Related Lung Carcinoma,0
5408,Unfavorable Clinical Outcome,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5409,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Pharynx Carcinoma,0
5410,Increased megakaryocytes (bone marrow),Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,0
5411,Increased megakaryocytes (bone marrow),Prognostic Stage II Breast Cancer AJCC v8,0
5412,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,0
5413,Increased megakaryocytes (bone marrow),Stage 0 Pancreatic Cancer AJCC v8,0
5414,Solar Radiation Toxicity,Adult Hodgkin Lymphoma,0
5415,Increased megakaryocytes (bone marrow),"Serous cystadenoma, borderline malignancy",0
5416,Increased megakaryocytes (bone marrow),FIGO Stage IIIA1 Ovarian Cancer,0
5417,Unfavorable Clinical Outcome,Clinical Stage IV Retinoblastoma AJCC v8,0
5418,Recurrent disease,Fox Fordyce disease,0
5419,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,0
5420,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Diabetic Nephropathy,0
5421,Fenestrated Pattern,Osteosarcoma recurrent,0
5422,Spindle Cell Metaplasia of Malignant Cells Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,0
5423,Solar Radiation Toxicity,"Trophoblastic tumor, epithelioid",0
5424,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Nasopharyngeal Carcinoma AJCC v7,0
5425,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Condyloma acuminata of cervix,0
5426,Tumor Mass,Nonanaplastic Kidney Wilms Tumor,0
5427,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of extrahepatic bile duct,0
5428,Tumor Mass,Hindgut Carcinoid Tumor,0
5429,Solar Radiation Toxicity,Fibromyxolipoma,0
5430,Intersecting Sharply Marginated Clusters of Spindle Cells Present,eccrine adenocarcinoma of vulva,0
5431,Fenestrated Pattern,Colorectal Traditional Serrated Adenoma,0
5432,Metaplasia of Malignant Cells Present,Malignant neoplasm of abdominal part of esophagus,0
5433,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urothelial carcinoma ureter recurrent,0
5434,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Unresectable Ureter Urothelial Carcinoma,0
5435,Cutaneous plaque,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",0
5436,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Childhood Central Nervous System Neoplasm,0
5437,Fenestrated Pattern,"Testicular Yolk Sac Tumor, Myxomatous Pattern",0
5438,Spindle Cell Metaplasia of Malignant Cells Present,Ductal Breast Carcinoma with Squamous Metaplasia,0
5439,Solar Radiation Toxicity,Endometrioid adenocarcinoma recurrent,0
5440,Increased megakaryocytes (bone marrow),Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,0
5441,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Breast Carcinoma with Choriocarcinomatous Features,0
5442,Villous Projections of the Neoplastic Epithelium Present,Germinative Follicular Epithelium Neoplasm,0
5443,Aberrant Thyroid Tissue Present,Thyroid Lymphoma,0
5444,Increased megakaryocytes (bone marrow),Rectosigmoid Adenocarcinoma,0
5445,Neoplastic Plasma Cells Present in Bone Marrow,Stage IA Bone Cancer AJCC v7,0
5446,Severe dysplasia,Severe pre-eclampsia,0
5447,Malignant Primitive Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor,0
5448,Increased megakaryocytes (bone marrow),Lung Adenocarcinoma In Situ,0
5449,Spindle Cell Metaplasia of Malignant Cells Present,follicular dendritic cell sarcoma of thyroid gland,0
5450,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Central Nervous System Immature Teratoma,0
5451,Retiform Structures Comprise 90% or More of the Tumor,Retiform hemangioendothelioma,0
5452,Intersecting Sharply Marginated Clusters of Spindle Cells Present,carcinoma of eye,0
5453,Increased megakaryocytes (bone marrow),Ph-Like Acute Lymphoblastic Leukemia,0
5454,Fenestrated Pattern,Stage III Bladder Cancer AJCC v8,0
5455,Endodermal Sinus Pattern,Ethmoid Sinus Adenoid Cystic Carcinoma,0
5456,Absence of Malignant Features,Secondary malignant neoplasm of parathyroid gland,0
5457,Low Grade Neuroendocrine Lesion,Grade 2 Colon Adenocarcinoma,0
5458,Increased megakaryocytes (bone marrow),Mammosomatotroph Adenoma,0
5459,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vaginal Cancer by AJCC v7 Stage,0
5460,High Grade Non Cartilaginous Sarcomatous Stroma Present,High grade cervical glandular intraepithelial neoplasia,0
5461,Increased megakaryocytes (bone marrow),Conventional Lipoma,0
5462,Solar Radiation Toxicity,Stage IVA Vulvar Cancer AJCC v8,0
5463,Cervical lymphadenopathy,Cervical Lymphoepithelioma-Like Carcinoma,0
5464,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IS Testicular Cancer AJCC v6 and v7,0
5465,Fenestrated Pattern,B-cell small lymphocytic lymphoma stage IV,0
5466,Metaplasia of Malignant Cells Present,Malignant tumor of myocardium,0
5467,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Rectal Cancer by AJCC v7 Stage,0
5468,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Osteochondromyxoma,0
5469,Mesenchymal Metaplasia,Central Nervous System Mesenchymal Chondrosarcoma,0
5470,Fenestrated Pattern,Stage IV Eyelid Carcinoma AJCC v8,0
5471,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated carcinoma,0
5472,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0
5473,Mixture of Embryonal and Alveolar Features Present,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0
5474,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal Thymoma,0
5475,Spindle Cell Metaplasia of Malignant Cells Present,Exacerbation of acne,0
5476,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Vulvar Cancer by AJCC v7 Stage,0
5477,Solar Radiation Toxicity,Pancreatic Serous Adenoma,0
5478,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,sebaceous adenoma of salivary gland,0
5479,Aggressive Clinical Course,Refractory Aggressive Non-Hodgkin Lymphoma,0
5480,Spindle Cell Metaplasia of Malignant Cells Present,leiomyosarcoma of mediastinum,0
5481,Solar Radiation Toxicity,Stage I Thymoma AJCC v8,0
5482,Solar Radiation Toxicity,Esophageal Non-Hodgkin Lymphoma,0
5483,Increased megakaryocytes (bone marrow),Cardiac hemangioma,0
5484,Disease regression,gamma-Chain Disease,0
5485,Increased megakaryocytes (bone marrow),Stage I Eyelid Carcinoma AJCC v8,0
5486,Absence of Malignant Features,Malignant Anterior Tongue Neoplasm,0
5487,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Polycythemia Vera, Polycythemic Phase",0
5488,Solar Radiation Toxicity,Cerebral hemangioma,0
5489,Solitary Skin Tumor,Adult Kidney Wilms Tumor,0
5490,Solar Radiation Toxicity,Stage III Esophageal Cancer,0
5491,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Funisitis (disorder),0
5492,Spindle Cell Metaplasia of Malignant Cells Present,Early Invasive Cervical Squamous Cell Carcinoma,0
5493,High Grade Non Cartilaginous Sarcomatous Stroma Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",0
5494,Mixed Neoplastic Glandular and Squamous Cell Population,Vaginal Squamous Neoplasm,0
5495,Cystic Change,Laryngeal Adenoid Cystic Carcinoma,0
5496,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of anus,0
5497,Spindle Cell Metaplasia of Malignant Cells Present,Keratinizing Head and Neck Squamous Cell Carcinoma,0
5498,Increased megakaryocytes (bone marrow),Vagina Carcinoma,0
5499,Pseudo-Psammoma Body Formation,Gastric Body Carcinoma,0
5500,Increased megakaryocytes (bone marrow),Intraneural perineurioma,0
5501,Immature Granulocytes in Peripheral Blood Increased,Localized Peripheral Primitive Neuroectodermal Tumor,0
5502,Fenestrated Pattern,Childhood Brain Germinoma,0
5503,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,0
5504,Solar Radiation Toxicity,Colon Lymphangioma,0
5505,Increased megakaryocytes (bone marrow),Stage III Prostate Carcinoma,0
5506,Increased megakaryocytes (bone marrow),Desmoplastic fibroma,0
5507,Increased megakaryocytes (bone marrow),Brain Hemangioma,0
5508,Fenestrated Pattern,Intracanalicular fibroadenoma,0
5509,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemolymphangioma,0
5510,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of intestinal tract,0
5511,Solar Radiation Toxicity,Stage IV Uterine Corpus Cancer AJCC v6,0
5512,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7,0
5513,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Desmoplastic Neurotropic Melanoma,0
5514,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Proneural Glioblastoma,0
5515,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Mucinous Cystadenoma,0
5516,Fenestrated Pattern,Pruritus,0
5517,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Central Nervous System Choriocarcinoma,0
5518,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vascular neoplasm of skin,0
5519,Recurrent Malignant Neoplasm,Benign Fibroblastic Neoplasm,0
5520,Increased megakaryocytes (bone marrow),Adult T-cell lymphoma/leukemia stage I,0
5521,Spindle Cell Metaplasia of Malignant Cells Present,liposarcoma of vulva,0
5522,Increased megakaryocytes (bone marrow),Myxofibroma,0
5523,Fenestrated Pattern,Stage III Hypopharyngeal Carcinoma AJCC v7,0
5524,No Evidence of Metastatic Disease,Metastatic Fallopian Tube Carcinoma,0
5525,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Adult Cerebellar Neoplasm,0
5526,Absence of Malignant Features,lipoma of bone,0
5527,Absence of Malignant Features,Serous cystadenocarcinoma of pancreas,0
5528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Mucinous Adenocarcinoma In Situ,0
5529,Solar Radiation Toxicity,Biliary papillomatosis,0
5530,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Major Salivary Gland Cancer AJCC v8,0
5531,Solar Radiation Toxicity,Vaginal cancer recurrent,0
5532,Fenestrated Pattern,Lymphoma stage,0
5533,Fenestrated Pattern,Anaplastic Diencephalic Astrocytoma,0
5534,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
5535,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,0
5536,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Osteosarcoma localised,0
5537,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Piloleiomyoma,0
5538,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hereditary Kidney Oncocytoma,0
5539,Increased megakaryocytes (bone marrow),Refractory Burkitt Leukemia,0
5540,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ataxia Telangiectasia,0
5541,Less than 2 Mitoses per 10HPF,Angiosarcoma NCI Grade 2,0
5542,Tumor Mass,Digestive System Neuroendocrine Tumor G2,0
5543,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Neuroendocrine cell hyperplasia of infancy,0
5544,Absence of Malignant Features,Stage III Carcinoma of Stomach,0
5545,Increased megakaryocytes (bone marrow),malignant neurologic neoplasms,0
5546,Spindle Cell Metaplasia of Malignant Cells Present,Adenoid cystic carcinoma of lacrimal gland,0
5547,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hybrid nerve sheath tumor,0
5548,Increased megakaryocytes (bone marrow),Stage II Hilar Cholangiocarcinoma AJCC v8,0
5549,Lesion with Diameter of 2cm or Less,Ovarian Dermoid Cyst with Sebaceous Adenoma,0
5550,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,adenoid cystic carcinoma of floor of mouth,0
5551,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7,0
5552,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIA Colorectal Cancer AJCC v7,0
5553,Mixture of Germ Cell Neoplastic Components Present,Adult Giant Cell Glioblastoma,0
5554,Spindle Cell Osteo-Fibrous Component Present,Stage III Merkel Cell Carcinoma AJCC v7,0
5555,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pineal Region Mature Teratoma,0
5556,Less than 2 Mitoses per 10HPF,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,0
5557,Spindle Cell Metaplasia of Malignant Cells Present,Pancreatic Acinar Cell Cystadenoma,0
5558,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Ovarian Immature Teratoma,0
5559,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,0
5560,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Supratentorial Neoplasm,0
5561,Recurrent Genetic Abnormalities Present,Recurrent Digestive System Neuroendocrine Carcinoma,0
5562,Non-Encapsulated Neoplasm,Stage III Thymus Epithelial Neoplasm AJCC v8,0
5563,Villous Projections of the Neoplastic Epithelium Present,Columnar Cell Lesion of the Breast,0
5564,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Recurrent Salivary Duct Carcinoma,0
5565,Solar Radiation Toxicity,Stage IA Testicular Cancer AJCC v8,0
5566,Primary Site Unspecified,Primary Systemic Amyloidosis,0
5567,Fenestrated Pattern,Brain Glioblastoma,0
5568,Endometrial Type Glands and Stroma Present,Stage IV Cervical Cancer AJCC v6 and v7,0
5569,Recurrent Malignant Neoplasm,Benign Diencephalic Neoplasm,0
5570,Fenestrated Pattern,Epidermolysis Bullosa Acquisita,0
5571,Spindle Cell Osteo-Fibrous Component Present,Acinar Cell Carcinoma,0
5572,Fenestrated Pattern,Stage IV Uterine Corpus Adenosarcoma AJCC v8,0
5573,Small Aggregates of Tumor Cells Present,Stage IIA Lung Small Cell Carcinoma AJCC v7,0
5574,Spindle Cell Metaplasia of Malignant Cells Present,"Carcinoma, Transitional Cell",0
5575,Gastric dysplasia,Gastric Glomus Tumor,0
5576,Immature Myeloid Cells Increased in Bone Marrow,Benign Bone Schwannoma,0
5577,Solar Radiation Toxicity,Stage 0 Uterine Corpus Cancer AJCC v6,0
5578,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Squamotransitional Carcinoma,0
5579,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Fallopian Tube Carcinoma,0
5580,Fenestrated Pattern,Infectious mononucleosis-like post-transplant lymphoproliferative disorder,0
5581,Low Grade Neuroendocrine Lesion,Ovarian Low Grade Endometrioid Stromal Sarcoma,0
5582,Erythroid hyperplasia,Adenomatous hyperplasia,0
5583,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Seminal Vesicle Cystadenoma,0
5584,Fenestrated Pattern,Stage I Rectal Cancer AJCC v8,0
5585,Unfavorable Clinical Outcome,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5586,Mixed Neoplastic Glandular and Squamous Cell Population,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0
5587,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign cystic nephroma,0
5588,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Childhood Malignant Peripheral Nerve Sheath Tumor,0
5589,Spindle Cell Metaplasia of Malignant Cells Present,Adenoma of large intestine,0
5590,Melanoma Cells Present,Old Burn Scar-Related Cutaneous Melanoma,0
5591,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of pineal gland,0
5592,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign neoplasm of pyriform sinus,0
5593,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Anemia, Hemolytic, Congenital",0
5594,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Thymic Undifferentiated Carcinoma,0
5595,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nipple Duct Carcinoma,0
5596,Fenestrated Pattern,Stage I Colorectal Cancer AJCC v8,0
5597,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
5598,Absence of Malignant Features,Malignant neoplasm of appendix,0
5599,Florid Follicular Hyperplasia,Nodular Bartholin Gland Hyperplasia,0
5600,Multihormonal Immunoreactivity Present in a Single Cell Type,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
5601,Fenestrated Pattern,Stage III Rectal Cancer AJCC v6,0
5602,Photosensitivity of skin,Malignant neoplasm of skin,0
5603,Primary Site Unspecified,Primary leiomyosarcoma,0
5604,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,0
5605,Fenestrated Pattern,Pseudomyxoma Peritonei,0
5606,Intravascular papillary endothelial hyperplasia,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
5607,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral Breast Papilloma,0
5608,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Parotid Gland Mixed Tumor,0
5609,Solar Radiation Toxicity,Ovarian Lymphoma,0
5610,Large Spaces Filled with Blood Present,Adult Systemic Anaplastic Large Cell Lymphoma,0
5611,Mammary Gland Type Features Present,Thyroid Gland Cavernous Hemangioma,0
5612,Large Spaces Filled with Blood Present,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
5613,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Hilar Cholangiocarcinoma by AJCC v7 Stage,0
5614,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Acute monoblastic leukemia,0
5615,Fenestrated Pattern,Occult Lung Adenocarcinoma,0
5616,Large Spaces Filled with Blood Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
5617,Gastric dysplasia,Gastric Cardia Squamous Cell Carcinoma,0
5618,No Evidence of Metastatic Disease,Metastatic Lung Non-Small Cell Carcinoma,0
5619,Absence of Malignant Features,Recurrent Malignant Soft Tissue Neoplasm,0
5620,Solitary Skin Tumor,Recurrent Skin Carcinoma,0
5621,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
5622,Increased megakaryocytes (bone marrow),Stage IV Adult Burkitt Lymphoma,0
5623,Increased megakaryocytes (bone marrow),"Carcinoma, Basosquamous",0
5624,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,T-cell lymphoma recurrent,0
5625,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Human Papillomavirus-Related Verrucous Carcinoma,0
5626,Cervical lymphadenopathy,Cervical Angiosarcoma,0
5627,Solar Radiation Toxicity,Adult Myxopapillary Ependymoma,0
5628,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pituitary Gland Paraganglioma,0
5629,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
5630,Solar Radiation Toxicity,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,0
5631,Melanoma Cells Present,Stage IIIB Cutaneous Melanoma AJCC v7,0
5632,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Desmoplastic Medulloblastoma,0
5633,Chronic lymphocytic inflammation,B-cell small lymphocytic lymphoma stage I,0
5634,Increased megakaryocytes (bone marrow),Uterine Corpus Rhabdomyosarcoma,0
5635,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Gastric Carcinoma,0
5636,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of carotid body,0
5637,Increased megakaryocytes (bone marrow),Stage IV Childhood Hepatocellular Carcinoma AJCC v7,0
5638,Nodular and Diffuse Pattern,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0
5639,Fenestrated Pattern,Gallbladder adenosquamous carcinoma,0
5640,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,neurofibroma,0
5641,Endometrial Type Glands and Stroma Present,Recurrent Endometrial Cancer,0
5642,Recurrent Malignant Neoplasm,Recurrent Malignant Ovarian Transitional Cell Tumor,0
5643,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
5644,Fenestrated Pattern,Acute monoblastic leukemia,0
5645,Fenestrated Pattern,Pancreatic Solid Serous Adenoma,0
5646,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",0
5647,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lichen Planus,0
5648,Immature Myeloid Cells Increased in Bone Marrow,Cardiac Myeloid Sarcoma,0
5649,Systemic disease,Anal margin Paget's disease,0
5650,Schwannian Stroma More than 50 Percent of the Tumor Volume,Parotid Gland Warthin Tumor,0
5651,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Childhood Hodgkin Lymphoma,0
5652,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of bone marrow,0
5653,Fenestrated Pattern,Region 17p13 Allelic Loss Associated Medulloblastoma,0
5654,Intersecting Sharply Marginated Clusters of Spindle Cells Present,basaloid squamous cell carcinoma of floor of mouth,0
5655,Fenestrated Pattern,Stage IV Laryngeal Cancer AJCC v7,0
5656,Increased megakaryocytes (bone marrow),Stage IVA Gallbladder Cancer AJCC v8,0
5657,Spindle Cell Metaplasia of Malignant Cells Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,0
5658,Fenestrated Pattern,Rhabdoid meningioma,0
5659,White blood cell count increased (lab result),Nasopharyngeal squamous cell carcinoma stage I,0
5660,Endometrial Type Glands and Stroma Present,Liver and Intrahepatic Biliary Tract Carcinoma,0
5661,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adrenal Cortex Sex Cord-Stromal Tumor,0
5662,High Grade Lesion,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
5663,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical Ductal Breast Hyperplasia,0
5664,Increased megakaryocytes (bone marrow),Stage III Renal Pelvis Cancer AJCC v8,0
5665,Increased megakaryocytes (bone marrow),"Papilloma, Intraductal",0
5666,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sertoli-Leydig cell tumor of ovary,0
5667,Increased megakaryocytes (bone marrow),Chest Wall Lymphoma,0
5668,Solar Radiation Toxicity,Middle Ear Paraganglioma,0
5669,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Osteoblastoma,0
5670,Recurrent Malignant Neoplasm,Megakaryocytic Neoplasm,0
5671,Spindle Cell Metaplasia of Malignant Cells Present,Epithelioid Cell Melanoma,0
5672,Dilated Terminal Duct Lobular Units Present,Prostatic Duct Urothelial Carcinoma,0
5673,Neoplastic Plasma Cells Present in Bone Marrow,"Neoplastic Syndromes, Hereditary",0
5674,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Undifferentiated Pleomorphic Sarcoma,0
5675,Aggressive Clinical Course,Clinical Stage I Retinoblastoma AJCC v8,0
5676,Spindle Cell Metaplasia of Malignant Cells Present,basaloid squamous cell carcinoma of vulva,0
5677,Fenestrated Pattern,Necrotic intraocular melanoma,0
5678,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary peritoneal carcinoma,0
5679,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage III Bladder Cancer AJCC v6 and v7,0
5680,Immature Myeloid Cells Increased in Bone Marrow,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0
5681,Fenestrated Pattern,AIDS-Related Non-Hodgkin Lymphoma,0
5682,Recurrent Malignant Neoplasm,Benign Childhood Supratentorial Neoplasm,0
5683,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage I Anal Canal Cancer AJCC v6 and v7,0
5684,Fenestrated Pattern,keratoacanthoma,0
5685,Fenestrated Pattern,Hutchinson's Melanotic Freckle,0
5686,Spindle Cell Osteo-Fibrous Component Present,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,0
5687,White blood cell count increased (lab result),Transitional cell carcinoma metastatic,0
5688,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA1 Ovarian Cancer AJCC v8,0
5689,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Degenerated Schwannoma,0
5690,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Embryonal Carcinoma,0
5691,Fenestrated Pattern,Kaposi's sarcoma classical type,0
5692,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,AIDS-Related Primary Effusion Lymphoma,0
5693,Fenestrated Pattern,Pineocytoma,0
5694,Mammary Gland Type Features Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
5695,Plasma cell inflammation,"Papillary transitional cell carcinoma, non-invasive",0
5696,Spindle Cell Metaplasia of Malignant Cells Present,Locally Advanced Malignant Neoplasm,0
5697,Microinvasive tumor,Subungual glomus tumor,0
5698,Increased megakaryocytes (bone marrow),Sternal Intraosseous Schwannoma,0
5699,Solar Radiation Toxicity,Plasmacytoma anaplastic,0
5700,Fried-Egg Appearance of the Bone Marrow,Adenocarcinoma of the prostate stage II,0
5701,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Childhood Thyroid Gland Papillary Carcinoma,0
5702,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Eyelid Carcinoma AJCC v7,0
5703,Acute inflammation,Refractory Ph-Like Acute Lymphoblastic Leukemia,0
5704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Subependymal Glioma,0
5705,Solar Radiation Toxicity,"Medulloblastoma, Not Otherwise Specified",0
5706,Endometrial Type Glands and Stroma Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
5707,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of pleura,0
5708,High Grade Non Cartilaginous Sarcomatous Stroma Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
5709,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Adenocarcinoma with cartilaginous metaplasia,0
5710,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of cecum,0
5711,Atypical Lymphocytes Present in Peripheral Blood,Peripheral Odontogenic Fibroma,0
5712,Fenestrated Pattern,Benign vascular neoplasm,0
5713,Fenestrated Pattern,Infant Acute Biphenotypic Leukemia,0
5714,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cystic tumor of atrio-ventricular node,0
5715,Mammary Gland Type Features Present,Childhood Thyroid Gland Medullary Carcinoma,0
5716,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extramedullary Plasmacytoma,0
5717,Low Grade Neuroendocrine Lesion,Childhood Grade II Meningioma,0
5718,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mature B-Cell Non-Hodgkin Lymphoma,0
5719,Fenestrated Pattern,Xeroderma,0
5720,High Grade Lesion,Recurrent Grade 1 Follicular Lymphoma,0
5721,Spindle Cell Metaplasia of Malignant Cells Present,Kaposi's sarcoma of cornea,0
5722,Endometrial Type Glands and Stroma Present,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0
5723,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intracranial Melanoma,0
5724,Spindle Cell Metaplasia of Malignant Cells Present,fibrosarcoma of ovary,0
5725,Increased megakaryocytes (bone marrow),Stage IB1 Cervical Cancer,0
5726,Spindle Cell Metaplasia of Malignant Cells Present,leiomyosarcoma of liver,0
5727,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage III Carcinoma of Penis,0
5728,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of extrahepatic bile duct,0
5729,Marked Thickening of the Bladder Urothelium Present,Bladder Alveolar Soft Part Sarcoma,0
5730,Skin Red Dot,Skin carcinoma,0
5731,Questionable Invasive Lesion,Invasive Prostate Carcinoma,0
5732,Increased megakaryocytes (bone marrow),Cardiac Rhabdomyosarcoma,0
5733,Recurrent Malignant Neoplasm,Malignant Reproductive System Neoplasm,0
5734,Metaplasia of Malignant Cells Present,Malignant neoplasm of pancreas,0
5735,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Osteosarcoma AJCC v7,0
5736,Intravascular papillary endothelial hyperplasia,serous surface papillary carcinoma of ovary,0
5737,NRBC - Nucleated red blood cell present result,Anal margin basal cell carcinoma,0
5738,Proliferation of Follicular Dendritic Cells Present,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma,0
5739,Marked Thickening of the Bladder Urothelium Present,Bladder squamous cell carcinoma stage IV,0
5740,Solar Radiation Toxicity,Extranodal marginal zone B-cell lymphoma (MALT type) stage III,0
5741,Solar Radiation Toxicity,Vaginal Leiomyoma,0
5742,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenoid cystic carcinoma of the oral cavity stage IV,0
5743,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Carcinoma,0
5744,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,large cell neuroendocrine carcinoma of bladder,0
5745,Intermediate Grade Neuroendocrine Lesion,Grade III Chondrosarcoma,0
5746,Mesenchymal Metaplasia,Childhood Mesenchymal Chondrosarcoma,0
5747,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0
5748,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Infiltrating duct and lobular carcinoma,0
5749,Recurrent Malignant Neoplasm,Low Grade Malignant Neoplasm,0
5750,NRBC - Nucleated red blood cell present result,Lung squamous cell carcinoma stage IV,0
5751,Unfavorable Clinical Outcome,Clinical Stage IIB Cutaneous Melanoma AJCC v8,0
5752,Acute inflammation,Acute leukemia,0
5753,Fenestrated Pattern,Lugano Classification Stage II Adult Lymphoma AJCC v8,0
5754,Endometrial Type Glands and Stroma Present,Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5755,Increased megakaryocytes (bone marrow),Lung Adenofibroma,0
5756,Melanoma Cells Present,Nevoid Melanoma,0
5757,Solar Radiation Toxicity,Adult Lymphoma,0
5758,Immature Myeloid Cells Increased in Bone Marrow,Childhood Central Nervous System Immature Teratoma,0
5759,Solar Radiation Toxicity,Stage I Laryngeal Cancer AJCC v8,0
5760,Absence of Malignant Features,Adenoid cystic carcinoma of submandibular gland,0
5761,Mixed Neoplastic Glandular and Squamous Cell Population,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,0
5762,Mixture of Germ Cell Neoplastic Components Present,Germinomatous Germ Cell Tumor,0
5763,Metaplasia of Malignant Cells Present,Malignant neoplasm of oropharynx,0
5764,Nodular and Diffuse Pattern,Stage II Ovarian Dysgerminoma AJCC v6 and v7,0
5765,In Situ Lesion,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,0
5766,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Signet-ring cell adenocarcinoma of colon,0
5767,Fenestrated Pattern,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0
5768,Increased megakaryocytes (bone marrow),"Schneiderian papilloma, inverted",0
5769,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Advanced Cervical Carcinoma,0
5770,Increased megakaryocytes (bone marrow),Stage I Oropharyngeal Carcinoma,0
5771,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Cervical Cancer AJCC v6 and v7,0
5772,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult T-cell lymphoma/leukemia stage I,0
5773,Fenestrated Pattern,Appendix Sessile Serrated Adenoma/Polyp,0
5774,Absence of Malignant Features,mucoepidermoid carcinoma of accessory sinus,0
5775,Increased megakaryocytes (bone marrow),Dedifferentiated chordoma,0
5776,Solitary Skin Tumor,Gastric Inflammatory Myofibroblastic Tumor,0
5777,Mammary Gland Type Features Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,0
5778,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Advanced Stage Adult Lymphoma AJCC v8,0
5779,Spindle Cell Metaplasia of Malignant Cells Present,Acinic Cell Breast Carcinoma,0
5780,Fried-Egg Appearance of the Bone Marrow,Dermoid Cyst of the Spinal Cord,0
5781,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mycosis fungoides stage III,0
5782,Non-Encapsulated Neoplasm,Childhood Multilocular Cystic Renal Neoplasm,0
5783,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of nasal cavity,0
5784,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Ovarian Mucinous Tumor,0
5785,Solar Radiation Toxicity,Colorectal Angiosarcoma,0
5786,Nodular and Diffuse Pattern,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,0
5787,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,0
5788,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Resectable Liposarcoma,0
5789,Fenestrated Pattern,Adult Brain Medulloblastoma,0
5790,Increased megakaryocytes (bone marrow),Uterine Corpus Adenosarcoma by AJCC v8 Stage,0
5791,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Hereditary Female Breast Carcinoma,0
5792,Solar Radiation Toxicity,Stage I Fallopian Tube Cancer AJCC v8,0
5793,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Dermal Duct Tumor,0
5794,Solar Radiation Toxicity,Colorectal Tubulovillous Adenoma,0
5795,Increased megakaryocytes (bone marrow),Breast Extraskeletal Osteosarcoma,0
5796,Abundance of Small Lymphocytes,Small Intestinal Mucinous Adenocarcinoma,0
5797,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,0
5798,High Grade Lesion,Recurrent Grade 2 Follicular Lymphoma,0
5799,Increased megakaryocytes (bone marrow),Stage IIB Vaginal Cancer AJCC v8,0
5800,Fenestrated Pattern,Acral Fibromyxoma,0
5801,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Adenocarcinoma by AJCC v7 Stage,0
5802,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Inflammatory carcinoma of breast stage III,0
5803,Absence of Malignant Features,Nonestrogen-Dependent Malignant Neoplasm,0
5804,Increased megakaryocytes (bone marrow),Nodular Sclerosis Classical Hodgkin Lymphoma,0
5805,Squamous metaplasia of bladder,large cell neuroendocrine carcinoma of bladder,0
5806,Fenestrated Pattern,Familial Hemophagocytic Lymphocytosis,0
5807,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Hepatocellular Carcinoma AJCC v7,0
5808,Solar Radiation Toxicity,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,0
5809,Fenestrated Pattern,Stage IVB Thymoma AJCC v8,0
5810,Large Spaces Filled with Blood Present,Acute Myeloid Leukemia with t(11;17)(q23;q21),0
5811,Fenestrated Pattern,Gastric Hodgkin's Lymphoma,0
5812,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Hemangioma, Cavernous, Central Nervous System",0
5813,Mixed Neoplastic Glandular and Squamous Cell Population,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0
5814,Unfavorable Clinical Outcome,Clinical Stage IB Cutaneous Melanoma AJCC v8,0
5815,Increased megakaryocytes (bone marrow),Plexiform ameloblastoma,0
5816,Fenestrated Pattern,Meningeal melanocytoma,0
5817,Mammary Gland Type Features Present,Atypical Pituitary Gland Adenoma,0
5818,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Ureter Cancer by AJCC v7 Stage,0
5819,Schwannian Stroma More than 50 Percent of the Tumor Volume,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5820,Increased megakaryocytes (bone marrow),Stage IV Prostate Cancer AJCC v8,0
5821,Fenestrated Pattern,Esophageal Synovial Sarcoma,0
5822,Endometrial Type Glands and Stroma Present,Stage IIB Cervical Cancer AJCC v6 and v7,0
5823,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Head and Neck Carcinoma,0
5824,Windblown Appearance of Atypical Keratinocytes,Childhood Atypical Choroid Plexus Papilloma,0
5825,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Rectosigmoid Cancer by AJCC v7 Stage,0
5826,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign fibrohistiocytic neoplasm of skin,0
5827,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prostate Angiosarcoma,0
5828,Increased megakaryocytes (bone marrow),"Pregnancy, Cornual",0
5829,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Ovarian Monodermal and Highly Specialized Teratoma,0
5830,Non-Encapsulated Neoplasm,Recurrent Childhood Kidney Neoplasm,0
5831,Nodular and Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
5832,Solar Radiation Toxicity,Stage IIIC Rectal Cancer AJCC v7,0
5833,Mixed Neoplastic Glandular and Squamous Cell Population,Adult Mixed Cellularity Classical Hodgkin Lymphoma,0
5834,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,0
5835,Spindle Cell Osteo-Fibrous Component Present,Bladder Signet Ring Cell Adenocarcinoma,0
5836,Mixed Neoplastic Glandular and Squamous Cell Population,Advanced Lung Non-Small Cell Squamous Carcinoma,0
5837,Mixed Neoplastic Glandular and Squamous Cell Population,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,0
5838,Spindle Cell Metaplasia of Malignant Cells Present,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,0
5839,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mature B-Cell Non-Hodgkin Lymphoma,0
5840,Bone Marrow Involvement,Metastatic Bone Ewing Sarcoma,0
5841,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cervical Esophagus Adenocarcinoma,0
5842,Fenestrated Pattern,Ovarian Serous Adenocarcinoma,0
5843,Argentaffin Positive Neoplastic Cells Present,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
5844,Glandular cell atypia,Tubulocystic renal cell carcinoma,0
5845,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Thyroid Gland Carcinoma,0
5846,Increased megakaryocytes (bone marrow),Mycosis fungoides/Sezary syndrome NOS,0
5847,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Small cell carcinoma of lung,0
5848,Metastatic/Recurrent Disease,Graft-vs-Host Disease,0
5849,Increased megakaryocytes (bone marrow),Pituitary Gland Double Adenomas,0
5850,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
5851,Fenestrated Pattern,Stage IVC Laryngeal Cancer AJCC v8,0
5852,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Mucinous cystadenocarcinoma of ovary,0
5853,Multihormonal Immunoreactivity Present in a Single Cell Type,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,0
5854,Fenestrated Pattern,Colorectal Kaposi Sarcoma,0
5855,Abundance of Small Lymphocytes,Small Cell Undifferentiated Hepatoblastoma,0
5856,Metaplasia of Malignant Cells Present,Malignant neoplasm of muscle,0
5857,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mixed phenotype acute leukemia T/myeloid,0
5858,Immature Myeloid Cells Increased in Bone Marrow,Adult Acute Myeloid Leukemia with Maturation,0
5859,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Renal Cell Cancer AJCC v7,0
5860,Absence of Malignant Features,Benign neoplasm of sweat gland,0
5861,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Nipple Carcinoma,0
5862,Recurrent Malignant Neoplasm,Recurrent Endometrial Serous Adenocarcinoma,0
5863,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of chest wall,0
5864,Increased megakaryocytes (bone marrow),Stage I Thymoma AJCC v8,0
5865,Increased megakaryocytes (bone marrow),Endocrine Gland Neoplasms,0
5866,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ceruminous Neoplasm,0
5867,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,0
5868,Follicular Cell Differentiation,Refractory Follicular Lymphoma,0
5869,Prominent Elastic Tissue Cores Present,Recurrent Childhood Soft Tissue Sarcoma,0
5870,Increased megakaryocytes (bone marrow),Adult Fibrosarcoma,0
5871,Increased megakaryocytes (bone marrow),Intraocular Lymphoma,0
5872,Increased megakaryocytes (bone marrow),Stage IV Oropharyngeal Carcinoma,0
5873,Mammary Gland Type Features Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
5874,Fenestrated Pattern,Stage IIIB Vulvar Cancer AJCC v8,0
5875,Spindle Cell Metaplasia of Malignant Cells Present,sarcoma of esophagus,0
5876,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Transplant-Related Bladder Urothelial Carcinoma,0
5877,Mixed Cellular Population,Anal Canal Mixed Adenoneuroendocrine Carcinoma,0
5878,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Digestive System Carcinoma,0
5879,Solar Radiation Toxicity,Solar lentigo,0
5880,Increased megakaryocytes (bone marrow),Hereditary Melanoma,0
5881,Large Spaces Filled with Blood Present,Myeloid Neoplasms with Germline Predisposition,0
5882,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraneural perineurioma,0
5883,Spindle Cell Metaplasia of Malignant Cells Present,alveolar rhabdomyosarcoma of orbit,0
5884,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Medulloblastoma, Genetically Defined",0
5885,Increased megakaryocytes (bone marrow),Stage IVA Colorectal Cancer AJCC v8,0
5886,Schwannian Stroma More than 50 Percent of the Tumor Volume,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
5887,Cervical Glandular Dysplasia,Cervical Blue Nevus,0
5888,Increased megakaryocytes (bone marrow),Ovarian Cystadenocarcinoma,0
5889,Localized Hydropic Villous Change,Localized Lymphoma,0
5890,Fenestrated Pattern,Childhood Brain Stem Gliosarcoma,0
5891,Inoperable Disease,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
5892,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Yolk Sac Tumor,0
5893,Solar Radiation Toxicity,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,0
5894,Recurrent Malignant Neoplasm,AIDS-Related Malignant Anal Neoplasm,0
5895,Increased megakaryocytes (bone marrow),Papillary craniopharyngioma,0
5896,Fenestrated Pattern,Acinar Prostate Mucinous Adenocarcinoma,0
5897,Glandular cell atypia,Bladder squamous cell carcinoma recurrent,0
5898,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,0
5899,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIA Gallbladder Cancer AJCC v7,0
5900,Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells,Plasma cell myeloma recurrent,0
5901,Nodular and Diffuse Pattern,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,0
5902,Tumor Mass,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5903,Increased megakaryocytes (bone marrow),Colorectal Leiomyoma,0
5904,Fenestrated Pattern,Cholangiocarcinoma metastatic,0
5905,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Non-Hodgkin Lymphoma by Ann Arbor Stage,0
5906,Fenestrated Pattern,Thyroid carcinoma,0
5907,Multihormonal Immunoreactivity Present in a Single Cell Type,Clear Cell Intrahepatic Cholangiocarcinoma,0
5908,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,0
5909,Fenestrated Pattern,Stage IIIA2 Ovarian Cancer AJCC v8,0
5910,Absence of Malignant Features,undifferentiated carcinoma of extrahepatic bile duct,0
5911,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Extrarenal rhabdoid tumor,0
5912,Increased megakaryocytes (bone marrow),Stage I Colon Cancer AJCC v8,0
5913,Absence of Malignant Features,Malignant Ovarian Teratoma,0
5914,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Malignant Neoplasm in the Viscera,0
5915,Absence of Malignant Features,Neuroendocrine neoplasm of lung,0
5916,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 1 Ovarian Teratoma,0
5917,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Distal Bile Duct Cancer by AJCC v8 Stage,0
5918,Spindle Cell Metaplasia of Malignant Cells Present,Stage III Renal Cell Cancer AJCC v7,0
5919,Marked Thickening of the Bladder Urothelium Present,Stage II Bladder Cancer AJCC v8,0
5920,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Uterine Sarcoma AJCC v7,0
5921,Solar Radiation Toxicity,Central Nervous System Leiomyosarcoma,0
5922,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Placenta Accreta,0
5923,Fenestrated Pattern,Mesothelioma malignant recurrent,0
5924,Schwannian Stroma More than 50 Percent of the Tumor Volume,Lung Inflammatory Myofibroblastic Tumor,0
5925,Nodular and Diffuse Pattern,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,0
5926,Multihormonal Immunoreactivity Present in a Single Cell Type,Ethmoid Sinus Squamous Cell Carcinoma,0
5927,Multihormonal Immunoreactivity Present in a Single Cell Type,Cervical Squamous Cell Carcinoma,0
5928,Fenestrated Pattern,Vulvar Alveolar Soft Part Sarcoma,0
5929,Fenestrated Pattern,Refractory Hematologic Malignancy,0
5930,Solar Radiation Toxicity,Childhood Protoplasmic Astrocytoma,0
5931,Recurrent Malignant Neoplasm,Poorly Differentiated Malignant Neoplasm,0
5932,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cutaneous schistosomiasis,0
5933,Fenestrated Pattern,"Thecoma, luteinized",0
5934,Marked Thickening of the Bladder Urothelium Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
5935,Multihormonal Immunoreactivity Present in a Single Cell Type,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
5936,Solitary Skin Tumor,"Temporal Lobe, Parietal Lobe, and Lateral Ventricle Ependymal Tumor",0
5937,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bile duct cancer recurrent,0
5938,Fenestrated Pattern,"Medulloblastoma, WNT-Activated",0
5939,Neutral Epithelial Mucin Present,Stage II Thymus Epithelial Neoplasm AJCC v8,0
5940,Recurrent Genetic Abnormalities Present,Recurrent Childhood Brain Stem Astrocytoma,0
5941,Tumor Mass,Adult Ependymal Tumor,0
5942,Schwannian Stroma More than 50 Percent of the Tumor Volume,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5943,Monoclonal Myeloid or Lymphoid Cells Present,Childhood Acute Myeloid Leukemia,0
5944,Chronic Clinical Course,Chronic lymphocytic leukemia stage 0,0
5945,Solar Radiation Toxicity,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,0
5946,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated Fallopian Tube Carcinoma,0
5947,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,clear cell adenocarcinoma of urethra,0
5948,Diffuse Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma,0
5949,Solar Radiation Toxicity,Metaplastic carcinoma,0
5950,Recurrent Malignant Neoplasm,Recurrent Acute Megakaryoblastic Leukemia,0
5951,Large Spaces Filled with Blood Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
5952,Spindle Cell Metaplasia of Malignant Cells Present,Malignant fibrous histiocytoma of skin,0
5953,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lugano Classification Stage IV Adult Lymphoma AJCC v8,0
5954,Fenestrated Pattern,Stage 0is Renal Pelvis Cancer AJCC v7,0
5955,Solar Radiation Toxicity,Rectal polyp,0
5956,Large Spaces Filled with Blood Present,Stage III Diffuse Large B-Cell Lymphoma,0
5957,Solar Radiation Toxicity,Hepatoid adenocarcinoma,0
5958,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Metastatic Carcinoma in the Lung,0
5959,Plasma cell inflammation,Non-small cell lung cancer stage III,0
5960,Absence of Malignant Features,large cell neuroendocrine carcinoma of extrahepatic bile duct,0
5961,Localized Lesion,Localized Non-Resectable Adult Liver Carcinoma,0
5962,Osseous Metaplasia of Malignant Cells Present,Malignant lymphoma of testis,0
5963,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Adult Non-Hodgkin Lymphoma,0
5964,Multihormonal Immunoreactivity Present in a Single Cell Type,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",0
5965,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Burkitt Lymphoma,0
5966,Solar Radiation Toxicity,Stage III Ureter Cancer AJCC v8,0
5967,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Radiation-Related Sarcoma,0
5968,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Locally Advanced Epithelioid Hemangioendothelioma,0
5969,Recurrent Malignant Neoplasm,Recurrent Hodgkin Lymphoma,0
5970,Recurrent Malignant Neoplasm,Poorly Differentiated Malignant Neoplasm,0
5971,New bone formation (morphologic abnormality),New Onset Diabetes After Transplant,0
5972,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of esophagus,0
5973,Monoclonal Myeloid or Lymphoid Cells Present,"Acute Myeloid Leukemia, M1",0
5974,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Childhood Hodgkin Lymphoma,0
5975,Intersecting Sharply Marginated Clusters of Spindle Cells Present,basaloid squamous cell carcinoma of vulva,0
5976,Solar Radiation Toxicity,Angiofibroma,0
5977,Spindle Cell Metaplasia of Malignant Cells Present,Childhood Malignant Small Intestinal Neoplasm,0
5978,Increased megakaryocytes (bone marrow),Pleural Epithelioid Hemangioendothelioma,0
5979,Intersecting Sharply Marginated Clusters of Spindle Cells Present,squamous cell carcinoma of ureter,0
5980,Nodular and Diffuse Pattern,Keratinizing Head and Neck Squamous Cell Carcinoma,0
5981,Fenestrated Pattern,Tracheal Carcinoma,0
5982,HIF1A Overexpression Positive,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
5983,Fenestrated Pattern,Stage IV Bladder Cancer AJCC v7,0
5984,Fenestrated Pattern,Dedifferentiated Dermatofibrosarcoma Protuberans,0
5985,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile Pilocytic Astrocytoma,0
5986,Fenestrated Pattern,Thymic Carcinoma,0
5987,Human Papillomavirus Negative,AIDS-Related Human Papillomavirus Infection,0
5988,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Fibrous histiocytoma of tendon sheath,0
5989,Fenestrated Pattern,Lactating adenoma,0
5990,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sellar Embryonal Carcinoma,0
5991,Increased megakaryocytes (bone marrow),Pilomyxoid astrocytoma,0
5992,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Stage III Ampulla of Vater Cancer AJCC v8,0
5993,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0
5994,Intersecting Sharply Marginated Clusters of Spindle Cells Present,sarcoma of lung,0
5995,Increased megakaryocytes (bone marrow),Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,0
5996,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Superior Sulcus Lung Carcinoma,0
5997,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Adrenal Cortex Carcinoma AJCC v7,0
5998,Increased megakaryocytes (bone marrow),Cerebellar hemangioblastoma,0
5999,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
6000,Solar Radiation Toxicity,Pericardial Angiosarcoma,0
6001,Solitary Skin Tumor,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
6002,Increased megakaryocytes (bone marrow),Adult T-cell lymphoma/leukemia stage III,0
6003,Increased megakaryocytes (bone marrow),Stage IVB Vaginal Cancer AJCC v8,0
6004,NRBC - Nucleated red blood cell present result,Bladder transitional cell carcinoma stage I,0
6005,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
6006,Human Papillomavirus Positive,Human Papillomavirus-Related Cervical Carcinoma,0
6007,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Spindle Cell/Pleomorphic Lipoma,0
6008,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign Dermal Schwannoma,0
6009,Nodular and Diffuse Pattern,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,0
6010,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of chest wall,0
6011,Fenestrated Pattern,Stage II Rectal Cancer AJCC v7,0
6012,Squamous metaplasia of bladder,Bladder Squamous Papilloma,0
6013,Solar Radiation Toxicity,Stage IB Ovarian Cancer AJCC v8,0
6014,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7,0
6015,Marked Thickening of the Bladder Urothelium Present,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
6016,Fenestrated Pattern,"Hepatocellular carcinoma, scirrhous",0
6017,Fenestrated Pattern,Erythema toxicum neonatorum,0
6018,Intersecting Sharply Marginated Clusters of Spindle Cells Present,squamous cell carcinoma of ovary,0
6019,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Biphasic Synovial Sarcoma,0
6020,Absence of Malignant Features,leiomyosarcoma of ovary,0
6021,Local disease,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,0
6022,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,"Carcinoma, Ovarian Epithelial",0
6023,Humoral hypercalcemia of malignancy (disorder),Acute vascular insufficiency of intestine (disorder),0
6024,Spindle Cell Metaplasia of Malignant Cells Present,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
6025,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Pylorus Carcinoma,0
6026,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Transplant-Related Bladder Urothelial Carcinoma,0
6027,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
6028,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hodgkin's disease of lymph nodes of inguinal region AND/OR lower limb,0
6029,Increased megakaryocytes (bone marrow),Serous surface papillary carcinoma,0
6030,Tubular Pattern,"Testicular Yolk Sac Tumor, Hepatoid Pattern",0
6031,Spindle Cell Metaplasia of Malignant Cells Present,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6032,Diffuse Cellular Infiltrate,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
6033,Increased megakaryocytes (bone marrow),Desmoplastic Neurotropic Melanoma,0
6034,Absence of Malignant Features,Herpes zoster dermatitis of eyelid,0
6035,Glandular cell atypia,Adenosquamous cell lung cancer recurrent,0
6036,Recurrent Genetic Abnormalities Present,Recurrent Indolent Adult Non-Hodgkin Lymphoma,0
6037,Low Grade Neuroendocrine Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,0
6038,Increased megakaryocytes (bone marrow),Burkitt Lymphoma,0
6039,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of Bartholin's gland,0
6040,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Digestive System Neuroendocrine Carcinoma,0
6041,Metaplasia of Malignant Cells Present,Malignant tumor of pyriform fossa,0
6042,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Malignant Ovarian Sex Cord-Stromal Tumor,0
6043,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoid tumor of the cecum,0
6044,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,squamous cell carcinoma of middle ear,0
6045,Solitary Skin Tumor,Childhood Kidney Wilms Tumor,0
6046,Follicular Differentiation,Ann Arbor Stage III Follicular Lymphoma,0
6047,Solar Radiation Toxicity,Stage 0 Vaginal Cancer AJCC v7,0
6048,Peau d'orange surface of breast,Benign neoplasm of breast,0
6049,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prognostic Stage IB Breast Cancer AJCC v8,0
6050,Spindle Cell Metaplasia of Malignant Cells Present,Benign tumor of endocrine gland,0
6051,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
6052,Plasma cell inflammation,Adenosquamous cell lung cancer stage II,0
6053,Spindle Cell Metaplasia of Malignant Cells Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
6054,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Soft tissue perineurioma,0
6055,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lung Carcinoma Metastatic in the Central Nervous System,0
6056,Increased megakaryocytes (bone marrow),Lung Mucinous Adenocarcinoma In Situ,0
6057,Fenestrated Pattern,Stage IV Vulvar Cancer AJCC v7,0
6058,Increased megakaryocytes (bone marrow),Stage IVC Laryngeal Cancer AJCC v8,0
6059,Multihormonal Immunoreactivity Present in a Single Cell Type,Intraepithelial Squamous Cell Carcinoma,0
6060,Endometrial Type Glands and Stroma Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",0
6061,Moderately Differentiated Lesion,Differentiated Thyroid Gland Carcinoma,0
6062,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Prostate Carcinoma,0
6063,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage I Appendix Carcinoma AJCC v8,0
6064,Solar Radiation Toxicity,Childhood Fibrosarcoma,0
6065,Fenestrated Pattern,Maxillary Sinus Inverted Papilloma,0
6066,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of lacrimal gland,0
6067,Increased megakaryocytes (bone marrow),Childhood Pilomyxoid Astrocytoma,0
6068,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Ampulla of Vater Clear Cell Adenocarcinoma,0
6069,Tumor Mass,Frontal Lobe Ependymal Tumor,0
6070,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Laryngeal Carcinoma,0
6071,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Familial Neuroblastoma,0
6072,Increased megakaryocytes (bone marrow),Acrodermatitis,0
6073,Endometrial Type Glands and Stroma Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,0
6074,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mucinous cystadenoma of ovary,0
6075,Spindle Cell Metaplasia of Malignant Cells Present,Environment-Related Malignant Neoplasm,0
6076,Hyperplastic Tissue Present,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6077,Disease regression,Hodgkin Disease,0
6078,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,liposarcoma of kidney,0
6079,Lesion with Diameter of 2cm or Less,Acute Myeloid Leukemia with t(11;17)(q23;q21),0
6080,Increased megakaryocytes (bone marrow),"Medulloblastoma, Non-WNT/Non-SHH",0
6081,Solar Radiation Toxicity,T-cell lymphoma refractory,0
6082,High Grade Lesion,Recurrent Grade II Lymphomatoid Granulomatosis,0
6083,Fenestrated Pattern,Endobronchial Leiomyoma,0
6084,Increased megakaryocytes (bone marrow),Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8,0
6085,Abundance of Small Lymphocytes,Locally Advanced Small Intestinal Carcinoma,0
6086,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Myelodysplastic Syndrome with Isolated del(5q),0
6087,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Juvenile polyp,0
6088,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Thymic Carcinoma,0
6089,Absence of Malignant Features,Sarcoma of breast,0
6090,Increased megakaryocytes (bone marrow),Castration-Sensitive Prostate Carcinoma,0
6091,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary malignant neoplasm of oculomotor nerve,0
6092,Mixed Cellular Population,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,0
6093,Recurrent Malignant Neoplasm,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0
6094,Fenestrated Pattern,Liver Extraskeletal Osteosarcoma,0
6095,Nodular and Diffuse Pattern,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",0
6096,Solar Radiation Toxicity,Ovarian Cystadenocarcinoma,0
6097,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Basal cell nevus with comedones,0
6098,Lesion Less than 5mm in Diameter,Proliferative dermal lesion in congenital nevus,0
6099,Mammary Gland Type Features Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,0
6100,Recurrent Malignant Neoplasm,Childhood Testicular Neoplasm,0
6101,More Than Two Separate Tumor Masses Present in the Same Organ,Metastatic Carcinoma in the Lung,0
6102,Fenestrated Pattern,Radiation-Induced Cancer,0
6103,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Carcinoma Metastatic to the Skin,0
6104,Increased megakaryocytes (bone marrow),Lugano Classification Stage IIE Adult Lymphoma AJCC v8,0
6105,Questionable Invasive Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",0
6106,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC Cutaneous Melanoma AJCC v7,0
6107,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Seminoma, anaplastic",0
6108,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Renal Pelvis Cancer AJCC v7,0
6109,Fenestrated Pattern,Gardner Fibroma,0
6110,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Metastatic Digestive System Carcinoma,0
6111,Distortion of the Hair Follicle,Non-Neoplastic Hair Disorder,0
6112,Tumor Mass,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
6113,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVC Pharyngeal Carcinoma,0
6114,Fenestrated Pattern,Stage III Esophageal Cancer,0
6115,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,0
6116,Spindle Cell Metaplasia of Malignant Cells Present,Carcinosarcoma of ovary,0
6117,Solar Radiation Toxicity,Stage IIIC Rectal Cancer AJCC v7,0
6118,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Vulvar Superficial Angiomyxoma,0
6119,Spindle Cell Metaplasia of Malignant Cells Present,Malignant tumor of mediastinum,0
6120,Lobular Pattern,"Invasive Lobular Breast Carcinoma, Alveolar Variant",0
6121,Spindle Cell Metaplasia of Malignant Cells Present,Adenocarcinoma of anal glands,0
6122,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of sphenoidal sinus,0
6123,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hereditary Female Breast Carcinoma,0
6124,Increased megakaryocytes (bone marrow),Stage IVB Uterine Corpus Cancer AJCC v7,0
6125,Fenestrated Pattern,Appendix adenoma,0
6126,Absence of Malignant Features,Secondary malignant neoplasm of retina,0
6127,Intersecting Sharply Marginated Clusters of Spindle Cells Present,leiomyosarcoma of appendix,0
6128,Pleural effusion disorder,Infectious mononucleosis-like post-transplant lymphoproliferative disorder,0
6129,Microinvasive tumor,Ovarian mucinous tumor,0
6130,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic Serous Neoplasm,0
6131,Fenestrated Pattern,Intracortical osteosarcoma,0
6132,Lesion with Diameter of 2cm or Less,Adenocarcinoma with metaplasia,0
6133,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Paranasal Sinus Cancer AJCC v7,0
6134,Increased megakaryocytes (bone marrow),Thyroid Gland Leiomyoma,0
6135,Fenestrated Pattern,Desmoplastic infantile ganglioglioma,0
6136,Solar Radiation Toxicity,Erythematosquamous dermatosis,0
6137,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Pulmonary Artery Angiosarcoma,0
6138,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hypopharyngeal Carcinoma by AJCC v8 Stage,0
6139,NRBC - Nucleated red blood cell present result,Non-small cell lung cancer recurrent,0
6140,Increased megakaryocytes (bone marrow),Resectable Neuroblastoma,0
6141,Glandular cell atypia,Large cell lung cancer stage IV,0
6142,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillary glioneuronal tumor,0
6143,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Brain Stem Intraparenchymal Clear Cell Meningioma,0
6144,Postneoadjuvant Therapy Pathologic TNM Finding,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,0
6145,Mixed Neoplastic Glandular and Squamous Cell Population,Fallopian Tube Squamous Cell Carcinoma,0
6146,Fenestrated Pattern,FIGO Stage IIIA2 Ovarian Cancer,0
6147,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Centroblastic Lymphoma by Ann Arbor Stage,0
6148,Malignant Primitive Cellular Infiltrate,Malignant Submandibular Gland Mixed Tumor,0
6149,Nodular and Diffuse Pattern,Stage III Testicular Cancer AJCC v6 and v7,0
6150,Increased megakaryocytes (bone marrow),Unresectable Esophageal Carcinoma,0
6151,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Atrophic lichen planus,0
6152,Nodular and Diffuse Pattern,Stage I Anal Canal Cancer AJCC v6 and v7,0
6153,Fenestrated Pattern,Clitoral Carcinoma,0
6154,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of the hypopharynx stage III,0
6155,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of larynx,0
6156,Solar Radiation Toxicity,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0
6157,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,cystic mucinous tumor of pancreas with moderate dysplasia,0
6158,Endometrial Type Glands and Stroma Present,Stage IB Pancreatic Cancer AJCC v6 and v7,0
6159,Lytic lesion,Angiocentric immunoproliferative lesion grade 2,0
6160,Fenestrated Pattern,Intrathoracic Paravertebral Paraganglioma,0
6161,Solar Radiation Toxicity,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma,0
6162,Increased megakaryocytes (bone marrow),Chondrosarcoma localised,0
6163,Increased megakaryocytes (bone marrow),Lung Adenocarcinoma by AJCC v7 Stage,0
6164,Absence of Malignant Features,Benign neoplasm of glottis,0
6165,Solar Radiation Toxicity,Ann Arbor Stage IA Hodgkin Lymphoma,0
6166,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage II Hepatocellular Carcinoma AJCC v8,0
6167,Increased megakaryocytes (bone marrow),Placenta Previa,0
6168,Refractory Disease,Refractory Neutropenia,0
6169,Absence of Malignant Features,Malignant Rectal Neoplasm,0
6170,Fenestrated Pattern,Stage III Adult Lymphoblastic Lymphoma,0
6171,Fenestrated Pattern,Colon Sessile Serrated Adenoma/Polyp,0
6172,Fenestrated Pattern,Nevoid Melanoma,0
6173,Fenestrated Pattern,Endolymphatic sac tumor,0
6174,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Colorectal Sarcoma,0
6175,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,0
6176,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",0
6177,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Sclerosing rhabdomyosarcoma,0
6178,Intestinal metaplasia of gastric mucosa,Intestinal T-cell lymphoma stage II,0
6179,Absence of Malignant Features,Infection of amniotic cavity,0
6180,Absence of Malignant Features,Paget's disease of penis,0
6181,Less than 2 Mitoses per 10HPF,Grade 2 Colorectal Adenocarcinoma,0
6182,Abundance of Small Lymphocytes,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,0
6183,Solar Radiation Toxicity,Lugano Classification Stage IV Adult Lymphoma AJCC v8,0
6184,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,0
6185,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Carcinoma,0
6186,Fenestrated Pattern,Kadish Stage B Olfactory Neuroblastoma,0
6187,Fenestrated Pattern,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,0
6188,Fenestrated Pattern,Chordoid meningioma,0
6189,Increased megakaryocytes (bone marrow),Childhood Neuroblastoma,0
6190,Solitary Skin Tumor,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
6191,Bone Marrow Involvement,Stage IIB Bone Sarcoma AJCC v7,0
6192,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bizarre leiomyoma,0
6193,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chronic rejection of renal transplant,0
6194,Odontogenic Cysts,Odontogenic myxoma,0
6195,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Urethral Carcinoma,0
6196,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Scrotal Infection,0
6197,Fenestrated Pattern,Stage I Hilar Cholangiocarcinoma AJCC v7,0
6198,Increased megakaryocytes (bone marrow),Colon Serrated Polyposis,0
6199,Spindle Cell Metaplasia of Malignant Cells Present,Gingival Spindle Cell Carcinoma,0
6200,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Traditional Serrated Adenoma,0
6201,Recurrent Genetic Abnormalities Present,Recurrent Childhood Anaplastic Oligoastrocytoma,0
6202,Atypical Lymphocytes Present in Peripheral Blood,Peripheral Ganglioneuroblastoma,0
6203,Fenestrated Pattern,Stage III Pancreatic Cancer AJCC v8,0
6204,Fenestrated Pattern,Monoblastic Sarcoma,0
6205,Intersecting Sharply Marginated Clusters of Spindle Cells Present,benign granular cell tumor of gallbladder,0
6206,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Gliosarcoma,0
6207,Increased megakaryocytes (bone marrow),Secondary haemophagocytic lymphohistiocytosis,0
6208,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Mature Ganglioneuroma,0
6209,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign pheochromocytoma of adrenal gland,0
6210,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of sternum,0
6211,Absence of Malignant Features,Pseudopolyposis of colon,0
6212,Disease regression,Hallopeau-Siemens Disease,0
6213,Solar Radiation Toxicity,Childhood Extraskeletal Osteosarcoma,0
6214,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelial hyperplasia of skin,0
6215,Spindle Cell Osteo-Fibrous Component Present,"Leukemia, Plasma Cell",0
6216,Dedifferentiated Malignant Infiltrate,Recurrent Dedifferentiated Liposarcoma,0
6217,Absence of Malignant Features,benign mature teratoma of pancreas,0
6218,Malignant Primitive Cellular Infiltrate,"Teratoma, Malignant",0
6219,Solar Radiation Toxicity,Cerebral Non-Hodgkin Lymphoma,0
6220,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Plexiform Schwannoma,0
6221,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,High Grade Salivary Gland Carcinoma,0
6222,Plasma cell inflammation,Testicular germ cell tumor mixed stage II,0
6223,Absence of Malignant Features,Non-hodgkin lymphoma of colon,0
6224,Increased megakaryocytes (bone marrow),Pleural mesothelioma malignant recurrent,0
6225,Increased megakaryocytes (bone marrow),Stage IIIA Hepatocellular Carcinoma AJCC v7,0
6226,Dermal Involvement,Benign Dermal Schwannoma,0
6227,Systemic disease,Fox Fordyce disease,0
6228,Loss of INI 1 Protein Expression,ROSE Cluster 1,0
6229,Mass of pleura,Secondary malignant neoplasm of pleura,0
6230,Humoral hypercalcemia of malignancy (disorder),"Papillary mucinous cystadenoma, borderline malignancy",0
6231,Increased megakaryocytes (bone marrow),Leukemia recurrent,0
6232,Aggressive Clinical Course,Clinical Stage III Cutaneous Melanoma AJCC v8,0
6233,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Columnar Cell Hyperplasia of the Breast with Atypia,0
6234,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage I Lip Basal Cell Carcinoma,0
6235,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Breast Lymphoma,0
6236,Increased megakaryocytes (bone marrow),Childhood Paranasal Sinus Carcinoma,0
6237,Aberrant Thyroid Tissue Present,Thyroid Non-Hodgkin's Lymphoma,0
6238,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Low-grade intraurothelial neoplasia,0
6239,Lesion with Diameter of 2cm or Less,adenocarcinoma of gallbladder with squamous metaplasia,0
6240,Windblown Appearance of Atypical Keratinocytes,Familial Atypical Mole Melanoma Syndrome,0
6241,Fenestrated Pattern,Stage I Testicular Cancer AJCC v8,0
6242,Solar Radiation Toxicity,Cauda Equina Paraganglioma,0
6243,Schwannian Stroma More than 50 Percent of the Tumor Volume,Lymphoproliferative Disorder of the Skin,0
6244,Increased megakaryocytes (bone marrow),"Hemangioma, Cavernous",0
6245,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6246,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Laryngeal Carcinoma,0
6247,Spindle Cell Metaplasia of Malignant Cells Present,Transitional Cell Neoplasm,0
6248,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Stage IIIA Pleural Malignant Mesothelioma AJCC v8,0
6249,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Colorectal Adenoma with Severe Dysplasia,0
6250,Endometrial Type Glands and Stroma Present,Stage IV Fallopian Tube Cancer AJCC v6 and v7,0
6251,Nodular and Diffuse Pattern,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,0
6252,Mixed Neoplastic Glandular and Squamous Cell Population,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,0
6253,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Renal Pelvis Urothelial Carcinoma,0
6254,Spindle Cell Metaplasia of Malignant Cells Present,leiomyosarcoma of lung,0
6255,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral T-cell lymphoma unspecified refractory,0
6256,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Multiple endocrine neoplasia type 4,0
6257,Intraepithelial Neoplasia,Prostatic Intraepithelial Neoplasias,0
6258,Increased megakaryocytes (bone marrow),FIGO Stage IVA Ovarian Cancer,0
6259,Intraepithelial Neoplasia,High-Grade Prostatic Intraepithelial Neoplasia,0
6260,Fenestrated Pattern,Refractory Neutropenia,0
6261,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Leiomyosarcoma of Vessels,0
6262,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Regional Digestive System Neuroendocrine Tumor G1,0
6263,Increased megakaryocytes (bone marrow),Stage 4S neuroblastoma,0
6264,Fenestrated Pattern,AIDS-Related Carcinoma,0
6265,Small Aggregates of Tumor Cells Present,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,0
6266,Fenestrated Pattern,Ureteric polyp,0
6267,Fenestrated Pattern,Myxoinflammatory fibroblastic sarcoma,0
6268,Increased megakaryocytes (bone marrow),Stage IIIA Rectal Cancer AJCC v8,0
6269,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Urothelial Carcinoma,0
6270,Endodermal Sinus Pattern,Paranasal Sinus Lymphoma,0
6271,Histiocytoid Differentiation,Histiocytoid hemangioma,0
6272,Increased megakaryocytes (bone marrow),BCLC Stage 0 Adult Hepatocellular Carcinoma,0
6273,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Papillary Epithelial Neoplasm,0
6274,Endodermal Sinus Pattern,Sphenoid Sinus Squamous Cell Carcinoma,0
6275,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraocular retinoblastoma,0
6276,Mixture of Germ Cell Neoplastic Components Present,Refractory Langerhans Cell Histiocytosis,0
6277,Fenestrated Pattern,Colon Hyperplastic Polyp,0
6278,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign tumor of exocrine pancreas,0
6279,Plexiform Vasculature Present,Gastric Plexiform Fibromyxoma,0
6280,Malignant Primitive Cellular Infiltrate,Moderately Differentiated Malignant Neoplasm,0
6281,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",0
6282,Fenestrated Pattern,Retinal hemangioblastoma,0
6283,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Synovioma, benign",0
6284,Schwannian Stroma More than 50 Percent of the Tumor Volume,Uterine Corpus Carcinoid Tumor,0
6285,Spindle Cell Metaplasia of Malignant Cells Present,Benign neoplasm of accessory sinus,0
6286,Solar Radiation Toxicity,Pityriasis Lichenoides,0
6287,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0
6288,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cutaneous leiomyoma,0
6289,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage I Vulvar Carcinoma,0
6290,Solar Radiation Toxicity,Encephalocraniocutaneous lipomatosis,0
6291,Recurrent Genetic Abnormalities Present,Recurrent Medulloblastoma,0
6292,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Elliptocytosis, Hereditary",0
6293,Increased megakaryocytes (bone marrow),Schwannomatosis,0
6294,Primary Site Unspecified,Primary Cutaneous Follicle Center Lymphoma,0
6295,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Advanced Lung Carcinoma,0
6296,Fenestrated Pattern,Oral Cavity Carcinoma,0
6297,Atypical Lymphocytes Present in Peripheral Blood,Atypical Breast Myoepitheliosis,0
6298,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Vaginal Neoplasm,0
6299,Mesenchymal Metaplasia,Mesenchymal Glioblastoma,0
6300,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage I Colorectal Cancer AJCC v6 and v7,0
6301,Multihormonal Immunoreactivity Present in a Single Cell Type,Classic Type Trichilemmoma,0
6302,Nodular and Diffuse Pattern,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
6303,NRBC - Nucleated red blood cell present result,Ovarian germ cell choriocarcinoma stage I,0
6304,Schwannian Stroma More than 50 Percent of the Tumor Volume,Benign Soft Tissue Tumor of Uncertain Differentiation,0
6305,Absence of Malignant Features,Refractory Human Papillomavirus-Related Malignant Neoplasm,0
6306,Malignant Primitive Cellular Infiltrate,Cellular fibroma,0
6307,Solitary Skin Tumor,Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6308,Arborising Network of Cords of Basaloid Cells Present,Basaloid squamous cell carcinoma,0
6309,Exophytic Papillary Lesion,Fallopian Tube Papillary Adenocarcinoma,0
6310,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Cutaneous Meningioma,0
6311,Absence of Malignant Features,Skin tumor of neural origin,0
6312,Increased megakaryocytes (bone marrow),Vaginal Adenosquamous Carcinoma,0
6313,Spindle Cell Metaplasia of Malignant Cells Present,Intraepithelial Squamous Cell Carcinoma,0
6314,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIIC1 Uterine Corpus Cancer AJCC v7,0
6315,Glandular metaplasia,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,0
6316,No Evidence of Metastatic Disease,Metastatic Unresectable Gastric Adenocarcinoma,0
6317,Recurrent Genetic Abnormalities Present,Recurrent HIV-Associated Lymphoproliferative Disorder,0
6318,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Breast Carcinoma Metastatic in the Liver,0
6319,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation,0
6320,Peau d'orange surface of breast,Mucinous carcinoma of breast,0
6321,Spindle Cell Osteo-Fibrous Component Present,Stage II Merkel Cell Carcinoma AJCC v7,0
6322,Fenestrated Pattern,Ph-Like Acute Lymphoblastic Leukemia,0
6323,Increased megakaryocytes (bone marrow),Schneiderian carcinoma,0
6324,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Melanoma of Unknown Primary,0
6325,Mast Cells 10 Percent or More of Peripheral Blood White Cells,Peripheral neuroepithelioma of bone recurrent,0
6326,Increased megakaryocytes (bone marrow),Intraepithelial Melanocytic Hyperplasia,0
6327,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Blast Phase,0
6328,Increased megakaryocytes (bone marrow),Hormone refractory prostate cancer,0
6329,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Circumferential Endothelial Hyperplasia,0
6330,Fenestrated Pattern,"Prostate Ductal Adenocarcinoma, Solid Pattern",0
6331,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Necrotic intraocular melanoma,0
6332,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,0
6333,Metaplasia of Malignant Cells Present,Malignant neoplasm of ovary,0
6334,Fenestrated Pattern,Colon Sessile Serrated Adenoma/Polyp,0
6335,Increased megakaryocytes (bone marrow),Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,0
6336,Spindle Cell Metaplasia of Malignant Cells Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,0
6337,Solar Radiation Toxicity,Childhood Ependymoma,0
6338,Absence of Malignant Features,Kaposi's sarcoma of liver,0
6339,Solar Radiation Toxicity,Tibial adamantinoma,0
6340,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papillary craniopharyngioma,0
6341,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Diffuse malignant mesothelioma,0
6342,Dilated Terminal Duct Lobular Units Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
6343,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Epithelioid sarcoma metastatic,0
6344,Fenestrated Pattern,FIGO Stage IC3 Ovarian Cancer,0
6345,Lesion with Diameter of 2cm or Less,Familial Acute Myeloid Leukemia with Mutated Cebpa,0
6346,Absence of Malignant Features,Transplant-Related Malignant Neoplasm,0
6347,Widely Invasive Lesion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
6348,Metastatic/Recurrent Disease,Paget Disease Extramammary,0
6349,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ancell-Spiegler cylindromas,0
6350,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",0
6351,Absence of Malignant Features,Vulvar Adenocarcinoma of Mammary Gland Type,0
6352,Increased megakaryocytes (bone marrow),Stage IVA Laryngeal Cancer AJCC v7,0
6353,Cutaneous plaque,Cutaneous Melanoma by AJCC v6 Stage,0
6354,Diffuse Proliferation of Pulmonary Neuroendocrine Cells Present,Liver Neuroendocrine Neoplasm,0
6355,Solitary Skin Tumor,Benign Prostate Phyllodes Tumor,0
6356,Recurrent Malignant Neoplasm,Recurrent Central Nervous System Non-Hodgkin Lymphoma,0
6357,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,0
6358,Recurrent Malignant Neoplasm,Breast Fibroepithelial Neoplasm,0
6359,Spindle Cell Metaplasia of Malignant Cells Present,Malignant neoplasm of testis,0
6360,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
6361,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Intrahepatic Bile Duct Papillary Neoplasm,0
6362,Increased NFkappaB Pathway Activation,Recurrent Childhood Visual Pathway Astrocytoma,0
6363,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
6364,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Early gastric cancer,0
6365,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bladder Urothelial Papilloma,0
6366,Recurrent Genetic Abnormalities Present,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
6367,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Facial paralysis,0
6368,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Renal Pelvis and Ureter Carcinoma,0
6369,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Serous Adenocarcinoma,0
6370,Multihormonal Immunoreactivity Present in a Single Cell Type,Stage IIIA Lung Squamous Cell Carcinoma AJCC v7,0
6371,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Central Neurocytoma,0
6372,Fenestrated Pattern,Lymphoma stage,0
6373,Mammary Gland Type Features Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,0
6374,Fenestrated Pattern,Stage I Rectal Cancer AJCC v8,0
6375,Fenestrated Pattern,Advanced Digestive System Carcinoma,0
6376,Multihormonal Immunoreactivity Present in a Single Cell Type,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",0
6377,Aberrant Thyroid Tissue Present,Adult Soft Tissue Sarcoma,0
6378,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cytogenetically normal acute myeloid leukemia,0
6379,Small Aggregates of Tumor Cells Present,Small Intestinal Tubular Adenoma,0
6380,Increased megakaryocytes (bone marrow),Ovarian mixed epithelial carcinoma,0
6381,Increased megakaryocytes (bone marrow),Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,0
6382,Fenestrated Pattern,Stage IIIC Colorectal Cancer AJCC v7,0
6383,Intravascular Spread,Refractory Intravascular Large B-Cell Lymphoma,0
6384,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,0
6385,Metaplasia of Malignant Cells Present,Malignant neoplasm of olfactory nerve,0
6386,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Favorable Prognosis Hodgkin Lymphoma,0
6387,Absence of Malignant Features,clear cell neoplasm of ovary,0
6388,Peau d'orange surface of breast,adenosquamous carcinoma of breast,0
6389,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Marginal zone lymphoma refractory,0
6390,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pre-Eclampsia,0
6391,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Folliculitis,0
6392,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Solid Neoplasm,0
6393,Cervical lymphadenopathy,Cervical carcinoma stage II AJCC v7,0
6394,Apocrine metaplasia,Invasive Apocrine Breast Carcinoma,0
6395,Metastatic/Recurrent Disease,Graft-vs-Host Disease,0
6396,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,0
6397,Spindle Cell Metaplasia of Malignant Cells Present,Sarcoma of kidney,0
6398,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Colon Carcinoma Metastatic in the Lung,0
6399,Non-Encapsulated Neoplasm,Ovarian Neuroendocrine Neoplasm,0
6400,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIB Appendix Carcinoma AJCC v7,0
6401,Increased megakaryocytes (bone marrow),Hepatoerythropoietic Porphyria,0
6402,Fenestrated Pattern,Stage 0 Gallbladder Cancer AJCC v8,0
6403,Fenestrated Pattern,Cauda Equina Paraganglioma,0
6404,Multihormonal Immunoreactivity Present in a Single Cell Type,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
6405,Spindle Cell Metaplasia of Malignant Cells Present,Colon Small Cell Neuroendocrine Carcinoma,0
6406,Diffuse Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma,0
6407,Endometrial Type Glands and Stroma Present,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma,0
6408,Exophytic Papillary Lesion,Papillary adenocarcinoma,0
6409,Increased megakaryocytes (bone marrow),"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",0
6410,Blasts Expressing T-Lymphoid and Myeloid Markers Present,Alkylating Agent-Related Acute Myeloid Leukemia,0
6411,Multihormonal Immunoreactivity Present in a Single Cell Type,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,0
6412,Fenestrated Pattern,Stage IA Lung Adenosquamous Carcinoma AJCC v7,0
6413,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",0
6414,Increased megakaryocytes (bone marrow),Juxtaglomerular tumor,0
6415,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Superficial angiomyxoma,0
6416,Mammary Gland Type Features Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,0
6417,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Splenic Manifestation of Leukemia,0
6418,Proliferation of Follicular Dendritic Cells Present,Follicular thyroid carcinoma,0
6419,High Grade Lesion,Low Grade Broad Ligament Serous Adenocarcinoma,0
6420,Fenestrated Pattern,Lugano Classification Stage I Adult Lymphoma AJCC v8,0
6421,Solar Radiation Toxicity,"Cancer, Supratentorial",0
6422,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Childhood Epithelioid Sarcoma,0
6423,Absence of Malignant Features,Metastatic Unresectable Malignant Neoplasm,0
6424,Follicular Differentiation,Ann Arbor Stage I Grade 3 Follicular Lymphoma,0
6425,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Extrahepatic Bile Duct Fibroma,0
6426,Increased megakaryocytes (bone marrow),Primary Lung Meningioma,0
6427,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Fibrosarcoma,0
6428,Nodular and Diffuse Pattern,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
6429,Increased megakaryocytes (bone marrow),Ovarian gonadoblastoma,0
6430,Rubbery Skin Lesion,Skin disorder arising from mental factors,0
6431,Acral Lesion,Acral Fibromyxoma,0
6432,Fenestrated Pattern,Scrotal Infection,0
6433,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Fallopian Tube Adenomatoid Tumor,0
6434,Increased megakaryocytes (bone marrow),Benign Ovarian Luteinized Thecoma,0
6435,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Asian desert cutaneous leishmaniasis,0
6436,Spindle Cell Metaplasia of Malignant Cells Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",0
6437,Recurrent Malignant Neoplasm,Biochemically Recurrent Prostate Carcinoma,0
6438,Absence of Malignant Features,sarcoma of vagina,0
6439,Solar Radiation Toxicity,Vestibular Micropapillomatosis,0
6440,Cervical lymphadenopathy,Cervical intraepithelial neoplasia grade 2,0
6441,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Intracranial Neoplasms By Morphology,0
6442,Large Spaces Filled with Blood Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,0
6443,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IVA Hepatocellular Carcinoma AJCC v7,0
6444,Non-Encapsulated Neoplasm,Unresectable Solid Neoplasm,0
6445,Spindle Cell Metaplasia of Malignant Cells Present,mucoepidermoid carcinoma of floor of mouth,0
6446,Large Spaces Filled with Blood Present,Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor,0
6447,Absence of Malignant Features,large cell carcinoma of salivary gland,0
6448,Solar Radiation Toxicity,Classical Hodgkin's Lymphoma,0
6449,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,0
6450,Prominent In Situ Component Present,Cervical Adenocarcinoma In Situ,0
6451,Increased megakaryocytes (bone marrow),Temporal Lobe Anaplastic Astrocytoma,0
6452,Fenestrated Pattern,Melanoacanthoma,0
6453,Schwannian Stroma More than 50 Percent of the Tumor Volume,Recurrent Cutaneous Melanoma of the Extremity,0
6454,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Mesothelioma of Peritoneum,0
6455,Tumor Mass,Rectal Neuroendocrine Tumor,0
6456,Low Grade Neuroendocrine Lesion,Rectal Neuroendocrine Neoplasm,0
6457,Spindle Cell Metaplasia of Malignant Cells Present,tubulopapillary adenoma of gallbladder,0
6458,Solar Radiation Toxicity,Stage II Renal Pelvis Cancer AJCC v7,0
6459,Absence of Malignant Features,Malignant neoplasm of adrenal cortex,0
6460,Malignant Primitive Cellular Infiltrate,Grade 4 Malignant Neoplasm,0
6461,Mixed Neoplastic Glandular and Squamous Cell Population,"Squamous cell carcinoma, large cell, nonkeratinizing",0
6462,Fenestrated Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",0
6463,Increased megakaryocytes (bone marrow),Meningeal Gliomatosis,0
6464,Fenestrated Pattern,Atrophic lichen planus,0
6465,Fenestrated Pattern,Liposarcoma metastatic,0
6466,Basal Cells with Pale Cytoplasm Present,Basal Cell Ameloblastoma,0
6467,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVB Rectal Cancer AJCC v8,0
6468,Blasts Expressing CD56 and Immature T-Cell Markers Present,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0
6469,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of anus,0
6470,Malignant Primitive Cellular Infiltrate,Unresectable Malignant Neoplasm,0
6471,Neoplastic Cells with TFH Cell Phenotype Present,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,0
6472,Spindle Cell Metaplasia of Malignant Cells Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
6473,Absence of Malignant Features,Choriocarcinoma of ovary,0
6474,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Intraductal Breast Papillomatosis,0
6475,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Parathyroid chief-cell hyperplasia,0
6476,Mammary Gland Type Features Present,Minor Salivary Gland Carcinoma,0
6477,Increased megakaryocytes (bone marrow),HIV Encephalopathy,0
6478,High Grade Non Cartilaginous Sarcomatous Stroma Present,Grade 2 Colon Adenocarcinoma,0
6479,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,leiomyosarcoma of ovary,0
6480,Solar Radiation Toxicity,CIC-DUX Sarcoma,0
6481,Fenestrated Pattern,Stage IV Laryngeal Cancer AJCC v6,0
6482,Solitary Skin Tumor,Anal Canal Neuroendocrine Tumor G2,0
6483,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Mycosis Fungoides by AJCC v7 Stage,0
6484,Fenestrated Pattern,Cardiac rhabdomyoma,0
6485,Epithelial hyperplasia of skin,Mucoepidermoid carcinoma of skin,0
6486,Solar Radiation Toxicity,Centroblastic lymphoma stage I,0
6487,Mammary Gland Type Features Present,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,0
6488,Fenestrated Pattern,Stage 2B Neuroblastoma,0
6489,Increased megakaryocytes (bone marrow),Cholangiocarcinoma resectable,0
6490,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Transplant-Related Hematologic Malignancy,0
6491,Solar Radiation Toxicity,Colorectal Cowden-Associated Polyp,0
6492,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Locally Advanced Urothelial Carcinoma,0
6493,Fenestrated Pattern,melanoma,0
6494,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Radial scar,0
6495,Increased megakaryocytes (bone marrow),Maxillary Sinus Inverted Papilloma,0
6496,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Borderline Resectable Carcinoma,0
6497,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Non-Destructive Post-Transplant Lymphoproliferative Disorder,0
6498,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Primary Systemic Amyloidosis,0
6499,Stable Disease,Letterer-Siwe Disease,0
6500,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Carcinoma of Male Breast,0
6501,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Ureter Carcinoma,0
6502,Locally Aggressive Lesion,Locally Advanced Carcinoma,0
6503,Increased megakaryocytes (bone marrow),T-cell lymphoma recurrent,0
6504,Extensive Secretory Changes Present,Secretory meningioma,0
6505,Monoclonal Myeloid or Lymphoid Cells Present,Lymphoid leukemia,0
6506,Solar Radiation Toxicity,Ovarian Rhabdomyosarcoma,0
6507,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Primary Vitreoretinal Lymphoma,0
6508,Systemic disease,Hodgkin's disease nodular sclerosis stage I,0
6509,Endometrial Type Glands and Stroma Present,Stage II Testicular Seminoma AJCC v6 and v7,0
6510,Nodular and Diffuse Pattern,Stage II Anal Canal Cancer AJCC v6 and v7,0
6511,Spindle Cell Metaplasia of Malignant Cells Present,Lower Gingival Squamous Cell Carcinoma,0
6512,Low Grade Neuroendocrine Lesion,High Grade Fallopian Tube Serous Adenocarcinoma,0
6513,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Lung Adenocarcinoma AJCC v7,0
6514,Increased megakaryocytes (bone marrow),Pericardial mesothelioma malignant advanced,0
6515,Increased megakaryocytes (bone marrow),Refractory Liver Carcinoma,0
6516,IDH Gene Family Mutation Status Unknown,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
6517,Fenestrated Pattern,Hepatitis Virus-Related Hepatocellular Carcinoma,0
6518,Absence of Malignant Features,Benign neoplasm of esophagus,0
6519,Increased megakaryocytes (bone marrow),Stage IVB Uterine Corpus Cancer AJCC v8,0
6520,Endometrial Type Glands and Stroma Present,Infiltrating duct and lobular carcinoma,0
6521,Photosensitivity of skin,Neoplasm of skin with adnexal differentiation,0
6522,Abundance of Small Lymphocytes,Metastatic Prostate Small Cell Carcinoma,0
6523,Cervical Glandular Dysplasia,Stage IV Cervical Cancer AJCC v8,0
6524,Spindle Cell Metaplasia of Malignant Cells Present,Refractory Langerhans Cell Histiocytosis,0
6525,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Bartholin Gland Adenomyoma,0
6526,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Undifferentiated Carcinoma of Unknown Primary,0
6527,Rubbery Skin Lesion,"Skin Diseases, Vascular",0
6528,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Paget Disease of the Breast without Invasive Carcinoma,0
6529,Spindle Cell Metaplasia of Malignant Cells Present,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
6530,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adenomatous Polyps,0
6531,Increased megakaryocytes (bone marrow),"Amyloidosis, Familial",0
6532,Osseous Metaplasia of Malignant Cells Present,Malignant neoplasm of labium majus,0
6533,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Aggressive osteoblastoma,0
6534,Solar Radiation Toxicity,Cementoma,0
6535,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0
6536,Increased megakaryocytes (bone marrow),Stage III Colorectal Cancer,0
6537,Absence of Malignant Features,choriocarcinoma of mediastinum,0
6538,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Resectable Carcinoma,0
6539,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0
6540,Low Grade Neuroendocrine Lesion,Low Grade Broad Ligament Serous Adenocarcinoma,0
6541,Spindle Cell Metaplasia of Malignant Cells Present,Malignant Childhood Neoplasm,0
6542,Solar Radiation Toxicity,"Somatostatinoma, malignant",0
6543,Solar Radiation Toxicity,Nasal Polyps,0
6544,Lipomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0
6545,Fenestrated Pattern,Stage III Osteosarcoma AJCC v7,0
6546,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Gestational Trophoblastic Neoplasm AJCC v8,0
6547,Fenestrated Pattern,Barrett's Adenocarcinoma,0
6548,Intersecting Sharply Marginated Clusters of Spindle Cells Present,squamous cell carcinoma of ureter,0
6549,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Hepatocellular Carcinoma AJCC v8,0
6550,Fenestrated Pattern,Nasopharyngeal Paraganglioma,0
6551,Increased megakaryocytes (bone marrow),Placental Non-Neoplastic Disorder,0
6552,Increased megakaryocytes (bone marrow),Thymoliposarcoma,0
6553,Increased megakaryocytes (bone marrow),Fanconi Anemia,0
6554,Spindle Cell Osteo-Fibrous Component Present,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,0
6555,Large Spaces Filled with Blood Present,Colorectal Large Cell Neuroendocrine Carcinoma,0
6556,Increased megakaryocytes (bone marrow),Radiation-Induced Intracranial Meningioma,0
6557,Aberrant Thyroid Tissue Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,0
6558,Plasma cell inflammation,Non-small cell lung cancer stage I,0
6559,Increased megakaryocytes (bone marrow),Suprasellar Germinoma,0
6560,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IV Uterine Corpus Cancer AJCC v6,0
6561,Spindle Cell Metaplasia of Malignant Cells Present,Skin Signet Ring Cell Basal Cell Carcinoma,0
6562,Increased megakaryocytes (bone marrow),Angiosarcoma non-metastatic,0
6563,Mature Neutrophils Present,Childhood Mature Teratoma,0
6564,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Infiltrating Urothelial Carcinoma,0
6565,Mixed Neoplastic Glandular and Squamous Cell Population,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
6566,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Adenocarcinoma of rete ovarii,0
6567,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7,0
6568,Increased megakaryocytes (bone marrow),Pituitary Gland Paraganglioma,0
6569,Superficial Monoclonal Gastrointestinal Tract T-Cell Infiltrate Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma,0
6570,Cavernous Lymphatic Space Formation,Cavernous Angioleiomyoma,0
6571,Low Grade Neuroendocrine Lesion,Grade 3 Endometrial Mucinous Adenocarcinoma,0
6572,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Sarcoma of orbit,0
6573,Mixed Neoplastic Glandular and Squamous Cell Population,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
6574,Blasts Expressing CD56 and Immature T-Cell Markers Present,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0
6575,Lesion with Diameter of 4mm or More,cystic mucinous tumor of pancreas with moderate dysplasia,0
6576,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hemangioma of breast,0
6577,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Ductal Breast Carcinoma,0
6578,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Undifferentiated Carcinoma of Unknown Primary,0
6579,Solar Radiation Toxicity,Acne Keloid,0
6580,Fenestrated Pattern,Gallbladder adenoma,0
6581,Vacuolated Plasma Cells in the Bone Marrow,Colon Carcinoma Metastatic in the Lung,0
6582,Increased megakaryocytes (bone marrow),Laryngeal verrucous carcinoma,0
6583,Increased megakaryocytes (bone marrow),Vaginal cancer recurrent,0
6584,Fenestrated Pattern,Stage IIB Lung Cancer AJCC v8,0
6585,Immature Myeloid Cells Increased in Bone Marrow,Metastatic Bone Ewing Sarcoma,0
6586,Absence of Malignant Features,neuroblastoma of spinal cord,0
6587,Postneoadjuvant Therapy Pathologic TNM Finding,Retinoblastoma by AJCC v8 Pathologic Stage,0
6588,Increased megakaryocytes (bone marrow),"Phyllodes tumor, benign",0
6589,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Prolactinoma,0
6590,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,0
6591,Endometrial Type Glands and Stroma Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
6592,Increased megakaryocytes (bone marrow),Colorectal Lymphoma,0
6593,Small Aggregates of Tumor Cells Present,Small cell carcinoma of prostate,0
6594,Canalicular Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",0
6595,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Neuroendocrine carcinoma of appendix,0
6596,Melanoma Cells Present,Stage III Acral Lentiginous Melanoma AJCC v7,0
6597,Spindle Cell Metaplasia of Malignant Cells Present,Minor Salivary Gland Acinic Cell Carcinoma,0
6598,Skin Erosion,Skin Squamous Cell Carcinoma In Situ,0
6599,Increased megakaryocytes (bone marrow),Angiomatous Meningioma,0
6600,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Secondary malignant neoplasm of heart,0
6601,Increased megakaryocytes (bone marrow),Esophageal Adenocarcinoma by AJCC v7 Stage,0
6602,Gastric dysplasia,Pathologic Stage I Gastric Cancer AJCC v8,0
6603,Cystic Change,Hard Palate Adenoid Cystic Carcinoma,0
6604,Mixed Neoplastic Glandular and Squamous Cell Population,Stage II Ovarian Germ Cell Tumor AJCC v6 and v7,0
6605,Mixture of Germ Cell Neoplastic Components Present,Childhood Germ Cell Tumor,0
6606,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage II Superficial Spreading Melanoma AJCC v6 and v7,0
6607,Fenestrated Pattern,Stage IA Retroperitoneal Sarcoma AJCC v8,0
6608,Fenestrated Pattern,"Adenocarcinoma, Scirrhous",0
6609,Spindle Cell Metaplasia of Malignant Cells Present,Leiomyosarcoma of small intestine,0
6610,Cytoplasmic Eosinophilic Globules Present,Childhood Acute Eosinophilic Leukemia,0
6611,Spindle Cell Metaplasia of Malignant Cells Present,adenoid cystic carcinoma of pharynx,0
6612,Glandular cell atypia,Bladder squamous cell carcinoma stage III,0
6613,Increased megakaryocytes (bone marrow),Infantile hemangioma,0
6614,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Paranasal Sinus Cancer AJCC v7,0
6615,Solar Radiation Toxicity,Sellar Neurocytoma,0
6616,Diffuse Lesion,Diffuse Lipomatosis,0
6617,Mixed Neoplastic Glandular and Squamous Cell Population,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,0
6618,Increased megakaryocytes (bone marrow),Periductal Breast Myoepitheliosis,0
6619,Absence of Malignant Features,Malignant neoplasm of choroid,0
6620,Marked Thickening of the Bladder Urothelium Present,Bladder Papillary Urothelial Neoplasm,0
6621,Intersecting Sharply Marginated Clusters of Spindle Cells Present,C-cell hyperplasia of thyroid,0
6622,Schwannian Stroma More than 50 Percent of the Tumor Volume,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
6623,Spindle Cell Metaplasia of Malignant Cells Present,polyembryoma of ovary,0
6624,Non-Encapsulated Neoplasm,Benign Adult Cerebral Neoplasm,0
6625,Recurrent Malignant Neoplasm,Malignant Lipomatous Neoplasm,0
6626,Recurrent Malignant Neoplasm,Refractory Malignant Pharyngeal Neoplasm,0
6627,Intravascular papillary endothelial hyperplasia,Invasive papillary breast carcinoma,0
6628,Malignant Primitive Cellular Infiltrate,Malignant nipple neoplasm,0
6629,Fenestrated Pattern,Early Favorable Non-Hodgkin Lymphoma,0
6630,Spindle Cell Metaplasia of Malignant Cells Present,Coloboma of eyelid,0
6631,Increased megakaryocytes (bone marrow),"Phyllodes tumor, benign",0
6632,Mammary Gland Type Features Present,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0
6633,Mixed Neoplastic Glandular and Squamous Cell Population,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,0
6634,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Alkylating Agent-Related Acute Myeloid Leukemia,0
6635,Solar Radiation Toxicity,"FANCONI ANEMIA, COMPLEMENTATION GROUP F",0
6636,Multihormonal Immunoreactivity Present in a Single Cell Type,Ciliary Body Epithelioid Cell Melanoma,0
6637,Increased megakaryocytes (bone marrow),Stage IV Uterine Sarcoma AJCC v7,0
6638,Moderately Differentiated Lesion,Well Differentiated Hepatocellular Carcinoma,0
6639,Spindle Cell Metaplasia of Malignant Cells Present,"Papilloma, Squamous Cell",0
6640,Immature Granulocytes in Peripheral Blood Increased,Immature Granulocytic Sarcoma,0
6641,Absence of Malignant Features,Condyloma acuminata of vulva,0
6642,Fenestrated Pattern,AIDS-Related Gastric Kaposi Sarcoma,0
6643,Epithelial hyperplasia of skin,Basal cell hyperplasia,0
6644,Recurrent Malignant Neoplasm,Recurrent Carcinoma,0
6645,Fenestrated Pattern,Stage IB Eyelid Carcinoma AJCC v8,0
6646,Absence of Malignant Features,Benign neoplasm of thyroid gland,0
6647,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,0
6648,Acute inflammation,"Acute myeloid leukemia, t(16;16)(p13;q22)",0
6649,Basal Cells with Pale Cytoplasm Present,"Basal cell carcinoma, micronodular",0
6650,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Prostate Undifferentiated Carcinoma,0
6651,Increased megakaryocytes (bone marrow),Adrenal Cancer,0
6652,Fenestrated Pattern,Acoustic Neuroma,0
6653,Spindle Cell Metaplasia of Malignant Cells Present,Clear Cell Hepatocellular Carcinoma,0
6654,Increased megakaryocytes (bone marrow),Childhood Laryngeal Carcinoma,0
6655,Absence of Malignant Features,Cancer of lymph node,0
6656,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Choroid Necrotic Melanoma,0
6657,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Squamous cell carcinoma of lung,0
6658,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IIB Esophageal Carcinoma,0
6659,Malignant Primitive Cellular Infiltrate,Malignant Blood Vessel Neoplasm,0
6660,Fenestrated Pattern,Multiple Intraspinal Meningiomas,0
6661,Prominent Elastic Tissue Cores Present,Metastatic Soft Tissue Sarcoma,0
6662,Primary Site Unspecified,Primary Prostate Urothelial Carcinoma,0
6663,Mixed Neoplastic Glandular and Squamous Cell Population,Esophageal Well Differentiated Squamous Cell Carcinoma,0
6664,Absence of Malignant Features,Dysplasia of anus,0
6665,Increased megakaryocytes (bone marrow),Breast Epithelioid Hemangioma,0
6666,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Precancerous Dermatitis,0
6667,Increased megakaryocytes (bone marrow),Central Nervous System Leiomyosarcoma,0
6668,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Papilloma of buccal mucosa,0
6669,Small Lesion,Small cell glioblastoma,0
6670,Plasma cell inflammation,Disseminated squamous cell carcinoma,0
6671,Intraepithelial Neoplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6672,Increased megakaryocytes (bone marrow),Colorectal Undifferentiated Carcinoma,0
6673,Glandular cell atypia,Oropharyngeal squamous cell carcinoma stage II,0
6674,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Recurrent Urinary System Carcinoma,0
6675,Recurrent Malignant Neoplasm,Recurrent B-Cell Prolymphocytic Leukemia,0
6676,Low Grade Cartilaginous Component Present,Low Grade Penile Intraepithelial Neoplasia,0
6677,Immature Myeloid Cells Increased in Bone Marrow,"Diffuse midline glioma, point mutation K27M in histone H3",0
6678,Schwannian Stroma More than 50 Percent of the Tumor Volume,Colloid Carcinoma of the Pancreas,0
6679,Fenestrated Pattern,Hemolymphangioma,0
6680,Increased megakaryocytes (bone marrow),Multiple endocrine neoplasia type 4,0
6681,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Micronodular thymoma with lymphoid stroma,0
6682,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
6683,Intersecting Sharply Marginated Clusters of Spindle Cells Present,cystadenoma of salivary gland,0
6684,Endometrial Type Glands and Stroma Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,0
6685,Increased megakaryocytes (bone marrow),B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,0
6686,Neoplastic Plasma Cells Present in Bone Marrow,Benign Bone Schwannoma,0
6687,Absence of Malignant Features,undifferentiated carcinoma of anal canal,0
6688,Increased megakaryocytes (bone marrow),Adult Immunoblastic Lymphoma,0
6689,Solitary Skin Tumor,Adult Ependymal Tumor,0
6690,Low Grade Neuroendocrine Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",0
6691,Increased megakaryocytes (bone marrow),Juvenile rheumatoid arthritis,0
6692,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,0
6693,Hyperplastic Tissue Present,Primary Childhood Soft Tissue Sarcoma,0
6694,Recurrent Genetic Abnormalities Present,Recurrent Aggressive Non-Hodgkin Lymphoma,0
6695,Photosensitivity of skin,Lymphangioma of skin,0
6696,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Vaginal Cancer by AJCC v7 Stage,0
6697,Recurrent Malignant Neoplasm,Recurrent Renal Pelvis Urothelial Carcinoma,0
6698,Increased megakaryocytes (bone marrow),Acute bilineal leukemia,0
6699,Cutaneous plaque,Stage I Cutaneous Melanoma AJCC v7,0
6700,Fenestrated Pattern,"Vaginal Deep ""Aggressive"" Angiomyxoma",0
6701,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Chronic leukemia (category),0
6702,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Erythematosquamous dermatosis,0
6703,Vacuolated Plasma Cells in the Bone Marrow,Metastatic Malignant Neoplasm in the Adult Brain,0
6704,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Carcinoid tumor of appendix,0
6705,High Grade Non Cartilaginous Sarcomatous Stroma Present,Low Grade Lung Neuroendocrine Neoplasm,0
6706,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of respiratory tract,0
6707,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Pancreatic sarcoma,0
6708,Recurrent Genetic Abnormalities Present,Recurrent Ovarian Mucinous Adenocarcinoma,0
6709,Hyperplastic Tissue Present,Primary Childhood Soft Tissue Sarcoma,0
6710,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Thrombocythemia, Essential",0
6711,Increased megakaryocytes (bone marrow),Lymphoplasmacytoid lymphoma/immunocytoma refractory,0
6712,Solar Radiation Toxicity,"Phyllodes tumor, borderline",0
6713,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Stage IV Oral Cavity Cancer AJCC v6 and v7,0
6714,Spindle Cell Metaplasia of Malignant Cells Present,Alcohol-Related Esophageal Squamous Cell Carcinoma,0
6715,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,0
6716,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lichen Sclerosus et Atrophicus,0
6717,Favorable Clinical Outcome,Adult Favorable Prognosis Hodgkin Lymphoma,0
6718,Recurrent Genetic Abnormalities Present,Recurrent Plasmablastic Lymphoma,0
6719,Photosensitivity of skin,Melanocytic tumor of skin,0
6720,Spindle Cell Osteo-Fibrous Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,0
6721,Absence of Malignant Features,Benign neoplasm of spleen,0
6722,Spindle Cell Metaplasia of Malignant Cells Present,Polyp of middle ear,0
6723,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Vulvar Congenital Melanocytic Nevus,0
6724,Slit-Like Vascular Channel Formation,Malignant Vascular Neoplasm,0
6725,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Sertoli Cell Tumor,0
6726,Intersecting Sharply Marginated Clusters of Spindle Cells Present,mucinous adenocarcinoma of bladder,0
6727,Absence of Malignant Features,Malignant neoplasm of nasopharynx,0
6728,Solar Radiation Toxicity,"Medulloblastoma, Genetically Defined",0
6729,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
6730,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Major Salivary Gland Cancer by AJCC v7 Stage,0
6731,Increased megakaryocytes (bone marrow),Placenta Previa,0
6732,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Pancoast Tumor,0
6733,Large Spaces Filled with Blood Present,Colorectal Diffuse Large B-Cell Lymphoma,0
6734,Intersecting Sharply Marginated Clusters of Spindle Cells Present,liposarcoma of mediastinum,0
6735,Fenestrated Pattern,Colon Sessile Serrated Adenoma/Polyp,0
6736,Fenestrated Pattern,Kasabach-Merritt syndrome,0
6737,Fenestrated Pattern,Thyroid Lymphoma,0
6738,Recurrent Genetic Abnormalities Present,Recurrent Childhood Cerebral Astrocytoma,0
6739,Solar Radiation Toxicity,Pineal Region Choriocarcinoma,0
6740,Fenestrated Pattern,Sinus histiocytosis,0
6741,Endometrial Type Glands and Stroma Present,Classic Type Trichilemmoma,0
6742,Multihormonal Immunoreactivity Present in a Single Cell Type,Vaginal Small Cell Carcinoma,0
6743,Prominent In Situ Component Present,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,0
6744,Solar Radiation Toxicity,Stage IV Anal Cancer AJCC v8,0
6745,Defective Alpha Heavy Chain Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6746,Glandular cell atypia,Large cell lung cancer stage II,0
6747,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Uveal Melanoma by Gene Expression Profile,0
6748,Solar Radiation Toxicity,Burkitt-like lymphoma,0
6749,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Spindle cell nevus of Reed,0
6750,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Prostate Cancer by Whitmore-Jewett Stage,0
6751,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage IVA Prostate Cancer AJCC v8,0
6752,Fenestrated Pattern,Colon Hodgkin Lymphoma,0
6753,Absence of Malignant Features,Malignant neoplasm of ovary,0
6754,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Laryngeal Adenosquamous Carcinoma,0
6755,Fenestrated Pattern,Thymus Lipofibroadenoma,0
6756,Intermediate Grade Neuroendocrine Lesion,Grade III Childhood Astrocytoma,0
6757,Fenestrated Pattern,Pulmonary Vein Leiomyosarcoma,0
6758,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Transformed B-cell Non-Hodgkin Lymphoma,0
6759,Spindle Cell Metaplasia of Malignant Cells Present,Secondary malignant neoplasm of pituitary gland,0
6760,Solar Radiation Toxicity,Extracutaneous Mastocytoma,0
6761,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Neoplasm,0
6762,Absence of Malignant Features,Malignant Smooth Muscle Neoplasm,0
6763,Solar Radiation Toxicity,Esophageal Synovial Sarcoma,0
6764,Fenestrated Pattern,Childhood Craniopharyngioma,0
6765,Mammary Gland Type Features Present,Adult Type Ovarian Granulosa Cell Tumor,0
6766,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Squamous cell carcinoma of the nasal cavity,0
6767,Low Grade Cartilaginous Component Present,Low Grade Corneal Intraepithelial Neoplasia,0
6768,Nodular and Diffuse Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
6769,Increased megakaryocytes (bone marrow),Stage IIB Appendix Carcinoma AJCC v7,0
6770,Fenestrated Pattern,Deep seated dermatophytosis,0
6771,Spindle Cell Metaplasia of Malignant Cells Present,Parathyroid Clear Cell Hyperplasia,0
6772,Aberrant Thyroid Tissue Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,0
6773,Increased megakaryocytes (bone marrow),Adult Craniopharyngioma,0
6774,Villous Projections of the Neoplastic Epithelium Present,Paget's Disease of the Nipple,0
6775,Diffuse Cellular Infiltrate,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
6776,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Fallopian Tube Papillary Adenocarcinoma,0
6777,Glandular cell atypia,Hairy cell leukemia variant,0
6778,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,basaloid squamous cell carcinoma of vulva,0
6779,Small Lesion,Small plaque parapsoriasis,0
6780,Solar Radiation Toxicity,Uterine Ligament Adenocarcinoma,0
6781,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0
6782,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Indolent Systemic Mastocytosis,0
6783,Solar Radiation Toxicity,Stage IA Uterine Corpus Cancer AJCC v7,0
6784,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
6785,Fenestrated Pattern,Familial Adrenal Gland Pheochromocytoma,0
6786,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Adult Classical Hodgkin Lymphoma,0
6787,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Myxoid Liposarcoma,0
6788,Malignant Primitive Cellular Infiltrate,Secondary Malignant Neoplasm,0
6789,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Atypical Breast Myoepitheliosis,0
6790,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Ovarian Cystadenocarcinoma,0
6791,Fenestrated Pattern,Stage IIIA Hepatocellular Carcinoma AJCC v8,0
6792,Low Grade Neuroendocrine Lesion,Low Grade Liver Dysplastic Nodule,0
6793,Blasts Expressing CD56 and Immature T-Cell Markers Present,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0
6794,Mixed Neoplastic Glandular and Squamous Cell Population,Cutaneous Squamous Cell Carcinoma of the Head and Neck,0
6795,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
6796,Marked Thickening of the Bladder Urothelium Present,Bladder Urachal Adenocarcinoma,0
6797,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Secondary malignant neoplasm of colon,0
6798,Increased megakaryocytes (bone marrow),"Carcinoma, Papillary",0
6799,Schwannian Stroma More than 50 Percent of the Tumor Volume,Fibroid Tumor,0
6800,Retiform Structures Comprise More than 10% and Less than 90% of the Tumor,Cerebellar and Brain Stem Ependymal Tumor,0
6801,Solar Radiation Toxicity,Ann Arbor Stage IIIB Hodgkin Lymphoma,0
6802,Gastrointestinal Type Epithelium Present,Gastrointestinal tract adenoma,0
6803,Large Spaces Filled with Blood Present,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",0
6804,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Benign tumor of nasopharynx,0
6805,Recurrent Malignant Neoplasm,"Recurrent NK-Cell Lymphoma, Unclassifiable",0
6806,Solar Radiation Toxicity,Stage III Liver Cancer,0
6807,White blood cell count increased (lab result),Gallbladder squamous cell carcinoma,0
6808,Increased megakaryocytes (bone marrow),Parotid Gland Sebaceous Lymphadenoma,0
6809,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Cobb's syndrome,0
6810,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Recurrent Ovarian Germ Cell Tumor,0
6811,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Ductal Breast Carcinoma with Squamous Metaplasia,0
6812,Solar Radiation Toxicity,Postcricoid cancer,0
6813,Fenestrated Pattern,Stage IIIA Hepatocellular Carcinoma AJCC v7,0
6814,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Thymic Basaloid Carcinoma,0
6815,Gastric dysplasia,Mild epithelial dysplasia,0
6816,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Recurrent Extragonadal Seminoma,0
6817,Fenestrated Pattern,Fanconi Anemia,0
6818,Blasts Expressing CD56 and Immature T-Cell Markers Present,T-Cell Prolymphocytic Leukemia,0
6819,Malignant Primitive Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,0
6820,Pleural effusion disorder,Pleural Biphasic Mesothelioma,0
6821,Fenestrated Pattern,BRCA2 Syndrome,0
6822,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
6823,Malignant Primitive Cellular Infiltrate,Malignant Skull Base Neoplasm,0
6824,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,GIANT PIGMENTED HAIRY NEVUS,0
6825,Solar Radiation Toxicity,Anal Ectopic Fibroadenoma,0
6826,Increased megakaryocytes (bone marrow),Breast Sclerosing Adenosis,0
6827,Venous Type Vascular Channel Formation,Type A Tylosis,0
6828,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Stage IIIA Ovarian Carcinoma,0
6829,Chronic Inflammatory Infiltrate,Chronic Myelomonocytic Leukemia-2,0
6830,Increased megakaryocytes (bone marrow),Extraskeletal Osteosarcoma,0
6831,Marked Thickening of the Bladder Urothelium Present,Urinary Bladder Nephrogenic Adenoma,0
6832,Absence of Malignant Features,Malignant neoplasm of salivary gland,0
6833,Spindle Cell Metaplasia of Malignant Cells Present,Medullary carcinoma of thyroid,0
6834,Microinvasive tumor,Benign neuroendocrine tumor,0
6835,Diffuse Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma,0
6836,Increased megakaryocytes (bone marrow),Uterine Corpus Adenofibroma,0
6837,Spindle Cell Metaplasia of Malignant Cells Present,carcinosarcoma of liver,0
6838,Blasts Expressing CD56 and Immature T-Cell Markers Present,Smoldering Adult T-Cell Leukemia/Lymphoma,0
6839,Multihormonal Immunoreactivity Present in a Single Cell Type,Pleomorphic Variant Mantle Cell Lymphoma,0
6840,Abundance of Small Lymphocytes,Pancreatic Small Cell Neuroendocrine Carcinoma,0
6841,Intersecting Sharply Marginated Clusters of Spindle Cells Present,germinoma of brain,0
6842,Absence of Malignant Features,Malignant tumor of endocardium,0
6843,Malignant Primitive Cellular Infiltrate,Cellular Blue Nevus,0
6844,Epithelioid Differentiation,Proximal-Type Epithelioid Sarcoma,0
6845,Low Grade Neuroendocrine Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
6846,Moderately Differentiated Lesion,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,0
6847,Solar Radiation Toxicity,Pancreatic adenocarcinoma recurrent,0
6848,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,0
6849,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Refractory Acute Lymphoblastic Leukemia,0
6850,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
6851,Epithelial hyperplasia of skin,Parathyroid chief-cell hyperplasia,0
6852,Increased megakaryocytes (bone marrow),Bile duct carcinoma,0
6853,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Pharyngeal Carcinoma by AJCC v8 Stage,0
6854,Fried-Egg Appearance of the Bone Marrow,Stage I Bone Cancer AJCC v8,0
6855,Fenestrated Pattern,Stage III Fallopian Tube Cancer AJCC v8,0
6856,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Stage III Rectal Cancer AJCC v6,0
6857,Osseous Metaplasia of Malignant Cells Present,Malignant melanoma of breast,0
6858,Mammary Gland Type Features Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,0
6859,Gastric dysplasia,Gastric Body Carcinoma,0
6860,Absence of Malignant Features,small cell carcinoma of breast,0
6861,Increased megakaryocytes (bone marrow),Basal-Like Breast Carcinoma,0
6862,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Hidradenoma Papilliferum,0
6863,Absence of Malignant Features,Benign neoplasm of adrenal gland,0
6864,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Optic Nerve Glioma, Childhood",0
6865,Absence of Malignant Features,Benign neoplasm of appendix,0
6866,Fenestrated Pattern,CNS metastases,0
6867,Fenestrated Pattern,Cardiac rhabdomyoma,0
6868,Endometrial Type Glands and Stroma Present,Stage III Ovarian Teratoma AJCC v6 and v7,0
6869,Marked Thickening of the Bladder Urothelium Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
6870,Local disease,Hodgkin's disease nodular sclerosis stage I,0
6871,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal T Acute Lymphoblastic Leukemia,0
6872,Fenestrated Pattern,Ichthyoses,0
6873,Multihormonal Immunoreactivity Present in a Single Cell Type,Human Papillomavirus-Related Squamous Cell Carcinoma,0
6874,Solar Radiation Toxicity,Stage III Prostate Cancer AJCC v8,0
6875,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Mediastinal Granulocytic Sarcoma,0
6876,Solitary Skin Tumor,Fallopian Tube Endometrioid Tumor,0
6877,Recurrent Malignant Neoplasm,Resectable Malignant Neoplasm,0
6878,Multihormonal Immunoreactivity Present in a Single Cell Type,Early Invasive Cervical Squamous Cell Carcinoma,0
6879,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7,0
6880,Spindle Cell Osteo-Fibrous Component Present,Inverted Squamous Cell Papilloma,0
6881,Spindle Cell Osteo-Fibrous Component Present,Metastatic Lip Squamous Cell Carcinoma,0
6882,Solar Radiation Toxicity,Pancreatic adenocarcinoma recurrent,0
6883,Spindle Cell Metaplasia of Malignant Cells Present,Neuroblastoma of brain,0
6884,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Erythroid Leukemia,0
6885,Absence of Malignant Features,Lipoma of small intestine,0
6886,Increased megakaryocytes (bone marrow),Stage II Adult Hodgkin Lymphoma,0
6887,Spindle Cell Osteo-Fibrous Component Present,"Carcinoma, Transitional Cell",0
6888,Neoplastic Plasma Cells Present in Bone Marrow,Proliferative dermal lesion in congenital nevus,0
6889,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Multiple hamartoma of lung,0
6890,Acute inflammation,Infant T Acute Lymphoblastic Leukemia,0
6891,Recurrent Malignant Neoplasm,Recurrent Appendix Mucinous Adenocarcinoma,0
6892,Solar Radiation Toxicity,Ewings sarcoma,0
6893,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Benign neoplasm of small intestine,0
6894,Prominent Elastic Tissue Cores Present,Resectable Soft Tissue Sarcoma,0
6895,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,0
6896,Schwannian Stroma More than 50 Percent of the Tumor Volume,Pericardial Solitary Fibrous Tumor,0
6897,Increased megakaryocytes (bone marrow),Combined Lung Carcinoma,0
6898,Malignant Primitive Cellular Infiltrate,Malignant Mediastinal Soft Tissue Neoplasm,0
6899,Atypical Lymphocytes Present in Peripheral Blood,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",0
6900,Increased megakaryocytes (bone marrow),Congenital spondylolysis,0
6901,Malignant Primitive Cellular Infiltrate,Malignant myoepithelioma,0
6902,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,"Acute Myeloid Leukemia, M1",0
6903,Increased megakaryocytes (bone marrow),Parapsoriasis,0
6904,Absence of Stromal Invasion,Uterine Corpus Endometrial Stromal Sarcoma,0
6905,Lesion with Diameter of 2cm or Less,Adult Primary Melanocytic Lesion of Meninges,0
6906,Solar Radiation Toxicity,Tonsillar Lymphoma,0
6907,Increased megakaryocytes (bone marrow),Classic Rhabdomyoma,0
6908,Fenestrated Pattern,Well-differentiated papillary mesothelioma,0
6909,Intravascular papillary endothelial hyperplasia,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
6910,Neoplastic Plasma Cells Present in Bone Marrow,"Castleman Disease, Plasma Cell Type",0
6911,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0
6912,Absence of Malignant Features,Vulvar Adenocarcinoma of Mammary Gland Type,0
6913,Solar Radiation Toxicity,Stage IIIA Ovarian Cancer AJCC v8,0
6914,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,"Phosphaturic mesenchymal tumor, benign",0
6915,Schwannian Stroma More than 50 Percent of the Tumor Volume,Squamous cell carcinoma of the hypopharynx stage I,0
6916,No Evidence of Metastatic Disease,Metastatic Vaginal Carcinoma,0
6917,Schwannian Stroma More than 50 Percent of the Tumor Volume,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
6918,Increased megakaryocytes (bone marrow),Stage IV Childhood Burkitt Lymphoma,0
6919,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,0
6920,Spindle Cell Metaplasia of Malignant Cells Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,0
6921,Inflammatory infiltrate,Anal Inflammatory Cloacogenic Polyp,0
6922,Mixed Neoplastic Glandular and Squamous Cell Population,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",0
6923,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Lymphoplasmacyte-rich meningioma,0
6924,Increased megakaryocytes (bone marrow),Stage I Uterine Corpus Adenosarcoma AJCC v8,0
6925,Primary Site Unspecified,Refractory Primary Cutaneous Lymphoma,0
6926,Spindle Cell Metaplasia of Malignant Cells Present,"Acanthoma, Clear Cell",0
6927,Spindle Cell Metaplasia of Malignant Cells Present,squamous cell carcinoma of urethra,0
6928,Solitary Skin Tumor,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6929,Intermediate Grade Neuroendocrine Lesion,Intermediate Fibrohistiocytic Neoplasm,0
6930,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Neoplasm malignant aggravated,0
6931,Fenestrated Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma,0
6932,Bone Marrow Involvement,Stage IVB Bone Sarcoma AJCC v7,0
6933,Solar Radiation Toxicity,Testicular choriocarcinoma stage I,0
6934,Fenestrated Pattern,Aleukemic Acute Lymphoblastic Leukemia,0
6935,Malignant Primitive Cellular Infiltrate,Malignant Lung and Pleural Neoplasm,0
6936,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Locally Advanced Angiosarcoma,0
6937,Increased megakaryocytes (bone marrow),Clear-Cell Myomelanocytic Tumors,0
6938,Mixed Neoplastic Glandular and Squamous Cell Population,Mixed Cell Uveal Melanoma,0
6939,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Metastatic Gastric Carcinoma,0
6940,"Undifferentiated ""Fetal-Type"" Tissues Present",Undifferentiated carcinoma,0
6941,Increased megakaryocytes (bone marrow),Stage IIA Vaginal Cancer AJCC v8,0
6942,Abundance of Small Lymphocytes,Stage IV Lung Small Cell Carcinoma AJCC v7,0
6943,Erythroid hyperplasia,Adult Acute Erythroid Leukemia,0
6944,Area of Depigmentation at the Periphery of the Dermal Melanocytic Infiltrate Present,Gastric Intestinal-Type Adenocarcinoma,0
6945,Increased megakaryocytes (bone marrow),BRCA2 Syndrome,0
6946,Increased megakaryocytes (bone marrow),Stage IIIB Esophageal Cancer AJCC v7,0
6947,Spindle Cell Metaplasia of Malignant Cells Present,Inflammatory pseudotumor of liver,0
6948,Schwannian Stroma More than 50 Percent of the Tumor Volume,Adrenal Cortex Adenomatoid Tumor,0
6949,Villous Projections of the Neoplastic Epithelium Present,Neoplastic disease of uncertain behavior,0
6950,Endometrial Type Glands and Stroma Present,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,0
6951,Spindle Cell Metaplasia of Malignant Cells Present,Columnar Cell Change of the Breast,0
6952,Lesion with Diameter of 2cm or Less,Refractory cytopenia with unilineage dysplasia,0
6953,Dilated Terminal Duct Lobular Units with Acini Lined by More than Two Layers of Columnar Epithelial Cells Present,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage,0
6954,Solar Radiation Toxicity,Vaginal intraepithelial neoplasia,0
6955,Intravascular papillary endothelial hyperplasia,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
6956,Absence of Malignant Features,Malignant Pericytic Neoplasm,0
6957,Mature Neutrophils Present,Adult Central Nervous System Mature Teratoma,0
6958,Solar Radiation Toxicity,Angiomatosis,0
6959,Spindle Cell Metaplasia of Malignant Cells Present,Lipid cell tumor of ovary,0
6960,Fenestrated Pattern,Stage IIC Prostate Cancer AJCC v8,0
6961,Multihormonal Immunoreactivity Present in a Single Cell Type,Islet Glucagon Cell Hyperplasia,0
6962,Chronic Inflammatory Infiltrate,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0
6963,More Than Two Separate Tumor Masses Present in the Same Organ,Prostate Carcinoma Metastatic in the Lung,0
6964,Mixture of Germ Cell Neoplastic Components Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,0
6965,Intersecting Sharply Marginated Clusters of Spindle Cells Present,Hemangiosarcoma of heart,0
6966,Focal Pattern,Focal glomerulosclerosis,0
6967,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Stage IB Testicular Cancer AJCC v6 and v7,0
6968,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,0
6969,Increased megakaryocytes (bone marrow),Stage IVA Paranasal Sinus Cancer AJCC v7,0
6970,Sarcomatoid Features,Rectal Sarcomatoid Carcinoma,0
6971,Follicular Cell Differentiation,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
6972,Contiguous Disease,Ann Arbor Stage II Contiguous Mantle Cell Lymphoma,1
6973,Malignant Cellular Infiltrate,Childhood Testicular Mixed Germ Cell Tumor,1
6974,Exophytic Polypoid Lesion,Urethral Villous Adenoma,1
6975,Nodular Pattern,Dysembryoplastic neuroepithelial tumor,1
6976,Nuclear pleomorphism,Uterine Corpus Bizarre Leiomyoma,1
6977,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor,1
6978,Carcinomatous Component Present,Unresectable Extrahepatic Bile Duct Carcinoma,1
6979,Neuroectodermal Differentiation,"Ganglioneuroblastoma, Intermixed",1
6980,Presence of a Hormonal Syndrome,"Glucagonoma, malignant",1
6981,Neuroendocrine Differentiation,Colorectal Neuroendocrine Carcinoma,1
6982,Refractory Disease,Refractory Acute Lymphoblastic Leukemia,1
6983,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
6984,Nuclear pleomorphism,Pleomorphic carcinoma,1
6985,Recurrent disease,Recurrent WHO Grade III Glioma,1
6986,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
6987,Cutaneous Involvement,GIANT PIGMENTED HAIRY NEVUS,1
6988,Exophytic Polypoid Lesion,Gardner Syndrome,1
6989,Mixed Cellular Population,Stage IVA Uterine Corpus Adenosarcoma AJCC v8,1
6990,Carcinomatous Component Present,Squamous cell carcinoma of esophagus,1
6991,Malignant Cellular Infiltrate,Recurrent Endometrial Endometrioid Adenocarcinoma,1
6992,Cartilaginous Differentiation,Grade III Chondrosarcoma,1
6993,Non-Invasive Lesion,"Papillary transitional cell carcinoma, non-invasive",1
6994,Metaplasia,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
6995,Thin-Walled Branching Vascular Pattern,Malignant Solitary Fibrous Tumor,1
6996,Cutaneous Involvement,Verrucous keratotic hemangioma,1
6997,Malignant Cellular Infiltrate,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
6998,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
6999,Cutaneous Involvement,Cutaneous pseudolymphoma,1
7000,Malignant Cellular Infiltrate,basal cell carcinoma of scrotum,1
7001,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
7002,Cystic Change,Serous cystadenocarcinoma of pancreas,1
7003,Epithelial Component Present,Brenner Tumor,1
7004,Tubular Structures Present,"Adenocarcinoma, Tubular",1
7005,Malignant Cellular Infiltrate,Malignant Vulvar Sweat Gland Neoplasm,1
7006,Hyperplastic Epithelial Tissue Present,Atypical Breast Myoepitheliosis,1
7007,Diffuse Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
7008,Neuroendocrine Differentiation,Stage IA Lung Small Cell Carcinoma AJCC v7,1
7009,Carcinomatous Component Present,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
7010,Skin Papule,Vulvar Trichoepithelioma,1
7011,Carcinomatous Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
7012,Carcinomatous Component Present,Adenocarcinoma,1
7013,Metaplasia of Malignant Cells Present,Adenocarcinoma with osseous metaplasia,1
7014,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
7015,Malignant Cellular Infiltrate,Choriocarcinoma of ovary,1
7016,Infiltrative Growth Pattern,Recurrent Childhood Diffuse Astrocytoma,1
7017,Cartilaginous Component Present,Endobronchial Hamartoma,1
7018,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Refractory Primary Amyloidosis,1
7019,Malignant Cellular Infiltrate,lymphoepithelial squamous cell carcinoma of salivary gland,1
7020,Mixed Cellular Population,Cervical Adenomyoma,1
7021,Malignant Cellular Infiltrate,Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7,1
7022,Well Differentiated Lesion,Verrucous carcinoma,1
7023,Neuroendocrine Differentiation,Primary malignant neoplasm of glomus jugulare,1
7024,Malignant Cellular Infiltrate,Vulvar Merkel Cell Carcinoma,1
7025,Secondary Lesion,Advanced Prostate Carcinoma,1
7026,Malignant Cellular Infiltrate,eccrine adenocarcinoma of vulva,1
7027,Sarcomatous Component Present,Carcinosarcoma of cervix uteri,1
7028,Epithelial Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
7029,Epithelial Component Present,Stage III Ovarian Cancer AJCC v8,1
7030,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
7031,Diffuse Pattern,Angioendotheliomatosis,1
7032,Sarcomatous Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma,1
7033,Cystic Change,Mucoepidermoid Carcinoma,1
7034,Malignant Cellular Infiltrate,Malignant Lung PEComa,1
7035,Cutaneous Involvement,Eccrine Neoplasm,1
7036,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
7037,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm,1
7038,Benign Cellular Infiltrate,"Acanthoma, Clear Cell",1
7039,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma,1
7040,Malignant Cellular Infiltrate,"Endocervical Adenocarcinoma, Usual Type",1
7041,Epithelial Component Present,Rectosigmoid Cancer by AJCC v7 Stage,1
7042,atypia morphology,Malignant Solitary Fibrous Tumor,1
7043,Hemorrhagic,Hemangiosarcoma of heart,1
7044,Benign Cellular Infiltrate,Glomerulosa Cell Adrenal Cortical Adenoma,1
7045,Vascular Channel Formation,Appendix Kaposi Sarcoma,1
7046,Epithelial Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
7047,Cutaneous Involvement,Stage I Skin Cancer,1
7048,Cutaneous Involvement,Eccrine angiomatous hamartoma,1
7049,Poorly Differentiated Lesion,Pancreatic Medullary Carcinoma,1
7050,Malignant Cellular Infiltrate,Ampulla of Vater Neuroendocrine Carcinoma,1
7051,Invasive Lesion,Infiltrating Cervical Carcinoma,1
7052,Pregnancy Complications,Chorioangioma,1
7053,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
7054,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ",1
7055,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage III,1
7056,Carcinomatous Component Present,Subglottic Squamous Cell Carcinoma,1
7057,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
7058,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
7059,Carcinomatous Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
7060,Epithelial Component Present,Stage IB Fallopian Tube Cancer AJCC v6 and v7,1
7061,Malignant Cellular Infiltrate,Thymoma malignant noninvasive,1
7062,Metastatic Lesion,Metastatic Bladder Urothelial Carcinoma,1
7063,Pseudostratified Columnar Tumor Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
7064,Malignant Cellular Infiltrate,Refractory Synovial Sarcoma,1
7065,Malignant Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
7066,Thick-Walled Hyalinized Vessels Present,Peripheral Nerve Schwannoma,1
7067,Malignant Cellular Infiltrate,Recurrent Alveolar Rhabdomyosarcoma,1
7068,Lobulated Growth Pattern,Sacral Chordoma,1
7069,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp,1
7070,Recurrent disease,Lentigo maligna recurrent,1
7071,Carcinomatous Component Present,Lymphangitis carcinomatosa,1
7072,Recurrent disease,Recurrent Breast Lymphoma,1
7073,Skin nodule,Blastic plasmacytoid dendritic cell neoplasm,1
7074,Malignant Cellular Infiltrate,mesenchymal chondrosarcoma of bone,1
7075,Epithelial Component Present,solid type ductal carcinoma in situ of breast,1
7076,Slow Growing Mass,Benign Intracranial Meningioma,1
7077,Cystic Change,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
7078,Benign Cellular Infiltrate,Seborrheic keratosis of eyelid,1
7079,Cutaneous Involvement,"Dermatitis, Allergic Contact",1
7080,Carcinomatous Component Present,Human Papillomavirus-Related Adenosquamous Carcinoma,1
7081,Malignant Cellular Infiltrate,Papillary Eccrine Carcinoma,1
7082,Malignant Cellular Infiltrate,Ameloblastic fibrosarcoma,1
7083,Varicosity,Phlebitis,1
7084,Indolent Clinical Course,Hemolymphangioma,1
7085,Malignant Cellular Infiltrate,Ampulla of Vater Cancer by AJCC v8 Stage,1
7086,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
7087,Carcinomatous Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
7088,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v8,1
7089,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
7090,Malignant Cellular Infiltrate,Malignant neoplasm of esophagus,1
7091,Glandular cell atypia,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
7092,Malignant Cellular Infiltrate,liposarcoma of mediastinum,1
7093,Epithelial Component Present,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
7094,Papillary Pattern,Intracystic Papillary Breast Carcinoma,1
7095,Carcinomatous Component Present,Gastric Mixed Adenocarcinoma,1
7096,Primary Lesion,Transplant-Related Hepatocellular Carcinoma,1
7097,Fibrotic Stroma Formation,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
7098,Mixed Cellular Population,Malignant Submandibular Gland Mixed Tumor,1
7099,Malignant Cellular Infiltrate,Mesothelioma malignant recurrent,1
7100,Splenomegaly,Refractory Hairy Cell Leukemia,1
7101,Malignant Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma,1
7102,Malignant Cellular Infiltrate,Cervical Clear Cell Adenocarcinoma,1
7103,Carcinomatous Component Present,Childhood Colorectal Carcinoma,1
7104,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
7105,Epithelial Component Present,Thymic Atypical Carcinoid Tumor,1
7106,Epithelial Component Present,Refractory Cholangiocarcinoma,1
7107,Benign Cellular Infiltrate,Benign Cardiac Germ Cell Tumor,1
7108,Benign Cellular Infiltrate,Kasabach-Merritt syndrome,1
7109,Malignant Cellular Infiltrate,Cervical Angiosarcoma,1
7110,Immunosuppression-Related Post-Transplant Toxicity,Intestinal Graft Versus Host Disease,1
7111,Chromogranin A Positive Neoplastic Cells Present,Hindgut Carcinoid Tumor,1
7112,Eccrine Differentiation,Vulvar Syringoma,1
7113,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
7114,Malignant Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma,1
7115,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
7116,Neuroendocrine Differentiation,Carcinoid Tumor,1
7117,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Lung Carcinoma,1
7118,Well-Circumscribed Lesion,"Cystadenoma, Papillary",1
7119,Slow Growing Mass,Pilar tumor,1
7120,Carcinomatous Component Present,Stage III Renal Cell Cancer AJCC v8,1
7121,Malignant Cellular Infiltrate,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
7122,Epithelial Component Present,Lepidic Predominant Adenocarcinoma,1
7123,Malignant Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma,1
7124,Malignant Cellular Infiltrate,Stage I Kidney Wilms Tumor,1
7125,Benign Cellular Infiltrate,Juxtaglomerular tumor,1
7126,Carcinomatous Component Present,Primary Carcinoma Unspecified Site,1
7127,Cutaneous Involvement,Juvenile Xanthogranuloma,1
7128,Adulthood Lesion,Adult Central Nervous System Mixed Germ Cell Tumor,1
7129,Epithelial Component Present,Stage IIA Gastric Cancer AJCC v7,1
7130,Epithelial Component Present,Stage I Vulvar Carcinoma,1
7131,Malignant Cellular Infiltrate,Exocervical Carcinoma,1
7132,Epithelial Component Present,Borderline Fallopian Tube Mucinous Tumor,1
7133,Dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,1
7134,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
7135,Dysplasia,Vulval intraepithelial neoplasia,1
7136,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
7137,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7,1
7138,Epithelial Component Present,Advanced Cervical Adenocarcinoma,1
7139,Childhood Lesion,Pediatric Intraocular Retinoblastoma,1
7140,Multinodular Mass,Prostate Angiosarcoma,1
7141,Sebaceous Differentiation,Benign neoplasm of sebaceous gland,1
7142,Malignant Cellular Infiltrate,Small Intestinal Angiosarcoma,1
7143,Epithelial Component Present,Stomach Carcinoma,1
7144,Proliferation of High Endothelial Venules Present,Angioimmunoblastic Lymphadenopathy,1
7145,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hyalinizing Trabecular Adenoma,1
7146,Epithelial Component Present,Testicular Tumor of the Thecoma/Fibroma Group,1
7147,Biphasic Pattern,Carcinosarcoma of ovary,1
7148,Recurrent disease,Recurrent Ovarian Endometrioid Adenocarcinoma,1
7149,Benign Cellular Infiltrate,Benign neoplasm of urethra,1
7150,Adnexal Differentiation,Benign neoplasm of adnexa of skin,1
7151,Epithelial Component Present,Gastrointestinal tract adenoma,1
7152,Malignant Cellular Infiltrate,Epiglottic carcinoma,1
7153,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
7154,Glial Differentiation,Childhood Ganglioglioma,1
7155,Epithelial Component Present,Stage IV Renal Cell Cancer,1
7156,Carcinomatous Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma,1
7157,Necrotic changes (finding),Childhood Brain Glioblastoma,1
7158,Malignant Cellular Infiltrate,Stage IVA Major Salivary Gland Cancer AJCC v7,1
7159,Exophytic Papillary Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
7160,Malignant Cellular Infiltrate,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
7161,Epithelial Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7,1
7162,Cystic Change,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
7163,Vascular Channel Formation,Histiocytoid hemangioma,1
7164,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Colon,1
7165,Mucoid Stroma Formation,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
7166,Carcinomatous Component Present,Small Intestinal Cancer by AJCC v7 Stage,1
7167,Koilocytotic atypia,Human Papillomavirus-Related Squamous Cell Carcinoma,1
7168,Pregnancy Complications,Ectopic Pregnancy,1
7169,Carcinomatous Component Present,Low Grade Salivary Gland Carcinoma,1
7170,Cutaneous Involvement,Skin squamous cell carcinoma recurrent,1
7171,Malignant Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma,1
7172,Severe cytologic atypia,Refractory Pancreatic Neuroendocrine Carcinoma,1
7173,Malignant Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma,1
7174,Metastatic Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
7175,Capillary Sized Vascular Channel Formation,Bone Epithelioid Hemangioma,1
7176,Severe dysplasia,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
7177,Cystic Change,Nipple Syringomatous Adenoma,1
7178,More than 10 Mitoses per 10HPF,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
7179,Slow Growing Mass,Giant Cell Angioblastoma,1
7180,Dysplasia,Cervical Squamous Cell Carcinoma In Situ,1
7181,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
7182,Neuroendocrine Differentiation,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
7183,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma,1
7184,Childhood Lesion,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
7185,Recurrent disease,Recurrent T-Cell Prolymphocytic Leukemia,1
7186,Vascular Channel Formation,Gallbladder Kaposi's Sarcoma,1
7187,Metastatic Lesion,Metastatic Penile Cancer,1
7188,Epithelial Component Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
7189,Epithelial Component Present,Esophageal squamous papilloma,1
7190,Malignant Cellular Infiltrate,Malignant Sternal Neoplasm,1
7191,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
7192,Secondary Lesion,Distantly Metastatic Malignant Neoplasm,1
7193,Absence of Invasion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7194,Epithelial Component Present,Trabecular adenocarcinoma,1
7195,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,1
7196,Chronic Inflammatory Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
7197,Malignant Cellular Infiltrate,"Sarcoma, metastatic",1
7198,Carcinomatous Component Present,Gastric Intestinal-Type Adenocarcinoma,1
7199,Fibrosis,Breast Blunt Duct Adenosis,1
7200,Epithelial Component Present,Ampulla of Vater Tubulovillous Adenoma,1
7201,Epithelial Component Present,Stage I Esophageal Adenocarcinoma AJCC v7,1
7202,Epithelial Component Present,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
7203,Epithelial Component Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,1
7204,Epithelial Component Present,Stage II Skin Cancer,1
7205,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
7206,Malignant Cellular Infiltrate,adenocarcinoma of renal pelvis,1
7207,Malignant Cellular Infiltrate,Secondary malignant neoplasm of peritoneum,1
7208,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent,1
7209,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v7,1
7210,Chronic lymphocytic inflammation,Histiocytoid hemangioma,1
7211,Cutaneous Involvement,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
7212,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",1
7213,Intraosseous Lesion,Solid/Multicystic Ameloblastoma,1
7214,Metastatic Lesion,Secondary malignant neoplasm of lip,1
7215,Epithelial Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
7216,Epithelial Component Present,Bartholin Gland Transitional Cell Carcinoma,1
7217,Malignant Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma,1
7218,Recurrent disease,Recurrent Malignant Head and Neck Neoplasm,1
7219,Malignant Cellular Infiltrate,Childhood Breast Carcinoma,1
7220,Necrotic changes (finding),Small cell neuroendocrine carcinoma of bladder,1
7221,Immunosuppression-Related Post-Transplant Toxicity,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
7222,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7223,Keratin pearl formation,"Squamous cell carcinoma, keratinizing",1
7224,Immunologic Deficiency Syndromes,AIDS-Related Carcinoma,1
7225,Multifocal Lesion,Uterine Corpus Diffuse Leiomyomatosis,1
7226,Adnexal Differentiation,Vulvar Papillary Hidradenoma,1
7227,Multifocal Lesion,Chondromatosis,1
7228,Neuroendocrine Differentiation,Cervical Atypical Carcinoid Tumor,1
7229,Epithelial Component Present,Adenocarcinoma with osseous metaplasia,1
7230,Carcinomatous Component Present,Recurrent Pancreatic Cystadenocarcinoma,1
7231,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
7232,Blasts Under 20 Percent of Peripheral Blood White Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",1
7233,Well-Circumscribed Lesion,Androgen-Producing Adrenal Cortex Adenoma,1
7234,Malignant Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7235,Encapsulated Mass,Clear cell papillary renal cell carcinoma,1
7236,Malignant Cellular Infiltrate,Malignant tumor of gum,1
7237,Adulthood Lesion,Adult Alveolar Soft Part Sarcoma,1
7238,Recurrent disease,Penis carcinoma recurrent,1
7239,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
7240,Squamous metaplasia of bladder,verrucous carcinoma of bladder,1
7241,Malignant Cellular Infiltrate,Retroperitoneal Lymphoma,1
7242,Epithelial Component Present,Carcinosarcoma of cervix uteri,1
7243,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v7 Stage,1
7244,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma metastatic,1
7245,Malignant Cellular Infiltrate,Stage IA Cervical Cancer AJCC v8,1
7246,Carcinomatous Component Present,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
7247,Vascular Channel Formation,Intracortical osteosarcoma,1
7248,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
7249,Malignant Cellular Infiltrate,TSH-Producing Pituitary Gland Carcinoma,1
7250,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v8,1
7251,Alternative Fascicle (Bundle) Pattern,Piloleiomyoma,1
7252,Carcinomatous Component Present,carcinoma of middle ear,1
7253,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm,1
7254,Indolent Clinical Course,Perifollicular fibroma,1
7255,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
7256,Carcinomatous Component Present,Acinar cell carcinoma of pancreas,1
7257,Malignant Cellular Infiltrate,Stage IV Kidney Wilms Tumor,1
7258,Epithelial Component Present,Biliary papillomatosis,1
7259,Spaces Lined by One to Three Layers of Monotonous Atypical Cells Present,Flat Ductal Epithelial Atypia of the Breast,1
7260,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
7261,Myxoid Stroma Formation,"Leiomyosarcoma, Myxoid",1
7262,Metastatic Lesion,Metastatic Bladder Squamous Cell Carcinoma,1
7263,Tubular Pattern,Appendix Tubular Carcinoid,1
7264,Childhood Lesion,Childhood Choroid Plexus Papilloma,1
7265,Carcinomatous Component Present,Invasive Lobular Breast Carcinoma,1
7266,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
7267,Neuroectodermal Differentiation,"Childhood Ganglioneuroblastoma, Nodular",1
7268,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
7269,Local disease,Localized Resectable Adult Hepatocellular Carcinoma,1
7270,Malignant Cellular Infiltrate,Major Salivary Gland Mucoepidermoid Carcinoma,1
7271,Severe cytologic atypia,Rectal Small Cell Neuroendocrine Carcinoma,1
7272,Carcinomatous Component Present,Stage I Colon Cancer AJCC v6 and v7,1
7273,Carcinomatous Component Present,Small intestine carcinoma stage III,1
7274,Bilateral Disease,bilateral breast cancer,1
7275,Papillary Pattern,Lung Micropapillary Adenocarcinoma,1
7276,Slow Growing Mass,Recurrent Childhood Ependymoma,1
7277,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
7278,Secondary Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
7279,Acanthosis,Vaginal Warty Carcinoma,1
7280,Well-Circumscribed Lesion,Recurrent Myxoid Liposarcoma,1
7281,Epithelial Component Present,Stage IVA Primary Peritoneal Cancer AJCC v8,1
7282,Local disease,Lung Myolipoma,1
7283,Malignant Cellular Infiltrate,Clear Cell Sarcoma of Soft Tissue,1
7284,Cutaneous Involvement,Telangiectatic Glomangioma,1
7285,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Neutropenia,1
7286,High Grade Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7,1
7287,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage III,1
7288,Fibrotic Stroma Formation,Ovarian Microcystic Stromal Tumor,1
7289,Benign Cellular Infiltrate,Peripheral Breast Papilloma,1
7290,Exophytic Papillary Lesion,Condyloma anal,1
7291,Lymphoplasmacytic Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
7292,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia,1
7293,Epithelial Component Present,Carcinoma of hard palate,1
7294,progesterone receptor negative,Triple-Negative Breast Carcinoma,1
7295,Benign Cellular Infiltrate,Breast Epithelioid Hemangioma,1
7296,Tartrate Resistant Acid Phosphatase Positive Cells Present,Hairy Cell Leukemia,1
7297,Slow Growing Mass,Recurrent Ependymoma,1
7298,Local disease,Endobronchial lipoma,1
7299,Solitary mass,Skull Base Chordoma,1
7300,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
7301,Poorly Differentiated Lesion,Large cell carcinoma of lung,1
7302,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
7303,Adulthood Lesion,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
7304,Benign Cellular Infiltrate,Spindle Cell/Pleomorphic Lipoma,1
7305,Chromogranin A Positive Neoplastic Cells Present,Malignant carcinoid tumor of lung,1
7306,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7,1
7307,Epithelial Component Present,Sebaceous adenoma,1
7308,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
7309,Clinical TNM Finding,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
7310,Epithelial Component Present,FIGO Stage IC3 Ovarian Cancer,1
7311,Malignant Cellular Infiltrate,Bone Epithelioid Hemangioendothelioma,1
7312,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8,1
7313,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma,1
7314,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7315,Malignant Cellular Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma,1
7316,Dilated Thin-Walled Vascular Space Formation,Vulvar Angiomyofibroblastoma,1
7317,Papillary Pattern,Cervical Mullerian Papilloma,1
7318,Epithelial Component Present,"Thymoma, type B3",1
7319,Carcinomatous Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
7320,Ground Glass Nuclear Inclusion,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
7321,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma,1
7322,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v7,1
7323,Malignant Cellular Infiltrate,"Transitional cell carcinoma, spindle cell",1
7324,Neuroendocrine Differentiation,Vulvar Merkel Cell Carcinoma,1
7325,Malignant Cellular Infiltrate,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
7326,Malignant Cellular Infiltrate,Advanced cancer,1
7327,Nuclear pleomorphism,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
7328,Borderline Lesion,Borderline Ovarian Mucinous Tumor,1
7329,Adnexal Differentiation,Apocrine breast carcinoma,1
7330,Epithelial Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
7331,Benign Cellular Infiltrate,Vulvar Inverted Follicular Keratosis,1
7332,Malignant Cellular Infiltrate,RISS Stage I Plasma Cell Myeloma,1
7333,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
7334,Benign Cellular Infiltrate,Benign Dermal Neoplasm,1
7335,Stromal Invasion,FIGO Stage IC2 Ovarian Cancer,1
7336,In Situ Lesion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
7337,Mitotic Activity,MGMT-Methylated Glioblastoma,1
7338,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Central Nervous System,1
7339,Malignant Cellular Infiltrate,Metastatic Bile Duct Carcinoma,1
7340,Carcinomatous Component Present,"Carcinoma, Skin Appendage",1
7341,Dysplasia,Filiform Serrated Adenoma,1
7342,Malignant Cellular Infiltrate,Epithelioid sarcoma recurrent,1
7343,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
7344,Exophytic Polypoid Lesion,Cervical Microglandular Polyp,1
7345,Malignant Cellular Infiltrate,Malignant vascular tumor of skin,1
7346,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
7347,CD30-Positive Neoplastic Cells Present,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
7348,Carcinomatous Component Present,carcinosarcoma of extrahepatic bile duct,1
7349,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
7350,Malignant Cellular Infiltrate,Recurrent Adult Soft Tissue Sarcoma,1
7351,Epithelial Component Present,Squamous cell carcinoma of vagina,1
7352,Bone Marrow Dysplasia Present,Refractory Cytopenia of Childhood,1
7353,Unresectable Mass,Locally Advanced Unresectable Malignant Neoplasm,1
7354,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
7355,Malignant Cellular Infiltrate,Proximal-Type Epithelioid Sarcoma,1
7356,Malignant Cellular Infiltrate,Osteosarcoma by AJCC v7 Stage,1
7357,Carcinomatous Component Present,Stage IV Laryngeal Cancer AJCC v6,1
7358,Neuroendocrine Differentiation,Stage III Merkel Cell Carcinoma AJCC v7,1
7359,Diffuse Pattern,Childhood Gliosarcoma,1
7360,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pericardium,1
7361,Carcinomatous Component Present,Endometrioid carcinoma ovary,1
7362,Low Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
7363,Childhood Lesion,Recurrent Childhood Cerebral Astrocytoma,1
7364,Cutaneous Involvement,Benign neoplasm of adnexa of skin,1
7365,Slow Growing Mass,Spinal hemangioblastoma,1
7366,Chronic lymphocytic inflammation,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
7367,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
7368,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
7369,High Grade Lesion,Alveolar rhabdomyosarcoma,1
7370,Mild cytologic atypia,verrucous carcinoma of bladder,1
7371,In Situ Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7372,Carcinomatous Component Present,Neck Carcinoma,1
7373,Locally Aggressive Lesion,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,1
7374,Malignant Cellular Infiltrate,Malignant neoplasm of cornea,1
7375,Epithelial Component Present,Cholangiocarcinoma recurrent,1
7376,Papillary Pattern,Papillary Thyroid Microcarcinoma,1
7377,Malignant Cellular Infiltrate,Splenic Manifestation of Leukemia,1
7378,Eosinophilic inflammation,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
7379,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
7380,Malignant Cellular Infiltrate,squamous cell carcinoma of salivary gland,1
7381,Syncytial Pattern,Cervical Lymphoepithelioma-Like Carcinoma,1
7382,Melanoma Cells Present,Breast Carcinoma with Melanotic Features,1
7383,Acquired Lesion,"Nose Deformities, Acquired",1
7384,Mixed Cellular Population,Epithelial Predominant Kidney Wilms Tumor,1
7385,Indolent Clinical Course,Esophageal hemangioma,1
7386,Therapy-Related Toxicity,Iatrogenic Kaposi Sarcoma,1
7387,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
7388,Carcinomatous Component Present,Stage IB Eyelid Carcinoma AJCC v8,1
7389,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
7390,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Lipoadenoma,1
7391,Ground Glass Nuclear Inclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
7392,Malignant Cellular Infiltrate,Metastatic Signet Ring Cell Breast Carcinoma,1
7393,Malignant Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma,1
7394,Epithelial Component Present,Carcinoma Arising in Nasal Papillomatosis,1
7395,Childhood Lesion,Cellular Congenital Mesoblastic Nephroma,1
7396,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",1
7397,Favorable Clinical Outcome,Ganglioneuroma of skin,1
7398,Cutaneous Involvement,Furunculosis,1
7399,Epithelial Component Present,Cystic basal cell carcinoma,1
7400,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage II Plasma Cell Myeloma,1
7401,Vascular Channel Formation,Childhood Angiosarcoma,1
7402,Cystic Change,Malignant ovarian cyst,1
7403,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
7404,Neuroendocrine Differentiation,Sporadic Thyroid Gland Medullary Carcinoma,1
7405,Malignant Cellular Infiltrate,"Sarcoma, Myeloid",1
7406,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
7407,Neuroendocrine Differentiation,Gastroesophageal Junction Neuroendocrine Carcinoma,1
7408,Childhood Lesion,Stage II Childhood Anaplastic Large Cell Lymphoma,1
7409,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
7410,In Situ Lesion,Stage 0 Vulvar Carcinoma,1
7411,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
7412,Non-Invasive Lesion,Ureter Urothelial Papilloma,1
7413,Carcinomatous Component Present,Colorectal Carcinoma,1
7414,Splenomegaly,Philadelphia chromosome negative chronic myelogenous leukemia,1
7415,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
7416,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
7417,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
7418,Carcinomatous Component Present,Lung Small Cell Carcinoma by AJCC v7 Stage,1
7419,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Sebaceous Tumor,1
7420,Cutaneous Involvement,Basal cell nevus with comedones,1
7421,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
7422,Biphasic Pattern,"Mixed Tumor, Mullerian",1
7423,Vascular Channel Formation,Synovial Hemangioma,1
7424,Malignant Cellular Infiltrate,Endometrial Transitional Cell Carcinoma,1
7425,Cystic Change,Thyroid Gland Mucoepidermoid Carcinoma,1
7426,Malignant Cellular Infiltrate,Ann Arbor Stage IVB Hodgkin Lymphoma,1
7427,Necrotic changes (finding),Childhood Gliosarcoma,1
7428,Epithelial Component Present,Bladder Villous Adenoma,1
7429,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
7430,Carcinomatous Component Present,Ceruminous adenocarcinoma,1
7431,Necrotic changes (finding),Stage I Lung Small Cell Carcinoma AJCC v7,1
7432,Malignant Cellular Infiltrate,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
7433,Slow Growing Mass,Childhood Subependymal Giant Cell Astrocytoma,1
7434,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v6 Stage,1
7435,Epithelial Component Present,Fallopian Tube Serous Adenofibroma,1
7436,Metastatic Lesion,Secondary malignant neoplasm of liver,1
7437,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
7438,Malignant Cellular Infiltrate,Stage I Carcinoma of Bladder,1
7439,Benign Cellular Infiltrate,benign granular cell tumor of gallbladder,1
7440,Malignant Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
7441,Malignant Cellular Infiltrate,Adenocarcinoma of Skene Gland Origin,1
7442,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v7,1
7443,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I,1
7444,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
7445,Exophytic Polypoid Lesion,Pseudopolyposis of colon,1
7446,Well-Circumscribed Lesion,Appendix adenoma,1
7447,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
7448,Epithelial Component Present,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,1
7449,Multinodular Mass,Ovarian Angiosarcoma,1
7450,Malignant Cellular Infiltrate,Refractory Head and Neck Squamous Cell Carcinoma,1
7451,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to nasopharynx,1
7452,Invasive Lesion,Ductal Carcinoma In Situ with Microinvasion,1
7453,Slow Growing Mass,Adult Ependymoma,1
7454,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemias,1
7455,Epithelial Component Present,Stage III Ovarian Cancer AJCC v8,1
7456,Stromal Invasion,Ovarian Cancer by AJCC v8 Stage,1
7457,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma,1
7458,Malignant Cellular Infiltrate,Stage III Ovarian Polyembryoma AJCC v6 and v7,1
7459,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
7460,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
7461,Malignant Cellular Infiltrate,Stage I Renal Cell Cancer AJCC v8,1
7462,Carcinomatous Component Present,Stage 0is Penile Cancer AJCC v8,1
7463,Multinodular Mass,Hemangiosarcoma,1
7464,Malignant Cellular Infiltrate,Recurrent Malignant Head and Neck Neoplasm,1
7465,Poorly Differentiated Lesion,Giant cell carcinoma of lung,1
7466,Solitary mass,Solitary Osseous Plasmacytoma,1
7467,Neuronal Differentiation,Desmoplastic infantile ganglioglioma,1
7468,Well-Circumscribed Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,1
7469,Epithelial Component Present,Malignant neoplasm of endocrine gland,1
7470,Malignant Cellular Infiltrate,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
7471,Malignant Cellular Infiltrate,Endodermal sinus tumor of ovary,1
7472,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v8,1
7473,Carcinomatous Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
7474,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma,1
7475,Increased Cellularity Present,Sellar Neuroblastoma,1
7476,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Myelodysplastic Syndrome,1
7477,Pseudoglandular Pattern,Sellar Embryonal Carcinoma,1
7478,Well-Circumscribed Lesion,"Phyllodes tumor, benign",1
7479,Papillary Pattern,Squamous Papilloma of the Nasopharynx,1
7480,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1B,1
7481,Malignant Cellular Infiltrate,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
7482,Benign Cellular Infiltrate,Skin Cavernous Hemangioma,1
7483,atypia morphology,Borderline Ovarian Serous Tumor with Microinvasion,1
7484,Infiltrative Growth Pattern,Adult Diffuse Astrocytoma,1
7485,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer,1
7486,Pushing Tumor Margin,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
7487,Adulthood Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
7488,Dermal Involvement,Vaginal Blue Nevus,1
7489,Epithelial Component Present,TSH-Producing Pituitary Gland Carcinoma,1
7490,Hyalinized Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
7491,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma refractory,1
7492,Edematous Stroma Formation,Myxoma,1
7493,Intracellular Accumulation of Lipids,Supratentorial Pleomorphic Xanthoastrocytoma,1
7494,Carcinomatous Component Present,Papillary mucinous cystadenocarcinoma,1
7495,Benign Cellular Infiltrate,"Hemangioma, Intramuscular",1
7496,Metastatic Lesion,Secondary malignant neoplasm of pharynx,1
7497,Epithelial Component Present,Bartholin Gland Transitional Cell Carcinoma,1
7498,Carcinomatous Component Present,Gastric Adenocarcinoma,1
7499,Childhood Lesion,Childhood Testicular Immature Teratoma,1
7500,Papillary Pattern,Fallopian Tube Papillary Adenocarcinoma,1
7501,Carcinomatous Component Present,Adenocarcinoma with spindle cell metaplasia,1
7502,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v7,1
7503,Malignant Cellular Infiltrate,Childhood Grade III Meningioma,1
7504,Indolent Clinical Course,Benign neoplasm of hard palate,1
7505,Carcinomatous Component Present,Non-small cell lung cancer stage III,1
7506,Smooth Muscle Component Present,Pulmonary lymphangioleiomyomatosis,1
7507,Plasma cell inflammation,Abdominal Inflammatory Myofibroblastic Tumor,1
7508,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
7509,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
7510,Epithelial Component Present,Small Intestinal Squamous Cell Carcinoma,1
7511,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
7512,Malignant Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm,1
7513,Vascular Channel Formation,Bone Epithelioid Hemangioma,1
7514,Malignant Cellular Infiltrate,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
7515,Adulthood Lesion,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
7516,Childhood Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
7517,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v8,1
7518,Benign Cellular Infiltrate,Benign Gastric Gastrointestinal Stromal Tumor,1
7519,Psammoma Body Formation,Psammomatous Meningioma,1
7520,Neuroendocrine Differentiation,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
7521,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
7522,Solar Radiation Toxicity,Solar Radiation-Related Cutaneous Melanoma,1
7523,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Acute monocytic/monoblastic leukemia,1
7524,Ventricular Involvement Only,Lateral Ventricle Ependymal Tumor,1
7525,High Grade Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
7526,Pseudoencapsulated Mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
7527,Carcinomatous Component Present,Stage IIA Lung Adenosquamous Carcinoma AJCC v7,1
7528,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent,1
7529,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
7530,Recurrent disease,Recurrent Meningioma,1
7531,Malignant Cellular Infiltrate,Upper Gingival Squamous Cell Carcinoma,1
7532,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
7533,Multifocal Lesion,Enchondromatosis,1
7534,atypia morphology,Borderline Ovarian Mucinous Adenofibroma,1
7535,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
7536,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
7537,Microvascular Proliferation,Acinar cell carcinoma of pancreas,1
7538,Cutaneous Involvement,Stage III Merkel Cell Carcinoma AJCC v7,1
7539,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
7540,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
7541,Carcinomatous Component Present,Unresectable Gallbladder Carcinoma,1
7542,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v8,1
7543,Childhood Lesion,Cystic Partially Differentiated Nephroblastoma,1
7544,Thick-Walled Hyalinized Vessels Present,Adrenal Gland Schwannoma,1
7545,VIP Positive Neoplastic Cells Present,Pancreatic Vipoma,1
7546,Carcinomatous Component Present,Prognostic Stage IIA Breast Cancer AJCC v8,1
7547,Schwannian Stroma Predominant Component of the Tumor Volume,Adrenal Gland Ganglioneuroma,1
7548,Malignant Cellular Infiltrate,Urethral Cancer by AJCC v7 Stage,1
7549,Recurrent disease,Metastasizing Chondroblastoma,1
7550,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
7551,Carcinomatous Component Present,Gallbladder adenosquamous carcinoma,1
7552,Mild dysplasia,Mild esophageal dysplasia,1
7553,Benign Cellular Infiltrate,hemangioma of mediastinum,1
7554,Epithelial Component Present,Glomus Tympanicum Tumor,1
7555,Dysplasia,Stage 0 Cervical Cancer AJCC v6,1
7556,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma,1
7557,Cutaneous Involvement,Pilomatrix carcinoma of skin,1
7558,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v7,1
7559,Cervical Glandular Dysplasia,Cervical Adenocarcinoma In Situ,1
7560,Primary Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
7561,Indolent Clinical Course,Hard Palate Pleomorphic Adenoma,1
7562,Epithelial Component Present,Mediastinal Thymoma,1
7563,Slow Growing Mass,Childhood Myxopapillary Ependymoma,1
7564,Epithelial Component Present,Childhood Paranasal Sinus Carcinoma,1
7565,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
7566,Tissue Differentiation Uncertain,Cutaneous myxoma,1
7567,Malignant Cellular Infiltrate,Recurrent Fibrolamellar Carcinoma,1
7568,Chromogranin A Positive Neoplastic Cells Present,Strumal carcinoid,1
7569,Papillary Pattern,papillary squamous cell carcinoma of larynx,1
7570,Mild cytologic atypia,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
7571,Polymorphic Cellular Infiltrate,"Post-transplant lymphoproliferative disorder, polymorphic",1
7572,Carcinomatous Component Present,Urothelial carcinoma urethra recurrent,1
7573,Malignant Cellular Infiltrate,PNET of bone localized,1
7574,Extensive Stage Lesion,Advanced Melanoma,1
7575,Carcinomatous Component Present,Stage IVC Oral Cavity Cancer AJCC v6 and v7,1
7576,Tubular Structures Present,Adenoameloblastoma,1
7577,Epithelial Component Present,Occult Lung Adenocarcinoma,1
7578,Mixed Cellular Population,Oral Cavity Pleomorphic Adenoma,1
7579,Borderline Lesion,"Serous cystadenoma, borderline malignancy",1
7580,Epithelial Component Present,Adult Type Testicular Granulosa Cell Tumor,1
7581,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
7582,Metastatic Lesion,Melanoma Metastatic in the Central Nervous System,1
7583,Generalized Dysplasia,Colorectal Traditional Serrated Adenoma,1
7584,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,1
7585,Dysplasia,High Grade Intraepithelial Neoplasia,1
7586,High Mitotic Activity,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
7587,Nuclear Atypia,Adult Anaplastic Astrocytoma,1
7588,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
7589,Secondary Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
7590,Malignant Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7,1
7591,Indolent Clinical Course,Lipoma of axilla,1
7592,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
7593,Lymphadenopathy,Nodal marginal zone B-cell lymphoma refractory,1
7594,Malignant Cellular Infiltrate,Uterine Ligament Mucinous Adenocarcinoma,1
7595,Benign Cellular Infiltrate,Benign Ovarian Luteinized Thecoma,1
7596,Epithelial Component Present,Adenocarcinoma in situ in adenomatous polyp,1
7597,Malignant Cellular Infiltrate,Childhood Unfavorable Prognosis Hodgkin Lymphoma,1
7598,Carcinomatous Component Present,Sebaceous Adenocarcinoma,1
7599,Epithelial Component Present,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
7600,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
7601,Malignant Cellular Infiltrate,Stage II Ureter Cancer AJCC v8,1
7602,Malignant Cellular Infiltrate,Sphenoid Sinus Squamous Cell Carcinoma,1
7603,Malignant Cellular Infiltrate,Unresectable Undifferentiated Pleomorphic Sarcoma,1
7604,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
7605,Carcinomatous Component Present,Squamous cell carcinoma of tonsil,1
7606,Malignant Cellular Infiltrate,Radiation-Related Angiosarcoma,1
7607,Malignant Cellular Infiltrate,Mature B-Cell Non-Hodgkin Lymphoma,1
7608,Malignant Cellular Infiltrate,Nasopharyngeal cancer recurrent,1
7609,Epithelial Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
7610,Borderline Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
7611,Malignant Cellular Infiltrate,rhabdomyosarcoma of mediastinum,1
7612,Malignant Cellular Infiltrate,Vulvar Cancer by AJCC v7 Stage,1
7613,Metastatic Lesion,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
7614,Malignant Cellular Infiltrate,Non-Hodgkin Breast Lymphoma,1
7615,Epithelial Component Present,Urethral Villous Adenoma,1
7616,Malignant Cellular Infiltrate,Advanced Well Differentiated Neuroendocrine Neoplasm,1
7617,Malignant Cellular Infiltrate,AJCC Grade 2 Sarcoma,1
7618,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
7619,Invasive Lesion,Well Differentiated Prostate Adenocarcinoma,1
7620,Low Mitotic Activity,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
7621,Metastatic Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
7622,Childhood Lesion,Childhood Pilocytic Astrocytoma,1
7623,Epithelial Component Present,Nasopharyngeal carcinoma,1
7624,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of thymus,1
7625,Malignant Cellular Infiltrate,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
7626,Hyaline Cartilage Differentiation,Chondrosarcoma recurrent,1
7627,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
7628,Well Differentiated Lesion,Cervical Verrucous Carcinoma,1
7629,Absence of Invasion,Stage 0 Breast Cancer AJCC v6 and v7,1
7630,Absence of Stromal Invasion,Benign Brenner Tumor,1
7631,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
7632,Well Differentiated Lesion,Low grade appendiceal mucinous neoplasm,1
7633,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
7634,Local disease,Liver Lipoma,1
7635,Malignant Cellular Infiltrate,Stage IB Soft Tissue Sarcoma AJCC v7,1
7636,Tissue Differentiation Uncertain,Lymphangiomyoma,1
7637,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III,1
7638,Multinodular Mass,Adult Angiosarcoma,1
7639,Carcinomatous Component Present,Small Intestinal Medullary Carcinoma,1
7640,Mesenchymal Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
7641,Epithelial Component Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
7642,Microvascular Proliferation,Cerebral Glioblastoma,1
7643,Well-Circumscribed Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
7644,Metastatic/Recurrent Disease,Epithelioid sarcoma recurrent,1
7645,High Grade Lesion,Combined Lung Carcinoma,1
7646,Malignant Cellular Infiltrate,Hormone Receptor Positive Breast Carcinoma,1
7647,Epithelial Component Present,Transitional cell carcinoma urethra,1
7648,Vascular Channel Formation,Hemangioma of liver,1
7649,Benign Cellular Infiltrate,Intracystic papillary adenoma,1
7650,Epithelial Component Present,Stage I Skin Cancer,1
7651,Malignant Cellular Infiltrate,Nonencapsulated sclerosing tumor,1
7652,Carcinomatous Component Present,Pleomorphic carcinoma,1
7653,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Endometrioid Adenocarcinoma,1
7654,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
7655,Edema,Inflammatory carcinoma of breast stage IV,1
7656,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v6 and v7,1
7657,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
7658,Epithelial Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
7659,Neuroectodermal Differentiation,Mediastinal Neuroblastoma,1
7660,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
7661,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma,1
7662,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
7663,Malignant Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma,1
7664,Dysplasia,"Vulvar Intraepithelial Neoplasia, Differentiated Type",1
7665,Malignant Cellular Infiltrate,Central Nervous System Angiosarcoma,1
7666,Carcinomatous Component Present,Primary Carcinoma Unspecified Site,1
7667,Favorable Clinical Outcome,Adrenal Gland Ganglioneuroma,1
7668,Epithelial Component Present,Mixed Squamous Cell Carcinoma of the Penis,1
7669,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of peritoneum,1
7670,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
7671,Indolent Clinical Course,Gastric Hemangioma,1
7672,Carcinomatous Component Present,Colorectal Undifferentiated Carcinoma,1
7673,Stromal Invasion,Carcinosarcoma of ovary,1
7674,Indolent Clinical Course,Benign Lung PEComa,1
7675,Indolent Clinical Course,Periosteal fibroma,1
7676,Malignant Cellular Infiltrate,Mycosis fungoides stage IV,1
7677,Malignant Cellular Infiltrate,Squamous cell carcinoma of colon,1
7678,Rapidly Enlarging Mass,Nodular fasciitis,1
7679,Cartilaginous Differentiation,Mediastinal Chondroma,1
7680,Benign Cellular Infiltrate,Oral Cavity Pleomorphic Adenoma,1
7681,Cutaneous Involvement,Follicular Myxoma,1
7682,Epithelial Component Present,Papillary transitional cell carcinoma,1
7683,Well-Circumscribed Lesion,Colon Serrated Polyposis,1
7684,Nuclear Molding,Stage I Lung Small Cell Carcinoma AJCC v7,1
7685,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
7686,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v7 Stage,1
7687,Pseudopapillary Pattern,Teratocarcinoma,1
7688,Epithelial Component Present,Sex Cord-Stromal Tumor,1
7689,Epithelial Component Present,Metastatic Colorectal Carcinoma,1
7690,Malignant Cellular Infiltrate,Abdominal Undifferentiated Pleomorphic Sarcoma,1
7691,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Carcinosarcoma,1
7692,Malignant Cellular Infiltrate,Adenoid cystic breast carcinoma,1
7693,Childhood Lesion,Childhood Malignant Liver Neoplasm,1
7694,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
7695,Low Mitotic Activity,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
7696,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp,1
7697,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v7 Stage,1
7698,Epithelial Component Present,Resectable Pancreatic Acinar Cell Carcinoma,1
7699,Carcinomatous Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
7700,Malignant Cellular Infiltrate,Rhabdomyosarcoma,1
7701,Local disease,Intramuscular lipoma,1
7702,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
7703,Severe cytologic atypia,small cell carcinoma of extrahepatic bile duct,1
7704,Stromal Invasion,Stage IIIA1 Ovarian Cancer AJCC v8,1
7705,Carcinomatous Component Present,Cecum Carcinoma,1
7706,Epithelial Component Present,Stage II Gastric Carcinoma,1
7707,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Recurrent Acute Myelomonocytic Leukemia,1
7708,Glandular Pattern,"Vulvar Adenocarcinoma, Intestinal-Type",1
7709,Plasma cell inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
7710,Malignant Cellular Infiltrate,Gallbladder Rhabdomyosarcoma,1
7711,Non-Contiguous Disease,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
7712,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin,1
7713,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
7714,Marked Nuclear Atypia Present,"Perivascular epithelioid tumor, malignant",1
7715,Malignant Cellular Infiltrate,Refractory Malignant Brain Neoplasm,1
7716,Benign Cellular Infiltrate,Vulvar Fibrolipoma,1
7717,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma,1
7718,Bilateral Disease,bilateral breast cancer,1
7719,Malignant Cellular Infiltrate,Leptomeningeal sarcoma,1
7720,Vascular Channel Formation,Skin Angiosarcoma,1
7721,Severe cytologic atypia,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
7722,Solid Growth Pattern,Pleuropulmonary blastoma type III,1
7723,Cutaneous Involvement,Pilosebaceous Hamartoma,1
7724,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
7725,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
7726,Anaplasia,"Glioblastoma, IDH-Mutant",1
7727,Carcinomatous Component Present,Stage II Colon Cancer AJCC v7,1
7728,Epithelial Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
7729,Eosinophil count raised (finding),Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,1
7730,Radiation Sickness,Radiation-Induced Intracranial Meningioma,1
7731,Epithelial Component Present,External Auditory Canal Ceruminous Adenoma,1
7732,Subcutaneous Involvement,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
7733,Malignant Cellular Infiltrate,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7734,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma,1
7735,Epithelial Component Present,Choroid Plexus Carcinoma,1
7736,Malignant Cellular Infiltrate,Centroblastic lymphoma stage II,1
7737,Infantile Lesion,Infant T Acute Lymphoblastic Leukemia,1
7738,Epithelial Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
7739,Anaplasia,Plasmacytoma anaplastic,1
7740,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v8,1
7741,Lymphoplasmacytic Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
7742,Firm mass,"Perineurioma, malignant",1
7743,Epithelial Component Present,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
7744,Pathologic TNM Finding,Pathologic Stage IIIA Gastric Cancer AJCC v8,1
7745,Multifocal Lesion,Enchondromatosis,1
7746,Single Cell Necrosis,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
7747,Epithelial Component Present,Intestinal Neuroendocrine Tumor G2,1
7748,Benign Cellular Infiltrate,Lung Mucous Gland Adenoma,1
7749,Carcinomatous Component Present,Head and Neck Carcinoma,1
7750,Epithelial Component Present,Stage III Carcinoma of Stomach,1
7751,Refractory Disease,Refractory Ewing Sarcoma,1
7752,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
7753,Dysplasia,Carcinoma in situ of penis,1
7754,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
7755,Invasive Lesion,large cell neuroendocrine carcinoma of breast,1
7756,Malignant Cellular Infiltrate,Metastatic Neuroblastoma,1
7757,Immunosuppression-Related Post-Transplant Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
7758,Malignant Cellular Infiltrate,Stage III Carcinoma of Penis,1
7759,Carcinomatous Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
7760,Metastatic Lesion,"Neuroendocrine carcinoma, metastatic",1
7761,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
7762,Tissue of Mullerian Origin Present,Adenosarcoma,1
7763,Diffuse Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,1
7764,Hyaline Cartilage Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
7765,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
7766,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater,1
7767,Epithelial Component Present,Stage IB2 Cervical Cancer,1
7768,Malignant Cellular Infiltrate,alk-positive anaplastic large cell lymphoma,1
7769,Carcinomatous Component Present,Hereditary Female Breast Carcinoma,1
7770,Epithelial Component Present,Stage III Colon Cancer AJCC v7,1
7771,Solar Radiation Toxicity,Solar Radiation-Related Malignant Neoplasm,1
7772,Pregnancy Complications,Morbidly adherent placenta (disorder),1
7773,High Grade Lesion,Secondary Supratentorial Anaplastic Astrocytoma,1
7774,Secondary Lesion,Metastatic Bone Sarcoma,1
7775,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer,1
7776,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v6 and v7,1
7777,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Leiomyosarcoma,1
7778,Metastatic Lesion,Poor Prognosis Metastatic Gestational Trophoblastic Tumor,1
7779,Cutaneous Involvement,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
7780,Malignant Cellular Infiltrate,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,1
7781,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
7782,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma,1
7783,Epithelial Component Present,Pyriform Fossa Squamous Cell Carcinoma,1
7784,Malignant Cellular Infiltrate,Endodermal sinus tumor of ovary,1
7785,Human Papillomavirus Positive,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
7786,Tissue Differentiation Uncertain,Adult Desmoplastic Small Round Cell Tumor,1
7787,Mitotic Activity,Childhood Brain Glioblastoma,1
7788,Indolent Clinical Course,Chondroma,1
7789,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma AJCC v8,1
7790,Carcinomatous Component Present,Stage IA Vulvar Carcinoma AJCC v6,1
7791,Perineural spread,Metastatic Adenoid Cystic Carcinoma,1
7792,Lytic lesion,Solitary Osseous Plasmacytoma,1
7793,Carcinomatous Component Present,Stage IIA Gallbladder Cancer AJCC v8,1
7794,Well Differentiated Lesion,Cervical Warty Carcinoma,1
7795,Malignant Cellular Infiltrate,Malignant Neoplasm with Regional Lymph Node Involvement,1
7796,Epithelial Component Present,Vaginal Carcinosarcoma,1
7797,Neuroendocrine Differentiation,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
7798,Carcinomatous Component Present,Subglottic Verrucous Carcinoma,1
7799,Malignant Cellular Infiltrate,Recurrent Breast Angiosarcoma,1
7800,Malignant Cellular Infiltrate,Bladder Lymphoma,1
7801,Storiform Growth Pattern,"Dermatofibrosarcoma Protuberans, Myxoid",1
7802,Benign Cellular Infiltrate,Cerebral Hemisphere Lipoma,1
7803,High Mitotic Activity,Childhood Choroid Plexus Carcinoma,1
7804,Lobulated Growth Pattern,Metastatic Chordoma,1
7805,Epithelial Component Present,Stage IIIA2 Fallopian Tube Cancer AJCC v8,1
7806,Epithelial Component Present,Stage I Lung Cancer AJCC v6,1
7807,Epithelial Component Present,Ovarian Squamous Cell Tumor,1
7808,Primary Lesion,Recurrent Childhood Gliomatosis Cerebri,1
7809,Well-Circumscribed Lesion,Uterine Corpus Adenomatoid Tumor,1
7810,Malignant Cellular Infiltrate,Clinical Stage III Cutaneous Melanoma AJCC v8,1
7811,Carcinomatous Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v8,1
7812,Platinum Resistance,Platinum-Resistant Urothelial Carcinoma,1
7813,Epithelial Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
7814,Malignant Cellular Infiltrate,Choriocarcinoma combined with other germ cell elements,1
7815,Malignant Cellular Infiltrate,Luminal B Prostate Carcinoma,1
7816,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer,1
7817,Dysplasia,Gallbladder adenoma,1
7818,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v6 and v7,1
7819,Diffuse Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
7820,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma,1
7821,Malignant Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,1
7822,Capillary Sized Vascular Channel Formation,Senile angioma,1
7823,Carcinomatous Component Present,Prostate cancer stage B,1
7824,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma by Ann Arbor Stage,1
7825,Stromal Invasion,Stage IIIA Ovarian Cancer AJCC v8,1
7826,Epithelial Component Present,Prognostic Stage IV Breast Cancer AJCC v8,1
7827,Lymphadenopathy,Nodal marginal zone B-cell lymphoma recurrent,1
7828,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor,1
7829,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ANKRD26 Mutation,1
7830,Carcinomatous Component Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,1
7831,Mass of body structure,Mediastinal Myeloid Sarcoma,1
7832,Carcinomatous Component Present,Stage II Renal Cell Cancer AJCC v7,1
7833,Epithelial Component Present,large cell neuroendocrine carcinoma of bladder,1
7834,Epithelial Component Present,Gonadotroph adenoma,1
7835,Cystic Change,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
7836,Intermediate Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
7837,Blasts of Mixed Phenotype Present,Infant Acute Biphenotypic Leukemia,1
7838,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
7839,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
7840,Absence of Invasion,Intermediate Grade Ductal Breast Carcinoma In Situ,1
7841,Metastatic Lesion,Myxoid liposarcoma metastatic,1
7842,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v8,1
7843,Metaplasia,Bladder squamous cell carcinoma recurrent,1
7844,Benign Cellular Infiltrate,Laryngeal Leiomyoma,1
7845,High Plasma Renin Activity,Juxtaglomerular tumor,1
7846,Fibrotic Stroma Formation,mucoepidermoid carcinoma of esophagus,1
7847,Epithelial Component Present,Locally Advanced Thymic Carcinoma,1
7848,Epithelial Component Present,Duodenal Adenoma,1
7849,Epithelial Component Present,Anal Canal Neuroendocrine Tumor G2,1
7850,Malignant Cellular Infiltrate,Head and neck cancer metastatic,1
7851,Epithelial Component Present,Stage IA1 Lung Cancer AJCC v8,1
7852,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v8,1
7853,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
7854,Congenital Lesion,Congenital Epulides,1
7855,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage I,1
7856,Epithelial Component Present,Small intestine carcinoma,1
7857,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
7858,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,1
7859,Recurrent disease,Recurrent Soft Tissue Sarcoma,1
7860,Mixed Cellular Population,"Uterine Carcinosarcoma, Homologous Type",1
7861,Malignant Cellular Infiltrate,Refractory Malignant Testicular Germ Cell Tumor,1
7862,Epithelial Component Present,"Carcinoma, Cribriform",1
7863,Diffuse Pattern,Diffuse Glioma,1
7864,Resectable Mass,Resectable Neuroblastoma,1
7865,Epithelial Component Present,undifferentiated carcinoma of extrahepatic bile duct,1
7866,Benign Cellular Infiltrate,Hibernoma,1
7867,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
7868,Malignant Cellular Infiltrate,Malignant neoplasm of thorax,1
7869,Clinical TNM Finding,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
7870,Malignant Cellular Infiltrate,Stage IB Cervical Cancer AJCC v6 and v7,1
7871,Well-Circumscribed Lesion,Angiomyofibroblastoma,1
7872,Metastatic Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
7873,Epithelial Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
7874,Malignant Cellular Infiltrate,"Dendritic Cell Sarcoma, Interdigitating",1
7875,Nuclear Clearing,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
7876,Multinodular Mass,Angiosarcoma of liver,1
7877,Epithelial Component Present,Adenocarcinoma of rectum,1
7878,Malignant Cellular Infiltrate,Stage IVA Lip Cancer AJCC v6 and v7,1
7879,Epithelial Component Present,Neuroendocrine neoplasm of larynx,1
7880,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Chronic Neutrophilic Leukemia,1
7881,Epithelial Component Present,"Thymoma, type AB, malignant",1
7882,Epithelial Component Present,Metastatic Vaginal Carcinoma,1
7883,Epithelial Component Present,Colon Neuroendocrine Neoplasm,1
7884,Malignant Cellular Infiltrate,Plantar Verrucous Skin Carcinoma,1
7885,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
7886,Anaplasia,Breast implant-associated anaplastic large cell lymphoma,1
7887,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
7888,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v7 Stage,1
7889,Storiform Growth Pattern,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
7890,Carcinomatous Component Present,"Cystadenocarcinoma, Serous",1
7891,Invasive Lesion,Small cell carcinoma of prostate,1
7892,Plasma cell inflammation,Lung Inflammatory Myofibroblastic Tumor,1
7893,Malignant Cellular Infiltrate,Colorectal Hodgkin Lymphoma,1
7894,Carcinomatous Component Present,Stage IB Lung Adenocarcinoma AJCC v7,1
7895,Carcinomatous Component Present,Stage I Paranasal Sinus Cancer,1
7896,Diffuse Pattern,Adult Brain Glioblastoma,1
7897,Malignant Cellular Infiltrate,Sarcoma of the Extremity,1
7898,Malignant Cellular Infiltrate,Refractory Aggressive NK-Cell Leukemia,1
7899,Monoclonal Cellular Population Present,Malignant mastocytosis,1
7900,Nerve palsy,Facial Nerve Palsy Related to Trauma,1
7901,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
7902,Bone Marrow Dysplasia Present,Refractory Chronic Myelomonocytic Leukemia,1
7903,Carcinomatous Component Present,Childhood Small Intestinal Carcinoma,1
7904,Invasive Lesion,Glomangiomatosis,1
7905,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
7906,Childhood Lesion,Postsurgical Stage II Hepatoblastoma,1
7907,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
7908,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
7909,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of appendix,1
7910,Acinar Cell Differentiation,Recurrent Prostate Acinar Adenocarcinoma,1
7911,High Grade Lesion,Stage I Lung Small Cell Carcinoma AJCC v7,1
7912,Fibrotic Stroma Formation,Posterior Tongue Mucoepidermoid Carcinoma,1
7913,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIB,1
7914,Epithelial Component Present,adenoid cystic carcinoma of accessory sinus,1
7915,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
7916,Carcinomatous Component Present,Colon Cancer by AJCC v7 Stage,1
7917,Carcinomatous Component Present,Ovarian Dermoid Cyst with Secondary Carcinoma,1
7918,Cystic Change,Benign Brenner Tumor,1
7919,Malignant Cellular Infiltrate,Childhood B Lymphoblastic Lymphoma,1
7920,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm,1
7921,Carcinomatous Component Present,"Carcinoid, Goblet Cell",1
7922,Pseudoencapsulated Mass,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
7923,Monomorphic Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
7924,Lobulated Growth Pattern,Sternal Chondromyxoid Fibroma,1
7925,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
7926,Mixed Cellular Population,Benign mixed epithelial and stromal tumor of kidney,1
7927,Nodules of Compact Keratin Present,Adamantinous Craniopharyngioma,1
7928,Benign Cellular Infiltrate,Fibroid Tumor,1
7929,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of skin,1
7930,Neuroectodermal Differentiation,Recurrent Primitive Neuroectodermal Tumor,1
7931,Vascular Channel Formation,vascular neoplasm of bone,1
7932,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
7933,Invasive Lesion,Sebaceous Breast Carcinoma,1
7934,Epithelial Component Present,Adenocarcinoid tumor,1
7935,Favorable Clinical Outcome,Cutaneous Mastocytosis,1
7936,Benign Cellular Infiltrate,Mediastinal Schwannoma,1
7937,Mixed Cellular Population,Mixed Congenital Mesoblastic Nephroma,1
7938,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Pathologic Stage,1
7939,Invasive Lesion,Moderately Differentiated Prostate Adenocarcinoma,1
7940,Benign Cellular Infiltrate,Intravascular fasciitis,1
7941,Childhood Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
7942,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v6,1
7943,Epithelial Component Present,Ovarian Sertoli-Stromal Cell Tumor,1
7944,Epithelial Component Present,Cerebellar Paraganglioma,1
7945,Malignant Cellular Infiltrate,Disseminated carcinoma,1
7946,Carcinomatous Component Present,Stage IIIB Bladder Cancer AJCC v8,1
7947,Neuroendocrine Differentiation,Metastatic carcinoid tumor,1
7948,Pseudoencapsulated Mass,Glandular malignant peripheral nerve sheath tumor,1
7949,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma,1
7950,Neuroendocrine Differentiation,Uterine Corpus Carcinoid Tumor,1
7951,Bilateral Disease,bilateral breast cancer,1
7952,Epithelial Component Present,Desmoplastic trichoepithelioma,1
7953,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v8,1
7954,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
7955,Desmoplastic Stroma Formation,Desmoplastic trichoepithelioma,1
7956,Borderline Lesion,Borderline Ovarian Mucinous Tumor,1
7957,Epithelial Component Present,Distal Urethral Carcinoma,1
7958,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",1
7959,Biphasic Pattern,Recurrent Childhood Gliosarcoma,1
7960,Collagenous Stroma Formation,Calcifying Fibrous Pseudotumor,1
7961,Exophytic Polypoid Lesion,Nasal Polyps,1
7962,Mitotic Activity,MGMT-Methylated Glioblastoma,1
7963,Low Mitotic Activity,Appendix Tubular Carcinoid,1
7964,Smooth Muscle Component Present,Lymphangiomyoma,1
7965,Benign Cellular Infiltrate,Pancreatic Macrocystic Serous Cystadenoma,1
7966,Carcinomatous Component Present,Cervical Esophagus Adenocarcinoma,1
7967,Malignant Cellular Infiltrate,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
7968,Epithelial Component Present,Nipple Carcinoma,1
7969,Dysplasia,Stage 0 Renal Pelvis Cancer AJCC v7,1
7970,Epithelial Component Present,Serous cystadenoma of ovary,1
7971,Carcinomatous Component Present,Prognostic Stage IIA Breast Cancer AJCC v8,1
7972,Malignant Cellular Infiltrate,Ciliary Body Mixed Cell Melanoma,1
7973,High Mitotic Activity,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
7974,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
7975,Dilated Vascular Space Formation,Hobnail Hemangioma,1
7976,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
7977,Biphasic Pattern,Breast Phyllodes Tumor,1
7978,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
7979,Recurrent disease,Recurrent Acute Monoblastic and Monocytic Leukemia,1
7980,Recurrent disease,Recurrent Thyroid Gland Medullary Carcinoma,1
7981,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
7982,Cartilaginous Differentiation,Solitary Osteochondroma,1
7983,Multinodular Mass,Prostate Angiosarcoma,1
7984,Extensive Stage Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
7985,Myxoid Stroma Formation,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
7986,Malignant Cellular Infiltrate,Childhood Cerebral Anaplastic Astrocytoma,1
7987,Malignant Cellular Infiltrate,Colon Cancer by AJCC v6 Stage,1
7988,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8,1
7989,Monomorphic Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
7990,Secondary Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
7991,Malignant Cellular Infiltrate,Stage IVC Major Salivary Gland Cancer AJCC v8,1
7992,Neuroendocrine Differentiation,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
7993,Mixed Cellular Population,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
7994,Apocrine Differentiation,Apocrine adenoma,1
7995,Low Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
7996,Glomeruloid Vessels Present,Childhood Pilocytic Astrocytoma,1
7997,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
7998,Malignant Cellular Infiltrate,Retromolar Trigone Squamous Cell Carcinoma,1
7999,Adnexal Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
8000,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8001,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
8002,Neuroendocrine Differentiation,Vulvar Small Cell Carcinoma,1
8003,Epithelial Component Present,Wolffian tumor,1
8004,Local disease,Lipoma,1
8005,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Neuroendocrine Carcinoma,1
8006,Malignant Cellular Infiltrate,Carcinoma of bladder,1
8007,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
8008,Ground Glass Nuclear Inclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
8009,Nodular and Diffuse Pattern,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,1
8010,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
8011,Malignant Cellular Infiltrate,Ovarian Cancer by FIGO Stage,1
8012,Epithelial Component Present,Prognostic Stage IIA Breast Cancer AJCC v8,1
8013,Ischemia,Acute vascular insufficiency of intestine (disorder),1
8014,Cutaneous Involvement,Stage IIC Merkel Cell Carcinoma AJCC v7,1
8015,Epithelial Component Present,Pituitary carcinoma,1
8016,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
8017,Myxoid Stroma Formation,Sellar Chordoma,1
8018,Malignant Cellular Infiltrate,B-Cell Lymphomas,1
8019,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v7,1
8020,Malignant Cellular Infiltrate,Bile duct carcinoma,1
8021,Epithelial Component Present,FIGO Stage IIIC Ovarian Cancer,1
8022,Epithelial Component Present,Oropharyngeal cancer recurrent,1
8023,Neuroendocrine Differentiation,Merkel cell carcinoma,1
8024,Primary Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
8025,Immunologic Deficiency Syndromes,Transplant-Related Disorder,1
8026,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma,1
8027,Nuclear Atypia,Temporal Lobe Anaplastic Astrocytoma,1
8028,Low Mitotic Activity,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
8029,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Neutropenia,1
8030,Cutaneous Involvement,Nevus comedonicus,1
8031,Anaplasia,Anaplastic Brain Stem Astrocytoma,1
8032,Secondary Lesion,Adenocarcinoma of the prostate stage IV,1
8033,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",1
8034,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8,1
8035,Childhood Lesion,Childhood B Lymphoblastic Lymphoma,1
8036,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Oncocytic Adenoma,1
8037,Carcinomatous Component Present,Platinum-Resistant Urothelial Carcinoma,1
8038,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
8039,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
8040,Malignant Cellular Infiltrate,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
8041,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
8042,Malignant Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,1
8043,Chronic lymphocytic inflammation,Nonencapsulated sclerosing tumor,1
8044,Papillary Pattern,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
8045,Osseous Differentiation,Duodenal Extraskeletal Osteosarcoma,1
8046,Carcinomatous Component Present,Stage IIIA Colon Cancer AJCC v8,1
8047,Malignant Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma,1
8048,Benign Cellular Infiltrate,Senile angioma,1
8049,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
8050,Carcinomatous Component Present,Stage IIA Rectal Cancer AJCC v8,1
8051,Skin Papule,Trichoepithelioma,1
8052,Malignant Cellular Infiltrate,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
8053,Peripheral Nuclear Palisading,basaloid carcinoma of penis,1
8054,Carcinomatous Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
8055,Adulthood Lesion,Adult Grade II Meningioma,1
8056,Malignant Cellular Infiltrate,"Carcinoma, Granular Cell",1
8057,Epithelial Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
8058,Epithelial Component Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
8059,Hereditary Lesion,Hereditary Male Breast Carcinoma,1
8060,Malignant Cellular Infiltrate,Low Grade Salivary Gland Mucoepidermoid Carcinoma,1
8061,Carcinomatous Component Present,Bladder Urothelial Carcinoma in Situ,1
8062,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
8063,Mixed Cellular Population,Mucinous cystadenofibroma,1
8064,Cutaneous Involvement,Melanoma Arising in Giant Congenital Nevus,1
8065,Absence of Invasion,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
8066,Chronic Phase of Disease,"Leukemia, Myeloid, Chronic-Phase",1
8067,Tubular Structures Present,"Gallbladder Adenocarcinoma, Biliary Type",1
8068,Primary Lesion,Chondroblastic osteosarcoma,1
8069,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia without Maturation,1
8070,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
8071,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
8072,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
8073,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
8074,Adulthood Lesion,Adult Pure Erythroid Leukemia,1
8075,Cutaneous Involvement,Acanthoma,1
8076,Glandular Pattern,"Vulvar Adenocarcinoma, Intestinal-Type",1
8077,Carcinomatous Component Present,Recurrent Adult Liver Carcinoma,1
8078,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage II,1
8079,Epithelial Component Present,Mucinous adenocarcinoma of appendix,1
8080,Metastatic Lesion,Secondary malignant neoplasm of prostate,1
8081,Acanthosis,Verrucous carcinoma,1
8082,Increased Cellularity Present,Recurrent Childhood Pineoblastoma,1
8083,Fibrotic Stroma Formation,Borderline Ovarian Serous Adenofibroma,1
8084,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma,1
8085,Malignant Cellular Infiltrate,Localized Carcinoma,1
8086,atypia morphology,Malignant Ovarian Luteinized Thecoma,1
8087,Malignant Cellular Infiltrate,Stage IIIA Ampulla of Vater Cancer AJCC v8,1
8088,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Lung,1
8089,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7,1
8090,Cutaneous Involvement,Cutaneous myxoma,1
8091,Carcinomatous Component Present,Non-small cell lung cancer stage II,1
8092,Villous atrophy,Immunoproliferative Small Intestinal Disease,1
8093,Malignant Cellular Infiltrate,Ewing's sarcoma recurrent,1
8094,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,IgM monoclonal gammopathy of uncertain significance,1
8095,Malignant Cellular Infiltrate,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
8096,Angiodestructive Pattern,Pulmonary Lymphomatoid Granulomatosis,1
8097,Malignant Cellular Infiltrate,Recurrent Childhood Burkitt Lymphoma,1
8098,Adulthood Lesion,Adult Mixed Glioma,1
8099,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
8100,Malignant Cellular Infiltrate,Stage IIIA Ovarian Carcinoma,1
8101,Epithelial Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
8102,Borderline Lesion,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
8103,Epithelial Component Present,Stage I Paranasal Sinus Cancer,1
8104,Infiltrative Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
8105,Chronic Inflammatory Infiltrate,Lymphomatoid Granulomatosis,1
8106,Endophytic Tumor Growth,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
8107,Desmoplastic Stroma Formation,Desmoplastic infantile astrocytoma,1
8108,Epithelial Component Present,Stage IVA Pharyngeal Carcinoma,1
8109,Malignant Cellular Infiltrate,Resectable Pleural Malignant Mesothelioma,1
8110,Malignant Cellular Infiltrate,Hypergranular promyelocytic leukemia,1
8111,Carcinomatous Component Present,"Carcinoma, Basal Cell",1
8112,Microinvasive tumor,Ductal Carcinoma In Situ with Microinvasion,1
8113,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
8114,Geographic Necrosis,Childhood Central Nervous System Embryonal Carcinoma,1
8115,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
8116,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,1
8117,Epithelial Component Present,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8118,Well-Circumscribed Lesion,Fundic gland polyp,1
8119,Unresectable Mass,Unresectable Bone Sarcoma,1
8120,Epithelial Component Present,Colorectal Adenocarcinoma Metastatic in the Liver,1
8121,Absence of Invasion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
8122,Epithelial Component Present,Anal Verrucous Carcinoma,1
8123,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
8124,Epithelial Component Present,Adenoma of the Colon with Intramucosal Adenocarcinoma,1
8125,Epithelial Component Present,Stage IIIB Bladder Cancer AJCC v8,1
8126,Epithelial Component Present,Non-small cell lung cancer stage IIIB,1
8127,Carcinomatous Component Present,Stage IIIA Distal Bile Duct Cancer AJCC v8,1
8128,Malignant Cellular Infiltrate,Rectal Carcinoma,1
8129,Exophytic Polypoid Lesion,Gastric Cronkhite Canada Polyposis,1
8130,Immunosuppression-Related Post-Transplant Toxicity,"Post-transplant lymphoproliferative disorder, polymorphic",1
8131,Recurrent disease,Recurrent Thyroid Gland Papillary Carcinoma,1
8132,Cartilaginous Differentiation,Osteochondromatosis,1
8133,High Grade Non Cartilaginous Sarcomatous Stroma Present,Dedifferentiated chondrosarcoma,1
8134,Peripheral Nuclear Palisading,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
8135,Monomorphic Cellular Infiltrate,Childhood Cerebral Ependymoma,1
8136,Carcinomatous Component Present,Adenocarcinoma of anal canal,1
8137,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrioid adenoma, borderline malignancy",1
8138,Childhood Lesion,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
8139,Epithelial Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
8140,Differentiating Neuroblasts Under 5 Percent of the Tumor Cells,Poorly Differentiated Neuroblastoma,1
8141,Immunologic Deficiency Syndromes,Transplant-Related Skin Squamous Cell Carcinoma,1
8142,Cutaneous Involvement,"Xeroderma pigmentosum, group F",1
8143,Unclassifiable Lesion,"Refractory NK-Cell Lymphoma, Unclassifiable",1
8144,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma,1
8145,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
8146,Microvascular Proliferation,MGMT-Methylated Glioblastoma,1
8147,Fibrotic Stroma Formation,Adenocarcinofibroma,1
8148,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8,1
8149,Malignant Cellular Infiltrate,Advanced Extracranial Malignant Solid Neoplasm,1
8150,Malignant Cellular Infiltrate,Kaposi's sarcoma of skin,1
8151,Intestinal metaplasia,Lung Enteric Adenocarcinoma,1
8152,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma refractory,1
8153,Pregnancy Complications,Morbidly adherent placenta (disorder),1
8154,Carcinomatous Component Present,Stage III Distal Bile Duct Cancer AJCC v7,1
8155,Carcinomatous Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
8156,Carcinomatous Component Present,Low Grade Salivary Gland Carcinoma,1
8157,Glomerular Hypertrophy,Secondary Focal Segmental Glomerulosclerosis,1
8158,Benign Cellular Infiltrate,Leiomyoma of ciliary body,1
8159,Malignant Cellular Infiltrate,Cervical Esophagus Adenocarcinoma,1
8160,Vascular Channel Formation,Hemangioma acquired,1
8161,High Grade Lesion,Secondary Supratentorial Anaplastic Astrocytoma,1
8162,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
8163,Cellular Pleomorphism,"Perivascular epithelioid tumor, malignant",1
8164,High Grade Lesion,Intracortical osteosarcoma,1
8165,Epithelial Component Present,Adenomatous Polyposis Coli,1
8166,Malignant Cellular Infiltrate,Region 17p13 Allelic Loss Associated Medulloblastoma,1
8167,Malignant Cellular Infiltrate,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage,1
8168,Carcinomatous Component Present,Hereditary Renal Cell Carcinoma,1
8169,Chronic lymphocytic inflammation,Parotid Gland Warthin Tumor,1
8170,Well Differentiated Lesion,Minimally Invasive Mucinous Lung Adenocarcinoma,1
8171,Carcinomatous Component Present,Squamous cell carcinoma of oropharynx,1
8172,Vascular Channel Formation,Composite hemangioendothelioma,1
8173,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
8174,Primary Lesion,Childhood Brain Anaplastic Astrocytoma,1
8175,Mesenchymal Component Present,Perineal Ectopic Fibroadenoma,1
8176,Benign Cellular Infiltrate,"Benign neoplasm of eye, unspecified",1
8177,Well Differentiated Neuroendocrine Lesion,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
8178,Epithelial Component Present,Carcinoma of base of tongue,1
8179,Immunosuppression-Related Post-Transplant Toxicity,Graft-vs-Host Disease,1
8180,Pregnancy Complications,Metastatic Neoplasm to the Placenta,1
8181,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
8182,Cutaneous Involvement,Skin Mastocytoma,1
8183,Malignant Cellular Infiltrate,Kaposi's sarcoma of extrahepatic bile duct,1
8184,Carcinomatous Component Present,"Urinary bladder carcinoma stage I, with cancer in situ",1
8185,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
8186,Mass of body structure,Immature Granulocytic Sarcoma,1
8187,Mild dysplasia,"Glandular intraepithelial neoplasia, low grade",1
8188,Absence of Stromal Invasion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
8189,Severe dysplasia,Stage 0 Anal Cancer AJCC v8,1
8190,Malignant Cellular Infiltrate,fibrosarcoma of small intestine,1
8191,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,1
8192,Epithelial Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
8193,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Microadenoma,1
8194,Carcinomatous Component Present,Paranasal Sinus Cancer,1
8195,Locally Aggressive Lesion,Atypical fibroxanthoma - spindle cell type,1
8196,Malignant Cellular Infiltrate,Hepatic cancer metastatic,1
8197,Carcinomatous Component Present,Prognostic Stage IB Breast Cancer AJCC v8,1
8198,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
8199,Lobulated Growth Pattern,Unresectable Chordoma,1
8200,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
8201,Epithelial Component Present,"Neuroendocrine carcinoma, metastatic",1
8202,Mixed Cellular Population,Adenomyoma,1
8203,Low Grade Lesion,Juvenile Pilocytic Astrocytoma,1
8204,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v7,1
8205,Benign Cellular Infiltrate,Benign Mediastinal Germ Cell Tumor,1
8206,Carcinomatous Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
8207,Epithelial Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
8208,Well Differentiated Neuroendocrine Lesion,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
8209,Carcinomatous Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
8210,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
8211,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma,1
8212,Absence of Stromal Invasion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
8213,Neuroendocrine Differentiation,Neoplasm of aortic body,1
8214,Recurrent disease,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
8215,Necrotic changes (finding),Brain Glioblastoma,1
8216,Tissue Differentiation Uncertain,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
8217,Epithelial Component Present,Metanephric stromal tumor,1
8218,Malignant Cellular Infiltrate,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",1
8219,Slow Growing Mass,Sellar Ependymoma,1
8220,Monoclonal Cellular Population Present,Thyroid Gland Black Follicular Adenoma,1
8221,Malignant Cellular Infiltrate,Advanced Unfavorable Hodgkin Lymphoma,1
8222,Tissue Differentiation Uncertain,"Phosphaturic mesenchymal tumor, benign",1
8223,Exophytic Polypoid Lesion,Colon Juvenile Polyp,1
8224,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Primitive",1
8225,Benign Cellular Infiltrate,Colon Cavernous Hemangioma,1
8226,Hereditary Lesion,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",1
8227,Cutaneous Involvement,Porokeratotic eccrine ostial and dermal duct nevus,1
8228,Cutaneous Involvement,Desmoplastic Nevus,1
8229,Malignant Cellular Infiltrate,Stage IA Uterine Sarcoma AJCC v7,1
8230,Neuroendocrine Differentiation,Benign neuroendocrine tumor,1
8231,Malignant Cellular Infiltrate,Refractory Peripheral Primitive Neuroectodermal Tumor,1
8232,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2b,1
8233,Invasive Lesion,adenocarcinoma of breast with spindle cell metaplasia,1
8234,Benign Cellular Infiltrate,Hemangioma of spleen,1
8235,Carcinomatous Component Present,Stage IIIA Breast Carcinoma,1
8236,Epithelial Component Present,Anal Intraepithelial Neoplasia 1,1
8237,Epithelial Component Present,carcinosarcoma of lung,1
8238,Malignant Cellular Infiltrate,Stage III Immature Testicular Teratoma AJCC v6 and v7,1
8239,Malignant Cellular Infiltrate,Gastrointestinal Stromal Sarcoma,1
8240,Epithelial Component Present,Poorly Differentiated Thyroid Carcinoma,1
8241,Multinodular Mass,Small Intestinal Angiosarcoma,1
8242,Carcinomatous Component Present,Resectable Pancreatic Ductal Adenocarcinoma,1
8243,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
8244,Malignant Cellular Infiltrate,Small Intestinal Myeloid Sarcoma,1
8245,Carcinomatous Component Present,Acinic cell carcinoma of salivary gland,1
8246,Unicystic Lesion,intraductal papilloma of salivary gland,1
8247,Carcinomatous Component Present,Metastatic signet ring cell carcinoma,1
8248,Myxoid Stroma Formation,Metastatic Epithelioid Hemangioendothelioma,1
8249,Malignant Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma,1
8250,Cutaneous Involvement,Eccrine Poroma,1
8251,Follicular Cell Differentiation,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
8252,Immunologic Deficiency Syndromes,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
8253,Malignant Cellular Infiltrate,Tonsillar Lymphoma,1
8254,Carcinomatous Component Present,Inflammatory Breast Carcinoma,1
8255,Benign Cellular Infiltrate,Benign neoplasm of hilus of lung,1
8256,Exophytic Polypoid Lesion,Colorectal hyperplastic polyp,1
8257,Epithelial Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
8258,Nuclear Pseudoinclusion,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
8259,Malignant Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma,1
8260,Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia,1
8261,Non-Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v7,1
8262,Carcinomatous Component Present,Follicular thyroid carcinoma,1
8263,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v8,1
8264,Schwannian Stroma More than 50 Percent of the Tumor Volume,Central Nervous System Ganglioneuroblastoma,1
8265,Cystic Change,mucoepidermoid carcinoma of lung,1
8266,Epithelial Component Present,insulinoma,1
8267,Malignant Cellular Infiltrate,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
8268,Invasive Lesion,Metastatic Squamous Cell Breast Carcinoma,1
8269,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor,1
8270,Recurrent disease,Squamous cell carcinoma of the hypopharynx recurrent,1
8271,'Starry-sky' pattern,Adult Burkitt Lymphoma,1
8272,Moderately Differentiated Lesion,Moderately Differentiated Prostate Adenocarcinoma,1
8273,Tissue Differentiation Uncertain,Kidney Epithelioid Type Angiomyolipoma,1
8274,Dysplasia,Carcinoma in situ of vagina,1
8275,Benign Cellular Infiltrate,Pericardial Adenomatoid Tumor,1
8276,Low Mitotic Activity,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
8277,Epithelial Component Present,Stage III Bladder Cancer AJCC v6 and v7,1
8278,Carcinomatous Component Present,Colorectal Undifferentiated Carcinoma,1
8279,Childhood Lesion,Childhood Testicular Neoplasm,1
8280,Necrotic changes (finding),Malignant Testicular Leydig Cell Tumor,1
8281,Dysplasia,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
8282,Lobulated Growth Pattern,Mediastinal Chondroma,1
8283,Epithelial Component Present,Carcinoma in situ of vagina,1
8284,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
8285,Cystic Change,Clear cell papillary renal cell carcinoma,1
8286,Primary Lesion,Adult Brain Stem Astrocytoma,1
8287,Malignant Cellular Infiltrate,"Carcinoma, Skin Appendage",1
8288,Metastatic/Recurrent Disease,Synovial sarcoma non-metastatic,1
8289,Carcinomatous Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
8290,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7,1
8291,Cutaneous Involvement,Hemangioendothelioma of skin,1
8292,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I,1
8293,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
8294,Hypercellular bone marrow,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
8295,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
8296,Alternative Fascicle (Bundle) Pattern,Endobronchial Leiomyoma,1
8297,Junctional Proliferation,Spindle cell nevus of Reed,1
8298,Complete Spontaneous Regression,Lymphomatoid Papulosis,1
8299,Invasive Lesion,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
8300,Marked Nuclear Atypia Present,Malignant Uterine Corpus PEComa,1
8301,Epithelial Component Present,Acantholytic squamous cell carcinoma of skin,1
8302,Malignant Cellular Infiltrate,Cloacogenic carcinoma,1
8303,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
8304,Carcinomatous Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
8305,Malignant Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma,1
8306,Adnexal Differentiation,Piloleiomyoma,1
8307,High Mitotic Activity,Endometrial Large Cell Neuroendocrine Carcinoma,1
8308,Malignant Cellular Infiltrate,Recurrent Ovarian Mucinous Adenocarcinoma,1
8309,Childhood Lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,1
8310,Carcinomatous Component Present,Trichilemmocarcinoma,1
8311,Generalized Dysplasia,Colorectal Filiform Serrated Adenoma,1
8312,Malignant Cellular Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
8313,Epithelial Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
8314,Malignant Cellular Infiltrate,Gastric Adenocarcinoma,1
8315,Malignant Cellular Infiltrate,Skin Signet Ring Cell Basal Cell Carcinoma,1
8316,Papillary Pattern,Oncocytic Schneiderian papilloma,1
8317,Absence of Invasion or Limited Invasion Present,Peritoneal Well Differentiated Papillary Mesothelioma,1
8318,Monomorphic Cellular Infiltrate,Childhood Infratentorial Ependymoma,1
8319,Complete Spontaneous Regression,Type D Lymphomatoid Papulosis,1
8320,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma,1
8321,Neuroendocrine Differentiation,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
8322,Resectable Mass,Resectable Malignant Liver Neoplasm,1
8323,Nuclear pleomorphism,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
8324,Borderline Lesion,Peritoneal cystic mesothelioma,1
8325,Malignant Cellular Infiltrate,malignant neoplasm of large intestine stage IV,1
8326,Malignant Cellular Infiltrate,Malignant Ovarian Teratoma,1
8327,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Papillary Carcinoma,1
8328,Malignant Cellular Infiltrate,leiomyosarcoma of appendix,1
8329,Epithelial Component Present,Stage IIIA Ovarian Carcinoma,1
8330,Epithelial Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
8331,Malignant Cellular Infiltrate,Stage II Adult Immunoblastic Lymphoma,1
8332,Carcinomatous Component Present,Stage I Merkel Cell Carcinoma AJCC v7,1
8333,Cauliflower-Like Mass,Lung Squamous Cell Papilloma,1
8334,Vascular Channel Formation,Parotid Gland Hemangioma,1
8335,Malignant Cellular Infiltrate,Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma,1
8336,Papillary Pattern,Vulvar Warty Carcinoma,1
8337,Malignant Cellular Infiltrate,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
8338,High Grade Lesion,synovial sarcoma,1
8339,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor,1
8340,Hyaline Cartilage Differentiation,Soft tissue chondroma,1
8341,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor,1
8342,Thin-Walled Branching Vascular Pattern,Epidural Spinal Canal Angiolipoma,1
8343,Non-Invasive Lesion,Ampulla of Vater Tubulovillous Adenoma,1
8344,Low Grade Neuroendocrine Lesion,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
8345,Cutaneous Involvement,Eccrine hidrocystoma,1
8346,Adulthood Lesion,Stage IV Adult Non-Hodgkin Lymphoma,1
8347,Slow Growing Mass,Adult Pilocytic Astrocytoma,1
8348,Malignant Cellular Infiltrate,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
8349,Necrotic changes (finding),Small Intestinal Small Cell Neuroendocrine Carcinoma,1
8350,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
8351,Benign Cellular Infiltrate,Colon Ganglioneuroma,1
8352,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
8353,Secondary Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
8354,"Fully Differentiated ""Adult-Type"" Tissues Present",Immature Gastric Teratoma,1
8355,Epithelial Component Present,Appendix Sessile Serrated Adenoma/Polyp,1
8356,Benign Cellular Infiltrate,Cellular Schwannoma,1
8357,Epithelial Component Present,Anal Canal Neuroendocrine Neoplasm,1
8358,In Situ Lesion,Stage 0 Lung Cancer AJCC v6 and v7,1
8359,Chromogranin A Positive Neoplastic Cells Present,Recurrent Digestive System Neuroendocrine Tumor G1,1
8360,Therapy-Related Toxicity,Transplant-Related Hematologic Malignancy,1
8361,Anaplasia,Recurrent Anaplastic Large Cell Lymphoma,1
8362,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ringed sideroblasts,1
8363,Malignant Cellular Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
8364,Mild cytologic atypia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
8365,Malignant Cellular Infiltrate,lymphoma of spinal cord,1
8366,Neuronal Differentiation,Desmoplastic infantile ganglioglioma,1
8367,Cystic Change,Dermoid Cyst,1
8368,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
8369,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
8370,Fibrosis,Lipomatosis of Nerve,1
8371,Malignant Cellular Infiltrate,"Supratentorial Embryonal Tumor, Not Otherwise Specified",1
8372,Neuroendocrine Differentiation,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
8373,Epithelial Component Present,Bladder Urachal Adenocarcinoma,1
8374,Malignant Cellular Infiltrate,Uterine Corpus Carcinosarcoma,1
8375,Indolent Clinical Course,Glomangiomatosis,1
8376,Malignant Cellular Infiltrate,Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8,1
8377,Malignant Cellular Infiltrate,Recurrent Pancreatic Acinar Cell Carcinoma,1
8378,Epithelial Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage,1
8379,Malignant Cellular Infiltrate,Blastic Granulocytic Sarcoma,1
8380,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
8381,Acinar Cell Differentiation,Acinar cell adenoma,1
8382,Nuclear Atypia,Cerebral Glioblastoma,1
8383,Extraosseous Lesion,Cardiac Extraskeletal Osteosarcoma,1
8384,Malignant Cellular Infiltrate,Refractory Soft Tissue Sarcoma,1
8385,Mixture of Germ Cell Neoplastic Components Present,Mixed Germ Cell Tumor,1
8386,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
8387,Recurrent disease,Recurrent Anal Mucinous Adenocarcinoma,1
8388,Monomorphic Cellular Infiltrate,Childhood Oligodendroglioma,1
8389,atypia morphology,Atypical hyperplasia of breast,1
8390,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
8391,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
8392,Exophytic Polypoid Lesion,Colorectal Villous Adenoma,1
8393,Malignant Component Present,Dermoid cyst with secondary tumor,1
8394,Carcinomatous Component Present,Stage IVC Colorectal Cancer AJCC v8,1
8395,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,1
8396,Refractory Disease,Refractory Malignant Germ Cell Tumor,1
8397,Chronic lymphocytic inflammation,Follicular Bronchitis/Bronchiolitis,1
8398,Primary Lesion,Diencephalic Astrocytoma,1
8399,Lobulated Growth Pattern,Unresectable Chordoma,1
8400,Malignant Cellular Infiltrate,Adult Anaplastic (Malignant) Meningioma,1
8401,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma,1
8402,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
8403,Carcinomatous Component Present,Adenosquamous cell lung cancer,1
8404,Low Mitotic Activity,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
8405,Biphasic Pattern,Borderline Ovarian Endometrioid Adenofibroma,1
8406,Recurrent disease,Recurrent Primary Peritoneal Carcinoma,1
8407,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
8408,Well-Circumscribed Lesion,Nephroblastoma,1
8409,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
8410,Malignant Cellular Infiltrate,Childhood Acute Basophilic Leukemia,1
8411,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
8412,Benign Cellular Infiltrate,inverted ductal papilloma of salivary gland,1
8413,Anaplasia,Stage I Childhood Anaplastic Large Cell Lymphoma,1
8414,Malignant Cellular Infiltrate,Adenocarcinoma in villous adenoma,1
8415,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
8416,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type",1
8417,Malignant Cellular Infiltrate,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
8418,Metastatic Lesion,Metastatic Malignant Pancreatic Neoplasm,1
8419,Ineffective hematopoiesis,Recurrent High Risk Myelodysplastic Syndrome,1
8420,Carcinomatous Component Present,Unresectable Head and Neck Squamous Cell Carcinoma,1
8421,Malignant Cellular Infiltrate,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,1
8422,Deep Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
8423,Recurrent disease,Recurrent Childhood Kidney Neoplasm,1
8424,Fibrotic Stroma Formation,Ossifying Fibroma,1
8425,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Follicular Lymphoma,1
8426,Malignant Cellular Infiltrate,Recurrent Lobular Breast Carcinoma,1
8427,High Grade Lesion,Glioblastoma with Primitive Neuronal Component,1
8428,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
8429,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
8430,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
8431,Enterochromaffin Type Granules Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
8432,Malignant Cellular Infiltrate,Pancreatic carcinoma,1
8433,Epithelial Component Present,Malignant Vulvar Phyllodes Tumor,1
8434,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ,1
8435,Primary Site Unknown,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
8436,Perivascular Pseudorosette Formation,Astroblastoma,1
8437,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
8438,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-1,1
8439,Epithelial Component Present,Proliferating Brenner Tumor,1
8440,Monomorphic Cellular Infiltrate,Childhood Ependymoma,1
8441,Epithelial Component Present,Carotid Body Paraganglioma,1
8442,Cutaneous Involvement,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
8443,Carcinomatous Component Present,Apocrine Breast Carcinoma In Situ,1
8444,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8445,Indolent Clinical Course,Vulvar Angiomyofibroblastoma,1
8446,Primary Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
8447,Carcinomatous Component Present,small cell carcinoma of extrahepatic bile duct,1
8448,Carcinomatous Component Present,Locally Advanced Lung Carcinoma,1
8449,Poorly Differentiated Lesion,Poorly Differentiated Hepatocellular Carcinoma,1
8450,Cystic Change,Malignant ovarian cyst,1
8451,Cystic Change,mucoepidermoid carcinoma of lung,1
8452,Malignant Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,1
8453,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
8454,Indolent Clinical Course,Skin Cavernous Hemangioma,1
8455,Indolent Clinical Course,Chondromyxoid fibroma,1
8456,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
8457,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP J",1
8458,Refractory Disease,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
8459,Recurrent disease,Recurrent Parotid Gland Carcinoma,1
8460,Epithelial Component Present,Cervical Mullerian Papilloma,1
8461,Childhood Lesion,Childhood Lymphoma,1
8462,Carcinomatous Component Present,Adult Liver Carcinoma,1
8463,Carcinomatous Component Present,Recurrent Endometrial Cancer,1
8464,Carcinomatous Component Present,Metastatic basal cell carcinoma,1
8465,Malignant Cellular Infiltrate,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
8466,Malignant Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
8467,Increased Cellularity Present,Recurrent Anaplastic Oligodendroglioma,1
8468,Invasive Lesion,Pituitary carcinoma,1
8469,Adnexal Differentiation,Papillary Eccrine Carcinoma,1
8470,Epithelial Component Present,Stage IV Urethral Cancer AJCC v7,1
8471,Pseudopapillary Pattern,Solid pseudopapillary tumor of the pancreas,1
8472,Malignant Cellular Infiltrate,embryonal rhabdomyosarcoma of orbit,1
8473,Epithelial Component Present,Gallbladder adenocarcinoma,1
8474,Thyroglobulin Positive Neoplastic Cells Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
8475,Mixed Cellular Population,Fallopian Tube Serous Adenofibroma,1
8476,Epithelial Component Present,Acinic Cell Breast Carcinoma,1
8477,Benign Cellular Infiltrate,Osteoblastoma,1
8478,Epithelial Component Present,Masaoka-Koga Stage IV,1
8479,Malignant Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
8480,Childhood Lesion,Childhood Brain Germinoma,1
8481,Hemorrhagic,Radiation-Related Angiosarcoma,1
8482,Malignant Cellular Infiltrate,Invasive Mucinous Lung Adenocarcinoma,1
8483,Absence of Invasion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
8484,Adulthood Lesion,Aggressive Adult Non-Hodgkin Lymphoma,1
8485,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
8486,Indolent Clinical Course,Venous Angioleiomyoma,1
8487,Minimal Invasion Present,Bronchioloalveolar Adenocarcinoma,1
8488,Epithelial Component Present,Bladder Urothelial Papilloma,1
8489,Secondary Lesion,Metastatic signet ring cell carcinoma,1
8490,Dysplasia,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
8491,Diffuse Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
8492,Malignant Cellular Infiltrate,Unfavorable Hodgkin Lymphoma,1
8493,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
8494,Malignant Cellular Infiltrate,Childhood Ganglioneuroblastoma,1
8495,Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
8496,Intraductal Lesion,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
8497,Well Differentiated Neuroendocrine Lesion,Stage II Gastric Neuroendocrine Tumor AJCC v8,1
8498,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
8499,High Grade Lesion,Unresectable Dedifferentiated Liposarcoma,1
8500,Benign Cellular Infiltrate,Cardiac Capillary Hemangioma,1
8501,Storiform Growth Pattern,Abdominal Undifferentiated Pleomorphic Sarcoma,1
8502,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v7,1
8503,Secondary Lesion,Secondary malignant neoplasm of anus,1
8504,In Situ Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
8505,Childhood Lesion,Childhood Pilomyxoid Astrocytoma,1
8506,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v7,1
8507,Chronic Inflammatory Infiltrate,Non-Ossifying Fibroma,1
8508,Benign Cellular Infiltrate,Multiple hamartoma of lung,1
8509,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia,1
8510,Local disease,Chondroid lipoma,1
8511,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
8512,Epithelial Component Present,EBV-Related Carcinoma,1
8513,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
8514,Epithelial Component Present,Stage IV Prostate Cancer AJCC v7,1
8515,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
8516,Solitary mass,Sellar Chordoma,1
8517,Malignant Cellular Infiltrate,Stage IA Ampulla of Vater Cancer AJCC v7,1
8518,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
8519,Borderline Lesion,cystic mucinous tumor of pancreas with moderate dysplasia,1
8520,Slow Growing Mass,Brain Ependymoma,1
8521,Malignant Cellular Infiltrate,Childhood Myxoid Chondrosarcoma,1
8522,Malignant Cellular Infiltrate,"Papillary renal cell carcinoma, sporadic",1
8523,Radiation Sickness,Radiation-Induced Cancer,1
8524,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma,1
8525,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
8526,Primary Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
8527,Intermediate Filaments Present,Extrarenal Rhabdoid Tumor of the Liver,1
8528,Malignant Cellular Infiltrate,Stage I Rectal Cancer AJCC v8,1
8529,Epithelial Component Present,Cervix carcinoma,1
8530,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage IV,1
8531,Malignant Cellular Infiltrate,Low Grade Mucoepidermoid Breast Carcinoma,1
8532,Burn injury,Old Burn Scar-Related Neoplasm,1
8533,Papillary Pattern,Sphenoid Sinus Schneiderian Papilloma,1
8534,Carcinomatous Component Present,Skin Basaloid Carcinoma,1
8535,Malignant Cellular Infiltrate,Cutaneous Melanoma,1
8536,Cystic Change,Brenner Tumor,1
8537,Perivascular fibrosis,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma,1
8538,Tissue of Mullerian Origin Present,Papillary adenofibroma,1
8539,Myxoid Stroma Formation,Vertebral chordoma,1
8540,Non-Invasive Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
8541,Malignant Cellular Infiltrate,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
8542,Epithelial Component Present,Nipple Carcinoma,1
8543,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
8544,Hyperplastic Tissue Present,Endometrial Hyperplasia,1
8545,Secondary Lesion,Metastatic Neoplasm to the Gallbladder,1
8546,Indolent Clinical Course,Deep Lipoma,1
8547,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
8548,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v7,1
8549,Malignant Cellular Infiltrate,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
8550,Malignant Cellular Infiltrate,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
8551,Carcinomatous Component Present,Stage 0 Gastric Cancer AJCC v6 and v7,1
8552,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Neoplasm,1
8553,Angioinvasion,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
8554,Malignant Cellular Infiltrate,Advanced Laryngeal Squamous Cell Carcinoma,1
8555,Refractory Disease,Refractory Gastric Carcinoma,1
8556,Epithelial Component Present,Thymic Squamous Cell Carcinoma,1
8557,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
8558,Secondary Lesion,Hormone refractory prostate cancer,1
8559,Malignant Cellular Infiltrate,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
8560,Indolent Clinical Course,Bone Leiomyoma,1
8561,Tubular Pattern,Somatostatinoma,1
8562,Epithelial Component Present,Low grade cervical glandular intraepithelial neoplasia,1
8563,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Papillary Variant",1
8564,Epithelial Component Present,Lung Pleomorphic Adenoma,1
8565,Indolent Clinical Course,Chondroma,1
8566,Oligodendroglial Component Present,Childhood Oligodendroglioma,1
8567,Well Differentiated Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor,1
8568,Severe cytologic atypia,Anaplastic Embryonal Rhabdomyosarcoma,1
8569,Anaplasia,Stage I Anaplastic Large Cell Lymphoma,1
8570,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Mature Teratoma,1
8571,Mitotic Activity,"Testicular Yolk Sac Tumor, Papillary Pattern",1
8572,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
8573,Mesenchymal Component Present,Benign Prostate Phyllodes Tumor,1
8574,Malignant Cellular Infiltrate,"Synovial sarcoma, biphasic",1
8575,Malignant Cellular Infiltrate,Recurrent Medulloblastoma,1
8576,Hyalinized Stroma Formation,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
8577,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Pulmonary Artery Choriocarcinoma,1
8578,Malignant Cellular Infiltrate,Methotrexate-Associated Hodgkin Lymphoma,1
8579,Toxic effect,Environment-Related Malignant Neoplasm,1
8580,Indolent Clinical Course,Benign Pericytic Neoplasm,1
8581,Malignant Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
8582,Epithelial Component Present,Fallopian Tube Carcinoma,1
8583,Epithelial Component Present,Typical Ovarian Thecoma,1
8584,Well Differentiated Lesion,Human Papillomavirus-Related Verrucous Carcinoma,1
8585,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
8586,Malignant Cellular Infiltrate,Lobular carcinoma in situ of breast,1
8587,Carcinomatous Component Present,Ductal Carcinoma In Situ with Microinvasion,1
8588,Immunosuppression-Related Post-Transplant Toxicity,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
8589,Vascular Channel Formation,Deep Hemangioma,1
8590,Malignant Cellular Infiltrate,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
8591,Infiltrative Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
8592,Cystic Change,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",1
8593,Epithelial Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
8594,Carcinomatous Component Present,Stage IB1 Cervical Cancer,1
8595,Carcinomatous Component Present,Stage I Skin Cancer,1
8596,Malignant Cellular Infiltrate,Palate carcinoma,1
8597,Cutaneous Involvement,Pathologic Stage IIC Cutaneous Melanoma AJCC v8,1
8598,Malignant Cellular Infiltrate,Malignant neoplasm of breast,1
8599,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans,1
8600,Anaplasia,Recurrent Childhood Giant Cell Glioblastoma,1
8601,Hereditary Lesion,BRCA2 Syndrome,1
8602,Epithelial Component Present,Stage I Prostate Cancer AJCC v8,1
8603,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
8604,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
8605,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
8606,Carcinomatous Component Present,small cell carcinoma of gallbladder,1
8607,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
8608,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
8609,Firm mass,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,1
8610,Anaplasia,Multifocal Glioblastomas,1
8611,Epithelial Component Present,signet ring cell carcinoma of gallbladder,1
8612,Epithelial Component Present,Fallopian Tube Carcinoma,1
8613,Epithelial Component Present,Alcohol-Related Hepatocellular Carcinoma,1
8614,Borderline Lesion,Childhood Grade III Lymphomatoid Granulomatosis,1
8615,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma,1
8616,Epithelial Component Present,High Grade Salivary Gland Carcinoma,1
8617,Cutaneous Involvement,Epithelioid hemangioma of skin,1
8618,Acanthosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
8619,Refractory Disease,Refractory Myxoid Liposarcoma,1
8620,Carcinomatous Component Present,Squamous cell carcinoma of palate,1
8621,Primary Lesion,lymphoma of spinal cord,1
8622,Cutaneous Involvement,Nodular melanoma,1
8623,Follicular Structures Present,Thyroid Gland Black Follicular Adenoma,1
8624,Carcinomatous Component Present,"Bronchiolo-alveolar carcinoma, non-mucinous",1
8625,Malignant Cellular Infiltrate,Metastatic Bladder Small Cell Carcinoma,1
8626,Invasive Lesion,Medullary carcinoma of breast,1
8627,Vascular Channel Formation,Myxoma,1
8628,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia,1
8629,Monophasic Pattern,"Synovial sarcoma, spindle cell",1
8630,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v6,1
8631,Benign Cellular Infiltrate,Sporadic Cylindroma,1
8632,Malignant Cellular Infiltrate,Seminoma,1
8633,Microvascular Proliferation,Infratentorial Glioblastoma,1
8634,Malignant Cellular Infiltrate,Low Grade Broad Ligament Serous Adenocarcinoma,1
8635,Severe dysplasia,Carcinoma in situ of cecum,1
8636,Cutaneous Involvement,Dermal Duct Tumor,1
8637,Epithelial Component Present,Metastatic Breast Neuroendocrine Neoplasm,1
8638,Low Mitotic Activity,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
8639,High Grade Lesion,Infratentorial Glioblastoma,1
8640,Dysplasia,villous adenoma of stomach,1
8641,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
8642,Benign Cellular Infiltrate,Angiomyofibroblastoma,1
8643,Intraductal Lesion,Atypical Ductal Breast Hyperplasia,1
8644,Dysplasia,Tubulovillous adenoma of rectum,1
8645,In Situ Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
8646,Breast Microcalcification,Childhood Brain Oligodendroglioma,1
8647,Secondary Lesion,Locally Advanced Malignant Solid Neoplasm,1
8648,Epithelial Component Present,"Carcinoma of urinary bladder, superficial",1
8649,Carcinomatous Component Present,Pseudomyxoma Peritonei,1
8650,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
8651,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Cortex,1
8652,Indolent Clinical Course,Oral Cavity Benign Granular Cell Tumor,1
8653,Epithelial Component Present,Multifocal breast carcinoma,1
8654,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
8655,Deep Lesion,Pelvic Fibromatosis,1
8656,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v7 Stage,1
8657,Carcinomatous Component Present,Multicentric Thyroid Gland Papillary Carcinoma,1
8658,Metastatic Lesion,Secondary malignant neoplasm of rectum,1
8659,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
8660,Malignant Cellular Infiltrate,Colon Small Cell Neuroendocrine Carcinoma,1
8661,High Mitotic Activity,Combined Lung Small Cell and Squamous Cell Carcinoma,1
8662,Primary Lesion,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
8663,Well Differentiated Lesion,Human Papillomavirus-Related Verrucous Carcinoma,1
8664,Solitary mass,Cardiac Epithelioid Hemangioendothelioma,1
8665,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast stage III,1
8666,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
8667,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7,1
8668,Malignant Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma,1
8669,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
8670,Refractory Disease,Refractory Melanoma,1
8671,Cutaneous Involvement,Bullous pemphigoid,1
8672,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
8673,Diffuse Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,1
8674,Carcinomatous Component Present,Prognostic Stage IIB Breast Cancer AJCC v8,1
8675,Recurrent disease,Recurrent Acute Erythroid Leukemia,1
8676,Carcinomatous Component Present,Bladder adenocarcinoma stage 0,1
8677,Carcinomatous Component Present,Undifferentiated carcinoma of ovary,1
8678,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1
8679,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
8680,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
8681,Malignant Cellular Infiltrate,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
8682,Carcinomatous Component Present,Carcinoma,1
8683,Biphasic Pattern,carcinosarcoma of extrahepatic bile duct,1
8684,Malignant Cellular Infiltrate,Stage IVB Bone Cancer AJCC v8,1
8685,Biphasic Pattern,carcinosarcoma of extrahepatic bile duct,1
8686,Nuclear pleomorphism,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma,1
8687,Refractory Disease,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
8688,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
8689,Intraductal Lesion,Atypical Ductal Breast Hyperplasia,1
8690,Malignant Cellular Infiltrate,clear cell adenocarcinoma of gallbladder,1
8691,Diffuse Lesion,Intraductal Breast Papillomatosis,1
8692,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
8693,Diffuse Pattern,Diffuse large B-cell lymphoma refractory,1
8694,Epithelial Component Present,Thyroid Gland Adenocarcinoma,1
8695,Carcinomatous Component Present,Esophageal carcinoma recurrent,1
8696,Malignant Cellular Infiltrate,"Testicular Intratubular Germ Cell Neoplasia, Unclassified",1
8697,Marked Thickening of the Bladder Urothelium Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
8698,Malignant Cellular Infiltrate,Acute lymphoblastic leukemia recurrent,1
8699,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
8700,Cutaneous Involvement,Cutaneous Melanoma by AJCC v7 Stage,1
8701,Erythema,Multifocal superficial basal cell carcinoma,1
8702,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
8703,Seizures,Dysembryoplastic neuroepithelial tumor,1
8704,Necrotic changes (finding),Resectable Dedifferentiated Liposarcoma,1
8705,Malignant Cellular Infiltrate,Stage IC Uterine Corpus Cancer AJCC v6,1
8706,High Mitotic Activity,Pleomorphic Variant Mantle Cell Lymphoma,1
8707,Carcinomatous Component Present,Stage IB Hepatocellular Carcinoma AJCC v8,1
8708,Cutaneous Involvement,Acanthosis Nigricans,1
8709,Malignant Cellular Infiltrate,Stage IIA Colorectal Cancer AJCC v8,1
8710,Nuclear Molding,Childhood Lung Small Cell Carcinoma,1
8711,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8,1
8712,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma non-metastatic,1
8713,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2,1
8714,Cystic Change,"Cystadenocarcinoma, Mucinous",1
8715,Metastatic Lesion,Metastatic angiosarcoma,1
8716,Infiltrative Growth Pattern,Glioblastoma by Gene Expression Profile,1
8717,Carcinomatous Component Present,Stomach Carcinoma,1
8718,Malignant Cellular Infiltrate,Metastatic angiosarcoma,1
8719,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
8720,Unresectable Mass,Unresectable Bone Sarcoma,1
8721,Mitotic Activity,Epithelioid glioblastoma,1
8722,Follicular Cell Differentiation,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,1
8723,Locally Aggressive Lesion,Giant Cell Tumor of Soft Tissue,1
8724,Pushing Tumor Margin,verrucous carcinoma of vulva,1
8725,Cutaneous Involvement,Pityriasis Rubra Pilaris,1
8726,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
8727,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma,1
8728,Primary Lesion,Recurrent Hepatocellular Carcinoma,1
8729,Malignant Cellular Infiltrate,Myeloid leukemia associated with Down Syndrome,1
8730,Malignant Cellular Infiltrate,Stage I Uterine Corpus Cancer,1
8731,Primary Lesion,Refractory Primary Effusion Lymphoma,1
8732,Malignant Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,1
8733,Locally Aggressive Lesion,Superficial fibromatosis,1
8734,Vascular Channel Formation,Benign neoplasm of lymph vessels,1
8735,Intraductal Lesion,Intraductal Hyperplasia,1
8736,Primary Lesion,Primary Effusion Lymphoma,1
8737,Thin-Walled Branching Vascular Pattern,Angiolipoma,1
8738,Carcinomatous Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
8739,Carcinomatous Component Present,Stage II Lung Cancer AJCC v6,1
8740,Borderline Lesion,Borderline Ovarian Serous Adenofibroma,1
8741,Solid Growth Pattern,solid type ductal carcinoma in situ of breast,1
8742,Carcinomatous Component Present,Bladder adenocarcinoma stage IV,1
8743,Regional Disease,Crohn Disease,1
8744,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7,1
8745,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
8746,Mild dysplasia,Vaginal intraepithelial neoplasia grade 1,1
8747,Invasive Lesion,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
8748,Necrotic changes (finding),Gastric Small Cell Carcinoma,1
8749,Serotonin Positive Neoplastic Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
8750,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
8751,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
8752,Malignant Cellular Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
8753,Hereditary Lesion,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome,1
8754,Papillary Pattern,Papilloma of eyelid,1
8755,High Grade Lesion,Kidney Synovial Sarcoma,1
8756,Malignant Cellular Infiltrate,Stage IV Adult Lymphoblastic Lymphoma,1
8757,Malignant Cellular Infiltrate,Malignant neoplasm of olfactory nerve,1
8758,Osseous Differentiation,Stage IA Osteosarcoma AJCC v7,1
8759,More than 10 Mitoses per 10HPF,Childhood Lung Small Cell Carcinoma,1
8760,Malignant Cellular Infiltrate,Immunoproliferative Small Intestinal Disease,1
8761,Severe cytologic atypia,Unresectable Pancreatic Neuroendocrine Carcinoma,1
8762,Necrotic changes (finding),Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
8763,Hyperplastic Tissue Present,Simple Endometrial Hyperplasia with Atypia,1
8764,Chronic Inflammatory Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
8765,Secondary Lesion,Vaginal adenocarcinoma metastatic,1
8766,Increased Cellularity Present,Childhood Anaplastic Oligodendroglioma,1
8767,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV,1
8768,Immunologic Deficiency Syndromes,Transplant-Related Kaposi Sarcoma,1
8769,Epithelial Component Present,Gingival Spindle Cell Carcinoma,1
8770,Meckel Diverticulum,Meckel Diverticulum Neuroendocrine Tumor G1,1
8771,Extensive Stage Lesion,Advanced Sarcoma of the Extremity,1
8772,Epithelial Component Present,Functioning Pituitary Gland Macroadenoma,1
8773,Secondary Lesion,Metastatic basal cell carcinoma,1
8774,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
8775,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,1
8776,Benign Cellular Infiltrate,Urethral Inverted Papilloma,1
8777,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma,1
8778,Cutaneous Involvement,Cercarial Dermatitis,1
8779,Calcinosis,Dentinogenic Ghost Cell Tumor,1
8780,Malignant Cellular Infiltrate,"Medulloblastoma, WNT-Activated",1
8781,Immunologic Deficiency Syndromes,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders,1
8782,Well Differentiated Neuroendocrine Lesion,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,1
8783,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v7,1
8784,Malignant Cellular Infiltrate,Stage IV Bone Sarcoma AJCC v7,1
8785,Indolent Clinical Course,"Perivascular epithelioid tumor, benign",1
8786,Malignant Cellular Infiltrate,Congenital Mesoblastic Nephroma,1
8787,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage II,1
8788,Endophytic Tumor Growth,Lower Gingival Verrucous Carcinoma,1
8789,Local disease,Transitional cell cancer of the renal pelvis and ureter localized,1
8790,Carcinomatous Component Present,Skin carcinoma,1
8791,Epithelial Component Present,Fallopian Tube Serous Neoplasm,1
8792,Epithelial Component Present,Stage IVB Liver Cancer,1
8793,Cutaneous Involvement,"Basal cell carcinoma, infundibulocystic",1
8794,Malignant Cellular Infiltrate,Metastatic non-small cell lung cancer,1
8795,Epithelial Component Present,Vulvar Eccrine Porocarcinoma,1
8796,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma,1
8797,Well Differentiated Neuroendocrine Lesion,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
8798,Nuclear Atypia,Anaplastic astrocytoma,1
8799,Absence of Invasion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
8800,High Mitotic Activity,small cell carcinoma of extrahepatic bile duct,1
8801,Neuroendocrine Differentiation,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
8802,Epithelial Component Present,Normal Breast-Like Subtype of Breast Carcinoma,1
8803,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v6,1
8804,Benign Cellular Infiltrate,Benign neoplasm of cornea,1
8805,Hyperplastic Tissue Present,Circumferential Endothelial Hyperplasia,1
8806,Follicular Differentiation,"Acanthoma, Pilar Sheath",1
8807,Epithelial Component Present,Neuroendocrine cervical carcinoma,1
8808,Multilayered Rosette Formation,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
8809,In Situ Lesion,Carcinoma in situ of middle ear,1
8810,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage III,1
8811,Adulthood Lesion,Adult Primary Melanocytic Lesion of Meninges,1
8812,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage III,1
8813,Anaplasia,Frontal Lobe Anaplastic Astrocytoma,1
8814,Lobulated Growth Pattern,Chondromyxoid fibroma,1
8815,Cutaneous Involvement,"Nevus, Spindle Cell",1
8816,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v8,1
8817,Childhood Lesion,Childhood Intracranial Neoplasm,1
8818,Cutaneous Involvement,Carcinoma ex Eccrine Spiradenoma,1
8819,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx recurrent,1
8820,Malignant Cellular Infiltrate,Adult Non-Hodgkin Lymphoma by Ann Arbor Stage,1
8821,Secondary Lesion,Secondary Cerebral Hodgkin Lymphoma,1
8822,Epithelial Component Present,Juvenile papillomatosis of breast,1
8823,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
8824,Benign Cellular Infiltrate,Benign Intraocular Schwannoma,1
8825,Papillary Pattern,Childhood Thyroid Gland Papillary Carcinoma,1
8826,Malignant Cellular Infiltrate,Prognostic Stage IB Breast Cancer AJCC v8,1
8827,Perivascular fibrosis,"Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion",1
8828,Necrotic changes (finding),Lung Small Cell Carcinoma by AJCC v7 Stage,1
8829,Epithelial Component Present,Fundic gland polyp,1
8830,Single Cell Necrosis,Stage IV Merkel Cell Carcinoma AJCC v7,1
8831,Nuclear Atypia,Mesenchymal Glioblastoma,1
8832,High Mitotic Activity,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
8833,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
8834,Splenomegaly,Blast Phase,1
8835,Carcinomatous Component Present,Thymic Sarcomatoid Carcinoma,1
8836,High Grade Lesion,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
8837,Oligodendroglial Component Present,Anaplastic Oligodendroglioma,1
8838,Parakeratosis,Trichilemmoma,1
8839,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
8840,Cutaneous Involvement,Recurrent Cutaneous Melanoma of the Extremity,1
8841,Recurrent disease,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
8842,High Grade Lesion,Leiomyosarcoma NCI Grade 3,1
8843,Metastatic/Recurrent Disease,Adult Extraskeletal Myxoid Chondrosarcoma,1
8844,Alternative Fascicle (Bundle) Pattern,Leiomyoma of esophagus,1
8845,Papillary Pattern,Skin Papilloma,1
8846,Cystic Change,Benign mixed epithelial and stromal tumor of kidney,1
8847,Malignant Cellular Infiltrate,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,1
8848,Microvascular Proliferation,Proneural Glioblastoma,1
8849,Tissue of Mullerian Origin Present,Recurrent Uterine Corpus Carcinosarcoma,1
8850,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage II,1
8851,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated NPM1,1
8852,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Neoplasm,1
8853,Mitotic Activity,Mesenchymal Glioblastoma,1
8854,Epithelial Component Present,Urethral Urothelial Papilloma,1
8855,Intraductal Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
8856,Benign Cellular Infiltrate,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
8857,Epithelial Component Present,Ovarian Mucinous Carcinoid Tumor,1
8858,Malignant Cellular Infiltrate,Basal-Like Prostate Carcinoma,1
8859,Indolent Clinical Course,Hemangioma of intracranial structure,1
8860,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
8861,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v7 Stage,1
8862,Mesenchymal Metaplasia of Malignant Cells Present,Breast Carcinoma with Osseous Metaplasia,1
8863,Diffuse Pattern,Primary Cutaneous Plasmablastic Lymphoma,1
8864,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome NOS,1
8865,Neuroendocrine Differentiation,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
8866,Thyroglobulin Positive Neoplastic Cells Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
8867,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Chronic Myelomonocytic Leukemia,1
8868,Neuroectodermal Differentiation,Kadish Stage A Olfactory Neuroblastoma,1
8869,Invasive Lesion,Invasive Cribriform Breast Carcinoma,1
8870,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
8871,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma,1
8872,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7,1
8873,Aggressive Clinical Course,Invasive micropapillary carcinoma of breast,1
8874,Epithelial Component Present,Masaoka-Koga Stage II,1
8875,Metastatic Lesion,Advanced Lymphoma,1
8876,Malignant Cellular Infiltrate,Adult Anaplastic Astrocytoma,1
8877,Angiocentric Pattern,Recurrent Grade I Lymphomatoid Granulomatosis,1
8878,Metastatic/Recurrent Disease,Pulmonary Artery Intimal Sarcoma,1
8879,Non-Invasive Lesion,Stage 0a Renal Pelvis Cancer AJCC v7,1
8880,Carcinomatous Component Present,Nasopharyngeal Papillary Adenocarcinoma,1
8881,Macrotrabecular Pattern,Macrotrabecular Hepatoblastoma,1
8882,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma,1
8883,Mild cytologic atypia,Low Grade Endometrial Stromal Sarcoma,1
8884,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
8885,Regional Disease,Ureteric cancer regional,1
8886,Childhood Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
8887,Secondary Lesion,Carcinoma bone,1
8888,Epithelial Component Present,Benign oncocytoma of salivary gland,1
8889,Epithelial Component Present,Stage IIB Gallbladder Cancer AJCC v8,1
8890,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
8891,Carcinomatous Component Present,Metastatic Gastric Neuroendocrine Carcinoma,1
8892,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7,1
8893,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma,1
8894,Infiltrative Growth Pattern,Recurrent Giant Cell Glioblastoma,1
8895,Malignant Cellular Infiltrate,Resectable Digestive System Carcinoma,1
8896,Crystal deposition,Alveolar soft part sarcoma non-metastatic,1
8897,Carcinomatous Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
8898,Epithelial Component Present,Stage 0a Renal Pelvis Cancer AJCC v8,1
8899,Benign Cellular Infiltrate,Benign neoplasm of cornea,1
8900,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage II,1
8901,Carcinomatous Component Present,Ovarian Transitional Cell Carcinoma,1
8902,Malignant Cellular Infiltrate,Myxoinflammatory fibroblastic sarcoma,1
8903,Benign Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma,1
8904,Infiltrative Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
8905,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Testicular Choriocarcinoma,1
8906,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma,1
8907,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
8908,Absence of Stromal Invasion,Borderline cystadenoma,1
8909,Adnexal Differentiation,Eccrine mixed tumor of skin,1
8910,Biphasic Pattern,Fallopian Tube Serous Adenofibroma,1
8911,Papillary Pattern,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
8912,Rapidly Enlarging Mass,Rhabdomyosarcoma of cervix uteri,1
8913,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
8914,Anaplasia,Anaplastic Oligoastrocytoma,1
8915,Plasma cell inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
8916,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v6,1
8917,Hyperplastic Tissue Present,Mesothelial hyperplasia,1
8918,Multinodular Mass,Gallbladder Angiosarcoma,1
8919,Fibrotic Stroma Formation,Brenner Tumor,1
8920,Malignant Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma,1
8921,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage I,1
8922,Malignant Cellular Infiltrate,Malignant neoplasm of gastrointestinal tract,1
8923,Epithelial Component Present,Invasive Ductal Breast Carcinoma,1
8924,Malignant Cellular Infiltrate,Rhabdoid Tumor of the Kidney,1
8925,Malignant Component Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,1
8926,High Mitotic Activity,Metastatic Gastric Neuroendocrine Carcinoma,1
8927,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
8928,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v8,1
8929,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Clear Cell Follicular Adenoma,1
8930,Carcinomatous Component Present,Stage III Lip Cancer AJCC v6 and v7,1
8931,Cutaneous Involvement,Parapsoriasis en Plaques,1
8932,Malignant Cellular Infiltrate,Gastric Synovial Sarcoma,1
8933,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
8934,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
8935,Carcinomatous Component Present,Stage IIIB Penile Cancer AJCC v8,1
8936,Malignant Cellular Infiltrate,Therapy-related myelodysplastic syndrome,1
8937,Severe dysplasia,Stage 0is Ureter Cancer AJCC v8,1
8938,Immunologic Deficiency Syndromes,AIDS-Related Idiopathic Thrombocytopenic Purpura,1
8939,Epithelial Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
8940,Benign Cellular Infiltrate,Ameloblastic fibrodentinoma,1
8941,Epithelial Component Present,Cervical Adenocarcinoma In Situ,1
8942,Benign Cellular Infiltrate,Lipoma of spinal cord,1
8943,Primary Lesion,Recurrent Giant Cell Glioblastoma,1
8944,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
8945,Metaplasia of Malignant Cells Present,Adenocarcinoma with osseous metaplasia,1
8946,Syncytial Pattern,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
8947,Mixed Cellular Population,Childhood Mixed Glioma,1
8948,Cutaneous Involvement,Dysplastic Nevus,1
8949,Immunoglobulin Deposition,Heavy Chain Deposition Disease,1
8950,Benign Cellular Infiltrate,Anal Papillary Hidradenoma,1
8951,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma,1
8952,Epithelial Component Present,papillary squamous cell carcinoma of larynx,1
8953,Moderately Differentiated Lesion,Moderately Differentiated Prostate Adenocarcinoma,1
8954,Papillary Pattern,Squamous cell papilloma of skin,1
8955,Carcinomatous Component Present,Stage IIC Colon Cancer AJCC v7,1
8956,Benign Cellular Infiltrate,Infantile hemangioma,1
8957,Epithelial Component Present,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
8958,Cutaneous Involvement,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
8959,Nodular Pattern,Skin Nodular Solid Basal Cell Carcinoma,1
8960,Tissue Differentiation Uncertain,Cardiac Synovial Sarcoma,1
8961,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monocytic Leukemia,1
8962,Indolent Clinical Course,Subcutaneous Nodular Fasciitis,1
8963,Aggressive Clinical Course,Intermediate Atypical Prostate Carcinoma,1
8964,Malignant Cellular Infiltrate,Stage 0 Colorectal Cancer AJCC v8,1
8965,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
8966,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v8 Stage,1
8967,Slow Growing Mass,Childhood Craniopharyngioma,1
8968,Malignant Cellular Infiltrate,Malignant neoplasm of bladder recurrent,1
8969,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage I,1
8970,Carcinomatous Component Present,Metastatic Cervical Adenosquamous Carcinoma,1
8971,Bilateral Mass,bilateral breast cancer,1
8972,Malignant Cellular Infiltrate,High Risk Myelodysplastic Syndrome,1
8973,Neuroectodermal Differentiation,Mediastinal Neuroblastoma,1
8974,Metastatic/Recurrent Disease,Gastric Synovial Sarcoma,1
8975,Malignant Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v7,1
8976,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
8977,Low Mitotic Activity,Rectal Neuroendocrine Tumor,1
8978,Malignant Cellular Infiltrate,Recurrent Childhood Acute Lymphoblastic Leukemia,1
8979,Malignant Cellular Infiltrate,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
8980,Neuroendocrine Differentiation,insulinoma,1
8981,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
8982,Malignant Cellular Infiltrate,Sporadic Gastric Adenocarcinoma,1
8983,Epithelial Component Present,Dysplasia of anus,1
8984,Syncytial Pattern,Lymphoepithelial carcinoma,1
8985,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
8986,Primary Lesion,Childhood Cerebral Ependymoma,1
8987,Extraosseous Lesion,Childhood Extraskeletal Osteosarcoma,1
8988,Malignant Cellular Infiltrate,Metastatic Bladder Squamous Cell Carcinoma,1
8989,Malignant Cellular Infiltrate,Pleural Desmoplastic Mesothelioma,1
8990,Glandular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
8991,Malignant Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,1
8992,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
8993,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
8994,Epithelial Component Present,Sarcomatoid Carcinoma of the Penis,1
8995,Malignant Cellular Infiltrate,Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma,1
8996,Malignant Cellular Infiltrate,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8,1
8997,Malignant Cellular Infiltrate,Fallopian Tube Lymphoma,1
8998,Malignant Cellular Infiltrate,Primary malignant neoplasm of pericardium,1
8999,Cutaneous Involvement,Malignant blue nevus of skin,1
9000,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
9001,Epithelial Component Present,Locally Advanced Small Intestinal Carcinoma,1
9002,Exophytic Polypoid Lesion,Polyp of vagina,1
9003,Local disease,Localized Malignant Neoplasm,1
9004,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
9005,Myxoid Stroma Formation,Myxoma,1
9006,BCR/ABL1 Fusion Negative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
9007,Malignant Cellular Infiltrate,Recurrent Childhood Soft Tissue Sarcoma,1
9008,Cystic Change,"Cystadenocarcinoma, Mucinous",1
9009,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma,1
9010,Malignant Cellular Infiltrate,Primary Effusion Lymphoma,1
9011,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage,1
9012,Increased Cellularity Present,olfactory neuroblastoma of nasal cavity,1
9013,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,1
9014,Benign Cellular Infiltrate,Adenolymphoma,1
9015,Malignant Cellular Infiltrate,Pleural Epithelioid Mesothelioma,1
9016,Low Mitotic Activity,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
9017,High Grade Lesion,Anaplastic astrocytoma,1
9018,Indolent Clinical Course,Gastric Lipoma,1
9019,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
9020,Benign Cellular Infiltrate,Cardiac neurofibroma,1
9021,Malignant Cellular Infiltrate,Fibrosarcoma of bone,1
9022,Carcinomatous Component Present,Stage IA2 Lung Cancer AJCC v8,1
9023,Slow Growing Mass,Childhood Cerebral Ependymoma,1
9024,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia,1
9025,Invasive Lesion,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
9026,Neuroendocrine Differentiation,Carcinoid tumor of appendix,1
9027,Floret-Like Pattern,Pleomorphic Lipoma,1
9028,Malignant Cellular Infiltrate,Lung Non-Keratinizing Squamous Cell Carcinoma,1
9029,Carcinomatous Component Present,Esophageal carcinoma recurrent,1
9030,Human Papillomavirus Negative,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
9031,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
9032,Epithelial Component Present,Colorectal Signet Ring Cell Carcinoma,1
9033,Nerve palsy,Facial Nerve Palsy Related to Birth,1
9034,Epithelial Component Present,Childhood Salivary Gland Carcinoma,1
9035,Carcinomatous Component Present,Tonsillar Undifferentiated Carcinoma,1
9036,Malignant Cellular Infiltrate,Stage IV Pancreatic Cancer AJCC v6 and v7,1
9037,Anaplasia,Small cell glioblastoma,1
9038,Immunologic Deficiency Syndromes,Plasma Cell Post-Transplant Lymphoproliferative Disorder,1
9039,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7,1
9040,Stromal Invasion,Stage I Ovarian Cancer AJCC v6 and v7,1
9041,Cutaneous Involvement,Trichilemmocarcinoma,1
9042,In Situ Lesion,Adenocarcinoma in situ in adenomatous polyp,1
9043,Refractory Disease,Refractory Ewing Sarcoma,1
9044,Splenomegaly,Blast Phase,1
9045,Carcinomatous Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
9046,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v8,1
9047,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition,1
9048,Cafe-au-Lait Spots,Recurrent Neurofibromatosis Type 1,1
9049,Carcinomatous Component Present,Stage I Carcinoma of Penis,1
9050,Indolent Clinical Course,Benign Ameloblastoma,1
9051,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v8,1
9052,Malignant Cellular Infiltrate,Adenocarcinoma gastric recurrent,1
9053,Malignant Cellular Infiltrate,Kaposi's sarcoma of liver,1
9054,Congenital Lesion,Congenital anomaly of eyelid,1
9055,Malignant Cellular Infiltrate,Advanced Kaposi Sarcoma,1
9056,Cystic Change,Minor Salivary Gland Mucoepidermoid Carcinoma,1
9057,Epithelial Component Present,Metanephric Tumor,1
9058,Malignant Cellular Infiltrate,"Carcinoma, Endometrioid",1
9059,Epithelial Component Present,Thymic Adenosquamous Carcinoma,1
9060,Epithelial Component Present,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
9061,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
9062,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
9063,atypia morphology,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
9064,Low Mitotic Activity,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
9065,Carcinomatous Component Present,Lung Cancer by AJCC v8 Stage,1
9066,Carcinomatous Component Present,Stage IIA Vaginal Cancer AJCC v8,1
9067,Perineural spread,Adenoid cystic eccrine carcinoma,1
9068,Anaplasia,Supratentorial Glioblastoma,1
9069,Malignant Cellular Infiltrate,Advanced Cervical Adenocarcinoma,1
9070,Benign Cellular Infiltrate,Benign Anterior Tongue Neoplasm,1
9071,Epithelial Component Present,Unresectable Esophageal Carcinoma,1
9072,Poorly Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma,1
9073,Anaplasia,Childhood Conventional Osteosarcoma,1
9074,Malignant Cellular Infiltrate,Breast Columnar Cell Mucinous Carcinoma,1
9075,Diffuse Pattern,Childhood Cerebellar Anaplastic Astrocytoma,1
9076,Childhood Lesion,Childhood Testicular Choriocarcinoma,1
9077,Malignant Cellular Infiltrate,Plasma Cell Myeloma by DS Stage,1
9078,Lobulated Growth Pattern,Metastatic Chordoma,1
9079,Epithelial Component Present,Stage I Vulvar Cancer,1
9080,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
9081,Epithelial Component Present,Small intestine carcinoma stage I,1
9082,Clinical TNM Finding,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
9083,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
9084,Epithelial Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
9085,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia,1
9086,Absence of Stromal Invasion,Borderline Fallopian Tube Endometrioid Tumor,1
9087,Follicular Cell Differentiation,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
9088,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
9089,Malignant Cellular Infiltrate,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
9090,Secondary Lesion,Secondary malignant neoplasm of neck,1
9091,Pathologic TNM Finding,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
9092,Epithelial Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma,1
9093,Cystic Change,Minor Salivary Gland Mucoepidermoid Carcinoma,1
9094,Carcinomatous Component Present,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
9095,Malignant Cellular Infiltrate,Anaplastic astrocytoma,1
9096,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
9097,Malignant Cellular Infiltrate,Advanced Favorable Hodgkin Lymphoma,1
9098,Childhood Lesion,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,1
9099,Vascular Channel Formation,Angiosarcoma non-metastatic,1
9100,Malignant Cellular Infiltrate,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
9101,Primary Lesion,Recurrent Childhood Anaplastic Oligodendroglioma,1
9102,Malignant Cellular Infiltrate,Bone Epithelioid Hemangioendothelioma,1
9103,Carcinomatous Component Present,Adenocarcinoma in situ in tubular adenoma,1
9104,Cutaneous Involvement,Tufted angioma of skin,1
9105,atypia morphology,Malignant Testicular Leydig Cell Tumor,1
9106,Diffuse Pattern,MCD Diffuse Large B-Cell Lymphoma,1
9107,Epithelial Component Present,Prognostic Stage III Breast Cancer AJCC v8,1
9108,Epithelial Component Present,mucinous adenocarcinoma of gallbladder,1
9109,Solid Growth Pattern,"Testicular Yolk Sac Tumor, Solid Pattern",1
9110,Recurrent disease,Recurrent Hematologic Malignancy,1
9111,Endophytic Tumor Growth,Laryngeal verrucous carcinoma stage IV,1
9112,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma,1
9113,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Papillary Pattern",1
9114,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
9115,Immunologic Deficiency Syndromes,Immunoblastic lymphoma associated with AIDS,1
9116,Benign Cellular Infiltrate,"Benign neoplasm of brain, unspecified",1
9117,Crystal deposition,Bladder Alveolar Soft Part Sarcoma,1
9118,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
9119,Pathologic TNM Finding,Pathologic Stage IB Gastric Cancer AJCC v8,1
9120,Malignant Germinomatous Cellular Infiltrate,Pineal germinoma,1
9121,High Mitotic Activity,small cell carcinoma of breast,1
9122,Epithelial Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
9123,Malignant Cellular Infiltrate,Refractory anemia with excess blasts II,1
9124,Metastatic Lesion,Adenocarcinoma of the prostate stage IV,1
9125,Malignant Cellular Infiltrate,Cholangiocarcinoma recurrent,1
9126,Vascular Channel Formation,Appendix Kaposi Sarcoma,1
9127,Slow Growing Mass,Recurrent Childhood Subependymal Giant Cell Astrocytoma,1
9128,Carcinomatous Component Present,Unresectable Lung Carcinoma,1
9129,Malignant Cellular Infiltrate,Stage IIA Esophagus Carcinoma,1
9130,Necrotic changes (finding),large cell neuroendocrine carcinoma of anal canal,1
9131,Malignant Cellular Infiltrate,AIDS-Related Primary Central Nervous System Lymphoma,1
9132,Malignant Cellular Infiltrate,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
9133,Unresectable Mass,Locally Advanced Unresectable Cervical Carcinoma,1
9134,Secondary Lesion,Secondary malignant neoplasm of skin,1
9135,Benign Cellular Infiltrate,Benign tumor of iris,1
9136,Epithelial Component Present,Papillary carcinoma of the breast,1
9137,Epithelial Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
9138,CD30-Positive Neoplastic Cells Present,Childhood Anaplastic Large Cell Lymphoma,1
9139,Malignant Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
9140,Epithelial Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
9141,Recurrent disease,Angioimmunoblastic T-cell lymphoma recurrent,1
9142,Adulthood Lesion,Adult Salivary Gland Carcinoma,1
9143,Epithelial Component Present,Stage 0 Ureter Cancer AJCC v7,1
9144,Cutaneous Involvement,Transplant-Related Skin Squamous Cell Carcinoma,1
9145,Well Differentiated Neuroendocrine Lesion,Gallbladder Tubular Carcinoid,1
9146,Absence of Stromal Invasion,"Papillary mucinous cystadenoma, borderline malignancy",1
9147,Invasive Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
9148,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater,1
9149,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
9150,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v8,1
9151,Neuroendocrine Differentiation,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
9152,C19MC Amplification,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
9153,Tissue of Mullerian Origin Present,mucinous adenocarcinofibroma of ovary,1
9154,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
9155,Glomeruloid Vessels Present,Third Ventricle Pilocytic Astrocytoma,1
9156,Primary Lesion,Recurrent Fibrolamellar Carcinoma,1
9157,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
9158,Malignant Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
9159,Carcinomatous Component Present,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
9160,Recurrent disease,Recurrent Malignant Endocrine Neoplasm,1
9161,Epithelial Component Present,Ovarian Endometrioid Cystadenofibroma,1
9162,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Larynx,1
9163,Metastatic Lesion,Secondary malignant neoplasm of retina,1
9164,Epithelial Component Present,Carcinoid tumor of ileum,1
9165,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
9166,Micropapillary Pattern,Colorectal Micropapillary Adenocarcinoma,1
9167,Fibrous Septa Present,Dysgerminoma of ovary,1
9168,Increased Cellularity Present,Childhood Neuroblastoma,1
9169,Epithelial Component Present,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
9170,Malignant Cellular Infiltrate,Choroid Plexus Carcinoma,1
9171,Unresectable Mass,Hepatoblastoma non-resectable,1
9172,Epithelial Component Present,Apocrine cystadenoma,1
9173,Neuroendocrine Differentiation,"Pheochromocytoma, malignant",1
9174,Benign Cellular Infiltrate,Myoma,1
9175,Carcinomatous Component Present,undifferentiated carcinoma of gallbladder,1
9176,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
9177,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage IV,1
9178,Invasive Lesion,Mucoepidermoid Breast Carcinoma,1
9179,Metastatic Lesion,Secondary malignant neoplasm of female breast,1
9180,Metastatic Lesion,Metastatic Gastrointestinal Stromal Tumor,1
9181,Carcinomatous Component Present,Vaginal Neuroendocrine Carcinoma,1
9182,Childhood Lesion,Childhood Cerebral Ependymoma,1
9183,Malignant Cellular Infiltrate,Metastatic Esophageal Carcinoma,1
9184,Carcinomatous Component Present,Refractory Uterine Corpus Carcinoma,1
9185,CD56-Positive Neoplastic Cells Present,childhood nasal type extranodal NK/T-cell lymphoma,1
9186,Epithelial Component Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,1
9187,Nodular Pattern,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,1
9188,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
9189,Epithelial Component Present,Serous surface papillary carcinoma,1
9190,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v8,1
9191,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
9192,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
9193,Indolent Clinical Course,lipoma of bone,1
9194,Well-Circumscribed Lesion,Cystadenocarcinoma of kidney,1
9195,Recurrent disease,Biochemically Recurrent Prostate Carcinoma,1
9196,Malignant Cellular Infiltrate,Adult Acute Basophilic Leukemia,1
9197,Carcinomatous Component Present,Primary Peritoneal High Grade Serous Adenocarcinoma,1
9198,Epithelial Component Present,Adenomatous Polyposis Coli,1
9199,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
9200,Cutaneous Involvement,Palmoplantar keratoderma with leukoplakia,1
9201,Primary Lesion,Childhood Periosteal Osteosarcoma,1
9202,Cutaneous Involvement,Anal margin Paget's disease,1
9203,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
9204,Epithelial Component Present,Juvenile granulosa cell tumor,1
9205,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
9206,Benign Cellular Infiltrate,Liver Lipoma,1
9207,Diffuse Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",1
9208,Mitotic Activity,Recurrent Anaplastic Astrocytoma,1
9209,Well-Circumscribed Lesion,Mediastinal Chondroma,1
9210,Myxoid Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
9211,Malignant Cellular Infiltrate,Choriocarcinoma,1
9212,Malignant Cellular Infiltrate,Stage I Immature Testicular Teratoma AJCC v6 and v7,1
9213,Malignant Cellular Infiltrate,Cervical Warty Carcinoma,1
9214,Malignant Cellular Infiltrate,Malignant Skull Base Neoplasm,1
9215,Carcinomatous Component Present,Metastatic Thyroid Gland Papillary Carcinoma,1
9216,Carcinomatous Component Present,Gallbladder adenosquamous carcinoma,1
9217,Recurrent disease,Recurrent Primary Effusion Lymphoma,1
9218,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma,1
9219,Epithelial Component Present,Pancreatic Intraductal Papillary Mucinous Neoplasm,1
9220,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
9221,Malignant Cellular Infiltrate,Extracranial Neuroblastoma,1
9222,Carcinomatous Component Present,Refractory Cholangiocarcinoma,1
9223,Hemorrhagic,Post-Radiotherapy Breast Angiosarcoma,1
9224,Malignant Cellular Infiltrate,Refractory Endometrial Endometrioid Adenocarcinoma,1
9225,Benign Cellular Infiltrate,Extrahepatic Bile Duct Fibroma,1
9226,Childhood Lesion,Childhood Melanoma,1
9227,Carcinomatous Component Present,Small intestine carcinoma,1
9228,Malignant Cellular Infiltrate,Hepatoblastoma,1
9229,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
9230,Carcinomatous Component Present,Papillary Renal Cell Carcinoma,1
9231,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
9232,Malignant Cellular Infiltrate,Comedocarcinoma,1
9233,Well-Circumscribed Lesion,Mixed Cell Type Kidney Wilms Tumor,1
9234,Malignant Cellular Infiltrate,Stage IV adult soft tissue sarcoma,1
9235,Carcinomatous Component Present,Hereditary Prostate Carcinoma,1
9236,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
9237,EBV-Positive Neoplastic Cells Present,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
9238,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor,1
9239,Malignant Cellular Infiltrate,Locally Advanced Unresectable Cervical Carcinoma,1
9240,Microvascular Proliferation,Giant Cell Glioblastoma,1
9241,Necrotic changes (finding),Childhood Glioblastoma,1
9242,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
9243,Tissue Differentiation Uncertain,Refractory Synovial Sarcoma,1
9244,Intraductal Lesion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
9245,Malignant Cellular Infiltrate,Stage IIA Ovarian Cancer AJCC v8,1
9246,Epithelial Component Present,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
9247,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
9248,Malignant Cellular Infiltrate,Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma,1
9249,Carcinomatous Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
9250,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
9251,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,1
9252,Benign Cellular Infiltrate,Lipoma of small intestine,1
9253,Locally Aggressive Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
9254,Well Differentiated Lesion,Vaginal Warty Carcinoma,1
9255,Neuroendocrine Differentiation,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
9256,Well-Circumscribed Lesion,Clear cell hidradenoma,1
9257,Diffuse Pattern,Childhood Glioblastoma,1
9258,Pseudoalveolar Pattern,Cervical Alveolar Soft Part Sarcoma,1
9259,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v8,1
9260,Low Grade Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor,1
9261,Malignant Cellular Infiltrate,Periosteal Osteosarcoma,1
9262,Malignant Cellular Infiltrate,Secondary malignant neoplasm of spinal cord,1
9263,Neuroendocrine Differentiation,Familial Paraganglioma,1
9264,Increased Cellularity Present,Poorly Differentiated Neuroblastoma,1
9265,Well-Circumscribed Lesion,Urethra Fibroepithelial Polyp,1
9266,Epithelial Component Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
9267,Epithelial Component Present,Advanced Renal Cell Carcinoma,1
9268,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v8,1
9269,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma stage III,1
9270,Carcinomatous Component Present,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
9271,Follicular Structures Present,Thyroid Gland Lipoadenoma,1
9272,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
9273,Extracutaneous Dissemination of Disease,Mycosis fungoides stage II,1
9274,Epithelial Component Present,Low Grade Corneal Intraepithelial Neoplasia,1
9275,Microcystic Change,Protoplasmic astrocytoma,1
9276,Low Mitotic Activity,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
9277,Refractory Disease,Refractory Urothelial Carcinoma,1
9278,Epithelial Component Present,Squamous intraepithelial neoplasia grade 2,1
9279,Well Differentiated Neuroendocrine Lesion,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
9280,Malignant Cellular Infiltrate,Oropharyngeal Carcinoma by AJCC v7 Stage,1
9281,High Grade Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9282,Malignant Cellular Infiltrate,Minimally Invasive Mucinous Lung Adenocarcinoma,1
9283,Tissue of Mullerian Origin Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
9284,Malignant Cellular Infiltrate,Refractory Testicular Lymphoma,1
9285,Carcinomatous Component Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,1
9286,Malignant Cellular Infiltrate,leiomyosarcoma of mediastinum,1
9287,Malignant Cellular Infiltrate,Sarcoma NCI Grade 3,1
9288,Epithelial Component Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
9289,Epithelial Component Present,Urothelial Carcinoma,1
9290,Neuronal Differentiation,Glioblastoma with Primitive Neuronal Component,1
9291,Pushing Tumor Margin,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
9292,Fibrotic Stroma Formation,Borderline Ovarian Mucinous Adenofibroma,1
9293,Epithelial Component Present,Small intestine carcinoma stage III,1
9294,Diffuse Cellular Infiltrate,"Carcinoma, diffuse type",1
9295,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage,1
9296,Nuclear Atypia,Childhood Gliosarcoma,1
9297,Malignant Cellular Infiltrate,Recurrent Thymic Carcinoma,1
9298,Alternative Fascicle (Bundle) Pattern,Prostate Leiomyoma,1
9299,Malignant Cellular Infiltrate,Prostate Undifferentiated Carcinoma,1
9300,Epithelial Component Present,Unresectable Urethral Urothelial Carcinoma,1
9301,Pregnancy Complications,Placenta Percreta,1
9302,Well-Circumscribed Lesion,Cerebral Hemangioblastoma,1
9303,Necrotic changes (finding),"Perivascular epithelioid tumor, malignant",1
9304,IDH Gene Family Mutation Status Unknown,Mixed Oligodendroglioma-Astrocytoma,1
9305,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma,1
9306,Carcinomatous Component Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
9307,Indolent Clinical Course,hemangioma of mediastinum,1
9308,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,1
9309,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
9310,Malignant Cellular Infiltrate,BALT lymphoma,1
9311,Vascular Channel Formation,Angiosarcoma recurrent,1
9312,Well-Circumscribed Lesion,Adamantinoma,1
9313,Dense Intercellular Reticulin Network Present,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
9314,Benign Cellular Infiltrate,Meyerson Nevus,1
9315,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Ovarian Carcinosarcoma,1
9316,Cutaneous Involvement,Erythematosquamous dermatosis,1
9317,Lipomatous Component Present,Angiomyolipoma of kidney,1
9318,Metastatic/Recurrent Disease,Lung Monophasic Synovial Sarcoma,1
9319,Peribronchial Proliferation of Neoplastic Cells Present,tumor miofibroblástico peribronquial congénito,1
9320,Primary Lesion,"Leukemia, Mast-Cell",1
9321,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
9322,Malignant Cellular Infiltrate,Cervical Esophagus Adenocarcinoma,1
9323,High Grade Lesion,Sarcoma NCI Grade 3,1
9324,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v6 Stage,1
9325,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
9326,Low Mitotic Activity,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
9327,Necrotic changes (finding),Recurrent Childhood Glioblastoma,1
9328,Low Mitotic Activity,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
9329,Benign Cellular Infiltrate,Benign Testicular Sertoli Cell Tumor,1
9330,Malignant Germinomatous Cellular Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
9331,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
9332,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
9333,Epithelial Component Present,"Hepatocellular carcinoma, scirrhous",1
9334,Carcinomatous Component Present,FIGO Stage IIIB Ovarian Cancer,1
9335,Malignant Cellular Infiltrate,Retroperitoneal Sarcoma by AJCC v8 Stage,1
9336,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus,1
9337,Benign Cellular Infiltrate,Extrahepatic Bile Duct Fibroma,1
9338,Malignant Cellular Infiltrate,Unresectable Digestive System Adenocarcinoma,1
9339,Malignant Cellular Infiltrate,Malignant Intracranial Neoplasms By Morphology,1
9340,Indolent Clinical Course,benign lipoma of gallbladder,1
9341,Childhood Lesion,Childhood Central Nervous System Neoplasm,1
9342,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
9343,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
9344,Benign Cellular Infiltrate,Spindle Cell/Pleomorphic Lipoma,1
9345,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I,1
9346,Recurrent disease,Recurrent Childhood Diffuse Astrocytoma,1
9347,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v7,1
9348,Carcinomatous Component Present,Metastatic urothelial carcinoma,1
9349,Follicular Differentiation,Pilomatrixoma,1
9350,Indolent Clinical Course,Hard Palate Pleomorphic Adenoma,1
9351,Diffuse Pattern,Primary mediastinal large B-cell lymphoma recurrent,1
9352,Epithelial Component Present,Lymphoepithelial malignant thymoma,1
9353,Malignant Cellular Infiltrate,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
9354,Malignant Cellular Infiltrate,Testicular yolk sac tumor,1
9355,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase",1
9356,Edema,Inflammatory carcinoma of breast stage III,1
9357,Epithelial Component Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
9358,Stromal Invasion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
9359,Epithelial Component Present,Serous surface papilloma,1
9360,Carcinomatous Component Present,Ameloblastic Carcinoma,1
9361,Epithelial Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
9362,Epithelial Component Present,Breast Carcinoma Metastatic in the Lung,1
9363,Benign Cellular Infiltrate,Anastomosing Hemangioma,1
9364,Intraepithelial Neoplasia,Malignant melanoma in precancerous melanosis,1
9365,Limited Early T-Cell Differentiation,Early T Acute Lymphoblastic Leukemia,1
9366,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v8,1
9367,Malignant Cellular Infiltrate,Metastatic Urethral Urothelial Carcinoma,1
9368,Severe dysplasia,Stage 0 Vulvar Carcinoma,1
9369,Organoid Pattern,Childhood Alveolar Soft Part Sarcoma,1
9370,Malignant Cellular Infiltrate,High Grade Broad Ligament Serous Adenocarcinoma,1
9371,Hereditary Lesion,Von Hippel-Lindau Syndrome,1
9372,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
9373,Epithelial Component Present,Recurrent Neuroendocrine Neoplasm,1
9374,Malignant Cellular Infiltrate,Skin Metatypical Carcinoma,1
9375,Malignant Cellular Infiltrate,Stage IVB Liver Cancer,1
9376,Carcinomatous Component Present,Prognostic Stage IIIA Breast Cancer AJCC v8,1
9377,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v8,1
9378,Epithelial Component Present,Serous adenofibroma,1
9379,Secondary Lesion,Stage IV Laryngeal Carcinoma,1
9380,Malignant Cellular Infiltrate,Recurrent Sarcoma of the Extremity,1
9381,Well Differentiated Lesion,"Papillary squamous cell carcinoma, non-invasive",1
9382,Necrotic changes (finding),"Carcinoma, Small Cell",1
9383,Emperipolesis,Sinus histiocytosis,1
9384,Malignant Cellular Infiltrate,Adenocarcinoma,1
9385,Cutaneous Involvement,Plexiform fibrohistiocytic tumor,1
9386,Lymphadenopathy,HHV8-Positive Multicentric Castleman Disease,1
9387,Epithelial Component Present,Crooke Cell Adenoma,1
9388,Malignant Cellular Infiltrate,Rectal Carcinoma,1
9389,Epithelial Component Present,mucinous adenocarcinoma of lung,1
9390,Osteoid formation,Central Nervous System Extraskeletal Osteosarcoma,1
9391,Low Mitotic Activity,"Glucagonoma, malignant",1
9392,Nested Pattern,Sclerosing Epithelioid Fibrosarcoma,1
9393,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
9394,Tubular Pattern,Rectal Tubular Adenoma,1
9395,Epithelial Component Present,Small cell carcinoma of ovary,1
9396,Hyperkeratosis,Laryngeal verrucous carcinoma recurrent,1
9397,Immunosuppression-Related Post-Transplant Toxicity,Maternally Derived Graft Versus Host Disease,1
9398,Juvenile Lesion,Juvenile papillomatosis of breast,1
9399,Hyperplastic Epithelial Tissue Present,Atypical hyperplasia of breast,1
9400,Epithelial Component Present,Schneiderian carcinoma,1
9401,Epithelial Component Present,Gallbladder Neuroendocrine Carcinoma,1
9402,Adulthood Lesion,Adult Pineal Gland Astrocytoma,1
9403,Epithelial Component Present,tubulopapillary adenoma of gallbladder,1
9404,High Mitotic Activity,Small cell lung cancer extensive stage,1
9405,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
9406,Refractory Disease,Refractory Acute Leukemia,1
9407,Mesenchymal Component Present,Anal Ectopic Fibroadenoma,1
9408,Malignant Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
9409,Carcinomatous Component Present,Carcinoma in situ of trachea,1
9410,Pseudoglandular Pattern,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
9411,Primary Lesion,Recurrent Primary Cutaneous Lymphoma,1
9412,Epithelial Component Present,Neuroendocrine carcinoma of appendix,1
9413,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
9414,Dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
9415,Hyperplastic Tissue Present,Pseudolymphoma,1
9416,Malignant Cellular Infiltrate,Meningeal melanoma,1
9417,Diffuse Pattern,Recurrent Childhood Oligodendroglioma,1
9418,Malignant Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
9419,Mesenchymal Metaplasia,Adenocarcinoma with osseous metaplasia,1
9420,Malignant Cellular Infiltrate,leiomyosarcoma of fallopian tube,1
9421,Epithelial Component Present,Benign Ovarian Transitional Cell Tumor,1
9422,Splenomegaly,Recurrent T-Cell Prolymphocytic Leukemia,1
9423,Necrotic changes (finding),Giant Cell Glioblastoma,1
9424,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
9425,High Grade Lesion,Stage IV Lung Small Cell Carcinoma AJCC v7,1
9426,Ineffective hematopoiesis,Refractory Neutropenia,1
9427,Rapidly Enlarging Mass,Vulvar Alveolar Rhabdomyosarcoma,1
9428,Epithelial Component Present,Carcinoma of the Appendix,1
9429,Malignant Cellular Infiltrate,Hepatoma resectable,1
9430,Low Grade Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1,1
9431,Diffuse Pattern,Grade III Childhood Astrocytoma,1
9432,Chronic Inflammatory Infiltrate,Recurrent Childhood Lymphomatoid Granulomatosis,1
9433,Epithelial Component Present,Basal Cell Neoplasm,1
9434,Biphasic Pattern,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
9435,Epithelial Component Present,High Grade Corneal Intraepithelial Neoplasia,1
9436,Epithelial Component Present,Carcinoma of the Appendix,1
9437,Benign Cellular Infiltrate,Giant Cell Lesion of Small Bones,1
9438,Mitotic Activity,"Anaplastic Astrocytoma, IDH-Wildtype",1
9439,Epithelial Component Present,Carcinoma of glottis,1
9440,Follicular Cell Differentiation,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
9441,Benign Cellular Infiltrate,Benign Non-Epithelial Gallbladder Neoplasm,1
9442,Epithelial Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
9443,Carcinomatous Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
9444,Malignant Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
9445,Carcinomatous Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
9446,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant",1
9447,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma,1
9448,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma refractory,1
9449,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v8,1
9450,Epithelial Component Present,Skin Metatypical Carcinoma,1
9451,Anaplasia,Stage I Anaplastic Large Cell Lymphoma,1
9452,Malignant Cellular Infiltrate,Cervical Serous Adenocarcinoma,1
9453,Metastatic/Recurrent Disease,Extrarenal Rhabdoid Tumor of the Liver,1
9454,Malignant Cellular Infiltrate,Metastatic basal cell carcinoma,1
9455,Microinvasive tumor,Ductal Carcinoma In Situ with Microinvasion,1
9456,Refractory Disease,Refractory Abdominal Neuroendocrine Neoplasm,1
9457,Severe dysplasia,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
9458,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7,1
9459,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer,1
9460,Carcinomatous Component Present,Cecum Carcinoma,1
9461,Malignant Cellular Infiltrate,Pleural Epithelioid Mesothelioma,1
9462,Neuroendocrine Differentiation,Stage IA Merkel Cell Carcinoma AJCC v7,1
9463,Vascular Channel Formation,Lymphangioma,1
9464,Malignant Cellular Infiltrate,Postsurgical Stage II Hepatoblastoma,1
9465,Stromal Invasion,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
9466,Malignant Cellular Infiltrate,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
9467,Exophytic Polypoid Lesion,Adenoma of ampulla of Vater,1
9468,Papillary Pattern,Endolymphatic sac tumor,1
9469,Epithelial Component Present,Tonsillar Undifferentiated Carcinoma,1
9470,In Situ Lesion,Intraepithelial Squamous Cell Carcinoma,1
9471,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
9472,Benign Cellular Infiltrate,Spindle cell lipoma,1
9473,Borderline Lesion,Type E Lymphomatoid Papulosis,1
9474,Epithelial Component Present,Grade 3 Clear Cell Renal Cell Carcinoma,1
9475,Carcinomatous Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma,1
9476,Intraosseous Lesion,Primary solid type intraosseous squamous cell carcinoma,1
9477,Epithelial Component Present,Small intestine carcinoma stage III,1
9478,Plexiform Growth Pattern,Plexiform Neurofibroma,1
9479,Fibrotic Stroma Formation,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
9480,Tissue of Mullerian Origin Present,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
9481,Childhood Lesion,Childhood Medulloblastoma,1
9482,Dysplasia,Pancreatic intraepithelial neoplasia,1
9483,Mass of body structure,Mediastinal Myeloid Sarcoma,1
9484,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
9485,Storiform Growth Pattern,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9486,Papillary Pattern,Intraductal Breast Papillomatosis,1
9487,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I,1
9488,Epithelial Component Present,Locally Advanced Unresectable Carcinoma,1
9489,Hyperplastic Tissue Present,Urothelial Hyperplasia,1
9490,Intraosseous Lesion,Sternal Intraosseous Schwannoma,1
9491,Malignant Cellular Infiltrate,Myxoid chondrosarcoma,1
9492,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
9493,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast,1
9494,Biphasic Pattern,Ovarian Mucinous Adenofibroma,1
9495,Endophytic Tumor Growth,Human Papillomavirus-Related Verrucous Carcinoma,1
9496,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
9497,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
9498,Epithelial Component Present,Inflammatory Breast Carcinoma,1
9499,Epithelial Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
9500,Epithelial Component Present,Papilloma of eyelid,1
9501,Malignant Cellular Infiltrate,Mesothelioma malignant localized,1
9502,Well-Circumscribed Lesion,Fallopian Tube Endometrioid Polyp,1
9503,Epithelial Component Present,Phyllodes Tumor,1
9504,Hyalinized Stroma Formation,Bone Epithelioid Hemangioendothelioma,1
9505,Well Differentiated Neuroendocrine Lesion,Vipoma,1
9506,Carcinomatous Component Present,"Carcinoma, Signet Ring Cell",1
9507,Benign Cellular Infiltrate,Fibrous Hamartoma of Infancy,1
9508,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Choriocarcinoma,1
9509,atypia morphology,Malignant Ovarian Granulosa Cell Tumor,1
9510,Papillary Pattern,Ethmoid Sinus Inverted Papilloma,1
9511,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
9512,Malignant Cellular Infiltrate,Cardiac Myeloid Sarcoma,1
9513,Epithelial Component Present,Scirrhous carcinoma of breast,1
9514,Tissue Differentiation Uncertain,"Synovial sarcoma, spindle cell",1
9515,Epithelial Component Present,Small cell carcinoma of lung,1
9516,Carcinomatous Component Present,Biliary Intraepithelial Neoplasia-3,1
9517,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
9518,Childhood Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
9519,Carcinomatous Component Present,Stage 0a Penile Cancer AJCC v8,1
9520,Malignant Cellular Infiltrate,mucinous adenocarcinoma of gallbladder,1
9521,Peripheral Nuclear Palisading,Combined Lung Large Cell Neuroendocrine Carcinoma,1
9522,Cutaneous Involvement,Pityriasis Lichenoides,1
9523,Refractory Disease,Diffuse large B-cell lymphoma refractory,1
9524,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
9525,Infiltrative Growth Pattern,Glioblastoma by Gene Expression Profile,1
9526,Epithelial Component Present,Locally Advanced Basal Cell Carcinoma,1
9527,Low Mitotic Activity,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
9528,Adulthood Lesion,Adult T-cell lymphoma/leukemia recurrent,1
9529,Rapidly Enlarging Mass,Childhood Pleomorphic Rhabdomyosarcoma,1
9530,Metastatic Lesion,Disseminated carcinoma,1
9531,Metastatic Lesion,Locally Advanced Prostate Adenocarcinoma,1
9532,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
9533,'Starry-sky' pattern,Immunodeficiency-associated Burkitt's lymphoma,1
9534,Severe dysplasia,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
9535,Neuroendocrine Differentiation,Small Intestinal Carcinoid Tumor,1
9536,Poorly Differentiated Lesion,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
9537,Preserved Nuclear Polarity,Papillary transitional cell neoplasm of low malignant potential,1
9538,Malignant Cellular Infiltrate,Vaginal Yolk Sac Tumor,1
9539,Epithelial Component Present,Stage IIIA Cervical Cancer AJCC v8,1
9540,Benign Cellular Infiltrate,Benign neoplasm of thorax,1
9541,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
9542,Indolent Clinical Course,"Hemangioma, Intramuscular",1
9543,Malignant Cellular Infiltrate,Stage IV Ovarian Carcinoma,1
9544,Adulthood Lesion,BCLC Stage C Adult Hepatocellular Carcinoma,1
9545,Moderate dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
9546,Intraductal Lesion,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
9547,Exophytic Polypoid Lesion,Rectal hyperplastic polyp,1
9548,Solitary mass,Adult Epithelioid Hemangioendothelioma,1
9549,Local disease,Localized Digestive System Neuroendocrine Tumor G1,1
9550,Epithelial Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
9551,Exophytic Polypoid Lesion,Gallbladder Papillary Adenoma,1
9552,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Myelodysplastic Syndrome,1
9553,Epithelial Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
9554,Carcinomatous Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
9555,Unresectable Mass,Unresectable Adrenal Cortex Carcinoma,1
9556,Carcinomatous Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
9557,Secondary Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
9558,Neuroectodermal Differentiation,Localized Primitive Neuroectodermal Tumor,1
9559,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
9560,Carcinomatous Component Present,Basal-Like Breast Carcinoma,1
9561,Pregnancy Complications,Eclampsia,1
9562,Adulthood Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
9563,Intermediate Grade Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,1
9564,Mixed Cellular Population,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
9565,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
9566,Malignant Cellular Infiltrate,Endometrial adenocarcinoma metastatic,1
9567,Childhood Lesion,Benign Childhood Central Nervous System Neoplasm,1
9568,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
9569,Malignant Cellular Infiltrate,Stage IV Appendix Carcinoma AJCC v8,1
9570,Mixed Cellular Population,Vaginal Carcinosarcoma,1
9571,Malignant Cellular Infiltrate,Secondary Heart Lymphoma,1
9572,Metastatic Lesion,Advanced Synovial Sarcoma,1
9573,Metastatic Lesion,Secondary malignant neoplasm of spinal cord,1
9574,Benign Cellular Infiltrate,Benign Peritoneal and Retroperitoneal Neoplasm,1
9575,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7,1
9576,Monomorphic Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
9577,Epithelial Component Present,Anal cancer recurrent,1
9578,Indolent Clinical Course,Glomangiomatosis,1
9579,Malignant Cellular Infiltrate,Anal Rhabdomyosarcoma,1
9580,More than 10 Mitoses per 10HPF,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
9581,Benign Cellular Infiltrate,Dartoic myoma,1
9582,Polymorphic Cellular Infiltrate,Grade I Lymphomatoid Granulomatosis,1
9583,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
9584,Papillary Pattern,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
9585,Epithelial Component Present,Hereditary Diffuse Gastric Adenocarcinoma,1
9586,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v6,1
9587,Epithelial Component Present,Adenocarcinoma with osseous metaplasia,1
9588,Exophytic Polypoid Lesion,Polyp of nasal sinus,1
9589,Metastatic Lesion,Pericardial mesothelioma malignant advanced,1
9590,Metastatic Lesion,Recurrent Carcinoma of Unknown Primary,1
9591,Carcinomatous Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
9592,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
9593,Exophytic Polypoid Lesion,Adenoma of rectum,1
9594,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
9595,Epithelial Component Present,Stage II Anal Canal Cancer AJCC v6 and v7,1
9596,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
9597,Carcinomatous Component Present,adenoid cystic carcinoma of floor of mouth,1
9598,Benign Cellular Infiltrate,Rectal Leiomyoma,1
9599,Pseudoglandular Pattern,Testicular embryonal carcinoma stage II,1
9600,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma,1
9601,Secondary Lesion,Secondary malignant neoplasm of anus,1
9602,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
9603,Anaplasia,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
9604,Epithelial Component Present,Colorectal Squamous Cell Carcinoma,1
9605,Carcinomatous Component Present,Papillary thyroid carcinoma,1
9606,Unclassifiable Lesion,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
9607,Intraductal Lesion,Flat Ductal Epithelial Atypia of the Breast,1
9608,Carcinomatous Component Present,adenoid cystic carcinoma of lung,1
9609,Indolent Clinical Course,Mediastinal Rhabdomyoma,1
9610,Carcinomatous Component Present,Refractory Laryngeal Squamous Cell Carcinoma,1
9611,Malignant Cellular Infiltrate,Thymoma malignant invasive,1
9612,Malignant Cellular Infiltrate,Anterior Tongue Adenoid Cystic Carcinoma,1
9613,Vascular Channel Formation,Cavernous hemangioma of the face,1
9614,Dermal Involvement,Vulvar Eccrine Porocarcinoma,1
9615,Glial Differentiation,gliosarcoma,1
9616,Primary Lesion,Childhood Brain Stem Gliosarcoma,1
9617,High Grade Lesion,large cell neuroendocrine carcinoma of lung,1
9618,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v6,1
9619,Immunologic Deficiency Syndromes,Methotrexate-Associated Hodgkin Lymphoma,1
9620,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
9621,Malignant Cellular Infiltrate,Superior Sulcus Lung Carcinoma,1
9622,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
9623,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone recurrent,1
9624,Neuroendocrine Differentiation,Carcinoid tumor of ileum,1
9625,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma,1
9626,Regional Disease,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
9627,High Mitotic Activity,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
9628,Neuroendocrine Differentiation,Advanced Neuroendocrine Carcinoma,1
9629,Malignant Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor,1
9630,Benign Cellular Infiltrate,Squamous odontogenic tumor,1
9631,Well-Circumscribed Lesion,Vulvar Cellular Angiofibroma,1
9632,Benign Cellular Infiltrate,Benign neoplasm of trachea,1
9633,Malignant Cellular Infiltrate,Hilar Cholangiocarcinoma by AJCC v8 Stage,1
9634,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma,1
9635,Recurrent disease,Recurrent Kidney Wilms Tumor,1
9636,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic,1
9637,Malignant Cellular Infiltrate,leiomyosarcoma,1
9638,Malignant Cellular Infiltrate,Stage IIA Bone Sarcoma AJCC v7,1
9639,Malignant Cellular Infiltrate,Colon Cribriform Comedo-Type Adenocarcinoma,1
9640,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile,1
9641,Unresectable Mass,Localized Unresectable Neuroblastoma,1
9642,Cutaneous Involvement,Sezary Syndrome,1
9643,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma,1
9644,Carcinomatous Component Present,Primary solid type intraosseous squamous cell carcinoma,1
9645,Benign Cellular Infiltrate,Myxoid leiomyoma,1
9646,Malignant Cellular Infiltrate,Gallbladder adenocarcinoma,1
9647,Epithelial Component Present,Cervical Mullerian Papilloma,1
9648,Epithelial Component Present,Acantholytic squamous cell carcinoma of skin,1
9649,Epithelial Component Present,carcinosarcoma of gallbladder,1
9650,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma,1
9651,Fibrotic Stroma Formation,Low-grade fibromyxoid sarcoma,1
9652,Papillary Pattern,Stage 0a Renal Pelvis Cancer AJCC v8,1
9653,Malignant Cellular Infiltrate,Childhood Ganglioneuroblastoma,1
9654,Invasive Lesion,Thymoma malignant invasive,1
9655,Mitotic Activity,"Anaplastic Astrocytoma, IDH-Wildtype",1
9656,Epithelial Component Present,Schneiderian papilloma,1
9657,Epithelial Component Present,Adenoid cystic carcinoma of lacrimal gland,1
9658,Metastatic Lesion,Metastatic Malignant Solid Neoplasm,1
9659,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
9660,Carcinomatous Component Present,Upper Gingival Squamous Cell Carcinoma,1
9661,Lymphoplasmacytic Infiltrate,Childhood Brain Germinoma,1
9662,Benign Cellular Infiltrate,Erosive Adenomatosis of the Nipple,1
9663,Non-Malignant Cellular Infiltrate,Cervical lymphadenitis,1
9664,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
9665,Microvascular Proliferation,Cerebellar Glioblastoma,1
9666,Neuroendocrine Differentiation,Childhood Adrenal Gland Pheochromocytoma,1
9667,Malignant Cellular Infiltrate,Locally Advanced Melanoma,1
9668,Papillary Pattern,Noninfiltrating intraductal papillary adenocarcinoma,1
9669,Congenital Lesion,Blue rubber bleb nevus syndrome,1
9670,Epithelial Component Present,Childhood Choroid Plexus Carcinoma,1
9671,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma recurrent,1
9672,Carcinomatous Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
9673,Malignant Cellular Infiltrate,Malignant Ovarian Clear Cell Tumor,1
9674,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
9675,Adulthood Lesion,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8,1
9676,Malignant Cellular Infiltrate,Therapy-related myelodysplastic syndrome,1
9677,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
9678,Primary Lesion,Recurrent Bone Ewing Sarcoma,1
9679,Carcinomatous Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
9680,Indolent Clinical Course,Oral Cavity Monomorphic Adenoma,1
9681,Epithelial Component Present,Stage III Gallbladder Cancer AJCC v8,1
9682,Malignant Cellular Infiltrate,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
9683,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9684,Low Mitotic Activity,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
9685,Chronic Inflammatory Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
9686,Cutaneous Involvement,Malignant Sebaceous Neoplasm,1
9687,Nodular lesions,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
9688,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
9689,Dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
9690,Carcinomatous Component Present,hepatoid adenocarcinoma of bladder,1
9691,Indolent Clinical Course,Benign Fibroblastic Neoplasm,1
9692,Exophytic Papillary Lesion,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
9693,Oligodendroglial Component Present,oligodendroglioma,1
9694,Increased Cellularity Present,Neuroblastoma,1
9695,Malignant Cellular Infiltrate,Childhood Malignant Kidney Neoplasm,1
9696,Neuroendocrine Differentiation,Rectal Neuroendocrine Tumor,1
9697,Glial Differentiation,Anaplastic ganglioglioma,1
9698,Carcinomatous Component Present,Major Salivary Gland Carcinoma,1
9699,Carcinomatous Component Present,Uterine Ligament Serous Adenocarcinoma,1
9700,Low Mitotic Activity,Colon Neuroendocrine Tumor G1,1
9701,Oligodendroglial Component Present,Childhood Anaplastic Oligodendroglioma,1
9702,Poorly Differentiated Lesion,Skin Sarcomatoid Basal Cell Carcinoma,1
9703,Malignant Cellular Infiltrate,sarcoma of lung,1
9704,Malignant Cellular Infiltrate,papillary squamous cell carcinoma of larynx,1
9705,Follicular Cell Differentiation,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
9706,Well-Circumscribed Lesion,Solid Angioleiomyoma,1
9707,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2,1
9708,Benign Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma,1
9709,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma,1
9710,Absence of Invasion,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
9711,Carcinomatous Component Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
9712,Collagenous Stroma Formation,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
9713,Single Malignant Cells Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
9714,Carcinomatous Component Present,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
9715,Epithelial Component Present,Adenocarcinoma with metaplasia,1
9716,Epithelial Component Present,Gastric Adenocarcinoma,1
9717,Malignant Cellular Infiltrate,Stage III Esophageal Cancer,1
9718,Osteoid formation,Duodenal Extraskeletal Osteosarcoma,1
9719,Stromal Invasion,Stage I Ovarian Cancer AJCC v8,1
9720,Childhood Lesion,Childhood Myelodysplastic Syndrome,1
9721,Therapy-Related Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
9722,Childhood Lesion,Benign Childhood Supratentorial Neoplasm,1
9723,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
9724,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
9725,Carcinomatous Component Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
9726,Malignant Cellular Infiltrate,Small Intestinal Undifferentiated Carcinoma,1
9727,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
9728,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma,1
9729,Pancytopenia,Acute panmyelosis with myelofibrosis,1
9730,Cystic Change,Solid pseudopapillary tumor of the pancreas,1
9731,Well-Circumscribed Lesion,Seminal Vesicle Cystadenoma,1
9732,Dysplasia,Appendix Traditional Serrated Adenoma,1
9733,Melanin Pigment Present,Melanocytic nevus of skin,1
9734,Pushing Tumor Margin,verrucous carcinoma of vagina,1
9735,Carcinomatous Component Present,Cervical Verrucous Carcinoma,1
9736,Fever,HHV8-Positive Multicentric Castleman Disease,1
9737,Childhood Lesion,Childhood Small Intestinal Leiomyosarcoma,1
9738,Carcinomatous Component Present,Ovarian Cystadenocarcinoma,1
9739,Borderline Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
9740,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
9741,Malignant Cellular Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
9742,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,1
9743,Malignant Cellular Infiltrate,adenoid cystic carcinoma of esophagus,1
9744,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
9745,Metastatic Lesion,Metastatic Carcinoma in the Lung,1
9746,Papillary Pattern,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
9747,Childhood Lesion,Childhood Gastric Carcinoma,1
9748,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of parotid gland,1
9749,Local disease,Localized Bone Ewing Sarcoma,1
9750,Benign Cellular Infiltrate,Apocrine adenoma,1
9751,Epithelial Component Present,Localized Extrahepatic Bile Duct Carcinoma,1
9752,Mild cytologic atypia,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
9753,S-100-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
9754,Immunosuppression-Related Post-Transplant Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
9755,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,1
9756,Carcinomatous Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
9757,Dysplasia,Appendix Mucinous Cystadenoma,1
9758,Carcinomatous Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
9759,Adulthood Lesion,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
9760,Recurrent disease,Centroblastic lymphoma recurrent,1
9761,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214,1
9762,Splenomegaly,Progressive Hairy Cell Leukemia Initial Treatment,1
9763,Glomerular Hypertrophy,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",1
9764,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
9765,Malignant Cellular Infiltrate,Angioendotheliomatosis,1
9766,Malignant Cellular Infiltrate,Alveolar soft part sarcoma metastatic,1
9767,Osseous Differentiation,Osteosarcoma,1
9768,Contiguous Disease,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma,1
9769,Epithelial Component Present,Intraepithelial Neoplasia,1
9770,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage I,1
9771,Malignant Cellular Infiltrate,Cervix carcinoma,1
9772,Malignant Cellular Infiltrate,Stage IVA Laryngeal Cancer AJCC v7,1
9773,Dysplasia,Squamous intraepithelial neoplasia grade 2,1
9774,Cord-Like Pattern,Vulvar Syringoma,1
9775,Solitary mass,Dedifferentiated chordoma,1
9776,Benign Cellular Infiltrate,Eccrine Poroma,1
9777,Malignant Cellular Infiltrate,Bowen's Disease,1
9778,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,1
9779,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
9780,Epithelial Component Present,Sclerosing thymoma,1
9781,Mixed Cellular Population,Combined Lung Carcinoma,1
9782,Epithelial Component Present,Carcinoma in situ in a polyp,1
9783,Carcinomatous Component Present,Unresectable Skin Carcinoma,1
9784,Carcinomatous Component Present,Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
9785,Clinical TNM Finding,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
9786,Recurrent disease,Recurrent Glioma,1
9787,Toxic effect,Environment-Related Neoplasm,1
9788,atypia morphology,Atypical adenomatous hyperplasia,1
9789,Favorable Clinical Outcome,Retroperitoneal Ganglioneuroma,1
9790,Vascular Channel Formation,Lymphangioma circumscriptum,1
9791,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
9792,Malignant Cellular Infiltrate,Recurrent Aggressive NK-Cell Leukemia,1
9793,Dilated Vascular Space Formation,Glomangioma,1
9794,Epithelial Component Present,Barrett's Adenocarcinoma,1
9795,Epithelial Component Present,Adenocarcinoma of anal canal,1
9796,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8,1
9797,Necrotic changes (finding),Large cell neuroendocrine carcinoma,1
9798,Invasive Lesion,Thymoma malignant invasive,1
9799,Benign Cellular Infiltrate,Benign neoplasm of sweat gland,1
9800,Local disease,Epicardial Lipoma,1
9801,Vascular Channel Formation,Locally Advanced Angiosarcoma,1
9802,Nuclear Pseudoinclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
9803,Benign Cellular Infiltrate,Parotid monomorphic adenoma,1
9804,Vascular Channel Formation,Thyroid Gland Benign Vascular Neoplasm,1
9805,Cutaneous Involvement,"Lichen Planus, Oral",1
9806,Pregnancy Complications,Stage III Gestational Trophoblastic Tumor AJCC v7,1
9807,Carcinomatous Component Present,Primary Peritoneal Cancer by AJCC v7 Stage,1
9808,Childhood Lesion,Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8,1
9809,Malignant Cellular Infiltrate,Laryngeal Adenoid Cystic Carcinoma,1
9810,Carcinomatous Component Present,Recurrent Biliary Tract Carcinoma,1
9811,Malignant Cellular Infiltrate,High Grade Astrocytic Tumor,1
9812,Malignant Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
9813,Malignant Cellular Infiltrate,Unresectable Adrenal Cortex Carcinoma,1
9814,High Mitotic Activity,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
9815,Malignant Cellular Infiltrate,Sublingual Gland Adenocarcinoma,1
9816,Malignant Cellular Infiltrate,Stage IVA Fallopian Tube Cancer AJCC v8,1
9817,Increased NFkappaB Pathway Activation,Mediastinal (Thymic) Large B-Cell Lymphoma,1
9818,Low Grade Neuroendocrine Lesion,Carcinoid tumor of ileum,1
9819,Vascular Channel Formation,Central Nervous System Hemangioma,1
9820,Epithelial Component Present,Thymoma malignant invasive,1
9821,Malignant Cellular Infiltrate,Laryngeal Adenosquamous Carcinoma,1
9822,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
9823,Endophytic Tumor Growth,Frontal Sinus Inverted Papilloma,1
9824,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v7,1
9825,Carcinomatous Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
9826,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
9827,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
9828,Cutaneous Involvement,Malignant Apocrine Neoplasm,1
9829,Epithelial Component Present,Non functioning pancreatic endocrine tumor,1
9830,Mixed Cellular Population,Childhood Kidney Wilms Tumor,1
9831,Unresectable Mass,Unresectable Soft Tissue Sarcoma,1
9832,Metastatic/Recurrent Disease,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
9833,Malignant Cellular Infiltrate,Skull Base Chordoma,1
9834,Extensive Stage Lesion,Peritoneal mesothelioma malignant advanced,1
9835,Carcinomatous Component Present,Locally Advanced Cervical Carcinoma,1
9836,Malignant Cellular Infiltrate,verrucous carcinoma of vagina,1
9837,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Fallopian Tube Gestational Choriocarcinoma,1
9838,Multinodular Mass,Recurrent Skin Angiosarcoma,1
9839,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
9840,Malignant Cellular Infiltrate,Metastatic Meningioma,1
9841,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
9842,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor,1
9843,Well Differentiated Lesion,verrucous carcinoma of esophagus,1
9844,Carcinomatous Component Present,Advanced Bile Duct Carcinoma,1
9845,Malignant Cellular Infiltrate,Metastatic Prostate Carcinoma,1
9846,Anaplasia,Intracortical osteosarcoma,1
9847,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
9848,Squamous metaplasia of bladder,Bladder Urachal Squamous Cell Carcinoma,1
9849,Epithelial Component Present,Stage II Oropharyngeal Carcinoma,1
9850,Recurrent disease,Osteosarcoma recurrent,1
9851,Indolent Clinical Course,Capillary hemangioma of retina,1
9852,Single Cell Necrosis,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
9853,Infiltrating Tumor Margins Present,Malignant Phyllodes Tumor of Prostate,1
9854,Carcinomatous Component Present,Adenosquamous cell lung cancer stage III,1
9855,Well Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
9856,Malignant Cellular Infiltrate,sarcoma of lung,1
9857,Epithelial Component Present,Mucoepidermoid Breast Carcinoma,1
9858,Indolent Clinical Course,benign neoplasm of floor of mouth,1
9859,Benign Cellular Infiltrate,Chondromatosis,1
9860,Malignant Cellular Infiltrate,High Grade Sarcoma,1
9861,Malignant Cellular Infiltrate,carcinoma of lacrimal gland,1
9862,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7,1
9863,Osseous Differentiation,Stage IVB Osteosarcoma AJCC v7,1
9864,Carcinomatous Component Present,undifferentiated carcinoma of liver,1
9865,Histiocytosis haematophagic,Refractory Hemophagocytic Lymphohistiocytosis,1
9866,Lobulated Growth Pattern,Cutaneous myxoma,1
9867,Infiltrative Growth Pattern,Adult Gliosarcoma,1
9868,Malignant Cellular Infiltrate,Childhood Extraskeletal Osteosarcoma,1
9869,Carcinomatous Component Present,Unresectable Extrahepatic Bile Duct Carcinoma,1
9870,Malignant Cellular Infiltrate,Abdominal Rhabdomyosarcoma,1
9871,Recurrent disease,Recurrent Childhood Pilocytic Astrocytoma,1
9872,Carcinomatous Component Present,Stage IB Vulvar Carcinoma AJCC v6,1
9873,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
9874,Low Mitotic Activity,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
9875,Primary Lesion,gliosarcoma,1
9876,Necrotic changes (finding),Digestive System Large Cell Neuroendocrine Carcinoma,1
9877,Benign Cellular Infiltrate,Osteochondromatosis,1
9878,Hemorrhagic,Small Intestinal Angiosarcoma,1
9879,Carcinomatous Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7,1
9880,Unresectable Mass,Unresectable Neuroblastoma,1
9881,Carcinomatous Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
9882,Pseudoglandular Pattern,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
9883,Epithelial Component Present,Crohn Disease-Associated Colorectal Adenocarcinoma,1
9884,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
9885,Indolent Clinical Course,Lipoma of skin,1
9886,Epithelial Component Present,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
9887,Hypokalemia,Juxtaglomerular tumor,1
9888,Malignant Cellular Infiltrate,Ann Arbor Stage III Follicular Lymphoma,1
9889,Carcinomatous Component Present,keratinizing squamous cell carcinoma of vulva,1
9890,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
9891,Carcinomatous Component Present,Mucoepidermoid carcinoma of submandibular gland,1
9892,Benign Cellular Infiltrate,Intra-Abdominal Lymphangioma,1
9893,Metaplasia,Bladder squamous cell carcinoma recurrent,1
9894,Epithelial Component Present,Prostatic Intraepithelial Neoplasias,1
9895,Biphasic Pattern,Fibroadenoma of breast,1
9896,Neuroendocrine Differentiation,Neuroendocrine carcinoma of the bladder,1
9897,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
9898,Malignant Cellular Infiltrate,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,1
9899,Tubular Pattern,Malignant Pancreatic Somatostatinoma,1
9900,Metastatic Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
9901,Splenomegaly,T-Cell Prolymphocytic Leukemia,1
9902,Epithelial Component Present,Warty dyskeratoma,1
9903,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
9904,Papillary Pattern,Peritoneal Well Differentiated Papillary Mesothelioma,1
9905,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
9906,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
9907,Epithelial Component Present,Recurrent Merkel Cell Carcinoma,1
9908,Low Grade Lesion,Pleural Epithelioid Hemangioendothelioma,1
9909,Malignant Cellular Infiltrate,Urothelial carcinoma urethra recurrent,1
9910,Indolent Clinical Course,"Hemangioma, Cavernous, Central Nervous System",1
9911,Carcinomatous Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
9912,Mitotic Activity,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
9913,Immunoglobulin Deposition,Primary Systemic Amyloidosis,1
9914,Exophytic Papillary Lesion,Vaginal Papillary Carcinoma,1
9915,Metastatic Lesion,Metastatic malignant neoplasm to nasopharynx,1
9916,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
9917,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v6,1
9918,Epithelial Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
9919,Carcinomatous Component Present,Vulvar Merkel Cell Carcinoma,1
9920,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
9921,Malignant Cellular Infiltrate,Adult Burkitt Lymphoma,1
9922,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma,1
9923,Hepatomegaly,Hepatosplenic T-cell lymphoma,1
9924,Malignant Cellular Infiltrate,Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
9925,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Central Nervous System Choriocarcinoma,1
9926,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
9927,Epithelial Component Present,Colorectal Cancer by AJCC v7 Stage,1
9928,Epithelial Component Present,Stage IA Vulvar Carcinoma AJCC v6,1
9929,Epithelial Component Present,Primary peritoneal carcinoma,1
9930,Childhood Lesion,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
9931,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage IV,1
9932,Epithelial Component Present,Stage II Oropharyngeal Carcinoma,1
9933,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v7,1
9934,Malignant Cellular Infiltrate,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
9935,Well-Circumscribed Lesion,tubulopapillary adenoma of gallbladder,1
9936,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v6 and v7,1
9937,Metastatic Lesion,Metastatic thymic carcinoma,1
9938,Epithelial Component Present,Schneiderian carcinoma,1
9939,Malignant Cellular Infiltrate,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
9940,Malignant Cellular Infiltrate,Penis carcinoma recurrent,1
9941,Seminomatous Component Present,Mixed Germ Cell Tumor,1
9942,Myxoid Stroma Formation,Juxta-Articular Myxoma,1
9943,Thick-Walled Hyalinized Vessels Present,Mediastinal Schwannoma,1
9944,Collagenous Stroma Formation,Myofibroblastoma,1
9945,Secondary Lesion,Metastatic Uveal Melanoma,1
9946,Biphasic Pattern,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
9947,Refractory Disease,Refractory Visual Pathway Glioma,1
9948,Malignant Cellular Infiltrate,Carcinoma of hard palate,1
9949,Malignant Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma,1
9950,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
9951,Malignant Cellular Infiltrate,"High Grade B-Cell Lymphoma, Not Otherwise Specified",1
9952,Infiltrative Growth Pattern,Secondary Supratentorial Anaplastic Astrocytoma,1
9953,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v8,1
9954,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
9955,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v7,1
9956,Hereditary Lesion,Hereditary Non-Polyposis Colon Cancer Type 2,1
9957,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
9958,Recurrent disease,Recurrent tumors of the Ewing's family,1
9959,Microvascular Proliferation,Juvenile Pilocytic Astrocytoma,1
9960,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma recurrent,1
9961,Exophytic Polypoid Lesion,Vaginal Fibroepithelial Polyp,1
9962,Malignant Cellular Infiltrate,Stage IIIA Gallbladder Cancer AJCC v8,1
9963,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v7 Stage,1
9964,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
9965,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck by AJCC v7 Stage,1
9966,Epithelial Component Present,Stage IV Penile Cancer AJCC v7,1
9967,Anaplasia,Glioblastoma multiforme of spinal cord,1
9968,Epithelial Component Present,Endometrial Mucinous Adenocarcinoma,1
9969,Metastatic Lesion,Secondary Central Nervous System Lymphoma,1
9970,High Mitotic Activity,Medulloepithelioma,1
9971,Neuroendocrine Differentiation,Vulvar Neuroendocrine Carcinoma,1
9972,Pregnancy Complications,Leuteoma of Pregnancy,1
9973,Adulthood Lesion,Stage IV Adult Non-Hodgkin Lymphoma,1
9974,Epithelial Component Present,Unresectable Thymic Carcinoma,1
9975,Secondary Lesion,Metastatic urothelial carcinoma,1
9976,Carcinomatous Component Present,Primary Cutaneous Mucinous Carcinoma,1
9977,Epithelial Component Present,Unresectable Lung Carcinoma,1
9978,Epithelial Component Present,Mucoepidermoid carcinoma of the oral cavity stage II,1
9979,Malignant Cellular Infiltrate,Secondary malignant neoplasm of mediastinum,1
9980,Metastatic Lesion,Locally Advanced Unresectable Carcinoma,1
9981,Epithelial Component Present,intestinal type adenocarcinoma of extrahepatic bile duct,1
9982,Malignant Cellular Infiltrate,Aleukemic Chronic Lymphocytic Leukemia,1
9983,Primary Lesion,Refractory Central Nervous System Lymphoma,1
9984,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
9985,Edematous Stroma Formation,Vaginal Angiomyofibroblastoma,1
9986,Firm mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
9987,Mitotic Activity,Recurrent Giant Cell Glioblastoma,1
9988,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
9989,Epithelial Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
9990,Malignant Cellular Infiltrate,Malignant neoplasm of cheek mucosa,1
9991,Epithelial Component Present,Adult Cholangiocarcinoma,1
9992,Malignant Cellular Infiltrate,Refractory B-Cell Prolymphocytic Leukemia,1
9993,Epithelial Component Present,Breast Fibroepithelial Neoplasm,1
9994,Malignant Cellular Infiltrate,Stage IVC Paranasal Sinus Cancer AJCC v7,1
9995,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer,1
9996,Malignant Cellular Infiltrate,Vulvar Warty Carcinoma,1
9997,High Mitotic Activity,small cell carcinoma of kidney,1
9998,Epithelial Component Present,Stage IVA Lip and Oral Cavity Cancer AJCC v8,1
9999,Epithelial Component Present,Desmoplastic trichoepithelioma,1
10000,Malignant Cellular Infiltrate,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
10001,S-100-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
10002,Osseous Differentiation,Intracortical osteosarcoma,1
10003,Epithelial Component Present,Recurrent Paget Disease of the Anal Canal,1
10004,Cutaneous Involvement,Basal cell carcinoma - keratotic,1
10005,Epithelial Component Present,Recurrent Hepatocellular Carcinoma,1
10006,Epithelial Component Present,"Somatostatinoma, malignant",1
10007,Malignant Cellular Infiltrate,Neuroblastoma of brain,1
10008,Regional Disease,Locally Advanced Melanoma,1
10009,Epithelial Component Present,Bronchial adenoma,1
10010,Metastatic Lesion,Secondary malignant neoplasm of stomach,1
10011,Benign Cellular Infiltrate,Cardiac rhabdomyoma,1
10012,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
10013,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Chronic Myelomonocytic Leukemia,1
10014,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
10015,Necrotic changes (finding),Suppurative lymphadenopathy,1
10016,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
10017,Microvascular Proliferation,Glioblastoma with Primitive Neuronal Component,1
10018,Malignant Component Present,Ovarian Dermoid Cyst with Sebaceous Carcinoma,1
10019,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8,1
10020,Recurrent disease,Recurrent Kaposi Sarcoma,1
10021,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
10022,Recurrent disease,Thymoma malignant recurrent,1
10023,Systemic disease,Primary Systemic Amyloidosis,1
10024,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
10025,Malignant Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma,1
10026,Calcitonin serum level increased,Familial medullary thyroid carcinoma,1
10027,High Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
10028,Malignant Cellular Infiltrate,Smoldering myeloma,1
10029,Malignant Cellular Infiltrate,Malignant germ cell neoplasm,1
10030,Resectable Mass,Carcinoma duodenum resectable,1
10031,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of prostate,1
10032,Adnexal Differentiation,Vulvar Neoplasm of Skin Appendage Origin,1
10033,Epithelial Component Present,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,1
10034,Epithelial Component Present,Malignant Cystosarcoma Phyllodes,1
10035,Adulthood Lesion,Adult Papillary Meningioma,1
10036,Cartilaginous Differentiation,Chondromatosis,1
10037,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the cecum,1
10038,Biphasic Pattern,Cervical Adenofibroma,1
10039,Epithelial Component Present,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
10040,Indolent Clinical Course,Benign Soft Tissue Tumor of Uncertain Differentiation,1
10041,Carcinomatous Component Present,Stage IVC Laryngeal Cancer AJCC v8,1
10042,Epithelial Component Present,Gastric Carcinoid Tumor,1
10043,Benign Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma,1
10044,Sinusoidal Infiltration,Recurrent Hepatosplenic T-Cell Lymphoma,1
10045,Exophytic Papillary Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
10046,Malignant Cellular Infiltrate,Recurrent Parathyroid Gland Carcinoma,1
10047,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IIIB,1
10048,Epithelial Component Present,Recurrent Anal Mucinous Adenocarcinoma,1
10049,Malignant Cellular Infiltrate,Mixed Cellularity Hodgkin Lymphoma,1
10050,Hyperkeratosis,Classic Type Trichilemmoma,1
10051,Malignant Cellular Infiltrate,Nipple Carcinoma,1
10052,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
10053,Carcinomatous Component Present,Adenocarcinoma of lacrimal gland,1
10054,Indolent Clinical Course,Lipoma of breast,1
10055,Necrotic changes (finding),Anaplastic adrenocortical carcinoma,1
10056,Carcinomatous Component Present,Infiltrating Urothelial Carcinoma,1
10057,Low Mitotic Activity,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
10058,Malignant Cellular Infiltrate,Choroidal and Ciliary Body Melanoma by AJCC v8 Stage,1
10059,Malignant Cellular Infiltrate,Stage IIIB Distal Bile Duct Cancer AJCC v8,1
10060,Well-Circumscribed Lesion,Endocervical polyp,1
10061,Ischemia,Vascular insufficiency of intestine,1
10062,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
10063,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of gallbladder with squamous metaplasia,1
10064,Malignant Cellular Infiltrate,Prostate cancer stage B,1
10065,High Grade Lesion,Stage III Lung Small Cell Carcinoma AJCC v7,1
10066,Sebaceous Differentiation,Sebaceoma,1
10067,Necrotic changes (finding),Malignant Solitary Fibrous Tumor,1
10068,High Grade Lesion,Embryonal Rhabdomyosarcoma,1
10069,Well-Circumscribed Lesion,Cellular angiofibroma,1
10070,Carcinomatous Component Present,Stage IIIC Lung Cancer AJCC v8,1
10071,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
10072,Benign Cellular Infiltrate,Benign neoplasm of endometrium,1
10073,Intermediate Filaments Present,Extrarenal rhabdoid tumor,1
10074,Epithelial Component Present,Squamous cell carcinoma of the nasal cavity,1
10075,High Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
10076,Epithelial Component Present,Grade II Penile Intraepithelial Neoplasia,1
10077,Cartilaginous Differentiation,Sternal Chondromyxoid Fibroma,1
10078,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
10079,Abundant Intracytoplasmic Lipofuscin Present,Heavily Pigmented Adrenal Cortical Adenoma,1
10080,Benign Cellular Infiltrate,Osteoblastoma,1
10081,Carcinomatous Component Present,Advanced Renal Cell Carcinoma,1
10082,Breast Microcalcification,Childhood Oligodendroglioma,1
10083,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v7,1
10084,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma,1
10085,Mixed Cellular Population,Broad Ligament Serous Adenofibroma,1
10086,Adulthood Lesion,Adult Non-Hodgkin Lymphoma,1
10087,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lacrimal gland,1
10088,Epithelial Component Present,"Cystadenocarcinoma, Serous",1
10089,Epithelial Component Present,Stage IIA Breast Carcinoma,1
10090,Carcinomatous Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type",1
10091,Carcinomatous Component Present,Recurrent Acinic Cell Breast Carcinoma,1
10092,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8,1
10093,Metaplasia,Squamous Lung Dysplasia,1
10094,Malignant Cellular Infiltrate,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
10095,Epithelial Component Present,Head and Neck Basaloid Carcinoma,1
10096,Malignant Cellular Infiltrate,Recurrent Lobular Breast Carcinoma,1
10097,Carcinomatous Component Present,Basophilic Adenocarcinoma,1
10098,Epithelial Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7,1
10099,Hyperkeratosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
10100,Poorly Differentiated Neuroendocrine Lesion,large cell neuroendocrine carcinoma of anal canal,1
10101,Mitotic Activity,Malignant Ovarian Thecoma,1
10102,Malignant Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
10103,Thyroglobulin Positive Neoplastic Cells Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
10104,Carcinomatous Component Present,Childhood Nasal Cavity Carcinoma,1
10105,Vascular Channel Formation,Kaposi's sarcoma of palate,1
10106,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
10107,Nuclear Expression of STAT6 Protein,Peritoneal Solitary Fibrous Tumor,1
10108,Recurrent disease,Recurrent tumor,1
10109,Extensive Secretory Changes Present,Lactating adenoma,1
10110,Biphasic Pattern,Breast Fibroepithelial Neoplasm,1
10111,Nuclear pleomorphism,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
10112,Primary Lesion,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
10113,Carcinomatous Component Present,Sarcomatoid Carcinoma of the Penis,1
10114,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",1
10115,Alternative Fascicle (Bundle) Pattern,Central Nervous System Leiomyoma,1
10116,Recurrent disease,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
10117,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma,1
10118,Malignant Cellular Infiltrate,Splenic B Lymphoblastic Lymphoma,1
10119,Epithelial Component Present,Small Intestinal Tubulovillous Adenoma,1
10120,Benign Cellular Infiltrate,Ovarian Endometrioid Cystadenoma,1
10121,Indolent Clinical Course,Cervical Rhabdomyoma,1
10122,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
10123,Fibromyxoid Stroma Formation,Fibromyxolipoma,1
10124,Benign Cellular Infiltrate,Anal Papillary Hidradenoma,1
10125,Fibrotic Stroma Formation,Clear Cell Intrahepatic Cholangiocarcinoma,1
10126,Malignant Cellular Infiltrate,Malignant tumor of nasal sinuses,1
10127,Obesity,Inflammatory Hepatocellular Adenoma,1
10128,Benign Cellular Infiltrate,Benign Thalamic Neoplasm,1
10129,Osseous Differentiation,Stage III Osteosarcoma AJCC v7,1
10130,Childhood Lesion,Childhood Testicular Teratoma,1
10131,Delicate Vascular Network Formation,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
10132,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ovary,1
10133,Malignant Cellular Infiltrate,Low Grade Paranasal Sinus Sarcoma,1
10134,Epithelial Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
10135,Carcinomatous Component Present,Metastatic Adenoid Cystic Carcinoma,1
10136,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma,1
10137,Carcinomatous Component Present,Seminal Vesicle Adenocarcinoma,1
10138,Solid Growth Pattern,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
10139,Carcinomatous Component Present,Thoracic NUT Carcinoma,1
10140,Biphasic Pattern,Uterine Corpus Adenomyoma,1
10141,Pathologic TNM Finding,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
10142,Benign Cellular Infiltrate,Benign neoplasm of glottis,1
10143,Keratin pearl formation,"Squamous cell carcinoma, keratinizing",1
10144,Malignant Cellular Infiltrate,Malignant Sternal Neoplasm,1
10145,Metastatic Lesion,Secondary malignant neoplasm of parathyroid gland,1
10146,Non-Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
10147,Malignant Cellular Infiltrate,Alveolar soft part sarcoma recurrent,1
10148,Adulthood Lesion,Adult Central Nervous System Teratoma,1
10149,Diffuse Pattern,Breast Diffuse Large B-Cell Lymphoma,1
10150,Childhood Lesion,Childhood Testicular Embryonal Carcinoma,1
10151,Moderate dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
10152,Epithelial Component Present,Stage IVB Fallopian Tube Cancer AJCC v8,1
10153,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma,1
10154,High Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
10155,No Evidence of Metastatic Disease,Chondroblastoma,1
10156,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
10157,Recurrent disease,Angiocentric lymphoma recurrent,1
10158,Malignant Cellular Infiltrate,Anatomic Stage I Breast Cancer AJCC v8,1
10159,Collagenous Stroma Formation,Sclerosing PEComa,1
10160,Epithelial Component Present,Cervical Cancer by AJCC v6 Stage,1
10161,Indolent Clinical Course,Leiomyoma of esophagus,1
10162,Epithelial Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
10163,Epithelial Component Present,Appendix Neuroendocrine Tumor G2,1
10164,Carcinomatous Component Present,Stage IIIA2 Ovarian Cancer AJCC v8,1
10165,Cutaneous Involvement,Pseudoporphyria,1
10166,Cellular Stratification,Borderline Ovarian Mucinous Adenofibroma,1
10167,Mitotic Activity,Recurrent Anaplastic Astrocytoma,1
10168,Malignant Cellular Infiltrate,Skin Pseudovascular Squamous Cell Carcinoma,1
10169,Malignant Cellular Infiltrate,Malignant Brenner Tumor,1
10170,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
10171,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
10172,Metastatic Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
10173,Carcinomatous Component Present,squamous cell carcinoma of the thyroid gland,1
10174,Primary Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",1
10175,Exophytic Papillary Lesion,Warty Carcinoma of the Penis,1
10176,Thin-Walled Branching Vascular Pattern,Peritoneal Solitary Fibrous Tumor,1
10177,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
10178,Cartilaginous Differentiation,Primary chondrosarcoma of bone,1
10179,Malignant Cellular Infiltrate,Metastatic Bladder Squamous Cell Carcinoma,1
10180,Nodular Pattern,"Hodgkin lymphoma, nodular sclerosis, cellular phase",1
10181,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
10182,Favorable Clinical Outcome,Ganglioneuroma,1
10183,Dense Intercellular Reticulin Network Present,Supratentorial Pleomorphic Xanthoastrocytoma,1
10184,Dysplasia,Vaginal Tubular Adenoma,1
10185,Cystic Change,Mucinous cystadenoma of ovary,1
10186,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
10187,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
10188,Non-Malignant Cellular Infiltrate,Histiocytic Necrotizing Lymphadenitis,1
10189,Mitotic Activity,"Testicular Yolk Sac Tumor, Enteric Pattern",1
10190,Carcinomatous Component Present,Head and Neck Basaloid Carcinoma,1
10191,Primary Lesion,"lymphomatoid papulosis, type A",1
10192,Indolent Clinical Course,Desmoplastic fibroblastoma,1
10193,Malignant Cellular Infiltrate,Acinar cell cystadenocarcinoma,1
10194,Myxoid Stroma Formation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
10195,Malignant Cellular Infiltrate,Lugano Classification Stage II Adult Lymphoma AJCC v8,1
10196,Cutaneous Involvement,Asian desert cutaneous leishmaniasis,1
10197,Childhood Lesion,Childhood Testicular Germ Cell Tumor,1
10198,Dysplasia,Gallbladder Flat Biliary Intraepithelial Neoplasia,1
10199,Hypercellular bone marrow,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
10200,BCR/ABL1 Fusion Negative,Ph-Like Acute Lymphoblastic Leukemia,1
10201,Peripheral Nuclear Palisading,Lung Basaloid Squamous Cell Carcinoma,1
10202,Carcinomatous Component Present,Refractory Endometrial Carcinoma,1
10203,Epithelial Component Present,Occult Lung Small Cell Carcinoma,1
10204,Microvascular Proliferation,Neural Glioblastoma,1
10205,Capillary Sized Vascular Channel Formation,Trichodiscoma,1
10206,Chronic Inflammatory Infiltrate,"lymphomatoid papulosis, type A",1
10207,Metastatic Lesion,Metastatic Renal Cell Carcinoma,1
10208,Carcinomatous Component Present,Major Salivary Gland Mucoepidermoid Carcinoma,1
10209,Myxoid Stroma Formation,Epithelioid hemangioendothelioma,1
10210,Increased Cellularity Present,Localized Unresectable Neuroblastoma,1
10211,Hyperplastic Tissue Present,Atypical adenomatous hyperplasia,1
10212,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx,1
10213,Capillary Sized Vascular Channel Formation,Cerebellar hemangioblastoma,1
10214,Intestinal metaplasia of gastric mucosa,adenomatous polyp of stomach,1
10215,Stromal Invasion,Stage IIA Ovarian Cancer AJCC V6 and v7,1
10216,Adulthood Lesion,Adult T Acute Lymphoblastic Leukemia,1
10217,Diffuse Pattern,Anaplastic Oligodendroglioma,1
10218,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Variant MLL Translocations,1
10219,Cutaneous Involvement,Cutaneous Fibrous Histiocytoma,1
10220,Recurrent disease,Recurrent Central Nervous System Lymphoma,1
10221,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v8,1
10222,Micronodular Pattern,Micronodular thymoma with lymphoid stroma,1
10223,Benign Cellular Infiltrate,Ectomesenchymal Chondromyxoid Tumor,1
10224,Carcinomatous Component Present,Ampulla of Vater Squamous Cell Carcinoma,1
10225,Metastatic/Recurrent Disease,Cardiac Biphasic Synovial Sarcoma,1
10226,Tubular Pattern,Colonic tubulovillous adenoma,1
10227,Carcinomatous Component Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
10228,Secondary Lesion,Undifferentiated Carcinoma of Unknown Primary,1
10229,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
10230,Dysplasia,adenomatous polyp of stomach,1
10231,Carcinomatous Component Present,Recurrent Fallopian Tube Carcinoma,1
10232,Necrotic changes (finding),Recurrent Childhood Giant Cell Glioblastoma,1
10233,Epithelial Component Present,Stage IV Colon Carcinoma,1
10234,Intraosseous Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
10235,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type",1
10236,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v8 Stage,1
10237,Carcinomatous Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
10238,Malignant Cellular Infiltrate,Dedifferentiated chondrosarcoma,1
10239,Exophytic Papillary Lesion,Human Papillomavirus-Related Verrucous Carcinoma,1
10240,Epithelial Component Present,"Basal cell carcinoma, micronodular",1
10241,Severe dysplasia,Stage 0 Anal Cancer AJCC v8,1
10242,Benign Cellular Infiltrate,Common blue nevus of skin,1
10243,Malignant Cellular Infiltrate,Thymic Carcinoma,1
10244,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
10245,Nuclear Grooves,Papillary Thyroid Microcarcinoma,1
10246,Unresectable Mass,Unresectable Bone Sarcoma,1
10247,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7,1
10248,Necrotic changes (finding),Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
10249,Cutaneous Involvement,Clinical Stage IIB Cutaneous Melanoma AJCC v8,1
10250,Epithelial Component Present,Malignant Breast Eccrine Spiradenoma,1
10251,Malignant Cellular Infiltrate,DS Stage III Plasma Cell Myeloma,1
10252,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma,1
10253,atypia morphology,Borderline serous tumor of ovary,1
10254,Metastatic Lesion,Metastatic Renal Cell Carcinoma,1
10255,Splenomegaly,Splenic Manifestation of Chronic Lymphocytic Leukemia,1
10256,Malignant Cellular Infiltrate,Fusion-Negative Rhabdomyosarcoma,1
10257,Monoclonal Cellular Population Present,Skin Mastocytoma,1
10258,Malignant Cellular Infiltrate,Malignant neoplasm of exocervix,1
10259,Severe cytologic atypia,Primary hepatic neuroendocrine carcinoma,1
10260,Anaplasia,Spindle cell squamous cell carcinoma,1
10261,Well-Circumscribed Lesion,Cerebral Hemangioblastoma,1
10262,Malignant Cellular Infiltrate,Pathologic Stage 0 Gastric Cancer AJCC v8,1
10263,Malignant Cellular Infiltrate,Plasma cell myeloma refractory,1
10264,Cutaneous Involvement,Perifollicular fibroma,1
10265,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia,1
10266,Low Grade Lesion,Lung Typical Carcinoid Tumor,1
10267,Carcinomatous Component Present,Stage 0 Vulvar Cancer,1
10268,Epithelial Component Present,"Squamous cell carcinoma, large cell, nonkeratinizing",1
10269,Malignant Cellular Infiltrate,Resectable Head and Neck Squamous Cell Carcinoma,1
10270,Immunologic Deficiency Syndromes,Non-Destructive Post-Transplant Lymphoproliferative Disorder,1
10271,Carcinomatous Component Present,Pharyngeal Carcinoma,1
10272,Invasive Lesion,Infiltrating Cervical Carcinoma,1
10273,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
10274,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
10275,Secondary Lesion,Metastatic Parathyroid Gland Carcinoma,1
10276,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
10277,Koilocytotic atypia,Human Papillomavirus-Related Verrucous Carcinoma,1
10278,Low Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor,1
10279,Immunologic Deficiency Syndromes,Transplant-Related Squamous Cell Carcinoma,1
10280,Well-Circumscribed Lesion,Anal Inflammatory Cloacogenic Polyp,1
10281,Recurrent disease,Recurrent Primary Cutaneous Lymphoma,1
10282,Epithelial Component Present,Stage IIB Prostate Cancer AJCC v8,1
10283,Antoni A Pattern,Benign Esophageal Schwannoma,1
10284,Indolent Clinical Course,Benign neoplasm of endometrium,1
10285,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
10286,Malignant Cellular Infiltrate,carcinoma of middle ear,1
10287,Low Mitotic Activity,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
10288,Malignant Cellular Infiltrate,Central Nervous System Epithelioid Hemangioendothelioma,1
10289,Malignant Cellular Infiltrate,Ocular Melanoma with Extraocular Extension,1
10290,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
10291,Collagenous Stroma Formation,Unresectable Desmoid-Type Fibromatosis,1
10292,Benign Cellular Infiltrate,Benign Lung PEComa,1
10293,Refractory Disease,Refractory Lymphoproliferative Disorder,1
10294,Secondary Lesion,Castration-Naive Prostate Carcinoma,1
10295,Benign Cellular Infiltrate,Classic Type Trichilemmoma,1
10296,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
10297,Regional Disease,Crohn's disease of the ileum,1
10298,Malignant Cellular Infiltrate,Ovarian Transitional Cell Carcinoma,1
10299,Carcinomatous Component Present,Anterior Tongue Mucoepidermoid Carcinoma,1
10300,Dermal Involvement,Compound nevus of skin,1
10301,Entrapped Respiratory Epithelium Present,Multiple hamartoma of lung,1
10302,Malignant Cellular Infiltrate,Mixed epithelioid and spindle cell melanoma,1
10303,High Mitotic Activity,large cell neuroendocrine carcinoma of breast,1
10304,Epithelial Component Present,Adult Type Granulosa Cell Tumor,1
10305,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
10306,Malignant Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma,1
10307,Well-Circumscribed Lesion,Epithelial Predominant Kidney Wilms Tumor,1
10308,Carcinomatous Component Present,Mucoepidermoid carcinoma of parotid gland,1
10309,Neuroendocrine Differentiation,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
10310,Monoclonal Paraproteinemia,Osteosclerotic Plasma Cell Myeloma,1
10311,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
10312,Non Lipogenic Sarcomatous Stroma Present,Unresectable Dedifferentiated Liposarcoma,1
10313,Infiltrative Growth Pattern,Malignant Lung PEComa,1
10314,Epithelial Component Present,Carcinoma Arising in Nasal Papillomatosis,1
10315,Mesenchymal Component Present,Giant fibroadenoma of breast,1
10316,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
10317,Carcinomatous Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma,1
10318,Severe dysplasia,Stage 0 Colon Cancer AJCC v6 and v7,1
10319,Malignant Cellular Infiltrate,Intracortical osteosarcoma,1
10320,Non-Hereditary Lesion,Gastric Hepatoid Adenocarcinoma,1
10321,Malignant Cellular Infiltrate,Metastatic hepatocellular carcinoma,1
10322,Vascular Channel Formation,Angiosarcoma non-metastatic,1
10323,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
10324,Neuroectodermal Differentiation,Retinoblastoma,1
10325,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer,1
10326,Multinodular Mass,Mediastinal Angiosarcoma,1
10327,Endophytic Tumor Growth,Human Papillomavirus-Related Verrucous Carcinoma,1
10328,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
10329,Angiocentric Pattern,Recurrent Lymphomatoid Granulomatosis,1
10330,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
10331,Capillary Sized Vascular Channel Formation,Peripheral Hemangioblastoma,1
10332,Carcinomatous Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
10333,Malignant Cellular Infiltrate,Cerebellar Vermis Medulloblastoma,1
10334,Epithelial Component Present,Colon Neuroendocrine Tumor G1,1
10335,Vascular Channel Formation,Hemangioma of intracranial structure,1
10336,Malignant Cellular Infiltrate,Prostate cancer stage A,1
10337,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v8,1
10338,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
10339,Pregnancy Complications,Clinical Chorioamnionitis,1
10340,Metastatic Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
10341,Non-Invasive Lesion,Papillary transitional cell neoplasm of low malignant potential,1
10342,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor,1
10343,Osseous Differentiation,Osteosarcoma of bone,1
10344,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
10345,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v8,1
10346,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8,1
10347,Chromogranin A Positive Neoplastic Cells Present,Testicular Carcinoid Tumor,1
10348,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
10349,Carcinomatous Component Present,Stomach Carcinoma,1
10350,Hyperplastic Tissue Present,Diffuse hyperplasia,1
10351,Primary Lesion,Primary Melanocytic Lesion of Meninges,1
10352,Invasive Lesion,Inflammatory carcinoma of breast recurrent,1
10353,Cutaneous Involvement,Non-neoplastic nevus of skin,1
10354,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v8,1
10355,Epithelial Component Present,Stage IV Prostate Carcinoma,1
10356,Malignant Cellular Infiltrate,histiocytic sarcoma of central nervous system,1
10357,Cystic Change,Cystic Neoplasm,1
10358,Epithelial Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7,1
10359,Malignant Cellular Infiltrate,Pericardial mesothelioma malignant advanced,1
10360,Epithelial Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
10361,Infiltrative Growth Pattern,Recurrent Childhood Diffuse Astrocytoma,1
10362,Storiform Growth Pattern,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
10363,Epithelial Component Present,Vipoma,1
10364,Epithelial Component Present,Gastric Neuroendocrine Tumor G2,1
10365,Chromogranin A Positive Neoplastic Cells Present,Carcinoid Tumor,1
10366,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage I,1
10367,Malignant Cellular Infiltrate,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
10368,Honeycomb Pattern,Oligodendroglioma of spinal cord,1
10369,Metastatic Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
10370,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
10371,Benign Cellular Infiltrate,benign lipoma of gallbladder,1
10372,Epithelial Component Present,Small intestine carcinoma stage IV,1
10373,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia,1
10374,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,1
10375,Necrotic changes (finding),Recurrent Giant Cell Glioblastoma,1
10376,Epithelial Component Present,Metastatic Lung Adenosquamous Carcinoma,1
10377,Hereditary Lesion,Rothmund-Thomson syndrome,1
10378,Primary Lesion,Stage IIB Osteosarcoma AJCC v7,1
10379,Malignant Cellular Infiltrate,Ampulla of Vater Mucinous Adenocarcinoma,1
10380,Malignant Cellular Infiltrate,Invasive Carcinoma,1
10381,Hemorrhagic Neuroblastic Nodules Present,"Childhood Ganglioneuroblastoma, Nodular",1
10382,Dysplasia,Gastric dysplasia,1
10383,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage III,1
10384,Carcinomatous Component Present,Nasopharyngeal lymphoepithelioma stage IV,1
10385,Ineffective hematopoiesis,High Risk Myelodysplastic Syndrome,1
10386,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
10387,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
10388,Cystic Change,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
10389,Biphasic Pattern,Adult Pilocytic Astrocytoma,1
10390,Geographic Necrosis,Childhood Testicular Embryonal Carcinoma,1
10391,Indolent Clinical Course,Bizarre leiomyoma,1
10392,Neuroendocrine Differentiation,Vulvar Small Cell Carcinoma,1
10393,Sarcomatous Component Present,Pleuropulmonary blastoma type III,1
10394,Epithelial Component Present,Recurrent Adult Liver Carcinoma,1
10395,Malignant Cellular Infiltrate,Sarcoma of pelvis,1
10396,Anaplasia,Anaplastic astrocytoma,1
10397,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
10398,Dysplasia,Adenomatous polyp of rectum,1
10399,Malignant Cellular Infiltrate,Malignant Vascular Neoplasm,1
10400,Malignant Cellular Infiltrate,Carcinoma ex pleomorphic adenoma,1
10401,Secondary Lesion,Metastatic Unresectable Gastric Adenocarcinoma,1
10402,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
10403,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
10404,Epithelial Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
10405,Well-Circumscribed Lesion,Small Intestinal Tubular Adenoma,1
10406,Metastatic Lesion,Metastatic Thyroid Gland Papillary Carcinoma,1
10407,Fibrovascular Septa Present,Clear cell sarcoma of kidney,1
10408,Epithelial Component Present,Colorectal cancer recurrent,1
10409,Malignant Cellular Infiltrate,FIGO Stage IIIA1(ii) Ovarian Cancer,1
10410,Malignant Cellular Infiltrate,"Medulloblastoma, WNT-Activated",1
10411,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
10412,Epithelial Component Present,Stage IVB Rectal Cancer AJCC v7,1
10413,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma,1
10414,Carcinomatous Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma,1
10415,Intraosseous Lesion,Solid/Multicystic Ameloblastoma,1
10416,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
10417,Slow Growing Mass,Adult Spinal Cord Ependymoma,1
10418,Recurrent disease,Recurrent Adult Liver Carcinoma,1
10419,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
10420,Epithelial Component Present,Lymphoepithelial carcinoma,1
10421,Angiodestructive Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
10422,Hyperkeratosis,Actinic keratosis,1
10423,Malignant Cellular Infiltrate,Indolent multiple myeloma,1
10424,Hyperplastic Tissue Present,Adenomatous hyperplasia,1
10425,Dysplasia,Vaginal intraepithelial neoplasia grade 2,1
10426,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
10427,Epithelial Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7,1
10428,Epithelial Component Present,Masaoka-Koga Stage II,1
10429,Carcinomatous Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
10430,Malignant Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8,1
10431,Macule,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,1
10432,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Epithelioid Leiomyoma,1
10433,Carcinomatous Component Present,Hilar Cholangiocarcinoma by AJCC v7 Stage,1
10434,High Mitotic Activity,Occult Lung Small Cell Carcinoma,1
10435,Regional Disease,Locally Advanced Malignant Solid Neoplasm,1
10436,Secondary Lesion,Breast Carcinoma Metastatic in the Spine,1
10437,Nodular Pattern,Follicular Bronchitis/Bronchiolitis,1
10438,Carcinomatous Component Present,Locally Advanced Head and Neck Carcinoma,1
10439,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Lung,1
10440,Tissue of Mullerian Origin Present,Ovarian Serous Adenofibroma,1
10441,Malignant Cellular Infiltrate,Burkitt Leukemia,1
10442,Epithelial Component Present,Childhood Thyroid Gland Medullary Carcinoma,1
10443,Malignant Cellular Infiltrate,Postsurgical Stage I Hepatoblastoma,1
10444,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
10445,Malignant Cellular Infiltrate,Synovial sarcoma recurrent,1
10446,Low Mitotic Activity,Colorectal Neuroendocrine Tumor,1
10447,Biphasic Pattern,Ovarian Clear Cell Adenofibroma,1
10448,Malignant Cellular Infiltrate,"Basal cell carcinoma, micronodular",1
10449,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
10450,Dysplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
10451,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
10452,Cartilaginous Differentiation,Chondrosarcoma metastatic,1
10453,Epithelial Component Present,Adenoma of rectum,1
10454,Malignant Cellular Infiltrate,malignant neoplasm of breast stage I,1
10455,Malignant Cellular Infiltrate,Small Intestinal Squamous Cell Carcinoma,1
10456,Malignant Cellular Infiltrate,embryonal carcinoma of mediastinum,1
10457,Necrotic changes (finding),Recurrent Malignant Peripheral Nerve Sheath Tumor,1
10458,Epithelial Component Present,Stage IVA Fallopian Tube Cancer AJCC v8,1
10459,Malignant Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma,1
10460,Local disease,Kidney Lipoma,1
10461,Refractory Disease,Refractory Classic Hodgkin Lymphoma,1
10462,Benign Cellular Infiltrate,Vulvar Ectopic Fibroadenoma,1
10463,Tissue of Mullerian Origin Present,Clear cell cystadenofibroma,1
10464,Carcinomatous Component Present,CARCINOMA OF VULVA,1
10465,High Grade Lesion,Bladder Alveolar Soft Part Sarcoma,1
10466,Neuroendocrine Differentiation,"Carcinoid, Goblet Cell",1
10467,Carcinomatous Component Present,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
10468,Epithelial Component Present,Upper Gingival Verrucous Carcinoma,1
10469,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",1
10470,Dysplasia,Biliary Intraepithelial Neoplasia-2,1
10471,Refractory Disease,Refractory Oropharyngeal Squamous Cell Carcinoma,1
10472,Malignant Cellular Infiltrate,Acute myeloid leukemia with mutated RUNX1,1
10473,Glial Differentiation,Anaplastic ganglioglioma,1
10474,Ionizing Radiation Toxicity,Ionizing Radiation-Related Malignant Neoplasm,1
10475,Bilateral Disease,Contralateral Breast Carcinoma,1
10476,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
10477,Epithelial Component Present,Occult Lung Adenocarcinoma,1
10478,Papillary Pattern,Central Breast Papilloma,1
10479,Malignant Cellular Infiltrate,Stage III Esophageal Cancer,1
10480,Malignant Cellular Infiltrate,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
10481,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",1
10482,Micropapillary Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
10483,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v8,1
10484,Cutaneous Involvement,Primary Cutaneous Mucinous Carcinoma,1
10485,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
10486,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
10487,Malignant Cellular Infiltrate,Unresectable Pleural Malignant Mesothelioma,1
10488,Infiltrative Growth Pattern,Diencephalic Glioblastoma,1
10489,Vascular Channel Formation,Mediastinal Angiosarcoma,1
10490,Malignant Cellular Infiltrate,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
10491,Collagenous Stroma Formation,Myofibroblastoma,1
10492,Carcinomatous Component Present,Stage IIIA Breast Carcinoma,1
10493,Epithelial Component Present,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
10494,Microvascular Proliferation,MGMT-Unmethylated Glioblastoma,1
10495,Epithelial Component Present,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
10496,Carcinomatous Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
10497,Recurrent disease,Recurrent Childhood Burkitt Lymphoma,1
10498,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
10499,Malignant Cellular Infiltrate,Malignant Solid Neoplasm,1
10500,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
10501,Malignant Cellular Infiltrate,High Grade Sarcoma,1
10502,Indolent Clinical Course,Benign chondrogenic neoplasm,1
10503,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Gene Mutation,1
10504,Malignant Cellular Infiltrate,"Thymoma, type B2, malignant",1
10505,Carcinomatous Component Present,Large cell lung cancer stage I,1
10506,Monomorphic Cellular Infiltrate,Refractory Ependymoma,1
10507,Angiodestructive Pattern,Recurrent Grade II Lymphomatoid Granulomatosis,1
10508,Malignant Cellular Infiltrate,Stage III Hodgkin Lymphoma,1
10509,Adulthood Lesion,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
10510,Pathologic TNM Finding,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
10511,Cutaneous Involvement,Asian desert cutaneous leishmaniasis,1
10512,Absence of Invasion,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
10513,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Ovarian Choriocarcinoma,1
10514,Carcinomatous Component Present,Laryngeal verrucous carcinoma stage IV,1
10515,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
10516,Epithelial Component Present,ENSAT Stage I Adrenal Cortex Carcinoma,1
10517,Malignant Cellular Infiltrate,Stage IIA Osteosarcoma AJCC v7,1
10518,Cutaneous Involvement,Stage IV Merkel Cell Carcinoma AJCC v7,1
10519,Immunologic Deficiency Syndromes,AIDS-Related Enterocolitis,1
10520,Secondary Lesion,Malignant fibrous histiocytoma metastatic,1
10521,Hyaline Cartilage Differentiation,Myxoid chondrosarcoma,1
10522,Malignant Cellular Infiltrate,Sarcoma NCI Grade 2,1
10523,Pathologic TNM Finding,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
10524,Carcinomatous Component Present,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
10525,Malignant Cellular Infiltrate,Stage IIB Testicular Cancer AJCC v8,1
10526,Malignant Cellular Infiltrate,stage IV pancreatic cancer,1
10527,Immunologic Deficiency Syndromes,Methotrexate-Associated Burkitt Lymphoma,1
10528,Epithelial Component Present,Malignant Ovarian Luteinized Thecoma,1
10529,Diffuse Pattern,Refractory Plasmablastic Lymphoma,1
10530,Therapy-Related Toxicity,Radiation-Related Angiosarcoma,1
10531,Severe dysplasia,solid type ductal carcinoma in situ of breast,1
10532,Adnexal Differentiation,Eccrine mixed tumor of skin,1
10533,Epithelial Component Present,Ampulla of Vater Hepatoid Adenocarcinoma,1
10534,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor,1
10535,Absence of Invasion,Lobular Neoplasia Type B,1
10536,Ineffective hematopoiesis,Refractory anemia with excess blasts I,1
10537,Necrotic changes (finding),"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
10538,Secondary Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
10539,Pregnancy Complications,Stage IA Gestational Trophoblastic Tumor AJCC v7,1
10540,Epithelial Component Present,Malignant Cystosarcoma Phyllodes,1
10541,Mesenchymal Component Present,Eccrine mixed tumor of skin,1
10542,Duct-Like Structures Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
10543,Benign Cellular Infiltrate,Benign germ cell tumor of ovary,1
10544,Benign Cellular Infiltrate,Ameloblastic fibrodentinoma,1
10545,Diffuse Pattern,Anaplastic Hemispheric Astrocytoma,1
10546,Malignant Cellular Infiltrate,Indolent Non-Hodgkin Lymphoma,1
10547,atypia morphology,Malignant Ovarian Luteinized Thecoma,1
10548,Carcinomatous Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma,1
10549,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
10550,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
10551,Malignant Cellular Infiltrate,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
10552,Syncytial Pattern,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
10553,High Mitotic Activity,Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7,1
10554,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v8,1
10555,Malignant Cellular Infiltrate,Gallbladder Melanoma,1
10556,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Lung,1
10557,Metastatic Lesion,Locally Advanced Skin Squamous Cell Carcinoma,1
10558,Epithelial Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
10559,Malignant Cellular Infiltrate,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
10560,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
10561,Secondary Lesion,Alveolar soft part sarcoma metastatic,1
10562,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
10563,Increased Cellularity Present,Stage 1 Neuroblastoma,1
10564,Epithelial Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
10565,Increased Cellularity Present,Pineal parenchymal tumor of intermediate differentiation,1
10566,Epithelial Component Present,Stage III Oropharyngeal Carcinoma AJCC v6,1
10567,Epithelial Component Present,Fundic gland polyp,1
10568,CD56-Positive Neoplastic Cells Present,Aggressive natural killer-cell leukemia,1
10569,Epithelial Component Present,Gallbladder squamous cell carcinoma,1
10570,Cytoplasmic Membrane-Bound Granules Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
10571,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
10572,Carcinomatous Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
10573,Metastatic Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,1
10574,Carcinomatous Component Present,Pituitary carcinoma,1
10575,Malignant Cellular Infiltrate,Unresectable Synovial Sarcoma,1
10576,Carcinomatous Component Present,Intestinal Neuroendocrine Carcinoma,1
10577,Benign Cellular Infiltrate,Hemangioma of Peripheral Nerve,1
10578,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v6 and v7,1
10579,Borderline Lesion,Borderline Fallopian Tube Endometrioid Tumor,1
10580,Intraductal Lesion,Noninfiltrating Intraductal Carcinoma,1
10581,CD30-Positive Neoplastic Cells Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
10582,Solid Growth Pattern,Pleuropulmonary blastoma type III,1
10583,Tissue of Mullerian Origin Present,Cervical Adenomyoma,1
10584,Cutaneous Involvement,Stage IV Skin Cancer,1
10585,High Mitotic Activity,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
10586,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Germ Cell Tumor,1
10587,Epithelial Component Present,Adenocarcinoma in situ in tubular adenoma,1
10588,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
10589,Malignant Cellular Infiltrate,Inflammatory liposarcoma,1
10590,Absence of Stromal Invasion,Borderline cystadenoma,1
10591,Infiltrative Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,1
10592,Cartilaginous Differentiation,Metastasizing Chondroblastoma,1
10593,Malignant Cellular Infiltrate,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,1
10594,CD56-Positive Neoplastic Cells Present,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
10595,Malignant Cellular Infiltrate,Stage IA Cervical Cancer AJCC v8,1
10596,Malignant Cellular Infiltrate,Major Salivary Gland Carcinoma,1
10597,Benign Cellular Infiltrate,Adenoma of rete ovarii,1
10598,Epithelial Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
10599,Well Differentiated Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
10600,Metaplasia,verrucous carcinoma of bladder,1
10601,Epithelial Component Present,large cell neuroendocrine carcinoma of thymus,1
10602,Vascular Channel Formation,Solid Angioleiomyoma,1
10603,Mixed Cellular Population,Perineal Ectopic Fibroadenoma,1
10604,Cribriform Pattern,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
10605,Locally Aggressive Lesion,Atypical Lipoma,1
10606,Mixed Cellular Population,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
10607,Reactive Germinal Centers Present,Pulmonary nodular lymphoid hyperplasia,1
10608,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v8,1
10609,Glandular Pattern,Somatostatinoma,1
10610,Recurrent disease,Angioimmunoblastic T-cell lymphoma recurrent,1
10611,Non-Invasive Lesion,Renal Pelvis Urothelial Papilloma,1
10612,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
10613,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity recurrent,1
10614,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v6 and v7,1
10615,Well-Circumscribed Lesion,Apocrine cystadenoma,1
10616,Papillary Pattern,Papilloma of eyelid,1
10617,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type III,1
10618,Secondary Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
10619,Malignant Cellular Infiltrate,Langerhans Cell Sarcoma,1
10620,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
10621,Malignant Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
10622,Malignant Cellular Infiltrate,Stage IIIC Adult Liver Cancer AJCC v7,1
10623,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
10624,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
10625,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
10626,Anaplasia,Giant Cell Glioblastoma,1
10627,Epithelial Component Present,Vaginal intraepithelial neoplasia,1
10628,Calcitonin serum level increased,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
10629,Radiation Sickness,Ionizing Radiation-Related Malignant Neoplasm,1
10630,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Cancer AJCC v6 and v7,1
10631,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
10632,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor,1
10633,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
10634,Carcinomatous Component Present,Metastatic Prostate Carcinoma,1
10635,Carcinomatous Component Present,Recurrent Thymic Carcinoma,1
10636,Malignant Cellular Infiltrate,Stage IVB Vulvar Cancer AJCC v6 and v7,1
10637,Malignant Cellular Infiltrate,Pancreatic Non-Hodgkin Lymphoma,1
10638,Poikilocytosis,Post polycythaemia vera myelofibrosis,1
10639,Epithelial Component Present,Cervical Squamotransitional Carcinoma,1
10640,Malignant Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple,1
10641,Invasive Lesion,Invasive Lobular Breast Carcinoma,1
10642,CD30-Positive Neoplastic Cells Present,Childhood Systemic Anaplastic Large Cell Lymphoma,1
10643,Carcinomatous Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
10644,Benign Cellular Infiltrate,Cellular fibroma,1
10645,Cutaneous Involvement,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
10646,In Situ Lesion,Carcinoma in situ of trachea,1
10647,Carcinomatous Component Present,"Neuroendocrine carcinoma, metastatic",1
10648,Neuroectodermal Differentiation,Localized Askin Tumor,1
10649,Poorly Differentiated Lesion,Large cell lung cancer recurrent,1
10650,Malignant Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
10651,Pseudopapillary Pattern,Solid pseudopapillary tumor of the pancreas,1
10652,Malignant Cellular Infiltrate,Sacral Chordoma,1
10653,Tubular Pattern,Colonic tubulovillous adenoma,1
10654,Diffuse Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,1
10655,Malignant Cellular Infiltrate,Locally Advanced Prostate Carcinoma,1
10656,Blasts of Mixed Phenotype Present,Acute biphenotypic leukemia,1
10657,Malignant Cellular Infiltrate,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
10658,Benign Cellular Infiltrate,leiomyoma of trachea,1
10659,Malignant Cellular Infiltrate,Malignant Pericytic Neoplasm,1
10660,Absence of Stromal Invasion,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
10661,Thin-Walled Branching Vascular Pattern,Pleural Solitary Fibrous Tumor,1
10662,Exophytic Polypoid Lesion,Adenoma of rectum,1
10663,Recurrent disease,Recurrent Female Reproductive System Carcinoma,1
10664,Malignant Cellular Infiltrate,PRETEXT Stage 1 Hepatoblastoma,1
10665,Well-Circumscribed Lesion,Appendix Hyperplastic Polyp,1
10666,Clinical TNM Finding,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
10667,Benign Cellular Infiltrate,Vaginal Myofibroblastoma,1
10668,Recurrent disease,Recurrent Ureter Carcinoma,1
10669,Microvascular Proliferation,Brain Glioblastoma,1
10670,Malignant Cellular Infiltrate,Resectable Renal Cell Carcinoma,1
10671,Malignant Cellular Infiltrate,verrucous carcinoma of bladder,1
10672,Skin nodule,Sebaceous adenoma,1
10673,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
10674,Malignant Cellular Infiltrate,Lip basal cell carcinoma,1
10675,Chronic Inflammatory Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma,1
10676,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage IV,1
10677,Intracanalicular Growth Pattern,Prostate Phyllodes Tumor,1
10678,Cutaneous Involvement,Lymphomatoid Papulosis,1
10679,Tissue of Mullerian Origin Present,Refractory Uterine Corpus Carcinosarcoma,1
10680,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v7,1
10681,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
10682,Tubular Pattern,Vaginal Tubular Adenoma,1
10683,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Recurrent Acute Monoblastic and Monocytic Leukemia,1
10684,Papillary Pattern,Gallbladder papillary adenocarcinoma,1
10685,Malignant Cellular Infiltrate,Secondary malignant neoplasm of peritoneum,1
10686,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v6 and v7,1
10687,Human Papillomavirus Negative,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
10688,Well-Circumscribed Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
10689,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
10690,Malignant Cellular Infiltrate,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
10691,Cutaneous Involvement,External Ear Squamous Cell Carcinoma,1
10692,Epithelial Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
10693,Malignant Cellular Infiltrate,Stage IIIC Anal Cancer AJCC v8,1
10694,Follicular Cell Differentiation,Recurrent Thyroid Gland Papillary Carcinoma,1
10695,Carcinomatous Component Present,Stage 0 Merkel Cell Carcinoma AJCC v7,1
10696,Metastatic Lesion,Locally Advanced Unresectable Carcinoma,1
10697,Epithelial Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
10698,Cutaneous Involvement,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,1
10699,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
10700,Carcinomatous Component Present,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
10701,Necrotic changes (finding),Malignant Uterine Corpus PEComa,1
10702,Epithelial Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
10703,Epithelial Component Present,Inverted urothelial papilloma,1
10704,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
10705,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
10706,Papillary Pattern,Adult Myxopapillary Ependymoma,1
10707,Poorly Differentiated Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma,1
10708,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
10709,Epithelial Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
10710,Malignant Cellular Infiltrate,Gastric Tubular Adenocarcinoma,1
10711,Well-Circumscribed Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
10712,Childhood Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
10713,Necrotic changes (finding),gliosarcoma,1
10714,Cutaneous Involvement,Recurrent Merkel Cell Carcinoma,1
10715,Myxoid Stroma Formation,Adult Extraskeletal Myxoid Chondrosarcoma,1
10716,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
10717,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v7,1
10718,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v7,1
10719,Cutaneous Involvement,Skin Angiosarcoma,1
10720,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
10721,HMB-45-Positive Neoplastic Cells Present,Lung PEComa,1
10722,Exophytic Papillary Lesion,Verrucous carcinoma of oral cavity,1
10723,Epithelial Component Present,Unresectable Carcinoid Tumor,1
10724,Well-Circumscribed Lesion,Gallbladder Papillary Adenoma,1
10725,Unilineage Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
10726,Malignant Cellular Infiltrate,Gallbladder Mixed Adenoneuroendocrine Carcinoma,1
10727,Malignant Cellular Infiltrate,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
10728,Anaplasia,Giant Cell Glioblastoma,1
10729,Neuroendocrine Differentiation,Urinary System Paraganglioma,1
10730,Intestinal metaplasia,"Adenocarcinoma, intestinal type",1
10731,Epithelial Component Present,Stage IVA Thymus Epithelial Neoplasm AJCC v8,1
10732,Epithelial Component Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
10733,Malignant Cellular Infiltrate,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
10734,High Mitotic Activity,Malignant Testicular Leydig Cell Tumor,1
10735,Neuroendocrine Differentiation,Neuroendocrine cervical carcinoma,1
10736,Carcinomatous Component Present,Stage II Renal Pelvis Cancer AJCC v7,1
10737,Malignant Cellular Infiltrate,Locally Advanced Bile Duct Carcinoma,1
10738,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage III,1
10739,Storiform Growth Pattern,Unresectable Undifferentiated Pleomorphic Sarcoma,1
10740,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
10741,Nuclear Molding,Stage I Lung Small Cell Carcinoma AJCC v7,1
10742,Cavernous Vascular Space Formation,Giant Hemangioma,1
10743,Mixed Cellular Population,Cellular Pleomorphic Adenoma,1
10744,Mixed Cellular Population,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
10745,Recurrent disease,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
10746,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v7,1
10747,Epithelial Component Present,Malignant Ovarian Serous Tumor,1
10748,Invasive Lesion,Recurrent Prostate Acinar Adenocarcinoma,1
10749,Dysplasia,Filiform Serrated Adenoma,1
10750,Pushing Tumor Margin,Laryngeal verrucous carcinoma stage IV,1
10751,Smooth Muscle Component Present,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,1
10752,HMB-45-Positive Neoplastic Cells Present,Sclerosing PEComa,1
10753,Malignant Cellular Infiltrate,Iatrogenic Kaposi Sarcoma,1
10754,High Grade Lesion,Fusion-Positive Rhabdomyosarcoma,1
10755,Epithelial Component Present,Regional Adrenal Gland Pheochromocytoma,1
10756,Infiltrative Growth Pattern,Childhood Fibrillary Astrocytoma,1
10757,Carcinomatous Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
10758,Carcinomatous Component Present,Lung Carcinoma Metastatic in the Liver,1
10759,Malignant Cellular Infiltrate,Histiocytoid Breast Carcinoma,1
10760,Mucoid Stroma Formation,mucinous adenocarcinoma of rectum,1
10761,Mixed Cellular Population,Lung Pleomorphic Adenoma,1
10762,Malignant Cellular Infiltrate,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
10763,Carcinomatous Component Present,Sebaceous Adenocarcinoma,1
10764,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Bladder,1
10765,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
10766,Childhood Lesion,Childhood Ovarian Embryonal Carcinoma,1
10767,Malignant Cellular Infiltrate,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
10768,Epithelial Component Present,Unresectable Thyroid Gland Carcinoma,1
10769,Benign Cellular Infiltrate,"Chondromatosis, Synovial",1
10770,Malignant Cellular Infiltrate,Anal squamous cell carcinoma,1
10771,Breast Microcalcification,Childhood Oligodendroglioma,1
10772,Exophytic Papillary Lesion,Laryngeal verrucous carcinoma recurrent,1
10773,Epithelial Component Present,Stage I Lung Cancer AJCC v7,1
10774,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
10775,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
10776,Epithelial Component Present,Recurrent Male Reproductive System Carcinoma,1
10777,Malignant Cellular Infiltrate,ENSAT Stage I Adrenal Cortex Carcinoma,1
10778,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),1
10779,Neuroendocrine Differentiation,insulinoma,1
10780,Well-Circumscribed Lesion,Adenomatous Polyposis Coli,1
10781,Epithelial Component Present,Stage III Anal Cancer AJCC v8,1
10782,Infiltrating Tumor Margins Present,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
10783,'Starry-sky' pattern,Recurrent Childhood Burkitt Lymphoma,1
10784,Dilated Vascular Space Formation,Hobnail Hemangioma,1
10785,Myxoid Stroma Formation,Locally Advanced Chordoma,1
10786,Metastatic Lesion,Metastatic Urethral Carcinoma,1
10787,Nodular Pattern,Eccrine spiradenoma,1
10788,Unfavorable Clinical Outcome,Ph-Like Acute Lymphoblastic Leukemia,1
10789,Epithelial Component Present,Hard Palate Mucoepidermoid Carcinoma,1
10790,Malignant Cellular Infiltrate,Malignant neoplasm of urethra,1
10791,Childhood Lesion,Childhood Cerebellar Neoplasm,1
10792,Cutaneous Involvement,Basal cell carcinoma - adamantinoid,1
10793,Carcinomatous Component Present,Carcinoma of extrahepatic bile duct,1
10794,Malignant Cellular Infiltrate,Stage II Pleural Malignant Mesothelioma AJCC v8,1
10795,Well Differentiated Neuroendocrine Lesion,Stage II Duodenal Neuroendocrine Tumor AJCC v8,1
10796,Cutaneous Involvement,Cutaneous Liposarcoma,1
10797,Benign Cellular Infiltrate,Ovarian Serous Adenofibroma,1
10798,Carcinomatous Component Present,Basal cell carcinoma of vulva,1
10799,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6,1
10800,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v8,1
10801,Benign Cellular Infiltrate,Oral Cavity Monomorphic Adenoma,1
10802,Neuroendocrine Differentiation,Ovarian Neuroendocrine Neoplasm,1
10803,Benign Cellular Infiltrate,Benign Teratoma,1
10804,Erythema,Inflammatory carcinoma of breast stage IV,1
10805,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor,1
10806,Neuroendocrine Differentiation,Carcinoid tumor of ileum,1
10807,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Myelodysplastic Syndrome,1
10808,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v7,1
10809,Mild dysplasia,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
10810,Epithelial Component Present,Stage IA Lung Squamous Cell Carcinoma AJCC v7,1
10811,Malignant Cellular Infiltrate,Recurrent Gliosarcoma,1
10812,Carcinomatous Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
10813,Carcinomatous Component Present,Laryngeal verrucous carcinoma stage IV,1
10814,Epithelial Component Present,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
10815,Seizures,Dysembryoplastic neuroepithelial tumor,1
10816,Epithelial Component Present,Lung Pleomorphic Carcinoma,1
10817,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
10818,Adulthood Lesion,Adult Myxoid Chondrosarcoma,1
10819,Malignant Germinomatous Cellular Infiltrate,Germinomatous Germ Cell Tumor,1
10820,CD56-Positive Neoplastic Cells Present,Blastic plasmacytoid dendritic cell neoplasm,1
10821,Malignant Cellular Infiltrate,Advanced Gastric Neuroendocrine Carcinoma,1
10822,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
10823,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
10824,atypia morphology,"Endometrioid adenoma, borderline malignancy",1
10825,Infiltrating Tumor Margins Present,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
10826,Cutaneous Involvement,Classic Type Trichilemmoma,1
10827,Indolent Clinical Course,Liver Cavernous Hemangioma,1
10828,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type",1
10829,Cutaneous Involvement,Ichthyoses,1
10830,Malignant Cellular Infiltrate,Exocervical Carcinoma,1
10831,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v7,1
10832,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
10833,Carcinomatous Component Present,Gallbladder adenocarcinoma,1
10834,Borderline Lesion,Borderline Uterine Ligament Neoplasm,1
10835,Presence of a Hormonal Syndrome,malignant gastrinoma of pancreas,1
10836,Malignant Cellular Infiltrate,Chest Wall Solitary Plasmacytoma,1
10837,Tissue of Mullerian Origin Present,Ovarian Serous Adenofibroma,1
10838,Fibrosis,Breast Blunt Duct Adenosis,1
10839,Necrotic changes (finding),Recurrent Giant Cell Glioblastoma,1
10840,Carcinomatous Component Present,Acinic Cell Breast Carcinoma,1
10841,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
10842,Pseudoglandular Pattern,Laryngeal Acantholytic Squamous Cell Carcinoma,1
10843,Carcinomatous Component Present,Cervical Clear Cell Adenocarcinoma,1
10844,Infiltrative Growth Pattern,Anaplastic astrocytoma,1
10845,Indolent Clinical Course,Laryngeal Leiomyoma,1
10846,Childhood Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
10847,Presence of a Hormonal Syndrome,malignant gastrinoma of pancreas,1
10848,Malignant Cellular Infiltrate,Stage IIC Rectal Cancer AJCC v7,1
10849,Diffuse Pattern,Cerebral Glioblastoma,1
10850,Microfollicular Structures Present,Ovarian gynandroblastoma,1
10851,Epithelial Component Present,basal cell carcinoma of penis,1
10852,Epithelial Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
10853,Metastatic Lesion,Metastatic Lung Carcinoma,1
10854,PSA Failure,Biochemically Recurrent Prostate Carcinoma,1
10855,Adulthood Lesion,Recurrent Adult Brain Neoplasm,1
10856,Epithelial Component Present,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,1
10857,Carcinomatous Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
10858,Necrotic changes (finding),Intraocular Malignant Peripheral Nerve Sheath Tumor,1
10859,Microvascular Proliferation,Cerebral Glioblastoma,1
10860,Benign Cellular Infiltrate,Benign Ovarian Transitional Cell Tumor,1
10861,Fibrotic Stroma Formation,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
10862,Extraocular Dissemination of Disease,Ocular Melanoma with Extraocular Extension,1
10863,Epithelial Component Present,Multiple Endocrine Neoplasia Type 2a,1
10864,Endophytic Tumor Growth,Inverting papilloma of the nasal cavity,1
10865,Neuroendocrine Differentiation,Islet Cell Tumor,1
10866,Diffuse Pattern,Adult Anaplastic Astrocytoma,1
10867,Indolent Clinical Course,Nuchal-type fibroma,1
10868,Epithelial Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
10869,Epithelial Component Present,Tubular adenoma,1
10870,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7,1
10871,Benign Cellular Infiltrate,Cervical Mullerian Papilloma,1
10872,Malignant Cellular Infiltrate,Stage IA Retroperitoneal Sarcoma AJCC v8,1
10873,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia refractory,1
10874,Epithelial Component Present,Recurrent Ovarian Serous Adenocarcinoma,1
10875,Hyperplastic Tissue Present,Neuroendocrine cell hyperplasia of infancy,1
10876,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
10877,Cystic Change,Hard Palate Mucoepidermoid Carcinoma,1
10878,Epithelial Component Present,Maxillary Sinus Carcinoma,1
10879,Well-Circumscribed Lesion,Medullary Hemangioblastoma,1
10880,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,1
10881,Carcinomatous Component Present,Intraductal carcinoma and lobular carcinoma in situ,1
10882,Pushing Tumor Margin,Buccal Mucosa Verrucous Carcinoma,1
10883,atypia morphology,Malignant Ovarian Thecoma,1
10884,Epithelial Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
10885,Malignant Cellular Infiltrate,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
10886,Carcinomatous Component Present,Recurrent Head and Neck Carcinoma,1
10887,Malignant Cellular Infiltrate,Bladder Signet Ring Cell Adenocarcinoma,1
10888,Composite Lesion,"Childhood Ganglioneuroblastoma, Nodular",1
10889,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
10890,Necrotic changes (finding),Childhood Malignant Peripheral Nerve Sheath Tumor,1
10891,Malignant Cellular Infiltrate,mantle cell lymphoma of stomach,1
10892,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis,1
10893,Malignant Cellular Infiltrate,External Ear Carcinoma,1
10894,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8,1
10895,Well Differentiated Lesion,Cervical Squamotransitional Carcinoma,1
10896,Severe dysplasia,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
10897,Metastatic Lesion,Locally Advanced Lung Carcinoma,1
10898,High Mitotic Activity,Childhood Ovarian Embryonal Carcinoma,1
10899,Epithelial Component Present,Stage IIIA1 Fallopian Tube Cancer AJCC v8,1
10900,Childhood Lesion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
10901,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Hydropic Leiomyoma,1
10902,Childhood Lesion,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
10903,Increased Cellularity Present,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
10904,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
10905,Invasive Lesion,Bladder transitional cell carcinoma stage I,1
10906,High Mitotic Activity,Platinum-Resistant Lung Small Cell Carcinoma,1
10907,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v8,1
10908,Cutaneous Involvement,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
10909,Carcinomatous Component Present,Spindle cell squamous cell carcinoma,1
10910,Multinodular Mass,Dedifferentiated Dermatofibrosarcoma Protuberans,1
10911,Epithelial Component Present,Vaginal Cancer by AJCC v7 Stage,1
10912,Carcinomatous Component Present,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,1
10913,Epithelial Component Present,"Uterine Carcinosarcoma, Heterologous Type",1
10914,Primary Lesion,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
10915,Cutaneous Involvement,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
10916,Epithelial Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
10917,High Grade Lesion,Childhood Brain Stem Gliosarcoma,1
10918,Exophytic Polypoid Lesion,Traditional Serrated Adenoma,1
10919,Carcinomatous Component Present,Pleomorphic lobular carcinoma in situ of breast,1
10920,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
10921,Epithelial Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
10922,Refractory Disease,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
10923,Epithelial Component Present,Transitional cell cancer of the renal pelvis and ureter localized,1
10924,Carcinomatous Component Present,small cell carcinoma of breast,1
10925,CD8-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma,1
10926,Carcinomatous Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
10927,Childhood Lesion,Recurrent Childhood Pineoblastoma,1
10928,Pregnancy Complications,"Pregnancy, Cornual",1
10929,Epithelial Component Present,Pancreatic Somatostatinoma,1
10930,Benign Cellular Infiltrate,Intraneural perineurioma,1
10931,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7,1
10932,Cutaneous Involvement,Malignant neoplasm of sweat gland,1
10933,Malignant Cellular Infiltrate,Orbital lymphoma,1
10934,Chromogranin A Positive Neoplastic Cells Present,Pancreatic Neuroendocrine Tumor G1,1
10935,Carcinomatous Component Present,Bladder Enteric Type Adenocarcinoma,1
10936,Carcinomatous Component Present,"Carcinoma of urinary bladder, superficial",1
10937,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
10938,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
10939,Malignant Cellular Infiltrate,Childhood Fibrosarcoma,1
10940,Neuroendocrine Differentiation,Refractory Adrenal Gland Pheochromocytoma,1
10941,Endophytic Tumor Growth,Verrucous carcinoma,1
10942,Local disease,Central Nervous System Angiolipoma,1
10943,Adnexal Differentiation,Eccrine ductal carcinoma,1
10944,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
10945,Epithelial Component Present,Vulvar Warty Carcinoma,1
10946,Indolent Clinical Course,Benign Glomus Tumor,1
10947,Malignant Cellular Infiltrate,Liver and Intrahepatic Biliary Tract Carcinoma,1
10948,Epithelial Component Present,Undifferentiated carcinoma of esophagus,1
10949,Epithelial Component Present,Mediastinal/Thymic NUT Carcinoma,1
10950,Adulthood Lesion,Adult Pure Erythroid Leukemia,1
10951,Lobulated Growth Pattern,Chondroid chordoma,1
10952,Severe dysplasia,Adenocarcinoma in Situ,1
10953,Benign Cellular Infiltrate,Adenoameloblastoma,1
10954,Epithelial Component Present,Gallbladder squamous cell carcinoma,1
10955,Well-Circumscribed Lesion,Vulvar Fibroepithelial Stromal Polyp,1
10956,Malignant Cellular Infiltrate,Anal Canal Mixed Adenoneuroendocrine Carcinoma,1
10957,Diffuse Pattern,Centroblastic lymphoma stage I,1
10958,Epithelial Component Present,FIGO Stage IC2 Ovarian Cancer,1
10959,Malignant Cellular Infiltrate,Urothelial carcinoma urethra recurrent,1
10960,Epithelial Component Present,Colorectal Filiform Serrated Adenoma,1
10961,Malignant Cellular Infiltrate,choriocarcinoma of mediastinum,1
10962,Cartilaginous Differentiation,"Chondrosarcoma, Clear Cell",1
10963,Malignant Cellular Infiltrate,Metastatic Lip Squamous Cell Carcinoma,1
10964,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
10965,Exophytic Polypoid Lesion,Colorectal Inflammatory Polyp,1
10966,Tubular Pattern,Collecting Duct Carcinoma of the Kidney,1
10967,Mixed Cellular Population,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
10968,Carcinomatous Component Present,Relapsed Hypopharynx Carcinoma,1
10969,Malignant Cellular Infiltrate,Stage I Retroperitoneal Sarcoma AJCC v8,1
10970,Primary Lesion,Angiosarcoma non-metastatic,1
10971,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma,1
10972,Papillary Pattern,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
10973,Carcinomatous Component Present,Locally Advanced Prostate Carcinoma,1
10974,Hyalinized Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
10975,Severe dysplasia,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
10976,Cystic Change,Broad Ligament Serous Cystadenoma,1
10977,Epithelial Component Present,Recurrent Endometrial Cancer,1
10978,Benign Cellular Infiltrate,Breast Leiomyoma,1
10979,Carcinomatous Component Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
10980,Childhood Lesion,Stage I Childhood Hodgkin Lymphoma,1
10981,Vascular Channel Formation,Peripheral Intraneural Angiosarcoma,1
10982,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
10983,Epithelial Component Present,Gastric Neuroendocrine Tumor,1
10984,Malignant Cellular Infiltrate,Adult Rhabdomyosarcoma,1
10985,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Stage,1
10986,Indolent Clinical Course,Odontogenic myxoma,1
10987,Epithelial Component Present,Lipid-rich carcinoma,1
10988,Malignant Cellular Infiltrate,AIDS-Related Malignant Neoplasm,1
10989,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
10990,Epithelial Component Present,Adenocarcinoma of pancreas,1
10991,Collagenous Stroma Formation,Vulvar Angiomyofibroblastoma,1
10992,Cystic Change,mucoepidermoid carcinoma of accessory sinus,1
10993,Malignant Cellular Infiltrate,Undifferentiated round cell sarcoma,1
10994,Anaplasia,gliosarcoma,1
10995,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
10996,Malignant Cellular Infiltrate,Thyroid Angiosarcoma,1
10997,Benign Cellular Infiltrate,Benign neoplasm of the lip,1
10998,Carcinomatous Component Present,Stage II Vulva Cancer AJCC v6,1
10999,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
11000,Benign Cellular Infiltrate,Chondroblastoma,1
11001,Invasive Lesion,Breast Carcinoma with Melanotic Features,1
11002,Well-Circumscribed Lesion,Hepatocellular Adenoma,1
11003,Epithelial Component Present,"Glandular intraepithelial neoplasia, grade III",1
11004,Carcinomatous Component Present,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
11005,Malignant Cellular Infiltrate,T-cell lymphoma stage IV,1
11006,Epithelial Component Present,Transplant-Related Carcinoma,1
11007,Malignant Cellular Infiltrate,Recurrent Digestive System Carcinoma,1
11008,Acanthosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
11009,Severe dysplasia,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
11010,Malignant Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,1
11011,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
11012,Biphasic Pattern,Borderline Ovarian Endometrioid Adenofibroma,1
11013,Epithelial Component Present,Schneiderian papilloma,1
11014,Mitotic Activity,Epithelioid glioblastoma,1
11015,Biphasic Pattern,Cardiac Biphasic Synovial Sarcoma,1
11016,Mesenchymal Component Present,Oral Cavity Pleomorphic Adenoma,1
11017,Cutaneous Involvement,Mycosis fungoides stage II,1
11018,Malignant Cellular Infiltrate,Multicentric Breast Carcinoma,1
11019,Malignant Cellular Infiltrate,FIGO Stage IVA Ovarian Cancer,1
11020,Carcinomatous Component Present,Unresectable Transitional Cell Carcinoma,1
11021,Severe dysplasia,Adenocarcinoma in Situ,1
11022,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast,1
11023,Benign Cellular Infiltrate,Benign neoplasm of parathyroid gland,1
11024,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder,1
11025,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
11026,Malignant Cellular Infiltrate,ENSAT Stage III Adrenal Cortex Carcinoma,1
11027,High Mitotic Activity,Ampulla of Vater Neuroendocrine Carcinoma,1
11028,Carcinomatous Component Present,TSH-Producing Pituitary Gland Carcinoma,1
11029,Cystic Change,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
11030,Acanthosis,Urethral Condyloma Acuminatum,1
11031,Refractory Disease,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
11032,Malignant Cellular Infiltrate,Recurrent Cutaneous Melanoma of the Extremity,1
11033,Benign Cellular Infiltrate,Benign neoplasm of uterus,1
11034,Malignant Cellular Infiltrate,Transplant-Related Squamous Cell Carcinoma,1
11035,Antoni A Pattern,Benign Mediastinal Psammomatous Schwannoma,1
11036,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction,1
11037,Metastatic Lesion,Bladder cancer stage IV,1
11038,C19MC Amplification,Ependymoblastoma,1
11039,Malignant Cellular Infiltrate,Transitional cell carcinoma in situ,1
11040,Trabecular Pattern,Trabecular adenocarcinoma,1
11041,Epithelial Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
11042,Carcinomatous Component Present,Fallopian Tube Papillary Adenocarcinoma,1
11043,Epithelial Component Present,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
11044,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
11045,Epithelial Component Present,Malignant basal cell tumor,1
11046,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
11047,Recurrent disease,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
11048,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
11049,Acanthosis,Verrucous carcinoma of the oral cavity recurrent,1
11050,Malignant Cellular Infiltrate,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
11051,Endophytic Tumor Growth,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
11052,Delicate Vascular Network Formation,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
11053,Acanthosis,Melanoacanthoma,1
11054,Ground Glass Nuclear Inclusion,Papillary thyroid carcinoma,1
11055,Vascular Channel Formation,Hemangioma of choroid,1
11056,Carcinomatous Component Present,Colorectal Neuroendocrine Carcinoma,1
11057,Malignant Cellular Infiltrate,T-cell/histiocyte rich large B-cell lymphoma,1
11058,Neoplastic Cells with TFH Cell Phenotype Present,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
11059,Epithelial Component Present,Transitional cell carcinoma urethra,1
11060,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma non-metastatic,1
11061,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7,1
11062,Malignant Cellular Infiltrate,Central Nervous System Mixed Germ Cell Tumor,1
11063,Papillary Pattern,Stage 0a Bladder Cancer AJCC v8,1
11064,Carcinomatous Component Present,Gallbladder papillary adenocarcinoma,1
11065,Malignant Cellular Infiltrate,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,1
11066,Malignant Cellular Infiltrate,Stage III Acral Lentiginous Melanoma AJCC v7,1
11067,Malignant Cellular Infiltrate,Adenoid basal carcinoma of cervix uteri,1
11068,Metastatic Lesion,Testicular cancer metastatic,1
11069,In Situ Lesion,Stage 0 Colorectal Cancer AJCC v6 and v7,1
11070,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis refractory,1
11071,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage III,1
11072,Dysplasia,Perianal Squamous Intraepithelial Neoplasia,1
11073,Absence of Invasion,Ampulla of Vater Tubular Adenoma,1
11074,Epithelial Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
11075,Well-Circumscribed Lesion,Retinal hemangioblastoma,1
11076,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
11077,Cutaneous Involvement,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7,1
11078,Indolent Clinical Course,Cementoma,1
11079,Malignant Cellular Infiltrate,Paget Disease Extramammary,1
11080,Pathologic TNM Finding,Pathologic Stage II Gastric Cancer AJCC v8,1
11081,Sarcomatous Component Present,Testicular Spermatocytic Seminoma with Sarcoma,1
11082,Childhood Lesion,Benign Childhood Cerebral Neoplasm,1
11083,Epithelial Component Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
11084,Epithelial Component Present,Stage II Carcinoma of Penis,1
11085,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1,1
11086,High Mitotic Activity,Small cell lung cancer extensive stage,1
11087,Epithelial Component Present,Juvenile Type Testicular Granulosa Cell Tumor,1
11088,Metastatic Lesion,Lung Carcinoma Metastatic in the Liver,1
11089,Nuclear Atypia,Temporal Lobe Anaplastic Astrocytoma,1
11090,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis,1
11091,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
11092,Firm mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
11093,Immunosuppression-Related Post-Transplant Toxicity,Acute cellular allograft nephropathy,1
11094,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
11095,Neuroectodermal Differentiation,Peripheral neuroepithelioma of bone metastatic,1
11096,Cutaneous Involvement,Aleukemic Leukemia Cutis,1
11097,Epithelial Component Present,Refractory Ovarian Carcinoma,1
11098,Benign Cellular Infiltrate,Seminal Vesicle Cystadenoma,1
11099,Benign Cellular Infiltrate,Uterine Corpus Dissecting Leiomyoma,1
11100,Malignant Cellular Infiltrate,Grade 2 Malignant Neoplasm,1
11101,Malignant Cellular Infiltrate,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
11102,Malignant Cellular Infiltrate,Recurrent Cervical Adenocarcinoma,1
11103,Malignant Cellular Infiltrate,Vaginal Rhabdomyosarcoma,1
11104,Epithelial Component Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
11105,High Grade Lesion,Childhood Alveolar Soft Part Sarcoma,1
11106,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma,1
11107,Nodular Pattern,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma,1
11108,Epithelial Component Present,Early-Stage Breast Carcinoma,1
11109,Epithelial Component Present,Paget disease of anal canal,1
11110,Biphasic Pattern,Adult Gliosarcoma,1
11111,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Liver,1
11112,Neuroendocrine Differentiation,Metastatic Prostate Small Cell Carcinoma,1
11113,Primary Lesion,Primary mediastinal large B-cell lymphoma recurrent,1
11114,Epithelial Component Present,Pancreatic Somatostatinoma,1
11115,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
11116,Epithelial Component Present,Stage IIIA Bladder Cancer AJCC v8,1
11117,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma refractory,1
11118,Regional Disease,Locally Advanced Basal Cell Carcinoma,1
11119,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
11120,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
11121,Borderline Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
11122,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7,1
11123,atypia morphology,Malignant Ovarian Luteinized Thecoma,1
11124,Malignant Cellular Infiltrate,Adenocarcinoma gastric recurrent,1
11125,Thyroglobulin Positive Neoplastic Cells Present,Follicular Variant Thyroid Gland Papillary Carcinoma,1
11126,Recurrent Lymphoma,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
11127,Carcinomatous Component Present,Clinical Stage III Gastric Cancer AJCC v8,1
11128,Therapy-Related Toxicity,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
11129,Storiform Growth Pattern,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
11130,Extraosseous Lesion,Mediastinal Extraskeletal Osteosarcoma,1
11131,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Carcinoma, Endometrioid",1
11132,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage II,1
11133,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
11134,Polymorphic Cellular Infiltrate,Infectious Mononucleosis,1
11135,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
11136,Benign Cellular Infiltrate,Oropharyngeal squamous papilloma,1
11137,Benign Cellular Infiltrate,Deep Penetrating Nevus,1
11138,Childhood Lesion,Childhood Testicular Embryonal Carcinoma,1
11139,Anaplasia,MGMT-Methylated Glioblastoma,1
11140,Epithelial Component Present,Undifferentiated Carcinoma of Unknown Primary,1
11141,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
11142,Metastatic Lesion,Metastatic Epithelioid Hemangioendothelioma,1
11143,Malignant Cellular Infiltrate,Malignant Breast Eccrine Spiradenoma,1
11144,Refractory Disease,Refractory Uterine Corpus Carcinoma,1
11145,Unresectable Mass,Unresectable Head and Neck Squamous Cell Carcinoma,1
11146,Fibrovascular Stroma Formation,Giant Fibrovascular Esophageal Polyp,1
11147,Exophytic Polypoid Lesion,Malignant lymphomatous polyposis,1
11148,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
11149,Epithelial Component Present,Stage III Ovarian Cancer AJCC v8,1
11150,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma by AJCC v7 Stage,1
11151,Single Cell Necrosis,Stage I Merkel Cell Carcinoma AJCC v7,1
11152,Cystic Change,Epididymal Papillary Cystadenoma,1
11153,Epithelial Component Present,"Carcinoma, Lobular",1
11154,Increased NFkappaB Pathway Activation,Mediastinal (Thymic) Large B-Cell Lymphoma,1
11155,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III,1
11156,Epithelial Component Present,Vagina Carcinoma,1
11157,Nodular Pattern,Ann Arbor Stage IV Grade 2 Follicular Lymphoma,1
11158,Epithelial Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
11159,Well-Circumscribed Lesion,Central Nervous System Hibernoma,1
11160,Stromal Invasion,Malignant Ovarian Mucinous Tumor,1
11161,Epithelial Component Present,basal cell carcinoma of scrotum,1
11162,Malignant Cellular Infiltrate,Bile duct cystadenocarcinoma,1
11163,Refractory Disease,Refractory Malignant Endocrine Neoplasm,1
11164,High Grade Lesion,Recurrent Alveolar Rhabdomyosarcoma,1
11165,Secondary Lesion,Metastatic Malignant Solid Neoplasm,1
11166,Sarcomatous Component Present,Malignant Cystosarcoma Phyllodes,1
11167,Malignant Cellular Infiltrate,Endometrial Clear Cell Adenocarcinoma,1
11168,Malignant Cellular Infiltrate,follicular lymphoma of spleen,1
11169,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
11170,Malignant Cellular Infiltrate,Acquired cystic disease associated renal cell carcinoma,1
11171,Capillary Sized Vascular Channel Formation,Pyogenic granuloma,1
11172,Cytoplasmic Membrane-Bound Granules Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
11173,Carcinomatous Component Present,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
11174,Carcinomatous Component Present,Colorectal Serrated Adenocarcinoma,1
11175,Peripheral Blood Involvement,Smoldering Adult T-Cell Leukemia/Lymphoma,1
11176,Epithelial Component Present,Oropharyngeal squamous papilloma,1
11177,Mixed Cellular Population,Malignant Parotid Gland Mixed Tumor,1
11178,Malignant Cellular Infiltrate,Stage II Hodgkin Lymphoma,1
11179,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
11180,Indolent Clinical Course,Uterine Corpus Epithelioid Leiomyoma,1
11181,Epithelial Component Present,Stage IV Rectosigmoid Cancer AJCC v6,1
11182,Carcinomatous Component Present,Metastatic Lip and Oral Cavity Carcinoma,1
11183,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v8,1
11184,Diffuse Pattern,Anaplastic Oligoastrocytoma,1
11185,Epithelial Component Present,Stage III Thymoma AJCC v8,1
11186,Nodular Pattern,Follicular T-cell lymphoma,1
11187,In Situ Lesion,Lung Squamous Cell Carcinoma In Situ,1
11188,Diffuse Pattern,Gemistocytic astrocytoma,1
11189,Absence of Invasion,Stage 0 Major Salivary Gland Cancer AJCC v8,1
11190,Carcinomatous Component Present,Metastatic Ureter Carcinoma,1
11191,Carcinomatous Component Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
11192,Dysplasia,Appendix Intraepithelial Neoplasia,1
11193,Dysplasia,Condyloma Acuminatum with Dysplasia,1
11194,Malignant Cellular Infiltrate,Minor Salivary Gland Small Cell Carcinoma,1
11195,Hydropic Villous Change,"Hydatidiform Mole, Partial",1
11196,Adulthood Lesion,Adult Pure Erythroid Leukemia,1
11197,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
11198,Epithelial Component Present,Sebaceous Breast Carcinoma,1
11199,Recurrent disease,Extranodal marginal zone B-cell lymphoma (MALT type) recurrent,1
11200,Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8,1
11201,Intermediate Filaments Present,Rhabdoid Tumor,1
11202,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Immature Teratoma,1
11203,Childhood Lesion,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
11204,Malignant Cellular Infiltrate,Large Cell/Anaplastic Medulloblastoma,1
11205,Eosinophilic inflammation,Cardiac Inflammatory Myofibroblastic Tumor,1
11206,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
11207,Carcinomatous Component Present,keratinizing squamous cell carcinoma of vulva,1
11208,Slow Growing Mass,Pituicytoma,1
11209,Follicular Cell Differentiation,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
11210,Low Grade Lesion,Pleural Epithelioid Hemangioendothelioma,1
11211,Malignant Cellular Infiltrate,Stage IVC Paranasal Sinus Cancer AJCC v7,1
11212,Epithelial Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
11213,Epithelial Component Present,Multicentric Breast Carcinoma,1
11214,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
11215,Bone marrow depression,Hypocellular Myelodysplastic Syndrome,1
11216,Malignant Cellular Infiltrate,"Carcinoma, diffuse type",1
11217,Carcinomatous Component Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
11218,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7,1
11219,Clinical TNM Finding,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
11220,Malignant Cellular Infiltrate,Platinum-Resistant Ovarian Carcinoma,1
11221,Malignant Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma,1
11222,Epithelial Component Present,Recurrent Anal Adenocarcinoma,1
11223,Malignant Cellular Infiltrate,Sarcomatosis,1
11224,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v7,1
11225,Malignant Cellular Infiltrate,ROSE Cluster 8,1
11226,Decreased platelet count,Myeloid Neoplasms with Germline Predisposition and Preexisting Platelet Disorders,1
11227,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",1
11228,Cutaneous Involvement,Epidermolysis Bullosa,1
11229,Multifocal Lesion,Erdheim-Chester Disease,1
11230,Cellular Stratification,Borderline Ovarian Mucinous Tumor,1
11231,Dysplasia,Endometrial intraepithelial neoplasia,1
11232,Immunologic Deficiency Syndromes,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
11233,Extramedullary Hematopoiesis (disorder),Overt Primary Myelofibrosis,1
11234,Epithelial Component Present,Basal Cell Neoplasm,1
11235,Smooth Muscle Component Present,Childhood Kidney Angiomyolipoma,1
11236,Absence of a Hormonal Syndrome,Non-Functioning Corticotroph Adenoma,1
11237,Carcinomatous Component Present,Adenocarcinoma of large intestine,1
11238,Melanin Pigment Present,Melanocytic nevus of skin,1
11239,Carcinomatous Component Present,Primary peritoneal carcinoma,1
11240,Cutaneous Involvement,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8,1
11241,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v7,1
11242,Epithelial Component Present,TSH-Producing Pituitary Gland Carcinoma,1
11243,Secondary Lesion,Secondary malignant neoplasm of epididymis,1
11244,Chronic lymphocytic inflammation,Nonencapsulated sclerosing tumor,1
11245,Epithelial Component Present,Recurrent Rectal Cancer,1
11246,Carcinomatous Component Present,Refractory Lung Carcinoma,1
11247,Low Mitotic Activity,Carcinoid tumor of ileum,1
11248,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Glandular Pattern",1
11249,Intramucosal Lesion,Gastric Intramucosal Adenocarcinoma,1
11250,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
11251,Benign Cellular Infiltrate,Myxoma of the Endocardium,1
11252,Indolent Clinical Course,Intramuscular lipoma,1
11253,Epithelial Component Present,Stage IIIA Lung Cancer AJCC v7,1
11254,Carcinomatous Component Present,Grade 1 Colorectal Adenocarcinoma,1
11255,Carcinomatous Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
11256,Epithelial Component Present,Cervical Squamous Cell Carcinoma,1
11257,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
11258,Refractory Disease,Refractory Childhood Acute Lymphoblastic Leukemia,1
11259,Low Mitotic Activity,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
11260,Malignant Cellular Infiltrate,Malignant neoplasm of acoustic nerve,1
11261,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Micromedullary Carcinoma,1
11262,Extensive Stage Lesion,Advanced Neuroendocrine Carcinoma,1
11263,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma,1
11264,Malignant Cellular Infiltrate,Adenocarcinoma of the prostate stage II,1
11265,Carcinomatous Component Present,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
11266,Malignant Cellular Infiltrate,Bile duct cancer resectable,1
11267,Capillary Sized Vascular Channel Formation,Breast Capillary Hemangioma,1
11268,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v8,1
11269,Recurrent disease,Recurrent Thyroid Gland Follicular Carcinoma,1
11270,Malignant Cellular Infiltrate,Ciliary Body Epithelioid Cell Melanoma,1
11271,Carcinomatous Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
11272,Recurrent disease,Recurrent Malignant Endocrine Neoplasm,1
11273,Malignant Cellular Infiltrate,Squamous cell carcinoma of conjunctiva,1
11274,Carcinomatous Component Present,Stage I Fallopian Tube Cancer,1
11275,Malignant Cellular Infiltrate,Stage II Non-Hodgkin Lymphoma,1
11276,Epithelial Component Present,Moderate epithelial dysplasia,1
11277,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
11278,Epithelial Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
11279,Infiltrating Tumor Margins Present,Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
11280,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma recurrent,1
11281,Papillary Pattern,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
11282,Malignant Cellular Infiltrate,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
11283,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
11284,Metastatic/Recurrent Disease,Epithelioid sarcoma non-metastatic,1
11285,Malignant Cellular Infiltrate,Normal Breast-Like Subtype of Breast Carcinoma,1
11286,Malignant Cellular Infiltrate,Urothelial carcinoma recurrent,1
11287,Epithelial Component Present,Childhood Renal Cell Carcinoma,1
11288,Malignant Cellular Infiltrate,Squamous cell carcinoma with horn formation,1
11289,Myxoid Stroma Formation,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
11290,Epithelial Component Present,Parathyroid Gland Adenocarcinoma,1
11291,Benign Cellular Infiltrate,Thyroid Gland Lipoadenoma,1
11292,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
11293,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor,1
11294,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v7 Stage,1
11295,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
11296,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
11297,Neuroectodermal Differentiation,Neuroblastoma of brain,1
11298,Invasive Lesion,Infiltrating angiolipoma,1
11299,Metastatic Lesion,Intermediate Atypical Prostate Carcinoma,1
11300,Indolent Clinical Course,fibroma of testis,1
11301,Pain,Subungual exostoses,1
11302,Malignant Cellular Infiltrate,Maxillary Sinus Adenocarcinoma,1
11303,Malignant Cellular Infiltrate,Metastatic Jugulotympanic Paraganglioma,1
11304,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy,1
11305,Bone Marrow Dysplasia Present,Alkylating Agent-Related Myelodysplastic Syndrome,1
11306,Cutaneous Involvement,Ichthyosis Bullosa of Siemens,1
11307,Epithelial Component Present,Lung Carcinoma Metastatic in the Bone,1
11308,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
11309,Malignant Cellular Infiltrate,leiomyosarcoma of bone,1
11310,Recurrent disease,Bladder adenocarcinoma recurrent,1
11311,Malignant Cellular Infiltrate,hepatoid adenocarcinoma of gallbladder,1
11312,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
11313,Carcinomatous Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
11314,Epithelial Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
11315,Hemorrhagic,Prostate Angiosarcoma,1
11316,Metastatic Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
11317,Nested Pattern,Childhood Clear Cell Sarcoma of Soft Parts,1
11318,Absence of Invasion,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
11319,Epithelial Component Present,Stage IIIB Small Intestinal Cancer AJCC v7,1
11320,Low Grade Lesion,Lung Typical Carcinoid Tumor,1
11321,Carcinomatous Component Present,Bladder cancer recurrent,1
11322,Malignant Cellular Infiltrate,Hard Palate Adenoid Cystic Carcinoma,1
11323,Rare Lesion,estrogen-producing adrenal cortical adenoma,1
11324,Pregnancy Complications,Infection of amniotic cavity,1
11325,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
11326,Malignant Cellular Infiltrate,Stage IIIB Lung Cancer AJCC v7,1
11327,Malignant Cellular Infiltrate,leiomyosarcoma of extrahepatic bile duct,1
11328,Local disease,Localized Castleman Disease,1
11329,Well-Circumscribed Lesion,Polyp of sphenoidal sinus,1
11330,Villous Pattern,Vaginal Villous Adenoma,1
11331,Cutaneous Involvement,Benign neoplasm of scrotum,1
11332,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
11333,Well Differentiated Lesion,verrucous carcinoma of vagina,1
11334,Carcinomatous Component Present,Stage IA1 Cervical Cancer,1
11335,Cystic Change,Nipple Syringomatous Adenoma,1
11336,Carcinomatous Component Present,verrucous carcinoma of bladder,1
11337,Dysplasia,High Grade Intraepithelial Neoplasia,1
11338,Dilated Vascular Space Formation,Hobnail Hemangioma,1
11339,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor,1
11340,Indolent Clinical Course,"Lymphangioma, Cystic",1
11341,Epithelial Component Present,Stage IVB Bladder Cancer AJCC v8,1
11342,Carcinomatous Component Present,Squamous cell carcinoma of cornea,1
11343,Vascular Channel Formation,Thyroid Gland Cavernous Hemangioma,1
11344,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2,1
11345,Malignant Cellular Infiltrate,MiT Family Translocation-Associated Renal Cell Carcinoma,1
11346,Cutaneous Involvement,Primary cutaneous diffuse large cell B-cell lymphoma,1
11347,Nested Pattern,Sclerosing Epithelioid Fibrosarcoma,1
11348,Invasive Lesion,large cell neuroendocrine carcinoma of breast,1
11349,Aggressive Clinical Course,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
11350,Epithelial Component Present,clear cell adenocarcinofibroma of ovary,1
11351,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
11352,Cutaneous Involvement,Herpes zoster dermatitis,1
11353,Malignant Cellular Infiltrate,Fusion-Positive Rhabdomyosarcoma,1
11354,Malignant Cellular Infiltrate,Locally Advanced Unresectable Soft Tissue Sarcoma,1
11355,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV,1
11356,Nodular Pattern,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,1
11357,Bone Marrow Involvement,Waldenstrom's macroglobulinemia recurrent,1
11358,Secondary Lesion,Breast Carcinoma Metastatic in the Bone,1
11359,Epithelial Component Present,Bladder Urothelial Papilloma,1
11360,Bone Marrow Eosinophilia,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
11361,Adulthood Lesion,Adult Liver Carcinoma,1
11362,Stromal Invasion,FIGO Stage IIIC Ovarian Cancer,1
11363,Monomorphic Cellular Infiltrate,Atypical Ductal Breast Hyperplasia,1
11364,Malignant Cellular Infiltrate,Stage 2A Neuroblastoma,1
11365,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
11366,Carcinomatous Component Present,Poorly Cohesive Gastric Carcinoma,1
11367,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
11368,Malignant Cellular Infiltrate,Stage 1 Neuroblastoma,1
11369,Secondary Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
11370,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
11371,Secondary Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
11372,Carcinomatous Component Present,Mucoepidermoid Carcinoma,1
11373,Absence of Invasion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
11374,Localized Lesion,Well-differentiated papillary mesothelioma,1
11375,Epithelial Component Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
11376,Secondary Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
11377,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Gastric Type",1
11378,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
11379,Carcinomatous Component Present,Stage IB Breast Cancer AJCC v7,1
11380,Epithelial Component Present,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
11381,Neuroendocrine Differentiation,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
11382,Carcinomatous Component Present,Grade 3 Invasive Breast Carcinoma,1
11383,Diffuse Pattern,Glioblastoma with Primitive Neuronal Component,1
11384,Borderline Lesion,Borderline Ovarian Serous Cystadenofibroma,1
11385,Dysplasia,Vulval intraepithelial neoplasia,1
11386,Epithelial Component Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
11387,Epithelial Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm,1
11388,Secondary Lesion,Carcinoma Arising from Craniopharyngioma,1
11389,Malignant Cellular Infiltrate,Stage IIA Eyelid Carcinoma AJCC v8,1
11390,Malignant Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma,1
11391,Adnexal Differentiation,Trichoepithelioma,1
11392,Malignant Cellular Infiltrate,Stage I Esophageal Cancer AJCC v7,1
11393,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
11394,Exophytic Polypoid Lesion,Epulides,1
11395,Benign Cellular Infiltrate,Infantile hemangioma of liver,1
11396,Low Mitotic Activity,Esophageal Neuroendocrine Tumor G1,1
11397,Koilocytotic atypia,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
11398,Well-Circumscribed Lesion,Apocrine adenoma,1
11399,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma,1
11400,Carcinomatous Component Present,Paget Disease of the Scrotum,1
11401,Infiltrative Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma,1
11402,Malignant Cellular Infiltrate,Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8,1
11403,High Mitotic Activity,Metastatic Lung Small Cell Carcinoma,1
11404,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,1
11405,Malignant Cellular Infiltrate,Mantle cell lymphoma stage I,1
11406,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
11407,Epithelial Component Present,Ovarian Cystadenocarcinoma,1
11408,Carcinomatous Component Present,Metastatic Oropharyngeal Carcinoma,1
11409,Extraocular Dissemination of Disease,Extraocular retinoblastoma,1
11410,Carcinomatous Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
11411,Malignant Cellular Infiltrate,Light chain disease,1
11412,Diffuse Pattern,Childhood Oligoastrocytoma,1
11413,Carcinomatous Component Present,Stage IC Eyelid Carcinoma AJCC v7,1
11414,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
11415,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
11416,Carcinomatous Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
11417,Epithelial Component Present,Malignant Ovarian Endometrioid Tumor,1
11418,Carcinomatous Component Present,Oropharyngeal Carcinoma,1
11419,Below the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
11420,Cutaneous Involvement,Skin-associated lymphoid tissue lymphoma,1
11421,Benign Cellular Infiltrate,Seborrheic keratosis of eyelid,1
11422,Neuroectodermal Differentiation,Retinoblastoma,1
11423,Hereditary Lesion,BRCA-Mutated Ovarian Carcinoma,1
11424,Severe dysplasia,Carcinoma in situ of fallopian tube,1
11425,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
11426,Epithelial Component Present,Squamous cell carcinoma of the nasal cavity,1
11427,Epithelial Component Present,Paget's Disease of the Nipple,1
11428,Secondary Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
11429,Recurrent disease,Vaginal cancer recurrent,1
11430,Malignant Cellular Infiltrate,Moderately Differentiated Prostate Adenocarcinoma,1
11431,Malignant Cellular Infiltrate,Breast Extraskeletal Osteosarcoma,1
11432,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
11433,Vascular Channel Formation,Parotid Gland Kaposi Sarcoma,1
11434,Secondary Lesion,Pancreatic neuroendocrine tumor metastatic,1
11435,Well-Circumscribed Lesion,villous adenoma of stomach,1
11436,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
11437,Collagenous Stroma Formation,Breast Myofibroblastoma,1
11438,Invasive Lesion,lipid-rich carcinoma of breast,1
11439,Malignant Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8,1
11440,Epithelial Component Present,Benign Breast Adenomyoepithelioma,1
11441,Benign Cellular Infiltrate,Parathyroid Gland Lipoadenoma,1
11442,Malignant Cellular Infiltrate,Squamous cell carcinoma of cornea,1
11443,Cutaneous Involvement,Pilosebaceous Hamartoma,1
11444,Epithelial Component Present,Cervical Large Cell Neuroendocrine Carcinoma,1
11445,Rapidly Enlarging Mass,Childhood Spindle Cell Rhabdomyosarcoma,1
11446,High Mitotic Activity,Metastatic Gastric Neuroendocrine Carcinoma,1
11447,Low Mitotic Activity,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
11448,Carcinomatous Component Present,Adenocarcinoma with osseous metaplasia,1
11449,Radiation Sickness,Enteritis due to radiation,1
11450,Malignant Cellular Infiltrate,Stage IV Adult Immunoblastic Lymphoma,1
11451,Hereditary Lesion,Hereditary clear cell renal cell carcinoma,1
11452,In Situ Lesion,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
11453,In Situ Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
11454,Indolent Clinical Course,chondroma of lung,1
11455,Benign Cellular Infiltrate,Peripheral Breast Papilloma,1
11456,Glial Differentiation,Childhood Gliosarcoma,1
11457,Anaplasia,Glioblastoma,1
11458,Myxoid Stroma Formation,Sternal Chondromyxoid Fibroma,1
11459,Epithelial Component Present,Thoracic NUT Carcinoma,1
11460,Indolent Clinical Course,Angiomatosis,1
11461,Nuclear Expression of STAT6 Protein,Solitary fibrous tumor,1
11462,Adulthood Lesion,Recurrent Adult Burkitt Lymphoma,1
11463,Defective Alpha Heavy Chain Present,Immunoproliferative Small Intestinal Disease,1
11464,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
11465,Perivascular Arrangement of Tumor Cells,Glomus Tumor,1
11466,'Starry-sky' pattern,Stage II Burkitt Lymphoma,1
11467,Malignant Cellular Infiltrate,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
11468,Epithelial Component Present,Gallbladder papillary adenocarcinoma,1
11469,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
11470,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
11471,Cutaneous Involvement,Carcinoma Metastatic to the Skin,1
11472,Chronic lymphocytic inflammation,Salivary Gland Sebaceous Lymphadenoma,1
11473,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
11474,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
11475,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
11476,Carcinomatous Component Present,Stage IIIB Penile Cancer AJCC v8,1
11477,Malignant Cellular Infiltrate,Stage IIA Appendix Carcinoma AJCC v7,1
11478,Carcinomatous Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
11479,Diffuse Pattern,Glioblastoma,1
11480,Epithelial Component Present,Stage IV Ileal Neuroendocrine Tumor AJCC v8,1
11481,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
11482,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
11483,Extraosseous Lesion,Breast Extraskeletal Osteosarcoma,1
11484,Peripheral Nuclear Palisading,basaloid carcinoma of penis,1
11485,Pancytopenia,Acute panmyelosis with myelofibrosis,1
11486,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement,1
11487,Neuroendocrine Differentiation,Glomus Jugulare Tumor,1
11488,Malignant Cellular Infiltrate,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
11489,Epithelial Component Present,Stage IV Esophageal Cancer AJCC v7,1
11490,Carcinomatous Component Present,Locally Advanced Skin Squamous Cell Carcinoma,1
11491,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy,1
11492,Malignant Cellular Infiltrate,Fallopian Tube Serous Adenocarcinoma,1
11493,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
11494,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
11495,Cutaneous Involvement,Cutaneous schistosomiasis,1
11496,Malignant Cellular Infiltrate,Carcinoma of larynx,1
11497,Well Differentiated Neuroendocrine Lesion,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,1
11498,Carcinomatous Component Present,Metastatic Thyroid Gland Carcinoma,1
11499,Tissue of Mullerian Origin Present,Clear cell cystadenofibroma,1
11500,Dysplasia,Vaginal high grade squamous intraepithelial lesion,1
11501,Pregnancy Complications,Fallopian Tube Gestational Choriocarcinoma,1
11502,Fibrotic Stroma Formation,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
11503,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
11504,Malignant Cellular Infiltrate,ROSE Cluster 1,1
11505,Epithelial Component Present,Ameloblastic Carcinoma,1
11506,Increased Cellularity Present,Neuroblastoma,1
11507,Epithelial Component Present,Stage IIB Appendix Carcinoma AJCC v8,1
11508,Regional Disease,Locally Advanced Unresectable Bone Sarcoma,1
11509,Epithelial Component Present,Asbestos-Related Lung Carcinoma,1
11510,Carcinomatous Component Present,Intrahepatic cholangiocarcinoma recurrent,1
11511,Secondary Lesion,Metastatic Adrenal Gland Pheochromocytoma,1
11512,Myxoid Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
11513,Benign Cellular Infiltrate,Tonsillar Lipoma,1
11514,Epithelial Component Present,Duodenal Adenoma,1
11515,Cystic Change,"Cystadenocarcinoma, Serous",1
11516,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type",1
11517,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
11518,Angiocentric Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
11519,Epithelial Component Present,Luminal B Prostate Carcinoma,1
11520,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
11521,Epithelial Component Present,Small Intestinal Neuroendocrine Carcinoma,1
11522,Low Grade Neuroendocrine Lesion,Descending Colon Neuroendocrine Tumor G1,1
11523,Epithelial Component Present,Stage IIIC Lung Cancer AJCC v8,1
11524,Refractory Disease,Refractory Leiomyosarcoma,1
11525,Myxoid Stroma Formation,Sellar Chordoma,1
11526,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
11527,Anaplasia,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
11528,High Grade Lesion,Gastric Synovial Sarcoma,1
11529,Malignant Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,1
11530,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
11531,Cystic Change,mucoepidermoid carcinoma of lung,1
11532,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,1
11533,Malignant Cellular Infiltrate,"Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
11534,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
11535,Carcinomatous Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11536,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
11537,Malignant Cellular Infiltrate,Refractory Liposarcoma,1
11538,Rapidly Enlarging Mass,Pleomorphic Rhabdomyosarcoma,1
11539,Carcinomatous Component Present,ENSAT Stage I Adrenal Cortex Carcinoma,1
11540,Cartilaginous Differentiation,Secondary Chondrosarcoma,1
11541,Carcinomatous Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
11542,Secondary Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
11543,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma,1
11544,Malignant Cellular Infiltrate,Malignant Eccrine Neoplasm,1
11545,Well-Circumscribed Lesion,Seminal Vesicle Cystadenoma,1
11546,Epithelial Component Present,minimally invasive follicular carcinoma of the thyroid gland,1
11547,Secondary Lesion,Myxoid liposarcoma metastatic,1
11548,Carcinomatous Component Present,mucoepidermoid carcinoma of lacrimal gland,1
11549,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v6,1
11550,Malignant Cellular Infiltrate,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
11551,Carcinomatous Component Present,Ceruminous adenocarcinoma,1
11552,Carcinomatous Component Present,Penis carcinoma recurrent,1
11553,Immunologic Deficiency Syndromes,Transplant-Related Kaposi Sarcoma,1
11554,Hyperkeratosis,Anal Verrucous Carcinoma,1
11555,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v8,1
11556,Malignant Cellular Infiltrate,Splenic Lymphoblastic Lymphoma,1
11557,Carcinomatous Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7,1
11558,Malignant Cellular Infiltrate,Malignant melanoma of rectum,1
11559,Malignant Primitive Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
11560,Favorable Clinical Outcome,Class 1a Uveal Melanoma,1
11561,Low Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
11562,Malignant Cellular Infiltrate,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
11563,Malignant Cellular Infiltrate,Stage IV Primary Peritoneal Cancer AJCC v7,1
11564,Malignant Cellular Infiltrate,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",1
11565,Childhood Lesion,Childhood Hodgkin Lymphoma,1
11566,Geographic Necrosis,Testicular embryonal carcinoma stage II,1
11567,Epithelial Component Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
11568,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
11569,Papillary Pattern,Glandular papilloma,1
11570,Biphasic Pattern,Carcinosarcoma of ovary,1
11571,Metastatic Lesion,Advanced Prostate Adenocarcinoma,1
11572,Cutaneous Involvement,"Mucinosis, Follicular",1
11573,Carcinomatous Component Present,Stage III Skin Cancer,1
11574,Epithelial Component Present,Carcinosarcoma of cervix uteri,1
11575,Carcinomatous Component Present,Stage IIC Colon Cancer AJCC v8,1
11576,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
11577,Diffuse Lesion,Lymphangiomatosis,1
11578,Epithelial Component Present,Pancreatic Cancer by AJCC v8 Stage,1
11579,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
11580,Epithelial Component Present,Stage II Small Intestinal Adenocarcinoma AJCC v8,1
11581,Ventricular Involvement Only,Third Ventricle Ependymal Tumor,1
11582,"Fully Differentiated ""Adult-Type"" Tissues Present",Mature Testicular Teratoma,1
11583,Carcinomatous Component Present,Renal medullary carcinoma,1
11584,Secondary Lesion,Secondary Neoplasm,1
11585,Primary Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
11586,Malignant Cellular Infiltrate,Stage I Ampulla of Vater Cancer AJCC v8,1
11587,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,1
11588,Diffuse Pattern,Colon Diffuse Large B-Cell Lymphoma,1
11589,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Central Nervous System,1
11590,Nuclear pleomorphism,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
11591,Malignant Cellular Infiltrate,Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage,1
11592,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
11593,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pleura,1
11594,Squamous Differentiation,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
11595,Malignant Cellular Infiltrate,verrucous carcinoma of vulva,1
11596,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
11597,Clinical TNM Finding,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
11598,Carcinomatous Component Present,Stage 0 Pharynx Carcinoma,1
11599,Pseudoencapsulated Mass,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
11600,Infiltrative Growth Pattern,Lipofibromatosis,1
11601,Metastatic Lesion,Metastatic malignant neoplasm to oropharynx,1
11602,Carcinomatous Component Present,Stage II Vulva Cancer AJCC v6,1
11603,Absence of Invasion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
11604,Malignant Cellular Infiltrate,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
11605,Malignant Cellular Infiltrate,Stage IV Childhood Lymphoblastic Lymphoma,1
11606,Mitotic Activity,Childhood Glioblastoma,1
11607,Unresectable Mass,Unresectable Digestive System Adenocarcinoma,1
11608,Papillary Pattern,Laryngeal papillomatosis,1
11609,Carcinomatous Component Present,Pathologic Stage III Gastric Cancer AJCC v8,1
11610,Cartilaginous Differentiation,Secondary Chondrosarcoma,1
11611,Malignant Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
11612,Secondary Lesion,Cholangiocarcinoma metastatic,1
11613,Epithelial Component Present,Anal Cancer by AJCC v8 Stage,1
11614,Carcinomatous Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
11615,Malignant Cellular Infiltrate,Refractory Primary Vitreoretinal Lymphoma,1
11616,Epithelial Component Present,Vaginal intraepithelial neoplasia,1
11617,Chronic lymphocytic inflammation,"Thymoma, type B2, malignant",1
11618,Well-Circumscribed Lesion,Apocrine adenoma,1
11619,Malignant Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
11620,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v7,1
11621,Hereditary Lesion,"Optic Atrophies, Hereditary",1
11622,Recurrent disease,Recurrent Thyroid Carcinoma,1
11623,Indolent Clinical Course,Angiomatosis,1
11624,Benign Cellular Infiltrate,"Transitional cell papilloma, benign",1
11625,Primary Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8,1
11626,Nuclear pleomorphism,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,1
11627,Indolent Clinical Course,Atrial myxoma,1
11628,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
11629,Regional Disease,Locally Advanced Unresectable Malignant Neoplasm,1
11630,Malignant Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm,1
11631,Epithelial Component Present,Ovarian Stromal Tumor with Minor Sex Cord Elements,1
11632,Malignant Cellular Infiltrate,Stage IV Ovarian Polyembryoma AJCC v6 and v7,1
11633,Exophytic Polypoid Lesion,Colorectal Adenoma with Severe Dysplasia,1
11634,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
11635,Vascular Channel Formation,hemangioma of mediastinum,1
11636,Epithelial Component Present,Prostate Cancer by AJCC v7 Stage,1
11637,Koilocytotic atypia,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
11638,Adulthood Lesion,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8,1
11639,Hyperplastic Tissue Present,Ductal Breast Hyperplasia,1
11640,Neuroectodermal Differentiation,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
11641,Epithelial Component Present,adenosquamous carcinoma of salivary gland,1
11642,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v7,1
11643,Primary Lesion,Temporal Lobe Ependymal Tumor,1
11644,Malignant Cellular Infiltrate,Thymic Hodgkin Lymphoma,1
11645,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
11646,Thick-Walled Hyalinized Vessels Present,Plexiform Schwannoma,1
11647,Malignant Cellular Infiltrate,Unresectable Adrenal Cortex Carcinoma,1
11648,Malignant Cellular Infiltrate,Mixed Liposarcoma,1
11649,Malignant Cellular Infiltrate,Stage 0 Merkel Cell Carcinoma AJCC v7,1
11650,Adulthood Lesion,Adult Malignant Peripheral Nerve Sheath Tumor,1
11651,Adulthood Lesion,Adult Ependymal Tumor,1
11652,Malignant Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma,1
11653,In Situ Lesion,Skin Squamous Cell Carcinoma In Situ,1
11654,Keratin pearl formation,Clear cell squamous cell carcinoma of skin,1
11655,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-3,1
11656,Nodular Pattern,Ovarian Myxoid Liposarcoma,1
11657,Malignant Cellular Infiltrate,Pleural Epithelioid Hemangioendothelioma,1
11658,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v8,1
11659,Epithelial Component Present,Thyroid Hurthle Cell Carcinoma,1
11660,Malignant Cellular Infiltrate,Pathologic Stage IIA Gastric Cancer AJCC v8,1
11661,Perineural spread,Vaginal Adenoid Cystic Carcinoma,1
11662,Slit-Like Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
11663,Borderline Lesion,cystic mucinous tumor of pancreas with moderate dysplasia,1
11664,Hemosiderin pigmentation,Hemosiderotic Fibrolipomatous Tumor,1
11665,atypia morphology,Classic Type Atypical Fibroxanthoma,1
11666,Epithelial Component Present,Adenocarcinoma of lacrimal gland,1
11667,Epithelial Component Present,Gastric dysplasia,1
11668,Malignant Cellular Infiltrate,Colon Cancer by AJCC v7 Stage,1
11669,Epithelial Component Present,"Adenocarcinoma of lung, stage III",1
11670,Malignant Cellular Infiltrate,Orbital Alveolar Soft Part Sarcoma,1
11671,Papillary Pattern,Sclerosing Breast Papilloma,1
11672,Epithelial Component Present,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
11673,Secondary Lesion,Stage IV Esophageal Squamous Cell Carcinoma,1
11674,Malignant Cellular Infiltrate,Infant Acute Undifferentiated Leukemia,1
11675,Fibrotic Stroma Formation,Biliary Adenofibroma,1
11676,Neuroectodermal Differentiation,Localized Resectable Neuroblastoma,1
11677,Extensive Stage Lesion,Advanced Neuroendocrine Neoplasm,1
11678,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
11679,Epithelial Component Present,Stage I Ovarian Cancer AJCC v6 and v7,1
11680,Epithelial Component Present,Breast Carcinoma Metastatic in the Bone,1
11681,Chronic lymphocytic inflammation,"Thymoma, type B1",1
11682,Adnexal Differentiation,Eccrine spiradenoma,1
11683,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v8,1
11684,Recurrent disease,Recurrent Childhood Liver Cancer,1
11685,Low Mitotic Activity,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
11686,Invasive Lesion,Small cell carcinoma of prostate,1
11687,Favorable Clinical Outcome,Duodenal-type follicular lymphoma,1
11688,Malignant Cellular Infiltrate,Lung Non-Mucinous Adenocarcinoma In Situ,1
11689,Malignant Cellular Infiltrate,ENSAT Stage IV Adrenal Cortex Carcinoma,1
11690,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
11691,Carcinomatous Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
11692,Carcinomatous Component Present,Hepatic cancer stage IVA,1
11693,Benign Cellular Infiltrate,Verrucous keratotic hemangioma,1
11694,Malignant Cellular Infiltrate,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
11695,Melanin Pigment Present,Melanoacanthoma,1
11696,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIA,1
11697,Epithelial Component Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
11698,Pregnancy Complications,Stage II Gestational Trophoblastic Neoplasm AJCC v8,1
11699,Childhood Lesion,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
11700,Malignant Cellular Infiltrate,Colon Small Cell Neuroendocrine Carcinoma,1
11701,Adnexal Differentiation,Classical Poroma,1
11702,Childhood Lesion,Childhood Central Nervous System Ganglioneuroblastoma,1
11703,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v7,1
11704,S-100-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin,1
11705,Carcinomatous Component Present,Appendix Carcinoma by AJCC v7 Stage,1
11706,Recurrent disease,Angiosarcoma recurrent,1
11707,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma metastatic,1
11708,Indolent Clinical Course,Squamous odontogenic tumor,1
11709,Epithelial Component Present,insulinoma,1
11710,Adnexal Differentiation,Malignant Sebaceous Neoplasm,1
11711,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
11712,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A",1
11713,Metaplasia,Refractory Barrett Esophagus,1
11714,Epithelial Component Present,Eccrine ductal carcinoma,1
11715,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Wildtype",1
11716,Invasive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
11717,Malignant Cellular Infiltrate,Locally Advanced Prostate Adenocarcinoma,1
11718,Malignant Cellular Infiltrate,Refractory Lung Small Cell Carcinoma,1
11719,Epithelial Component Present,Lung Cancer by AJCC v6 Stage,1
11720,Recurrent disease,Recurrent Malignant Neoplasm of Salivary Gland,1
11721,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v7 Stage,1
11722,Plasma cell inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
11723,Extraosseous Lesion,Duodenal Extraskeletal Osteosarcoma,1
11724,Carcinomatous Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
11725,Glomerular Hypertrophy,Primary Focal Segmental Glomerulosclerosis,1
11726,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia B/myeloid,1
11727,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of submandibular gland,1
11728,Pregnancy Complications,Stage IIA Gestational Trophoblastic Tumor AJCC v7,1
11729,Cutaneous Involvement,Syringoma,1
11730,Malignant Cellular Infiltrate,Prostate Kaposi Sarcoma,1
11731,Endobronchial Lesion,Lung Glandular Papilloma,1
11732,Epithelial Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
11733,Malignant Cellular Infiltrate,Lymphangitis carcinomatosa,1
11734,Fibrotic Stroma Formation,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
11735,Benign Cellular Infiltrate,Vulvar Fibrolipoma,1
11736,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
11737,In Situ Lesion,Serous Tubal Intraepithelial Carcinoma,1
11738,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct,1
11739,Epithelial Component Present,Adenoma of middle ear,1
11740,Alternative Fascicle (Bundle) Pattern,Dartoic myoma,1
11741,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
11742,Low Grade Lesion,Congenital Mesoblastic Nephroma,1
11743,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
11744,Malignant Cellular Infiltrate,Villous adenocarcinoma,1
11745,Cutaneous Involvement,Anal margin basal cell carcinoma,1
11746,Carcinomatous Component Present,Primary Peritoneal Cancer by AJCC v7 Stage,1
11747,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
11748,Multilayered Rosette Formation,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
11749,Cutaneous plaque,"Basal cell carcinoma, micronodular",1
11750,Refractory Disease,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
11751,Fibrosis,Primary mediastinal large B-cell lymphoma stage III,1
11752,Juvenile Lesion,Scheuermann's Disease,1
11753,Malignant Cellular Infiltrate,Stage I Urethral Cancer AJCC v7,1
11754,Papillary Pattern,Inverting papilloma of the paranasal sinus,1
11755,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
11756,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck,1
11757,Cord-Like Pattern,Syringoma,1
11758,Epithelial Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
11759,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
11760,Necrotic changes (finding),large cell neuroendocrine carcinoma of anal canal,1
11761,Cutaneous Involvement,Herpes zoster dermatitis of eyelid,1
11762,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
11763,Recurrent disease,Recurrent Parotid Gland Acinic Cell Carcinoma,1
11764,Glandular Pattern,Gastric Intestinal-Type Adenocarcinoma,1
11765,Dysplasia,Appendix Intraepithelial Neoplasia,1
11766,Adulthood Lesion,Adult Intracranial Germ Cell Tumor,1
11767,Papillary Pattern,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
11768,Cystic Change,Childhood Multilocular Cystic Renal Neoplasm,1
11769,Nuclear pleomorphism,Anaplastic Medulloblastoma,1
11770,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
11771,Epithelial Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
11772,Epithelial Component Present,Carcinoid tumor of the cecum,1
11773,Refractory Disease,Refractory Malignant Male Reproductive System Neoplasm,1
11774,Malignant Cellular Infiltrate,Stage 2B Neuroblastoma,1
11775,Hemorrhagic,Pulmonary Artery Angiosarcoma,1
11776,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage II,1
11777,Epithelial Component Present,Stage I Vulvar Cancer AJCC v8,1
11778,Resectable Mass,Resectable Malignant Mesothelioma,1
11779,Indolent Clinical Course,Ovarian Adenomatoid Tumor,1
11780,Histiocytosis,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
11781,Metastatic Lesion,Locally Metastatic Malignant Neoplasm,1
11782,Osteoid formation,Osteoma,1
11783,Malignant Cellular Infiltrate,Skin squamous cell carcinoma recurrent,1
11784,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
11785,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
11786,Malignant Cellular Infiltrate,Stage III Adult Burkitt Lymphoma,1
11787,"Undifferentiated ""Fetal-Type"" Tissues Present",Central Nervous System Immature Teratoma,1
11788,Secondary Lesion,Advanced Cervical Adenocarcinoma,1
11789,Primary Lesion,Hepatocellular Carcinoma by AJCC v8 Stage,1
11790,Metastatic Lesion,Meningeal Carcinomatosis,1
11791,Edematous Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
11792,Hemorrhagic,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
11793,Carcinomatous Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
11794,Carcinomatous Component Present,Occult Lung Non-Small Cell Carcinoma,1
11795,Locally Aggressive Lesion,Giant Cell Tumor of Soft Tissue,1
11796,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
11797,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v7,1
11798,Secondary Lesion,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
11799,Anaplasia,Stage IV Anaplastic Large Cell Lymphoma,1
11800,Carcinomatous Component Present,Breast Carcinoma Metastatic in Lymph Node,1
11801,Malignant Cellular Infiltrate,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
11802,Thick-Walled Vessels Present,Angiomyolipoma,1
11803,Epithelial Component Present,Stage I Gastric Carcinoma,1
11804,Epithelial Component Present,Stage I Merkel Cell Carcinoma AJCC v7,1
11805,Carcinomatous Component Present,adenocarcinoma of renal pelvis,1
11806,Secondary Lesion,Metastatic Bladder Small Cell Carcinoma,1
11807,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
11808,Hydropic Villous Change,Hydatidiform Mole,1
11809,Benign Cellular Infiltrate,Syringofibroadenoma,1
11810,bone marrow fibrosis,Acute panmyelosis with myelofibrosis,1
11811,Mitotic Activity,Grade III Childhood Astrocytoma,1
11812,Squamous metaplasia,Adenolymphoma,1
11813,Low Grade Lesion,Tibial adamantinoma,1
11814,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
11815,Cutaneous Involvement,Erythema Multiforme Major,1
11816,Epithelial Component Present,Adult Salivary Gland Carcinoma,1
11817,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
11818,Nuclear pleomorphism,Childhood Choroid Plexus Carcinoma,1
11819,Monoclonal Eosinophils Present,Chronic eosinophilic leukemia,1
11820,Malignant Cellular Infiltrate,Recurrent Salivary Duct Carcinoma,1
11821,Carcinomatous Component Present,Laryngeal verrucous carcinoma recurrent,1
11822,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
11823,Childhood Lesion,Non-Metastatic Childhood Soft Tissue Sarcoma,1
11824,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
11825,Carcinomatous Component Present,Pharyngeal Carcinoma by AJCC v6 Stage,1
11826,Benign Cellular Infiltrate,Oropharyngeal Polyp,1
11827,Recurrent Lymphoma,Recurrent Grade III Lymphomatoid Granulomatosis,1
11828,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
11829,Benign Cellular Infiltrate,Acoustic Neuroma,1
11830,Malignant Cellular Infiltrate,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
11831,Well-Circumscribed Lesion,Vaginal Fibroepithelial Polyp,1
11832,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
11833,Neuroendocrine Differentiation,Ovarian Insular Carcinoid Tumor,1
11834,Malignant Cellular Infiltrate,Adult T Lymphoblastic Lymphoma,1
11835,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
11836,Recurrent disease,Recurrent Childhood Pilomyxoid Astrocytoma,1
11837,Malignant Cellular Infiltrate,Refractory Malignant Neoplasm of Multiple Primary Sites,1
11838,Intraductal Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
11839,Epithelial Component Present,squamous cell carcinoma of renal pelvis,1
11840,Carcinomatous Component Present,Pathologic Stage IIA Gastric Cancer AJCC v8,1
11841,Childhood Lesion,Childhood Myelodysplastic Syndrome,1
11842,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v8,1
11843,Melanin-Forming Neuroepithelial Cells Present,"Neuroectodermal Tumor, Melanotic",1
11844,High Grade Lesion,Tongue Alveolar Soft Part Sarcoma',1
11845,Biphasic Pattern,Pleural Biphasic Synovial Sarcoma,1
11846,Vascular Channel Formation,Skin Cavernous Hemangioma,1
11847,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
11848,Myomatous Stroma Formation,Uterine Corpus Adenomyoma,1
11849,Adulthood Lesion,Adult Acute Megakaryoblastic Leukemia,1
11850,Malignant Cellular Infiltrate,Malignant tumor of extrahepatic bile duct,1
11851,Carcinomatous Component Present,Upper Gingival Verrucous Carcinoma,1
11852,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
11853,Malignant Cellular Infiltrate,Systemic Anaplastic Large Cell Lymphoma,1
11854,Carcinomatous Component Present,Sweat gland carcinoma,1
11855,Lobulated Growth Pattern,Pyogenic granuloma of oral mucosa,1
11856,Malignant Cellular Infiltrate,AIDS with Kaposi's sarcoma,1
11857,Well-Circumscribed Lesion,Seminal Vesicle Cystadenoma,1
11858,Papillary Pattern,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
11859,Cutaneous Involvement,Aplasia Cutis Congenita,1
11860,Epithelial Component Present,Major Salivary Gland Carcinoma,1
11861,Epithelial Component Present,Stage IIIA Gastric Carcinoma,1
11862,Primary Lesion,Ependymoma of brain stem,1
11863,Benign Cellular Infiltrate,Benign neoplasm of buccal mucosa,1
11864,Secondary Lesion,Breast Carcinoma Metastatic in the Bone,1
11865,More than 5 Mitoses per 50HPF,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
11866,Carcinomatous Component Present,Small intestine carcinoma stage II,1
11867,Malignant Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8,1
11868,Hereditary Lesion,BRCA-Mutated Ovarian Carcinoma,1
11869,Borderline Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
11870,Epithelial Component Present,adenosquamous carcinoma of salivary gland,1
11871,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
11872,Malignant Cellular Infiltrate,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
11873,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
11874,Mesenchymal Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
11875,Cutaneous Involvement,Erythematosquamous dermatosis,1
11876,Epithelial Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
11877,Mixed Cellular Population,Pericanalicular fibroadenoma,1
11878,Carcinomatous Component Present,Cystadenocarcinoma of pancreas,1
11879,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
11880,Adulthood Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
11881,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
11882,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
11883,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement,1
11884,Carcinomatous Component Present,Carcinoma in situ of fallopian tube,1
11885,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
11886,Epithelial Component Present,Pancreatic Solid Serous Adenoma,1
11887,Carcinomatous Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
11888,Capsular Invasion,"Thymoma, type B1, malignant",1
11889,Well-Circumscribed Lesion,Osteoid osteoma,1
11890,Refractory Disease,Refractory Langerhans Cell Histiocytosis,1
11891,Schwannian Stroma More than 50 Percent of the Tumor Volume,Childhood Ganglioneuroblastoma,1
11892,Hereditary Lesion,Hereditary Malignant Neoplasm,1
11893,Primary Lesion,Adult Brain Glioblastoma,1
11894,Lepidic Growth Pattern,Minimally Invasive Mucinous Lung Adenocarcinoma,1
11895,Transformed Phase of Disease,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,1
11896,Malignant Cellular Infiltrate,Head and neck cancer metastatic,1
11897,Hereditary Lesion,BRCA-Mutated Ovarian Carcinoma,1
11898,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II,1
11899,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
11900,Well-Circumscribed Lesion,Gingival Angiofibroma,1
11901,Carcinomatous Component Present,Large cell lung cancer stage I,1
11902,Malignant Cellular Infiltrate,Spindle cell liposarcoma,1
11903,Childhood Lesion,Recurrent Childhood Visual Pathway Astrocytoma,1
11904,Malignant Cellular Infiltrate,Classic medulloblastoma,1
11905,Epithelial Component Present,Inflammatory carcinoma of breast stage III,1
11906,Mixed Cellular Population,Childhood Mixed Glioma,1
11907,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v7,1
11908,Invasive Lesion,Adenocarcinoma of the prostate stage IV,1
11909,Malignant Cellular Infiltrate,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
11910,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
11911,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
11912,Recurrent disease,Small intestine carcinoma recurrent,1
11913,Secondary Lesion,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
11914,Indolent Clinical Course,Pelvic lipomatosis,1
11915,Psammoma Body Formation,Benign Mediastinal Psammomatous Schwannoma,1
11916,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
11917,Cutaneous Involvement,Common wart,1
11918,Hyperplastic Tissue Present,Stromal hyperplasia,1
11919,Perineural spread,Desmoplastic Neurotropic Melanoma,1
11920,Carcinomatous Component Present,Recurrent Adult Hepatocellular Carcinoma,1
11921,Malignant Cellular Infiltrate,Ovarian Non-Dysgerminomatous Germ Cell Tumor,1
11922,Low Grade Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1,1
11923,Borderline Lesion,Proliferating Brenner Tumor,1
11924,Epithelial Component Present,Lung Cancer by AJCC v7 Stage,1
11925,Epithelial Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
11926,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v7,1
11927,Malignant Component Present,Testicular Teratoma with Somatic-Type Malignancy,1
11928,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
11929,Carcinomatous Component Present,Gastric carcinoma stage IV,1
11930,Indolent Clinical Course,Palisaded Lymph Node Myofibroblastoma,1
11931,Carcinomatous Component Present,Clinical Stage IIA Gastric Cancer AJCC v8,1
11932,High Grade Lesion,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
11933,Burn injury,Old Burn Scar-Related Neoplasm,1
11934,Malignant Cellular Infiltrate,Recurrent Cervical Adenosquamous Carcinoma,1
11935,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v7,1
11936,Malignant Cellular Infiltrate,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
11937,Malignant Cellular Infiltrate,Childhood Favorable Prognosis Hodgkin Lymphoma,1
11938,Epithelial Component Present,Anatomic Stage IV Breast Cancer AJCC v8,1
11939,Malignant Cellular Infiltrate,Methotrexate-Associated Follicular Lymphoma,1
11940,Epithelial Component Present,Stage III Liver Cancer,1
11941,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
11942,Single Cell Necrosis,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
11943,Biphasic Pattern,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
11944,atypia morphology,"Papillary cystadenoma, borderline malignancy",1
11945,Carcinomatous Component Present,Bladder transitional cell carcinoma stage 0,1
11946,Epithelial Component Present,Colorectal Small Cell Neuroendocrine Carcinoma,1
11947,Alternative Fascicle (Bundle) Pattern,Vaginal Leiomyoma,1
11948,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
11949,Carcinomatous Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
11950,Benign Cellular Infiltrate,Vulvar Inverted Follicular Keratosis,1
11951,Benign Cellular Infiltrate,Macrofollicular adenoma,1
11952,Carcinomatous Component Present,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
11953,Well Differentiated Neuroendocrine Lesion,Gallbladder Neuroendocrine Tumor G1,1
11954,Benign Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma,1
11955,Malignant Cellular Infiltrate,Carcinoma in situ of prostate,1
11956,Glandular Pattern,Ovarian Mucinous Carcinoid Tumor,1
11957,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),1
11958,Recurrent disease,Recurrent respiratory papillomatosis,1
11959,Mitotic Activity,Testicular yolk sac tumor stage III,1
11960,Recurrent disease,Recurrent Gliosarcoma,1
11961,Encapsulated Mass,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,1
11962,Malignant Cellular Infiltrate,Bladder cancer recurrent,1
11963,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma,1
11964,Cutaneous Involvement,Mycosis fungoides refractory,1
11965,Thick-Walled Hyalinized Vessels Present,Jugular Foramen Schwannoma,1
11966,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma,1
11967,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
11968,Epithelial Component Present,Grade 1 Clear Cell Renal Cell Carcinoma,1
11969,Epithelial Component Present,Atypical carcinoid tumor,1
11970,Solitary mass,Bronchioloalveolar Adenocarcinoma,1
11971,Adnexal Differentiation,Malignant neoplasm of sweat gland,1
11972,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
11973,Epithelial Component Present,Inverted urothelial papilloma,1
11974,Malignant Cellular Infiltrate,Squamous cell carcinoma of mouth,1
11975,Carcinomatous Component Present,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
11976,Epithelial Component Present,Vaginal Adenoma,1
11977,Intracanalicular Growth Pattern,"Phyllodes tumor, benign",1
11978,Malignant Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma,1
11979,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma,1
11980,Endophytic Tumor Growth,Anal Verrucous Carcinoma,1
11981,Fried-Egg Appearance of the Bone Marrow,Recurrent Hairy Cell Leukemia,1
11982,Hereditary Lesion,Hereditary Melanoma,1
11983,Benign Cellular Infiltrate,Conventional Cardiac Rhabdomyoma,1
11984,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v8,1
11985,Cutaneous Involvement,Malignant Germinative Follicular Epithelium Neoplasm,1
11986,Keratin pearl formation,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
11987,Malignant Cellular Infiltrate,Peripheral Ganglioneuroblastoma,1
11988,Epithelial Component Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
11989,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
11990,Carcinomatous Component Present,Occult Lung Large Cell Carcinoma,1
11991,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ,1
11992,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4,1
11993,Locally Aggressive Lesion,Kaposiform Hemangioendothelioma,1
11994,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
11995,Malignant Cellular Infiltrate,Carcinoma of submandibular gland,1
11996,Epithelial Component Present,Hilar Cholangiocarcinoma by AJCC v8 Stage,1
11997,Cutaneous Involvement,Outer Hair Sheath and Infundibulum Neoplasm,1
11998,Perineural spread,adenoid cystic carcinoma of pharynx,1
11999,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
12000,Epithelial Component Present,Stage III Esophageal Adenocarcinoma AJCC v7,1
12001,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
12002,Epithelial Component Present,Carcinoma in a polyp,1
12003,Hypocellular Tissue,Intramuscular Myxoma,1
12004,Epithelial Component Present,Stage III Prostate Cancer AJCC v8,1
12005,Cutaneous Involvement,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
12006,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC v8,1
12007,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia,1
12008,Epithelial Component Present,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
12009,Epithelial Component Present,Unresectable Bladder Urothelial Carcinoma,1
12010,Mixed Cellular Population,Mixed parotid tumor,1
12011,Malignant Cellular Infiltrate,Ovarian Transitional Cell Carcinoma,1
12012,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12013,Refractory Disease,Diffuse large B-cell lymphoma refractory,1
12014,Epithelial Component Present,Prolactinoma,1
12015,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Cystadenofibroma,1
12016,Malignant Cellular Infiltrate,Salivary Gland Oncocytic Carcinoma,1
12017,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
12018,Infiltrative Growth Pattern,Multifocal Glioblastomas,1
12019,Fibroblastoma-Like Differentiation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
12020,Benign Cellular Infiltrate,Endometrial stromal nodule,1
12021,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
12022,Epithelial Component Present,Non-Functioning Pituitary Gland Macroadenoma,1
12023,Malignant Cellular Infiltrate,Bladder Lymphoma,1
12024,Carcinomatous Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
12025,Entrapped Respiratory Epithelium Present,Endobronchial Hamartoma,1
12026,Hypercellular bone marrow,"Leukemia, Myeloid, Accelerated Phase",1
12027,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor G1,1
12028,Absence of Invasion,Stage 0 Cervical Cancer AJCC v6,1
12029,Less than 2 Mitoses per 10HPF,Thymic Typical Carcinoid Tumor,1
12030,Malignant Cellular Infiltrate,Laryngeal Acantholytic Squamous Cell Carcinoma,1
12031,Epithelial Component Present,Intraductal papillary adenocarcinoma with invasion,1
12032,Severe cytologic atypia,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
12033,Carcinomatous Component Present,Fibrolamellar Hepatocellular Carcinoma,1
12034,Neuroendocrine Differentiation,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
12035,Aflatoxins Toxicity,Aflatoxins-Related Hepatocellular Carcinoma,1
12036,Thick-Walled Hyalinized Vessels Present,Degenerated Schwannoma,1
12037,Sarcomatous Component Present,Advanced Uterine Corpus Carcinosarcoma,1
12038,Malignant Cellular Infiltrate,Hepatic cancer stage IVA,1
12039,Recurrent disease,Pleural mesothelioma malignant recurrent,1
12040,Dysplasia,Appendix Intraepithelial Neoplasia,1
12041,Diffuse Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
12042,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v7,1
12043,Well Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,1
12044,Severe cytologic atypia,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
12045,Necrotic changes (finding),Adult Brain Glioblastoma,1
12046,Cutaneous Involvement,Dermatitis due to substances taken internally,1
12047,Ineffective hematopoiesis,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
12048,Indolent Clinical Course,Giant Hemangioma,1
12049,Malignant Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
12050,Primary Site Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
12051,Well Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
12052,Metastatic Lesion,Metastatic Genitourinary System Carcinoma,1
12053,Mesenchymal Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
12054,Carcinomatous Component Present,Stage II Colon Cancer AJCC v8,1
12055,atypia morphology,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
12056,Borderline Lesion,"lymphomatoid papulosis, type C",1
12057,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
12058,Carcinomatous Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
12059,Chronic Inflammatory Infiltrate,Intracranial Benign Fibrous Histiocytoma,1
12060,Malignant Cellular Infiltrate,Adenocarcinoma of colon,1
12061,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,1
12062,Malignant Cellular Infiltrate,Stage II Distal Bile Duct Cancer AJCC v8,1
12063,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Cystadenofibroma,1
12064,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
12065,Eosinophil count raised (finding),B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,1
12066,Nuclear Atypia,Anaplastic Oligoastrocytoma,1
12067,Diffuse Pattern,Stage I Diffuse Large B-Cell Lymphoma,1
12068,Dysplasia,"Gastric Adenoma, Gastric-Type",1
12069,Less than 2 Mitoses per 10HPF,Thymic Typical Carcinoid Tumor,1
12070,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
12071,Recurrent disease,Recurrent Malignant Bone Neoplasm,1
12072,Carcinomatous Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
12073,Malignant Cellular Infiltrate,Vaginal Melanoma,1
12074,Lesion with Diameter Greater than 15mm,Medium/Large Size Posterior Uveal Melanoma,1
12075,Carcinomatous Component Present,Stage IB Esophageal Adenocarcinoma AJCC v7,1
12076,Carcinomatous Component Present,Postcricoid cancer,1
12077,Carcinomatous Component Present,Undifferentiated Fallopian Tube Carcinoma,1
12078,Childhood Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
12079,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
12080,Mixed Cellular Population,Malignant phyllodes tumor of breast,1
12081,Mitotic Activity,Supratentorial Glioblastoma,1
12082,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
12083,Epithelial Component Present,Stage IIC Rectal Cancer AJCC v7,1
12084,Epithelial Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
12085,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Epithelioid Leiomyoma,1
12086,Epithelial Component Present,Primary Peritoneal Serous Adenocarcinoma,1
12087,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anaemia with excess blasts,1
12088,Nodular Pattern,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,1
12089,Mitotic Activity,Brain Stem Glioblastoma,1
12090,Primary Lesion,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
12091,Dysplasia,tubular adenoma of extrahepatic bile duct,1
12092,Malignant Cellular Infiltrate,Recurrent Aggressive Non-Hodgkin Lymphoma,1
12093,atypia morphology,Malignant Granulosa Cell Tumor,1
12094,Sarcomatous Component Present,Pleuropulmonary blastoma type II,1
12095,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
12096,Malignant Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
12097,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
12098,Chromogranin A Positive Neoplastic Cells Present,Gastric Carcinoid Tumor,1
12099,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified,1
12100,Malignant Cellular Infiltrate,Sellar Yolk Sac Tumor,1
12101,atypia morphology,"Leydig cell tumor, malignant",1
12102,Recurrent disease,Recurrent Grade 3a Follicular Lymphoma,1
12103,Carcinomatous Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
12104,Cutaneous Involvement,Ichthyosis Vulgaris,1
12105,Malignant Cellular Infiltrate,Bladder cancer recurrent,1
12106,Adulthood Lesion,Adult T Lymphoblastic Lymphoma,1
12107,Cutaneous Involvement,Giant Cell Fibroblastoma,1
12108,Hyperplastic Tissue Present,Atypical Mesothelial Hyperplasia,1
12109,Acanthosis,Lower Gingival Verrucous Carcinoma,1
12110,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
12111,Nodular Pattern,Eccrine spiradenoma,1
12112,Indolent Clinical Course,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
12113,Malignant Cellular Infiltrate,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
12114,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
12115,Blasts Under 20 Percent of Peripheral Blood White Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",1
12116,Mixture of Germ Cell Neoplastic Components Present,Teratocarcinoma,1
12117,Epithelial Component Present,malignant myoepithelioma of breast,1
12118,Secondary Lesion,Advanced Unresectable Gastric Adenocarcinoma,1
12119,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
12120,Indolent Clinical Course,Hemangioma of retina,1
12121,Benign Cellular Infiltrate,Ovarian Mucinous Cystadenofibroma,1
12122,Cutaneous Involvement,"Keratoderma, Palmoplantar",1
12123,Exophytic Polypoid Lesion,Villous adenoma of duodenum,1
12124,Carcinomatous Component Present,Mucin-producing adenocarcinoma,1
12125,Benign Cellular Infiltrate,Lipoma,1
12126,Local disease,Intramuscular lipoma,1
12127,Secondary Lesion,Advanced Digestive System Carcinoma,1
12128,Vascular Channel Formation,Adrenal Gland Angiosarcoma,1
12129,Epithelioid Component Present,"Synovial sarcoma, biphasic",1
12130,Immunologic Deficiency Syndromes,AIDS-Related Hodgkin Lymphoma,1
12131,Multinodular Pattern,Conventional Extraskeletal Myxoid Chondrosarcoma,1
12132,Primary Lesion,Metastatic Fibrolamellar Carcinoma,1
12133,Neuroendocrine Differentiation,Pituitary Gland Paraganglioma,1
12134,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma,1
12135,Epithelial Component Present,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
12136,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Mucinous adenocarcinoma, endocervical type",1
12137,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant",1
12138,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous and osseous metaplasia,1
12139,Carcinomatous Component Present,Villous adenocarcinoma,1
12140,Malignant Cellular Infiltrate,Proneural Glioblastoma,1
12141,Recurrent disease,Intestinal T-cell lymphoma recurrent,1
12142,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
12143,Malignant Cellular Infiltrate,"Ganglioneuroblastoma, Nodular",1
12144,Perivascular Arrangement of Tumor Cells,Telangiectatic Glomangioma,1
12145,Malignant Cellular Infiltrate,Combined Lung Large Cell Neuroendocrine Carcinoma,1
12146,Deep Lesion,"Liposarcoma, well differentiated",1
12147,Malignant Cellular Infiltrate,Lymphoma,1
12148,Carcinomatous Component Present,High Grade Broad Ligament Serous Adenocarcinoma,1
12149,Capillary Sized Vascular Channel Formation,Senile angioma,1
12150,Benign Cellular Infiltrate,Benign neoplasm of tongue,1
12151,Human Papillomavirus Positive,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
12152,Tissue Differentiation Uncertain,Benign Lung PEComa,1
12153,Cutaneous Involvement,Mycosis Fungoides,1
12154,Blasts of Mixed Phenotype Present,Acute biphenotypic leukemia,1
12155,Malignant Cellular Infiltrate,Classic Congenital Mesoblastic Nephroma,1
12156,Benign Cellular Infiltrate,Angiomyofibroblastoma,1
12157,Malignant Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v7,1
12158,Malignant Cellular Infiltrate,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
12159,Indolent Clinical Course,Solitary Myofibromatosis,1
12160,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
12161,Tissue Differentiation Uncertain,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
12162,Sarcomatous Component Present,carcinosarcoma of lung,1
12163,Benign Cellular Infiltrate,Mature Teratoma,1
12164,Epithelial Component Present,Bladder Signet Ring Cell Adenocarcinoma,1
12165,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,1
12166,Vascular Channel Formation,Lymphangioma of skin,1
12167,Malignant Cellular Infiltrate,Prognostic Stage IA Breast Cancer AJCC v8,1
12168,Papillary Pattern,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
12169,In Situ Lesion,Lung Squamous Cell Carcinoma In Situ,1
12170,Malignant Cellular Infiltrate,leiomyosarcoma of appendix,1
12171,Local disease,PNET of bone localized,1
12172,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
12173,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
12174,In Situ Lesion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
12175,Well-Circumscribed Lesion,Osteoid osteoma,1
12176,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
12177,Microvascular Proliferation,Glioblastoma multiforme of spinal cord,1
12178,Carcinomatous Component Present,Squamous cell carcinoma of vagina,1
12179,Benign Cellular Infiltrate,Lung Mucinous Cystadenoma,1
12180,Carcinomatous Component Present,Vaginal Endometrioid Adenocarcinoma,1
12181,Diffuse Pattern,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
12182,Diffuse Pattern,Recurrent Childhood Gliosarcoma,1
12183,Bone Marrow Dysplasia Present,Refractory anemia with ringed sideroblasts,1
12184,Primary Lesion,Brain Glioblastoma,1
12185,Biphasic Pattern,Benign Vaginal Mixed Tumor,1
12186,Mixed Cellular Population,Clear cell cystadenofibroma,1
12187,Epithelial Component Present,Urethral Carcinoma,1
12188,Epithelial Component Present,Stage III Pharynx Carcinoma,1
12189,Malignant Cellular Infiltrate,Colorectal cancer recurrent,1
12190,Primary Lesion,Primary Peritoneal Serous Adenocarcinoma,1
12191,Mixed Cellular Population,Benign Vaginal Mixed Tumor,1
12192,In Situ Lesion,Lung Non-Mucinous Adenocarcinoma In Situ,1
12193,Biphasic Pattern,Ovarian Clear Cell Adenofibroma,1
12194,Cutaneous Involvement,Skin Abnormalities,1
12195,Epithelial Component Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
12196,Malignant Cellular Infiltrate,Malignant tumor of supraglottis,1
12197,Absence of Invasion,Lung Non-Mucinous Adenocarcinoma In Situ,1
12198,Epithelial Component Present,Chromophobe Renal Cell Carcinoma,1
12199,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Cortex,1
12200,Carcinomatous Component Present,Hereditary Female Breast Carcinoma,1
12201,Inflammatory infiltrate,Inflammatory Leiomyosarcoma,1
12202,Cutaneous Involvement,Spongiotic dermatitis,1
12203,Cutaneous Involvement,keratoacanthoma,1
12204,Recurrent disease,Recurrent Primary Cutaneous Lymphoma,1
12205,Childhood Lesion,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
12206,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v6 and v7,1
12207,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v6,1
12208,Malignant Cellular Infiltrate,Metastatic Cervical Adenocarcinoma,1
12209,In Situ Lesion,Adenocarcinoma in situ in tubulovillous adenoma,1
12210,Malignant Cellular Infiltrate,Undifferentiated carcinoma of stomach,1
12211,Malignant Cellular Infiltrate,Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
12212,Malignant Cellular Infiltrate,Intraductal Non-Comedo Breast Adenocarcinoma,1
12213,Malignant Cellular Infiltrate,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
12214,Epithelial Component Present,Stage IIA Lung Large Cell Carcinoma AJCC v7,1
12215,Adulthood Lesion,Adult Cholangiocarcinoma,1
12216,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
12217,Epithelial Component Present,Prostate cancer stage A,1
12218,Carcinomatous Component Present,Recurrent Extrahepatic Bile Duct Carcinoma,1
12219,Slow Growing Mass,Sacral Chordoma,1
12220,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma,1
12221,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
12222,High Grade Lesion,synovial sarcoma,1
12223,Pregnancy Complications,Placental Site Nodule or Plaque,1
12224,Unresectable Mass,Unresectable Urethral Urothelial Carcinoma,1
12225,Epithelial Component Present,Cervical Squamous Cell Carcinoma In Situ,1
12226,Increased Cellularity Present,Ependymoblastoma,1
12227,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia,1
12228,Malignant Cellular Infiltrate,Recurrent Adult Immunoblastic Lymphoma,1
12229,Epithelial Component Present,adenosquamous carcinoma of esophagus,1
12230,Invasive Lesion,Thymoma malignant invasive,1
12231,Low Mitotic Activity,Ampulla of Vater Gangliocytic Paraganglioma,1
12232,Carcinomatous Component Present,Stage II Rectosigmoid Cancer AJCC v7,1
12233,Malignant Cellular Infiltrate,Malignant neoplasm of endocervix,1
12234,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12235,Well-Circumscribed Lesion,Serous cystadenoma of pancreas,1
12236,Epithelial Component Present,Carcinoma bone,1
12237,Malignant Cellular Infiltrate,Epiglottic carcinoma,1
12238,Carcinomatous Component Present,Endometrioid adenocarcinoma metastatic,1
12239,Carcinomatous Component Present,Stage IB Lung Cancer AJCC v7,1
12240,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type",1
12241,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
12242,Monoclonal Langerhans Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
12243,Refractory Disease,Hodgkin's disease mixed cellularity refractory,1
12244,Follicular Cell Differentiation,Atypical follicular adenoma,1
12245,Bone Marrow Dysplasia Present,Refractory Thrombocytopenia,1
12246,Cystic Change,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
12247,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
12248,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
12249,Papillary Pattern,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
12250,Malignant Component Present,Ovarian Dermoid Cyst with Leiomyosarcoma,1
12251,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage III,1
12252,Anaplasia,Adult Brain Glioblastoma,1
12253,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
12254,Malignant Cellular Infiltrate,Locally Advanced Unresectable Carcinoma,1
12255,Mucinous degeneration,Childhood Protoplasmic Astrocytoma,1
12256,High Grade Lesion,Esophageal Rhabdomyosarcoma,1
12257,Malignant Cellular Infiltrate,Leukemic Nonnodal Mantle Cell Lymphoma,1
12258,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Acute monocytic/monoblastic leukemia,1
12259,Malignant Cellular Infiltrate,Refractory Paranasal Sinus Squamous Cell Carcinoma,1
12260,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
12261,Mixture of Germ Cell Neoplastic Components Present,Sellar Mixed Germ Cell Tumor,1
12262,Benign Cellular Infiltrate,Adult Pineocytoma,1
12263,Malignant Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
12264,Recurrent disease,Recurrent Childhood Lymphomatoid Granulomatosis,1
12265,Regional Disease,Locally Advanced Digestive System Carcinoma,1
12266,Malignant Cellular Infiltrate,Colorectal Signet Ring Cell Carcinoma,1
12267,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
12268,Mixed Cellular Population,Combined Lung Large Cell Neuroendocrine Carcinoma,1
12269,Single Cell Necrosis,Stage IIA Merkel Cell Carcinoma AJCC v7,1
12270,Malignant Cellular Infiltrate,Burkitt Lymphoma,1
12271,Malignant Cellular Infiltrate,Locally Advanced Digestive System Carcinoma,1
12272,Indolent Clinical Course,Cutaneous myxoma,1
12273,Benign Cellular Infiltrate,Benign neoplasm of oropharynx,1
12274,Metastatic Lesion,Advanced Head and Neck Carcinoma,1
12275,Carcinomatous Component Present,Occult Lung Carcinoma,1
12276,Pseudoalveolar Pattern,Tongue Alveolar Soft Part Sarcoma',1
12277,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV,1
12278,atypia morphology,Borderline epithelial tumor of ovary,1
12279,Subcutaneous Involvement,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
12280,Neuroendocrine Differentiation,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
12281,Diffuse Pattern,Frontal Lobe Anaplastic Astrocytoma,1
12282,Malignant Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,1
12283,Malignant Cellular Infiltrate,Undifferentiated Epithelioid Sarcoma,1
12284,Pathologic TNM Finding,Pathologic Stage IIA Gastric Cancer AJCC v8,1
12285,Fibrotic Stroma Formation,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
12286,Benign Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,1
12287,Secondary Lesion,Stage IV Laryngeal Carcinoma,1
12288,atypia morphology,Borderline Uterine Ligament Neoplasm,1
12289,Carcinomatous Component Present,Stage III Pharynx Carcinoma,1
12290,Stromal Invasion,Malignant Ovarian Mucinous Tumor,1
12291,Carcinomatous Component Present,"Carcinoma, Granular Cell",1
12292,Malignant Cellular Infiltrate,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
12293,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
12294,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
12295,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
12296,Anaplasia,Glioblastoma,1
12297,Carcinomatous Component Present,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12298,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma,1
12299,Epithelial Component Present,Urethral Cancer by AJCC v8 Stage,1
12300,Malignant Cellular Infiltrate,Basal cell carcinoma of vulva,1
12301,Childhood Lesion,Childhood Ovarian Yolk Sac Tumor,1
12302,Recurrent disease,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
12303,Pseudopapillary Pattern,Testicular embryonal carcinoma stage II,1
12304,Cutaneous Involvement,Extraocular Cutaneous Sebaceous Carcinoma,1
12305,Childhood Lesion,Malignant Childhood Germ Cell Tumor,1
12306,Vascular Channel Formation,Polymorphus Hemangioendothelioma,1
12307,Solitary mass,malignant epithelioid hemangioendothelioma of liver,1
12308,Malignant Cellular Infiltrate,Stage IIB Colorectal Cancer AJCC v7,1
12309,Vascular Channel Formation,Central Nervous System Hemangioma,1
12310,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
12311,Carcinomatous Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
12312,Benign Cellular Infiltrate,Benign tumor of penis,1
12313,Epithelial Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
12314,Slow Growing Mass,Clivus Chondroid Chordoma,1
12315,Cytoplasmic Membrane-Bound Granules Present,Stage I Merkel Cell Carcinoma AJCC v7,1
12316,Carcinomatous Component Present,Metastatic Lung Adenosquamous Carcinoma,1
12317,Exophytic Polypoid Lesion,Gastric hyperplastic polyp,1
12318,Carcinomatous Component Present,Stage IIB Cervical Cancer AJCC v6 and v7,1
12319,Carcinomatous Component Present,Pericardial Carcinomatosis,1
12320,Syncytial Pattern,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
12321,Hyperchromatism,Large Cell Dysplasia,1
12322,'Starry-sky' pattern,Stage I Childhood Burkitt Lymphoma,1
12323,BCR/ABL1 Fusion Negative,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
12324,Desmoplastic Stroma Formation,Desmoplastic trichoepithelioma,1
12325,Epithelial Component Present,Labia Majora Carcinoma,1
12326,Carcinomatous Component Present,Major Salivary Gland Acinic Cell Carcinoma,1
12327,Carcinomatous Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
12328,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8,1
12329,Follicular Cell Differentiation,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
12330,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
12331,Primary Lesion,Adult Primary Melanocytic Lesion of Meninges,1
12332,Recurrent disease,Recurrent Anal Adenocarcinoma,1
12333,Epithelial Component Present,Basophilic Adenocarcinoma,1
12334,Dense Collagenized Tissue Present,Vulvar Syringoma,1
12335,High Grade Lesion,Epithelioid glioblastoma,1
12336,Carcinomatous Component Present,Non-small cell carcinoma,1
12337,Epithelial Component Present,Stage IIIC Ovarian Cancer,1
12338,Infiltrative Growth Pattern,Anaplastic Brain Stem Astrocytoma,1
12339,Benign Cellular Infiltrate,Osteochondromyxoma,1
12340,Hereditary Lesion,Constitutional Mismatch Repair Deficiency Syndrome,1
12341,Infiltrative Growth Pattern,Adult Infiltrating Astrocytoma,1
12342,Carcinomatous Component Present,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant",1
12343,Increased Cellularity Present,Prostate Stromal Sarcoma,1
12344,High Mitotic Activity,Small cell carcinoma of esophagus,1
12345,Epithelial Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
12346,Epithelial Component Present,Cervical Mullerian Papilloma,1
12347,Epithelial Component Present,Stage IA2 Cervical Cancer,1
12348,Epithelial Component Present,Pancreatic Endocrine Carcinoma,1
12349,Diffuse Pattern,Frontal Lobe Anaplastic Oligodendroglioma,1
12350,Stromal Invasion,Stage IV Ovarian Cancer AJCC v6 and v7,1
12351,Malignant Cellular Infiltrate,Maxillary Sinus Adenoid Cystic Carcinoma,1
12352,Intermediate Filaments Present,Rhabdoid Tumor of the Kidney,1
12353,Dermal Involvement,Vulvar Eccrine Porocarcinoma,1
12354,Epithelial Component Present,Cervix carcinoma,1
12355,Childhood Lesion,Childhood Malignant Ovarian Germ Cell Tumor,1
12356,Cutaneous Involvement,Stage IIA Merkel Cell Carcinoma AJCC v7,1
12357,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
12358,Anaplasia,carcinosarcoma of lung,1
12359,Malignant Cellular Infiltrate,Grade III Chondrosarcoma,1
12360,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
12361,Moderate dysplasia,Moderate epithelial dysplasia,1
12362,Refractory Disease,Refractory Malignant Female Reproductive System Neoplasm,1
12363,Well-Circumscribed Lesion,Venous Angioleiomyoma,1
12364,Secondary Lesion,Carcinomatosis,1
12365,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v8,1
12366,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage IV,1
12367,Angiocentric Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
12368,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v8,1
12369,Mixed Cellular Population,Adenomyoma,1
12370,Secondary Lesion,Metastatic Squamous Cell Breast Carcinoma,1
12371,Anaplasia,carcinosarcoma of lung,1
12372,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
12373,Papillary Pattern,Papillary carcinoma in situ,1
12374,Increased Cellularity Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
12375,Malignant Cellular Infiltrate,Sporadic Burkitt's lymphoma,1
12376,Childhood Lesion,Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage,1
12377,Epithelial Component Present,Thyroid Gland Follicular Adenoma,1
12378,Borderline Lesion,Monoclonal Gammopathy of Undetermined Significance,1
12379,Metastatic Lesion,Metastases to adrenals,1
12380,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
12381,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor G2,1
12382,CD1a-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
12383,Malignant Cellular Infiltrate,Undifferentiated carcinoma,1
12384,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma recurrent,1
12385,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Mutant",1
12386,Intracellular Accumulation of Lipids,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
12387,Neuroendocrine Differentiation,small cell carcinoma of salivary gland,1
12388,Epithelial Component Present,"Thymoma, type B2, malignant",1
12389,Indolent Clinical Course,Cellular angiofibroma,1
12390,Epithelial Component Present,Stage IB Distal Bile Duct Cancer AJCC v7,1
12391,Indolent Clinical Course,Lipoma of spermatic cord,1
12392,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Neoplasm,1
12393,Benign Cellular Infiltrate,Benign neoplasm of frontal sinus,1
12394,Benign Cellular Infiltrate,Bone island,1
12395,Epithelial Component Present,Adenoma of rete ovarii,1
12396,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v7,1
12397,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
12398,Extensive Stage Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
12399,Malignant Cellular Infiltrate,Malignant neoplasm of great vessels,1
12400,Recurrent disease,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
12401,Epithelial Component Present,Adult Cholangiocarcinoma,1
12402,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma refractory,1
12403,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
12404,Carcinomatous Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
12405,Mixed Cellular Population,Phyllodes Tumor,1
12406,Chronic lymphocytic inflammation,Parotid Gland Warthin Tumor,1
12407,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Disseminated",1
12408,Epithelial Component Present,Macrofollicular adenoma,1
12409,Myxoid Stroma Formation,Vertebral chordoma,1
12410,Epithelial Component Present,Prostate cancer stage C,1
12411,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
12412,Carcinomatous Component Present,Squamous cell carcinoma of oropharynx,1
12413,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Insulinoma,1
12414,Malignant Cellular Infiltrate,Recurrent Kaposi Sarcoma,1
12415,Indolent Clinical Course,Elastofibroma,1
12416,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
12417,Dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
12418,Hyaline Cartilage Differentiation,Childhood Mesenchymal Chondrosarcoma,1
12419,Epithelial Component Present,Invasive Prostate Carcinoma,1
12420,Metastatic Lesion,Metastatic Malignant Solid Neoplasm,1
12421,Primary Lesion,Primary Childhood Soft Tissue Sarcoma,1
12422,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
12423,Malignant Cellular Infiltrate,Metastatic Bladder Urothelial Carcinoma,1
12424,High Mitotic Activity,Adult Central Nervous System Embryonal Carcinoma,1
12425,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Mature Teratoma,1
12426,Malignant Cellular Infiltrate,Submucosal Invasive Colon Adenocarcinoma,1
12427,Dysplasia,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
12428,Diffuse Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,1
12429,Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines,Refractory cytopenia with multilineage dysplasia,1
12430,Benign Cellular Infiltrate,Trichodiscoma,1
12431,Collagenous Stroma Formation,Calcifying Fibrous Pseudotumor,1
12432,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma,1
12433,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with recurrent genetic abnormality,1
12434,Low Mitotic Activity,Ileal Neuroendocrine Tumor by AJCC v8 Stage,1
12435,Acanthosis,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
12436,Malignant Cellular Infiltrate,Non-small cell lung cancer stage I,1
12437,Epithelial Component Present,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
12438,Immunologic Deficiency Syndromes,Ann Arbor Stage III AIDS-Related Lymphoma,1
12439,Carcinomatous Component Present,adenoid cystic carcinoma of pharynx,1
12440,Epithelial Component Present,Vaginal Glandular Neoplasm,1
12441,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
12442,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma,1
12443,Necrotic changes (finding),Rectal Small Cell Neuroendocrine Carcinoma,1
12444,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v7,1
12445,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
12446,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
12447,Diffuse Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
12448,Malignant Cellular Infiltrate,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,1
12449,Fever,HHV8-Positive Multicentric Castleman Disease,1
12450,Carcinomatous Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
12451,atypia morphology,Borderline Ovarian Clear Cell Tumor,1
12452,Benign Cellular Infiltrate,Benign neoplasm of retina,1
12453,Neuroendocrine Differentiation,Familial medullary thyroid carcinoma,1
12454,Extensive Stage Lesion,Advanced Lymphoma,1
12455,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma by AJCC v8 Stage,1
12456,Neuroendocrine Differentiation,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
12457,Increased megakaryocytes (bone marrow),"Thrombocythemia, Essential",1
12458,High Mitotic Activity,"Leydig cell tumor, malignant",1
12459,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Erythroleukemia (Erythroid/Myeloid),1
12460,Epithelial Component Present,Stage IIA Anal Cancer AJCC v8,1
12461,Epithelial Component Present,Adenocarcinoma with neuroendocrine differentiation,1
12462,Carcinomatous Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
12463,Malignant Cellular Infiltrate,Testicular Typical Seminoma,1
12464,Cavernous Vascular Space Formation,Cavernous hemangioma of orbit,1
12465,Epithelial Component Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
12466,Poorly Differentiated Lesion,Sarcomatoid carcinoma of the lung,1
12467,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
12468,Necrotic changes (finding),Refractory Dedifferentiated Liposarcoma,1
12469,Carcinomatous Component Present,Bladder Urachal Urothelial Carcinoma,1
12470,Malignant Cellular Infiltrate,Mycosis fungoides stage I,1
12471,Malignant Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma,1
12472,Malignant Cellular Infiltrate,Cutaneous B Lymphoblastic Leukemia/Lymphoma,1
12473,Epithelial Component Present,Morpheic basal cell carcinoma,1
12474,Cutaneous Involvement,"Lymphoma, T-Cell, Cutaneous",1
12475,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v8,1
12476,Endophytic Tumor Growth,Inverting papilloma of the paranasal sinus,1
12477,Photosensitivity of skin,Rothmund-Thomson syndrome,1
12478,Malignant Cellular Infiltrate,Stage II Prostate Cancer AJCC v7,1
12479,Extensive Stage Lesion,Advanced Cervical Adenocarcinoma,1
12480,Indolent Clinical Course,Cardiac Capillary Hemangioma,1
12481,Local disease,Cerebral Hemisphere Lipoma,1
12482,Well Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
12483,Malignant Cellular Infiltrate,Secondary malignant neoplasm of neck,1
12484,Immunologic Deficiency Syndromes,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
12485,Well Differentiated Neuroendocrine Lesion,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
12486,Papillary Pattern,Papillary tumor of renal pelvis,1
12487,Immunosuppression-Related Post-Transplant Toxicity,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
12488,Malignant Cellular Infiltrate,Cerebral Glioblastoma,1
12489,Metastatic/Recurrent Disease,Lung Synovial Sarcoma,1
12490,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
12491,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage,1
12492,Malignant Cellular Infiltrate,Ampulla of Vater Intestinal-Type Adenocarcinoma,1
12493,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Vulvar Dysplastic Melanocytic Nevus,1
12494,Neoplastic Cells with Double Expression of MYC and BCL2 Proteins Present,Double expressor lymphoma,1
12495,Chromogranin A Positive Neoplastic Cells Present,Breast Carcinoid Tumor,1
12496,Cystic Change,Mucoepidermoid carcinoma of submandibular gland,1
12497,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma,1
12498,Hemorrhagic,Angiosarcoma NCI Grade 3,1
12499,Malignant Cellular Infiltrate,Lymphoma stage IV,1
12500,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
12501,Low Mitotic Activity,Gallbladder Neuroendocrine Tumor G1,1
12502,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
12503,Malignant Cellular Infiltrate,AIDS-Related Malignant Anal Neoplasm,1
12504,Carcinomatous Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
12505,Resectable Mass,Hepatoblastoma resectable,1
12506,Carcinomatous Component Present,Carcinoma ex Eccrine Spiradenoma,1
12507,Childhood Lesion,Metastatic Childhood Soft Tissue Sarcoma,1
12508,Monoclonal Paraproteinemia,Indolent multiple myeloma,1
12509,Malignant Cellular Infiltrate,Stage IIIA Hepatocellular Carcinoma AJCC v7,1
12510,Malignant Cellular Infiltrate,Childhood Choroid Plexus Carcinoma,1
12511,Epithelial Component Present,Stage IB Cervical Cancer AJCC v6 and v7,1
12512,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
12513,Carcinomatous Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
12514,Pseudoencapsulated Mass,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
12515,Neuroendocrine Differentiation,small cell carcinoma of ureter,1
12516,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of accessory sinus,1
12517,CD30-Positive Neoplastic Cells Present,Stage II Childhood Anaplastic Large Cell Lymphoma,1
12518,Malignant Cellular Infiltrate,Malignant tumor of mediastinum,1
12519,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
12520,Malignant Cellular Infiltrate,Carcinoma bone,1
12521,Tissue Differentiation Uncertain,Adult Desmoplastic Small Round Cell Tumor,1
12522,Epithelial Component Present,Unresectable Digestive System Adenocarcinoma,1
12523,Indolent Clinical Course,Fibromyxolipoma,1
12524,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
12525,Epithelial Component Present,Stage II Lung Cancer AJCC v6,1
12526,atypia morphology,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
12527,Cribriform Pattern,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
12528,Childhood Lesion,Childhood Testicular Mixed Germ Cell Tumor,1
12529,Angiodestructive Pattern,Cutaneous Lymphomatoid Granulomatosis,1
12530,Malignant Cellular Infiltrate,Colorectal Medullary Carcinoma,1
12531,Malignant Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
12532,Mixed Cellular Population,Broad Ligament Serous Adenofibroma,1
12533,Well-Circumscribed Lesion,Apocrine adenoma,1
12534,Hepatomegaly,Refractory Hepatosplenic T-Cell Lymphoma,1
12535,Locally Aggressive Lesion,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
12536,Neuroendocrine Differentiation,Stage I Appendix Neuroendocrine Tumor AJCC v7,1
12537,Malignant Cellular Infiltrate,Endometrial adenocarcinoma,1
12538,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage,1
12539,Childhood Lesion,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
12540,Malignant Cellular Infiltrate,Refractory Diffuse Intrinsic Pontine Glioma,1
12541,Vascular Channel Formation,Pericardial Angiosarcoma,1
12542,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v6 and v7,1
12543,Papillary Pattern,Bladder Papillary Urothelial Carcinoma,1
12544,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
12545,Mixed Cellular Population,Recurrent Childhood Anaplastic Oligoastrocytoma,1
12546,Primary Lesion,Stage I Osteosarcoma AJCC v7,1
12547,Epithelial Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
12548,Hormone Receptor Positive,Hormone Receptor Positive Breast Carcinoma,1
12549,Infantile Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
12550,Dense Intercellular Reticulin Network Present,Childhood Pleomorphic Xanthoastrocytoma,1
12551,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
12552,Recurrent disease,Malignant neoplasm of nasopharynx recurrent,1
12553,Malignant Cellular Infiltrate,Mucinous adenocarcinoma of appendix,1
12554,Primary Lesion,Melanoma recurrent,1
12555,Chromogranin A Positive Neoplastic Cells Present,Metastatic carcinoid tumor,1
12556,Nuclear Pseudoinclusion,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
12557,No Evidence of Metastatic Disease,"Phosphaturic mesenchymal tumor, benign",1
12558,Epithelial Component Present,Endometrioid adenocarcinoma recurrent,1
12559,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
12560,Fibrotic Stroma Formation,Ovarian Endometrioid Cystadenofibroma,1
12561,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v7,1
12562,Malignant Cellular Infiltrate,Malignant tumor of endocardium,1
12563,Carcinomatous Component Present,Malignant neoplasm of stomach stage I,1
12564,Malignant Cellular Infiltrate,Metastatic Unresectable Basal Cell Carcinoma,1
12565,Neuroendocrine Differentiation,Adenocarcinoid tumor,1
12566,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v7,1
12567,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
12568,Favorable Clinical Outcome,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
12569,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
12570,Single Cell Necrosis,Vulvar Merkel Cell Carcinoma,1
12571,Castration Resistance,Hormone refractory prostate cancer,1
12572,Malignant Cellular Infiltrate,Stage IIIA Rectal Cancer AJCC v7,1
12573,Malignant Cellular Infiltrate,Recurrent Childhood Soft Tissue Sarcoma,1
12574,Cutaneous Involvement,Dermatofibrosarcoma protuberans with myoid differentiation,1
12575,Epithelial Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
12576,Epithelial Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
12577,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A",1
12578,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
12579,Hypoglycemia,Malignant Pancreatic Insulinoma,1
12580,Well Differentiated Neuroendocrine Lesion,Stage II Ileal Neuroendocrine Tumor AJCC v8,1
12581,Fibrotic Stroma Formation,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
12582,Mixed Cellular Population,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
12583,Benign Cellular Infiltrate,Lung Mucous Gland Adenoma,1
12584,Carcinomatous Component Present,Rectal Adenosquamous Carcinoma,1
12585,Benign Cellular Infiltrate,benign endometrioid tumor of ovary,1
12586,atypia morphology,Borderline serous tumor of ovary,1
12587,Solid Growth Pattern,solid type ductal carcinoma in situ of breast,1
12588,Pagetoid Proliferation,Stage I Superficial Spreading Melanoma AJCC v7,1
12589,Hereditary Lesion,BRCA-Mutated Ovarian Carcinoma,1
12590,Monoclonal Cellular Population Present,"Mastocytosis, Systemic",1
12591,Dysplasia,Anal Canal Squamous Intraepithelial Neoplasia,1
12592,Nuclear Atypia,Brain Stem Glioblastoma,1
12593,Malignant Cellular Infiltrate,Stage I Renal Cell Cancer AJCC v8,1
12594,Exophytic Polypoid Lesion,Polyp of sphenoidal sinus,1
12595,Refractory Disease,Splenic marginal zone lymphoma refractory,1
12596,Epithelial Component Present,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
12597,Well Differentiated Neuroendocrine Lesion,Metastatic carcinoid tumor,1
12598,Bone Marrow and Blood Involvement,Childhood Burkitt Leukemia,1
12599,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
12600,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v8,1
12601,Secondary Lesion,Metastatic Carcinoma in the Liver,1
12602,Splenomegaly,Refractory B-Cell Prolymphocytic Leukemia,1
12603,Adulthood Lesion,Stage IV Adult Burkitt Lymphoma,1
12604,Non-Invasive Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
12605,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma recurrent,1
12606,Pregnancy Complications,Severe pre-eclampsia,1
12607,Biphasic Pattern,Myofibromatosis,1
12608,Cutaneous Involvement,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7,1
12609,Solitary Skin Tumor,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",1
12610,Invasive Lesion,Invasive Ductal Breast Carcinoma,1
12611,Pseudopapillary Pattern,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
12612,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
12613,Malignant Cellular Infiltrate,Secondary malignant neoplasm of larynx,1
12614,Neuroendocrine Differentiation,insulinoma,1
12615,Malignant Cellular Infiltrate,Dedifferentiated chondrosarcoma,1
12616,Metaplasia of Malignant Cells Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
12617,Skin nodule,Nodulo-ulcerative basal cell carcinoma,1
12618,Cartilaginous Component Present,Osteochondromyxoma,1
12619,Malignant Cellular Infiltrate,Merkel cell carcinoma,1
12620,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma,1
12621,Nuclear Atypia,Childhood Fibrillary Astrocytoma,1
12622,Epithelial Component Present,Non-small cell lung cancer stage IIIB,1
12623,Biphasic Pattern,Stage IVA Uterine Corpus Adenosarcoma AJCC v8,1
12624,Malignant Cellular Infiltrate,DS Stage II Plasma Cell Myeloma,1
12625,Malignant Cellular Infiltrate,Acute Myeloid Leukemia (AML-M2),1
12626,Refractory Disease,Refractory Uterine Corpus Carcinosarcoma,1
12627,Thyroglobulin Positive Neoplastic Cells Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
12628,S-100-Positive Neoplastic Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
12629,Epithelial Component Present,Benign Eccrine Neoplasm,1
12630,Poorly Differentiated Lesion,Rectal Sarcomatoid Carcinoma,1
12631,Malignant Cellular Infiltrate,Pigmented Basal Cell Carcinoma,1
12632,Malignant Cellular Infiltrate,Mixed Ductal-Endocrine Carcinoma,1
12633,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent,1
12634,Malignant Cellular Infiltrate,Advanced B-Cell Neoplasm,1
12635,Epithelial Component Present,"Somatostatinoma, malignant",1
12636,Malignant Cellular Infiltrate,Squamous cell carcinoma of mouth,1
12637,Local disease,Central Nervous System Hibernoma,1
12638,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
12639,Hemosiderin pigmentation,Hemosiderotic Fibrolipomatous Tumor,1
12640,Malignant Cellular Infiltrate,AIDS-Related Cervical Carcinoma,1
12641,Epithelial Component Present,Advanced Gastric Neuroendocrine Carcinoma,1
12642,Epithelial Component Present,Lung squamous cell carcinoma stage IV,1
12643,Malignant Cellular Infiltrate,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
12644,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung,1
12645,Neuroendocrine Differentiation,small cell carcinoma of larynx,1
12646,Benign Cellular Infiltrate,Childhood Cystic Nephroma,1
12647,Epithelial Component Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
12648,Epithelial Component Present,Cervical Microglandular Polyp,1
12649,Hereditary Lesion,Hereditary Kidney Wilms Tumor,1
12650,Benign Cellular Infiltrate,Pancreatic Solid Serous Adenoma,1
12651,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage,1
12652,Histiocytosis,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
12653,Borderline Lesion,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
12654,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
12655,Epithelial Component Present,Locally Advanced Prostate Adenocarcinoma,1
12656,Epithelial Component Present,Masaoka-Koga Stage IIa,1
12657,Malignant Cellular Infiltrate,Stage II Fallopian Tube Cancer AJCC v8,1
12658,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8,1
12659,Malignant Cellular Infiltrate,Refractory Testicular Lymphoma,1
12660,Epithelial Component Present,Paget Disease,1
12661,Absence of Invasion,Intermediate Grade Ductal Breast Carcinoma In Situ,1
12662,Vascular Channel Formation,Hemangioma of subcutaneous tissue,1
12663,Malignant Cellular Infiltrate,Stage III Adult Liver Cancer AJCC v7,1
12664,Tubular Pattern,Small Intestinal Tubulovillous Adenoma,1
12665,Neuroendocrine Differentiation,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
12666,Epithelial Component Present,Recurrent Parotid Gland Carcinoma,1
12667,Malignant Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor,1
12668,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
12669,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
12670,Cutaneous Involvement,Nevus of Ota,1
12671,Malignant Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8,1
12672,Immunologic Deficiency Syndromes,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
12673,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
12674,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory,1
12675,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma,1
12676,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Carcinosarcoma,1
12677,Indolent Clinical Course,Ectomesenchymal Chondromyxoid Tumor,1
12678,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome recurrent,1
12679,Benign Cellular Infiltrate,"Fibro-odontoma, Ameloblastic",1
12680,Somatostatin Positive Neoplastic Cells Present,Malignant Pancreatic Somatostatinoma,1
12681,Carcinomatous Component Present,Periampullary Adenocarcinoma,1
12682,Well-Circumscribed Lesion,Adenomatous polyp of colon,1
12683,Fenestrated Pattern,Vulvar Trichoepithelioma,1
12684,Benign Cellular Infiltrate,Dermal Fibroma,1
12685,Well Differentiated Lesion,Well Differentiated Leiomyosarcoma,1
12686,Carcinomatous Component Present,Occult Lung Adenosquamous Carcinoma,1
12687,Lymphoplasmacytic Infiltrate,Lymphoplasmacyte-rich meningioma,1
12688,Indolent Clinical Course,Vulvar Angiomyxoma,1
12689,Malignant Cellular Infiltrate,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
12690,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
12691,Delicate Arborizing Vascular Channel Formation,Ovarian Myxoid Liposarcoma,1
12692,Malignant Cellular Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma,1
12693,Epithelial Component Present,Renal Pelvis and Ureter Urothelial Carcinoma,1
12694,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
12695,Cellular Pleomorphism,Cardiac Malignant Fibrous Histiocytoma,1
12696,Epithelial Component Present,Thoracic NUT Carcinoma,1
12697,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Tumor G1,1
12698,Carcinomatous Component Present,Mucin-producing adenocarcinoma,1
12699,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
12700,Epithelial Component Present,adenomatous polyp of stomach,1
12701,Cutaneous Involvement,Chronic Adult T-Cell Leukemia/Lymphoma,1
12702,Malignant Cellular Infiltrate,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
12703,Fibrovascular Septa Present,Conventional Alveolar Rhabdomyosarcoma,1
12704,Granulocytes Increased in Bone Marrow,Overt Primary Myelofibrosis,1
12705,Exophytic Polypoid Lesion,Small Intestinal Villous Adenoma,1
12706,High Mitotic Activity,Esophageal Neuroendocrine Carcinoma,1
12707,Glandular Pattern,Ovarian Mucinous Carcinoid Tumor,1
12708,Metastatic/Recurrent Disease,Kidney Synovial Sarcoma,1
12709,Carcinomatous Component Present,Carcinoma of Cowper Glands,1
12710,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma,1
12711,Malignant Cellular Infiltrate,testicular leukemia,1
12712,Malignant Cellular Infiltrate,Medullomyoblastoma,1
12713,Carcinomatous Component Present,Intraductal papillary adenocarcinoma with invasion,1
12714,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage III,1
12715,Carcinomatous Component Present,Stage IIA Eyelid Carcinoma AJCC v8,1
12716,Hereditary Lesion,"Optic Atrophy, Hereditary, Leber",1
12717,Epithelial Component Present,Colon Small Cell Neuroendocrine Carcinoma,1
12718,Malignant Cellular Infiltrate,Grade III Meningioma,1
12719,Malignant Cellular Infiltrate,Squamous cell carcinoma of lung,1
12720,Epithelial Component Present,"Oncocytoma, renal",1
12721,High Grade Lesion,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
12722,Dermal Involvement,"Nevus, Intradermal",1
12723,Malignant Cellular Infiltrate,Carcinoma of base of tongue,1
12724,Birbeck Granules Present,Letterer-Siwe Disease,1
12725,Cytoplasmic Membrane-Bound Granules Present,Stage III Merkel Cell Carcinoma AJCC v7,1
12726,Metastatic Lesion,Metastatic Digestive System Carcinoma,1
12727,Refractory Disease,Refractory Erdheim-Chester Disease,1
12728,Carcinomatous Component Present,Subglottic Verrucous Carcinoma,1
12729,Mixed Cellular Population,Hybrid nerve sheath tumor,1
12730,In Situ Lesion,Anatomic Stage 0 Breast Cancer AJCC v8,1
12731,Biphasic Pattern,Pleural Biphasic Mesothelioma,1
12732,Cellular Pleomorphism,Malignant Testicular Sertoli Cell Tumor,1
12733,Pregnancy Complications,Malignant Placental Neoplasm,1
12734,Capillary Sized Vascular Channel Formation,Breast Epithelioid Hemangioma,1
12735,Carcinomatous Component Present,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12736,Poorly Differentiated Neuroendocrine Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
12737,Malignant Cellular Infiltrate,Stage 3 Neuroblastoma,1
12738,Neuroendocrine Differentiation,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
12739,Honeycomb Pattern,Brain Oligodendroglioma,1
12740,Benign Cellular Infiltrate,Benign neoplasm of extrahepatic bile ducts,1
12741,Carcinomatous Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
12742,Carcinomatous Component Present,Type I Endometrial Adenocarcinoma,1
12743,Metastatic Lesion,Metastatic Bile Duct Carcinoma,1
12744,Primary Lesion,Clear Cell Hepatocellular Carcinoma,1
12745,Malignant Cellular Infiltrate,Stage II Anal Cancer AJCC v8,1
12746,Differentiating Neuroblasts More than 5 Percent of the Tumor Cells,Differentiating Neuroblastoma,1
12747,Carcinomatous Component Present,adenoid cystic carcinoma of floor of mouth,1
12748,Epithelial Component Present,Borderline Ovarian Endometrioid Cystadenofibroma,1
12749,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
12750,Malignant Cellular Infiltrate,Stage I Ovarian Dysgerminoma AJCC v6 and v7,1
12751,High Grade Lesion,"Synovial sarcoma, biphasic",1
12752,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
12753,Neuroendocrine Differentiation,Gastric Small Cell Carcinoma,1
12754,Secondary Lesion,Secondary malignant neoplasm of vertebral column,1
12755,Nodular Pattern,Balloon cell malignant melanoma,1
12756,Lymphadenopathy,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
12757,Exophytic Papillary Lesion,keratoacanthoma,1
12758,Delicate Arborizing Vascular Channel Formation,Recurrent Myxoid Liposarcoma,1
12759,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma,1
12760,Hemosiderin pigmentation,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
12761,Pregnancy Complications,Necrotizing Funisitis,1
12762,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v8,1
12763,Adulthood Lesion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
12764,Metastatic Lesion,Lung Carcinoma Metastatic in the Bone,1
12765,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma,1
12766,Increased Cellularity Present,olfactory neuroblastoma of nasal cavity,1
12767,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v7,1
12768,Vascular Channel Formation,Angiosarcoma recurrent,1
12769,Decreased platelet count,Kasabach-Merritt syndrome,1
12770,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
12771,Primary Lesion,Ependymoma of brain,1
12772,Epidermal Involvement,Eccrine porocarcinoma,1
12773,Peripheral Nuclear Palisading,Stage IA Lung Small Cell Carcinoma AJCC v7,1
12774,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma,1
12775,Multinodular Pattern,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
12776,Secondary Lesion,Metastatic Chordoma,1
12777,Absence of Muscle Invasion,"Carcinoma of urinary bladder, superficial",1
12778,Slit-Like Vascular Channel Formation,Solid Angioleiomyoma,1
12779,Malignant Cellular Infiltrate,Basal cell carcinoma,1
12780,Epithelial Component Present,Recurrent Lobular Breast Carcinoma,1
12781,Dysplasia,Mild epithelial dysplasia,1
12782,Secondary Lesion,Metastatic Gastric Carcinoma,1
12783,Epithelial Component Present,Rectosigmoid Signet Ring Cell Carcinoma,1
12784,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
12785,Malignant Cellular Infiltrate,Adult Angiosarcoma,1
12786,Cutaneous Involvement,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
12787,Malignant Cellular Infiltrate,Angiosarcoma of the breast,1
12788,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,1
12789,Estrogen receptor negative,Triple-Negative Breast Carcinoma,1
12790,Malignant Cellular Infiltrate,Angiosarcoma recurrent,1
12791,Exophytic Polypoid Lesion,Gastric Juvenile Polyp,1
12792,Carcinomatous Component Present,Gallbladder Cribriform Carcinoma,1
12793,Malignant Cellular Infiltrate,Nasopharyngeal Differentiated Carcinoma,1
12794,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma,1
12795,Benign Cellular Infiltrate,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
12796,Absence of Stromal Invasion,"Endometrioid adenoma, borderline malignancy",1
12797,Metastatic Lesion,Pleural mesothelioma malignant advanced,1
12798,Congenital Lesion,Coloboma of eyelid,1
12799,Malignant Cellular Infiltrate,Pituitary carcinoma,1
12800,Absence of Invasion,Adenocarcinoma in situ in a polyp,1
12801,Cutaneous Involvement,"Dermatitis, Irritant",1
12802,Malignant Cellular Infiltrate,Malignant Central Nervous System Neoplasm,1
12803,Refractory Disease,Lymphoplasmacytoid lymphoma/immunocytoma refractory,1
12804,Hereditary Lesion,Familial meningioma,1
12805,Malignant Cellular Infiltrate,Malignant Ovarian Endometrioid Tumor,1
12806,Follicular Structures Present,Follicular Variant Thyroid Gland Papillary Carcinoma,1
12807,Carcinomatous Component Present,Stage IVB Bladder Cancer AJCC v8,1
12808,Tissues Derived from Two or Three Embryonic Layers Present,Mature Ovarian Teratoma,1
12809,Carcinomatous Component Present,Occult Lung Adenocarcinoma,1
12810,Pathologic TNM Finding,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
12811,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
12812,Well-Circumscribed Lesion,Rectal Juvenile Polyp,1
12813,Malignant Cellular Infiltrate,Hereditary Non-Polyposis Colon Cancer Type 2,1
12814,Well Differentiated Neuroendocrine Lesion,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
12815,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v7,1
12816,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
12817,Benign Cellular Infiltrate,Clear Cell Adrenal Cortical Adenoma,1
12818,Hereditary Lesion,Bannayan-Riley-Ruvalcaba Syndrome,1
12819,Cutaneous Involvement,Dartoic myoma,1
12820,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
12821,Malignant Cellular Infiltrate,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
12822,Exophytic Polypoid Lesion,Gastric Juvenile Polyp,1
12823,Mitotic Activity,Recurrent Gliosarcoma,1
12824,Eccrine Differentiation,eccrine adenocarcinoma of vulva,1
12825,Epithelial Component Present,Oropharyngeal Poorly Differentiated Carcinoma,1
12826,Malignant Cellular Infiltrate,Squamous cell carcinoma of scrotum,1
12827,Geographic Necrosis,embryonal carcinoma of mediastinum,1
12828,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Prefibrotic/Early Primary Myelofibrosis,1
12829,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
12830,Monomorphic Cellular Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
12831,Indolent Clinical Course,Infiltrating Intramuscular Lipoma,1
12832,Necrotic changes (finding),Adult Brain Glioblastoma,1
12833,Malignant Cellular Infiltrate,pleomorphic carcinoma of breast,1
12834,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
12835,Firm mass,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
12836,Malignant Cellular Infiltrate,Hodgkin Lymphoma by Ann Arbor Stage,1
12837,Hereditary Lesion,Hereditary Female Breast Carcinoma,1
12838,Primary Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
12839,Malignant Cellular Infiltrate,Grade 3 Colorectal Adenocarcinoma,1
12840,Malignant Cellular Infiltrate,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
12841,High Grade Lesion,Adult Alveolar Soft Part Sarcoma,1
12842,Myxoid Stroma Formation,Ventricular myxoma,1
12843,High Grade Lesion,Abdominal Rhabdomyosarcoma,1
12844,Malignant Cellular Infiltrate,Stage 0a Penile Cancer AJCC v8,1
12845,Dysplasia,Stage 0 Esophageal Cancer AJCC v7,1
12846,Carcinomatous Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
12847,Benign Cellular Infiltrate,Benign neoplasm of extrahepatic bile ducts,1
12848,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma,1
12849,Osteoid formation,Mediastinal Extraskeletal Osteosarcoma,1
12850,Cutaneous Involvement,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
12851,Epithelial Component Present,Stage IV Thymoma AJCC v8,1
12852,High Mitotic Activity,Gastric Small Cell Carcinoma,1
12853,Cutaneous Involvement,Stage II Merkel Cell Carcinoma AJCC v7,1
12854,Melanoma Cells Present,Breast Carcinoma with Melanotic Features,1
12855,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v8,1
12856,Epithelial Component Present,Stage IIB Gastric Cancer AJCC v7,1
12857,Malignant Cellular Infiltrate,Malignant neoplasm of submandibular gland,1
12858,Epithelial Component Present,Laryngeal verrucous carcinoma recurrent,1
12859,Cytoplasmic Membrane-Bound Granules Present,Stage II Merkel Cell Carcinoma AJCC v7,1
12860,Undifferentiated Lesion,"Endometrial stromal sarcoma, high grade",1
12861,Carcinomatous Component Present,Early gastric cancer,1
12862,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
12863,Carcinomatous Component Present,Adenocarcinoma of the prostate metastatic,1
12864,Vascular Channel Formation,Hemangiosarcoma of heart,1
12865,Epithelial Component Present,Bile duct adenocarcinoma,1
12866,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
12867,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,1
12868,Papillary Pattern,inverted ductal papilloma of salivary gland,1
12869,Recurrent disease,recurrent adult acute myeloid leukemia,1
12870,Primary Lesion,Primary Lung Meningioma,1
12871,Malignant Cellular Infiltrate,Sarcoma of soft tissue,1
12872,Anaplasia,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
12873,Mitotic Activity,Secondary Supratentorial Anaplastic Astrocytoma,1
12874,Resectable Mass,Resectable Neuroblastoma,1
12875,Scattered Collections of Differentiating Neuroblasts Present,Maturing Ganglioneuroma,1
12876,Monocytosis,Recurrent Chronic Myelomonocytic Leukemia,1
12877,Abnormal Eosinophilic Granules Present,"Acute myeloid leukemia, inv(16)(p13q22)",1
12878,Severe cytologic atypia,Pancreatic Large Cell Neuroendocrine Carcinoma,1
12879,Malignant Cellular Infiltrate,Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7,1
12880,Indolent Clinical Course,Rhabdomyoma,1
12881,High Grade Lesion,"Synovial sarcoma, spindle cell",1
12882,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
12883,Hemorrhagic,Pericardial Angiosarcoma,1
12884,Severe dysplasia,Stage 0is Urethral Cancer AJCC v7,1
12885,Epithelial Component Present,Advanced Small Intestinal Neuroendocrine Carcinoma,1
12886,Carcinomatous Component Present,solid type ductal carcinoma in situ of breast,1
12887,Cutaneous Involvement,Mycosis fungoides stage II,1
12888,Carcinomatous Component Present,Squamous cell carcinoma of pharynx,1
12889,Cystic Change,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
12890,Malignant Cellular Infiltrate,Spindle Cell Melanoma,1
12891,Epithelial Component Present,Gastro-enteropancreatic neuroendocrine tumor,1
12892,Severe cytologic atypia,large cell neuroendocrine carcinoma of gallbladder,1
12893,Indolent Clinical Course,Cardiac hemangioma,1
12894,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
12895,Metastatic Lesion,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
12896,Peripheral Nuclear Palisading,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
12897,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
12898,Infantile Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
12899,High Mitotic Activity,Stage IB Lung Small Cell Carcinoma AJCC v7,1
12900,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
12901,Epithelial Component Present,Stage I Cervical Cancer AJCC v8,1
12902,Local disease,benign lipoma of gallbladder,1
12903,Malignant Cellular Infiltrate,sarcoma of rectum,1
12904,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
12905,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v8,1
12906,Epithelial Component Present,Squamous intraepithelial neoplasia grade 2,1
12907,Carcinomatous Component Present,stage IV pancreatic cancer,1
12908,Epithelial Component Present,Stage IV Major Salivary Gland Cancer AJCC v7,1
12909,Glial Differentiation,Adult Brain Stem Gliosarcoma,1
12910,Epithelial Component Present,Papillary serous endometrial carcinoma,1
12911,Primary Lesion,Pineal Gland Astrocytoma,1
12912,Refractory Disease,Refractory Mediastinal Lymphoma,1
12913,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent,1
12914,Carcinomatous Component Present,Refractory Metastatic Digestive System Carcinoma,1
12915,Malignant Cellular Infiltrate,Chest Wall Hodgkin Lymphoma,1
12916,Multinodular Mass,Central Nervous System Angiosarcoma,1
12917,Mural Nodule,Ovarian Mucinous Cystic Tumor with Mural Nodules,1
12918,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Refractory Primary Amyloidosis,1
12919,Malignant Cellular Infiltrate,Thyroid Immunoblastic Lymphoma,1
12920,Carcinomatous Component Present,Lipid-rich carcinoma,1
12921,Malignant Cellular Infiltrate,Refractory Colon Carcinoma,1
12922,Dysplasia,Biliary Intraepithelial Neoplasia,1
12923,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Solid Variant",1
12924,Benign Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma,1
12925,Biphasic Pattern,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
12926,Poorly Differentiated Lesion,Pancreatic Endocrine Carcinoma,1
12927,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
12928,Refractory Disease,Refractory Malignant Thymoma,1
12929,Malignant Cellular Infiltrate,Stage IIIB Prostate Cancer AJCC v8,1
12930,Malignant Cellular Infiltrate,Skin Nodular Solid Basal Cell Carcinoma,1
12931,Chromogranin A Positive Neoplastic Cells Present,Metastatic Breast Carcinoid Tumor,1
12932,Malignant Cellular Infiltrate,Adrenal Gland Angiosarcoma,1
12933,High Grade Lesion,Recurrent Childhood Rhabdomyosarcoma,1
12934,Epithelial Component Present,Large cell lung cancer recurrent,1
12935,Papillary Pattern,verrucous carcinoma of vulva,1
12936,Epithelial Component Present,Squamous Cell Neoplasms,1
12937,Secondary Lesion,Secondary malignant neoplasm of ureter,1
12938,Malignant Cellular Infiltrate,Cardiac Leiomyosarcoma,1
12939,Thin-Walled Branching Vascular Pattern,Angiolipoma,1
12940,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
12941,Osteoid formation,Childhood Extraskeletal Osteosarcoma,1
12942,Malignant Cellular Infiltrate,Occult Lung Cancer AJCC v8,1
12943,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
12944,Carcinomatous Component Present,Mucinous carcinoma of breast,1
12945,Deep Lesion,Recurrent Desmoid-Type Fibromatosis,1
12946,Benign Cellular Infiltrate,"Chondromatosis, Synovial",1
12947,Malignant Cellular Infiltrate,Carcinoma of anal margin,1
12948,Malignant Cellular Infiltrate,Fibroblastic osteosarcoma,1
12949,Malignant Cellular Infiltrate,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
12950,Adulthood Lesion,Adult T Acute Lymphoblastic Leukemia,1
12951,Malignant Cellular Infiltrate,"Thymoma, type A, malignant",1
12952,Malignant Cellular Infiltrate,Pharyngeal Carcinoma,1
12953,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
12954,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
12955,Epithelial Component Present,Hidrocystoma,1
12956,Cutaneous Involvement,Flexural Skin Nevus,1
12957,Malignant Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
12958,Malignant Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ,1
12959,Misplaced Exocytosis Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
12960,Melanin-Forming Neuroepithelial Cells Present,"Neuroectodermal Tumor, Melanotic",1
12961,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v7,1
12962,Epithelial Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma,1
12963,Favorable Clinical Outcome,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
12964,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
12965,Cutaneous Involvement,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
12966,Myxoid Stroma Formation,Cellular neurothekeoma,1
12967,Benign Cellular Infiltrate,Syringoma,1
12968,Epithelial Component Present,Benign Ovarian Serous Tumor,1
12969,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage IV,1
12970,Malignant Cellular Infiltrate,Malignant neoplasm of large intestine,1
12971,Hyperkeratosis,Subglottic Verrucous Carcinoma,1
12972,Malignant Cellular Infiltrate,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
12973,Recurrent disease,Recurrent Ovarian Cystadenocarcinoma,1
12974,Carcinomatous Component Present,Gingival Spindle Cell Carcinoma,1
12975,Primary Lesion,anaplastic large cell lymphoma of central nervous system,1
12976,Carcinomatous Component Present,Stage I Lip Carcinoma,1
12977,High Grade Lesion,Glioblastoma multiforme of spinal cord,1
12978,Hypokalemia,Juxtaglomerular tumor,1
12979,Glandular Pattern,Malignant Pancreatic Somatostatinoma,1
12980,Infiltrative Growth Pattern,Small cell glioblastoma,1
12981,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
12982,Carcinomatous Component Present,Colorectal Carcinoma Metastatic in the Liver,1
12983,Intravascular Fibrin Thrombus Formation,Epidural Spinal Canal Angiolipoma,1
12984,Malignant Cellular Infiltrate,Colorectal Squamous Cell Carcinoma,1
12985,Biphasic Pattern,Childhood Brain Stem Gliosarcoma,1
12986,Hyalinized Vessels Present,Pilocytic astrocytoma of cerebellum,1
12987,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
12988,Negative Peripheral Blood,Aleukemic Monocytic Leukemia Cutis,1
12989,Hereditary Lesion,Hereditary Leiomyomatosis and Renal Cell Cancer,1
12990,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
12991,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Carcinoma,1
12992,Nuclear pleomorphism,Cardiac Myxofibrosarcoma,1
12993,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
12994,Pregnancy Complications,Placenta Accreta,1
12995,Low Mitotic Activity,"Gastrinoma, malignant",1
12996,Papillary Pattern,Collecting Duct Carcinoma of the Kidney,1
12997,Well-Circumscribed Lesion,Syringocystadenoma Papilliferum,1
12998,Metastatic Lesion,Metastatic Endometrial Carcinoma,1
12999,Recurrent disease,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
13000,High Grade Lesion,Vaginal Rhabdomyosarcoma,1
13001,Malignant Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
13002,High Mitotic Activity,Recurrent Childhood Anaplastic Oligoastrocytoma,1
13003,Childhood Lesion,Childhood Craniopharyngioma,1
13004,Epithelial Component Present,Adult Hepatocellular Carcinoma,1
13005,White blood cell count increased (lab result),"Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
13006,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
13007,High Mitotic Activity,undifferentiated sarcoma of ovary,1
13008,Metastatic Lesion,Lung squamous cell carcinoma stage IV,1
13009,Recurrent disease,Recurrent Ovarian Adenocarcinoma,1
13010,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor,1
13011,Malignant Cellular Infiltrate,Stage IIIA Lung Large Cell Carcinoma AJCC v7,1
13012,Non-Hereditary Lesion,Gastric Tubular Adenocarcinoma,1
13013,CD30-Positive Neoplastic Cells Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
13014,Malignant Cellular Infiltrate,Carcinoma ex Eccrine Spiradenoma,1
13015,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
13016,Epithelial Component Present,Low Grade Ductal Breast Carcinoma In Situ,1
13017,Malignant Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia,1
13018,Malignant Cellular Infiltrate,Recurrent Hepatosplenic T-Cell Lymphoma,1
13019,Carcinomatous Component Present,Bile duct cystadenocarcinoma,1
13020,Epithelial Component Present,Alcohol-Related Carcinoma,1
13021,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor,1
13022,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
13023,Poorly Differentiated Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma,1
13024,High Mitotic Activity,pleomorphic carcinoma of breast,1
13025,Childhood Lesion,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,1
13026,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage II Plasma Cell Myeloma,1
13027,Epithelial Component Present,Inflammatory carcinoma of breast recurrent,1
13028,Malignant Cellular Infiltrate,Bladder Papillary Urothelial Carcinoma,1
13029,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
13030,Cutaneous Involvement,Stage IB Cutaneous Melanoma AJCC v7,1
13031,Malignant Cellular Infiltrate,Stage IIB Merkel Cell Carcinoma AJCC v7,1
13032,Indolent Clinical Course,Scrotal Hemangioma,1
13033,Acanthosis,Upper Gingival Verrucous Carcinoma,1
13034,Polymorphic Cellular Infiltrate,"Post-transplant lymphoproliferative disorder, polymorphic",1
13035,Carcinomatous Component Present,Small cell lung cancer recurrent,1
13036,Malignant Germinomatous Cellular Infiltrate,Intracranial Germinoma,1
13037,Epithelial Component Present,Superficial basal cell carcinoma,1
13038,Benign Cellular Infiltrate,Benign Anal Granular Cell Tumor,1
13039,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
13040,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
13041,Benign Cellular Infiltrate,Benign neoplasm of the lip,1
13042,Epithelial Component Present,Stage I Oral Cavity Cancer AJCC v6 and v7,1
13043,Slow Growing Mass,Adult Brain Ependymoma,1
13044,Epithelial Component Present,Skin Papilloma,1
13045,Benign Cellular Infiltrate,Spindle cell lipoma,1
13046,Rhabdomyosarcomatous Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
13047,Malignant Cellular Infiltrate,AIDS-Related Hodgkin Lymphoma,1
13048,Malignant Cellular Infiltrate,Adenocarcinoma in tubulovillous adenoma,1
13049,Indolent Clinical Course,Angiomatosis,1
13050,Plexiform Growth Pattern,Gastric Plexiform Fibromyxoma,1
13051,Malignant Cellular Infiltrate,Abdominal Undifferentiated Pleomorphic Sarcoma,1
13052,Epithelial Component Present,Perihilar Intrahepatic Cholangiocarcinoma,1
13053,Carcinomatous Component Present,Adenosquamous carcinoma,1
13054,Malignant Cellular Infiltrate,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
13055,Congenital Lesion,Congenital anomaly of lens,1
13056,Well Differentiated Neuroendocrine Lesion,Gastrinoma,1
13057,Mucoid Stroma Formation,Rectosigmoid Mucinous Adenocarcinoma,1
13058,Neutral Epithelial Mucin Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
13059,Benign Cellular Infiltrate,Myofibroblastoma,1
13060,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
13061,Splenomegaly,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
13062,Fascicles of Spindly Tumor Cells Present,Tanycytic ependymoma,1
13063,Malignant Cellular Infiltrate,Leiomyosarcoma of uterus,1
13064,Myxoid Stroma Formation,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
13065,Malignant Cellular Infiltrate,acute biphenotypic leukemia in relapse,1
13066,Malignant Cellular Infiltrate,Paget disease of anal canal,1
13067,Papillary Pattern,papillary squamous cell carcinoma of larynx,1
13068,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
13069,Metastatic Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
13070,High Grade Lesion,Cardiac Synovial Sarcoma,1
13071,Absence of Stromal Invasion,Borderline serous tumor of ovary,1
13072,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
13073,Epithelial Component Present,"Glandular intraepithelial neoplasia, low grade",1
13074,Carcinomatous Component Present,Parotid Gland Adenocarcinoma,1
13075,Skin Ulcer,Epstein Barr virus positive mucocutaneous ulcer,1
13076,Papillary Pattern,Schneiderian papilloma,1
13077,Extensive Stage Lesion,Uveal Melanoma Metastatic in the Liver,1
13078,Organoid Pattern,Alveolar soft part sarcoma metastatic,1
13079,Diffuse Pattern,Stage I Diffuse Large B-Cell Lymphoma,1
13080,Locally Aggressive Lesion,Polymorphus Hemangioendothelioma,1
13081,Epithelial Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
13082,Malignant Cellular Infiltrate,Synchronous Multifocal Osteosarcoma,1
13083,Childhood Lesion,Recurrent Childhood Pilomyxoid Astrocytoma,1
13084,Epithelial Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma,1
13085,Epithelial Component Present,Sparsely Granulated Non-Functioning Corticotroph Adenoma,1
13086,Epithelial Component Present,Hereditary clear cell renal cell carcinoma,1
13087,Lobulated Growth Pattern,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,1
13088,Malignant Cellular Infiltrate,"Carcinoma, Signet Ring Cell",1
13089,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
13090,Epithelial Component Present,basaloid squamous cell carcinoma of floor of mouth,1
13091,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
13092,Metastatic/Recurrent Disease,Monophasic Synovial Sarcoma,1
13093,Malignant Cellular Infiltrate,Refractory Peripheral Primitive Neuroectodermal Tumor,1
13094,Mixed Cellular Population,Adenosarcoma of cervix uteri,1
13095,Carcinomatous Component Present,Stage IIIA Anal Canal Cancer AJCC v6 and v7,1
13096,Malignant Cellular Infiltrate,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
13097,Non-Invasive Lesion,Urethral Inverted Papilloma,1
13098,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Solid Pattern",1
13099,Epithelial Component Present,Rectosigmoid Mucinous Adenocarcinoma,1
13100,Slow Growing Mass,Third Ventricle Pilocytic Astrocytoma,1
13101,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v6,1
13102,Malignant Cellular Infiltrate,Adenosarcoma,1
13103,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage IV,1
13104,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,1
13105,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v7 Stage,1
13106,Adnexal Differentiation,Sebaceous Breast Carcinoma,1
13107,Recurrent disease,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
13108,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
13109,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma,1
13110,Microvascular Proliferation,MGMT-Methylated Glioblastoma,1
13111,Dysplasia,Colonic tubulovillous adenoma,1
13112,Metastatic Lesion,Metastatic Lip Squamous Cell Carcinoma,1
13113,Benign Cellular Infiltrate,Solitary Myofibromatosis,1
13114,Pseudorosette Formation,Gastric Gastrin-Producing Neuroendocrine Tumor,1
13115,Favorable Clinical Outcome,Urticaria Pigmentosa,1
13116,Benign Cellular Infiltrate,Frontal Sinus Inverted Papilloma,1
13117,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
13118,Dysplasia,Tubular adenoma,1
13119,Diffuse Pattern,Mesenchymal Glioblastoma,1
13120,Malignant Cellular Infiltrate,Giant Cell Glioblastoma,1
13121,Edematous Stroma Formation,Aggressive angiomyxoma,1
13122,Low Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
13123,Anaplasia,Anaplastic Oligodendroglioma,1
13124,Gyriform Trabecular Pattern,malignant gastrinoma of pancreas,1
13125,Systemic disease,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",1
13126,Malignant Cellular Infiltrate,Melanoma of Unknown Primary,1
13127,Hyalinized Stroma Formation,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
13128,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Pseudoglandular Variant",1
13129,Metastatic Lesion,Metastatic Adenoid Cystic Carcinoma,1
13130,Well-Circumscribed Lesion,Mediastinal Rhabdomyoma,1
13131,Malignant Cellular Infiltrate,Chronic leukemia (category),1
13132,Lobular Pattern,Sebaceous adenoma,1
13133,Cutaneous Involvement,Skin appendage adenoma,1
13134,Childhood Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
13135,Local disease,Pagetoid reticulosis,1
13136,Indolent Clinical Course,Cutaneous leiomyoma,1
13137,Epithelial Component Present,Lip and Oral Cavity Squamous Cell Carcinoma,1
13138,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v6 and v7,1
13139,Acinar Cell Differentiation,Acinic cell carcinoma of salivary gland,1
13140,Gyriform Trabecular Pattern,Gastrinoma,1
13141,Malignant Cellular Infiltrate,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
13142,Metastatic Lesion,Secondary malignant neoplasm of pleura,1
13143,Epithelial Component Present,Endometrial intraepithelial neoplasia,1
13144,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
13145,Carcinomatous Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v8,1
13146,Ground Glass Nuclear Inclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
13147,Exophytic Polypoid Lesion,Villous adenoma of duodenum,1
13148,Pseudopapillary Pattern,embryonal carcinoma of mediastinum,1
13149,Exophytic Papillary Lesion,Human Papillomavirus-Related Verrucous Carcinoma,1
13150,Indolent Clinical Course,Lipoma of pleura,1
13151,Benign Cellular Infiltrate,Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm,1
13152,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7,1
13153,Well-Circumscribed Lesion,"Cystadenoma, Papillary",1
13154,Indolent Clinical Course,"Histiocytoma, Benign Fibrous",1
13155,Absence of Stromal Invasion,Borderline Ovarian Mucinous Tumor,1
13156,Malignant Cellular Infiltrate,adenocarcinoma of renal pelvis,1
13157,Lobulated Growth Pattern,Clivus Chondroid Chordoma,1
13158,Carcinomatous Component Present,Stage IVB Rectal Cancer AJCC v8,1
13159,Carcinomatous Component Present,Adenoid basal carcinoma of cervix uteri,1
13160,Papillary Pattern,Papillary tumor of the pineal region,1
13161,Dysplasia,Gardner Syndrome,1
13162,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
13163,Epithelial Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
13164,Epithelial Component Present,Gallbladder adenosquamous carcinoma,1
13165,Carcinomatous Component Present,FIGO Stage III Carcinoma of the Fallopian Tube,1
13166,Malignant Cellular Infiltrate,Renal Cell Carcinoma,1
13167,Multilayered Rosette Formation,Ependymoblastoma,1
13168,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
13169,Epithelial Component Present,"Endometrioid adenoma, borderline malignancy",1
13170,Dilated Vascular Space Formation,Glomangioma,1
13171,Cutaneous Involvement,Recurrent Nevus,1
13172,Benign Cellular Infiltrate,Cardiac Lipoma,1
13173,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
13174,Myxoid Stroma Formation,Ovarian Myxoid Liposarcoma,1
13175,Malignant Cellular Infiltrate,Malignant neoplasm of glottis,1
13176,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
13177,Recurrent disease,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
13178,Carcinomatous Component Present,Metastatic Bladder Small Cell Carcinoma,1
13179,Metastatic Lesion,Vaginal adenocarcinoma metastatic,1
13180,Indolent Clinical Course,Primary cutaneous acral CD8 positive T-cell lymphoma,1
13181,Benign Cellular Infiltrate,Leiomyomatosis,1
13182,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
13183,Refractory Disease,Nodal marginal zone B-cell lymphoma refractory,1
13184,Refractory Disease,Refractory Breast Lymphoma,1
13185,Nodular Pattern,Recurrent Follicular Lymphoma,1
13186,Biphasic Pattern,Adenosarcoma,1
13187,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
13188,Carcinomatous Component Present,Clinical Stage I Gastric Cancer AJCC v8,1
13189,Recurrent disease,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
13190,Adnexal Differentiation,Benign Eccrine Neoplasm,1
13191,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
13192,Multilocular Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
13193,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
13194,Vascular Channel Formation,Angiosarcoma of liver,1
13195,Carcinomatous Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
13196,atypia morphology,Liver Dysplastic Nodule,1
13197,Juvenile Lesion,Scheuermann's Disease,1
13198,Necrotic changes (finding),malignant peripheral nerve sheath tumor (MPNST) of mediastinum,1
13199,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6,1
13200,Slow Growing Mass,Ependymoma,1
13201,Locally Aggressive Lesion,"Fibromatosis, Abdominal",1
13202,Epithelial Component Present,lipid-rich carcinoma of breast,1
13203,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
13204,Villous Pattern,Colorectal Tubulovillous Adenoma,1
13205,Mucinous degeneration,Recurrent Childhood Protoplasmic Astrocytoma,1
13206,Crystal deposition,Alveolar soft part sarcoma recurrent,1
13207,Epithelial Component Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
13208,Benign Cellular Infiltrate,Subglottic Hemangioma,1
13209,Epithelial Component Present,Inverted urothelial papilloma,1
13210,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans,1
13211,Malignant Cellular Infiltrate,Refractory anaemia with excess blasts,1
13212,Antoni A Pattern,Benign Bone Schwannoma,1
13213,Exophytic Polypoid Lesion,Colorectal Tubulovillous Adenoma,1
13214,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
13215,Dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
13216,Malignant Cellular Infiltrate,Adrenal neuroblastoma,1
13217,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma,1
13218,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v6,1
13219,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
13220,CD56-Positive Neoplastic Cells Present,"NK-Cell Lymphoma, Unclassifiable",1
13221,Adulthood Lesion,Adult Subependymoma,1
13222,Epithelial Component Present,Bladder Urothelial Carcinoma in Situ,1
13223,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Cancer AJCC v8,1
13224,Neuroendocrine Differentiation,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
13225,Malignant Cellular Infiltrate,Unresectable Osteosarcoma,1
13226,Local disease,Angiolipoma,1
13227,Recurrent disease,recurrent childhood acute myeloid leukemia,1
13228,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma,1
13229,Mitotic Activity,Adult Anaplastic Astrocytoma,1
13230,Adnexal Differentiation,Malignant Vulvar Sweat Gland Neoplasm,1
13231,Refractory Disease,Refractory Spindle Cell Sarcoma,1
13232,Keratin pearl formation,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
13233,Adulthood Lesion,Adult Grade I Meningioma,1
13234,Dysplasia,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
13235,Epithelial Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma,1
13236,Intraductal Lesion,Peripheral Breast Papilloma,1
13237,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
13238,Malignant Cellular Infiltrate,Stage I Bone Cancer AJCC v7,1
13239,Malignant Cellular Infiltrate,Mediastinal Mixed Germ Cell Tumor,1
13240,Skin nodule,Proliferative dermal lesion in congenital nevus,1
13241,Epithelial Component Present,Small Intestinal Low Grade Intraepithelial Neoplasia,1
13242,Thick-Walled Hyalinized Vessels Present,Schwannoma of the Twelfth Cranial Nerve,1
13243,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v6 and v7,1
13244,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
13245,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
13246,Therapy-Related Toxicity,Transplant-Related Skin Squamous Cell Carcinoma,1
13247,Epithelial Component Present,Benign squamous cell tumor,1
13248,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
13249,Malignant Cellular Infiltrate,AIDS-Related Primary Effusion Lymphoma,1
13250,In Situ Lesion,Stage 0 Pharynx Carcinoma,1
13251,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
13252,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
13253,Epithelial Component Present,Condyloma acuminata of vagina,1
13254,Dysplasia,Grade II Penile Intraepithelial Neoplasia,1
13255,Secondary Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
13256,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
13257,Malignant Cellular Infiltrate,Epithelioid Cell Uveal Melanoma,1
13258,Severe cytologic atypia,Gastric Neuroendocrine Carcinoma,1
13259,Epithelial Component Present,Stage 0 Appendix Carcinoma AJCC v7,1
13260,Malignant Cellular Infiltrate,Adult Brain Stem Gliosarcoma,1
13261,Stromal Invasion,FIGO Stage III Ovarian Cancer,1
13262,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter,1
13263,Malignant Cellular Infiltrate,Acute panmyelosis with myelofibrosis,1
13264,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v8,1
13265,Perivascular Arrangement of Tumor Cells,Sclerosing PEComa,1
13266,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
13267,Primary Lesion,Recurrent Childhood Rhabdomyosarcoma,1
13268,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
13269,Secondary Lesion,Locally Advanced Chordoma,1
13270,Mass of body structure,"Sarcoma, Myeloid",1
13271,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage I,1
13272,Superficial Lesion,Atypical Lipoma,1
13273,Epithelial Component Present,Stage III Ureter Cancer AJCC v8,1
13274,Epithelial Component Present,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
13275,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
13276,Epithelial Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
13277,Nodular Pattern,Eccrine acrospiroma,1
13278,Malignant Cellular Infiltrate,Stage II Cervical Cancer AJCC v6,1
13279,Benign Cellular Infiltrate,Calcifying Fibrous Pseudotumor,1
13280,Epithelial Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
13281,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
13282,Metaplasia,Metaplastic carcinoma,1
13283,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
13284,Malignant Cellular Infiltrate,Stage I Adult Lymphoblastic Lymphoma,1
13285,Extensive Stage Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
13286,Mild cytologic atypia,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,1
13287,Neuroendocrine Differentiation,Gastric Gastrin-Producing Neuroendocrine Tumor,1
13288,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
13289,Carcinomatous Component Present,Occult Lung Adenosquamous Carcinoma,1
13290,Malignant Cellular Infiltrate,Lung squamous cell carcinoma recurrent,1
13291,Benign Cellular Infiltrate,Cardiac Lipoma,1
13292,Malignant Cellular Infiltrate,Follicular T-cell lymphoma,1
13293,Malignant Cellular Infiltrate,Chest Wall Solitary Plasmacytoma,1
13294,Severe cytologic atypia,Gastric Large Cell Neuroendocrine Carcinoma,1
13295,Carcinomatous Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
13296,Thick-Walled Hyalinized Vessels Present,Sympathetic Schwannoma,1
13297,Benign Cellular Infiltrate,Endometrial Polyp,1
13298,Carcinomatous Component Present,Pancreatic Endocrine Carcinoma,1
13299,Epithelial Component Present,Metastatic Bile Duct Carcinoma,1
13300,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of parotid gland,1
13301,Exophytic Polypoid Lesion,"Polyposis, Gastric",1
13302,Epithelial Component Present,Low Grade Gastric Intraepithelial Neoplasia,1
13303,Malignant Cellular Infiltrate,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
13304,Malignant Cellular Infiltrate,Stage I Adult Non-Hodgkin Lymphoma,1
13305,In Situ Lesion,"Urinary bladder carcinoma stage I, with cancer in situ",1
13306,Malignant Cellular Infiltrate,"Synovial sarcoma, biphasic",1
13307,Extraosseous Lesion,Extra-osseous Ewing's sarcoma non-metastatic,1
13308,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
13309,Neuroendocrine Differentiation,Intestinal Neuroendocrine Tumor G2,1
13310,Papillary Pattern,Peritoneal Well Differentiated Papillary Mesothelioma,1
13311,Non-Invasive Lesion,Renal Pelvis Urothelial Papilloma,1
13312,Malignant Cellular Infiltrate,Major Salivary Gland Adenoid Cystic Carcinoma,1
13313,Biphasic Pattern,Breast Fibroepithelial Neoplasm,1
13314,Human Papillomavirus Negative,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
13315,Carcinomatous Component Present,Stage IVC Lip Cancer AJCC v6 and v7,1
13316,Solitary mass,Chest Wall Solitary Plasmacytoma,1
13317,Carcinomatous Component Present,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
13318,Malignant Cellular Infiltrate,Esophageal Neuroendocrine Carcinoma,1
13319,Carcinomatous Component Present,Recurrent Female Reproductive System Carcinoma,1
13320,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by Gene Expression Profile,1
13321,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
13322,Carcinomatous Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
13323,Epithelial Component Present,Pericanalicular fibroadenoma,1
13324,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1,1
13325,Biphasic Pattern,Third Ventricle Pilocytic Astrocytoma,1
13326,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage I,1
13327,Infiltrative Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma,1
13328,Recurrent disease,Recurrent Pancreatic Ductal Adenocarcinoma,1
13329,Tubular Structures Present,Ovarian Sertoli Cell Tumor,1
13330,Malignant Cellular Infiltrate,Peripheral Intraneural Angiosarcoma,1
13331,Hyperplastic Tissue Present,Papillary Urothelial Hyperplasia,1
13332,Malignant Cellular Infiltrate,Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8,1
13333,Malignant Cellular Infiltrate,Soft Tissue Angiosarcoma,1
13334,Carcinomatous Component Present,Cystadenocarcinoma,1
13335,Malignant Cellular Infiltrate,Glandular malignant peripheral nerve sheath tumor,1
13336,Nuclear Atypia,Recurrent Childhood Anaplastic Oligoastrocytoma,1
13337,Immunologic Deficiency Syndromes,Transplant-Related Hematologic Malignancy,1
13338,Malignant Cellular Infiltrate,Marginal zone lymphoma stage III,1
13339,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v8,1
13340,Well-Circumscribed Lesion,Anal Canal Squamous Papilloma,1
13341,Malignant Cellular Infiltrate,"Carcinoma, Large Cell",1
13342,Epithelial Component Present,Bladder Papillary Urothelial Neoplasm,1
13343,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
13344,Malignant Cellular Infiltrate,Fibroblastic reticular cell tumor,1
13345,Malignant Cellular Infiltrate,Unresectable Renal Cell Carcinoma,1
13346,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
13347,Mixed Cellular Population,Adenomyoma,1
13348,Slow Growing Mass,Plexiform fibrohistiocytic tumor,1
13349,Recurrent Genetic Abnormalities Present,Acute Promyelocytic Leukemia,1
13350,Malignant Cellular Infiltrate,Advanced Kaposi Sarcoma,1
13351,Biphasic Pattern,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
13352,CD30-Positive Neoplastic Cells Present,Adult Anaplastic Large Cell Lymphoma,1
13353,Malignant Cellular Infiltrate,Nasopharyngeal Differentiated Carcinoma,1
13354,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myelomonocytic Leukemia,1
13355,Dysplasia,Carcinoma in situ of prostate,1
13356,Epithelial Component Present,Acinar cell adenoma,1
13357,Invasive Lesion,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
13358,Epithelial Component Present,Stage IV Rectal Cancer AJCC v8,1
13359,Malignant Cellular Infiltrate,"Hodgkin lymphoma, lymphocyte depletion",1
13360,CD30-Positive Neoplastic Cells Present,Adult Anaplastic Large Cell Lymphoma,1
13361,Vascular Channel Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
13362,Recurrent disease,Recurrent Bone Ewing Sarcoma,1
13363,Malignant Cellular Infiltrate,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
13364,Epithelial Component Present,Urethral Urothelial Papilloma,1
13365,Malignant Cellular Infiltrate,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,1
13366,Necrotic changes (finding),Refractory Lung Small Cell Carcinoma,1
13367,Malignant Cellular Infiltrate,B-cell lymphoma recurrent,1
13368,Pancytopenia,Acute panmyelosis with myelofibrosis,1
13369,Carcinomatous Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
13370,Tissue of Mullerian Origin Present,Adenosarcoma of cervix uteri,1
13371,Carcinomatous Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
13372,Benign Cellular Infiltrate,Fetal rhabdomyoma,1
13373,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7,1
13374,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis,1
13375,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v6,1
13376,Dysplasia,Colon adenoma,1
13377,Epithelial Component Present,Major Salivary Gland Adenocarcinoma,1
13378,Metastatic Lesion,Advanced Adult Hepatocellular Carcinoma,1
13379,CD56-Positive Neoplastic Cells Present,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
13380,Carcinomatous Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
13381,Malignant Cellular Infiltrate,"Liposarcoma, well differentiated",1
13382,Cutaneous Involvement,Outer Hair Sheath and Infundibulum Neoplasm,1
13383,Myxoid Stroma Formation,Fibromyxosarcoma,1
13384,Malignant Cellular Infiltrate,Primary central nervous system lymphoma,1
13385,Metaplasia,Squamous Lung Dysplasia,1
13386,Malignant Cellular Infiltrate,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
13387,Secondary Lesion,Metachronous Osteosarcoma,1
13388,Malignant Cellular Infiltrate,Platinum-Resistant Fallopian Tube Carcinoma,1
13389,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
13390,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,1
13391,Dysplasia,Small Intestinal Tubular Adenoma,1
13392,Carcinomatous Component Present,Refractory Lung Non-Small Cell Carcinoma,1
13393,Carcinomatous Component Present,Stage I Carcinoma of Bladder,1
13394,Mixed Cellular Population,Vulvar Ectopic Fibroadenoma,1
13395,Epithelial Component Present,Mucin-producing adenocarcinoma,1
13396,Metastatic Lesion,Metastatic Neoplasm,1
13397,Epithelial Component Present,Cerebellar Paraganglioma,1
13398,Malignant Cellular Infiltrate,Posterior Tongue Mucoepidermoid Carcinoma,1
13399,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v6 Stage,1
13400,Epithelial Component Present,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,1
13401,Well Differentiated Neuroendocrine Lesion,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,1
13402,Malignant Cellular Infiltrate,Stage II Lung Cancer AJCC v7,1
13403,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage III,1
13404,Carcinomatous Component Present,Childhood Colorectal Carcinoma,1
13405,Malignant Cellular Infiltrate,AJCC Grade 2 Sarcoma,1
13406,Hemorrhagic,Metastatic angiosarcoma,1
13407,Epithelial Component Present,Stage IIB Lung Cancer AJCC v7,1
13408,Carcinomatous Component Present,Adenocarcinoid tumor,1
13409,High Mitotic Activity,Testicular embryonal carcinoma stage III,1
13410,Malignant Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
13411,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
13412,Monomorphic Cellular Infiltrate,Adult Ependymoma,1
13413,Epithelial Component Present,Gallbladder Carcinoma,1
13414,Therapy-Related Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
13415,Mixed Cellular Population,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
13416,Benign Cellular Infiltrate,Atypical Breast Papilloma,1
13417,Cutaneous Involvement,Deep seated dermatophytosis,1
13418,Carcinomatous Component Present,Solid Lung Adenocarcinoma,1
13419,Epithelial Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
13420,High Mitotic Activity,Malignant tenosynovial giant cell tumor,1
13421,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
13422,Malignant Cellular Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v6 and v7,1
13423,Malignant Cellular Infiltrate,Unresectable Lymphoma,1
13424,Myxoid Stroma Formation,Cardiac Epithelioid Hemangioendothelioma,1
13425,Carcinomatous Component Present,Refractory Gastric Carcinoma,1
13426,Malignant Cellular Infiltrate,Stage IB Pancreatic Cancer AJCC v8,1
13427,Primary Site Unknown,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
13428,Epithelial Component Present,Refractory Endometrial Carcinoma,1
13429,Epithelial Component Present,Lower Gingival Verrucous Carcinoma,1
13430,High Grade Lesion,Stage IA Lung Small Cell Carcinoma AJCC v7,1
13431,Malignant Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma,1
13432,Epithelial Component Present,Choroid Plexus Papilloma,1
13433,Exophytic Polypoid Lesion,tubular adenoma of stomach,1
13434,Cutaneous Involvement,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
13435,Apocrine Differentiation,Apocrine Breast Carcinoma In Situ,1
13436,Glandular Pattern,intestinal type adenocarcinoma of gallbladder,1
13437,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7,1
13438,Well Differentiated Neuroendocrine Lesion,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
13439,Infiltrative Growth Pattern,Adult Giant Cell Glioblastoma,1
13440,Invasive Lesion,Adenocarcinoma of the prostate stage II,1
13441,Malignant Cellular Infiltrate,Childhood Periosteal Osteosarcoma,1
13442,Indolent Clinical Course,mediastinal lipomatosis,1
13443,Epithelial Component Present,Stage IV Urethral Cancer AJCC v8,1
13444,Nodular lesions,Giant Cell Tumor of Soft Tissue,1
13445,Exanthema,Rothmund-Thomson syndrome,1
13446,Recurrent disease,Recurrent Digestive System Carcinoma,1
13447,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
13448,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage IV,1
13449,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v8,1
13450,High Grade Lesion,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
13451,Mucoid Stroma Formation,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
13452,Indolent Clinical Course,Benign neoplasm of spleen,1
13453,Epithelial Component Present,Ovarian mixed epithelial carcinoma,1
13454,Epithelial Component Present,Malignant tumor of choroid plexus,1
13455,Recurrent disease,Recurrent Parotid Gland Squamous Cell Carcinoma,1
13456,Invasive Lesion,Breast Carcinoma with Osseous Metaplasia,1
13457,Indolent Clinical Course,Benign Soft Tissue Tumor of Uncertain Differentiation,1
13458,Exposure to asbestos,Asbestos-Related Malignant Mesothelioma,1
13459,Recurrent disease,Recurrent Chronic Lymphoid Leukemia,1
13460,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
13461,Hyperkeratosis,Human Papillomavirus-Related Verrucous Carcinoma,1
13462,High Mitotic Activity,Childhood Anaplastic Oligoastrocytoma,1
13463,Fibrotic Stroma Formation,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
13464,Pseudoalveolar Pattern,Alveolar soft part sarcoma metastatic,1
13465,Monomorphic Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma,1
13466,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v8,1
13467,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
13468,Diffuse Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
13469,Chronic lymphocytic inflammation,Adenolymphoma,1
13470,Malignant Cellular Infiltrate,Squamous cell carcinoma of buccal mucosa,1
13471,Carcinomatous Component Present,Medullary carcinoma of breast,1
13472,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Neoplasm,1
13473,Mild cytologic atypia,Anal Verrucous Carcinoma,1
13474,Carcinomatous Component Present,Stage IV Rectosigmoid Cancer AJCC v7,1
13475,Malignant Cellular Infiltrate,Cervix carcinoma,1
13476,Low Grade Lesion,malignant epithelioid hemangioendothelioma of liver,1
13477,Extensive Stage Lesion,Advanced Melanoma,1
13478,Epithelial Component Present,Stage I Fallopian Tube Cancer,1
13479,Pathologic TNM Finding,Pathologic Stage IA Gastric Cancer AJCC v8,1
13480,Sarcomatous Component Present,Uterine Carcinosarcoma,1
13481,Epithelial Component Present,Cervical Adenoid Cystic Carcinoma,1
13482,Malignant Cellular Infiltrate,Stage IV Childhood Anaplastic Large Cell Lymphoma,1
13483,Cutaneous Involvement,Mycosis Fungoides by AJCC v7 Stage,1
13484,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
13485,Malignant Cellular Infiltrate,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,1
13486,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
13487,Primary Lesion,"Brain Stem Neoplasms, Primary",1
13488,Epithelial Component Present,Multicentric Breast Carcinoma,1
13489,Benign Cellular Infiltrate,Uterine Corpus Cellular Leiomyoma,1
13490,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7,1
13491,Carcinomatous Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
13492,Well Differentiated Neuroendocrine Lesion,Stage I Rectal Neuroendocrine Tumor AJCC v8,1
13493,Epithelial Component Present,Lung Carcinoma Metastatic in the Brain,1
13494,Epithelial Component Present,Non-small cell lung cancer stage IIIB,1
13495,Malignant Cellular Infiltrate,Rectal Lymphoma,1
13496,Malignant Cellular Infiltrate,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
13497,Epithelial Component Present,Vaginal Papillary Carcinoma,1
13498,Plexiform Vasculature Present,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
13499,Refractory Disease,Refractory B-Cell Prolymphocytic Leukemia,1
13500,Malignant Cellular Infiltrate,Adenocarcinoma of Accessory Sinus,1
13501,Malignant Cellular Infiltrate,Carcinoma of supraglottis,1
13502,Malignant Cellular Infiltrate,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
13503,Slow Growing Mass,Acral Fibromyxoma,1
13504,Epithelial Component Present,Stage II Vulvar Cancer AJCC v7,1
13505,Recurrent disease,Hodgkin's disease nodular sclerosis recurrent,1
13506,Malignant Cellular Infiltrate,Malignant tumor of palate,1
13507,Malignant Cellular Infiltrate,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
13508,Childhood Lesion,Childhood Ganglioglioma,1
13509,Carcinomatous Component Present,Alcohol-Related Carcinoma,1
13510,Epithelial Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
13511,Epithelial Component Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma,1
13512,Indolent Clinical Course,leiomyoma of extrahepatic bile duct,1
13513,Carcinomatous Component Present,Advanced Small Intestinal Neuroendocrine Carcinoma,1
13514,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
13515,Osseous Differentiation,Extraskeletal Osteosarcoma,1
13516,Geographic Necrosis,Central Nervous System Embryonal Carcinoma,1
13517,Calcinosis,"Ossifying fibromyxoid tumor, malignant",1
13518,Absence of Invasion,Stage 0 Colorectal Cancer AJCC v8,1
13519,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v8,1
13520,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Seminoma,1
13521,Adulthood Lesion,Adult Papillary Meningioma,1
13522,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v7 Stage,1
13523,Malignant Cellular Infiltrate,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
13524,Malignant Cellular Infiltrate,Uterine Ligament Adenosarcoma,1
13525,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
13526,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
13527,Neuroendocrine Differentiation,Metastatic Breast Carcinoid Tumor,1
13528,Malignant Cellular Infiltrate,Adult Epithelioid Sarcoma,1
13529,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7,1
13530,High Grade Lesion,Adult Pleomorphic Rhabdomyosarcoma,1
13531,Chromogranin A Positive Neoplastic Cells Present,Laryngeal Carcinoid Tumor,1
13532,Malignant Cellular Infiltrate,Endometrial Dedifferentiated Carcinoma,1
13533,Diffuse Lesion,Lymphangitis carcinomatosa,1
13534,Basal Cells with Pale Cytoplasm Present,"Acanthoma, Clear Cell",1
13535,Epithelial Component Present,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
13536,Primary Lesion,Primary Peritoneal Serous Adenocarcinoma,1
13537,Serotonin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
13538,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
13539,Benign Cellular Infiltrate,"Nevus, Intradermal",1
13540,Primary Lesion,Astrocytoma of brain,1
13541,Malignant Cellular Infiltrate,Locally Advanced Sarcoma,1
13542,Malignant Cellular Infiltrate,Refractory Oropharyngeal Squamous Cell Carcinoma,1
13543,Mixed Cellular Population,Recurrent Childhood Anaplastic Oligoastrocytoma,1
13544,Epithelial Component Present,Bile Duct Biliary Intraepithelial Neoplasia,1
13545,Nodular Pattern,Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage,1
13546,Epithelial Component Present,Metastatic Colorectal Carcinoma,1
13547,Epithelial Component Present,Refractory Uterine Corpus Carcinosarcoma,1
13548,Malignant Cellular Infiltrate,Stage IIIa Penile Cancer AJCC v7,1
13549,Therapy-Related Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
13550,Hereditary Lesion,Hereditary Leiomyomatosis and Renal Cell Cancer,1
13551,Malignant Cellular Infiltrate,Spindle Cell Type A Uveal Melanoma,1
13552,Epithelial Component Present,Endometrial Mucinous Adenocarcinoma,1
13553,Hemorrhagic,Radiation-Related Angiosarcoma,1
13554,Epithelial Component Present,Lip and Oral Cavity Carcinoma,1
13555,Absence of Invasion,Stage 0is Bladder Cancer AJCC v8,1
13556,High Mitotic Activity,large cell neuroendocrine carcinoma of bladder,1
13557,Malignant Cellular Infiltrate,"Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2",1
13558,Edematous Stroma Formation,Spermatocytic seminoma,1
13559,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
13560,Childhood Lesion,Childhood Subependymal Giant Cell Astrocytoma,1
13561,Severe dysplasia,"Glandular intraepithelial neoplasia, grade III",1
13562,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
13563,Pseudoglandular Pattern,Moderately Differentiated Hepatocellular Carcinoma,1
13564,Solitary mass,Epithelioid hemangioendothelioma of lung,1
13565,Adulthood Lesion,Stage IV Adult Lymphoblastic Lymphoma,1
13566,Malignant Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v8,1
13567,Malignant Cellular Infiltrate,Pediatric Intraocular Retinoblastoma,1
13568,Cutaneous Involvement,"Carcinoma, Skin Appendage",1
13569,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
13570,Refractory Disease,Refractory Malignant Endocrine Neoplasm,1
13571,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma,1
13572,Malignant Cellular Infiltrate,Stage 0 Pharynx Carcinoma,1
13573,Epithelial Component Present,Stage III Breast Cancer AJCC v6,1
13574,Absence of Invasion,Cervical Squamous Cell Carcinoma In Situ,1
13575,Recurrent disease,Penis carcinoma recurrent,1
13576,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth,1
13577,Carcinomatous Component Present,undifferentiated carcinoma of cervix,1
13578,Hyperkeratosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
13579,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma,1
13580,Carcinomatous Component Present,Transplant-Related Hepatocellular Carcinoma,1
13581,Severe dysplasia,Stage 0 Vaginal Cancer AJCC v7,1
13582,Epithelial Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
13583,Epithelial Component Present,High Grade Glandular Intraepithelial Neoplasia,1
13584,Non-Hereditary Lesion,Vulvar Acquired Melanocytic Nevus,1
13585,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
13586,Metastatic/Recurrent Disease,Refractory Desmoplastic Small Round Cell Tumor,1
13587,Drug toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
13588,Extensive Stage Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
13589,Malignant Cellular Infiltrate,Small intestine adenocarcinoma metastatic NOS,1
13590,Carcinomatous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
13591,Papulovesicular Lesion,Hydroa vacciniforme-like lymphoma,1
13592,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
13593,Nuclear pleomorphism,Fibromyxosarcoma,1
13594,Carcinomatous Component Present,Stage IIB Rectal Cancer AJCC v7,1
13595,Secondary Lesion,Secondary malignant neoplasm of ciliary body,1
13596,Pre-existing condition,Myeloid Neoplasms with Germline GATA2 Mutation,1
13597,Chronic Inflammatory Infiltrate,Dysgerminoma,1
13598,Diffuse Pattern,Childhood Cerebral Diffuse Astrocytoma,1
13599,Cementum Formation,Ossifying Fibroma,1
13600,Epithelial Component Present,Unresectable Digestive System Neuroendocrine Carcinoma,1
13601,Papillary Pattern,Upper Gingival Verrucous Carcinoma,1
13602,Epithelial Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
13603,Cribriform Pattern,Colon Cribriform Comedo-Type Adenocarcinoma,1
13604,Epithelial Component Present,Pilomatrixoma,1
13605,Epithelial Component Present,FIGO Stage IIIB Ovarian Cancer,1
13606,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
13607,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,1
13608,Pregnancy Complications,Stage IA Gestational Trophoblastic Tumor AJCC v7,1
13609,Carcinomatous Component Present,Small intestine carcinoma stage I,1
13610,Mesenchymal Component Present,"Neoplasms, Fibroepithelial",1
13611,Benign Cellular Infiltrate,Squamous Papilloma of the Larynx,1
13612,Recurrent disease,Recurrent Hairy Cell Leukemia,1
13613,Secondary Lesion,Secondary malignant neoplasm of vertebral column,1
13614,Hereditary Lesion,TUBEROUS SCLEROSIS 2 (disorder),1
13615,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm,1
13616,Skin nodule,Proliferative dermal lesion in congenital nevus,1
13617,Malignant Cellular Infiltrate,Low Grade Endometrial Stromal Sarcoma,1
13618,Storiform Growth Pattern,Refractory Undifferentiated Pleomorphic Sarcoma,1
13619,Primary Lesion,Gastric T-Cell Non-Hodgkin Lymphoma,1
13620,Refractory Disease,Refractory Mixed Phenotype Acute Leukemia,1
13621,Carcinomatous Component Present,Recurrent Lung Carcinoma Cell Type Unspecified,1
13622,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(5;17)(q35;q21),1
13623,Malignant Cellular Infiltrate,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
13624,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
13625,Endophytic Tumor Growth,Inverted papilloma of urinary bladder,1
13626,Epithelial Component Present,Squamous Cell Neoplasms,1
13627,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage II,1
13628,Cysts Containing Proteinaceous Fluid Present,Broad Ligament Serous Cystadenoma,1
13629,Benign Cellular Infiltrate,fibroma of testis,1
13630,Hemosiderin pigmentation,Hemosiderotic Fibrolipomatous Tumor,1
13631,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
13632,Indolent Clinical Course,Lipoma of pleura,1
13633,Villous Pattern,Cecum Villous Adenoma,1
13634,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Testicular Immature Teratoma,1
13635,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v6 and v7,1
13636,Malignant Cellular Infiltrate,basaloid carcinoma of penis,1
13637,Vascular Channel Formation,Kaposi Sarcoma NCI Grade 2,1
13638,Epithelial Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma,1
13639,Neuroendocrine Differentiation,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
13640,Malignant Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia,1
13641,Recurrent disease,Recurrent Paraganglioma,1
13642,Mild dysplasia,Low Grade Cervical Squamous Intraepithelial Neoplasia,1
13643,Childhood Lesion,Stage IV Childhood Non-Hodgkin Lymphoma,1
13644,Epithelial Component Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia,1
13645,Exophytic Papillary Lesion,Glottis Verrucous Carcinoma,1
13646,Mesenchymal Component Present,Intracanalicular fibroadenoma,1
13647,Carcinomatous Component Present,Stage III Merkel Cell Carcinoma AJCC v7,1
13648,Unresectable Mass,Unresectable Pancreatic Neuroendocrine Carcinoma,1
13649,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
13650,Well-Circumscribed Lesion,Hibernoma,1
13651,Non-Invasive Lesion,Stage 0is Renal Pelvis Cancer AJCC v8,1
13652,Necrotic changes (finding),Bartholin Gland Small Cell Carcinoma,1
13653,Refractory Disease,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
13654,Epithelial Component Present,undifferentiated carcinoma of appendix,1
13655,Malignant Cellular Infiltrate,Adenocarcinofibroma,1
13656,Pregnancy Complications,"Pregnancy, Abdominal",1
13657,Recurrent disease,Recurrent B-Cell Prolymphocytic Leukemia,1
13658,Lymphadenopathy,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
13659,Malignant Cellular Infiltrate,Childhood Grade III Meningioma,1
13660,HMB-45-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
13661,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v8,1
13662,Follicular Cell Differentiation,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
13663,Malignant Cellular Infiltrate,Scirrhous carcinoma of breast,1
13664,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
13665,High Mitotic Activity,High Grade Ovarian Serous Adenocarcinoma,1
13666,Carcinomatous Component Present,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
13667,Severe cytologic atypia,Gastroesophageal Junction Neuroendocrine Carcinoma,1
13668,Perivascular fibrosis,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
13669,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
13670,Immunologic Deficiency Syndromes,AIDS-related anal cancer recurrent,1
13671,Carcinomatous Component Present,Stage IC Ovarian Cancer AJCC v6 and v7,1
13672,Monomorphic Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
13673,Benign Cellular Infiltrate,Odontogenic myxofibroma,1
13674,Epithelial Component Present,Warty dyskeratoma,1
13675,Epithelial Component Present,Vaginal Undifferentiated Carcinoma,1
13676,Nuclear Atypia,Recurrent Childhood Anaplastic Oligoastrocytoma,1
13677,Malignant Cellular Infiltrate,Fetal Lung Adenocarcinoma,1
13678,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Solid Teratoma,1
13679,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma,1
13680,Fibrosis,Primary mediastinal large B-cell lymphoma refractory,1
13681,Childhood Lesion,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,1
13682,Metaplasia,Refractory Barrett Esophagus,1
13683,Pain,mesenchymal chondrosarcoma of bone,1
13684,Malignant Cellular Infiltrate,Secondary Central Chondrosarcoma,1
13685,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage III,1
13686,Neuroectodermal Differentiation,Refractory Neuroblastoma,1
13687,Carcinomatous Component Present,"Adenocarcinoma of lung, stage III",1
13688,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor,1
13689,Nuclear Atypia,Childhood Brain Stem Gliosarcoma,1
13690,Carcinomatous Component Present,Pancreatic carcinoma recurrent,1
13691,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
13692,Epithelial Component Present,Hard Palate Mucoepidermoid Carcinoma,1
13693,Epithelial Component Present,Hormone refractory breast cancer,1
13694,Malignant Cellular Infiltrate,Non-small cell carcinoma,1
13695,Anaplasia,Recurrent Gliosarcoma,1
13696,Refractory Disease,Refractory T-Cell Prolymphocytic Leukemia,1
13697,Malignant Cellular Infiltrate,Secondary malignant neoplasm of small intestine,1
13698,Epithelial Component Present,Stage II Ovarian Cancer AJCC v8,1
13699,Well Differentiated Neuroendocrine Lesion,Gastric Gastrin-Producing Neuroendocrine Tumor,1
13700,Mitotic Activity,Pilomyxoid astrocytoma,1
13701,Malignant Cellular Infiltrate,Childhood Salivary Gland Carcinoma,1
13702,Epithelial Component Present,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
13703,Epithelial Component Present,Vestibular Papilloma,1
13704,Necrotic changes (finding),Diencephalic Glioblastoma,1
13705,Carcinomatous Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
13706,Epithelial Component Present,hepatoid adenocarcinoma of gallbladder,1
13707,Papillary Pattern,sialadenoma papilliferum of salivary gland,1
13708,Nuclear Grooves,Recurrent Thyroid Gland Papillary Carcinoma,1
13709,Childhood Lesion,Childhood Malignant Liver Neoplasm,1
13710,Epithelial Component Present,Adenoid cystic carcinoma of the oral cavity stage IV,1
13711,Severe dysplasia,solid type ductal carcinoma in situ of breast,1
13712,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
13713,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
13714,Epithelial Component Present,Papillary mucinous cystadenoma,1
13715,Epithelial Component Present,Skin Pseudovascular Squamous Cell Carcinoma,1
13716,Malignant Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma,1
13717,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage,1
13718,Aggressive Clinical Course,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",1
13719,Perivascular Arrangement of Tumor Cells,Malignant Lung PEComa,1
13720,Malignant Cellular Infiltrate,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
13721,Tissue of Mullerian Origin Present,Carcinosarcoma of ovary,1
13722,Malignant Cellular Infiltrate,Leukemic infiltration of skin,1
13723,Capillary Sized Vascular Channel Formation,Tufted angioma of skin,1
13724,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
13725,Benign Cellular Infiltrate,Adrenal Gland Schwannoma,1
13726,Malignant Cellular Infiltrate,Malignant neoplasm of uvula,1
13727,Nuclear Grooves,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
13728,Poorly Differentiated Lesion,Stage IB Lung Large Cell Carcinoma AJCC v7,1
13729,Epithelial Component Present,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
13730,Malignant Cellular Infiltrate,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
13731,Secondary Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
13732,Carcinomatous Component Present,Stage IIIB Breast Carcinoma,1
13733,Epithelial Component Present,Peripheral Intrahepatic Cholangiocarcinoma,1
13734,Infiltrative Growth Pattern,"Fibromatosis, Plantar",1
13735,Epithelial Component Present,Dysplasia of anus,1
13736,High Mitotic Activity,small cell carcinoma of kidney,1
13737,Malignant Cellular Infiltrate,Alveolar soft part sarcoma recurrent,1
13738,Mixed Cellular Population,Mixed Neoplasm,1
13739,Invasive Lesion,Dermatofibrosarcoma protuberans with myoid differentiation,1
13740,Malignant Cellular Infiltrate,Refractory Human Papillomavirus-Related Malignant Neoplasm,1
13741,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6,1
13742,Cystic Change,Central Nervous System Dermoid Cyst,1
13743,Numerous Stromal Mast Cells Present,Vaginal Angiomyofibroblastoma,1
13744,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage II,1
13745,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
13746,Cavernous Vascular Space Formation,Cavernous hemangioma of retina,1
13747,Carcinomatous Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7,1
13748,Malignant Cellular Infiltrate,Recurrent BRCA-Mutated Ovarian Carcinoma,1
13749,Neuroendocrine Differentiation,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
13750,Glandular Pattern,Gastric Mixed Adenocarcinoma,1
13751,Monomorphic Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
13752,Firm mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
13753,Malignant Cellular Infiltrate,Mucinous adenocarcinoma gastric,1
13754,Nuclear Atypia,Childhood Brain Stem Gliosarcoma,1
13755,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
13756,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,1
13757,VIP Positive Neoplastic Cells Present,Malignant Vipoma,1
13758,Childhood Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
13759,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
13760,Epithelial Component Present,Peripheral Breast Papilloma,1
13761,Deep Lesion,Deep Hemangioma,1
13762,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
13763,Refractory Disease,Refractory Hepatosplenic T-Cell Lymphoma,1
13764,Cutaneous Involvement,Scrotal Carcinoma,1
13765,Non-Hereditary Lesion,Helicobacter Pylori-Related Gastric Adenocarcinoma,1
13766,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage IV,1
13767,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma,1
13768,Edematous Stroma Formation,Testicular Spermatocytic Seminoma with Sarcoma,1
13769,Epithelial Component Present,squamous cell carcinoma of lacrimal gland,1
13770,In Situ Lesion,Biliary Intraepithelial Neoplasia-3,1
13771,Benign Cellular Infiltrate,Venous Angioleiomyoma,1
13772,Malignant Cellular Infiltrate,Stage I Fallopian Tube Cancer AJCC v8,1
13773,Malignant Germinomatous Cellular Infiltrate,Third Ventricle Germinoma,1
13774,Recurrent disease,Centroblastic lymphoma recurrent,1
13775,Breast Microcalcification,Oligodendroglioma of spinal cord,1
13776,Birbeck Granules Present,Refractory Langerhans Cell Histiocytosis,1
13777,Stromal Invasion,Stage II Ovarian Cancer AJCC v8,1
13778,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma,1
13779,Carcinomatous Component Present,carcinoma of middle ear,1
13780,Infiltrating Tumor Margins Present,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
13781,Low Mitotic Activity,Malignant Pancreatic Somatostatinoma,1
13782,Epithelial Component Present,clear cell adenocarcinoma of bladder,1
13783,Epithelial Component Present,Stage IA Vulvar Carcinoma AJCC v6,1
13784,atypia morphology,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
13785,Carcinomatous Component Present,Hypopharyngeal Carcinoma,1
13786,Vascular Channel Formation,Venous Angioleiomyoma,1
13787,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
13788,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma,1
13789,High Mitotic Activity,Stage IB Lung Small Cell Carcinoma AJCC v7,1
13790,Nuclear Atypia,Multifocal Glioblastomas,1
13791,Well-Circumscribed Lesion,Mixed Cell Adrenal Cortical Adenoma,1
13792,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
13793,Poorly Differentiated Lesion,Large cell lung cancer stage I,1
13794,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
13795,Pathologic TNM Finding,Pathologic Stage IA Gastric Cancer AJCC v8,1
13796,Well-Circumscribed Lesion,Recurrent Myxoid Liposarcoma,1
13797,Chromogranin A Positive Neoplastic Cells Present,Midgut Carcinoid Tumor,1
13798,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
13799,Epithelial Component Present,Prognostic Stage IIIC Breast Cancer AJCC v8,1
13800,Clinical TNM Finding,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
13801,Dysplasia,Appendix Tubular Adenoma,1
13802,Childhood Lesion,Childhood Immature Teratoma,1
13803,Well Differentiated Lesion,papillary squamous cell carcinoma of larynx,1
13804,Mixed Cellular Population,Stage IB Uterine Corpus Adenosarcoma AJCC v8,1
13805,Hyalinized Stroma Formation,Solitary fibrous tumor,1
13806,Lobulated Growth Pattern,Ventricular myxoma,1
13807,Epithelial Component Present,Pericanalicular fibroadenoma,1
13808,Benign Cellular Infiltrate,Benign tumor of eyelid,1
13809,Recurrent disease,Recurrent Hepatocellular Carcinoma,1
13810,Malignant Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage,1
13811,Carcinomatous Component Present,Breast Carcinoma with Melanotic Features,1
13812,Splenomegaly,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
13813,Exophytic Polypoid Lesion,Precancerous Polyp,1
13814,Absence of Invasion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
13815,Childhood Lesion,Childhood Testicular Teratoma,1
13816,Malignant Cellular Infiltrate,Grade 2 Colorectal Adenocarcinoma,1
13817,Malignant Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
13818,Polymorphic Cellular Infiltrate,Childhood Langerhans Cell Histiocytosis,1
13819,Malignant Cellular Infiltrate,leiomyosarcoma of lung,1
13820,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia,1
13821,Tissue Differentiation Uncertain,Right atrial myxoma,1
13822,Epithelial Component Present,Eccrine dermal cylindroma,1
13823,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v8,1
13824,In Situ Lesion,Bladder adenocarcinoma stage 0,1
13825,Cutaneous Involvement,Skin tumor of smooth muscle origin,1
13826,Cutaneous Involvement,Eccrine dermal cylindroma,1
13827,Malignant Cellular Infiltrate,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
13828,Extracutaneous Dissemination of Disease,Disseminated Juvenile Xanthogranuloma,1
13829,Epithelial Component Present,Papillary Epithelial Neoplasm,1
13830,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
13831,Carcinomatous Component Present,Thymic Basaloid Carcinoma,1
13832,Epithelial Component Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,1
13833,Extraosseous Lesion,Central Nervous System Extraskeletal Osteosarcoma,1
13834,Malignant Cellular Infiltrate,Recurrent Adult Hepatocellular Carcinoma,1
13835,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma,1
13836,Well-Circumscribed Lesion,Brain Stem Hemangioblastoma,1
13837,Carcinomatous Component Present,Breast Cancer by AJCC v8 Stage,1
13838,Diffuse Pattern,Childhood Gemistocytic Astrocytoma,1
13839,Well-Circumscribed Lesion,Villous adenoma of colon,1
13840,Malignant Cellular Infiltrate,Malignant neoplasm of penis,1
13841,Mild cytologic atypia,verrucous carcinoma of bladder,1
13842,Carcinomatous Component Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,1
13843,Poorly Differentiated Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
13844,Mitotic Activity,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
13845,Carcinomatous Component Present,Stage 0 Anal Cancer AJCC v8,1
13846,Neuroendocrine Differentiation,Metastatic Digestive System Neuroendocrine Carcinoma,1
13847,Increased Cellularity Present,Frontal Lobe Anaplastic Astrocytoma,1
13848,Childhood Lesion,Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,1
13849,Blasts Under 5 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-1,1
13850,Benign Cellular Infiltrate,Endometrial stromal nodule,1
13851,Tissues Derived from Two or Three Embryonic Layers Present,Childhood Ovarian Mature Teratoma,1
13852,Malignant Cellular Infiltrate,Colon Burkitt Lymphoma,1
13853,Poorly Differentiated Lesion,Sarcomatoid Renal Cell Carcinoma,1
13854,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
13855,Lipomatous Component Present,Epithelioid Type Angiomyolipoma,1
13856,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
13857,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
13858,Neuroendocrine Differentiation,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
13859,Fibrotic Stroma Formation,Low-grade fibromyxoid sarcoma,1
13860,Neuroectodermal Differentiation,"Ganglioneuroblastoma, Nodular",1
13861,In Situ Lesion,Carcinoma in situ of small intestine,1
13862,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
13863,Epithelial Component Present,Small Intestinal High Grade Intraepithelial Neoplasia,1
13864,Carcinomatous Component Present,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
13865,Epithelial Component Present,Maxillary Sinus Adenocarcinoma,1
13866,Refractory Disease,Refractory Histiocytic and Dendritic Cell Neoplasm,1
13867,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage II,1
13868,Benign Cellular Infiltrate,Superficial angiomyxoma,1
13869,Mesenchymal Component Present,Juvenile fibroadenoma of breast,1
13870,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
13871,Epithelial Component Present,Stage III Carcinoma of Stomach,1
13872,Biphasic Pattern,Cystadenofibroma,1
13873,Epithelial Component Present,Papilloma of buccal mucosa,1
13874,Malignant Cellular Infiltrate,Squamous Cell Carcinoma In Situ of the Nipple,1
13875,Malignant Cellular Infiltrate,adenocarcinoma of renal pelvis,1
13876,Epithelial Component Present,Sporadic Thyroid Gland Medullary Carcinoma,1
13877,Secondary Lesion,Squamous cell carcinoma of head and neck metastatic,1
13878,Fibrotic Stroma Formation,Mucin-Producing Intrahepatic Cholangiocarcinoma,1
13879,Perivascular Arrangement of Tumor Cells,Myofibromatosis,1
13880,Epithelial Component Present,Carcinoma of subglottis,1
13881,Malignant Cellular Infiltrate,Mediastinal Extraskeletal Osteosarcoma,1
13882,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
13883,Malignant Cellular Infiltrate,Pleural mesothelioma malignant recurrent,1
13884,Malignant Cellular Infiltrate,Leukemic Phase of Non-Hodgkin's Lymphoma,1
13885,Malignant Cellular Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8,1
13886,Lipomatous Differentiation,Cerebellar Liponeurocytoma,1
13887,Firm mass,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
13888,Recurrent disease,Small cell lung cancer recurrent,1
13889,Secondary Lesion,"Neoplasms, Unknown Primary",1
13890,Primary Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
13891,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
13892,Cystic Change,Nipple Syringomatous Adenoma,1
13893,Primary Lesion,Recurrent Primary Malignant Neoplasm,1
13894,Benign Cellular Infiltrate,lipoma of bone,1
13895,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
13896,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
13897,Edematous Stroma Formation,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
13898,Increased red cell mass,"Polycythemia Vera, Polycythemic Phase",1
13899,Rapidly Enlarging Mass,Cranial Nodular Fasciitis,1
13900,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
13901,Benign Cellular Infiltrate,Benign Testicular Sertoli Cell Tumor,1
13902,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma,1
13903,Pathologic TNM Finding,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
13904,Malignant Cellular Infiltrate,Major Salivary Gland Adenocarcinoma,1
13905,Carcinomatous Component Present,Stage IA Esophageal Cancer AJCC v7,1
13906,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
13907,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
13908,Epithelial Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
13909,Carcinomatous Component Present,Squamous non-small cell lung cancer,1
13910,Carcinomatous Component Present,Childhood Thyroid Gland Papillary Carcinoma,1
13911,Refractory Disease,Refractory Primary Cutaneous Lymphoma,1
13912,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7,1
13913,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
13914,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
13915,Malignant Cellular Infiltrate,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
13916,Fibrotic Stroma Formation,Peripheral Intrahepatic Cholangiocarcinoma,1
13917,Macule,Acral Lentiginous Malignant Melanoma,1
13918,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
13919,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
13920,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm,1
13921,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v7,1
13922,Hypercellular bone marrow,"Myeloid Leukemia, Chronic",1
13923,Metastatic Lesion,Locally Advanced Bone Sarcoma,1
13924,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
13925,Carcinomatous Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v8,1
13926,Collagenous Stroma Formation,Odontogenic myxofibroma,1
13927,Epithelial Component Present,adenosquamous carcinoma of breast,1
13928,Metastatic/Recurrent Disease,Alveolar soft part sarcoma non-metastatic,1
13929,Epithelial Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
13930,Carcinomatous Component Present,Unilateral Breast Carcinoma,1
13931,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8,1
13932,Carcinomatous Component Present,Breast Carcinoma with Osseous Metaplasia,1
13933,Osteoid formation,Adult Extraskeletal Osteosarcoma,1
13934,Indolent Clinical Course,Venous Angioleiomyoma,1
13935,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
13936,Epithelial Component Present,Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
13937,Malignant Cellular Infiltrate,Rectal Cribriform Comedo-Type Adenocarcinoma,1
13938,Ineffective hematopoiesis,Refractory Thrombocytopenia,1
13939,Epithelial Component Present,Platinum-Resistant Primary Peritoneal Carcinoma,1
13940,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
13941,Childhood Lesion,Childhood Meningeal Melanoma,1
13942,Malignant Cellular Infiltrate,Pancoast Tumor,1
13943,Absence of Invasion,Bladder adenocarcinoma stage 0,1
13944,Alternative Fascicle (Bundle) Pattern,Bone Leiomyoma,1
13945,High Mitotic Activity,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
13946,Malignant Cellular Infiltrate,Posterior Pharyngeal Wall Carcinoma,1
13947,Epithelial Component Present,Stage III Vaginal Cancer AJCC v6 and v7,1
13948,Benign Cellular Infiltrate,External Auditory Canal Ceruminous Adenoma,1
13949,Carcinomatous Component Present,Gastric carcinoma stage IV,1
13950,Carcinomatous Component Present,Anal Extramucosal (Perianal) Adenocarcinoma,1
13951,Perivascular fibrosis,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
13952,Malignant Cellular Infiltrate,Breast Carcinoma,1
13953,Recurrent disease,Malignant neoplasm of bladder recurrent,1
13954,Carcinomatous Component Present,Moderately Differentiated Hepatocellular Carcinoma,1
13955,atypia morphology,Dedifferentiated Solitary Fibrous Tumor,1
13956,Angiodestructive Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
13957,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
13958,Epithelial Component Present,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
13959,Hereditary Lesion,Familial Atypical Mole Melanoma Syndrome,1
13960,Malignant Cellular Infiltrate,Anal Rhabdomyosarcoma,1
13961,Epithelial Component Present,Stage IB Esophageal Squamous Cell Carcinoma AJCC v7,1
13962,Epithelial Component Present,Primary myoepithelial carcinoma of lung,1
13963,Malignant Cellular Infiltrate,Anaplastic Brain Stem Astrocytoma,1
13964,Cutaneous Involvement,Morpheic basal cell carcinoma,1
13965,Epithelial Component Present,Recurrent Pancreatic Acinar Cell Carcinoma,1
13966,Epithelial Component Present,Benign neoplasm of sweat gland,1
13967,Lipomatous Component Present,Angiomyolipoma of kidney,1
13968,Adulthood Lesion,Adult Burkitt Leukemia,1
13969,Resectable Mass,Carcinoma duodenum resectable,1
13970,Malignant Cellular Infiltrate,Thyroid Lymphoma,1
13971,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
13972,Carcinomatous Component Present,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
13973,Dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
13974,Refractory Disease,Refractory Nasopharyngeal Carcinoma,1
13975,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
13976,Epithelial Component Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,1
13977,Carcinomatous Component Present,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
13978,"Amorphus, Eosinophilic, and Acellular Deposit",Amyloidosis,1
13979,Malignant Cellular Infiltrate,Carcinoma in situ of ampulla of Vater,1
13980,Malignant Cellular Infiltrate,Transitional cell carcinoma of ureter,1
13981,Epithelial Component Present,Hilus cell tumor of ovary,1
13982,Carcinomatous Component Present,Distal Esophagus Adenocarcinoma,1
13983,Malignant Cellular Infiltrate,Adult Glioblastoma,1
13984,Absence of Invasion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
13985,Well-Circumscribed Lesion,Benign Prostate Phyllodes Tumor,1
13986,Malignant Cellular Infiltrate,Refractory cancer,1
13987,Invasive Lesion,Invasive Ductal and Lobular Carcinoma,1
13988,Metastatic Lesion,Advanced Unfavorable Hodgkin Lymphoma,1
13989,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
13990,Biphasic Pattern,Mucinous adenofibroma,1
13991,Benign Cellular Infiltrate,Leiomyomatosis,1
13992,Malignant Cellular Infiltrate,Refractory Uterine Corpus Carcinosarcoma,1
13993,Papillary Pattern,Recurrent Thyroid Gland Papillary Carcinoma,1
13994,Epithelial Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
13995,Recurrent disease,Recurrent Adult Brain Neoplasm,1
13996,Epithelial Component Present,Stage IV Oropharyngeal Carcinoma,1
13997,Benign Cellular Infiltrate,Hemangioma of skin,1
13998,Cutaneous Involvement,Malignant neoplasm of sweat gland,1
13999,High Grade Lesion,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
14000,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
14001,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
14002,Malignant Cellular Infiltrate,Adenocarcinoma of salivary gland,1
14003,Borderline Lesion,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
14004,Endophytic Tumor Growth,Anal Verrucous Carcinoma,1
14005,Monomorphic Cellular Infiltrate,Skin Basaloid Carcinoma,1
14006,Malignant Cellular Infiltrate,Localized Bone Ewing Sarcoma,1
14007,Borderline Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
14008,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
14009,Epithelial Component Present,Stage IIIA Distal Bile Duct Cancer AJCC v8,1
14010,Carcinomatous Component Present,Intraductal carcinoma and lobular carcinoma in situ,1
14011,Papillary Pattern,"Papillary transitional cell carcinoma, non-invasive",1
14012,Recurrent disease,Recurrent Adult Hodgkin Lymphoma,1
14013,Benign Cellular Infiltrate,Skin Cavernous Hemangioma,1
14014,Malignant Cellular Infiltrate,Orbital Melanoma,1
14015,Perineural spread,Adenoid cystic carcinoma of trachea,1
